ID   B2RB13_HUMAN            Unreviewed;       697 AA.
AC   B2RB13;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   16-JAN-2019, entry version 47.
DE   SubName: Full=cDNA, FLJ95253, highly similar to Homo sapiens acyl-CoA synthetase long-chain family member 6(ACSL6), mRNA {ECO:0000313|EMBL:BAG37060.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG37060.1};
RN   [1] {ECO:0000313|EMBL:BAG37060.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:BAG37060.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK314452; BAG37060.1; -; mRNA.
DR   RefSeq; NP_001192177.1; NM_001205248.1.
DR   RefSeq; NP_001192180.1; NM_001205251.1.
DR   UniGene; Hs.14945; -.
DR   ProteinModelPortal; B2RB13; -.
DR   PeptideAtlas; B2RB13; -.
DR   PRIDE; B2RB13; -.
DR   DNASU; 23305; -.
DR   GeneID; 23305; -.
DR   KEGG; hsa:23305; -.
DR   CTD; 23305; -.
DR   eggNOG; KOG1256; Eukaryota.
DR   eggNOG; COG1022; LUCA.
DR   HOGENOM; HOG000159459; -.
DR   HOVERGEN; HBG050452; -.
DR   KO; K01897; -.
DR   OrthoDB; 630541at2759; -.
DR   GenomeRNAi; 23305; -.
DR   Genevisible; B2RB13; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0003824; F:catalytic activity; IEA:InterPro.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   Pfam; PF00501; AMP-binding; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     21     44       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      115    562       AMP-binding. {ECO:0000259|Pfam:PF00501}.
SQ   SEQUENCE   697 AA;  77681 MW;  F70492502C212FA7 CRC64;
     MQTQEILRIL RLPELGDLGQ FFRSLSATTL VSMGALAAIL AYWFTHRPKA LQPPCNLLMQ
     SEEVEDSGGA RRSVIGSGPQ LLTHYYDDAR TMYQVFRRGL SISGNGPCLG FRKPKQPYQW
     LSYQEVADRA EFLGSGLLQH NCKACTDQFI GVFAQNRPEW IIVELACYTY SMVVVPLYDT
     LGPGAIRYII NTADISTVIV DKPQKAVLLL EHVERKETPG LKLIILMDPF EEALKERGQK
     CGVVIKSMQA VEDCGQENHQ APVPPQPDDL SIVCFTSGTT GNPKGAMLTH GNVVADFSGF
     LKVTESQWAP TCADVHISYL PLAHMFERMV QSVVYCHGGR VGFFQGDIRL LSDDMKALCP
     TIFPVVPRLL NRMYDKIFSQ ANTPLKRWLL EFAAKRKQAE VRSGIIRNDS IWDELFFNKI
     QASLGGCVRM IVTGAAPASP TVLGFLRAAL GCQVYEGYGQ TECTAGCTFT TPGDWTSGHV
     GAPLPCNHIK LVDVEELNYW ACKGEGEICV RGPNVFKGYL KDPDRTKEAL DSDGWLHTGD
     IGKWLPAGTL KIIDRKKHIF KLAQGEYVAP EKIENIYIRS QPVAQIYVHG DSLKAFLVGI
     VVPDPEVMPS WAQKRGIEGT YADLCTNKDL KKAILEDMVR LGKESGLHSF EQVKAIHIHS
     DMFSVQNGLL TPTLKAKRPE LREYFKKQIE ELYSIPM
//
ID   B4DFW3_HUMAN            Unreviewed;       687 AA.
AC   B4DFW3;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   16-JAN-2019, entry version 43.
DE   SubName: Full=cDNA FLJ55964, highly similar to Long-chain-fatty-acid--CoA ligase 6 {ECO:0000313|EMBL:BAG57574.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG57574.1};
RN   [1] {ECO:0000313|EMBL:BAG57574.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Amygdala {ECO:0000313|EMBL:BAG57574.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK294291; BAG57574.1; -; mRNA.
DR   RefSeq; NP_001192176.1; NM_001205247.1.
DR   RefSeq; NP_056071.2; NM_015256.3.
DR   UniGene; Hs.14945; -.
DR   ProteinModelPortal; B4DFW3; -.
DR   PeptideAtlas; B4DFW3; -.
DR   PRIDE; B4DFW3; -.
DR   DNASU; 23305; -.
DR   GeneID; 23305; -.
DR   CTD; 23305; -.
DR   eggNOG; KOG1256; Eukaryota.
DR   eggNOG; COG1022; LUCA.
DR   HOGENOM; HOG000159459; -.
DR   HOVERGEN; HBG050452; -.
DR   OrthoDB; 630541at2759; -.
DR   GenomeRNAi; 23305; -.
DR   Genevisible; B4DFW3; HS.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   Pfam; PF00501; AMP-binding; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   2: Evidence at transcript level;
KW   Ligase {ECO:0000313|EMBL:BAG57574.1}.
FT   DOMAIN      105    552       AMP-binding. {ECO:0000259|Pfam:PF00501}.
SQ   SEQUENCE   687 AA;  76660 MW;  A0C1630F6C0C593D CRC64;
     MLTFFLVSGG SLWLFVEFVL SLLEKMQTQE ILRILRLPEL GDLGQFFRSL SATTLDSGGA
     RRSVIGSGPQ LLTHYYDDAR TMYQVFRRGL SISGNGPCLG FRKPKQPYQW LSYQEVADRA
     EFLGSGLLQH NCKACTDQFI GVFAQNRPEW IIVELACYTY SMVVVPLYDT LGPGAIRYII
     NTADISTVIV DKPQKAVLLL EHVERKETPG LKLIILMDPF EEALKERGQK CGVVIKSMQA
     VEDCGQENHQ APVPPQPDDL SIVCFTSGTT GNPKGAMLTH GNVVADFSGF LKVTESQWAP
     TCADVHISYL PLAHMFERMV QSVVYCHGGR VGFFQGDIRL LSDDMKALCP TIFPVVPRLL
     NRMYDKIFSR ANTPLKRWLL EFAAKRKQAE VRSGIIRNDS IWDELFFNKI QASLGGCVRM
     IVTGAAPASP TVLGFLRAAL GCQVYEGYGQ TECTAGCTFT TPGDWTSGHV GAPLPCNHIK
     LVDVEELNYW ACKGEGEICV RGPNVFKGYL KDPDRTKEAL DSDGWLHTGD IGKWLPAGTL
     KIIDRKKHIF KLAQGEYVAP EKIENIYIRS QPVAQIYVHG DSLKAFLVGI VVPDPEVMPS
     WAQKRGIEGT YADLCTNKDL KKAILEDMVR LGKESGLHSF EQVKAIHIHS DMFSVQNGLL
     TPTLKAKRPE LREYFKKQIE ELYSISM
//
ID   ACSL6_HUMAN             Reviewed;         697 AA.
AC   Q9UKU0; J3KPG3; O94924; O95829; Q108M9; Q108N0; Q4G191; Q86TN7;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 4.
DT   13-FEB-2019, entry version 169.
DE   RecName: Full=Long-chain-fatty-acid--CoA ligase 6;
DE            EC=6.2.1.3;
DE   AltName: Full=Long-chain acyl-CoA synthetase 6;
DE            Short=LACS 6;
GN   Name=ACSL6; Synonyms=ACS2, FACL6, KIAA0837, LACS5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND TISSUE SPECIFICITY.
RX   PubMed=10548543; DOI=10.1042/bj3440135;
RA   Malhotra K.T., Malhotra K., Lubin B.H., Kuypers F.A.;
RT   "Identification and molecular characterization of acyl-CoA synthetase
RT   in human red cells and erythroid precursor.";
RL   Biochem. J. 344:135-143(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND CHROMOSOMAL TRANSLOCATION
RP   WITH ETV6.
RC   TISSUE=Bone marrow;
RX   PubMed=10502316;
RX   DOI=10.1002/(SICI)1098-2264(199911)26:3<192::AID-GCC2>3.0.CO;2-E;
RA   Yagasaki F., Jinnai I., Yoshida S., Yokoyama Y., Matsuda A.,
RA   Kusumoto S., Kobayashi H., Terasaki H., Ohyashiki K., Asou N.,
RA   Murohashi I., Bessho M., Hirashima K.;
RT   "Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and
RT   acute myelogenous leukemia with t(5;12)(q31;p13).";
RL   Genes Chromosomes Cancer 26:192-202(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   253-374 (ISOFORM 5), AND ALTERNATIVE SPLICING (ISOFORM 8).
RX   PubMed=16834775; DOI=10.1186/1471-2199-7-21;
RA   Soupene E., Kuypers F.A.;
RT   "Multiple erythroid isoforms of human long-chain acyl-CoA synthetases
RT   are produced by switch of the fatty acid gate domains.";
RL   BMC Mol. Biol. 7:21-21(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Brain;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE
RP   SPLICING (ISOFORM 8).
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 7 AND 9).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Activation of long-chain fatty acids for both synthesis
CC       of cellular lipids, and degradation via beta-oxidation. Plays an
CC       important role in fatty acid metabolism in brain and the acyl-CoAs
CC       produced may be utilized exclusively for the synthesis of the
CC       brain lipid.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a long-chain fatty acid + ATP + CoA = a long-chain fatty
CC         acyl-CoA + AMP + diphosphate; Xref=Rhea:RHEA:15421,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57560, ChEBI:CHEBI:83139, ChEBI:CHEBI:456215;
CC         EC=6.2.1.3;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250};
CC       Single-pass type III membrane protein {ECO:0000250}. Peroxisome
CC       membrane {ECO:0000250}; Single-pass type III membrane protein
CC       {ECO:0000250}. Microsome membrane {ECO:0000250}; Single-pass type
CC       III membrane protein {ECO:0000250}. Endoplasmic reticulum membrane
CC       {ECO:0000250}; Single-pass type III membrane protein
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=9;
CC       Name=4;
CC         IsoId=Q9UKU0-4; Sequence=Displayed;
CC       Name=1; Synonyms=Long, v2;
CC         IsoId=Q9UKU0-1; Sequence=VSP_037819;
CC       Name=2; Synonyms=Short;
CC         IsoId=Q9UKU0-2; Sequence=VSP_021024, VSP_000241;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9UKU0-3; Sequence=VSP_021024;
CC         Note=No experimental confirmation available.;
CC       Name=5; Synonyms=v4;
CC         IsoId=Q9UKU0-5; Sequence=VSP_037823;
CC       Name=6; Synonyms=v5;
CC         IsoId=Q9UKU0-6; Sequence=VSP_037821;
CC       Name=7; Synonyms=v3;
CC         IsoId=Q9UKU0-7; Sequence=VSP_037820, VSP_037822;
CC       Name=8; Synonyms=v1;
CC         IsoId=Q9UKU0-8; Sequence=VSP_037819, VSP_021024;
CC         Note=No experimental confirmation available.;
CC       Name=9;
CC         IsoId=Q9UKU0-9; Sequence=VSP_046954;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in erythrocyte
CC       precursors, in particular in reticulocytes, fetal blood cells
CC       derived from fetal liver, hemopoietic stem cells from cord blood,
CC       bone marrow and brain. {ECO:0000269|PubMed:10548543}.
CC   -!- DEVELOPMENTAL STAGE: Expression is low at earlier stages of
CC       erythroid development but is very high in reticulocytes.
CC   -!- DISEASE: Note=A chromosomal aberration involving ACSL6 may be a
CC       cause of myelodysplastic syndrome with basophilia. Translocation
CC       t(5;12)(q31;p13) with ETV6. {ECO:0000269|PubMed:10502316}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ACSL6 may be a
CC       cause of acute myelogenous leukemia with eosinophilia.
CC       Translocation t(5;12)(q31;p13) with ETV6.
CC       {ECO:0000269|PubMed:10502316}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ACSL6 may be a
CC       cause of acute eosinophilic leukemia (AEL). Translocation
CC       t(5;12)(q31;p13) with ETV6. {ECO:0000269|PubMed:10502316}.
CC   -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH26161.1; Type=Erroneous termination; Positions=72; Note=Translated as Arg.; Evidence={ECO:0000305};
CC       Sequence=BAA74860.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF129166; AAD47199.1; -; mRNA.
DR   EMBL; AF099740; AAD17853.1; -; mRNA.
DR   EMBL; DQ083030; AAZ30713.1; -; mRNA.
DR   EMBL; DQ083031; AAZ30714.1; -; mRNA.
DR   EMBL; AB020644; BAA74860.1; ALT_INIT; mRNA.
DR   EMBL; CR606980; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC025772; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026398; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC034228; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC026161; AAH26161.1; ALT_SEQ; mRNA.
DR   EMBL; BC047453; AAH47453.1; -; mRNA.
DR   CCDS; CCDS34228.1; -. [Q9UKU0-8]
DR   CCDS; CCDS34229.1; -. [Q9UKU0-1]
DR   CCDS; CCDS56381.1; -. [Q9UKU0-3]
DR   CCDS; CCDS56382.1; -. [Q9UKU0-7]
DR   CCDS; CCDS56383.1; -. [Q9UKU0-9]
DR   RefSeq; NP_001009185.1; NM_001009185.2. [Q9UKU0-1]
DR   RefSeq; NP_001192176.1; NM_001205247.1.
DR   RefSeq; NP_001192177.1; NM_001205248.1. [Q9UKU0-3]
DR   RefSeq; NP_001192179.1; NM_001205250.1. [Q9UKU0-9]
DR   RefSeq; NP_001192180.1; NM_001205251.1. [Q9UKU0-7]
DR   RefSeq; NP_056071.2; NM_015256.3. [Q9UKU0-8]
DR   UniGene; Hs.14945; -.
DR   ProteinModelPortal; Q9UKU0; -.
DR   SMR; Q9UKU0; -.
DR   BioGrid; 116897; 1.
DR   IntAct; Q9UKU0; 4.
DR   STRING; 9606.ENSP00000296869; -.
DR   SwissLipids; SLP:000000203; -.
DR   iPTMnet; Q9UKU0; -.
DR   PhosphoSitePlus; Q9UKU0; -.
DR   BioMuta; ACSL6; -.
DR   DMDM; 146322303; -.
DR   jPOST; Q9UKU0; -.
DR   MaxQB; Q9UKU0; -.
DR   PaxDb; Q9UKU0; -.
DR   PeptideAtlas; Q9UKU0; -.
DR   PRIDE; Q9UKU0; -.
DR   ProteomicsDB; 84870; -.
DR   ProteomicsDB; 84871; -. [Q9UKU0-1]
DR   ProteomicsDB; 84872; -. [Q9UKU0-2]
DR   ProteomicsDB; 84873; -. [Q9UKU0-3]
DR   ProteomicsDB; 84874; -. [Q9UKU0-5]
DR   ProteomicsDB; 84875; -. [Q9UKU0-6]
DR   ProteomicsDB; 84876; -. [Q9UKU0-7]
DR   ProteomicsDB; 84877; -. [Q9UKU0-8]
DR   DNASU; 23305; -.
DR   Ensembl; ENST00000296869; ENSP00000296869; ENSG00000164398. [Q9UKU0-8]
DR   Ensembl; ENST00000357096; ENSP00000349608; ENSG00000164398. [Q9UKU0-7]
DR   Ensembl; ENST00000379240; ENSP00000368542; ENSG00000164398. [Q9UKU0-4]
DR   Ensembl; ENST00000379244; ENSP00000368546; ENSG00000164398. [Q9UKU0-3]
DR   Ensembl; ENST00000379246; ENSP00000368548; ENSG00000164398. [Q9UKU0-9]
DR   Ensembl; ENST00000379255; ENSP00000368557; ENSG00000164398. [Q9UKU0-7]
DR   Ensembl; ENST00000379264; ENSP00000368566; ENSG00000164398. [Q9UKU0-1]
DR   Ensembl; ENST00000543479; ENSP00000442124; ENSG00000164398. [Q9UKU0-6]
DR   GeneID; 23305; -.
DR   KEGG; hsa:23305; -.
DR   UCSC; uc003kvv.3; human. [Q9UKU0-4]
DR   CTD; 23305; -.
DR   DisGeNET; 23305; -.
DR   EuPathDB; HostDB:ENSG00000164398.12; -.
DR   EuPathDB; HostDB:ENSG00000281938.1; -.
DR   GeneCards; ACSL6; -.
DR   HGNC; HGNC:16496; ACSL6.
DR   HPA; HPA040470; -.
DR   MIM; 604443; gene.
DR   neXtProt; NX_Q9UKU0; -.
DR   OpenTargets; ENSG00000164398; -.
DR   PharmGKB; PA27970; -.
DR   eggNOG; KOG1256; Eukaryota.
DR   eggNOG; COG1022; LUCA.
DR   GeneTree; ENSGT00940000154508; -.
DR   GeneTree; ENSGT00940000162308; -.
DR   HOGENOM; HOG000159459; -.
DR   HOVERGEN; HBG050452; -.
DR   InParanoid; Q9UKU0; -.
DR   KO; K01897; -.
DR   OMA; KNDIATQ; -.
DR   OrthoDB; 630541at2759; -.
DR   PhylomeDB; Q9UKU0; -.
DR   TreeFam; TF313877; -.
DR   BioCyc; MetaCyc:HS15193-MONOMER; -.
DR   BRENDA; 6.2.1.3; 2681.
DR   Reactome; R-HSA-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   ChiTaRS; ACSL6; human.
DR   GeneWiki; ACSL6; -.
DR   GenomeRNAi; 23305; -.
DR   PRO; PR:Q9UKU0; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000164398; Expressed in 150 organ(s), highest expression level in corpus callosum.
DR   ExpressionAtlas; Q9UKU0; baseline and differential.
DR   Genevisible; Q9UKU0; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005778; C:peroxisomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; NAS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0102391; F:decanoate-CoA ligase activity; IEA:UniProtKB-EC.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0004467; F:long-chain fatty acid-CoA ligase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0006637; P:acyl-CoA metabolic process; NAS:UniProtKB.
DR   GO; GO:0001676; P:long-chain fatty acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   GO; GO:0007405; P:neuroblast proliferation; IEA:Ensembl.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   Pfam; PF00501; AMP-binding; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; ATP-binding; Chromosomal rearrangement;
KW   Complete proteome; Endoplasmic reticulum; Fatty acid metabolism;
KW   Ligase; Lipid metabolism; Magnesium; Membrane; Microsome;
KW   Mitochondrion; Mitochondrion outer membrane; Nucleotide-binding;
KW   Peroxisome; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    697       Long-chain-fatty-acid--CoA ligase 6.
FT                                /FTId=PRO_0000193115.
FT   TRANSMEM     25     45       Helical; Signal-anchor for type III
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     46    697       Cytoplasmic. {ECO:0000255}.
FT   VAR_SEQ       1      1       M -> MLTFFLVSGGSLWLFVEFVLSLLEKM (in
FT                                isoform 1 and isoform 8).
FT                                {ECO:0000303|PubMed:10048485}.
FT                                /FTId=VSP_037819.
FT   VAR_SEQ       1      1       M -> MPEFVLSLLEKM (in isoform 9).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046954.
FT   VAR_SEQ      31     65       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037820.
FT   VAR_SEQ     192    192       T -> TGLSCQEGASATASTQ (in isoform 6).
FT                                {ECO:0000303|PubMed:16834775}.
FT                                /FTId=VSP_037821.
FT   VAR_SEQ     306    345       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037822.
FT   VAR_SEQ     306    330       KVIFPRQDDVLISFLPLAHMFERVI -> SQWAPTCADVHI
FT                                SYLPLAHMFERMV (in isoform 3, isoform 2
FT                                and isoform 8).
FT                                {ECO:0000303|PubMed:10502316,
FT                                ECO:0000303|PubMed:10548543}.
FT                                /FTId=VSP_021024.
FT   VAR_SEQ     306    312       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:16834775}.
FT                                /FTId=VSP_037823.
FT   VAR_SEQ     653    697       VKAIHIHSDMFSVQNGLLTPTLKAKRPELREYFKKQIEELY
FT                                SISM -> DLPQCLIQIKVFSKY (in isoform 2).
FT                                {ECO:0000303|PubMed:10502316}.
FT                                /FTId=VSP_000241.
FT   CONFLICT     19     19       G -> E (in Ref. 1; AAD47199).
FT                                {ECO:0000305}.
FT   CONFLICT     46     46       H -> Q (in Ref. 1; AAD47199).
FT                                {ECO:0000305}.
FT   CONFLICT    257    257       E -> A (in Ref. 7; AAH47453).
FT                                {ECO:0000305}.
FT   CONFLICT    260    260       Q -> L (in Ref. 7; AAH26161).
FT                                {ECO:0000305}.
FT   CONFLICT    356    356       K -> R (in Ref. 3; AAZ30714).
FT                                {ECO:0000305}.
FT   CONFLICT    696    696       S -> P (in Ref. 1; AAD47199 and 3;
FT                                AAZ30714). {ECO:0000305}.
SQ   SEQUENCE   697 AA;  77752 MW;  AC566177B47D0975 CRC64;
     MQTQEILRIL RLPELGDLGQ FFRSLSATTL VSMGALAAIL AYWFTHRPKA LQPPCNLLMQ
     SEEVEDSGGA RRSVIGSGPQ LLTHYYDDAR TMYQVFRRGL SISGNGPCLG FRKPKQPYQW
     LSYQEVADRA EFLGSGLLQH NCKACTDQFI GVFAQNRPEW IIVELACYTY SMVVVPLYDT
     LGPGAIRYII NTADISTVIV DKPQKAVLLL EHVERKETPG LKLIILMDPF EEALKERGQK
     CGVVIKSMQA VEDCGQENHQ APVPPQPDDL SIVCFTSGTT GNPKGAMLTH GNVVADFSGF
     LKVTEKVIFP RQDDVLISFL PLAHMFERVI QSVVYCHGGR VGFFQGDIRL LSDDMKALCP
     TIFPVVPRLL NRMYDKIFSQ ANTPLKRWLL EFAAKRKQAE VRSGIIRNDS IWDELFFNKI
     QASLGGCVRM IVTGAAPASP TVLGFLRAAL GCQVYEGYGQ TECTAGCTFT TPGDWTSGHV
     GAPLPCNHIK LVDVEELNYW ACKGEGEICV RGPNVFKGYL KDPDRTKEAL DSDGWLHTGD
     IGKWLPAGTL KIIDRKKHIF KLAQGEYVAP EKIENIYIRS QPVAQIYVHG DSLKAFLVGI
     VVPDPEVMPS WAQKRGIEGT YADLCTNKDL KKAILEDMVR LGKESGLHSF EQVKAIHIHS
     DMFSVQNGLL TPTLKAKRPE LREYFKKQIE ELYSISM
//
ID   Q5GIA7_HUMAN            Unreviewed;      1016 AA.
AC   Q5GIA7;
DT   01-MAR-2005, integrated into UniProtKB/TrEMBL.
DT   01-MAR-2005, sequence version 1.
DT   16-JAN-2019, entry version 58.
DE   SubName: Full=Antigen MU-RMS-40.16A {ECO:0000313|EMBL:AAT44400.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAT44400.1};
RN   [1] {ECO:0000313|EMBL:AAT44400.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Embryonal rhabdomyosarcoma {ECO:0000313|EMBL:AAT44400.1};
RA   Behrends U., Gotz C., Mautner J.;
RT   "SEREX-defined rhabdomyosarcoma antigens.";
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AY528715; AAT44400.1; -; mRNA.
DR   RefSeq; NP_005742.4; NM_005751.4.
DR   RefSeq; NP_671714.1; NM_147185.2.
DR   UniGene; Hs.651221; -.
DR   ProteinModelPortal; Q5GIA7; -.
DR   PeptideAtlas; Q5GIA7; -.
DR   PRIDE; Q5GIA7; -.
DR   GeneID; 10142; -.
DR   KEGG; hsa:10142; -.
DR   CTD; 10142; -.
DR   PharmGKB; PA24673; -.
DR   eggNOG; ENOG410II47; Eukaryota.
DR   eggNOG; ENOG41101YB; LUCA.
DR   KO; K16551; -.
DR   OrthoDB; 8180at2759; -.
DR   GenomeRNAi; 10142; -.
DR   Genevisible; Q5GIA7; HS.
DR   GO; GO:0032947; F:protein-containing complex scaffold activity; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   InterPro; IPR028745; AKAP9/Pericentrin.
DR   PANTHER; PTHR44981; PTHR44981; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   COILED      243    273       {ECO:0000256|SAM:Coils}.
FT   COILED      288    343       {ECO:0000256|SAM:Coils}.
FT   COILED      373    450       {ECO:0000256|SAM:Coils}.
FT   COILED      475    516       {ECO:0000256|SAM:Coils}.
FT   COILED      541    621       {ECO:0000256|SAM:Coils}.
FT   COILED      644    671       {ECO:0000256|SAM:Coils}.
FT   COILED      674    726       {ECO:0000256|SAM:Coils}.
FT   COILED      738    800       {ECO:0000256|SAM:Coils}.
FT   COILED      979   1016       {ECO:0000256|SAM:Coils}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAT44400.1}.
FT   NON_TER    1016   1016       {ECO:0000313|EMBL:AAT44400.1}.
SQ   SEQUENCE   1016 AA;  118199 MW;  58C4F432AF444604 CRC64;
     DNENLVSERE RVLLEELEAL KQLSLAGREK LCCELRNSST QTQNGNENQG EVEEQTFKEK
     ELDRKPEDVP PEILSNERYA LQKANNRLLK ILLEVVKTTA AVEETIGRHV LGILDRSSKS
     QSSASLIWRS EAEASVKSCV HEEHTRVTDE SIPSYSGSDM PRNDINMWSK VTEEGTELSQ
     RLVRSGFAGT EIDPENEELM LNISSRLQAA VEKLLEAISE TSSQLEHAKV TQTELMRESF
     RQKQEATESL KCQEELRERL HEESRAREQL AVELSKAEGV IDGYADEKTL FERQIQEKTD
     IIDRLEQELL CASNRLQELE AEQQQIQEER ELLSRQKEAM KAEAGPVEQQ LLQETEKLMK
     EKLEVQCQAE KVRDDLQKQV KALEIDVEEQ VSRFIELEQE KNTELMDLRQ QNQALEKQLE
     KMRKFLDEQA IDREHERDVF QQEIQKLEQQ LKVVPRFQPI SEHQTREVEQ LANHLKEKTD
     KCSELLLSKE QLQRDIQERN EEIEKLEFRV RELEQALLVS ADTFQKVEDR KHFGAVEAKP
     ELSLEVQLQA ERDAIDRKEK EITNLEEQLE QFREELENKN EEVQQLHMQL EIQKKESTTR
     LQELEQENKL FKDDMEKLGL AIKESDAMST QDQHVLFGKF AQIIQEKEVE IDQLNEQVTK
     LQQQLKITTD NKVIEEKNEL IRDLETQIEC LMSDQECVKR NREEEIEQLN EVIEKLQQEL
     ANIGQKTSMN AHSLSEEADS LKHQLDVVIA EKLALEQQVE TANEEMTFMK NVLKETNFKM
     NQLTQELFSL KRERESVEKI QSIPENSVNV AIDHLSKDKP ELEVVLTEDA LKSLENQTYF
     RSFEENGKGS IINLETRLLQ LESTVSAKDL ELTQCYKQIK DMQEQGQFET EMLQKKIVNL
     QKIVEEKVAA ALVSQIQLEA VQEYAKFCQD NQTISSEPER TNIQNLNQLR EDELGSDISA
     LTLRISELES QVVEMHTSLI LEKEQVEIAE KNVLEKEKKL LELQKLLEGN EKKQRE
//
ID   Q6PJH3_HUMAN            Unreviewed;       314 AA.
AC   Q6PJH3;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   13-FEB-2019, entry version 112.
DE   SubName: Full=A kinase (PRKA) anchor protein (Yotiao) 9, isoform CRA_c {ECO:0000313|EMBL:EAW76862.1};
DE   SubName: Full=A-kinase anchor protein 9 {ECO:0000313|Ensembl:ENSP00000378065};
DE   SubName: Full=AKAP9 protein {ECO:0000313|EMBL:AAH15533.1};
GN   Name=AKAP9 {ECO:0000313|EMBL:EAW76862.1,
GN   ECO:0000313|Ensembl:ENSP00000378065};
GN   ORFNames=hCG_1812018 {ECO:0000313|EMBL:EAW76862.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH15533.1};
RN   [1] {ECO:0000313|EMBL:EAW76862.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000378065, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3] {ECO:0000313|EMBL:AAH15533.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus {ECO:0000313|EMBL:AAH15533.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000313|EMBL:EAW76862.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [6] {ECO:0000313|Ensembl:ENSP00000378065}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [7] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AC000066; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC000120; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC003086; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004013; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458509; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC015533; AAH15533.1; -; mRNA.
DR   EMBL; CH471091; EAW76862.1; -; Genomic_DNA.
DR   RefSeq; NP_005742.4; NM_005751.4.
DR   RefSeq; NP_671714.1; NM_147185.2.
DR   UniGene; Hs.651221; -.
DR   IntAct; Q6PJH3; 22.
DR   Ensembl; ENST00000394564; ENSP00000378065; ENSG00000127914.
DR   GeneID; 10142; -.
DR   KEGG; hsa:10142; -.
DR   UCSC; uc003uld.5; human.
DR   CTD; 10142; -.
DR   EuPathDB; HostDB:ENSG00000127914.16; -.
DR   HGNC; HGNC:379; AKAP9.
DR   OpenTargets; ENSG00000127914; -.
DR   PharmGKB; PA24673; -.
DR   eggNOG; ENOG410II47; Eukaryota.
DR   eggNOG; ENOG41101YB; LUCA.
DR   GeneTree; ENSGT00730000110871; -.
DR   HOGENOM; HOG000143447; -.
DR   HOVERGEN; HBG062995; -.
DR   KO; K16551; -.
DR   OrthoDB; 8180at2759; -.
DR   ChiTaRS; AKAP9; human.
DR   GenomeRNAi; 10142; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000127914; Expressed in 230 organ(s), highest expression level in jejunal mucosa.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0032947; F:protein-containing complex scaffold activity; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   InterPro; IPR028745; AKAP9/Pericentrin.
DR   PANTHER; PTHR44981; PTHR44981; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Kinase {ECO:0000313|EMBL:EAW76862.1};
KW   Proteomics identification {ECO:0000213|EPD:Q6PJH3,
KW   ECO:0000213|MaxQB:Q6PJH3, ECO:0000213|PeptideAtlas:Q6PJH3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transferase {ECO:0000313|EMBL:EAW76862.1}.
FT   COILED      157    184       {ECO:0000256|SAM:Coils}.
FT   COILED      207    241       {ECO:0000256|SAM:Coils}.
FT   COILED      270    304       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   314 AA;  36171 MW;  70D4D3357B87EAEF CRC64;
     MEDEERQKKL EAGKAKLAQF RQRKAQSDGQ SPSKKQKKKR KTSSSKHDVS AHHDLNIDQS
     QCNEMYINSS QRVESTVIPE STIMRTLHSG EITSHEQGFS VELESEISTT ADDCSSEVNG
     CSFVMRTGKP TNLLREEEFG VDDSYSEQGA QDSPTHLEMM ESELAGKQHE IEELNRELEE
     MRVTYGTEGL QQLQEFEAAI KQRDGIITQL TANLQQARRE KDETMREFLE LTEQSQKLQI
     QFQQLQASET LRNSTHSSTA ADLLQAKQQI LTHQQQLEEQ DHLLEDYQKK KEDFTMQISF
     LQEKIKVYEM VCLF
//
ID   AKAP9_HUMAN             Reviewed;        3907 AA.
AC   Q99996; A4D1F0; A4D1F2; A4D1F4; O14869; O43355; O94895; Q75N20;
AC   Q9UQH3; Q9UQQ4; Q9Y6B8; Q9Y6Y2;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   25-APR-2018, sequence version 4.
DT   13-FEB-2019, entry version 188.
DE   RecName: Full=A-kinase anchor protein 9;
DE            Short=AKAP-9;
DE   AltName: Full=A-kinase anchor protein 350 kDa;
DE            Short=AKAP 350;
DE            Short=hgAKAP 350;
DE   AltName: Full=A-kinase anchor protein 450 kDa;
DE            Short=AKAP 450;
DE   AltName: Full=AKAP 120-like protein;
DE   AltName: Full=Centrosome- and Golgi-localized PKN-associated protein {ECO:0000303|PubMed:10358086};
DE            Short=CG-NAP {ECO:0000303|PubMed:10358086};
DE   AltName: Full=Protein hyperion {ECO:0000303|Ref.4};
DE   AltName: Full=Protein kinase A-anchoring protein 9;
DE            Short=PRKA9;
DE   AltName: Full=Protein yotiao {ECO:0000303|PubMed:9482789};
GN   Name=AKAP9; Synonyms=AKAP350, AKAP450, KIAA0803;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), FUNCTION (ISOFORM 4), AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9482789;
RA   Lin J.W., Wyszynski M., Madhavan R., Sealock R., Kim J.U., Sheng M.;
RT   "Yotiao, a novel protein of neuromuscular junction and brain that
RT   interacts with specific splice variants of NMDA receptor subunit
RT   NR1.";
RL   J. Neurosci. 18:2017-2027(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TISSUE SPECIFICITY,
RP   AND VARIANT GLN-1335 INS.
RX   PubMed=10202149; DOI=10.1093/emboj/18.7.1858;
RA   Witczak O., Skaalhegg B.S., Keryer G., Bornens M., Tasken K.,
RA   Jahnsen T., Oerstavik S.;
RT   "Cloning and characterization of a cDNA encoding an A-kinase anchoring
RT   protein located in the centrosome, AKAP450.";
RL   EMBO J. 18:1858-1868(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND VARIANTS ILE-463 AND
RP   SER-2979.
RC   TISSUE=Brain;
RX   PubMed=10358086; DOI=10.1074/jbc.274.24.17267;
RA   Takahashi M., Shibata H., Shimakawa M., Miyamoto M., Mukai H., Ono Y.;
RT   "Characterization of a novel giant scaffolding protein, CG-NAP, that
RT   anchors multiple signaling enzymes to centrosome and the Golgi
RT   apparatus.";
RL   J. Biol. Chem. 274:17267-17274(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Kemmner W.A., Deiss S., Schwarz U.;
RT   "Cloning of Hyperion.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 311-3907 (ISOFORM 2), NUCLEOTIDE
RP   SEQUENCE [MRNA] OF 2145-3907 (ISOFORM 6), SUBCELLULAR LOCATION, AND
RP   VARIANT SER-2979.
RC   TISSUE=Gastric parietal cell, and Lung;
RX   PubMed=9915845; DOI=10.1074/jbc.274.5.3055;
RA   Schmidt P.H., Dransfield D.T., Claudio J.O., Hawley R.G.,
RA   Trotter K.W., Milgram S.L., Goldenring J.R.;
RT   "AKAP350, a multiply spliced protein kinase A-anchoring protein
RT   associated with centrosomes.";
RL   J. Biol. Chem. 274:3055-3066(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2200-3907 (ISOFORMS 2/3),
RP   AND VARIANT SER-2979.
RC   TISSUE=Brain;
RX   PubMed=9872452; DOI=10.1093/dnares/5.5.277;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XI.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:277-286(1998).
RN   [9]
RP   INTERACTION WITH CLIC1; CLIC4 AND CLIC5.
RX   PubMed=12163479; DOI=10.1074/jbc.M112277200;
RA   Shanks R.A., Larocca M.C., Berryman M., Edwards J.C., Urushidani T.,
RA   Navarre J., Goldenring J.R.;
RT   "AKAP350 at the Golgi apparatus. II. Association of AKAP350 with a
RT   novel chloride intracellular channel (CLIC) family member.";
RL   J. Biol. Chem. 277:40973-40980(2002).
RN   [10]
RP   INTERACTION WITH CSNK1D, AND SUBCELLULAR LOCATION.
RX   PubMed=12270714; DOI=10.1016/S0022-2836(02)00857-4;
RA   Sillibourne J.E., Milne D.M., Takahashi M., Ono Y., Meek D.W.;
RT   "Centrosomal anchoring of the protein kinase CK1delta mediated by
RT   attachment to the large, coiled-coil scaffolding protein CG-
RT   NAP/AKAP450.";
RL   J. Mol. Biol. 322:785-797(2002).
RN   [11]
RP   INTERACTION WITH KCNQ1.
RX   PubMed=11799244; DOI=10.1126/science.1066843;
RA   Marx S.O., Kurokawa J., Reiken S., Motoike H., D'Armiento J.,
RA   Marks A.R., Kass R.S.;
RT   "Requirement of a macromolecular signaling complex for beta adrenergic
RT   receptor modulation of the KCNQ1-KCNE1 potassium channel.";
RL   Science 295:496-499(2002).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A.,
RA   Mann M.;
RT   "Proteomic characterization of the human centrosome by protein
RT   correlation profiling.";
RL   Nature 426:570-574(2003).
RN   [13]
RP   FUNCTION, INTERACTION WITH CIP4 AND FNBP1, AND SUBCELLULAR LOCATION.
RX   PubMed=15047863; DOI=10.1091/mbc.E03-10-0757;
RA   Larocca M.C., Shanks R.A., Tian L., Nelson D.L., Stewart D.M.,
RA   Goldenring J.R.;
RT   "AKAP350 interaction with cdc42 interacting protein 4 at the Golgi
RT   apparatus.";
RL   Mol. Biol. Cell 15:2771-2781(2004).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3865, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [15]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH GOLGA2.
RX   PubMed=19242490; DOI=10.1038/emboj.2009.47;
RA   Rivero S., Cardenas J., Bornens M., Rios R.M.;
RT   "Microtubule nucleation at the cis-side of the Golgi apparatus
RT   requires AKAP450 and GM130.";
RL   EMBO J. 28:1016-1028(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153 AND SER-3842, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1327; SER-1765;
RP   SER-3690; SER-3842 AND SER-3897, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   INTERACTION WITH PDE4DIP, AND SUBCELLULAR LOCATION.
RX   PubMed=25217626; DOI=10.1242/jcs.155408;
RA   Wang Z., Zhang C., Qi R.Z.;
RT   "A newly identified myomegalin isoform functions in Golgi microtubule
RT   organization and ER-Golgi transport.";
RL   J. Cell Sci. 127:4904-4917(2014).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25657325; DOI=10.1091/mbc.E14-09-1366;
RA   Ohta S., Wood L., Toramoto I., Yagyu K., Fukagawa T., Earnshaw W.C.;
RT   "CENP-32 is required to maintain centrosomal dominance in bipolar
RT   spindle assembly.";
RL   Mol. Biol. Cell 26:1225-1237(2015).
RN   [22]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PDE4DIP;
RP   GAMMA-TUBULIN RING COMPLEX AND CAMSAP2.
RX   PubMed=27666745; DOI=10.1016/j.devcel.2016.08.009;
RA   Wu J., de Heus C., Liu Q., Bouchet B.P., Noordstra I., Jiang K.,
RA   Hua S., Martin M., Yang C., Grigoriev I., Katrukha E.A.,
RA   Altelaar A.F., Hoogenraad C.C., Qi R.Z., Klumperman J., Akhmanova A.;
RT   "Molecular pathway of microtubule organization at the Golgi
RT   apparatus.";
RL   Dev. Cell 39:44-60(2016).
RN   [23]
RP   FUNCTION, AND INTERACTION WITH PDE4DIP; MAPRE1 AND MAPRE3.
RX   PubMed=28814570; DOI=10.1083/jcb.201701024;
RA   Yang C., Wu J., de Heus C., Grigoriev I., Liv N., Yao Y., Smal I.,
RA   Meijering E., Klumperman J., Qi R.Z., Akhmanova A.;
RT   "EB1 and EB3 regulate microtubule minus end organization and Golgi
RT   morphology.";
RL   J. Cell Biol. 216:3179-3198(2017).
RN   [24]
RP   INTERACTION WITH CAMSAP3.
RX   PubMed=28089391; DOI=10.1016/j.jgg.2016.11.005;
RA   Wang J., Xu H., Jiang Y., Takahashi M., Takeichi M., Meng W.;
RT   "CAMSAP3-dependent microtubule dynamics regulates Golgi assembly in
RT   epithelial cells.";
RL   J. Genet. Genomics 44:39-49(2017).
RN   [25]
RP   FUNCTION, INTERACTION WITH CDK5RAP2; MAPRE1 AND PDE4DIP, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=29162697; DOI=10.1073/pnas.1705682114;
RA   Bouguenina H., Salaun D., Mangon A., Muller L., Baudelet E.,
RA   Camoin L., Tachibana T., Cianferani S., Audebert S.,
RA   Verdier-Pinard P., Badache A.;
RT   "EB1-binding-myomegalin protein complex promotes centrosomal
RT   microtubules functions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:E10687-E10696(2017).
RN   [26]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-2409 AND GLN-3297.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [27]
RP   VARIANT LQT11 LEU-1570.
RX   PubMed=18093912; DOI=10.1073/pnas.0710527105;
RA   Chen L., Marquardt M.L., Tester D.J., Sampson K.J., Ackerman M.J.,
RA   Kass R.S.;
RT   "Mutation of an A-kinase-anchoring protein causes long-QT syndrome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:20990-20995(2007).
CC   -!- FUNCTION: Scaffolding protein that assembles several protein
CC       kinases and phosphatases on the centrosome and Golgi apparatus.
CC       Required to maintain the integrity of the Golgi apparatus
CC       (PubMed:10202149, PubMed:15047863). Required for microtubule
CC       nucleation at the cis-side of the Golgi apparatus
CC       (PubMed:15047863, PubMed:19242490). Required for association of
CC       the centrosomes with the poles of the bipolar mitotic spindle
CC       during metaphase (PubMed:25657325). In complex with PDE4DIP
CC       isoform 13/MMG8/SMYLE, recruits CAMSAP2 to the Golgi apparatus and
CC       tethers non-centrosomal minus-end microtubules to the Golgi, an
CC       important step for polarized cell movement (PubMed:27666745,
CC       PubMed:28814570). In complex with PDE4DIP isoform 13/MMG8/SMYLE,
CC       EB1/MAPRE1 and CDK5RAP2, contributes to microtubules nucleation
CC       and extension also from the centrosome to the cell periphery
CC       (PubMed:29162697). {ECO:0000269|PubMed:10202149,
CC       ECO:0000269|PubMed:15047863, ECO:0000269|PubMed:19242490,
CC       ECO:0000269|PubMed:25657325, ECO:0000269|PubMed:27666745,
CC       ECO:0000269|PubMed:28814570, ECO:0000269|PubMed:29162697}.
CC   -!- FUNCTION: Isoform 4: Associated with the N-methyl-D-aspartate
CC       receptor and is specifically found in the neuromuscular junction
CC       (NMJ) as well as in neuronal synapses, suggesting a role in the
CC       organization of postsynaptic specializations.
CC       {ECO:0000269|PubMed:9482789}.
CC   -!- SUBUNIT: Interacts with the regulatory region of protein kinase N
CC       (PKN), protein phosphatase 2A (PP2A), protein phosphatase 1 (PP1)
CC       and the immature non-phosphorylated form of PKC epsilon. Interacts
CC       with CIP4 and FNBP1 (PubMed:15047863). Interacts with chloride
CC       intracellular channel proteins CLIC1, CLIC4 and CLIC5
CC       (PubMed:12163479). CSNK1D binding promotes its centrosomal
CC       subcellular location (PubMed:12270714). Interacts with
CC       GM130/GOLGA2; leading to recruitment to the Golgi apparatus
CC       (PubMed:19242490). Interacts with KCNQ1; targets protein kinase A
CC       (PKA) catalytic and regulatory subunits and protein phosphatase 1
CC       (PP1), to the heterodimer KCNQ1-KCNE1 (PubMed:11799244). Interacts
CC       with PDE4DIP isoform 13/MMG8/SMYLE; this interaction stabilizes
CC       both proteins (PubMed:25217626, PubMed:27666745, PubMed:28814570).
CC       In complex with PDE4DIP isoform 13, recruits CAMSAP2 to the Golgi
CC       apparatus (PubMed:27666745, PubMed:28814570). Forms a
CC       pericentrosomal complex with CDK5RAP2, EB1/MAPRE1 and PDE4DIP
CC       isoform 13; within this complex, MAPRE1 binding to CDK5RAP2 may be
CC       mediated by PDE4DIP (PubMed:29162697). Interacts with MAPRE1 and
CC       MAPRE3 (PubMed:28814570). Interacts (via C-terminus) with CAMSAP2;
CC       this interaction is much stronger in the presence of PDE4DIP
CC       isoform 13/MMG8/SMYLE (PubMed:27666745). Interacts with CAMSAP3
CC       (PubMed:28089391). Interacts (via C-terminus) with the gamma-
CC       tubulin ring complex (gamma-TuRC), composed of gamma-tubulin,
CC       TUBGCP2, TUBGCP3, TUBGCP4, TUBGCP5 and TUBGCP6 (PubMed:27666745).
CC       {ECO:0000269|PubMed:11799244, ECO:0000269|PubMed:12163479,
CC       ECO:0000269|PubMed:12270714, ECO:0000269|PubMed:15047863,
CC       ECO:0000269|PubMed:19242490, ECO:0000269|PubMed:25217626,
CC       ECO:0000269|PubMed:27666745, ECO:0000269|PubMed:28089391,
CC       ECO:0000269|PubMed:28814570, ECO:0000269|PubMed:29162697}.
CC   -!- INTERACTION:
CC       P26769:Adcy2 (xeno); NbExp=3; IntAct=EBI-15676518, EBI-1027877;
CC       Q9H2G9:BLZF1; NbExp=3; IntAct=EBI-9641546, EBI-2548012;
CC       Q6P1W5:C1orf94; NbExp=3; IntAct=EBI-9641546, EBI-946029;
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-1048311, EBI-618309;
CC       P52272:HNRNPM; NbExp=3; IntAct=EBI-9641546, EBI-486809;
CC       Q9UKT9:IKZF3; NbExp=3; IntAct=EBI-9641546, EBI-747204;
CC       O60341:KDM1A; NbExp=2; IntAct=EBI-1048311, EBI-710124;
CC       P43360:MAGEA6; NbExp=3; IntAct=EBI-9641546, EBI-1045155;
CC       Q9Y5V3:MAGED1; NbExp=3; IntAct=EBI-9641546, EBI-716006;
CC       Q9GZV8:PRDM14; NbExp=3; IntAct=EBI-9641546, EBI-3957793;
CC       Q8N6K7:SAMD3; NbExp=3; IntAct=EBI-9641546, EBI-748741;
CC       Q16385:SSX2B; NbExp=3; IntAct=EBI-9641546, EBI-2210673;
CC       Q9NVV9:THAP1; NbExp=3; IntAct=EBI-9641546, EBI-741515;
CC       Q8N6Y0:USHBP1; NbExp=3; IntAct=EBI-9641546, EBI-739895;
CC       O60763:USO1; NbExp=3; IntAct=EBI-9641546, EBI-356164;
CC       Q9BTA9:WAC; NbExp=3; IntAct=EBI-9641546, EBI-749118;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus
CC       {ECO:0000269|PubMed:15047863, ECO:0000269|PubMed:19242490,
CC       ECO:0000269|PubMed:25217626, ECO:0000269|PubMed:27666745}.
CC       Cytoplasm {ECO:0000269|PubMed:9915845}. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:12270714, ECO:0000269|PubMed:14654843,
CC       ECO:0000269|PubMed:25657325, ECO:0000269|PubMed:29162697,
CC       ECO:0000269|PubMed:9915845}. Note=Cytoplasmic in parietal cells
CC       (PubMed:9915845). Recruited to the Golgi apparatus by GM130/GOLGA2
CC       (PubMed:25657325). Localization at the centrosome versus Golgi
CC       apparatus may be cell line-dependent. In SKBr3 and HEK293F cells,
CC       exclusively located at the centrosome (PubMed:29162697). In HeLa,
CC       MDA-MB231 and RPE-1 cells, detected at the Golgi apparatus
CC       (PubMed:25217626, PubMed:29162697). In SK-BR-3 cells, recruited to
CC       the centrosome in the presence of CDK5RAP2 (PubMed:29162697).
CC       {ECO:0000269|PubMed:25217626, ECO:0000269|PubMed:25657325,
CC       ECO:0000269|PubMed:29162697, ECO:0000269|PubMed:9915845}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=2;
CC         IsoId=Q99996-2; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q99996-1; Sequence=VSP_059522, VSP_059526;
CC         Note=No experimental confirmation available.;
CC       Name=3; Synonyms=CG-NAP;
CC         IsoId=Q99996-3; Sequence=VSP_059525;
CC       Name=4; Synonyms=Yotiao;
CC         IsoId=Q99996-4; Sequence=VSP_059522, VSP_059523, VSP_059524;
CC       Name=5;
CC         IsoId=Q99996-5; Sequence=VSP_059522, VSP_059527;
CC       Name=6; Synonyms=AKAP350;
CC         IsoId=Q99996-6; Sequence=VSP_059522, VSP_059525, VSP_059528;
CC         Note=Ref.7 (AAD39719) sequence is in conflict in position:
CC         2175:E->Q.;
CC   -!- TISSUE SPECIFICITY: Widely expressed (PubMed:10202149). Isoform 4:
CC       Highly expressed in skeletal muscle and in pancreas
CC       (PubMed:9482789). {ECO:0000269|PubMed:10202149,
CC       ECO:0000269|PubMed:9482789}.
CC   -!- DOMAIN: RII-binding site, predicted to form an amphipathic helix,
CC       could participate in protein-protein interactions with a
CC       complementary surface on the R-subunit dimer.
CC       {ECO:0000250|UniProtKB:Q28628}.
CC   -!- DISEASE: Long QT syndrome 11 (LQT11) [MIM:611820]: A heart
CC       disorder characterized by a prolonged QT interval on the ECG and
CC       polymorphic ventricular arrhythmias. They cause syncope and sudden
CC       death in response to exercise or emotional stress, and can present
CC       with a sentinel event of sudden cardiac death in infancy.
CC       {ECO:0000269|PubMed:18093912}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB86384.1; Type=Frameshift; Positions=1625; Evidence={ECO:0000305};
CC       Sequence=AAC60380.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AKAP9ID42999ch7q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ131693; CAB40713.1; -; mRNA.
DR   EMBL; AB019691; BAA78718.1; -; mRNA.
DR   EMBL; AJ010770; CAA09361.1; -; Genomic_DNA.
DR   EMBL; AF026245; AAB86384.1; ALT_FRAME; mRNA.
DR   EMBL; AC004013; AAB96867.2; -; Genomic_DNA.
DR   EMBL; AC000066; AAC60380.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC000120; AAS07419.1; -; Genomic_DNA.
DR   EMBL; CH236949; EAL24155.1; -; Genomic_DNA.
DR   EMBL; CH236949; EAL24156.1; -; Genomic_DNA.
DR   EMBL; CH236949; EAL24157.1; -; Genomic_DNA.
DR   EMBL; AF083037; AAD22767.1; -; mRNA.
DR   EMBL; AF091711; AAD39719.1; -; mRNA.
DR   EMBL; AB018346; BAA34523.1; -; mRNA.
DR   CCDS; CCDS5622.1; -. [Q99996-2]
DR   PIR; T08880; T08880.
DR   RefSeq; NP_005742.4; NM_005751.4. [Q99996-2]
DR   RefSeq; NP_671714.1; NM_147185.2. [Q99996-3]
DR   UniGene; Hs.651221; -.
DR   ProteinModelPortal; Q99996; -.
DR   SMR; Q99996; -.
DR   BioGrid; 115445; 102.
DR   CORUM; Q99996; -.
DR   DIP; DIP-29942N; -.
DR   IntAct; Q99996; 62.
DR   MINT; Q99996; -.
DR   STRING; 9606.ENSP00000348573; -.
DR   CarbonylDB; Q99996; -.
DR   iPTMnet; Q99996; -.
DR   PhosphoSitePlus; Q99996; -.
DR   SwissPalm; Q99996; -.
DR   BioMuta; AKAP9; -.
DR   DMDM; 14194461; -.
DR   EPD; Q99996; -.
DR   jPOST; Q99996; -.
DR   PaxDb; Q99996; -.
DR   PeptideAtlas; Q99996; -.
DR   PRIDE; Q99996; -.
DR   ProteomicsDB; 78566; -.
DR   ProteomicsDB; 78567; -. [Q99996-2]
DR   ProteomicsDB; 78568; -. [Q99996-3]
DR   ProteomicsDB; 78569; -. [Q99996-4]
DR   ProteomicsDB; 78570; -. [Q99996-5]
DR   ProteomicsDB; 78571; -. [Q99996-6]
DR   Ensembl; ENST00000356239; ENSP00000348573; ENSG00000127914. [Q99996-2]
DR   GeneID; 10142; -.
DR   KEGG; hsa:10142; -.
DR   UCSC; uc003ulg.4; human. [Q99996-2]
DR   CTD; 10142; -.
DR   DisGeNET; 10142; -.
DR   EuPathDB; HostDB:ENSG00000127914.16; -.
DR   GeneCards; AKAP9; -.
DR   GeneReviews; AKAP9; -.
DR   HGNC; HGNC:379; AKAP9.
DR   HPA; CAB012909; -.
DR   HPA; HPA008548; -.
DR   HPA; HPA026109; -.
DR   MalaCards; AKAP9; -.
DR   MIM; 604001; gene.
DR   MIM; 611820; phenotype.
DR   neXtProt; NX_Q99996; -.
DR   OpenTargets; ENSG00000127914; -.
DR   Orphanet; 130; Brugada syndrome.
DR   Orphanet; 101016; Romano-Ward syndrome.
DR   PharmGKB; PA24673; -.
DR   eggNOG; ENOG410II47; Eukaryota.
DR   eggNOG; ENOG41101YB; LUCA.
DR   GeneTree; ENSGT00730000110871; -.
DR   HOVERGEN; HBG050481; -.
DR   InParanoid; Q99996; -.
DR   KO; K16551; -.
DR   OrthoDB; 8180at2759; -.
DR   PhylomeDB; Q99996; -.
DR   TreeFam; TF105408; -.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5576890; Phase 3 - rapid repolarisation.
DR   Reactome; R-HSA-5576893; Phase 2 - plateau phase.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   SignaLink; Q99996; -.
DR   ChiTaRS; AKAP9; human.
DR   GeneWiki; AKAP9; -.
DR   GenomeRNAi; 10142; -.
DR   PRO; PR:Q99996; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000127914; Expressed in 230 organ(s), highest expression level in jejunal mucosa.
DR   ExpressionAtlas; Q99996; baseline and differential.
DR   Genevisible; Q99996; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005801; C:cis-Golgi network; IDA:SYSCILIA_CCNET.
DR   GO; GO:0005856; C:cytoskeleton; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0044307; C:dendritic branch; IEA:Ensembl.
DR   GO; GO:0099147; C:extrinsic component of postsynaptic density membrane; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0005795; C:Golgi stack; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0097060; C:synaptic membrane; IBA:GO_Central.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:BHF-UCL.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0044325; F:ion channel binding; IPI:BHF-UCL.
DR   GO; GO:0015459; F:potassium channel regulator activity; IMP:BHF-UCL.
DR   GO; GO:0034237; F:protein kinase A regulatory subunit binding; IPI:UniProtKB.
DR   GO; GO:0032947; F:protein-containing complex scaffold activity; IDA:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; TAS:ProtInc.
DR   GO; GO:0071320; P:cellular response to cAMP; IMP:BHF-UCL.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0051661; P:maintenance of centrosome location; IMP:UniProtKB.
DR   GO; GO:0007020; P:microtubule nucleation; IMP:UniProtKB.
DR   GO; GO:0007194; P:negative regulation of adenylate cyclase activity; IEA:Ensembl.
DR   GO; GO:0031116; P:positive regulation of microtubule polymerization; IMP:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:BHF-UCL.
DR   GO; GO:1901018; P:positive regulation of potassium ion transmembrane transporter activity; IMP:BHF-UCL.
DR   GO; GO:0098909; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; IMP:BHF-UCL.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:1903358; P:regulation of Golgi organization; IDA:UniProtKB.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IMP:BHF-UCL.
DR   GO; GO:0060306; P:regulation of membrane repolarization; IMP:BHF-UCL.
DR   GO; GO:0098962; P:regulation of postsynaptic neurotransmitter receptor activity; IDA:SynGO.
DR   GO; GO:0060307; P:regulation of ventricular cardiac muscle cell membrane repolarization; IMP:BHF-UCL.
DR   GO; GO:0051602; P:response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR028745; AKAP9/Pericentrin.
DR   InterPro; IPR005539; ELK_dom.
DR   InterPro; IPR019528; PACT_domain.
DR   PANTHER; PTHR44981; PTHR44981; 1.
DR   Pfam; PF10495; PACT_coil_coil; 1.
DR   SMART; SM01188; ELK; 4.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Disease mutation; Golgi apparatus; Long QT syndrome;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1   3907       A-kinase anchor protein 9.
FT                                /FTId=PRO_0000064534.
FT   REGION     2542   2555       PKA-RII subunit binding domain.
FT   COILED      152    902       {ECO:0000255}.
FT   COILED      932   1010       {ECO:0000255}.
FT   COILED     1088   1173       {ECO:0000255}.
FT   COILED     1241   1268       {ECO:0000255}.
FT   COILED     1324   1380       {ECO:0000255}.
FT   COILED     1422   1447       {ECO:0000255}.
FT   COILED     1573   1647       {ECO:0000255}.
FT   COILED     1845   2443       {ECO:0000255}.
FT   COILED     2532   2549       {ECO:0000255}.
FT   COILED     2591   2764       {ECO:0000255}.
FT   COILED     3061   3088       {ECO:0000255}.
FT   COILED     3120   3466       {ECO:0000255}.
FT   COILED     3583   3685       {ECO:0000255}.
FT   COMPBIAS    191    280       Gln-rich.
FT   COMPBIAS    309    998       Glu-rich.
FT   COMPBIAS   1834   2760       Glu-rich.
FT   COMPBIAS   3722   3726       Poly-Leu.
FT   MOD_RES     153    153       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1327   1327       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1765   1765       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3690   3690       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3842   3842       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    3865   3865       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES    3897   3897       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      16     16       K -> KIEELSLAFLVRQ (in isoform 1, isoform
FT                                4, isoform 5 and isoform 6).
FT                                /FTId=VSP_059522.
FT   VAR_SEQ    1625   3900       Missing (in isoform 4).
FT                                /FTId=VSP_059523.
FT   VAR_SEQ    2163   2171       SADTFQKVE -> E (in isoform 3 and isoform
FT                                6).
FT                                /FTId=VSP_059525.
FT   VAR_SEQ    2883   2903       GSSIPELAHSDAYQTREICSS -> VFGFYNMCFSTLC
FT                                (in isoform 1).
FT                                /FTId=VSP_059526.
FT   VAR_SEQ    2884   2945       Missing (in isoform 5).
FT                                /FTId=VSP_059527.
FT   VAR_SEQ    3897   3907       STTQFHAGMRR -> ALSLTTSWQHHSARPTAPLFFEILSH
FT                                SLG (in isoform 6).
FT                                /FTId=VSP_059528.
FT   VAR_SEQ    3901   3907       FHAGMRR -> LAQVRVL (in isoform 4).
FT                                /FTId=VSP_059524.
FT   VARIANT     463    463       M -> I (in dbSNP:rs6964587).
FT                                {ECO:0000269|PubMed:10358086}.
FT                                /FTId=VAR_024249.
FT   VARIANT    1335   1335       K -> KQ. {ECO:0000269|PubMed:10202149}.
FT                                /FTId=VAR_010926.
FT   VARIANT    1570   1570       S -> L (in LQT11; dbSNP:rs121908566).
FT                                {ECO:0000269|PubMed:18093912}.
FT                                /FTId=VAR_043489.
FT   VARIANT    2409   2409       M -> I (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035785.
FT   VARIANT    2484   2484       K -> R (in dbSNP:rs35759833).
FT                                /FTId=VAR_043490.
FT   VARIANT    2792   2792       N -> S (in dbSNP:rs6960867).
FT                                /FTId=VAR_030162.
FT   VARIANT    2979   2979       P -> S (in dbSNP:rs1063242).
FT                                {ECO:0000269|PubMed:10358086,
FT                                ECO:0000269|PubMed:9872452,
FT                                ECO:0000269|PubMed:9915845}.
FT                                /FTId=VAR_030163.
FT   VARIANT    3297   3297       E -> Q (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs756245027).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035786.
FT   VARIANT    3444   3444       Q -> R (in dbSNP:rs34956633).
FT                                /FTId=VAR_043491.
FT   VARIANT    3614   3614       M -> V (in dbSNP:rs34327395).
FT                                /FTId=VAR_043492.
FT   CONFLICT     64     64       E -> Q (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT    542    542       E -> G (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT    626    626       R -> S (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT    651    651       N -> S (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT    901    901       H -> N (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT    944    944       K -> N (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT    968    970       QKH -> PKP (in Ref. 1; AAB86384 and 2;
FT                                CAB40713). {ECO:0000305}.
FT   CONFLICT    985    985       Q -> P (in Ref. 1; AAB86384 and 2;
FT                                CAB40713). {ECO:0000305}.
FT   CONFLICT    989    989       Q -> P (in Ref. 1; AAB86384 and 2;
FT                                CAB40713). {ECO:0000305}.
FT   CONFLICT   1008   1008       N -> D (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT   1016   1016       V -> E (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT   1614   1614       R -> P (in Ref. 1; AAB86384 and 2;
FT                                CAB40713). {ECO:0000305}.
FT   CONFLICT   1691   1691       N -> T (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT   1695   1695       V -> G (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT   1790   1791       Missing (in Ref. 7; AAD22767).
FT                                {ECO:0000305}.
FT   CONFLICT   1831   1831       A -> P (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT   1944   1944       I -> V (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT   2015   2015       V -> D (in Ref. 7; AAD22767).
FT                                {ECO:0000305}.
FT   CONFLICT   2145   2146       EI -> HE (in Ref. 7; AAD39719).
FT                                {ECO:0000305}.
FT   CONFLICT   2157   2157       E -> V (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT   2171   2171       E -> Q (in Ref. 7; AAD39719).
FT                                {ECO:0000305}.
FT   CONFLICT   2502   2502       L -> R (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT   2839   2839       I -> N (in Ref. 8; BAA34523).
FT                                {ECO:0000305}.
FT   CONFLICT   2953   2953       E -> D (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT   3083   3083       Q -> H (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT   3214   3214       Q -> H (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT   3303   3305       ESE -> QSQ (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT   3747   3747       P -> A (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
FT   CONFLICT   3829   3829       T -> S (in Ref. 3; BAA78718).
FT                                {ECO:0000305}.
SQ   SEQUENCE   3907 AA;  452987 MW;  81761B4341430CDF CRC64;
     MEDEERQKKL EAGKAKLAQF RQRKAQSDGQ SPSKKQKKKR KTSSSKHDVS AHHDLNIDQS
     QCNEMYINSS QRVESTVIPE STIMRTLHSG EITSHEQGFS VELESEISTT ADDCSSEVNG
     CSFVMRTGKP TNLLREEEFG VDDSYSEQGA QDSPTHLEMM ESELAGKQHE IEELNRELEE
     MRVTYGTEGL QQLQEFEAAI KQRDGIITQL TANLQQARRE KDETMREFLE LTEQSQKLQI
     QFQQLQASET LRNSTHSSTA ADLLQAKQQI LTHQQQLEEQ DHLLEDYQKK KEDFTMQISF
     LQEKIKVYEM EQDKKVENSN KEEIQEKETI IEELNTKIIE EEKKTLELKD KLTTADKLLG
     ELQEQIVQKN QEIKNMKLEL TNSKQKERQS SEEIKQLMGT VEELQKRNHK DSQFETDIVQ
     RMEQETQRKL EQLRAELDEM YGQQIVQMKQ ELIRQHMAQM EEMKTRHKGE MENALRSYSN
     ITVNEDQIKL MNVAINELNI KLQDTNSQKE KLKEELGLIL EEKCALQRQL EDLVEELSFS
     REQIQRARQT IAEQESKLNE AHKSLSTVED LKAEIVSASE SRKELELKHE AEVTNYKIKL
     EMLEKEKNAV LDRMAESQEA ELERLRTQLL FSHEEELSKL KEDLEIEHRI NIEKLKDNLG
     IHYKQQIDGL QNEMSQKIET MQFEKDNLIT KQNQLILEIS KLKDLQQSLV NSKSEEMTLQ
     INELQKEIEI LRQEEKEKGT LEQEVQELQL KTELLEKQMK EKENDLQEKF AQLEAENSIL
     KDEKKTLEDM LKIHTPVSQE ERLIFLDSIK SKSKDSVWEK EIEILIEENE DLKQQCIQLN
     EEIEKQRNTF SFAEKNFEVN YQELQEEYAC LLKVKDDLED SKNKQELEYK SKLKALNEEL
     HLQRINPTTV KMKSSVFDED KTFVAETLEM GEVVEKDTTE LMEKLEVTKR EKLELSQRLS
     DLSEQLKQKH GEISFLNEEV KSLKQEKEQV SLRCRELEII INHNRAENVQ SCDTQVSSLL
     DGVVTMTSRG AEGSVSKVNK SFGEESKIMV EDKVSFENMT VGEESKQEQL ILDHLPSVTK
     ESSLRATQPS ENDKLQKELN VLKSEQNDLR LQMEAQRICL SLVYSTHVDQ VREYMENEKD
     KALCSLKEEL IFAQEEKIKE LQKIHQLELQ TMKTQETGDE GKPLHLLIGK LQKAVSEECS
     YFLQTLCSVL GEYYTPALKC EVNAEDKENS GDYISENEDP ELQDYRYEVQ DFQENMHTLL
     NKVTEEYNKL LVLQTRLSKI WGQQTDGMKL EFGEENLPKE ETEFLSIHSQ MTNLEDIDVN
     HKSKLSSLQD LEKTKLEEQV QELESLISSL QQQLKETEQN YEAEIHCLQK RLQAVSESTV
     PPSLPVDSVV ITESDAQRTM YPGSCVKKNI DGTIEFSGEF GVKEETNIVK LLEKQYQEQL
     EEEVAKVIVS MSIAFAQQTE LSRISGGKEN TASSKQAHAV CQQEQHYFNE MKLSQDQIGF
     QTFETVDVKF KEEFKPLSKE LGEHGKEILL SNSDPHDIPE SKDCVLTISE EMFSKDKTFI
     VRQSIHDEIS VSSMDASRQL MLNEEQLEDM RQELVRQYQE HQQATELLRQ AHMRQMERQR
     EDQEQLQEEI KRLNRQLAQR SSIDNENLVS ERERVLLEEL EALKQLSLAG REKLCCELRN
     SSTQTQNGNE NQGEVEEQTF KEKELDRKPE DVPPEILSNE RYALQKANNR LLKILLEVVK
     TTAAVEETIG RHVLGILDRS SKSQSSASLI WRSEAEASVK SCVHEEHTRV TDESIPSYSG
     SDMPRNDINM WSKVTEEGTE LSQRLVRSGF AGTEIDPENE ELMLNISSRL QAAVEKLLEA
     ISETSSQLEH AKVTQTELMR ESFRQKQEAT ESLKCQEELR ERLHEESRAR EQLAVELSKA
     EGVIDGYADE KTLFERQIQE KTDIIDRLEQ ELLCASNRLQ ELEAEQQQIQ EERELLSRQK
     EAMKAEAGPV EQQLLQETEK LMKEKLEVQC QAEKVRDDLQ KQVKALEIDV EEQVSRFIEL
     EQEKNTELMD LRQQNQALEK QLEKMRKFLD EQAIDREHER DVFQQEIQKL EQQLKVVPRF
     QPISEHQTRE VEQLANHLKE KTDKCSELLL SKEQLQRDIQ ERNEEIEKLE FRVRELEQAL
     LVSADTFQKV EDRKHFGAVE AKPELSLEVQ LQAERDAIDR KEKEITNLEE QLEQFREELE
     NKNEEVQQLH MQLEIQKKES TTRLQELEQE NKLFKDDMEK LGLAIKESDA MSTQDQHVLF
     GKFAQIIQEK EVEIDQLNEQ VTKLQQQLKI TTDNKVIEEK NELIRDLETQ IECLMSDQEC
     VKRNREEEIE QLNEVIEKLQ QELANIGQKT SMNAHSLSEE ADSLKHQLDV VIAEKLALEQ
     QVETANEEMT FMKNVLKETN FKMNQLTQEL FSLKRERESV EKIQSIPENS VNVAIDHLSK
     DKPELEVVLT EDALKSLENQ TYFKSFEENG KGSIINLETR LLQLESTVSA KDLELTQCYK
     QIKDMQEQGQ FETEMLQKKI VNLQKIVEEK VAAALVSQIQ LEAVQEYAKF CQDNQTISSE
     PERTNIQNLN QLREDELGSD ISALTLRISE LESQVVEMHT SLILEKEQVE IAEKNVLEKE
     KKLLELQKLL EGNEKKQREK EKKRSPQDVE VLKTTTELFH SNEESGFFNE LEALRAESVA
     TKAELASYKE KAEKLQEELL VKETNMTSLQ KDLSQVRDHL AEAKEKLSIL EKEDETEVQE
     SKKACMFEPL PIKLSKSIAS QTDGTLKISS SNQTPQILVK NAGIQINLQS ECSSEEVTEI
     ISQFTEKIEK MQELHAAEIL DMESRHISET ETLKREHYVA VQLLKEECGT LKAVIQCLRS
     KEGSSIPELA HSDAYQTREI CSSDSGSDWG QGIYLTHSQG FDIASEGRGE ESESATDSFP
     KKIKGLLRAV HNEGMQVLSL TESPYSDGED HSIQQVSEPW LEERKAYINT ISSLKDLITK
     MQLQREAEVY DSSQSHESFS DWRGELLLAL QQVFLEERSV LLAAFRTELT ALGTTDAVGL
     LNCLEQRIQE QGVEYQAAME CLQKADRRSL LSEIQALHAQ MNGRKITLKR EQESEKPSQE
     LLEYNIQQKQ SQMLEMQVEL SSMKDRATEL QEQLSSEKMV VAELKSELAQ TKLELETTLK
     AQHKHLKELE AFRLEVKDKT DEVHLLNDTL ASEQKKSREL QWALEKEKAK LGRSEERDKE
     ELEDLKFSLE SQKQRNLQLN LLLEQQKQLL NESQQKIESQ RMLYDAQLSE EQGRNLELQV
     LLESEKVRIR EMSSTLDRER ELHAQLQSSD GTGQSRPPLP SEDLLKELQK QLEEKHSRIV
     ELLNETEKYK LDSLQTRQQM EKDRQVHRKT LQTEQEANTE GQKKMHELQS KVEDLQRQLE
     EKRQQVYKLD LEGQRLQGIM QEFQKQELER EEKRESRRIL YQNLNEPTTW SLTSDRTRNW
     VLQQKIEGET KESNYAKLIE MNGGGTGCNH ELEMIRQKLQ CVASKLQVLP QKASERLQFE
     TADDEDFIWV QENIDEIILQ LQKLTGQQGE EPSLVSPSTS CGSLTERLLR QNAELTGHIS
     QLTEEKNDLR NMVMKLEEQI RWYRQTGAGR DNSSRFSLNG GANIEAIIAS EKEVWNREKL
     TLQKSLKRAE AEVYKLKAEL RNDSLLQTLS PDSEHVTLKR IYGKYLRAES FRKALIYQKK
     YLLLLLGGFQ ECEDATLALL ARMGGQPAFT DLEVITNRPK GFTRFRSAVR VSIAISRMKF
     LVRRWHRVTG SVSININRDG FGLNQGAEKT DSFYHSSGGL ELYGEPRHTT YRSRSDLDYI
     RSPLPFQNRY PGTPADFNPG SLACSQLQNY DPDRALTDYI TRLEALQRRL GTIQSGSTTQ
     FHAGMRR
//
ID   A0A384NPN7_HUMAN        Unreviewed;       517 AA.
AC   A0A384NPN7;
DT   05-DEC-2018, integrated into UniProtKB/TrEMBL.
DT   05-DEC-2018, sequence version 1.
DT   13-FEB-2019, entry version 3.
DE   SubName: Full=Aldehyde dehydrogenase 2 family (Mitochondrial), isoform CRA_c {ECO:0000313|EMBL:EAW97975.1};
DE   SubName: Full=Epididymis secretory sperm binding protein {ECO:0000313|EMBL:ADO22228.1};
GN   Name=ALDH2 {ECO:0000313|EMBL:EAW97975.1};
GN   ORFNames=hCG_2039620 {ECO:0000313|EMBL:EAW97975.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADO22228.1};
RN   [1] {ECO:0000313|EMBL:EAW97975.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW97975.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADO22228.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hoernsten L., Su C., Osbourn A.E., Hellman U., Wernstedt C.,
RA   Oliw E.H.;
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family.
CC       {ECO:0000256|RuleBase:RU003345}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; GQ891366; ADO22228.1; -; mRNA.
DR   EMBL; CH471054; EAW97975.1; -; Genomic_DNA.
DR   RefSeq; NP_000681.2; NM_000690.3.
DR   GeneID; 217; -.
DR   GO; GO:0016620; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; IEA:InterPro.
DR   Gene3D; 3.40.309.10; -; 1.
DR   Gene3D; 3.40.605.10; -; 1.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR016163; Ald_DH_C.
DR   InterPro; IPR016160; Ald_DH_CS_CYS.
DR   InterPro; IPR029510; Ald_DH_CS_GLU.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR015590; Aldehyde_DH_dom.
DR   Pfam; PF00171; Aldedh; 1.
DR   SUPFAM; SSF53720; SSF53720; 1.
DR   PROSITE; PS00070; ALDEHYDE_DEHYDR_CYS; 1.
DR   PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; 1.
PE   2: Evidence at transcript level;
KW   Oxidoreductase {ECO:0000256|RuleBase:RU003345}.
FT   DOMAIN       45    508       Aldedh. {ECO:0000259|Pfam:PF00171}.
FT   ACT_SITE    285    285       {ECO:0000256|PROSITE-ProRule:PRU10007}.
FT   ACT_SITE    319    319       {ECO:0000256|PROSITE-ProRule:PRU10008}.
SQ   SEQUENCE   517 AA;  56381 MW;  E8F74D44D285A00E CRC64;
     MLRAAARFGP RLGRRLLSAA ATQAVPAPNQ QPEVFCNQIF INNEWHDAVS RKTFPTVNPS
     TGEVICQVAE GDKEDVDKAV KAARAAFQLG SPWRRMDASH RGRLLNRLAD LIERDRTYLA
     ALETLDNGKP YVISYLVDLD MVLKCLRYYA GWADKYHGKT IPIDGDFFSY TRHEPVGVCG
     QIIPWNFPLL MQAWKLGPAL ATGNVVVMKV AEQTPLTALY VANLIKEAGF PPGVVNIVPG
     FGPTAGAAIA SHEDVDKVAF TGSTEIGRVI QVAAGSSNLK RVTLELGGKS PNIIMSDADM
     DWAVEQAHFA LFFNQGQCCC AGSRTFVQED IYDEFVERSV ARAKSRVVGN PFDSKTEQGP
     QVDETQFKKI LGYINTGKQE GAKLLCGGGI AADRGYFIQP TVFGDVQDGM TIAKEEIFGP
     VMQILKFKTI EEVVGRANNS TYGLAAAVFT KDLDKANYLS QALQAGTVWV NCYDVFGAQS
     PFGGYKMSGS GRELGEYGLQ AYTEVKTVTV KVPQKNS
//
ID   ALDH2_HUMAN             Reviewed;         517 AA.
AC   P05091; B4DW54; E7EUE5; Q03639; Q6IB13; Q6IV71;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 2.
DT   13-FEB-2019, entry version 228.
DE   RecName: Full=Aldehyde dehydrogenase, mitochondrial;
DE            EC=1.2.1.3;
DE   AltName: Full=ALDH class 2;
DE   AltName: Full=ALDH-E2;
DE   AltName: Full=ALDHI;
DE   Flags: Precursor;
GN   Name=ALDH2; Synonyms=ALDM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=3582651; DOI=10.1016/0014-5793(87)80152-7;
RA   Braun T., Bober E., Singh S., Agarwal D.P., Goedde H.W.;
RT   "Evidence for a signal peptide at the amino-terminal end of human
RT   mitochondrial aldehyde dehydrogenase.";
RL   FEBS Lett. 215:233-236(1987).
RN   [2]
RP   ERRATUM, AND SEQUENCE REVISION TO N-TERMINUS.
RA   Braun T., Bober E., Singh S., Agarwal D.P., Goedde H.W.;
RL   FEBS Lett. 233:440-440(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=3562250; DOI=10.1093/nar/15.7.3179;
RA   Braun T., Bober E., Singh S., Agarwal D.P., Goedde H.W.;
RT   "Isolation and sequence analysis of a full length cDNA clone coding
RT   for human mitochondrial aldehyde dehydrogenase.";
RL   Nucleic Acids Res. 15:3179-3179(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2838413; DOI=10.1016/0888-7543(88)90109-7;
RA   Hsu L.C., Bendel R.E., Yoshida A.;
RT   "Genomic structure of the human mitochondrial aldehyde dehydrogenase
RT   gene.";
RL   Genomics 2:57-65(1988).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Lassen N., Estey T., Vasiliou V.;
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 18-517 (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=4065146; DOI=10.1111/j.1432-1033.1985.tb09260.x;
RA   Hempel J., Kaiser R., Joernvall H.;
RT   "Mitochondrial aldehyde dehydrogenase from human liver. Primary
RT   structure, differences in relation to the cytosolic enzyme, and
RT   functional correlations.";
RL   Eur. J. Biochem. 153:13-28(1985).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 119-517 (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=2987944; DOI=10.1073/pnas.82.11.3771;
RA   Hsu L.C., Tani K., Fujiyoshi T., Kurachi K., Yoshida A.;
RT   "Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:3771-3775(1985).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 119-517 (ISOFORM 1).
RX   PubMed=4015823; DOI=10.1016/0741-8329(85)90024-2;
RA   Yoshida A., Ikawa M., Hsu L.C., Tani K.;
RT   "Molecular abnormality and cDNA cloning of human aldehyde
RT   dehydrogenases.";
RL   Alcohol 2:103-106(1985).
RN   [13]
RP   PROTEIN SEQUENCE OF 160-172 AND 325-338, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [14]
RP   PROTEIN SEQUENCE OF 196-226 AND 325-338.
RC   TISSUE=Adipocyte;
RX   PubMed=15242332; DOI=10.1042/BJ20040647;
RA   Aboulaich N., Vainonen J.P., Stralfors P., Vener A.V.;
RT   "Vectorial proteomics reveal targeting, phosphorylation and specific
RT   fragmentation of polymerase I and transcript release factor (PTRF) at
RT   the surface of caveolae in human adipocytes.";
RL   Biochem. J. 383:237-248(2004).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 214-500, AND VARIANT VAL-337.
RC   TISSUE=Liver;
RX   PubMed=3610592;
RA   Agarwal D.P., Goedde H.W.;
RT   "Human aldehyde dehydrogenase isozymes and alcohol sensitivity.";
RL   Isozymes Curr. Top. Biol. Med. Res. 16:21-48(1987).
RN   [16]
RP   DESCRIPTION OF ORIGIN OF CONFLICTS BETWEEN THE SEQUENCE DESCRIBED IN
RP   PUBMED:4065146 AND DNA SEQUENCES.
RX   PubMed=3653404; DOI=10.1016/0014-5793(87)80198-9;
RA   Hempel J., Hoeoeg J.-O., Joernvall H.;
RT   "Mitochondrial aldehyde dehydrogenase. Homology of putative targeting
RT   sequence to that of carbamyl phosphate synthetase I revealed by
RT   correlation of cDNA and protein data.";
RL   FEBS Lett. 222:95-98(1987).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.58 ANGSTROMS).
RX   PubMed=10631996; DOI=10.1110/ps.8.12.2784;
RA   Ni L., Zhou J., Hurley T.D., Weiner H.;
RT   "Human liver mitochondrial aldehyde dehydrogenase: three-dimensional
RT   structure and the restoration of solubility and activity of chimeric
RT   forms.";
RL   Protein Sci. 8:2784-2790(1999).
RN   [20]
RP   VARIANT LYS-504.
RX   PubMed=6582480; DOI=10.1073/pnas.81.1.258;
RA   Yoshida A., Huang I.-Y., Ikawa M.;
RT   "Molecular abnormality of an inactive aldehyde dehydrogenase variant
RT   commonly found in Orientals.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:258-261(1984).
RN   [21]
RP   VARIANT LYS-496.
RX   PubMed=8561277; DOI=10.1111/j.1530-0277.1995.tb01587.x;
RA   Novoradovsky A., Tsai S.J., Goldfarb L., Peterson R., Long J.C.,
RA   Goldman D.;
RT   "Mitochondrial aldehyde dehydrogenase polymorphism in Asian and
RT   American Indian populations: detection of new ALDH2 alleles.";
RL   Alcohol. Clin. Exp. Res. 19:1105-1110(1995).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an aldehyde + H2O + NAD(+) = a carboxylate + 2 H(+) +
CC         NADH; Xref=Rhea:RHEA:16185, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17478, ChEBI:CHEBI:29067,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.2.1.3;
CC   -!- PATHWAY: Alcohol metabolism; ethanol degradation; acetate from
CC       ethanol: step 2/2.
CC   -!- SUBUNIT: Homotetramer.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P05091-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P05091-2; Sequence=VSP_046715;
CC         Note=No experimental confirmation available.;
CC   -!- POLYMORPHISM: Genetic variation in ALDH2 is responsible for
CC       individual differences in responses to drinking alcohol
CC       [MIM:610251]. Allele ALDH2*2 is associated with a very high
CC       incidence of acute alcohol intoxication in Orientals and South
CC       American Indians, as compared to Caucasians.
CC       {ECO:0000269|PubMed:8561277}.
CC   -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA62825.1; Type=Frameshift; Positions=424, 444, 448, 461; Evidence={ECO:0000305};
CC       Sequence=CAA68290.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC       Sequence=CAA68290.1; Type=Miscellaneous discrepancy; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ALDH2ID250.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; X05409; CAA28990.1; -; mRNA.
DR   EMBL; Y00109; CAA68290.1; ALT_SEQ; mRNA.
DR   EMBL; M20456; AAA51693.1; -; Genomic_DNA.
DR   EMBL; M20444; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20445; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20446; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20447; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20448; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20449; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20450; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20451; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20452; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20453; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; M20454; AAA51693.1; JOINED; Genomic_DNA.
DR   EMBL; AY621070; AAT41621.1; -; mRNA.
DR   EMBL; CR456991; CAG33272.1; -; mRNA.
DR   EMBL; AK301375; BAG62916.1; -; mRNA.
DR   EMBL; AC002996; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC003029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002967; AAH02967.1; -; mRNA.
DR   EMBL; BC071839; AAH71839.1; -; mRNA.
DR   EMBL; K03001; AAB59500.1; -; mRNA.
DR   EMBL; M26760; AAA51694.1; -; mRNA.
DR   EMBL; M54931; AAA62825.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS55885.1; -. [P05091-2]
DR   CCDS; CCDS9155.1; -. [P05091-1]
DR   PIR; A29975; DEHUE2.
DR   RefSeq; NP_000681.2; NM_000690.3. [P05091-1]
DR   RefSeq; NP_001191818.1; NM_001204889.1. [P05091-2]
DR   UniGene; Hs.604551; -.
DR   PDB; 1CW3; X-ray; 2.58 A; A/B/C/D/E/F/G/H=24-517.
DR   PDB; 1NZW; X-ray; 2.65 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1NZX; X-ray; 2.45 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1NZZ; X-ray; 2.45 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1O00; X-ray; 2.60 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1O01; X-ray; 2.15 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1O02; X-ray; 1.90 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1O04; X-ray; 1.42 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1O05; X-ray; 2.25 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 1ZUM; X-ray; 2.10 A; A/B/C/D/E/F/G/H/I/J/K/L=18-517.
DR   PDB; 2ONM; X-ray; 2.50 A; A/B/C/D/E/F/G/H/I/J/K/L=18-517.
DR   PDB; 2ONN; X-ray; 2.75 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 2ONO; X-ray; 2.15 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 2ONP; X-ray; 2.00 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 2VLE; X-ray; 2.40 A; A/B/C/D/E/F/G/H=24-517.
DR   PDB; 3INJ; X-ray; 1.69 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 3INL; X-ray; 1.86 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 3N80; X-ray; 1.50 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 3N81; X-ray; 1.70 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 3N82; X-ray; 2.25 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 3N83; X-ray; 1.90 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 3SZ9; X-ray; 2.10 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 4FQF; X-ray; 2.28 A; A/B/C/D=18-517.
DR   PDB; 4FR8; X-ray; 2.20 A; A/B/C/D/E/F/G/H=18-517.
DR   PDB; 4KWF; X-ray; 2.31 A; A/B/C/D/E/F/G/H=24-517.
DR   PDB; 4KWG; X-ray; 2.10 A; A/B/C/D/E/F/G/H=24-517.
DR   PDB; 5L13; X-ray; 2.40 A; A/B/C/D/E/F/G/H=1-517.
DR   PDBsum; 1CW3; -.
DR   PDBsum; 1NZW; -.
DR   PDBsum; 1NZX; -.
DR   PDBsum; 1NZZ; -.
DR   PDBsum; 1O00; -.
DR   PDBsum; 1O01; -.
DR   PDBsum; 1O02; -.
DR   PDBsum; 1O04; -.
DR   PDBsum; 1O05; -.
DR   PDBsum; 1ZUM; -.
DR   PDBsum; 2ONM; -.
DR   PDBsum; 2ONN; -.
DR   PDBsum; 2ONO; -.
DR   PDBsum; 2ONP; -.
DR   PDBsum; 2VLE; -.
DR   PDBsum; 3INJ; -.
DR   PDBsum; 3INL; -.
DR   PDBsum; 3N80; -.
DR   PDBsum; 3N81; -.
DR   PDBsum; 3N82; -.
DR   PDBsum; 3N83; -.
DR   PDBsum; 3SZ9; -.
DR   PDBsum; 4FQF; -.
DR   PDBsum; 4FR8; -.
DR   PDBsum; 4KWF; -.
DR   PDBsum; 4KWG; -.
DR   PDBsum; 5L13; -.
DR   ProteinModelPortal; P05091; -.
DR   SMR; P05091; -.
DR   BioGrid; 106719; 52.
DR   DIP; DIP-40262N; -.
DR   IntAct; P05091; 24.
DR   MINT; P05091; -.
DR   STRING; 9606.ENSP00000261733; -.
DR   BindingDB; P05091; -.
DR   ChEMBL; CHEMBL1935; -.
DR   DrugBank; DB01612; Amyl Nitrite.
DR   DrugBank; DB06770; Benzyl alcohol.
DR   DrugBank; DB04381; Crotonaldehyde.
DR   DrugBank; DB02115; Daidzin.
DR   DrugBank; DB00822; Disulfiram.
DR   DrugBank; DB00536; Guanidine.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB00435; Nitric Oxide.
DR   DrugBank; DB00727; Nitroglycerin.
DR   GuidetoPHARMACOLOGY; 2595; -.
DR   iPTMnet; P05091; -.
DR   PhosphoSitePlus; P05091; -.
DR   SwissPalm; P05091; -.
DR   BioMuta; ALDH2; -.
DR   DMDM; 118504; -.
DR   REPRODUCTION-2DPAGE; IPI00006663; -.
DR   REPRODUCTION-2DPAGE; P05091; -.
DR   UCD-2DPAGE; P05091; -.
DR   EPD; P05091; -.
DR   jPOST; P05091; -.
DR   MaxQB; P05091; -.
DR   PaxDb; P05091; -.
DR   PeptideAtlas; P05091; -.
DR   PRIDE; P05091; -.
DR   ProteomicsDB; 51788; -.
DR   DNASU; 217; -.
DR   Ensembl; ENST00000261733; ENSP00000261733; ENSG00000111275. [P05091-1]
DR   Ensembl; ENST00000416293; ENSP00000403349; ENSG00000111275. [P05091-2]
DR   GeneID; 217; -.
DR   KEGG; hsa:217; -.
DR   UCSC; uc001tst.4; human. [P05091-1]
DR   CTD; 217; -.
DR   DisGeNET; 217; -.
DR   EuPathDB; HostDB:ENSG00000111275.12; -.
DR   GeneCards; ALDH2; -.
DR   HGNC; HGNC:404; ALDH2.
DR   HPA; HPA051065; -.
DR   MalaCards; ALDH2; -.
DR   MIM; 100650; gene+phenotype.
DR   MIM; 610251; phenotype.
DR   neXtProt; NX_P05091; -.
DR   OpenTargets; ENSG00000111275; -.
DR   PharmGKB; PA24696; -.
DR   eggNOG; KOG2450; Eukaryota.
DR   eggNOG; COG1012; LUCA.
DR   GeneTree; ENSGT00940000156240; -.
DR   HOGENOM; HOG000271505; -.
DR   HOVERGEN; HBG000097; -.
DR   InParanoid; P05091; -.
DR   KO; K00128; -.
DR   OMA; TFVQEDV; -.
DR   OrthoDB; 100626at2759; -.
DR   PhylomeDB; P05091; -.
DR   TreeFam; TF300455; -.
DR   BioCyc; MetaCyc:MONOMER66-302; -.
DR   BRENDA; 1.2.1.3; 2681.
DR   Reactome; R-HSA-380612; Metabolism of serotonin.
DR   Reactome; R-HSA-71384; Ethanol oxidation.
DR   SABIO-RK; P05091; -.
DR   UniPathway; UPA00780; UER00768.
DR   ChiTaRS; ALDH2; human.
DR   EvolutionaryTrace; P05091; -.
DR   GeneWiki; ALDH2; -.
DR   GenomeRNAi; 217; -.
DR   PRO; PR:P05091; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111275; Expressed in 231 organ(s), highest expression level in liver.
DR   ExpressionAtlas; P05091; baseline and differential.
DR   Genevisible; P05091; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0004029; F:aldehyde dehydrogenase (NAD) activity; IDA:CACAO.
DR   GO; GO:0004030; F:aldehyde dehydrogenase [NAD(P)+] activity; TAS:ProtInc.
DR   GO; GO:0009055; F:electron transfer activity; TAS:UniProtKB.
DR   GO; GO:0043878; F:glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity; IEA:UniProtKB-EC.
DR   GO; GO:0051287; F:NAD binding; ISS:CAFA.
DR   GO; GO:0006066; P:alcohol metabolic process; TAS:ProtInc.
DR   GO; GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc.
DR   GO; GO:0006068; P:ethanol catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006069; P:ethanol oxidation; TAS:Reactome.
DR   Gene3D; 3.40.309.10; -; 1.
DR   Gene3D; 3.40.605.10; -; 1.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR016163; Ald_DH_C.
DR   InterPro; IPR016160; Ald_DH_CS_CYS.
DR   InterPro; IPR029510; Ald_DH_CS_GLU.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR015590; Aldehyde_DH_dom.
DR   Pfam; PF00171; Aldedh; 1.
DR   SUPFAM; SSF53720; SSF53720; 1.
DR   PROSITE; PS00070; ALDEHYDE_DEHYDR_CYS; 1.
DR   PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Mitochondrion; NAD; Oxidoreductase;
KW   Polymorphism; Reference proteome; Transit peptide.
FT   TRANSIT       1     17       Mitochondrion.
FT   CHAIN        18    517       Aldehyde dehydrogenase, mitochondrial.
FT                                /FTId=PRO_0000007168.
FT   NP_BIND     262    267       NAD. {ECO:0000250}.
FT   ACT_SITE    285    285       Proton acceptor.
FT   ACT_SITE    319    319       Nucleophile.
FT   SITE        186    186       Transition state stabilizer.
FT                                {ECO:0000250|UniProtKB:P20000}.
FT   MOD_RES      52     52       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P47738}.
FT   MOD_RES      73     73       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P47738}.
FT   MOD_RES      78     78       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P47738}.
FT   MOD_RES     159    159       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P47738}.
FT   MOD_RES     368    368       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P47738}.
FT   MOD_RES     383    383       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P47738}.
FT   MOD_RES     426    426       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P47738}.
FT   MOD_RES     428    428       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P47738}.
FT   MOD_RES     451    451       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P47738}.
FT   VAR_SEQ      74    120       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046715.
FT   VARIANT     337    337       E -> V (in dbSNP:rs1062136).
FT                                {ECO:0000269|PubMed:3610592}.
FT                                /FTId=VAR_011869.
FT   VARIANT     496    496       E -> K (in allele ALDH2*3;
FT                                dbSNP:rs769724893).
FT                                {ECO:0000269|PubMed:8561277}.
FT                                /FTId=VAR_011302.
FT   VARIANT     504    504       E -> K (in allele ALDH2*2; drastic
FT                                reduction of enzyme activity;
FT                                dbSNP:rs671).
FT                                {ECO:0000269|PubMed:6582480}.
FT                                /FTId=VAR_002248.
FT   CONFLICT      7     12       RFGPRL -> ARAPP (in Ref. 1; CAA28990).
FT                                {ECO:0000305}.
FT   CONFLICT     18     18       S -> A (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     60     60       S -> F (in Ref. 6; CAG33272).
FT                                {ECO:0000305}.
FT   CONFLICT     80     85       VKAARA -> REGRPG (in Ref. 1; CAA28990).
FT                                {ECO:0000305}.
FT   CONFLICT    101    101       R -> S (in Ref. 1; CAA28990).
FT                                {ECO:0000305}.
FT   CONFLICT    116    116       R -> Q (in Ref. 5; AAT41621).
FT                                {ECO:0000305}.
FT   CONFLICT    216    216       L -> S (in Ref. 15; AAA62825).
FT                                {ECO:0000305}.
FT   CONFLICT    218    218       A -> R (in Ref. 15; AAA62825).
FT                                {ECO:0000305}.
FT   CONFLICT    247    247       A -> P (in Ref. 15; AAA62825).
FT                                {ECO:0000305}.
FT   CONFLICT    332    332       Y -> C (in Ref. 7; BAG62916).
FT                                {ECO:0000305}.
FT   CONFLICT    362    362       V -> L (in Ref. 6; CAG33272).
FT                                {ECO:0000305}.
FT   CONFLICT    380    380       E -> Q (in Ref. 4; AAA51693).
FT                                {ECO:0000305}.
FT   STRAND       38     41       {ECO:0000244|PDB:1O04}.
FT   STRAND       44     46       {ECO:0000244|PDB:1O04}.
FT   STRAND       53     57       {ECO:0000244|PDB:1O04}.
FT   TURN         59     61       {ECO:0000244|PDB:1O04}.
FT   STRAND       64     69       {ECO:0000244|PDB:1O04}.
FT   HELIX        73     86       {ECO:0000244|PDB:1O04}.
FT   HELIX        92     95       {ECO:0000244|PDB:1O04}.
FT   HELIX        98    114       {ECO:0000244|PDB:1O04}.
FT   HELIX       116    127       {ECO:0000244|PDB:1O04}.
FT   HELIX       131    136       {ECO:0000244|PDB:1O04}.
FT   HELIX       138    152       {ECO:0000244|PDB:1O04}.
FT   TURN        153    155       {ECO:0000244|PDB:1O04}.
FT   STRAND      158    161       {ECO:0000244|PDB:1O04}.
FT   STRAND      164    175       {ECO:0000244|PDB:1O04}.
FT   STRAND      178    182       {ECO:0000244|PDB:1O04}.
FT   STRAND      185    187       {ECO:0000244|PDB:1O04}.
FT   HELIX       188    201       {ECO:0000244|PDB:1O04}.
FT   STRAND      205    209       {ECO:0000244|PDB:1O04}.
FT   STRAND      212    214       {ECO:0000244|PDB:4KWF}.
FT   HELIX       216    228       {ECO:0000244|PDB:1O04}.
FT   STRAND      234    237       {ECO:0000244|PDB:1O04}.
FT   TURN        242    244       {ECO:0000244|PDB:1O04}.
FT   HELIX       245    250       {ECO:0000244|PDB:1O04}.
FT   STRAND      257    262       {ECO:0000244|PDB:1O04}.
FT   HELIX       264    276       {ECO:0000244|PDB:1O04}.
FT   STRAND      281    285       {ECO:0000244|PDB:1O04}.
FT   STRAND      290    294       {ECO:0000244|PDB:1O04}.
FT   HELIX       300    312       {ECO:0000244|PDB:1O04}.
FT   HELIX       313    316       {ECO:0000244|PDB:1O04}.
FT   STRAND      322    328       {ECO:0000244|PDB:1O04}.
FT   HELIX       329    345       {ECO:0000244|PDB:1O04}.
FT   HELIX       364    379       {ECO:0000244|PDB:1O04}.
FT   STRAND      383    386       {ECO:0000244|PDB:1O04}.
FT   STRAND      389    391       {ECO:0000244|PDB:3INL}.
FT   STRAND      393    396       {ECO:0000244|PDB:1O04}.
FT   STRAND      401    405       {ECO:0000244|PDB:1O04}.
FT   HELIX       411    414       {ECO:0000244|PDB:1O04}.
FT   STRAND      419    427       {ECO:0000244|PDB:1O04}.
FT   HELIX       430    438       {ECO:0000244|PDB:1O04}.
FT   STRAND      439    441       {ECO:0000244|PDB:3INL}.
FT   STRAND      444    449       {ECO:0000244|PDB:1O04}.
FT   HELIX       453    462       {ECO:0000244|PDB:1O04}.
FT   STRAND      465    471       {ECO:0000244|PDB:1O04}.
FT   STRAND      478    480       {ECO:0000244|PDB:2ONO}.
FT   HELIX       486    488       {ECO:0000244|PDB:1O04}.
FT   STRAND      489    491       {ECO:0000244|PDB:1O04}.
FT   HELIX       496    502       {ECO:0000244|PDB:1O04}.
FT   STRAND      503    511       {ECO:0000244|PDB:1O04}.
SQ   SEQUENCE   517 AA;  56381 MW;  E8F74D44D285A00E CRC64;
     MLRAAARFGP RLGRRLLSAA ATQAVPAPNQ QPEVFCNQIF INNEWHDAVS RKTFPTVNPS
     TGEVICQVAE GDKEDVDKAV KAARAAFQLG SPWRRMDASH RGRLLNRLAD LIERDRTYLA
     ALETLDNGKP YVISYLVDLD MVLKCLRYYA GWADKYHGKT IPIDGDFFSY TRHEPVGVCG
     QIIPWNFPLL MQAWKLGPAL ATGNVVVMKV AEQTPLTALY VANLIKEAGF PPGVVNIVPG
     FGPTAGAAIA SHEDVDKVAF TGSTEIGRVI QVAAGSSNLK RVTLELGGKS PNIIMSDADM
     DWAVEQAHFA LFFNQGQCCC AGSRTFVQED IYDEFVERSV ARAKSRVVGN PFDSKTEQGP
     QVDETQFKKI LGYINTGKQE GAKLLCGGGI AADRGYFIQP TVFGDVQDGM TIAKEEIFGP
     VMQILKFKTI EEVVGRANNS TYGLAAAVFT KDLDKANYLS QALQAGTVWV NCYDVFGAQS
     PFGGYKMSGS GRELGEYGLQ AYTEVKTVTV KVPQKNS
//
ID   CO065_HUMAN             Reviewed;         121 AA.
AC   H3BRN8;
DT   18-SEP-2013, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2012, sequence version 1.
DT   16-JAN-2019, entry version 42.
DE   RecName: Full=Uncharacterized protein C15orf65;
GN   Name=C15orf65;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Endometrium;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; BX648577; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK130862; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC013355; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471082; EAW77489.1; -; Genomic_DNA.
DR   CCDS; CCDS58363.1; -.
DR   RefSeq; NP_001185713.1; NM_001198784.1.
DR   UniGene; Hs.97300; -.
DR   ProteinModelPortal; H3BRN8; -.
DR   IntAct; H3BRN8; 1.
DR   BioMuta; C15orf65; -.
DR   PaxDb; H3BRN8; -.
DR   PRIDE; H3BRN8; -.
DR   ProteomicsDB; 42122; -.
DR   Ensembl; ENST00000569691; ENSP00000456337; ENSG00000261652.
DR   GeneID; 145788; -.
DR   KEGG; hsa:145788; -.
DR   UCSC; uc002ada.4; human.
DR   CTD; 145788; -.
DR   EuPathDB; HostDB:ENSG00000261652.2; -.
DR   GeneCards; C15orf65; -.
DR   HGNC; HGNC:44654; C15orf65.
DR   HPA; HPA067189; -.
DR   neXtProt; NX_H3BRN8; -.
DR   OpenTargets; ENSG00000261652; -.
DR   eggNOG; ENOG410J67E; Eukaryota.
DR   eggNOG; ENOG410Y12M; LUCA.
DR   GeneTree; ENSGT00940000154745; -.
DR   InParanoid; H3BRN8; -.
DR   OMA; MIMYKTS; -.
DR   OrthoDB; 1488437at2759; -.
DR   TreeFam; TF323876; -.
DR   GenomeRNAi; 145788; -.
DR   PRO; PR:H3BRN8; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000261652; Expressed in 174 organ(s), highest expression level in bronchial epithelial cell.
DR   Genevisible; H3BRN8; HS.
DR   InterPro; IPR026507; UPF0691.
DR   PANTHER; PTHR20899; PTHR20899; 1.
DR   Pfam; PF14892; DUF4490; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Reference proteome.
FT   CHAIN         1    121       Uncharacterized protein C15orf65.
FT                                /FTId=PRO_0000423417.
FT   CONFLICT      5      5       N -> K (in Ref. 1; BX648577).
FT                                {ECO:0000305}.
FT   CONFLICT     10     10       S -> G (in Ref. 1; BX648577).
FT                                {ECO:0000305}.
SQ   SEQUENCE   121 AA;  13763 MW;  7B799AC08A1B561A CRC64;
     MTDRNRDKKS TSPSNSDTEM KSEQLPPCVN PGNPVFSCML DPKTLQTATS LSKPQMIMYK
     TNSSHYGEFL PIPQFFPCNY TPKEQVFSSH IRATGFYQNN TLNTAPDRTR TLDFPNIQHT
     L
//
ID   CEP89_HUMAN             Reviewed;         783 AA.
AC   Q96ST8; B9EGA6; Q8N5J8;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   13-FEB-2019, entry version 124.
DE   RecName: Full=Centrosomal protein of 89 kDa;
DE            Short=Cep89;
DE   AltName: Full=Centrosomal protein 123;
DE            Short=Cep123;
DE   AltName: Full=Coiled-coil domain-containing protein 123;
GN   Name=CEP89; Synonyms=CCDC123;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   ALA-398.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   ALA-398.
RC   TISSUE=Brain, and Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A.,
RA   Mann M.;
RT   "Proteomic characterization of the human centrosome by protein
RT   correlation profiling.";
RL   Nature 426:570-574(2003).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21976302; DOI=10.1002/cm.20536;
RA   Sillibourne J.E., Specht C.G., Izeddin I., Hurbain I., Tran P.,
RA   Triller A., Darzacq X., Dahan M., Bornens M.;
RT   "Assessing the localization of centrosomal proteins by PALM/STORM
RT   nanoscopy.";
RL   Cytoskeleton 68:619-627(2011).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=21399614; DOI=10.1038/emboj.2011.63;
RA   Jakobsen L., Vanselow K., Skogs M., Toyoda Y., Lundberg E., Poser I.,
RA   Falkenby L.G., Bennetzen M., Westendorf J., Nigg E.A., Uhlen M.,
RA   Hyman A.A., Andersen J.S.;
RT   "Novel asymmetrically localizing components of human centrosomes
RT   identified by complementary proteomics methods.";
RL   EMBO J. 30:1520-1535(2011).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23348840; DOI=10.1101/gad.207043.112;
RA   Tanos B.E., Yang H.J., Soni R., Wang W.J., Macaluso F.P., Asara J.M.,
RA   Tsou M.F.;
RT   "Centriole distal appendages promote membrane docking, leading to
RT   cilia initiation.";
RL   Genes Dev. 27:163-168(2013).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISEASE.
RX   PubMed=23575228; DOI=10.1093/hmg/ddt170;
RA   van Bon B.W., Oortveld M.A., Nijtmans L.G., Fenckova M., Nijhof B.,
RA   Besseling J., Vos M., Kramer J.M., de Leeuw N., Castells-Nobau A.,
RA   Asztalos L., Viragh E., Ruiter M., Hofmann F., Eshuis L., Collavin L.,
RA   Huynen M.A., Asztalos Z., Verstreken P., Rodenburg R.J.,
RA   Smeitink J.A., de Vries B.B., Schenck A.;
RT   "CEP89 is required for mitochondrial metabolism and neuronal function
RT   in man and fly.";
RL   Hum. Mol. Genet. 22:3138-3151(2013).
CC   -!- FUNCTION: Required for ciliogenesis. Also plays a role in
CC       mitochondrial metabolism where it may modulate complex IV
CC       activity. {ECO:0000269|PubMed:23348840,
CC       ECO:0000269|PubMed:23575228}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:14654843}. Cytoplasm, cytoskeleton, spindle
CC       pole. Cytoplasm, cytoskeleton, microtubule organizing center,
CC       centrosome, centriole. Mitochondrion intermembrane space.
CC       Note=Localizes to the distal appendage region of the centriole,
CC       which anchors the mother centriole to the plasma membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q96ST8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96ST8-2; Sequence=VSP_039181;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q96ST8-3; Sequence=VSP_039182, VSP_039183;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Note=Homozygous deletion comprising CEP89 and SLC7A9
CC       genes has been reported in a patient with isolated complex IV
CC       deficiency, intellectual disability and multisystemic problems
CC       that include cystinuria, cataract, broad based walking pattern and
CC       deafness. {ECO:0000269|PubMed:23575228}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK027546; BAB55190.1; -; mRNA.
DR   EMBL; AC008805; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC119048; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011449; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032307; AAH32307.1; -; mRNA.
DR   EMBL; BC136328; AAI36329.1; -; mRNA.
DR   CCDS; CCDS32987.1; -. [Q96ST8-1]
DR   RefSeq; NP_116205.3; NM_032816.4. [Q96ST8-1]
DR   RefSeq; XP_011525727.1; XM_011527425.2.
DR   UniGene; Hs.599703; -.
DR   ProteinModelPortal; Q96ST8; -.
DR   SMR; Q96ST8; -.
DR   BioGrid; 124342; 90.
DR   DIP; DIP-47325N; -.
DR   IntAct; Q96ST8; 89.
DR   STRING; 9606.ENSP00000306105; -.
DR   iPTMnet; Q96ST8; -.
DR   PhosphoSitePlus; Q96ST8; -.
DR   BioMuta; CEP89; -.
DR   DMDM; 296439414; -.
DR   EPD; Q96ST8; -.
DR   jPOST; Q96ST8; -.
DR   MaxQB; Q96ST8; -.
DR   PaxDb; Q96ST8; -.
DR   PeptideAtlas; Q96ST8; -.
DR   PRIDE; Q96ST8; -.
DR   ProteomicsDB; 78147; -.
DR   ProteomicsDB; 78148; -. [Q96ST8-2]
DR   ProteomicsDB; 78149; -. [Q96ST8-3]
DR   Ensembl; ENST00000305768; ENSP00000306105; ENSG00000121289. [Q96ST8-1]
DR   GeneID; 84902; -.
DR   KEGG; hsa:84902; -.
DR   UCSC; uc002nty.4; human. [Q96ST8-1]
DR   CTD; 84902; -.
DR   DisGeNET; 84902; -.
DR   EuPathDB; HostDB:ENSG00000121289.17; -.
DR   GeneCards; CEP89; -.
DR   H-InvDB; HIX0022917; -.
DR   HGNC; HGNC:25907; CEP89.
DR   HPA; HPA039382; -.
DR   HPA; HPA040056; -.
DR   MIM; 615470; gene.
DR   neXtProt; NX_Q96ST8; -.
DR   OpenTargets; ENSG00000121289; -.
DR   PharmGKB; PA147358250; -.
DR   eggNOG; ENOG410IGSG; Eukaryota.
DR   eggNOG; ENOG410ZNEI; LUCA.
DR   GeneTree; ENSGT00390000018876; -.
DR   HOGENOM; HOG000111383; -.
DR   HOVERGEN; HBG075238; -.
DR   InParanoid; Q96ST8; -.
DR   KO; K16543; -.
DR   OMA; KTAQYQQ; -.
DR   OrthoDB; 476357at2759; -.
DR   PhylomeDB; Q96ST8; -.
DR   TreeFam; TF329234; -.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   ChiTaRS; CEP89; human.
DR   GenomeRNAi; 84902; -.
DR   PRO; PR:Q96ST8; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000121289; Expressed in 167 organ(s), highest expression level in tendon of biceps brachii.
DR   ExpressionAtlas; Q96ST8; baseline and differential.
DR   Genevisible; Q96ST8; HS.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0097539; C:ciliary transition fiber; IDA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IEA:UniProtKB-SubCell.
DR   GO; GO:0031514; C:motile cilium; IEA:Ensembl.
DR   GO; GO:0097730; C:non-motile cilium; IDA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0000922; C:spindle pole; IDA:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; IEA:InterPro.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0060271; P:cilium assembly; IMP:UniProtKB.
DR   GO; GO:0007005; P:mitochondrion organization; IEA:InterPro.
DR   GO; GO:1905515; P:non-motile cilium assembly; IMP:GO_Central.
DR   InterPro; IPR033545; CEP89.
DR   PANTHER; PTHR36170; PTHR36170; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cilium biogenesis/degradation; Coiled coil;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Mitochondrion;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    783       Centrosomal protein of 89 kDa.
FT                                /FTId=PRO_0000288809.
FT   COILED      234    333       {ECO:0000255}.
FT   COILED      369    719       {ECO:0000255}.
FT   MOD_RES      50     50       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   VAR_SEQ       1    247       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_039181.
FT   VAR_SEQ     344    356       SLNIEGLPSKGPI -> VTFPIVKISFSDF (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039182.
FT   VAR_SEQ     357    782       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039183.
FT   VARIANT     194    194       R -> W (in dbSNP:rs3764633).
FT                                /FTId=VAR_063122.
FT   VARIANT     398    398       V -> A (in dbSNP:rs4805825).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_063123.
SQ   SEQUENCE   783 AA;  89590 MW;  7EE45B222951CED0 CRC64;
     MLLGFRRGRR SHFKHIIHGL LPAASVAPKA AVPRTPPPRS PNPSPERPRS ALAAAILATT
     LTGRTVAIPQ PRQRSRSESD VSSVEQDSFI EPYATTSQLR PRPNWQSEMG RRSSLPSFET
     LDYGDEEDIE TQLSSSGKEL GDVSAREDRG GHSDDLYAVP HRNQVPLLHE VNSEDDENIS
     HQDGFPGSPP APQRTQQKDG KHPVLNLKDE KPPLCEKPPP SPDITGRARQ RYTEITREKF
     EALKEENMDL NNMNQSLTLE LNTMKQAMKE LQLKLKGMEK EKRKLKEAEK ASSQEVAAPE
     LLYLRKQAQE LVDENDGLKM TVHRLNVELS RYQTKFRHLS KEESLNIEGL PSKGPIPPWL
     LDIKYLSPLL LAYEDMMKEK DELNATLKEE MRMFRMRVQE VVKENEELHQ ELNKSSAVTS
     EEWRQLQTQA KLVLEENKLL LEQLEIQQRK AKDSHQERLQ EVSKLTKQLM LLEAKTHGQE
     KELAENREQL EILRAKCQEL KTHSDGKIAV EVHKSIVNEL KSQLQKEEEK ERAEMEELME
     KLTVLQAQKK SLLLEKNSLT EQNKALEAEL ERAQKINRKS QKKIEVLKKQ VEKAMGNEMS
     AHQYLANLVG LAENITQERD SLMCLAKCLE SEKDGVLNKV IKSNIRLGKL EEKVKGYKKQ
     AALKLGDISH RLLEQQEDFA GKTAQYRQEM RHLHQVLKDK QEVLDQALQQ NREMEGELEV
     IWESTFRENR RIRELLQDTL TRTGVQDNPR ALVAPSLNGV SQADLLDGCD VCSYDLKSHA
     PTC
//
ID   CHIC2_HUMAN             Reviewed;         165 AA.
AC   Q9UKJ5; B2R639;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   13-FEB-2019, entry version 129.
DE   RecName: Full=Cysteine-rich hydrophobic domain-containing protein 2;
DE   AltName: Full=BrX-like translocated in leukemia;
GN   Name=CHIC2; Synonyms=BTL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL TRANSLOCATION WITH ETV6.
RX   PubMed=10477709;
RA   Cools J., Bilhou-Nabera C., Wlodarska I., Cabrol C., Talmant P.,
RA   Bernard P., Hagemeijer A., Marynen P.;
RT   "Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with
RT   a t(4;12)(q11-q12;p13).";
RL   Blood 94:1820-1824(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF 88-CYS--CYS-95, AND
RP   PALMITOYLATION.
RX   PubMed=11257495; DOI=10.1016/S0014-5793(01)02240-2;
RA   Cools J., Mentens N., Marynen P.;
RT   "A new family of small, palmitoylated, membrane-associated proteins,
RT   characterized by the presence of a cysteine-rich hydrophobic motif.";
RL   FEBS Lett. 492:204-209(2001).
CC   -!- INTERACTION:
CC       Q8NEC5:CATSPER1; NbExp=3; IntAct=EBI-741528, EBI-744545;
CC       Q01850:CDR2; NbExp=5; IntAct=EBI-741528, EBI-1181367;
CC       Q9C0F1:CEP44; NbExp=3; IntAct=EBI-741528, EBI-744115;
CC       Q53SE7:FLJ13057; NbExp=3; IntAct=EBI-741528, EBI-10172181;
CC       P49639:HOXA1; NbExp=3; IntAct=EBI-741528, EBI-740785;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-741528, EBI-10171697;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-741528, EBI-10172290;
CC       P60410:KRTAP10-8; NbExp=5; IntAct=EBI-741528, EBI-10171774;
CC       P60411:KRTAP10-9; NbExp=3; IntAct=EBI-741528, EBI-10172052;
CC       Q9BYR5:KRTAP4-2; NbExp=3; IntAct=EBI-741528, EBI-10172511;
CC       P26371:KRTAP5-9; NbExp=5; IntAct=EBI-741528, EBI-3958099;
CC       Q5TA76:LCE3A; NbExp=4; IntAct=EBI-741528, EBI-9394625;
CC       Q5T5A8:LCE3C; NbExp=4; IntAct=EBI-741528, EBI-10245291;
CC       P50222:MEOX2; NbExp=3; IntAct=EBI-741528, EBI-748397;
CC       Q7Z3S9:NOTCH2NLA; NbExp=5; IntAct=EBI-741528, EBI-945833;
CC       P32242:OTX1; NbExp=3; IntAct=EBI-741528, EBI-740446;
CC       Q9H8W4:PLEKHF2; NbExp=3; IntAct=EBI-741528, EBI-742388;
CC       Q8ND90:PNMA1; NbExp=3; IntAct=EBI-741528, EBI-302345;
CC       Q8NA61:SPERT; NbExp=3; IntAct=EBI-741528, EBI-741724;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-741528, EBI-533224;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11257495}.
CC       Cytoplasmic vesicle {ECO:0000269|PubMed:11257495}. Note=Also
CC       present at a Golgi-like vesicular compartment and at scattered
CC       vesicles.
CC   -!- PTM: Palmitoylation in the CHIC motif is required for membrane
CC       association. {ECO:0000269|PubMed:11257495}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CHIC2 is found in
CC       a form of acute myeloid leukemia (AML). Translocation
CC       t(4;12)(q12;p13) with ETV6. {ECO:0000269|PubMed:10477709}.
CC   -!- SIMILARITY: Belongs to the CHIC family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CHIC2ID373.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF159423; AAD55981.1; -; mRNA.
DR   EMBL; AK312427; BAG35336.1; -; mRNA.
DR   EMBL; CH471057; EAX05453.1; -; Genomic_DNA.
DR   EMBL; BC034691; AAH34691.1; -; mRNA.
DR   CCDS; CCDS3493.1; -.
DR   RefSeq; NP_036242.1; NM_012110.3.
DR   UniGene; Hs.335393; -.
DR   ProteinModelPortal; Q9UKJ5; -.
DR   BioGrid; 117716; 29.
DR   IntAct; Q9UKJ5; 60.
DR   STRING; 9606.ENSP00000263921; -.
DR   iPTMnet; Q9UKJ5; -.
DR   PhosphoSitePlus; Q9UKJ5; -.
DR   SwissPalm; Q9UKJ5; -.
DR   BioMuta; CHIC2; -.
DR   DMDM; 62901505; -.
DR   EPD; Q9UKJ5; -.
DR   PaxDb; Q9UKJ5; -.
DR   PeptideAtlas; Q9UKJ5; -.
DR   PRIDE; Q9UKJ5; -.
DR   ProteomicsDB; 84809; -.
DR   DNASU; 26511; -.
DR   Ensembl; ENST00000263921; ENSP00000263921; ENSG00000109220.
DR   GeneID; 26511; -.
DR   KEGG; hsa:26511; -.
DR   UCSC; uc003haj.3; human.
DR   CTD; 26511; -.
DR   DisGeNET; 26511; -.
DR   EuPathDB; HostDB:ENSG00000109220.10; -.
DR   GeneCards; CHIC2; -.
DR   HGNC; HGNC:1935; CHIC2.
DR   HPA; HPA026782; -.
DR   HPA; HPA026784; -.
DR   HPA; HPA076603; -.
DR   MalaCards; CHIC2; -.
DR   MIM; 604332; gene.
DR   neXtProt; NX_Q9UKJ5; -.
DR   OpenTargets; ENSG00000109220; -.
DR   PharmGKB; PA26466; -.
DR   eggNOG; KOG4101; Eukaryota.
DR   eggNOG; ENOG4111JK6; LUCA.
DR   GeneTree; ENSGT00390000003601; -.
DR   HOGENOM; HOG000236313; -.
DR   HOVERGEN; HBG050942; -.
DR   InParanoid; Q9UKJ5; -.
DR   OMA; ENSRLYH; -.
DR   OrthoDB; 1449345at2759; -.
DR   PhylomeDB; Q9UKJ5; -.
DR   TreeFam; TF314908; -.
DR   GenomeRNAi; 26511; -.
DR   PRO; PR:Q9UKJ5; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000109220; Expressed in 210 organ(s), highest expression level in testis.
DR   ExpressionAtlas; Q9UKJ5; baseline and differential.
DR   Genevisible; Q9UKJ5; HS.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0005798; C:Golgi-associated vesicle; IBA:GO_Central.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   InterPro; IPR039735; CHIC1/2.
DR   InterPro; IPR019383; Golgin_A_7/ERF4.
DR   PANTHER; PTHR13005; PTHR13005; 1.
DR   Pfam; PF10256; Erf4; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Chromosomal rearrangement; Coiled coil;
KW   Complete proteome; Cytoplasmic vesicle; Lipoprotein; Membrane;
KW   Palmitate; Reference proteome.
FT   CHAIN         1    165       Cysteine-rich hydrophobic domain-
FT                                containing protein 2.
FT                                /FTId=PRO_0000189556.
FT   COILED        1     26       {ECO:0000255}.
FT   MOTIF        88    106       CHIC motif (Cys-rich).
FT   COMPBIAS      9     15       Poly-Glu.
FT   SITE        111    112       Breakpoint for translocation to form
FT                                CHIC2-ETV6 in AML.
FT   MUTAGEN      88     95       CGCLCCCC->SGSLSSSS: Loss of
FT                                palmitoylation. Abolishes membrane
FT                                association.
FT                                {ECO:0000269|PubMed:11257495}.
SQ   SEQUENCE   165 AA;  19254 MW;  DC32A9C58524B55E CRC64;
     MADFDEIYEE EEDEERALEE QLLKYSPDPV VVRGSGHVTV FGLSNKFESE FPSSLTGKVA
     PEEFKASINR VNSCLKKNLP VNVRWLLCGC LCCCCTLGCS MWPVICLSKR TRRSIEKLLE
     WENNRLYHKL CLHWRLSKRK CETNNMMEYV ILIEFLPKTP IFRPD
//
ID   CLP1_HUMAN              Reviewed;         425 AA.
AC   Q92989; B2R7J6; B4DTI8;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   13-FEB-2019, entry version 152.
DE   RecName: Full=Polyribonucleotide 5'-hydroxyl-kinase Clp1 {ECO:0000255|HAMAP-Rule:MF_03035};
DE            EC=2.7.1.78 {ECO:0000255|HAMAP-Rule:MF_03035};
DE   AltName: Full=Polyadenylation factor Clp1 {ECO:0000255|HAMAP-Rule:MF_03035};
DE   AltName: Full=Polynucleotide kinase Clp1 {ECO:0000255|HAMAP-Rule:MF_03035};
DE   AltName: Full=Pre-mRNA cleavage complex II protein Clp1 {ECO:0000255|HAMAP-Rule:MF_03035};
GN   Name=CLP1 {ECO:0000255|HAMAP-Rule:MF_03035}; Synonyms=HEAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8896421;
RA   Tanabe S., Bohlander S.K., Vignon C.V., Espinosa R. III, Zhao N.,
RA   Strissel P.L., Zeleznik-Le N.J., Rowley J.D.;
RT   "AF10 is split by MLL and HEAB, a human homolog to a putative
RT   Caenorhabditis elegans ATP/GTP-binding protein in an
RT   invins(10;11)(p12;q23q12).";
RL   Blood 88:3535-3545(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cerebellum, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION AS A COMPONENT OF
RP   THE PRE-MRNA CLEAVAGE COMPLEX II, ASSOCIATION WITH THE PRE-MRNA
RP   CLEAVAGE COMPLEX I, AND SUBCELLULAR LOCATION.
RX   PubMed=11060040; DOI=10.1093/emboj/19.21.5895;
RA   de Vries H., Rueegsegger U., Huebner W., Friedlein A., Langen H.,
RA   Keller W.;
RT   "Human pre-mRNA cleavage factor II(m) contains homologs of yeast
RT   proteins and bridges two other cleavage factors.";
RL   EMBO J. 19:5895-5904(2000).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN A COMPLEX WITH
RP   TSEN2; TSEN15; TSEN34 TSEN54, AND INTERACTION WITH CSTF2 AND SYMPK.
RX   PubMed=15109492; DOI=10.1016/S0092-8674(04)00342-3;
RA   Paushkin S.V., Patel M., Furia B.S., Peltz S.W., Trotta C.R.;
RT   "Identification of a human endonuclease complex reveals a link between
RT   tRNA splicing and pre-mRNA 3' end formation.";
RL   Cell 117:311-321(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, IDENTIFICATION IN A COMPLEX WITH TSEN2; TSEN15; TSEN34
RP   TSEN54, AND MUTAGENESIS OF 127-LYS-SER-128.
RX   PubMed=17495927; DOI=10.1038/nature05777;
RA   Weitzer S., Martinez J.;
RT   "The human RNA kinase hClp1 is active on 3' transfer RNA exons and
RT   short interfering RNAs.";
RL   Nature 447:222-226(2007).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF 127-LYS-SER-128 AND
RP   ASP-151.
RX   PubMed=18648070; DOI=10.1261/rna.1142908;
RA   Ramirez A., Shuman S., Schwer B.;
RT   "Human RNA 5'-kinase (hClp1) can function as a tRNA splicing enzyme in
RT   vivo.";
RL   RNA 14:1737-1745(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10]
RP   VARIANT PCH10 HIS-140, FUNCTION, IDENTIFICATION IN THE TRNA SPLICING
RP   ENDONUCLEASE COMPLEX, MUTAGENESIS OF LYS-127, AND CHARACTERIZATION OF
RP   VARIANT PCH10 HIS-140.
RX   PubMed=24766809; DOI=10.1016/j.cell.2014.02.058;
RG   Baylor Hopkins Center for Mendelian Genomics;
RA   Karaca E., Weitzer S., Pehlivan D., Shiraishi H., Gogakos T.,
RA   Hanada T., Jhangiani S.N., Wiszniewski W., Withers M., Campbell I.M.,
RA   Erdin S., Isikay S., Franco L.M., Gonzaga-Jauregui C., Gambin T.,
RA   Gelowani V., Hunter J.V., Yesil G., Koparir E., Yilmaz S., Brown M.,
RA   Briskin D., Hafner M., Morozov P., Farazi T.A., Bernreuther C.,
RA   Glatzel M., Trattnig S., Friske J., Kronnerwetter C., Bainbridge M.N.,
RA   Gezdirici A., Seven M., Muzny D.M., Boerwinkle E., Ozen M.,
RA   Clausen T., Tuschl T., Yuksel A., Hess A., Gibbs R.A., Martinez J.,
RA   Penninger J.M., Lupski J.R.;
RT   "Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral
RT   and central nervous system function.";
RL   Cell 157:636-650(2014).
RN   [11]
RP   VARIANT PCH10 HIS-140, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=24766810; DOI=10.1016/j.cell.2014.03.049;
RA   Schaffer A.E., Eggens V.R., Caglayan A.O., Reuter M.S., Scott E.,
RA   Coufal N.G., Silhavy J.L., Xue Y., Kayserili H., Yasuno K.,
RA   Rosti R.O., Abdellateef M., Caglar C., Kasher P.R., Cazemier J.L.,
RA   Weterman M.A., Cantagrel V., Cai N., Zweier C., Altunoglu U.,
RA   Satkin N.B., Aktar F., Tuysuz B., Yalcinkaya C., Caksen H.,
RA   Bilguvar K., Fu X.D., Trotta C.R., Gabriel S., Reis A., Gunel M.,
RA   Baas F., Gleeson J.G.;
RT   "CLP1 founder mutation links tRNA splicing and maturation to
RT   cerebellar development and neurodegeneration.";
RL   Cell 157:651-663(2014).
CC   -!- FUNCTION: Polynucleotide kinase that can phosphorylate the 5'-
CC       hydroxyl groups of double-stranded RNA (dsRNA), single-stranded
CC       RNA (ssRNA), double-stranded DNA (dsDNA) and double-stranded
CC       DNA:RNA hybrids. dsRNA is phosphorylated more efficiently than
CC       dsDNA, and the RNA component of a DNA:RNA hybrid is phosphorylated
CC       more efficiently than the DNA component. Plays a key role in both
CC       tRNA splicing and mRNA 3'-end formation. Component of the tRNA
CC       splicing endonuclease complex: phosphorylates the 5'-terminus of
CC       the tRNA 3'-exon during tRNA splicing; this phosphorylation event
CC       is a prerequisite for the subsequent ligation of the two exon
CC       halves and the production of a mature tRNA (PubMed:24766809,
CC       PubMed:24766810). Its role in tRNA splicing and maturation is
CC       required for cerebellar development (PubMed:24766809,
CC       PubMed:24766810). Component of the pre-mRNA cleavage complex II
CC       (CF-II), which seems to be required for mRNA 3'-end formation.
CC       Also phosphorylates the 5'-terminus of exogenously introduced
CC       short interfering RNAs (siRNAs), which is a necessary prerequisite
CC       for their incorporation into the RNA-induced silencing complex
CC       (RISC). However, endogenous siRNAs and microRNAs (miRNAs) that are
CC       produced by the cleavage of dsRNA precursors by DICER1 already
CC       contain a 5'-phosphate group, so this protein may be dispensible
CC       for normal RNA-mediated gene silencing.
CC       {ECO:0000269|PubMed:17495927, ECO:0000269|PubMed:18648070,
CC       ECO:0000269|PubMed:24766809, ECO:0000269|PubMed:24766810}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5'-dephospho-(DNA) + ATP = ADP + H(+) + phospho-5'-(DNA);
CC         Xref=Rhea:RHEA:15669, Rhea:RHEA-COMP:13180, Rhea:RHEA-
CC         COMP:13184, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:136412, ChEBI:CHEBI:136416, ChEBI:CHEBI:456216;
CC         EC=2.7.1.78; Evidence={ECO:0000255|HAMAP-Rule:MF_03035};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5'-dephospho-(RNA) + ATP = 5'-end-(RNA) + ADP + H(+);
CC         Xref=Rhea:RHEA:54580, Rhea:RHEA-COMP:13935, Rhea:RHEA-
CC         COMP:13936, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:138282, ChEBI:CHEBI:138284, ChEBI:CHEBI:456216;
CC         EC=2.7.1.78; Evidence={ECO:0000255|HAMAP-Rule:MF_03035};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03035,
CC         ECO:0000269|PubMed:17495927};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03035,
CC         ECO:0000269|PubMed:17495927};
CC       Name=Ni(2+); Xref=ChEBI:CHEBI:49786;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03035,
CC         ECO:0000269|PubMed:17495927};
CC   -!- SUBUNIT: Component of the tRNA splicing endonuclease complex,
CC       composed of CLP1, TSEN2, TSEN15, TSEN34 and TSEN54
CC       (PubMed:24766809). Component of pre-mRNA cleavage complex II (CF-
CC       II). Also associates with numerous components of the pre-mRNA
CC       cleavage complex I (CF-I/CFIm), including NUDT21, CPSF2, CPSF3,
CC       CPSF6 and CPSF7. Interacts with CSTF2 and SYMPK.
CC       {ECO:0000269|PubMed:15109492, ECO:0000269|PubMed:17495927,
CC       ECO:0000269|PubMed:24766809}.
CC   -!- INTERACTION:
CC       Q7Z6J9:TSEN54; NbExp=4; IntAct=EBI-2559831, EBI-2559824;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|HAMAP-Rule:MF_03035,
CC       ECO:0000269|PubMed:11060040, ECO:0000269|PubMed:24766810}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q92989-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92989-2; Sequence=VSP_041164;
CC   -!- DISEASE: Pontocerebellar hypoplasia 10 (PCH10) [MIM:615803]: A
CC       form of pontocerebellar hypoplasia, a disorder characterized by
CC       structural defects of the pons and cerebellum, evident upon brain
CC       imaging. PCH10 features include cortical dysgenesis marked by a
CC       simplified gyral pattern, cortical atrophy, mild or focal
CC       cerebellar vermian volume loss, delayed myelination, progressive
CC       microcephaly, global growth and developmental delays, severe
CC       intellectual disabilities, and seizures refractory to treatment.
CC       {ECO:0000269|PubMed:24766809, ECO:0000269|PubMed:24766810}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry. Neurodegeneration is due to defects in
CC       tRNA splicing (PubMed:24766809, PubMed:24766810).
CC       {ECO:0000269|PubMed:24766809, ECO:0000269|PubMed:24766810}.
CC   -!- SIMILARITY: Belongs to the Clp1 family. Clp1 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03035}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U73524; AAC50780.1; -; mRNA.
DR   EMBL; AK300232; BAG62000.1; -; mRNA.
DR   EMBL; AK313007; BAG35843.1; -; mRNA.
DR   EMBL; CH471076; EAW73770.1; -; Genomic_DNA.
DR   EMBL; BC000446; AAH00446.1; -; mRNA.
DR   CCDS; CCDS44600.1; -. [Q92989-2]
DR   CCDS; CCDS7964.1; -. [Q92989-1]
DR   RefSeq; NP_001136069.1; NM_001142597.1. [Q92989-2]
DR   RefSeq; NP_006822.1; NM_006831.2. [Q92989-1]
DR   UniGene; Hs.523687; -.
DR   ProteinModelPortal; Q92989; -.
DR   SMR; Q92989; -.
DR   BioGrid; 116174; 24.
DR   CORUM; Q92989; -.
DR   IntAct; Q92989; 14.
DR   MINT; Q92989; -.
DR   STRING; 9606.ENSP00000434995; -.
DR   iPTMnet; Q92989; -.
DR   PhosphoSitePlus; Q92989; -.
DR   BioMuta; CLP1; -.
DR   DMDM; 13431366; -.
DR   EPD; Q92989; -.
DR   jPOST; Q92989; -.
DR   MaxQB; Q92989; -.
DR   PaxDb; Q92989; -.
DR   PeptideAtlas; Q92989; -.
DR   PRIDE; Q92989; -.
DR   ProteomicsDB; 75650; -.
DR   ProteomicsDB; 75651; -. [Q92989-2]
DR   DNASU; 10978; -.
DR   Ensembl; ENST00000302731; ENSP00000304704; ENSG00000172409. [Q92989-2]
DR   Ensembl; ENST00000525602; ENSP00000436066; ENSG00000172409. [Q92989-1]
DR   Ensembl; ENST00000533682; ENSP00000434995; ENSG00000172409. [Q92989-1]
DR   GeneID; 10978; -.
DR   KEGG; hsa:10978; -.
DR   UCSC; uc001nkw.4; human. [Q92989-1]
DR   CTD; 10978; -.
DR   DisGeNET; 10978; -.
DR   EuPathDB; HostDB:ENSG00000172409.5; -.
DR   GeneCards; CLP1; -.
DR   HGNC; HGNC:16999; CLP1.
DR   HPA; HPA057770; -.
DR   MalaCards; CLP1; -.
DR   MIM; 608757; gene.
DR   MIM; 615803; phenotype.
DR   neXtProt; NX_Q92989; -.
DR   OpenTargets; ENSG00000172409; -.
DR   Orphanet; 411493; Pontocerebellar hypoplasia type 10.
DR   PharmGKB; PA162382477; -.
DR   eggNOG; KOG2749; Eukaryota.
DR   eggNOG; COG5623; LUCA.
DR   GeneTree; ENSGT00940000153668; -.
DR   HOGENOM; HOG000231935; -.
DR   HOVERGEN; HBG000921; -.
DR   KO; K14399; -.
DR   OrthoDB; 814241at2759; -.
DR   PhylomeDB; Q92989; -.
DR   TreeFam; TF105795; -.
DR   Reactome; R-HSA-109688; Cleavage of Growing Transcript in the Termination Region.
DR   Reactome; R-HSA-6784531; tRNA processing in the nucleus.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72187; mRNA 3'-end processing.
DR   Reactome; R-HSA-77595; Processing of Intronless Pre-mRNAs.
DR   GenomeRNAi; 10978; -.
DR   PRO; PR:Q92989; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000172409; Expressed in 212 organ(s), highest expression level in secondary oocyte.
DR   ExpressionAtlas; Q92989; baseline and differential.
DR   Genevisible; Q92989; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005849; C:mRNA cleavage factor complex; IEA:UniProtKB-UniRule.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000214; C:tRNA-intron endonuclease complex; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; TAS:UniProtKB.
DR   GO; GO:0046404; F:ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0051736; F:ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity; IDA:UniProtKB.
DR   GO; GO:0051733; F:polydeoxyribonucleotide kinase activity; IDA:UniProtKB.
DR   GO; GO:0021695; P:cerebellar cortex development; IMP:UniProtKB.
DR   GO; GO:0031124; P:mRNA 3'-end processing; TAS:UniProtKB.
DR   GO; GO:0006378; P:mRNA polyadenylation; IBA:GO_Central.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0035087; P:siRNA loading onto RISC involved in RNA interference; IDA:UniProtKB.
DR   GO; GO:0030423; P:targeting of mRNA for destruction involved in RNA interference; IMP:UniProtKB.
DR   GO; GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome.
DR   GO; GO:0006388; P:tRNA splicing, via endonucleolytic cleavage and ligation; IDA:UniProtKB.
DR   Gene3D; 2.60.120.1030; -; 1.
DR   Gene3D; 3.30.70.2410; -; 1.
DR   HAMAP; MF_03035; Clp1; 1.
DR   InterPro; IPR028606; Clp1.
DR   InterPro; IPR010655; Clp1_C.
DR   InterPro; IPR038238; Clp1_C_sf.
DR   InterPro; IPR032324; Clp1_N.
DR   InterPro; IPR038239; Clp1_N_sf.
DR   InterPro; IPR032319; CLP1_P.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF06807; Clp1; 1.
DR   Pfam; PF16573; CLP1_N; 1.
DR   Pfam; PF16575; CLP1_P; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome;
KW   Disease mutation; Kinase; Magnesium; Manganese; mRNA processing;
KW   Neurodegeneration; Nickel; Nucleotide-binding; Nucleus;
KW   Reference proteome; Transferase; tRNA processing.
FT   CHAIN         1    425       Polyribonucleotide 5'-hydroxyl-kinase
FT                                Clp1.
FT                                /FTId=PRO_0000089863.
FT   NP_BIND     124    129       ATP. {ECO:0000255|HAMAP-Rule:MF_03035}.
FT   BINDING      22     22       ATP. {ECO:0000255|HAMAP-Rule:MF_03035}.
FT   BINDING      62     62       ATP; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03035}.
FT   VAR_SEQ     139    202       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041164.
FT   VARIANT     140    140       R -> H (in PCH10; decreases kinase
FT                                activity, impairs formation of the tRNA
FT                                splicing endonuclease complex and impairs
FT                                ability to mediate tRNA splicing and
FT                                maturation; dbSNP:rs587777616).
FT                                {ECO:0000269|PubMed:24766809,
FT                                ECO:0000269|PubMed:24766810}.
FT                                /FTId=VAR_070952.
FT   MUTAGEN     127    128       KS->AA: Abrogates RNA kinase activity.
FT                                Abrogates complementation of tRNA
FT                                splicing activity in yeast; when
FT                                associated with A-128.
FT                                {ECO:0000269|PubMed:17495927,
FT                                ECO:0000269|PubMed:18648070}.
FT   MUTAGEN     127    127       K->A: Abrogates RNA kinase activity and
FT                                tRNA splicing activity.
FT                                {ECO:0000269|PubMed:24766809}.
FT   MUTAGEN     151    151       D->A: Abrogates complementation of tRNA
FT                                splicing activity in yeast.
FT                                {ECO:0000269|PubMed:18648070}.
SQ   SEQUENCE   425 AA;  47646 MW;  640AF4768994CFE6 CRC64;
     MGEEANDDKK PTTKFELERE TELRFEVEAS QSVQLELLTG MAEIFGTELT RNKKFTFDAG
     AKVAVFTWHG CSVQLSGRTE VAYVSKDTPM LLYLNTHTAL EQMRRQAEKE EERGPRVMVV
     GPTDVGKSTV CRLLLNYAVR LGRRPTYVEL DVGQGSVSIP GTMGALYIER PADVEEGFSI
     QAPLVYHFGS TTPGTNIKLY NKITSRLADV FNQRCEVNRR ASVSGCVINT CGWVKGSGYQ
     ALVHAASAFE VDVVVVLDQE RLYNELKRDL PHFVRTVLLP KSGGVVERSK DFRRECRDER
     IREYFYGFRG CFYPHAFNVK FSDVKIYKVG APTIPDSCLP LGMSQEDNQL KLVPVTPGRD
     MVHHLLSVST AEGTEENLSE TSVAGFIVVT SVDLEHQVFT VLSPAPRPLP KNFLLIMDIR
     FMDLK
//
ID   CO3A1_HUMAN             Reviewed;        1466 AA.
AC   P02461; D2JYH5; D3DPH4; P78429; Q15112; Q16403; Q53S91; Q541P8;
AC   Q6LDB3; Q6LDJ2; Q6LDJ3; Q7KZ56; Q8N6U4; Q9UC88; Q9UC89; Q9UC90;
AC   Q9UC91; R4N3C5; V9GZI1;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   16-JAN-2019, entry version 213.
DE   RecName: Full=Collagen alpha-1(III) chain;
DE   Flags: Precursor;
GN   Name=COL3A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLN-1353.
RC   TISSUE=Skin fibroblast;
RX   PubMed=2764886; DOI=10.1042/bj2600509;
RA   Ala-Kokko L., Kontusaari S., Baldwin C.T., Kuivaniemi H.,
RA   Prockop D.J.;
RT   "Structure of cDNA clones coding for the entire prepro alpha 1 (III)
RT   chain of human type III procollagen. Differences in protein structure
RT   from type I procollagen and conservation of codon preferences.";
RL   Biochem. J. 260:509-516(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANT GLN-1353.
RX   PubMed=11566270; DOI=10.1016/S0945-053X(01)00145-7;
RA   Valkkila M., Melkoniemi M., Kvist L., Kuivaniemi H., Tromp G.,
RA   Ala-Kokko L.;
RT   "Genomic organization of the human COL3A1 and COL5A2 genes: COL5A2 has
RT   evolved differently than the other minor fibrillar collagen genes.";
RL   Matrix Biol. 20:357-366(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ARG-726.
RA   Fang H.;
RL   Submitted (JAN-2013) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLN-1353.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   GLN-1353.
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-176.
RX   PubMed=2777083; DOI=10.1016/0378-1119(89)90228-X;
RA   Benson-Chanda V., Su M.W., Weil D., Chu M.-L., Ramirez F.;
RT   "Cloning and analysis of the 5' portion of the human type-III
RT   procollagen gene (COL3A1).";
RL   Gene 78:255-265(1989).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-170 (ISOFORMS 1/2).
RC   TISSUE=Placenta;
RX   PubMed=3405773; DOI=10.1093/nar/16.14.7201;
RA   Toman D., Ricca G., de Crombrugghe B.;
RT   "Nucleotide sequence of a cDNA coding for the amino-terminal region of
RT   human prepro alpha 1(III) collagen.";
RL   Nucleic Acids Res. 16:7201-7201(1988).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 149-1225 (ISOFORM 1).
RX   PubMed=2780304; DOI=10.1093/nar/17.16.6742;
RA   Janeczko R.A., Ramirez F.;
RT   "Nucleotide and amino acid sequences of the entire human alpha 1 (III)
RT   collagen.";
RL   Nucleic Acids Res. 17:6742-6742(1989).
RN   [11]
RP   PROTEIN SEQUENCE OF 168-398, AND HYDROXYLATION AT PRO-173; PRO-179;
RP   PRO-182; PRO-185; PRO-191; PRO-194; PRO-197; PRO-203; PRO-206;
RP   PRO-215; PRO-218; PRO-236; PRO-239; PRO-245; PRO-248; PRO-257;
RP   PRO-260; LYS-263; PRO-281; LYS-284; PRO-290; PRO-296; PRO-305;
RP   PRO-311; PRO-314; PRO-332; PRO-335; PRO-338; PRO-344; PRO-347;
RP   PRO-359; PRO-365; PRO-371; PRO-383; PRO-386 AND PRO-392.
RX   PubMed=557335; DOI=10.1021/bi00625a020;
RA   Seyer J.M., Kang A.H.;
RT   "Covalent structure of collagen: amino acid sequence of cyanogen
RT   bromide peptides from the amino-terminal segment of type III collagen
RT   of human liver.";
RL   Biochemistry 16:1158-1164(1977).
RN   [12]
RP   SEQUENCE REVISION.
RA   Seyer J.M.;
RL   Submitted (DEC-1977) to the PIR data bank.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 186-194 (ISOFORMS 1/2).
RX   PubMed=8317500;
RA   Milewicz D.M., Witz A.M., Smith A.C., Manchester D.K., Waldstein G.,
RA   Byers P.H.;
RT   "Parental somatic and germ-line mosaicism for a multiexon deletion
RT   with unusual endpoints in a type III collagen (COL3A1) allele produces
RT   Ehlers-Danlos syndrome type IV in the heterozygous offspring.";
RL   Am. J. Hum. Genet. 53:62-70(1993).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 302-423 (ISOFORMS 1/2).
RX   PubMed=7487954; DOI=10.1042/bj3110939;
RA   Chiodo A.A., Sillence D.O., Cole W.G., Bateman J.F.;
RT   "Abnormal type III collagen produced by an exon-17-skipping mutation
RT   of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not
RT   incorporated into the extracellular matrix.";
RL   Biochem. J. 311:939-943(1995).
RN   [15]
RP   PROTEIN SEQUENCE OF 395-416; 579-595; 800-814 AND 1064-1079.
RC   TISSUE=Colon carcinoma;
RX   PubMed=7864881; DOI=10.1006/bbrc.1995.1264;
RA   Minafra I.P., Andriolo M., Basirico L., Aquino A., Minafra S.,
RA   Boutillon M.-M., van der Rest M.;
RT   "Onco-fetal/laminin-binding collagen from colon carcinoma: detection
RT   of new sequences.";
RL   Biochem. Biophys. Res. Commun. 207:852-859(1995).
RN   [16]
RP   PROTEIN SEQUENCE OF 399-727, AND HYDROXYLATION AT PRO-404; PRO-407;
RP   PRO-416; PRO-425; PRO-434; PRO-443; PRO-455; PRO-458; PRO-470;
RP   PRO-473; PRO-479; PRO-488; PRO-500; PRO-512; PRO-524; PRO-530;
RP   PRO-533; PRO-539; PRO-542; PRO-545; PRO-551; PRO-554; PRO-563;
RP   PRO-566; PRO-575; PRO-581; PRO-590; PRO-599; PRO-602; PRO-608;
RP   PRO-620; PRO-635; PRO-644; PRO-650; PRO-656; PRO-659; PRO-661;
RP   PRO-668; PRO-671; PRO-680; PRO-686; PRO-692; PRO-701; PRO-703;
RP   PRO-713; PRO-716 AND PRO-722.
RX   PubMed=687591; DOI=10.1021/bi00609a034;
RA   Seyer J.M., Kang A.H.;
RT   "Covalent structure of collagen: amino acid sequence of five
RT   consecutive CNBr peptides from type III collagen of human liver.";
RL   Biochemistry 17:3404-3411(1978).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 537-605.
RX   PubMed=1672129;
RA   Lee B., Vitale E., Superti-Furga A., Steinmann B., Ramirez F.;
RT   "G to T transversion at position +5 of a splice donor site causes
RT   skipping of the preceding exon in the type III procollagen transcripts
RT   of a patient with Ehlers-Danlos syndrome type IV.";
RL   J. Biol. Chem. 266:5256-5259(1991).
RN   [18]
RP   PROTEIN SEQUENCE OF 728-964, AND HYDROXYLATION AT PRO-728; PRO-737;
RP   PRO-746; PRO-749; PRO-755; PRO-770; PRO-776; PRO-785; PRO-788;
RP   PRO-797; PRO-806; PRO-812; PRO-815; PRO-821; PRO-830; PRO-839;
RP   PRO-845; PRO-854; LYS-860; PRO-866; PRO-869; PRO-875; PRO-881;
RP   PRO-884; PRO-890; PRO-892; PRO-899; PRO-905; PRO-914; PRO-917;
RP   PRO-929; PRO-935; PRO-941; PRO-944 AND PRO-962.
RX   PubMed=6246925; DOI=10.1021/bi00549a008;
RA   Seyer J.M., Mainardi C., Kang A.H.;
RT   "Covalent structure of collagen: amino acid sequence of alpha 1 (III)-
RT   CB5 from type III collagen of human liver.";
RL   Biochemistry 19:1583-1589(1980).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 861-1015 (ISOFORM 1).
RX   PubMed=2145268;
RA   Cole W.G., Chiodo A.A., Lamande S.R., Janeczko R., Ramirez F.,
RA   Dahl H.-H.M., Chan D., Bateman J.F.;
RT   "A base substitution at a splice site in the COL3A1 gene causes exon
RT   skipping and generates abnormal type III procollagen in a patient with
RT   Ehlers-Danlos syndrome type IV.";
RL   J. Biol. Chem. 265:17070-17077(1990).
RN   [20]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 950-1466 (ISOFORM 1), AND VARIANT
RP   GLN-1353.
RX   PubMed=3357782; DOI=10.1093/nar/16.5.2337;
RA   Mankoo B.S., Dalgleish R.;
RT   "Human pro alpha 1(III) collagen: cDNA sequence for the 3' end.";
RL   Nucleic Acids Res. 16:2337-2337(1988).
RN   [21]
RP   SEQUENCE REVISION TO 1184.
RX   PubMed=3211760; DOI=10.1093/nar/16.24.11833;
RA   Molyneux K., Dalgleish R.;
RT   "Human type III collagen 'variant' is a cDNA cloning artefact.";
RL   Nucleic Acids Res. 16:11833-11833(1988).
RN   [22]
RP   PROTEIN SEQUENCE OF 965-1200, AND HYDROXYLATION AT PRO-965; PRO-971;
RP   LYS-977; PRO-983; PRO-995; PRO-1001; PRO-1010; PRO-1016; PRO-1022;
RP   PRO-1028; PRO-1040; PRO-1043; PRO-1046; PRO-1049; PRO-1052; PRO-1076;
RP   PRO-1085; LYS-1106; PRO-1112; PRO-1115; PRO-1118; PRO-1121; PRO-1133;
RP   PRO-1148; PRO-1157; PRO-1163; PRO-1178; PRO-1181; PRO-1184; PRO-1187;
RP   PRO-1190 AND PRO-1193.
RX   PubMed=7016180; DOI=10.1021/bi00512a040;
RA   Seyer J.M., Kang A.H.;
RT   "Covalent structure of collagen: amino acid sequence of alpha 1(III)-
RT   CB9 from type III collagen of human liver.";
RL   Biochemistry 20:2621-2627(1981).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1065-1466 (ISOFORM 1).
RX   PubMed=6096827; DOI=10.1093/nar/12.24.9383;
RA   Loidl H.R., Brinker J.M., May M., Pihlajaniemi T., Morrow S.,
RA   Rosenbloom J., Myers J.C.;
RT   "Molecular cloning and carboxyl-propeptide analysis of human type III
RT   procollagen.";
RL   Nucleic Acids Res. 12:9383-9394(1984).
RN   [24]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1161-1200 (ISOFORMS 1/2).
RX   PubMed=3754462; DOI=10.1021/bi00354a033;
RA   Miskulin M., Dalgleish R., Kluve-Beckerman B., Rennard S.I.,
RA   Tolstoshev P., Brantly M., Crystal R.G.;
RT   "Human type III collagen gene expression is coordinately modulated
RT   with the type I collagen genes during fibroblast growth.";
RL   Biochemistry 25:1408-1413(1986).
RN   [25]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1165-1196 (ISOFORMS 1/2).
RX   PubMed=3858826; DOI=10.1073/pnas.82.10.3385;
RA   Emanuel B.S., Cannizzaro L.A., Seyer J.M., Myers J.C.;
RT   "Human alpha 1(III) and alpha 2(V) procollagen genes are located on
RT   the long arm of chromosome 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:3385-3389(1985).
RN   [26]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1122-1466 (ISOFORMS 1/2), AND VARIANT
RP   GLN-1353.
RX   PubMed=2579949;
RA   Chu M.-L., Weil D., de Wet W.J., Bernard M.P., Sippola M., Ramirez F.;
RT   "Isolation of cDNA and genomic clones encoding human pro-alpha 1 (III)
RT   collagen. Partial characterization of the 3' end region of the gene.";
RL   J. Biol. Chem. 260:4357-4363(1985).
RN   [27]
RP   REVIEW ON VARIANTS.
RX   PubMed=9101290;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9;
RA   Kuivaniemi H., Tromp G., Prockop D.J.;
RT   "Mutations in fibrillar collagens (types I, II, III, and XI), fibril-
RT   associated collagen (type IX), and network-forming collagen (type X)
RT   cause a spectrum of diseases of bone, cartilage, and blood vessels.";
RL   Hum. Mutat. 9:300-315(1997).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1158-1199, AND INTERCHAIN
RP   DISULFIDE BONDS.
RX   PubMed=18805790; DOI=10.1074/jbc.M805394200;
RA   Boudko S.P., Engel J., Okuyama K., Mizuno K., Bachinger H.P.,
RA   Schumacher M.A.;
RT   "Crystal structure of human type III collagen Gly991-Gly1032 cystine
RT   knot-containing peptide shows both 7/2 and 10/3 triple helical
RT   symmetries.";
RL   J. Biol. Chem. 283:32580-32589(2008).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (1.68 ANGSTROMS) OF 1222-1466, PROPEPTIDE,
RP   DISULFIDE BONDS, AND CALCIUM-BINDING SITES.
RX   PubMed=23001006; DOI=10.1038/nsmb.2389;
RA   Bourhis J.M., Mariano N., Zhao Y., Harlos K., Exposito J.Y.,
RA   Jones E.Y., Moali C., Aghajari N., Hulmes D.J.;
RT   "Structural basis of fibrillar collagen trimerization and related
RT   genetic disorders.";
RL   Nat. Struct. Mol. Biol. 19:1031-1036(2012).
RN   [32]
RP   VARIANT EDSVASC ARG-303, AND VARIANT THR-668.
RX   PubMed=8514866; DOI=10.1172/JCI116490;
RA   Tromp G., Wu Y., Prockop D.J., Madhatheri S.L., Kleinert C.,
RA   Earley J.J., Zhuang J., Noerrgaard O., Darling R.C., Abbott W.M.,
RA   Cole C.W., Jaakkola P., Ryynaenen M., Pearce W.H., Yao J.S.T.,
RA   Majamaa K., Smullens S.N., Gatalica Z., Ferrell R.E., Jimenez S.A.,
RA   Jackson C.E., Michels V.V., Kaye M., Kuivaniemi H.;
RT   "Sequencing of cDNA from 50 unrelated patients reveals that mutations
RT   in the triple-helical domain of type III procollagen are an infrequent
RT   cause of aortic aneurysms.";
RL   J. Clin. Invest. 91:2539-2545(1993).
RN   [33]
RP   VARIANT THR-698.
RX   PubMed=2235526; DOI=10.1093/nar/18.20.6180;
RA   Zafarullah K., Kleinert C., Tromp G., Kuivaniemi H., Kontusaari S.,
RA   Wu Y., Ganguly A., Prockop D.J.;
RT   "G to A polymorphism in exon 31 of the COL3A1 gene.";
RL   Nucleic Acids Res. 18:6180-6180(1990).
RN   [34]
RP   VARIANT EDSVASC ARG-786.
RX   PubMed=2243125; DOI=10.1172/JCI114863;
RA   Kontusaari S., Tromp G., Kuivaniemi H., Romanic A.M., Prockop D.J.;
RT   "A mutation in the gene for type III procollagen (COL3A1) in a family
RT   with aortic aneurysms.";
RL   J. Clin. Invest. 86:1465-1473(1990).
RN   [35]
RP   VARIANT EDSVASC 830-PRO--PRO-838 DEL.
RX   PubMed=1370809; DOI=10.1007/BF00197268;
RA   Richards A.J., Lloyd J.C., Narcisi P., Ward P.N., Nicholls A.C.,
RA   De Paepe A., Pope F.M.;
RT   "A 27-bp deletion from one allele of the type III collagen gene
RT   (COL3A1) in a large family with Ehlers-Danlos syndrome type IV.";
RL   Hum. Genet. 88:325-330(1992).
RN   [36]
RP   VARIANT EDSVASC ARG-828.
RX   PubMed=8411057; DOI=10.1136/jmg.30.8.690;
RA   Richards A.J., Narcisi P., Lloyd J.C., Ferguson C., Pope F.M.;
RT   "The substitution of glycine 661 by arginine in type III collagen
RT   produces mutant molecules with different thermal stabilities and
RT   causes Ehlers-Danlos syndrome type IV.";
RL   J. Med. Genet. 30:690-693(1993).
RN   [37]
RP   VARIANT EDSVASC SER-957.
RX   PubMed=2492273;
RA   Tromp G., Kuivaniemi H., Shikata H., Prockop D.J.;
RT   "A single base mutation that substitutes serine for glycine 790 of the
RT   alpha 1 (III) chain of type III procollagen exposes an arginine and
RT   causes Ehlers-Danlos syndrome IV.";
RL   J. Biol. Chem. 264:1349-1352(1989).
RN   [38]
RP   VARIANT EDSVASC VAL-960.
RX   PubMed=7749417; DOI=10.1002/humu.1380050213;
RA   Tromp G., de Paepe A., Nuytinck L., Madhatheri S.L., Kuivaniemi H.;
RT   "Substitution of valine for glycine 793 in type III procollagen in
RT   Ehlers-Danlos syndrome type IV.";
RL   Hum. Mutat. 5:179-181(1995).
RN   [39]
RP   VARIANT EDSVASC GLU-1014.
RX   PubMed=1352273; DOI=10.1007/BF00194313;
RA   Richards A.J., Ward P.N., Narcisi P., Nicholls A.C., Lloyd J.C.,
RA   Pope F.M.;
RT   "A single base mutation in the gene for type III collagen (COL3A1)
RT   converts glycine 847 to glutamic acid in a family with Ehlers-Danlos
RT   syndrome type IV. An unaffected family member is mosaic for the
RT   mutation.";
RL   Hum. Genet. 89:414-418(1992).
RN   [40]
RP   VARIANT EDSVASC ASP-1050.
RX   PubMed=2808425;
RA   Tromp G., Kuivaniemi H., Stolle C.A., Pope F.M., Prockop D.J.;
RT   "Single base mutation in the type III procollagen gene that converts
RT   the codon for glycine 883 to aspartate in a mild variant of Ehlers-
RT   Danlos syndrome IV.";
RL   J. Biol. Chem. 264:19313-19317(1989).
RN   [41]
RP   INVOLVEMENT IN EDSVASC.
RX   PubMed=2349939;
RA   Kontusaari S., Tromp G., Kuivaniemi H., Ladda R.L., Prockop D.J.;
RT   "Inheritance of an RNA splicing mutation (G+ 1 IVS20) in the type III
RT   procollagen gene (COL3A1) in a family having aortic aneurysms and easy
RT   bruisability: phenotypic overlap between familial arterial aneurysms
RT   and Ehlers-Danlos syndrome type IV.";
RL   Am. J. Hum. Genet. 47:112-120(1990).
RN   [42]
RP   VARIANT EDSVASC VAL-1077.
RX   PubMed=1895316; DOI=10.1136/jmg.28.7.458;
RA   Richards A.J., Lloyd J.C., Ward P.N., de Paepe A., Narcisi P.,
RA   Pope F.M.;
RT   "Characterisation of a glycine to valine substitution at amino acid
RT   position 910 of the triple helical region of type III collagen in a
RT   patient with Ehlers-Danlos syndrome type IV.";
RL   J. Med. Genet. 28:458-463(1991).
RN   [43]
RP   VARIANT EDSVASC GLU-1173.
RX   PubMed=1357232; DOI=10.1007/BF02435995;
RA   Johnson P.H., Richards A.J., Pope F.M., Hopkinson D.A.;
RT   "A COL3A1 glycine 1006 to glutamic acid substitution in a patient with
RT   Ehlers-Danlos syndrome type IV detected by denaturing gradient gel
RT   electrophoresis.";
RL   J. Inherit. Metab. Dis. 15:426-430(1992).
RN   [44]
RP   VARIANT EDSVASC ASP-1185.
RX   PubMed=1496983;
RA   Kontusaari S., Tromp G., Kuivaniemi H., Stolle C.A., Pope F.M.,
RA   Prockop D.J.;
RT   "Substitution of aspartate for glycine 1018 in the type III
RT   procollagen (COL3A1) gene causes type IV Ehlers-Danlos syndrome: the
RT   mutated allele is present in most blood leukocytes of the asymptomatic
RT   and mosaic mother.";
RL   Am. J. Hum. Genet. 51:497-507(1992).
RN   [45]
RP   VARIANT EDSVASC GLU-1188.
RX   PubMed=8098182; DOI=10.1002/ajmg.1320460308;
RA   Narcisi P., Wu Y., Tromp G., Earley J.J., Richards A.J., Pope F.M.,
RA   Kuivaniemi H.;
RT   "Single base mutation that substitutes glutamic acid for glycine 1021
RT   in the COL3A1 gene and causes Ehlers-Danlos syndrome type IV.";
RL   Am. J. Med. Genet. 46:278-283(1993).
RN   [46]
RP   VARIANTS EDSVASC VAL-1167; ASP-1170 AND GLU-1173.
RA   Richards A.J., Narcisi P., Lloyd J.C., Johnson P.H., Hopkinson D.A.,
RA   Pope F.M.;
RT   "Substitution of glycines 1000, 1003 and 1006 in type III collagen all
RT   cause the acrogeric form of EDS-IV, and destabilise the collagen
RT   triple helix.";
RL   Matrix 13:47-47(1993).
RN   [47]
RP   VARIANTS THR-602 AND LEU-635.
RX   PubMed=8255472; DOI=10.1212/WNL.43.12.2652;
RA   Kuivaniemi H., Prockop D.J., Wu Y., Madhatheri S.L., Kleinert C.,
RA   Earley J.J., Jokinen A., Stolle C.A., Majamaa K., Mylllylae V.V.,
RA   Noerrgaard O., Schievink W.I., Mokri B., Fukawa O., Ter Berg J.W.M.,
RA   de Paepe A., Lozano A.M., Leblanc R., Ryynaenen M., Baxter B.T.,
RA   Shikata H., Ferrell R.E., Tromp G.;
RT   "Exclusion of mutations in the gene for type III collagen (COL3A1) as
RT   a common cause of intracranial aneurysms or cervical artery
RT   dissections: results from sequence analysis of the coding sequences of
RT   type III collagen from 55 unrelated patients.";
RL   Neurology 43:2652-2658(1993).
RN   [48]
RP   VARIANT EDSVASC GLU-756.
RX   PubMed=7912131; DOI=10.1093/hmg/3.3.511;
RA   Madhatheri S.L., Tromp G., Gustavson K.H., Kuivaniemi H.;
RT   "Substitution of glutamic acid for glycine 589 in the triple-helical
RT   domain of type III procollagen (COL3A1) in a family with variable
RT   phenotype of the Ehlers-Danlos syndrome type IV.";
RL   Hum. Mol. Genet. 3:511-512(1994).
RN   [49]
RP   VARIANT EDSVASC SER-804.
RX   PubMed=7833919; DOI=10.1093/hmg/3.9.1617;
RA   Narcisi P., Richards A.J., Ferguson S.D., Pope F.M.;
RT   "A family with Ehlers-Danlos syndrome type III/articular hypermobility
RT   syndrome has a glycine 637-to-serine substitution in type III
RT   collagen.";
RL   Hum. Mol. Genet. 3:1617-1620(1994).
RN   [50]
RP   VARIANT EDSVASC VAL-1176.
RX   PubMed=8019562; DOI=10.1002/humu.1380030315;
RA   Nuytinck L., De Paepe A., Renard J.P., Adriaens F., Leroy J.;
RT   "Single-strand conformation polymorphism (SSCP) analysis of the COL3A1
RT   gene detects a mutation that results in the substitution of glycine
RT   1009 to valine and causes severe Ehlers-Danlos syndrome type IV.";
RL   Hum. Mutat. 3:268-274(1994).
RN   [51]
RP   VARIANTS EDSVASC CYS-183; ARG-201; GLU-228; ARG-540; ARG-936; GLU-996;
RP   VAL-1071; ALA-1104; GLU-1182; VAL-1185; GLU-1188 AND ARG-1188.
RA   Goldstein J.A., Schwarze U., Witz A., Byers P.H.;
RT   "Marked heterogeneity in COL3A1 mutations that produce the EDS type IV
RT   phenotype.";
RL   Matrix Biol. 14:392-393(1994).
RN   [52]
RP   VARIANTS EDSVASC ASP-909 AND ASP-939.
RX   PubMed=8680408; DOI=10.1002/humu.1380060408;
RA   Johnson P.H., Richards A.J., Lloyd J.C., Pope F.M., Hopkinson D.A.;
RT   "Efficient strategy for the detection of mutations in acrogeric
RT   Ehlers-Danlos syndrome type IV.";
RL   Hum. Mutat. 6:336-342(1995).
RN   [53]
RP   VARIANTS EDSVASC GLU-567; CYS-762 AND ASP-1170.
RX   PubMed=8884076;
RA   Mackay K., Raghunath M., Superti-Furga A., Steinmann B., Dalgleish R.;
RT   "Ehlers-Danlos syndrome type IV caused by Gly400Glu, Gly595Cys and
RT   Gly1003Asp substitutions in collagen III: clinical features,
RT   biochemical screening, and molecular confirmation.";
RL   Clin. Genet. 49:286-295(1996).
RN   [54]
RP   VARIANT EDSVASC GLU-1101.
RX   PubMed=9147870;
RA   McGrory J., Weksberg R., Thorner P., Cole W.G.;
RT   "Abnormal extracellular matrix in Ehlers-Danlos syndrome type IV due
RT   to the substitution of glycine 934 by glutamic acid in the triple
RT   helical domain of type III collagen.";
RL   Clin. Genet. 50:442-445(1996).
RN   [55]
RP   VARIANT EDSVASC ASP-666.
RX   PubMed=8664902;
RX   DOI=10.1002/(SICI)1098-1004(1996)7:1<59::AID-HUMU8>3.3.CO;2-R;
RA   McGrory J., Costa T., Cole W.G.;
RT   "A novel G499D substitution in the alpha 1(III) chain of type III
RT   collagen produces variable forms of Ehlers-Danlos syndrome type IV.";
RL   Hum. Mutat. 7:59-60(1996).
RN   [56]
RP   VARIANT EDSVASC SER-582.
RX   PubMed=8990011;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:1<62::AID-HUMU11>3.3.CO;2-B;
RA   Anderson D.W., Thakker-Varia S., Tromp G., Kuivaniemi H., Stolle C.A.;
RT   "A glycine (415)-to-serine substitution results in impaired secretion
RT   and decreased thermal stability of type III procollagen in a patient
RT   with Ehlers-Danlos syndrome type IV.";
RL   Hum. Mutat. 9:62-63(1997).
RN   [57]
RP   VARIANTS EDSVASC CYS-183; ARG-201; GLU-228; ARG-540 AND ARG-936.
RX   PubMed=9036918; DOI=10.1111/1523-1747.ep12286441;
RA   Smith L.T., Schwarze U., Goldstein J., Byers P.H.;
RT   "Mutations in the COL3A1 gene result in the Ehlers-Danlos syndrome
RT   type IV and alterations in the size and distribution of the major
RT   collagen fibrils of the dermis.";
RL   J. Invest. Dermatol. 108:241-247(1997).
RN   [58]
RP   VARIANT EDSVASC ARG-726.
RX   PubMed=9452103;
RA   Bateman J.F., Chiodo A.A., Weng Y.M., Chan D., Haan E.;
RT   "A type III collagen Gly559 to Arg helix mutation in Ehler's-Danlos
RT   syndrome type IV.";
RL   Hum. Mutat. Suppl. 1:S257-S259(1998).
RN   [59]
RP   VARIANT EDS-IV ARG-1173.
RX   PubMed=10819545; DOI=10.1046/j.1365-2133.2000.03266.x;
RA   Jansen T., de Paepe A., Luytinck N., Plewig G.;
RT   "COL3A1 mutation leading to acrogeria (Gottron Type).";
RL   Br. J. Dermatol. 142:178-180(2000).
RN   [60]
RP   VARIANTS EDSVASC ASP-204; ASP-210; ARG-264; ASP-327; ASP-1098 AND
RP   GLU-1173.
RX   PubMed=10923041;
RX   DOI=10.1002/1098-1004(200008)16:2<176::AID-HUMU12>3.0.CO;2-E;
RA   Giunta C., Steinmann B.;
RT   "Characterization of 11 new mutations in COL3A1 of individuals with
RT   Ehlers-Danlos syndrome type IV: preliminary comparison of RNase
RT   cleavage, EMC and DHPLC assays.";
RL   Hum. Mutat. 16:176-177(2000).
RN   [61]
RP   VARIANTS EDSVASC.
RX   PubMed=10706896; DOI=10.1056/NEJM200003093421001;
RA   Pepin M., Schwarze U., Superti-Furga A., Byers P.H.;
RT   "Clinical and genetic features of Ehlers-Danlos syndrome type IV, the
RT   vascular type.";
RL   N. Engl. J. Med. 342:673-680(2000).
RN   [62]
RP   VARIANT EDSVASC ASP-1044.
RX   PubMed=11168790; DOI=10.1046/j.1365-2796.2001.00761.x;
RA   Nishiyama Y., Nejima J., Watanabe A., Kotani E., Sakai N.,
RA   Hatamochi A., Shinkai H., Kiuchi K., Tamura K., Shimada T., Takano T.,
RA   Katayama Y.;
RT   "Ehlers-Danlos syndrome type IV with a unique point mutation in COL3A1
RT   and familial phenotype of myocardial infarction without organic
RT   coronary stenosis.";
RL   J. Intern. Med. 249:103-108(2001).
RN   [63]
RP   VARIANT EDSVASC ARG-297.
RX   PubMed=12694234; DOI=10.1034/j.1399-0004.2003.00047.x;
RA   Kroes H.Y., Pals G., van Essen A.J.;
RT   "Ehlers-Danlos syndrome type IV: unusual congenital anomalies in a
RT   mother and son with a COL3A1 mutation and a normal collagen III
RT   protein profile.";
RL   Clin. Genet. 63:224-227(2003).
RN   [64]
RP   ERRATUM.
RA   Kroes H.Y., Pals G., van Essen A.J.;
RL   Clin. Genet. 64:375-375(2003).
RN   [65]
RP   VARIANT EDSVASC VAL-1050.
RX   PubMed=12786757; DOI=10.1034/j.1399-0004.2003.00075.x;
RA   Palmeri S., Mari F., Meloni I., Malandrini A., Ariani F.,
RA   Villanova M., Pompilio A., Schwarze U., Byers P.H., Renieri A.;
RT   "Neurological presentation of Ehlers-Danlos syndrome type IV in a
RT   family with parental mosaicism.";
RL   Clin. Genet. 63:510-515(2003).
RN   [66]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-420 AND CYS-1434.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [67]
RP   VARIANTS THR-679; THR-698; VAL-1205 AND GLN-1353.
RX   PubMed=18272325; DOI=10.1016/j.ygeno.2007.12.008;
RA   Chan T.F., Poon A., Basu A., Addleman N.R., Chen J., Phong A.,
RA   Byers P.H., Klein T.E., Kwok P.Y.;
RT   "Natural variation in four human collagen genes across an ethnically
RT   diverse population.";
RL   Genomics 91:307-314(2008).
CC   -!- FUNCTION: Collagen type III occurs in most soft connective tissues
CC       along with type I collagen. Involved in regulation of cortical
CC       development. Is the major ligand of ADGRG1 in the developing brain
CC       and binding to ADGRG1 inhibits neuronal migration and activates
CC       the RhoA pathway by coupling ADGRG1 to GNA13 and possibly GNA12.
CC   -!- SUBUNIT: Trimers of identical alpha 1(III) chains. The chains are
CC       linked to each other by interchain disulfide bonds. Trimers are
CC       also cross-linked via hydroxylysines.
CC   -!- INTERACTION:
CC       O01949:AAEL010235 (xeno); NbExp=2; IntAct=EBI-2431491, EBI-7685554;
CC       P09486:SPARC; NbExp=4; IntAct=EBI-15740444, EBI-2800983;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P02461-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P02461-2; Sequence=VSP_022502;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The C-terminal propeptide, also known as COLFI domain,
CC       have crucial roles in tissue growth and repair by controlling both
CC       the intracellular assembly of procollagen molecules and the
CC       extracellular assembly of collagen fibrils. It binds a calcium ion
CC       which is essential for its function.
CC   -!- PTM: Proline residues at the third position of the tripeptide
CC       repeating unit (G-X-Y) are hydroxylated in some or all of the
CC       chains. {ECO:0000269|PubMed:557335, ECO:0000269|PubMed:7016180}.
CC   -!- PTM: O-linked glycan consists of a Glc-Gal disaccharide bound to
CC       the oxygen atom of a post-translationally added hydroxyl group.
CC   -!- DISEASE: Ehlers-Danlos syndrome, vascular type (EDSVASC)
CC       [MIM:130050]: A severe form of Ehlers-Danlos syndrome, a group of
CC       connective tissue disorders characterized by skin
CC       hyperextensibility, articular hypermobility, and tissue fragility.
CC       EDSVASC is an autosomal dominant disease characterized by joint
CC       and dermal manifestations as in other forms of the syndrome, and
CC       by proneness to spontaneous rupture of bowel and large arteries.
CC       The vascular complications may affect all anatomical areas.
CC       {ECO:0000269|PubMed:10706896, ECO:0000269|PubMed:10923041,
CC       ECO:0000269|PubMed:11168790, ECO:0000269|PubMed:12694234,
CC       ECO:0000269|PubMed:12786757, ECO:0000269|PubMed:1352273,
CC       ECO:0000269|PubMed:1357232, ECO:0000269|PubMed:1370809,
CC       ECO:0000269|PubMed:1496983, ECO:0000269|PubMed:1895316,
CC       ECO:0000269|PubMed:2243125, ECO:0000269|PubMed:2349939,
CC       ECO:0000269|PubMed:2492273, ECO:0000269|PubMed:2808425,
CC       ECO:0000269|PubMed:7749417, ECO:0000269|PubMed:7833919,
CC       ECO:0000269|PubMed:7912131, ECO:0000269|PubMed:8019562,
CC       ECO:0000269|PubMed:8098182, ECO:0000269|PubMed:8411057,
CC       ECO:0000269|PubMed:8514866, ECO:0000269|PubMed:8664902,
CC       ECO:0000269|PubMed:8680408, ECO:0000269|PubMed:8884076,
CC       ECO:0000269|PubMed:8990011, ECO:0000269|PubMed:9036918,
CC       ECO:0000269|PubMed:9147870, ECO:0000269|PubMed:9452103,
CC       ECO:0000269|Ref.46, ECO:0000269|Ref.51}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the fibrillar collagen family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- WEB RESOURCE: Name=COL3A1; Note=Collagen type III alpha-1 chain
CC       mutations;
CC       URL="https://eds.gene.le.ac.uk/home.php?select_db=COL3A1";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Type-III collagen entry;
CC       URL="https://en.wikipedia.org/wiki/Type-III_collagen";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; X14420; CAA32583.1; -; mRNA.
DR   EMBL; AY054301; AAL13167.1; -; Genomic_DNA.
DR   EMBL; AY016295; AAL13167.1; JOINED; Genomic_DNA.
DR   EMBL; KC567894; AGL34959.1; -; Genomic_DNA.
DR   EMBL; GU143397; ACZ58371.1; -; Genomic_DNA.
DR   EMBL; AC066694; AAY24164.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX10910.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX10911.1; -; Genomic_DNA.
DR   EMBL; BC028178; AAH28178.1; -; mRNA.
DR   EMBL; M26939; AAA52040.1; -; Genomic_DNA.
DR   EMBL; X07240; CAA30229.1; -; mRNA.
DR   EMBL; X15332; CAA33387.1; -; mRNA.
DR   EMBL; S62925; AAD13937.1; -; Genomic_DNA.
DR   EMBL; S79877; AAB35615.1; -; mRNA.
DR   EMBL; M59312; AAA52041.1; -; Genomic_DNA.
DR   EMBL; M59227; AAB59383.1; -; mRNA.
DR   EMBL; M55603; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X06700; CAA29886.1; -; mRNA.
DR   EMBL; X01655; CAA25821.1; -; mRNA.
DR   EMBL; X01742; CAA25879.1; -; mRNA.
DR   EMBL; M13146; AAA52003.1; -; mRNA.
DR   EMBL; M11134; AAA52004.1; -; mRNA.
DR   EMBL; M10795; AAA52002.1; -; Genomic_DNA.
DR   EMBL; M10615; AAA52002.1; JOINED; Genomic_DNA.
DR   EMBL; M10793; AAA52002.1; JOINED; Genomic_DNA.
DR   EMBL; M10794; AAA52002.1; JOINED; Genomic_DNA.
DR   EMBL; M10800; AAA52002.1; JOINED; Genomic_DNA.
DR   EMBL; M10801; AAA52002.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS2297.1; -. [P02461-1]
DR   PIR; S05272; CGHU7L.
DR   RefSeq; NP_000081.1; NM_000090.3.
DR   UniGene; Hs.443625; -.
DR   PDB; 2V53; X-ray; 3.20 A; B/C/D=564-584.
DR   PDB; 3DMW; X-ray; 2.30 A; A/B/C=1158-1199.
DR   PDB; 4AE2; X-ray; 1.68 A; A/B/C=1222-1466.
DR   PDB; 4AEJ; X-ray; 2.21 A; A/B/C=1222-1466.
DR   PDB; 4AK3; X-ray; 3.50 A; A=1222-1466.
DR   PDB; 4GYX; X-ray; 1.49 A; A/B/C=1158-1200.
DR   PDB; 6FZV; X-ray; 2.70 A; A/B/C=1222-1466.
DR   PDB; 6FZW; X-ray; 2.78 A; A/B/C=1185-1466.
DR   PDBsum; 2V53; -.
DR   PDBsum; 3DMW; -.
DR   PDBsum; 4AE2; -.
DR   PDBsum; 4AEJ; -.
DR   PDBsum; 4AK3; -.
DR   PDBsum; 4GYX; -.
DR   PDBsum; 6FZV; -.
DR   PDBsum; 6FZW; -.
DR   ProteinModelPortal; P02461; -.
DR   SMR; P02461; -.
DR   BioGrid; 107678; 12.
DR   ComplexPortal; CPX-1714; Collagen type III trimer.
DR   DIP; DIP-57177N; -.
DR   IntAct; P02461; 23.
DR   MINT; P02461; -.
DR   STRING; 9606.ENSP00000304408; -.
DR   ChEMBL; CHEMBL2364188; -.
DR   DrugBank; DB00048; Collagenase clostridium histolyticum.
DR   GlyConnect; 1127; -.
DR   iPTMnet; P02461; -.
DR   PhosphoSitePlus; P02461; -.
DR   BioMuta; COL3A1; -.
DR   DMDM; 124056490; -.
DR   EPD; P02461; -.
DR   jPOST; P02461; -.
DR   PaxDb; P02461; -.
DR   PeptideAtlas; P02461; -.
DR   PRIDE; P02461; -.
DR   ProteomicsDB; 51522; -.
DR   ProteomicsDB; 51523; -. [P02461-2]
DR   Ensembl; ENST00000304636; ENSP00000304408; ENSG00000168542. [P02461-1]
DR   Ensembl; ENST00000317840; ENSP00000315243; ENSG00000168542. [P02461-2]
DR   GeneID; 1281; -.
DR   KEGG; hsa:1281; -.
DR   UCSC; uc002uqj.2; human. [P02461-1]
DR   CTD; 1281; -.
DR   DisGeNET; 1281; -.
DR   EuPathDB; HostDB:ENSG00000168542.12; -.
DR   GeneCards; COL3A1; -.
DR   GeneReviews; COL3A1; -.
DR   HGNC; HGNC:2201; COL3A1.
DR   HPA; CAB016766; -.
DR   HPA; CAB059993; -.
DR   HPA; HPA007583; -.
DR   MalaCards; COL3A1; -.
DR   MIM; 120180; gene.
DR   MIM; 130050; phenotype.
DR   neXtProt; NX_P02461; -.
DR   OpenTargets; ENSG00000168542; -.
DR   Orphanet; 2500; Acrogeria.
DR   Orphanet; 286; Ehlers-Danlos syndrome, vascular type.
DR   Orphanet; 86; Familial abdominal aortic aneurysm.
DR   Orphanet; 231160; Familial cerebral saccular aneurysm.
DR   PharmGKB; PA26716; -.
DR   eggNOG; KOG3544; Eukaryota.
DR   eggNOG; ENOG410XNMM; LUCA.
DR   GeneTree; ENSGT00940000161229; -.
DR   HOVERGEN; HBG004933; -.
DR   InParanoid; P02461; -.
DR   KO; K19720; -.
DR   OMA; DFKINTD; -.
DR   OrthoDB; 1406711at2759; -.
DR   PhylomeDB; P02461; -.
DR   TreeFam; TF344135; -.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1474244; Extracellular matrix organization.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-HSA-186797; Signaling by PDGF.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3000171; Non-integrin membrane-ECM interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-3000480; Scavenging by Class A Receptors.
DR   Reactome; R-HSA-419037; NCAM1 interactions.
DR   Reactome; R-HSA-8874081; MET activates PTK2 signaling.
DR   Reactome; R-HSA-8948216; Collagen chain trimerization.
DR   SIGNOR; P02461; -.
DR   ChiTaRS; COL3A1; human.
DR   EvolutionaryTrace; P02461; -.
DR   GeneWiki; Collagen,_type_III,_alpha_1; -.
DR   GenomeRNAi; 1281; -.
DR   PRO; PR:P02461; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000168542; Expressed in 229 organ(s), highest expression level in uterine cervix.
DR   ExpressionAtlas; P02461; baseline and differential.
DR   Genevisible; P02461; HS.
DR   GO; GO:0005586; C:collagen type III trimer; IDA:CAFA.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IMP:UniProtKB.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0031012; C:extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IMP:UniProtKB.
DR   GO; GO:0030020; F:extracellular matrix structural constituent conferring tensile strength; HDA:BHF-UCL.
DR   GO; GO:0005178; F:integrin binding; IMP:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0048407; F:platelet-derived growth factor binding; IDA:MGI.
DR   GO; GO:0002020; F:protease binding; IPI:CAFA.
DR   GO; GO:0046332; F:SMAD binding; IEA:Ensembl.
DR   GO; GO:0060414; P:aorta smooth muscle tissue morphogenesis; IEA:Ensembl.
DR   GO; GO:0007160; P:cell-matrix adhesion; IDA:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; ISS:UniProtKB.
DR   GO; GO:0030199; P:collagen fibril organization; IMP:UniProtKB.
DR   GO; GO:0048565; P:digestive tract development; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; IBA:GO_Central.
DR   GO; GO:0007507; P:heart development; IMP:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0050777; P:negative regulation of immune response; IMP:UniProtKB.
DR   GO; GO:2001223; P:negative regulation of neuron migration; ISS:UniProtKB.
DR   GO; GO:0018149; P:peptide cross-linking; IDA:UniProtKB.
DR   GO; GO:0030168; P:platelet activation; NAS:UniProtKB.
DR   GO; GO:0035025; P:positive regulation of Rho protein signal transduction; ISS:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0034097; P:response to cytokine; IDA:UniProtKB.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0009314; P:response to radiation; IDA:UniProtKB.
DR   GO; GO:0001501; P:skeletal system development; IEA:Ensembl.
DR   GO; GO:0043588; P:skin development; IMP:UniProtKB.
DR   GO; GO:0097435; P:supramolecular fiber organization; IMP:UniProtKB.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0042060; P:wound healing; IDA:UniProtKB.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR000885; Fib_collagen_C.
DR   InterPro; IPR001007; VWF_dom.
DR   Pfam; PF01410; COLFI; 1.
DR   Pfam; PF01391; Collagen; 8.
DR   Pfam; PF00093; VWC; 1.
DR   ProDom; PD002078; Fib_collagen_C; 1.
DR   SMART; SM00038; COLFI; 1.
DR   SMART; SM00214; VWC; 1.
DR   PROSITE; PS51461; NC1_FIB; 1.
DR   PROSITE; PS01208; VWFC_1; 1.
DR   PROSITE; PS50184; VWFC_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Aortic aneurysm; Calcium;
KW   Collagen; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; Ehlers-Danlos syndrome;
KW   Extracellular matrix; Glycoprotein; Hydroxylation; Metal-binding;
KW   Polymorphism; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL        1     23
FT   PROPEP       24    153       N-terminal propeptide.
FT                                /FTId=PRO_0000005740.
FT   CHAIN       154   1221       Collagen alpha-1(III) chain.
FT                                /FTId=PRO_0000005741.
FT   PROPEP     1222   1466       C-terminal propeptide.
FT                                /FTId=PRO_0000005742.
FT   DOMAIN       30     89       VWFC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00220}.
FT   DOMAIN     1232   1466       Fibrillar collagen NC1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00793}.
FT   REGION      149    167       Nonhelical region (N-terminal).
FT   REGION      168   1196       Triple-helical region.
FT   REGION     1197   1205       Nonhelical region (C-terminal).
FT   METAL      1280   1280       Calcium.
FT   METAL      1282   1282       Calcium.
FT   METAL      1283   1283       Calcium; via carbonyl oxygen.
FT   METAL      1285   1285       Calcium; via carbonyl oxygen.
FT   METAL      1288   1288       Calcium.
FT   MOD_RES     173    173       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     179    179       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     182    182       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     185    185       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     191    191       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     194    194       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     197    197       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     203    203       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     206    206       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     215    215       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     218    218       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     236    236       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     239    239       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     245    245       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     248    248       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     257    257       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     260    260       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     263    263       5-hydroxylysine; alternate.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     281    281       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     284    284       5-hydroxylysine.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     290    290       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     296    296       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     305    305       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     311    311       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     314    314       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     332    332       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     335    335       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     338    338       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     344    344       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     347    347       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     359    359       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     365    365       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     371    371       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     383    383       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     386    386       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     392    392       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:557335}.
FT   MOD_RES     404    404       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     407    407       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     416    416       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     425    425       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     434    434       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     443    443       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     455    455       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     458    458       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     470    470       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     473    473       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     479    479       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     488    488       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     500    500       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     512    512       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     524    524       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     530    530       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     533    533       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     539    539       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     542    542       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     545    545       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     551    551       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     554    554       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     563    563       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     566    566       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     575    575       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     581    581       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     590    590       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     599    599       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     602    602       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     608    608       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     620    620       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     635    635       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     644    644       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     650    650       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     656    656       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     659    659       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     661    661       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     668    668       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     671    671       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     680    680       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     686    686       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     692    692       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     701    701       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     703    703       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     713    713       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     716    716       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     722    722       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:687591}.
FT   MOD_RES     728    728       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     737    737       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     746    746       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     749    749       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     755    755       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     770    770       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     776    776       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     785    785       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     788    788       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     797    797       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     806    806       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     812    812       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     815    815       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     821    821       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     830    830       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     839    839       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     845    845       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     854    854       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     860    860       5-hydroxylysine.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     866    866       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     869    869       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     875    875       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     881    881       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     884    884       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     890    890       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     892    892       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     899    899       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     905    905       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     914    914       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     917    917       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     929    929       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     935    935       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     941    941       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     944    944       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     962    962       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:6246925}.
FT   MOD_RES     965    965       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES     971    971       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES     977    977       5-hydroxylysine.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES     983    983       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES     995    995       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1001   1001       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1010   1010       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1016   1016       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1022   1022       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1028   1028       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1040   1040       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1043   1043       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1046   1046       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1049   1049       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1052   1052       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1076   1076       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1085   1085       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1106   1106       5-hydroxylysine.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1112   1112       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1115   1115       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1118   1118       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1121   1121       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1133   1133       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1148   1148       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1157   1157       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1163   1163       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1178   1178       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1181   1181       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1184   1184       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1187   1187       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1190   1190       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   MOD_RES    1193   1193       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:7016180}.
FT   CARBOHYD    263    263       O-linked (Gal...) hydroxylysine;
FT                                alternate.
FT   DISULFID   1196   1196       Interchain. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00793,
FT                                ECO:0000269|PubMed:23001006}.
FT   DISULFID   1197   1197       Interchain. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00793,
FT                                ECO:0000269|PubMed:23001006}.
FT   DISULFID   1262   1294       {ECO:0000255|PROSITE-ProRule:PRU00793,
FT                                ECO:0000269|PubMed:23001006}.
FT   DISULFID   1268   1268       Interchain (with C-1285).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00793,
FT                                ECO:0000269|PubMed:23001006}.
FT   DISULFID   1285   1285       Interchain (with C-1268).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00793,
FT                                ECO:0000269|PubMed:23001006}.
FT   DISULFID   1302   1464       {ECO:0000255|PROSITE-ProRule:PRU00793,
FT                                ECO:0000269|PubMed:23001006}.
FT   DISULFID   1372   1417       {ECO:0000255|PROSITE-ProRule:PRU00793,
FT                                ECO:0000269|PubMed:23001006}.
FT   VAR_SEQ     847   1149       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_022502.
FT   VARIANT     169    169       L -> F (in dbSNP:rs111391222).
FT                                /FTId=VAR_001767.
FT   VARIANT     183    183       G -> C (in EDSVASC; dbSNP:rs121912926).
FT                                {ECO:0000269|PubMed:9036918,
FT                                ECO:0000269|Ref.51}.
FT                                /FTId=VAR_001768.
FT   VARIANT     183    183       G -> D (in EDSVASC; dbSNP:rs587779420).
FT                                /FTId=VAR_011095.
FT   VARIANT     183    183       G -> S (in EDSVASC; dbSNP:rs121912926).
FT                                /FTId=VAR_011096.
FT   VARIANT     192    192       G -> V (in EDSVASC; dbSNP:rs587779710).
FT                                /FTId=VAR_011097.
FT   VARIANT     201    201       G -> R (in EDSVASC; dbSNP:rs587779436).
FT                                {ECO:0000269|PubMed:9036918,
FT                                ECO:0000269|Ref.51}.
FT                                /FTId=VAR_001769.
FT   VARIANT     204    204       G -> D (in EDSVASC; dbSNP:rs587779626).
FT                                {ECO:0000269|PubMed:10923041}.
FT                                /FTId=VAR_011098.
FT   VARIANT     204    204       G -> S (in EDSVASC; dbSNP:rs587779711).
FT                                /FTId=VAR_011099.
FT   VARIANT     210    210       G -> D (in EDSVASC).
FT                                {ECO:0000269|PubMed:10923041}.
FT                                /FTId=VAR_011100.
FT   VARIANT     219    219       G -> C (in EDSVASC; dbSNP:rs587779624).
FT                                /FTId=VAR_011101.
FT   VARIANT     225    225       G -> V (in EDSVASC; dbSNP:rs587779533).
FT                                /FTId=VAR_011102.
FT   VARIANT     228    228       G -> E (in EDSVASC; dbSNP:rs587779555).
FT                                {ECO:0000269|PubMed:9036918,
FT                                ECO:0000269|Ref.51}.
FT                                /FTId=VAR_001770.
FT   VARIANT     240    240       G -> R (in EDSVASC; dbSNP:rs587779468).
FT                                /FTId=VAR_011103.
FT   VARIANT     243    243       G -> V (in EDSVASC; dbSNP:rs587779629).
FT                                /FTId=VAR_011104.
FT   VARIANT     249    249       G -> D (in EDSVASC; dbSNP:rs121912927).
FT                                /FTId=VAR_011105.
FT   VARIANT     249    249       G -> V (in EDSVASC; dbSNP:rs121912927).
FT                                /FTId=VAR_011106.
FT   VARIANT     252    252       G -> D (in EDSVASC; dbSNP:rs587779464).
FT                                /FTId=VAR_011107.
FT   VARIANT     252    252       G -> R (in EDSVASC; dbSNP:rs587779705).
FT                                /FTId=VAR_011108.
FT   VARIANT     252    252       G -> V (in EDSVASC; dbSNP:rs587779464).
FT                                /FTId=VAR_011109.
FT   VARIANT     255    255       G -> V (in EDSVASC; dbSNP:rs587779605).
FT                                /FTId=VAR_011110.
FT   VARIANT     264    264       G -> R (in EDSVASC).
FT                                {ECO:0000269|PubMed:10923041}.
FT                                /FTId=VAR_011111.
FT   VARIANT     267    267       G -> V (in EDSVASC; dbSNP:rs587779427).
FT                                /FTId=VAR_011112.
FT   VARIANT     297    297       G -> R (in EDSVASC).
FT                                {ECO:0000269|PubMed:12694234}.
FT                                /FTId=VAR_037007.
FT   VARIANT     303    303       G -> R (in EDSVASC; dbSNP:rs121912919).
FT                                {ECO:0000269|PubMed:8514866}.
FT                                /FTId=VAR_001771.
FT   VARIANT     321    321       G -> V (in EDSVASC; dbSNP:rs587779588).
FT                                /FTId=VAR_011113.
FT   VARIANT     327    327       G -> D (in EDSVASC).
FT                                {ECO:0000269|PubMed:10923041}.
FT                                /FTId=VAR_011114.
FT   VARIANT     345    345       G -> R (in EDSVASC; dbSNP:rs587779419).
FT                                /FTId=VAR_011115.
FT   VARIANT     417    417       G -> R (in EDSVASC; dbSNP:rs587779637).
FT                                /FTId=VAR_011116.
FT   VARIANT     420    420       G -> S (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs587779692).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035738.
FT   VARIANT     444    444       G -> R (in EDSVASC; dbSNP:rs587779489).
FT                                /FTId=VAR_011117.
FT   VARIANT     489    489       G -> E (in EDSVASC; dbSNP:rs587779476).
FT                                /FTId=VAR_011118.
FT   VARIANT     501    501       G -> R (in EDSVASC; dbSNP:rs587779523).
FT                                /FTId=VAR_011119.
FT   VARIANT     519    519       G -> V (in EDSVASC).
FT                                /FTId=VAR_011120.
FT   VARIANT     534    534       G -> E (in dbSNP:rs41263744).
FT                                /FTId=VAR_055665.
FT   VARIANT     540    540       G -> R (in EDSVASC; dbSNP:rs587779584).
FT                                {ECO:0000269|PubMed:9036918,
FT                                ECO:0000269|Ref.51}.
FT                                /FTId=VAR_001772.
FT   VARIANT     549    549       G -> E (in EDSVASC; dbSNP:rs587779679).
FT                                /FTId=VAR_011121.
FT   VARIANT     552    552       G -> E (in EDSVASC; dbSNP:rs121912928).
FT                                /FTId=VAR_011122.
FT   VARIANT     567    567       G -> E (in EDSVASC).
FT                                {ECO:0000269|PubMed:8884076}.
FT                                /FTId=VAR_001773.
FT   VARIANT     582    582       G -> S (in EDSVASC; dbSNP:rs121912923).
FT                                {ECO:0000269|PubMed:8990011}.
FT                                /FTId=VAR_001774.
FT   VARIANT     588    588       G -> D (in EDSVASC; dbSNP:rs587779691).
FT                                /FTId=VAR_011123.
FT   VARIANT     602    602       P -> T (in dbSNP:rs35795890).
FT                                {ECO:0000269|PubMed:8255472}.
FT                                /FTId=VAR_001775.
FT   VARIANT     635    635       P -> L (in dbSNP:rs902780774).
FT                                {ECO:0000269|PubMed:8255472}.
FT                                /FTId=VAR_001776.
FT   VARIANT     636    636       G -> R (in EDSVASC; dbSNP:rs587779522).
FT                                /FTId=VAR_011124.
FT   VARIANT     657    657       G -> E (in EDSVASC; dbSNP:rs587779699).
FT                                /FTId=VAR_011125.
FT   VARIANT     660    660       G -> D (in EDSVASC; dbSNP:rs587779493).
FT                                /FTId=VAR_011126.
FT   VARIANT     666    666       G -> D (in EDSVASC; dbSNP:rs121912921).
FT                                {ECO:0000269|PubMed:8664902}.
FT                                /FTId=VAR_001777.
FT   VARIANT     668    668       P -> T (in dbSNP:rs1801183).
FT                                {ECO:0000269|PubMed:8514866}.
FT                                /FTId=VAR_011127.
FT   VARIANT     679    679       A -> T (in dbSNP:rs41263773).
FT                                {ECO:0000269|PubMed:18272325}.
FT                                /FTId=VAR_055666.
FT   VARIANT     686    686       P -> A (in dbSNP:rs41263775).
FT                                /FTId=VAR_055667.
FT   VARIANT     698    698       A -> T (in dbSNP:rs1800255).
FT                                {ECO:0000269|PubMed:18272325,
FT                                ECO:0000269|PubMed:2235526}.
FT                                /FTId=VAR_001778.
FT   VARIANT     699    699       G -> R (in EDSVASC; dbSNP:rs587779668).
FT                                /FTId=VAR_011128.
FT   VARIANT     726    726       G -> R (in EDSVASC; dbSNP:rs587779638).
FT                                {ECO:0000269|PubMed:9452103,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_001779.
FT   VARIANT     738    738       G -> S (in EDSVASC; dbSNP:rs121912925).
FT                                /FTId=VAR_011129.
FT   VARIANT     738    738       G -> V (in EDSVASC; dbSNP:rs587779615).
FT                                /FTId=VAR_011130.
FT   VARIANT     744    744       G -> V (in EDSVASC; dbSNP:rs587779697).
FT                                /FTId=VAR_011131.
FT   VARIANT     756    756       G -> E (in EDSVASC).
FT                                {ECO:0000269|PubMed:7912131}.
FT                                /FTId=VAR_001780.
FT   VARIANT     762    762       G -> C (in EDSVASC).
FT                                {ECO:0000269|PubMed:8884076}.
FT                                /FTId=VAR_001781.
FT   VARIANT     786    786       G -> R (in EDSVASC; dbSNP:rs113485686).
FT                                {ECO:0000269|PubMed:2243125}.
FT                                /FTId=VAR_001782.
FT   VARIANT     804    804       G -> S (in EDSVASC; dbSNP:rs121912920).
FT                                {ECO:0000269|PubMed:7833919}.
FT                                /FTId=VAR_001783.
FT   VARIANT     828    828       G -> R (in EDSVASC).
FT                                {ECO:0000269|PubMed:8411057}.
FT                                /FTId=VAR_001784.
FT   VARIANT     828    828       G -> W (in EDSVASC; dbSNP:rs587779486).
FT                                /FTId=VAR_011132.
FT   VARIANT     830    838       Missing (in EDSVASC).
FT                                {ECO:0000269|PubMed:1370809}.
FT                                /FTId=VAR_037008.
FT   VARIANT     852    852       G -> C (in EDSVASC; dbSNP:rs587779690).
FT                                /FTId=VAR_011133.
FT   VARIANT     879    879       G -> V (in EDSVASC; dbSNP:rs587779645).
FT                                /FTId=VAR_011134.
FT   VARIANT     882    882       G -> D (in EDSVASC; dbSNP:rs587779622).
FT                                /FTId=VAR_011135.
FT   VARIANT     900    900       G -> D (in EDSVASC; dbSNP:rs587779599).
FT                                /FTId=VAR_011136.
FT   VARIANT     903    903       G -> E (in EDSVASC; dbSNP:rs587779505).
FT                                /FTId=VAR_011137.
FT   VARIANT     909    909       G -> D (in EDSVASC).
FT                                {ECO:0000269|PubMed:8680408}.
FT                                /FTId=VAR_001785.
FT   VARIANT     909    909       G -> V (in EDSVASC; dbSNP:rs587779483).
FT                                /FTId=VAR_011138.
FT   VARIANT     918    918       G -> E (in EDSVASC; dbSNP:rs587779662).
FT                                /FTId=VAR_011139.
FT   VARIANT     924    924       G -> C (in EDSVASC; dbSNP:rs587779471).
FT                                /FTId=VAR_011140.
FT   VARIANT     936    936       G -> R (in EDSVASC; dbSNP:rs587779566).
FT                                {ECO:0000269|PubMed:9036918,
FT                                ECO:0000269|Ref.51}.
FT                                /FTId=VAR_001786.
FT   VARIANT     936    936       G -> S (in EDSVASC).
FT                                /FTId=VAR_001787.
FT   VARIANT     939    939       G -> D (in EDSVASC; dbSNP:rs112978464).
FT                                {ECO:0000269|PubMed:8680408}.
FT                                /FTId=VAR_001788.
FT   VARIANT     942    942       G -> E (in EDSVASC; dbSNP:rs587779517).
FT                                /FTId=VAR_011141.
FT   VARIANT     957    957       G -> S (in EDSVASC; severe variant;
FT                                dbSNP:rs121912913).
FT                                {ECO:0000269|PubMed:2492273}.
FT                                /FTId=VAR_001789.
FT   VARIANT     960    960       G -> V (in EDSVASC; severe variant;
FT                                dbSNP:rs121912922).
FT                                {ECO:0000269|PubMed:7749417}.
FT                                /FTId=VAR_001790.
FT   VARIANT     966    966       G -> V (in EDSVASC; dbSNP:rs587779571).
FT                                /FTId=VAR_011142.
FT   VARIANT     972    972       G -> A (in EDSVASC; dbSNP:rs587779559).
FT                                /FTId=VAR_011143.
FT   VARIANT     984    984       G -> T (in EDSVASC; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_011144.
FT   VARIANT     996    996       G -> E (in EDSVASC; dbSNP:rs587779576).
FT                                {ECO:0000269|Ref.51}.
FT                                /FTId=VAR_001791.
FT   VARIANT     999    999       G -> R (in EDSVASC; dbSNP:rs587779548).
FT                                /FTId=VAR_011145.
FT   VARIANT    1011   1011       G -> E (in EDSVASC; dbSNP:rs587779552).
FT                                /FTId=VAR_011146.
FT   VARIANT    1014   1014       G -> E (in EDSVASC; dbSNP:rs121912916).
FT                                {ECO:0000269|PubMed:1352273}.
FT                                /FTId=VAR_001792.
FT   VARIANT    1032   1032       G -> V (in EDSVASC; dbSNP:rs587779428).
FT                                /FTId=VAR_011147.
FT   VARIANT    1035   1035       G -> C (in EDSVASC; dbSNP:rs587779704).
FT                                /FTId=VAR_011148.
FT   VARIANT    1044   1044       G -> D (in EDSVASC).
FT                                {ECO:0000269|PubMed:11168790}.
FT                                /FTId=VAR_011149.
FT   VARIANT    1050   1050       G -> D (in EDSVASC; mild variant;
FT                                dbSNP:rs121912914).
FT                                {ECO:0000269|PubMed:2808425}.
FT                                /FTId=VAR_001793.
FT   VARIANT    1050   1050       G -> V (in EDSVASC; dbSNP:rs121912914).
FT                                {ECO:0000269|PubMed:12786757}.
FT                                /FTId=VAR_011150.
FT   VARIANT    1071   1071       G -> V (in EDSVASC; dbSNP:rs587779709).
FT                                {ECO:0000269|Ref.51}.
FT                                /FTId=VAR_001794.
FT   VARIANT    1077   1077       G -> V (in EDSVASC; dbSNP:rs121912915).
FT                                {ECO:0000269|PubMed:1895316}.
FT                                /FTId=VAR_001795.
FT   VARIANT    1089   1089       G -> D (in EDSVASC; dbSNP:rs587779672).
FT                                /FTId=VAR_011151.
FT   VARIANT    1098   1098       G -> D (in EDSVASC).
FT                                {ECO:0000269|PubMed:10923041}.
FT                                /FTId=VAR_011152.
FT   VARIANT    1098   1098       G -> V (in EDSVASC; dbSNP:rs587779614).
FT                                /FTId=VAR_011153.
FT   VARIANT    1101   1101       G -> E (in EDSVASC; dbSNP:rs121912924).
FT                                {ECO:0000269|PubMed:9147870}.
FT                                /FTId=VAR_001796.
FT   VARIANT    1104   1104       G -> A (in EDSVASC).
FT                                {ECO:0000269|Ref.51}.
FT                                /FTId=VAR_001797.
FT   VARIANT    1161   1161       G -> V (in EDSVASC; dbSNP:rs587779473).
FT                                /FTId=VAR_011154.
FT   VARIANT    1164   1164       G -> E (in EDSVASC; dbSNP:rs587779431).
FT                                /FTId=VAR_011155.
FT   VARIANT    1164   1164       G -> R (in EDSVASC; dbSNP:rs587779553).
FT                                /FTId=VAR_011156.
FT   VARIANT    1164   1164       G -> S (in spondyloepiphyseal dysplasia).
FT                                /FTId=VAR_001798.
FT   VARIANT    1167   1167       G -> V (in EDSVASC; dbSNP:rs587779578).
FT                                {ECO:0000269|Ref.46}.
FT                                /FTId=VAR_001799.
FT   VARIANT    1170   1170       G -> D (in EDSVASC; dbSNP:rs587779465).
FT                                {ECO:0000269|PubMed:8884076,
FT                                ECO:0000269|Ref.46}.
FT                                /FTId=VAR_001800.
FT   VARIANT    1170   1170       G -> V (in EDSVASC; dbSNP:rs587779465).
FT                                /FTId=VAR_011157.
FT   VARIANT    1173   1173       G -> E (in EDSVASC; dbSNP:rs121912918).
FT                                {ECO:0000269|PubMed:10923041,
FT                                ECO:0000269|PubMed:1357232,
FT                                ECO:0000269|Ref.46}.
FT                                /FTId=VAR_001801.
FT   VARIANT    1173   1173       G -> R (in EDSVASC; Gottron type
FT                                acrogeria; dbSNP:rs587779521).
FT                                {ECO:0000269|PubMed:10819545}.
FT                                /FTId=VAR_011158.
FT   VARIANT    1176   1176       G -> V (in EDSVASC; severe).
FT                                {ECO:0000269|PubMed:8019562}.
FT                                /FTId=VAR_001802.
FT   VARIANT    1179   1179       G -> R (in EDSVASC; dbSNP:rs587779574).
FT                                /FTId=VAR_011159.
FT   VARIANT    1182   1182       G -> E (in EDSVASC; dbSNP:rs111505097).
FT                                {ECO:0000269|Ref.51}.
FT                                /FTId=VAR_001803.
FT   VARIANT    1185   1185       G -> D (in EDSVASC; severe variant;
FT                                dbSNP:rs121912917).
FT                                {ECO:0000269|PubMed:1496983}.
FT                                /FTId=VAR_001804.
FT   VARIANT    1185   1185       G -> V (in EDSVASC; dbSNP:rs121912917).
FT                                {ECO:0000269|Ref.51}.
FT                                /FTId=VAR_001805.
FT   VARIANT    1188   1188       G -> E (in EDSVASC; severe variant;
FT                                dbSNP:rs112456072).
FT                                {ECO:0000269|PubMed:8098182,
FT                                ECO:0000269|Ref.51}.
FT                                /FTId=VAR_001806.
FT   VARIANT    1188   1188       G -> R (in EDSVASC; dbSNP:rs587779504).
FT                                {ECO:0000269|Ref.51}.
FT                                /FTId=VAR_001807.
FT   VARIANT    1205   1205       I -> V (in dbSNP:rs2271683).
FT                                {ECO:0000269|PubMed:18272325}.
FT                                /FTId=VAR_020012.
FT   VARIANT    1353   1353       H -> Q (in dbSNP:rs1516446).
FT                                {ECO:0000269|PubMed:11566270,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:18272325,
FT                                ECO:0000269|PubMed:2579949,
FT                                ECO:0000269|PubMed:2764886,
FT                                ECO:0000269|PubMed:3357782,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_030115.
FT   VARIANT    1434   1434       R -> C (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs747324731).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035739.
FT   CONFLICT    163    163       G -> GG (in Ref. 10; CAA33387).
FT                                {ECO:0000305}.
FT   CONFLICT    168    168       G -> V (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    226    228       Missing (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    241    241       E -> D (in Ref. 10; CAA33387).
FT                                {ECO:0000305}.
FT   CONFLICT    278    278       T -> A (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    293    295       NGA -> DGS (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    401    401       A -> L (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    409    409       L -> P (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    472    472       E -> D (in Ref. 10; CAA33387).
FT                                {ECO:0000305}.
FT   CONFLICT    488    490       PGF -> LGS (in Ref. 10; CAA33387).
FT                                {ECO:0000305}.
FT   CONFLICT    589    589       A -> E (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    614    614       T -> Y (in Ref. 10; CAA33387).
FT                                {ECO:0000305}.
FT   CONFLICT    635    635       P -> R (in Ref. 10; CAA33387).
FT                                {ECO:0000305}.
FT   CONFLICT    664    664       D -> E (in Ref. 10; CAA33387).
FT                                {ECO:0000305}.
FT   CONFLICT    676    676       D -> N (in Ref. 16; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    803    803       T -> P (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    896    896       S -> A (in Ref. 18; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    980    980       S -> A (in Ref. 22; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    985    989       ANGLS -> PSGQN (in Ref. 22; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   1019   1019       D -> Y (in Ref. 20; CAA29886).
FT                                {ECO:0000305}.
FT   CONFLICT   1067   1067       S -> P (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   1070   1070       A -> P (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   1097   1097       T -> P (in Ref. 22; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   1153   1154       TS -> AT (in Ref. 22; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   1156   1156       H -> S (in Ref. 22; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   1184   1184       P -> S (in Ref. 10; CAA33387).
FT                                {ECO:0000305}.
FT   CONFLICT   1203   1203       A -> P (in Ref. 10; CAA33387).
FT                                {ECO:0000305}.
FT   CONFLICT   1210   1210       G -> A (in Ref. 10; CAA33387).
FT                                {ECO:0000305}.
FT   CONFLICT   1222   1222       D -> P (in Ref. 26; AAA52002).
FT                                {ECO:0000305}.
FT   CONFLICT   1235   1235       M -> I (in Ref. 26; AAA52002).
FT                                {ECO:0000305}.
FT   CONFLICT   1241   1241       V -> A (in Ref. 20; CAA29886 and 23;
FT                                CAA25879). {ECO:0000305}.
FT   CONFLICT   1274   1274       S -> T (in Ref. 26; AAA52002).
FT                                {ECO:0000305}.
FT   CONFLICT   1332   1332       M -> I (in Ref. 26; AAA52002).
FT                                {ECO:0000305}.
FT   CONFLICT   1357   1357       L -> P (in Ref. 26; AAA52002).
FT                                {ECO:0000305}.
FT   HELIX      1231   1249       {ECO:0000244|PDB:6FZV}.
FT   STRAND     1253   1257       {ECO:0000244|PDB:4AE2}.
FT   STRAND     1259   1261       {ECO:0000244|PDB:6FZV}.
FT   HELIX      1262   1268       {ECO:0000244|PDB:4AE2}.
FT   STRAND     1274   1279       {ECO:0000244|PDB:4AE2}.
FT   HELIX      1286   1288       {ECO:0000244|PDB:4AE2}.
FT   STRAND     1290   1295       {ECO:0000244|PDB:4AE2}.
FT   TURN       1296   1299       {ECO:0000244|PDB:4AE2}.
FT   STRAND     1300   1303       {ECO:0000244|PDB:4AE2}.
FT   STRAND     1305   1307       {ECO:0000244|PDB:4AE2}.
FT   STRAND     1309   1313       {ECO:0000244|PDB:4AE2}.
FT   STRAND     1320   1322       {ECO:0000244|PDB:4AK3}.
FT   HELIX      1328   1331       {ECO:0000244|PDB:4AE2}.
FT   STRAND     1339   1341       {ECO:0000244|PDB:4AEJ}.
FT   STRAND     1343   1345       {ECO:0000244|PDB:4AK3}.
FT   HELIX      1347   1360       {ECO:0000244|PDB:4AE2}.
FT   STRAND     1364   1374       {ECO:0000244|PDB:4AE2}.
FT   TURN       1381   1384       {ECO:0000244|PDB:4AE2}.
FT   STRAND     1391   1393       {ECO:0000244|PDB:4AE2}.
FT   STRAND     1395   1397       {ECO:0000244|PDB:4AE2}.
FT   STRAND     1399   1404       {ECO:0000244|PDB:4AE2}.
FT   HELIX      1406   1408       {ECO:0000244|PDB:6FZV}.
FT   STRAND     1411   1415       {ECO:0000244|PDB:4AE2}.
FT   STRAND     1422   1434       {ECO:0000244|PDB:4AE2}.
FT   HELIX      1436   1438       {ECO:0000244|PDB:4AE2}.
FT   STRAND     1443   1445       {ECO:0000244|PDB:4AE2}.
FT   STRAND     1451   1453       {ECO:0000244|PDB:6FZV}.
FT   STRAND     1455   1465       {ECO:0000244|PDB:4AE2}.
SQ   SEQUENCE   1466 AA;  138564 MW;  B904B4E05E17D339 CRC64;
     MMSFVQKGSW LLLALLHPTI ILAQQEAVEG GCSHLGQSYA DRDVWKPEPC QICVCDSGSV
     LCDDIICDDQ ELDCPNPEIP FGECCAVCPQ PPTAPTRPPN GQGPQGPKGD PGPPGIPGRN
     GDPGIPGQPG SPGSPGPPGI CESCPTGPQN YSPQYDSYDV KSGVAVGGLA GYPGPAGPPG
     PPGPPGTSGH PGSPGSPGYQ GPPGEPGQAG PSGPPGPPGA IGPSGPAGKD GESGRPGRPG
     ERGLPGPPGI KGPAGIPGFP GMKGHRGFDG RNGEKGETGA PGLKGENGLP GENGAPGPMG
     PRGAPGERGR PGLPGAAGAR GNDGARGSDG QPGPPGPPGT AGFPGSPGAK GEVGPAGSPG
     SNGAPGQRGE PGPQGHAGAQ GPPGPPGING SPGGKGEMGP AGIPGAPGLM GARGPPGPAG
     ANGAPGLRGG AGEPGKNGAK GEPGPRGERG EAGIPGVPGA KGEDGKDGSP GEPGANGLPG
     AAGERGAPGF RGPAGPNGIP GEKGPAGERG APGPAGPRGA AGEPGRDGVP GGPGMRGMPG
     SPGGPGSDGK PGPPGSQGES GRPGPPGPSG PRGQPGVMGF PGPKGNDGAP GKNGERGGPG
     GPGPQGPPGK NGETGPQGPP GPTGPGGDKG DTGPPGPQGL QGLPGTGGPP GENGKPGEPG
     PKGDAGAPGA PGGKGDAGAP GERGPPGLAG APGLRGGAGP PGPEGGKGAA GPPGPPGAAG
     TPGLQGMPGE RGGLGSPGPK GDKGEPGGPG ADGVPGKDGP RGPTGPIGPP GPAGQPGDKG
     EGGAPGLPGI AGPRGSPGER GETGPPGPAG FPGAPGQNGE PGGKGERGAP GEKGEGGPPG
     VAGPPGGSGP AGPPGPQGVK GERGSPGGPG AAGFPGARGL PGPPGSNGNP GPPGPSGSPG
     KDGPPGPAGN TGAPGSPGVS GPKGDAGQPG EKGSPGAQGP PGAPGPLGIA GITGARGLAG
     PPGMPGPRGS PGPQGVKGES GKPGANGLSG ERGPPGPQGL PGLAGTAGEP GRDGNPGSDG
     LPGRDGSPGG KGDRGENGSP GAPGAPGHPG PPGPVGPAGK SGDRGESGPA GPAGAPGPAG
     SRGAPGPQGP RGDKGETGER GAAGIKGHRG FPGNPGAPGS PGPAGQQGAI GSPGPAGPRG
     PVGPSGPPGK DGTSGHPGPI GPPGPRGNRG ERGSEGSPGH PGQPGPPGPP GAPGPCCGGV
     GAAAIAGIGG EKAGGFAPYY GDEPMDFKIN TDEIMTSLKS VNGQIESLIS PDGSRKNPAR
     NCRDLKFCHP ELKSGEYWVD PNQGCKLDAI KVFCNMETGE TCISANPLNV PRKHWWTDSS
     AEKKHVWFGE SMDGGFQFSY GNPELPEDVL DVHLAFLRLL SSRASQNITY HCKNSIAYMD
     QASGNVKKAL KLMGSNEGEF KAEGNSKFTY TVLEDGCTKH TGEWSKTVFE YRTRKAVRLP
     IVDIAPYDIG GPDQEFGVDV GPVCFL
//
ID   A0A024R9B7_HUMAN        Unreviewed;        75 AA.
AC   A0A024R9B7;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   16-JAN-2019, entry version 40.
DE   SubName: Full=Cytochrome c oxidase subunit VIc, isoform CRA_a {ECO:0000313|EMBL:EAW91792.1};
DE   SubName: Full=Epididymis secretory sperm binding protein {ECO:0000313|EMBL:ADO22528.1};
GN   Name=COX6C {ECO:0000313|EMBL:EAW91792.1};
GN   ORFNames=hCG_1781497 {ECO:0000313|EMBL:EAW91792.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW91792.1};
RN   [1] {ECO:0000313|EMBL:EAW91792.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW91792.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADO22528.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hoernsten L., Su C., Osbourn A.E., Hellman U., Wernstedt C.,
RA   Oliw E.H.;
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; GQ901011; ADO22528.1; -; mRNA.
DR   EMBL; CH471060; EAW91792.1; -; Genomic_DNA.
DR   EMBL; CH471060; EAW91793.1; -; Genomic_DNA.
DR   RefSeq; NP_004365.1; NM_004374.3.
DR   RefSeq; XP_016868509.1; XM_017013020.1.
DR   UniGene; Hs.351875; -.
DR   GeneID; 1345; -.
DR   KEGG; hsa:1345; -.
DR   CTD; 1345; -.
DR   EuPathDB; HostDB:ENSG00000164919.10; -.
DR   eggNOG; ENOG410J83U; Eukaryota.
DR   eggNOG; ENOG41124VH; LUCA.
DR   KO; K02268; -.
DR   OMA; KPVMRGL; -.
DR   OrthoDB; 1618740at2759; -.
DR   ChiTaRS; COX6C; human.
DR   GenomeRNAi; 1345; -.
DR   Bgee; ENSG00000164919; Expressed in 241 organ(s), highest expression level in heart.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro.
DR   CDD; cd00927; Cyt_c_Oxidase_VIc; 1.
DR   Gene3D; 4.10.93.10; -; 1.
DR   InterPro; IPR004204; COX6C.
DR   InterPro; IPR034884; Cytochrome_c_oxidase_VIc/VIIs.
DR   InterPro; IPR037169; Cytochrome_c_oxidase_VIc_sf.
DR   PANTHER; PTHR12916; PTHR12916; 1.
DR   Pfam; PF02937; COX6C; 1.
DR   ProDom; PD015032; Cyt_c_oxidase_su6c; 1.
DR   SUPFAM; SSF81415; SSF81415; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     20     37       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN        6     74       COX6C. {ECO:0000259|Pfam:PF02937}.
SQ   SEQUENCE   75 AA;  8781 MW;  D09FEE0C0AA7A798 CRC64;
     MAPEVLPKPR MRGLLARRLR NHMAVAFVLS LGVAALYKFR VADQRKKAYA DFYRNYDVMK
     DFEEMRKAGI FQSVK
//
ID   COX6C_HUMAN             Reviewed;          75 AA.
AC   P09669; B2R4D7;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   13-FEB-2019, entry version 171.
DE   RecName: Full=Cytochrome c oxidase subunit 6C;
DE   AltName: Full=Cytochrome c oxidase polypeptide VIc;
GN   Name=COX6C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2849755; DOI=10.1093/nar/16.22.10916;
RA   Otsuka M., Mizuno Y., Yoshida M., Kagawa Y., Ohta S.;
RT   "Nucleotide sequence of cDNA encoding human cytochrome c oxidase
RT   subunit VIc.";
RL   Nucleic Acids Res. 16:10916-10916(1988).
RN   [2]
RP   SEQUENCE REVISION TO 52.
RA   Ohta S.;
RL   Submitted (FEB-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10072584;
RA   Hofmann S., Lichtner P., Schuffenhauer S., Gerbitz K.D., Meitinger T.;
RT   "Assignment of the human genes coding for cytochrome c oxidase
RT   subunits Va (COX5A), VIc (COX6C) and VIIc (COX7C) to chromosome bands
RT   15q25, 8q22-->q23 and 5q14 and of three pseudogenes (COX5AP1, COX6CP1,
RT   COX7CP1) to 14q22, 16p12 and 13q14-->q21 by FISH and radiation hybrid
RT   mapping.";
RL   Cytogenet. Cell Genet. 83:226-227(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE [LARGE SCALE ANALYSIS] OF 2-11.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19892738; DOI=10.1073/pnas.0908958106;
RA   Xu G., Shin S.B., Jaffrey S.R.;
RT   "Global profiling of protease cleavage sites by chemoselective
RT   labeling of protein N-termini.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:19310-19315(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: This protein is one of the nuclear-coded polypeptide
CC       chains of cytochrome c oxidase, the terminal oxidase in
CC       mitochondrial electron transport.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane.
CC   -!- SIMILARITY: Belongs to the cytochrome c oxidase subunit 6c family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/COX6CID251.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; X13238; CAA31624.1; -; mRNA.
DR   EMBL; AF067637; AAC73061.1; -; Genomic_DNA.
DR   EMBL; AF067636; AAC73061.1; JOINED; Genomic_DNA.
DR   EMBL; BT007007; AAP35653.1; -; mRNA.
DR   EMBL; AK311791; BAG34734.1; -; mRNA.
DR   EMBL; CH471060; EAW91791.1; -; Genomic_DNA.
DR   EMBL; BC000187; AAH00187.1; -; mRNA.
DR   CCDS; CCDS6284.1; -.
DR   PIR; S01960; OGHU6C.
DR   RefSeq; NP_004365.1; NM_004374.3.
DR   RefSeq; XP_016868509.1; XM_017013020.1.
DR   UniGene; Hs.351875; -.
DR   ProteinModelPortal; P09669; -.
DR   SMR; P09669; -.
DR   BioGrid; 107738; 41.
DR   CORUM; P09669; -.
DR   IntAct; P09669; 37.
DR   MINT; P09669; -.
DR   STRING; 9606.ENSP00000297564; -.
DR   DrugBank; DB02659; Cholic Acid.
DR   DrugBank; DB04464; N-Formylmethionine.
DR   iPTMnet; P09669; -.
DR   PhosphoSitePlus; P09669; -.
DR   BioMuta; COX6C; -.
DR   EPD; P09669; -.
DR   jPOST; P09669; -.
DR   MaxQB; P09669; -.
DR   PaxDb; P09669; -.
DR   PeptideAtlas; P09669; -.
DR   PRIDE; P09669; -.
DR   ProteomicsDB; 52263; -.
DR   TopDownProteomics; P09669; -.
DR   DNASU; 1345; -.
DR   Ensembl; ENST00000297564; ENSP00000297564; ENSG00000164919.
DR   Ensembl; ENST00000517682; ENSP00000429714; ENSG00000164919.
DR   Ensembl; ENST00000518171; ENSP00000429755; ENSG00000164919.
DR   Ensembl; ENST00000520271; ENSP00000428150; ENSG00000164919.
DR   Ensembl; ENST00000520468; ENSP00000428895; ENSG00000164919.
DR   Ensembl; ENST00000520517; ENSP00000429991; ENSG00000164919.
DR   Ensembl; ENST00000522934; ENSP00000428702; ENSG00000164919.
DR   Ensembl; ENST00000522940; ENSP00000428965; ENSG00000164919.
DR   Ensembl; ENST00000523016; ENSP00000429707; ENSG00000164919.
DR   Ensembl; ENST00000524245; ENSP00000429410; ENSG00000164919.
DR   GeneID; 1345; -.
DR   KEGG; hsa:1345; -.
DR   UCSC; uc003yiy.3; human.
DR   CTD; 1345; -.
DR   DisGeNET; 1345; -.
DR   EuPathDB; HostDB:ENSG00000164919.10; -.
DR   GeneCards; COX6C; -.
DR   HGNC; HGNC:2285; COX6C.
DR   HPA; CAB016244; -.
DR   HPA; HPA014295; -.
DR   MIM; 124090; gene.
DR   neXtProt; NX_P09669; -.
DR   OpenTargets; ENSG00000164919; -.
DR   PharmGKB; PA26802; -.
DR   eggNOG; ENOG410J83U; Eukaryota.
DR   eggNOG; ENOG41124VH; LUCA.
DR   GeneTree; ENSGT00940000162275; -.
DR   HOGENOM; HOG000039249; -.
DR   HOVERGEN; HBG051091; -.
DR   InParanoid; P09669; -.
DR   KO; K02268; -.
DR   OMA; KPVMRGL; -.
DR   OrthoDB; 1618740at2759; -.
DR   PhylomeDB; P09669; -.
DR   TreeFam; TF353619; -.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-611105; Respiratory electron transport.
DR   ChiTaRS; COX6C; human.
DR   GeneWiki; COX6C; -.
DR   GenomeRNAi; 1345; -.
DR   PRO; PR:P09669; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000164919; Expressed in 241 organ(s), highest expression level in heart.
DR   ExpressionAtlas; P09669; baseline and differential.
DR   Genevisible; P09669; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0004129; F:cytochrome-c oxidase activity; IEA:InterPro.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc.
DR   CDD; cd00927; Cyt_c_Oxidase_VIc; 1.
DR   Gene3D; 4.10.93.10; -; 1.
DR   InterPro; IPR004204; COX6C.
DR   InterPro; IPR034884; Cytochrome_c_oxidase_VIc/VIIs.
DR   InterPro; IPR037169; Cytochrome_c_oxidase_VIc_sf.
DR   PANTHER; PTHR12916; PTHR12916; 1.
DR   Pfam; PF02937; COX6C; 1.
DR   ProDom; PD015032; Cyt_c_oxidase_su6c; 1.
DR   SUPFAM; SSF81415; SSF81415; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Direct protein sequencing; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1     75       Cytochrome c oxidase subunit 6C.
FT                                /FTId=PRO_0000006131.
FT   TOPO_DOM      1     13       Mitochondrial matrix. {ECO:0000250}.
FT   TRANSMEM     14     54       Helical. {ECO:0000250}.
FT   TOPO_DOM     55     75       Mitochondrial intermembrane.
FT                                {ECO:0000250}.
SQ   SEQUENCE   75 AA;  8781 MW;  D09FEE0C0AA7A798 CRC64;
     MAPEVLPKPR MRGLLARRLR NHMAVAFVLS LGVAALYKFR VADQRKKAYA DFYRNYDVMK
     DFEEMRKAGI FQSVK
//
ID   B3KRT8_HUMAN            Unreviewed;       617 AA.
AC   B3KRT8;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   16-JAN-2019, entry version 63.
DE   SubName: Full=Elastin (Supravalvular aortic stenosis, Williams-Beuren syndrome), isoform CRA_l {ECO:0000313|EMBL:EAW69636.1};
DE   SubName: Full=cDNA FLJ34913 fis, clone NT2RP7000311, moderately similar to ELASTIN {ECO:0000313|EMBL:BAG52500.1};
GN   Name=ELN {ECO:0000313|EMBL:EAW69636.1,
GN   ECO:0000313|Ensembl:ENSP00000480955};
GN   ORFNames=hCG_18037 {ECO:0000313|EMBL:EAW69636.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG52500.1};
RN   [1] {ECO:0000313|EMBL:EAW69636.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000480955, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3] {ECO:0000313|EMBL:BAG52500.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4] {ECO:0000313|EMBL:EAW69636.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|Ensembl:ENSP00000480955}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AC005056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK092232; BAG52500.1; -; mRNA.
DR   EMBL; CH471200; EAW69636.1; -; Genomic_DNA.
DR   RefSeq; NP_001265847.1; NM_001278918.1.
DR   UniGene; Hs.647061; -.
DR   jPOST; B3KRT8; -.
DR   PRIDE; B3KRT8; -.
DR   DNASU; 2006; -.
DR   Ensembl; ENST00000621115; ENSP00000480955; ENSG00000049540.
DR   GeneID; 2006; -.
DR   UCSC; uc003tzp.5; human.
DR   CTD; 2006; -.
DR   EuPathDB; HostDB:ENSG00000049540.16; -.
DR   HGNC; HGNC:3327; ELN.
DR   OpenTargets; ENSG00000049540; -.
DR   PharmGKB; PA27757; -.
DR   GeneTree; ENSGT00730000111510; -.
DR   ChiTaRS; ELN; human.
DR   GenomeRNAi; 2006; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000049540; Expressed in 181 organ(s), highest expression level in thoracic aorta.
DR   ExpressionAtlas; B3KRT8; baseline and differential.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 4.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:B3KRT8,
KW   ECO:0000213|PeptideAtlas:B3KRT8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     26       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        27    617       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014567665.
SQ   SEQUENCE   617 AA;  53630 MW;  A5244FCC64986330 CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPALGPGG KPLKPVPGGL
     AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG LGVSAGAVVP
     QPGAGVKPGK VPGVGLPGVY PGGVLPGVGP FGGPQPGVPL GYPIKAPKLP GGYGLPYTTG
     KLPYGYGPGG VAGAAGKAGY PTGTGVGPQA AAAAAAKAAA KFGAGAAGVL PGVGGAGVPG
     VPGAIPGIGG IAGVGTPAAA AAAAAAAKAA KYGAAAGLVP GGPGFGPGVV GVPGAGVPGV
     GVPGAGIPVV PGAGIPGAAV PGVVSPEAAA KAAAKAAKYG ARPGVGVGGI PTYGVGAGGF
     PGFGVGVGAE AQAAAAAKAA KYGLVPGVGV APGVGVAPGV GVAPGVGLAP GVGVAPGVGV
     APGVGVAPGI GPGGVAAAAK SAAKVAAKAQ LRAAAGLGAG IPGLGVGVGV PGLGVGAGVP
     GLGVGAGVPG FGAVPGALAA AKAAKYGAAV PGVLGGLGAL GGVGIPGGVV GAGPAAAAAA
     AKAAAKAAQF GLVGAAGLGG LGVGGLGVPG VGGLGGIPPA AAAKAAKYGV AARPGFGLSP
     IFPGGACLGK ACGRKRK
//
ID   B4E3S4_HUMAN            Unreviewed;       706 AA.
AC   B4E3S4;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   16-JAN-2019, entry version 35.
DE   SubName: Full=cDNA FLJ56005, highly similar to Elastin {ECO:0000313|EMBL:BAG65586.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG65586.1};
RN   [1] {ECO:0000313|EMBL:BAG65586.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Uterus {ECO:0000313|EMBL:BAG65586.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK304845; BAG65586.1; -; mRNA.
DR   RefSeq; NP_001265841.1; NM_001278912.1.
DR   UniGene; Hs.647061; -.
DR   Allergome; 11040; Hom s Elastin.
DR   PeptideAtlas; B4E3S4; -.
DR   PRIDE; B4E3S4; -.
DR   GeneID; 2006; -.
DR   CTD; 2006; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   OrthoDB; 930292at2759; -.
DR   GenomeRNAi; 2006; -.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 3.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     26       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        27    706       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002801176.
SQ   SEQUENCE   706 AA;  61182 MW;  84D3B457CED67CA5 CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPGAGLGA LGGGALGPGG
     KPLKPVPGGL AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG
     LGVSAGAVVP QPGAGVKPGK VPGVGLPGVY PGGVLPGARF PGVGVLPGVP TGAGVKPKAP
     GVGGAFAGIP GVGPFGGPQP GVPLGYPIKA PKLPGGYGLP YTTGKLPYGY GPGGVAGAAG
     KAGYPTGTGV GPQAVAAAAA KAAAKFGAGA AGVLPGVGGA GVPGVPGAIP GIGGIAGVGT
     PAAAAAAAAA AKAAKYGAAA GLVPGGPGFG PGVVGVPGAG VPGVGVPGAG IPVVPGAGIP
     GAAVPGVVSP EAAAKAAAKA AKYGARPGVG VGGIPTYGVG AGGFPGFGVG VGGIPGVAGV
     PGVGGVPGVG GVPGVGISPE AQAAAAAKAA KYGVGTPAAA AAKAAAKAAQ FGLVPGVGVA
     PGVGVAPGVG VAPGVGLAPG VGVAPGVGVA PGVGVAPGIG PGGVAAAAKS AAKVAAKAQL
     RAAAGLGAGI PGLGVGVGVP GLGVGAGVPG LGVGAGVPGF GAVPGALAAA KAAKYGAAVP
     GVLGGLGALG GVGIPGGVVG AGPAAAAAAA KAAAKAAQFG LVGAAGLGGL GVGGLGVPGV
     GGLGGIPPAA AAKAAKYGVA ARPGFGLSPI FPGGACLGKA CGRKRK
//
ID   E7EN65_HUMAN            Unreviewed;       714 AA.
AC   E7EN65;
DT   08-MAR-2011, integrated into UniProtKB/TrEMBL.
DT   08-MAR-2011, sequence version 1.
DT   16-JAN-2019, entry version 50.
DE   SubName: Full=Elastin {ECO:0000313|Ensembl:ENSP00000403162};
GN   Name=ELN {ECO:0000313|Ensembl:ENSP00000403162};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000403162, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000403162, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000403162}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AC005056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001265846.1; NM_001278917.1.
DR   UniGene; Hs.647061; -.
DR   ProteinModelPortal; E7EN65; -.
DR   Allergome; 11040; Hom s Elastin.
DR   jPOST; E7EN65; -.
DR   PeptideAtlas; E7EN65; -.
DR   PRIDE; E7EN65; -.
DR   Ensembl; ENST00000458204; ENSP00000403162; ENSG00000049540.
DR   GeneID; 2006; -.
DR   UCSC; uc003tzx.5; human.
DR   CTD; 2006; -.
DR   EuPathDB; HostDB:ENSG00000049540.16; -.
DR   HGNC; HGNC:3327; ELN.
DR   OpenTargets; ENSG00000049540; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   GeneTree; ENSGT00730000111510; -.
DR   OrthoDB; 930292at2759; -.
DR   ChiTaRS; ELN; human.
DR   GenomeRNAi; 2006; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000049540; Expressed in 181 organ(s), highest expression level in thoracic aorta.
DR   ExpressionAtlas; E7EN65; baseline and differential.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 3.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:E7EN65,
KW   ECO:0000213|PeptideAtlas:E7EN65};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     26       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        27    714       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003217306.
SQ   SEQUENCE   714 AA;  61923 MW;  0159DB68B68BAAFB CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPALGPGG KPLKPVPGGL
     AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG LGVSAGAVVP
     QPGAGVKPGK VPGVGLPGVY PGGVLPGARF PGVGVLPGVP TGAGVKPKAP GVGGAFAGIP
     GVGPFGGPQP GVPLGYPIKA PKLPGGYGLP YTTGKLPYGY GPGGVAGAAG KAGYPTGTGV
     GPQAAAAAAA KAAAKFGAGA AGVLPGVGGA GVPGVPGAIP GIGGIAGVGT PAAAAAAAAA
     AKAAKYGAAA GLVPGGPGFG PGVVGVPGAG VPGVGVPGAG IPVVPGAGIP GAAVPGVVSP
     EAAAKAAAKA AKYGARPGVG VGGIPTYGVG AGGFPGFGVG VGGIPGVAGV PGVGGVPGVG
     GVPGVGISPE AQAAAAAKAA KYGVGTPAAA AAKAAAKAAQ FGLVPGVGVA PGVGVAPGVG
     VAPGVGLAPG VGVAPGVGVA PGVGVAPGIG PGGVAAAAKS AAKVAAKAQL RAAAGLGAGI
     PGLGVGVGVP GLGVGAGVPG LGVGAGVPGF GAVPGALAAA KAAKYGAAVP GVLGGLGALG
     GVGIPGGVVG AGPAAAAAAA KAAAKAAQFG LVGAAGLGGL GVGGLGVPGV GGLGGIPPAA
     AAKAAKYGAA GLGGVLGGAG QFPLGGVAAR PGFGLSPIFP GGACLGKACG RKRK
//
ID   E7ENM0_HUMAN            Unreviewed;       706 AA.
AC   E7ENM0;
DT   08-MAR-2011, integrated into UniProtKB/TrEMBL.
DT   08-MAR-2011, sequence version 1.
DT   16-JAN-2019, entry version 49.
DE   SubName: Full=Elastin {ECO:0000313|Ensembl:ENSP00000389857};
GN   Name=ELN {ECO:0000313|Ensembl:ENSP00000389857};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000389857, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000389857, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000389857}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AC005056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001265841.1; NM_001278912.1.
DR   UniGene; Hs.647061; -.
DR   ProteinModelPortal; E7ENM0; -.
DR   Allergome; 11040; Hom s Elastin.
DR   jPOST; E7ENM0; -.
DR   PeptideAtlas; E7ENM0; -.
DR   PRIDE; E7ENM0; -.
DR   Ensembl; ENST00000445912; ENSP00000389857; ENSG00000049540.
DR   GeneID; 2006; -.
DR   UCSC; uc011kff.4; human.
DR   CTD; 2006; -.
DR   EuPathDB; HostDB:ENSG00000049540.16; -.
DR   HGNC; HGNC:3327; ELN.
DR   OpenTargets; ENSG00000049540; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   GeneTree; ENSGT00730000111510; -.
DR   OrthoDB; 930292at2759; -.
DR   ChiTaRS; ELN; human.
DR   GenomeRNAi; 2006; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000049540; Expressed in 181 organ(s), highest expression level in thoracic aorta.
DR   ExpressionAtlas; E7ENM0; baseline and differential.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 3.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:E7ENM0,
KW   ECO:0000213|PeptideAtlas:E7ENM0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     26       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        27    706       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003219423.
SQ   SEQUENCE   706 AA;  61154 MW;  34BF630B341E2F50 CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPGAGLGA LGGGALGPGG
     KPLKPVPGGL AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG
     LGVSAGAVVP QPGAGVKPGK VPGVGLPGVY PGGVLPGARF PGVGVLPGVP TGAGVKPKAP
     GVGGAFAGIP GVGPFGGPQP GVPLGYPIKA PKLPGGYGLP YTTGKLPYGY GPGGVAGAAG
     KAGYPTGTGV GPQAAAAAAA KAAAKFGAGA AGVLPGVGGA GVPGVPGAIP GIGGIAGVGT
     PAAAAAAAAA AKAAKYGAAA GLVPGGPGFG PGVVGVPGAG VPGVGVPGAG IPVVPGAGIP
     GAAVPGVVSP EAAAKAAAKA AKYGARPGVG VGGIPTYGVG AGGFPGFGVG VGGIPGVAGV
     PGVGGVPGVG GVPGVGISPE AQAAAAAKAA KYGVGTPAAA AAKAAAKAAQ FGLVPGVGVA
     PGVGVAPGVG VAPGVGLAPG VGVAPGVGVA PGVGVAPGIG PGGVAAAAKS AAKVAAKAQL
     RAAAGLGAGI PGLGVGVGVP GLGVGAGVPG LGVGAGVPGF GAVPGALAAA KAAKYGAAVP
     GVLGGLGALG GVGIPGGVVG AGPAAAAAAA KAAAKAAQFG LVGAAGLGGL GVGGLGVPGV
     GGLGGIPPAA AAKAAKYGVA ARPGFGLSPI FPGGACLGKA CGRKRK
//
ID   F8WAH6_HUMAN            Unreviewed;       786 AA.
AC   F8WAH6;
DT   21-SEP-2011, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 2.
DT   16-JAN-2019, entry version 50.
DE   SubName: Full=Elastin {ECO:0000313|Ensembl:ENSP00000351807};
GN   Name=ELN {ECO:0000313|Ensembl:ENSP00000351807};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000351807, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000351807, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000351807}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AC005056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001265868.1; NM_001278939.1.
DR   UniGene; Hs.647061; -.
DR   ProteinModelPortal; F8WAH6; -.
DR   Allergome; 11040; Hom s Elastin.
DR   jPOST; F8WAH6; -.
DR   PeptideAtlas; F8WAH6; -.
DR   PRIDE; F8WAH6; -.
DR   Ensembl; ENST00000358929; ENSP00000351807; ENSG00000049540.
DR   GeneID; 2006; -.
DR   KEGG; hsa:2006; -.
DR   UCSC; uc032zrp.2; human.
DR   CTD; 2006; -.
DR   EuPathDB; HostDB:ENSG00000049540.16; -.
DR   HGNC; HGNC:3327; ELN.
DR   OpenTargets; ENSG00000049540; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   KO; K14211; -.
DR   OMA; GRAMGEI; -.
DR   OrthoDB; 930292at2759; -.
DR   ChiTaRS; ELN; human.
DR   GenomeRNAi; 2006; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000049540; Expressed in 181 organ(s), highest expression level in thoracic aorta.
DR   ExpressionAtlas; F8WAH6; baseline and differential.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0071953; C:elastic fiber; IEA:Ensembl.
DR   GO; GO:0050840; F:extracellular matrix binding; IEA:Ensembl.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:Ensembl.
DR   GO; GO:0030833; P:regulation of actin filament polymerization; IEA:Ensembl.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl.
DR   GO; GO:0043149; P:stress fiber assembly; IEA:Ensembl.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 2.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:F8WAH6,
KW   ECO:0000213|PeptideAtlas:F8WAH6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     26       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        27    786       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003379646.
SQ   SEQUENCE   786 AA;  68398 MW;  4A128EC9EA2CC29F CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPGAGLGA LGGGALGPGG
     KPLKPVPGGL AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG
     LGVSAGAVVP QPGAGVKPGK VPGVGLPGVY PGGVLPGARF PGVGVLPGVP TGAGVKPKAP
     GVGGAFAGIP GVGPFGGPQP GVPLGYPIKA PKLPGGYGLP YTTGKLPYGY GPGGVAGAAG
     KAGYPTGTGV GPQAAAAAAA KAAAKFGAGA AGVLPGVGGA GVPGVPGAIP GIGGIAGVGT
     PAAAAAAAAA AKAAKYGAAA GLVPGGPGFG PGVVGVPGAG VPGVGVPGAG IPVVPGAGIP
     GAAVPGVVSP EAAAKAAAKA AKYGARPGVG VGGIPTYGVG AGGFPGFGVG VGGIPGVAGV
     PGVGGVPGVG GVPGVGISPE AQAAAAAKAA KYGAAGAGVL GGLVPGAPGA VPGVPGTGGV
     PGVGTPAAAA AKAAAKAAQF GLVPGVGVAP GVGVAPGVGV APGVGLAPGV GVAPGVGVAP
     GVGVAPGIGP GGVAAAAKSA AKVAAKAQLR AAAGLGAGIP GLGVGVGVPG LGVGAGVPGL
     GVGAGVPGFG AGADEGVRRS LSPELREGDP SSSQHLPSTP SSPRVPGALA AAKAAKYGAA
     VPGVLGGLGA LGGVGIPGGV VGAGPAAAAA AAKAAAKAAQ FGLVGAAGLG GLGVGGLGVP
     GVGGLGGIPP AAAAKAAKYG AAGLGGVLGG AGQFPLGGVA ARPGFGLSPI FPGGACLGKA
     CGRKRK
//
ID   G3V0G6_HUMAN            Unreviewed;       700 AA.
AC   G3V0G6;
DT   16-NOV-2011, integrated into UniProtKB/TrEMBL.
DT   16-NOV-2011, sequence version 1.
DT   13-FEB-2019, entry version 75.
DE   SubName: Full=Elastin {ECO:0000313|Ensembl:ENSP00000392575};
DE   SubName: Full=Elastin (Supravalvular aortic stenosis, Williams-Beuren syndrome), isoform CRA_e {ECO:0000313|EMBL:EAW69628.1};
GN   Name=ELN {ECO:0000313|EMBL:EAW69628.1,
GN   ECO:0000313|Ensembl:ENSP00000392575};
GN   ORFNames=hCG_18037 {ECO:0000313|EMBL:EAW69628.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000392575, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW69628.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000392575, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3] {ECO:0000313|EMBL:EAW69628.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|Ensembl:ENSP00000392575}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AC005056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471200; EAW69628.1; -; Genomic_DNA.
DR   RefSeq; NP_001265843.1; NM_001278914.1.
DR   UniGene; Hs.647061; -.
DR   Allergome; 11040; Hom s Elastin.
DR   jPOST; G3V0G6; -.
DR   Ensembl; ENST00000414324; ENSP00000392575; ENSG00000049540.
DR   GeneID; 2006; -.
DR   UCSC; uc003tzy.5; human.
DR   CTD; 2006; -.
DR   EuPathDB; HostDB:ENSG00000049540.16; -.
DR   HGNC; HGNC:3327; ELN.
DR   OpenTargets; ENSG00000049540; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   GeneTree; ENSGT00730000111510; -.
DR   OrthoDB; 930292at2759; -.
DR   ChiTaRS; ELN; human.
DR   GenomeRNAi; 2006; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000049540; Expressed in 181 organ(s), highest expression level in thoracic aorta.
DR   ExpressionAtlas; G3V0G6; baseline and differential.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 3.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:G3V0G6,
KW   ECO:0000213|PeptideAtlas:G3V0G6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     26       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        27    700       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5015091584.
SQ   SEQUENCE   700 AA;  60721 MW;  B611796F2E23E1F4 CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPALGPGG KPLKPVPGGL
     AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG LGVSAAPSVP
     GAVVPQPGAG VKPGKVPGVG LPGVYPGGVL PGARFPGVGV LPGVPTGAGV KPKAPGVGGA
     FAGIPGVGPF GGPQPGVPLG YPIKAPKLPG GYGLPYTTGK LPYGYGPGGV AGAAGKAGYP
     TGTGVGPQAA AAAAAKAAAK FGAGAAGVLP GVGGAGVPGV PGAIPGIGGI AGVGTPAAAA
     AAAAAAKAAK YGAAAGLVPG GPGFGPGVVG VPGAGVPGVG VPGAGIPVVP GAGIPGAAVP
     GVVSPEAAAK AAAKAAKYGA RPGVGVGGIP TYGVGAGGFP GFGVGVGGIP GVAGVPGVGG
     VPGVGGVPGV GISPEAQAAA AAKAAKYGLV PGVGVAPGVG VAPGVGVAPG VGLAPGVGVA
     PGVGVAPGVG VAPGIGPGGV AAAAKSAAKV AAKAQLRAAA GLGAGIPGLG VGVGVPGLGV
     GAGVPGLGVG AGVPGFGAVP GALAAAKAAK YGAAVPGVLG GLGALGGVGI PGGVVGAGPA
     AAAAAAKAAA KAAQFGLVGA AGLGGLGVGG LGVPGVGGLG GIPPAAAAKA AKYGAAGLGG
     VLGGAGQFPL GGVAARPGFG LSPIFPGGAC LGKACGRKRK
//
ID   G5E950_HUMAN            Unreviewed;       643 AA.
AC   G5E950;
DT   14-DEC-2011, integrated into UniProtKB/TrEMBL.
DT   14-DEC-2011, sequence version 1.
DT   16-JAN-2019, entry version 62.
DE   SubName: Full=Elastin (Supravalvular aortic stenosis, Williams-Beuren syndrome), isoform CRA_h {ECO:0000313|EMBL:EAW69632.1};
GN   Name=ELN {ECO:0000313|EMBL:EAW69632.1,
GN   ECO:0000313|Ensembl:ENSP00000315607};
GN   ORFNames=hCG_18037 {ECO:0000313|EMBL:EAW69632.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000315607, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW69632.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000315607, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3] {ECO:0000313|EMBL:EAW69632.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|Ensembl:ENSP00000315607}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (OCT-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AC005056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471200; EAW69632.1; -; Genomic_DNA.
DR   RefSeq; NP_001265842.1; NM_001278913.1.
DR   UniGene; Hs.647061; -.
DR   jPOST; G5E950; -.
DR   PRIDE; G5E950; -.
DR   Ensembl; ENST00000320492; ENSP00000315607; ENSG00000049540.
DR   GeneID; 2006; -.
DR   UCSC; uc003tzz.5; human.
DR   CTD; 2006; -.
DR   EuPathDB; HostDB:ENSG00000049540.16; -.
DR   HGNC; HGNC:3327; ELN.
DR   OpenTargets; ENSG00000049540; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   GeneTree; ENSGT00730000111510; -.
DR   ChiTaRS; ELN; human.
DR   GenomeRNAi; 2006; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000049540; Expressed in 181 organ(s), highest expression level in thoracic aorta.
DR   ExpressionAtlas; G5E950; baseline and differential.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 3.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:G5E950,
KW   ECO:0000213|PeptideAtlas:G5E950};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     26       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        27    643       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014571900.
SQ   SEQUENCE   643 AA;  55643 MW;  F9AD070710972A69 CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPGAGLGA LGGGALGPGG
     KPLKPGLGAF PAVTFPGALV PGGVADAAAA YKAAKAGAGL GGVPGVGGLG VSAGAVVPQP
     GAGVKPGKVP GVGLPGVYPG GVLPGARFPG VGVLPGVPTG AGVKPKAPGV GPFGGPQPGV
     PLGYPIKAPK LPGYGPGGVA GAAGKAGYPT GTGVGPQAAA AAAAKAAAKF GAGAAGVLPG
     VGGAGVPGVP GAIPGIGGIA GVGTPAAAAA AAAAAKAAKY GAAAGLVPGG PGFGPGVVGV
     PGAGVPGVGV PGAGIPVVPG AGIPGAAVPG VVSPEAAAKA AAKAAKYGAR PGVGVGGIPT
     YGVGAGGFPG FGVGVGAEAQ AAAAAKAAKY GLVPGVGVAP GVGVAPGVGV APGVGLAPGV
     GVAPGVGVAP GVGVAPGIGP GGVAAAAKSA AKVAAKAQLR AAAGLGAGIP GLGVGVGVPG
     LGVGAGVPGL GVGAGVPGFG AVPGALAAAK AAKYGAAVPG VLGGLGALGG VGIPGGVVGA
     GPAAAAAAAK AAAKAAQFGL VGAAGLGGLG VGGLGVPGVG GLGGIPPAAA AKAAKYGAAG
     LGGVLGGAGQ FPLGGVAARP GFGLSPIFPG GACLGKACGR KRK
//
ID   ELN_HUMAN               Reviewed;         786 AA.
AC   P15502; B3KTS6; O15336; O15337; Q14233; Q14234; Q14235; Q14238;
AC   Q6P0L4; Q6ZWJ6; Q75MU5; Q7Z316; Q7Z3F5; Q9UMF5;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   18-JUL-2018, sequence version 4.
DT   13-FEB-2019, entry version 198.
DE   RecName: Full=Elastin;
DE   AltName: Full=Tropoelastin;
DE   Flags: Precursor;
GN   Name=ELN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 2; 3; 4 AND 6), AND
RP   VARIANT SER-422.
RX   PubMed=3039501; DOI=10.1073/pnas.84.16.5680;
RA   Indik Z., Yeh H., Ornstein-Goldstein N., Sheppard P., Anderson N.,
RA   Rosenbloom J.C., Peltonen L., Rosenbloom J.;
RT   "Alternative splicing of human elastin mRNA indicated by sequence
RT   analysis of cloned genomic and complementary DNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:5680-5684(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT SER-422.
RC   TISSUE=Skin fibroblast;
RX   PubMed=3171221; DOI=10.1111/1523-1747.ep12476591;
RA   Fazio M.J., Olsen D.R., Kauh E.A., Baldwin C.T., Indik Z.,
RA   Ornstein-Goldstein N., Yeh H., Rosenbloom J., Uitto J.;
RT   "Cloning of full-length elastin cDNAs from a human skin fibroblast
RT   recombinant cDNA library: further elucidation of alternative splicing
RT   utilizing exon-specific oligonucleotides.";
RL   J. Invest. Dermatol. 91:458-464(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 11 AND 12), AND
RP   VARIANT SER-422.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5 AND 7).
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 13).
RC   TISSUE=Gastric mucosa;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 8), AND VARIANTS
RP   SER-422 AND ARG-610.
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-27.
RX   PubMed=2722804;
RA   Bashir M.M., Indik Z., Yeh H., Ornstein-Goldstein N., Rosenbloom J.C.,
RA   Abrams W., Fazio M., Uitto J., Rosenbloom J.;
RT   "Characterization of the complete human elastin gene. Delineation of
RT   unusual features in the 5'-flanking region.";
RL   J. Biol. Chem. 264:8887-8891(1989).
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 1-27.
RA   Bressan G.M.;
RL   Submitted (JUN-1989) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   SEQUENCE REVISION.
RA   Bressan G.M.;
RL   Submitted (OCT-1991) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-657 (ISOFORMS 9 AND 10), AND
RP   VARIANTS SER-422 AND ARG-610.
RX   PubMed=9215670; DOI=10.1093/hmg/6.7.1021;
RA   Li D.Y., Toland A.E., Boak B.B., Atkinson D.L., Ensing G.J.,
RA   Morris C.A., Keating M.T.;
RT   "Elastin point mutations cause an obstructive vascular disease,
RT   supravalvular aortic stenosis.";
RL   Hum. Mol. Genet. 6:1021-1028(1997).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 164-724 (ISOFORM 2), AND VARIANT
RP   SER-422.
RC   TISSUE=Placenta;
RX   PubMed=2831431;
RA   Fazio M.J., Olsen D.R., Kuivaniemi H., Chu M.L., Davidson J.M.,
RA   Rosenbloom J., Uitto J.;
RT   "Isolation and characterization of human elastin cDNAs, and age-
RT   associated variation in elastin gene expression in cultured skin
RT   fibroblasts.";
RL   Lab. Invest. 58:270-277(1988).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 496-786 (ISOFORM 1/10), AND
RP   TISSUE SPECIFICITY.
RX   PubMed=8812460; DOI=10.1006/geno.1996.0469;
RA   Osborne L.R., Martindale D.W., Scherer S.W., Shi X.-M., Huizenga J.,
RA   Heng H.H.Q., Costa T., Pober B., Lew L., Brinkman J., Rommens J.,
RA   Koop B.F., Tsui L.-C.;
RT   "Identification of genes from a 500-kb region at 7q11.23 that is
RT   commonly deleted in Williams syndrome patients.";
RL   Genomics 36:328-336(1996).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 659-786, AND VARIANT SER-422.
RC   TISSUE=Hippocampus, and Placenta;
RX   PubMed=8689688; DOI=10.1016/S0092-8674(00)80077-X;
RA   Frangiskakis J.M., Ewart A.K., Morris C.A., Mervis C.B., Bertrand J.,
RA   Robinson B.F., Klein B.P., Ensing G.J., Everett L.A., Green E.D.,
RA   Proeschel C., Gutowski N.J., Noble M., Atkinson D.L., Odelberg S.J.,
RA   Keating M.T.;
RT   "LIM-kinase1 hemizygosity implicated in impaired visuospatial
RT   constructive cognition.";
RL   Cell 86:59-69(1996).
RN   [16]
RP   INVOLVEMENT IN ADCL1.
RX   PubMed=9873040; DOI=10.1074/jbc.274.2.981;
RA   Zhang M.-C., He L., Giro M., Yong S.L., Tiller G.E., Davidson J.M.;
RT   "Cutis laxa arising from frameshift mutations in exon 30 of the
RT   elastin gene (ELN).";
RL   J. Biol. Chem. 274:981-986(1999).
RN   [17]
RP   INVOLVEMENT IN SVAS.
RX   PubMed=10942104; DOI=10.1007/s004390000285;
RA   Urban Z., Michels V.V., Thibodeau S.N., Davis E.C., Bonnefont J.-P.,
RA   Munnich A., Eyskens B., Gewillig M., Devriendt K., Boyd C.D.;
RT   "Isolated supravalvular aortic stenosis: functional haploinsufficiency
RT   of the elastin gene as a result of nonsense-mediated decay.";
RL   Hum. Genet. 106:577-588(2000).
RN   [18]
RP   INTERACTION WITH FBN1 AND FBLN5.
RX   PubMed=15790312; DOI=10.1042/BJ20050368;
RA   Freeman L.J., Lomas A., Hodson N., Sherratt M.J., Mellody K.T.,
RA   Weiss A.S., Shuttleworth A., Kielty C.M.;
RT   "Fibulin-5 interacts with fibrillin-1 molecules and microfibrils.";
RL   Biochem. J. 388:1-5(2005).
RN   [19]
RP   HYDROXYLATION AT PRO-65; PRO-67; PRO-88; PRO-116; PRO-156; PRO-177;
RP   PRO-190; PRO-286; PRO-290; PRO-415; PRO-427; PRO-465; PRO-481;
RP   PRO-522; PRO-580; PRO-607; PRO-646; PRO-677; PRO-769 AND PRO-772, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16078697; DOI=10.1016/j.chroma.2005.06.034;
RA   Schmelzer C.E.H., Getie M., Neubert R.H.H.;
RT   "Mass spectrometric characterization of human skin elastin peptides
RT   produced by proteolytic digestion with pepsin and thermitase.";
RL   J. Chromatogr. A 1083:120-126(2005).
RN   [20]
RP   HYDROXYLATION AT PRO-34; PRO-167; PRO-170; PRO-190; PRO-283; PRO-286;
RP   PRO-327; PRO-342; PRO-347; PRO-352; PRO-355; PRO-360; PRO-421;
RP   PRO-427; PRO-550; PRO-580; PRO-589; PRO-598 AND PRO-677, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16161116; DOI=10.1002/prot.20643;
RA   Getie M., Schmelzer C.E.H., Neubert R.H.H.;
RT   "Characterization of peptides resulting from digestion of human skin
RT   elastin with elastase.";
RL   Proteins 61:649-657(2005).
RN   [21]
RP   INTERACTION WITH FBLN5, AND SUBCELLULAR LOCATION.
RX   PubMed=17035250; DOI=10.1093/hmg/ddl414;
RA   Hu Q., Loeys B.L., Coucke P.J., De Paepe A., Mecham R.P., Choi J.,
RA   Davis E.C., Urban Z.;
RT   "Fibulin-5 mutations: mechanisms of impaired elastic fiber formation
RT   in recessive cutis laxa.";
RL   Hum. Mol. Genet. 15:3379-3386(2006).
RN   [22]
RP   INTERACTION WITH FBN1; FBLN2 AND FBLN5.
RX   PubMed=17255108; DOI=10.1074/jbc.M608204200;
RA   El-Hallous E., Sasaki T., Hubmacher D., Getie M., Tiedemann K.,
RA   Brinckmann J., Baetge B., Davis E.C., Reinhardt D.P.;
RT   "Fibrillin-1 interactions with fibulins depend on the first hybrid
RT   domain and provide an adaptor function to tropoelastin.";
RL   J. Biol. Chem. 282:8935-8946(2007).
RN   [23]
RP   VARIANT SER-211.
RX   PubMed=19194475; DOI=10.1038/jid.2008.450;
RA   Megarbane H., Florence J., Sass J.O., Schwonbeck S., Foglio M.,
RA   de Cid R., Cure S., Saker S., Megarbane A., Fischer J.;
RT   "An autosomal-recessive form of cutis laxa is due to homozygous
RT   elastin mutations, and the phenotype may be modified by a heterozygous
RT   fibulin 5 polymorphism.";
RL   J. Invest. Dermatol. 129:1650-1655(2009).
CC   -!- FUNCTION: Major structural protein of tissues such as aorta and
CC       nuchal ligament, which must expand rapidly and recover completely.
CC       Molecular determinant of the late arterial morphogenesis,
CC       stabilizing arterial structure by regulating proliferation and
CC       organization of vascular smooth muscle (By similarity).
CC       {ECO:0000250|UniProtKB:P54320}.
CC   -!- SUBUNIT: The polymeric elastin chains are cross-linked together
CC       into an extensible 3D network. Forms a ternary complex with BGN
CC       and MFAP2. Interacts with MFAP2 via divalent cations (calcium >
CC       magnesium > manganese) in a dose-dependent and saturating manner.
CC       Interacts with FBLN5 (PubMed:15790312, PubMed:17035250). Interacts
CC       with FBN1 (PubMed:15790312). Forms a ternary complex with FBN1 and
CC       FBLN2 or FBLN5 (PubMed:17255108). Interacts with MFAP4 in a Ca
CC       (2+)-dependent manner; this interaction promotes ELN self-assembly
CC       (By similarity). {ECO:0000250|UniProtKB:P04985,
CC       ECO:0000269|PubMed:15790312, ECO:0000269|PubMed:17035250,
CC       ECO:0000269|PubMed:17255108}.
CC   -!- INTERACTION:
CC       O95967:EFEMP2; NbExp=5; IntAct=EBI-1222108, EBI-743414;
CC       Q9UBX5:FBLN5; NbExp=3; IntAct=EBI-1222108, EBI-947897;
CC       P28300:LOX; NbExp=2; IntAct=EBI-1222108, EBI-3893481;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000269|PubMed:17035250}. Note=Extracellular matrix of
CC       elastic fibers. {ECO:0000269|PubMed:17035250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=13;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=3;
CC         IsoId=P15502-3; Sequence=Displayed;
CC       Name=1;
CC         IsoId=P15502-1; Sequence=VSP_012484, VSP_012485, VSP_012487;
CC       Name=2;
CC         IsoId=P15502-2; Sequence=VSP_012484, VSP_012487;
CC       Name=4;
CC         IsoId=P15502-4; Sequence=VSP_012484;
CC       Name=5;
CC         IsoId=P15502-5; Sequence=VSP_012481, VSP_012484, VSP_012487,
CC                                  VSP_012488;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=P15502-6; Sequence=VSP_012483, VSP_012487, VSP_012488;
CC       Name=7;
CC         IsoId=P15502-7; Sequence=VSP_012479, VSP_012483, VSP_012487,
CC                                  VSP_012488;
CC         Note=No experimental confirmation available.;
CC       Name=8;
CC         IsoId=P15502-8; Sequence=VSP_012482, VSP_012483, VSP_012486,
CC                                  VSP_012487, VSP_012488;
CC         Note=No experimental confirmation available.;
CC       Name=9;
CC         IsoId=P15502-9; Sequence=VSP_012485;
CC         Note=No experimental confirmation available.;
CC       Name=10;
CC         IsoId=P15502-10; Sequence=VSP_012485, VSP_012487;
CC         Note=No experimental confirmation available.;
CC       Name=11;
CC         IsoId=P15502-11; Sequence=VSP_012480, VSP_012482, VSP_012483,
CC                                   VSP_012487, VSP_012488;
CC         Note=No experimental confirmation available.;
CC       Name=12;
CC         IsoId=P15502-12; Sequence=VSP_012481, VSP_012483, VSP_012487,
CC                                   VSP_012488;
CC       Name=13;
CC         IsoId=P15502-13; Sequence=VSP_012483, VSP_012487;
CC   -!- TISSUE SPECIFICITY: Expressed within the outer myometrial smooth
CC       muscle and throughout the arteriolar tree of uterus (at protein
CC       level). Also expressed in the large arteries, lung and skin.
CC       {ECO:0000269|PubMed:8812460}.
CC   -!- PTM: Elastin is formed through the cross-linking of its soluble
CC       precursor tropoelastin. Cross-linking is initiated through the
CC       action of lysyl oxidase on exposed lysines to form allysine.
CC       Subsequent spontaneous condensation reactions with other allysine
CC       or unmodified lysine residues result in various bi-, tri-, and
CC       tetrafunctional cross-links. The most abundant cross-links in
CC       mature elastin fibers are lysinonorleucine, allysine aldol,
CC       desmosine, and isodesmosine.
CC   -!- PTM: Hydroxylation on proline residues within the sequence motif,
CC       GXPG, is most likely 4-hydroxy as this fits the requirement for 4-
CC       hydroxylation in vertebrates. {ECO:0000250}.
CC   -!- DISEASE: Cutis laxa, autosomal dominant, 1 (ADCL1) [MIM:123700]: A
CC       connective tissue disorder characterized by loose, hyperextensible
CC       skin with decreased resilience and elasticity leading to a
CC       premature aged appearance. Face, hands, feet, joints, and torso
CC       may be differentially affected. Additional variable clinical
CC       features are gastrointestinal diverticula, hernia, and genital
CC       prolapse. Rare manifestations are pulmonary artery stenosis,
CC       aortic aneurysm, bronchiectasis, and emphysema.
CC       {ECO:0000269|PubMed:9873040}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Supravalvular aortic stenosis (SVAS) [MIM:185500]:
CC       Congenital narrowing of the ascending aorta which can occur
CC       sporadically, as an autosomal dominant condition, or as one
CC       component of Williams-Beuren syndrome.
CC       {ECO:0000269|PubMed:10942104}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=ELN is located in the Williams-Beuren syndrome (WBS)
CC       critical region. WBS results from a hemizygous deletion of several
CC       genes on chromosome 7q11.23, thought to arise as a consequence of
CC       unequal crossing over between highly homologous low-copy repeat
CC       sequences flanking the deleted region. Haploinsufficiency of ELN
CC       may be the cause of certain cardiovascular and musculo-skeletal
CC       abnormalities observed in the disease (PubMed:8812460).
CC       {ECO:0000269|PubMed:8812460}.
CC   -!- SIMILARITY: Belongs to the elastin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD98065.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Elastin entry;
CC       URL="https://en.wikipedia.org/wiki/Elastin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; M17282; AAC98393.1; -; Genomic_DNA.
DR   EMBL; M16983; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17265; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17266; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17267; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17268; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17271; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17272; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17273; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17275; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17276; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17277; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17278; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17279; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17281; AAC98393.1; JOINED; Genomic_DNA.
DR   EMBL; M17282; AAC98394.1; -; Genomic_DNA.
DR   EMBL; M16983; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17265; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17266; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17267; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17268; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17270; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17271; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17272; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17273; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17275; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17276; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17277; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17278; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17279; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17280; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17281; AAC98394.1; JOINED; Genomic_DNA.
DR   EMBL; M17282; AAC98395.1; -; Genomic_DNA.
DR   EMBL; M16983; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17265; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17266; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17267; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17268; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17270; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17271; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17272; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17273; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17274; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17275; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17276; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17277; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17278; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17279; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17280; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M17281; AAC98395.1; JOINED; Genomic_DNA.
DR   EMBL; M36860; AAA52382.1; -; mRNA.
DR   EMBL; AK095990; BAG53188.1; -; mRNA.
DR   EMBL; AK122731; BAC85506.1; -; mRNA.
DR   EMBL; BX537939; CAD97910.1; -; mRNA.
DR   EMBL; BX538199; CAD98065.1; ALT_INIT; mRNA.
DR   EMBL; AK225659; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC005056; AAS07435.1; -; Genomic_DNA.
DR   EMBL; CH471200; EAW69627.1; -; Genomic_DNA.
DR   EMBL; BC065566; AAH65566.1; -; mRNA.
DR   EMBL; X15603; CAA33627.1; -; Genomic_DNA.
DR   EMBL; U93037; AAB65620.1; -; Genomic_DNA.
DR   EMBL; U93034; AAB65620.1; JOINED; Genomic_DNA.
DR   EMBL; U93035; AAB65620.1; JOINED; Genomic_DNA.
DR   EMBL; U93036; AAB65620.1; JOINED; Genomic_DNA.
DR   EMBL; U93037; AAB65621.1; -; Genomic_DNA.
DR   EMBL; U93034; AAB65621.1; JOINED; Genomic_DNA.
DR   EMBL; U93035; AAB65621.1; JOINED; Genomic_DNA.
DR   EMBL; U93036; AAB65621.1; JOINED; Genomic_DNA.
DR   EMBL; M24782; AAA53190.1; -; mRNA.
DR   EMBL; U63721; AAC13884.1; -; Genomic_DNA.
DR   EMBL; U62292; AAB17544.1; -; Genomic_DNA.
DR   CCDS; CCDS43598.1; -. [P15502-5]
DR   CCDS; CCDS43599.1; -. [P15502-7]
DR   CCDS; CCDS47611.1; -. [P15502-12]
DR   CCDS; CCDS47612.1; -. [P15502-13]
DR   CCDS; CCDS5562.2; -. [P15502-2]
DR   CCDS; CCDS64673.1; -. [P15502-1]
DR   CCDS; CCDS64675.1; -. [P15502-8]
DR   CCDS; CCDS75616.1; -. [P15502-3]
DR   PIR; A32707; EAHU.
DR   RefSeq; NP_000492.2; NM_000501.3. [P15502-2]
DR   RefSeq; NP_001075221.1; NM_001081752.2. [P15502-7]
DR   RefSeq; NP_001075222.1; NM_001081753.2. [P15502-12]
DR   RefSeq; NP_001075223.1; NM_001081754.2. [P15502-5]
DR   RefSeq; NP_001075224.1; NM_001081755.2. [P15502-13]
DR   RefSeq; NP_001265844.1; NM_001278915.1. [P15502-1]
DR   RefSeq; NP_001265845.1; NM_001278916.1. [P15502-8]
DR   RefSeq; NP_001265868.1; NM_001278939.1. [P15502-3]
DR   UniGene; Hs.647061; -.
DR   ProteinModelPortal; P15502; -.
DR   BioGrid; 108321; 14.
DR   CORUM; P15502; -.
DR   IntAct; P15502; 12.
DR   STRING; 9606.ENSP00000252034; -.
DR   ChEMBL; CHEMBL3713712; -.
DR   DrugBank; DB00533; Rofecoxib.
DR   Allergome; 11040; Hom s Elastin.
DR   iPTMnet; P15502; -.
DR   PhosphoSitePlus; P15502; -.
DR   BioMuta; ELN; -.
DR   DMDM; 306526276; -.
DR   jPOST; P15502; -.
DR   PaxDb; P15502; -.
DR   PeptideAtlas; P15502; -.
DR   PRIDE; P15502; -.
DR   ProteomicsDB; 53144; -.
DR   ProteomicsDB; 53145; -. [P15502-1]
DR   ProteomicsDB; 53146; -. [P15502-10]
DR   ProteomicsDB; 53147; -. [P15502-11]
DR   ProteomicsDB; 53148; -. [P15502-12]
DR   ProteomicsDB; 53149; -. [P15502-13]
DR   ProteomicsDB; 53150; -. [P15502-2]
DR   ProteomicsDB; 53151; -. [P15502-4]
DR   ProteomicsDB; 53152; -. [P15502-5]
DR   ProteomicsDB; 53153; -. [P15502-6]
DR   ProteomicsDB; 53154; -. [P15502-7]
DR   ProteomicsDB; 53155; -. [P15502-8]
DR   ProteomicsDB; 53156; -. [P15502-9]
DR   DNASU; 2006; -.
DR   Ensembl; ENST00000252034; ENSP00000252034; ENSG00000049540. [P15502-2]
DR   Ensembl; ENST00000320399; ENSP00000313565; ENSG00000049540. [P15502-4]
DR   Ensembl; ENST00000357036; ENSP00000349540; ENSG00000049540. [P15502-5]
DR   Ensembl; ENST00000358929; ENSP00000351807; ENSG00000049540. [P15502-3]
DR   Ensembl; ENST00000380553; ENSP00000369926; ENSG00000049540. [P15502-11]
DR   Ensembl; ENST00000380562; ENSP00000369936; ENSG00000049540. [P15502-1]
DR   Ensembl; ENST00000380575; ENSP00000369949; ENSG00000049540. [P15502-7]
DR   Ensembl; ENST00000380576; ENSP00000369950; ENSG00000049540. [P15502-13]
DR   Ensembl; ENST00000380584; ENSP00000369958; ENSG00000049540. [P15502-8]
DR   Ensembl; ENST00000429192; ENSP00000391129; ENSG00000049540. [P15502-12]
DR   GeneID; 2006; -.
DR   KEGG; hsa:2006; -.
DR   UCSC; uc003tzn.5; human. [P15502-3]
DR   CTD; 2006; -.
DR   DisGeNET; 2006; -.
DR   EuPathDB; HostDB:ENSG00000049540.16; -.
DR   GeneCards; ELN; -.
DR   GeneReviews; ELN; -.
DR   H-InvDB; HIX0006761; -.
DR   HGNC; HGNC:3327; ELN.
DR   HPA; CAB010750; -.
DR   HPA; HPA018111; -.
DR   HPA; HPA056941; -.
DR   MalaCards; ELN; -.
DR   MIM; 123700; phenotype.
DR   MIM; 130160; gene.
DR   MIM; 185500; phenotype.
DR   neXtProt; NX_P15502; -.
DR   OpenTargets; ENSG00000049540; -.
DR   Orphanet; 90348; Autosomal dominant cutis laxa.
DR   Orphanet; 91387; Familial thoracic aortic aneurysm and aortic dissection.
DR   Orphanet; 3193; Supravalvular aortic stenosis.
DR   Orphanet; 904; Williams syndrome.
DR   PharmGKB; PA27757; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   GeneTree; ENSGT00730000111510; -.
DR   InParanoid; P15502; -.
DR   KO; K14211; -.
DR   OrthoDB; 1437076at2759; -.
DR   TreeFam; TF338594; -.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-1566948; Elastic fibre formation.
DR   Reactome; R-HSA-2129379; Molecules associated with elastic fibres.
DR   SIGNOR; P15502; -.
DR   ChiTaRS; ELN; human.
DR   GeneWiki; Elastin; -.
DR   GenomeRNAi; 2006; -.
DR   PMAP-CutDB; P15502; -.
DR   PRO; PR:P15502; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000049540; Expressed in 181 organ(s), highest expression level in thoracic aorta.
DR   ExpressionAtlas; P15502; baseline and differential.
DR   Genevisible; P15502; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0071953; C:elastic fiber; IDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; TAS:ProtInc.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0050840; F:extracellular matrix binding; IEA:Ensembl.
DR   GO; GO:0030023; F:extracellular matrix constituent conferring elasticity; HDA:BHF-UCL.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; HDA:BHF-UCL.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0003180; P:aortic valve morphogenesis; IC:BHF-UCL.
DR   GO; GO:0008015; P:blood circulation; TAS:ProtInc.
DR   GO; GO:0008283; P:cell population proliferation; TAS:ProtInc.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0003151; P:outflow tract morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0030833; P:regulation of actin filament polymerization; IEA:Ensembl.
DR   GO; GO:0007585; P:respiratory gaseous exchange; TAS:ProtInc.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl.
DR   GO; GO:0043149; P:stress fiber assembly; IEA:Ensembl.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 2.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disulfide bond;
KW   Extracellular matrix; Hydroxylation; Polymorphism; Reference proteome;
KW   Repeat; Secreted; Signal; Williams-Beuren syndrome.
FT   SIGNAL        1     26       {ECO:0000250|UniProtKB:Q99372}.
FT   CHAIN        27    786       Elastin.
FT                                /FTId=PRO_0000021163.
FT   COMPBIAS     97    102       Poly-Ala.
FT   COMPBIAS    236    742       Ala-rich.
FT   MOD_RES      34     34       Hydroxyproline.
FT                                {ECO:0000269|PubMed:16161116}.
FT   MOD_RES      65     65       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697}.
FT   MOD_RES      67     67       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697}.
FT   MOD_RES      88     88       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697}.
FT   MOD_RES     104    104       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     107    107       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     116    116       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697}.
FT   MOD_RES     156    156       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697}.
FT   MOD_RES     167    167       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16161116}.
FT   MOD_RES     170    170       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16161116}.
FT   MOD_RES     177    177       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697}.
FT   MOD_RES     190    190       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697,
FT                                ECO:0000269|PubMed:16161116}.
FT   MOD_RES     241    241       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     261    261       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     265    265       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     283    283       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16161116}.
FT   MOD_RES     286    286       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697,
FT                                ECO:0000269|PubMed:16161116}.
FT   MOD_RES     290    290       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697}.
FT   MOD_RES     312    312       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     315    315       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     327    327       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16161116}.
FT   MOD_RES     342    342       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16161116}.
FT   MOD_RES     347    347       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16161116}.
FT   MOD_RES     352    352       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16161116}.
FT   MOD_RES     355    355       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16161116}.
FT   MOD_RES     360    360       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16161116}.
FT   MOD_RES     375    375       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     379    379       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     382    382       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     415    415       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697}.
FT   MOD_RES     421    421       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16161116}.
FT   MOD_RES     427    427       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697,
FT                                ECO:0000269|PubMed:16161116}.
FT   MOD_RES     448    448       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     451    451       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     465    465       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697}.
FT   MOD_RES     481    481       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697}.
FT   MOD_RES     492    492       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     496    496       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     522    522       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697}.
FT   MOD_RES     550    550       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16161116}.
FT   MOD_RES     558    558       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     562    562       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     566    566       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     580    580       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697,
FT                                ECO:0000269|PubMed:16161116}.
FT   MOD_RES     589    589       4-hydroxyproline.
FT                                {ECO:0000305|PubMed:16161116}.
FT   MOD_RES     598    598       4-hydroxyproline.
FT                                {ECO:0000305|PubMed:16161116}.
FT   MOD_RES     607    607       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697}.
FT   MOD_RES     646    646       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697}.
FT   MOD_RES     653    653       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     656    656       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     677    677       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697,
FT                                ECO:0000269|PubMed:16161116}.
FT   MOD_RES     693    693       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     697    697       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     735    735       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     738    738       Allysine. {ECO:0000250|UniProtKB:P04985}.
FT   MOD_RES     769    769       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697}.
FT   MOD_RES     772    772       Hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16078697}.
FT   DISULFID    776    781       {ECO:0000250}.
FT   VAR_SEQ      45     54       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_012479.
FT   VAR_SEQ      78    180       Missing (in isoform 11).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_012480.
FT   VAR_SEQ     125    125       A -> AAPSVP (in isoform 5 and isoform
FT                                12). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_012481.
FT   VAR_SEQ     215    228       Missing (in isoform 8 and isoform 11).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012482.
FT   VAR_SEQ     453    500       Missing (in isoform 6, isoform 7, isoform
FT                                8, isoform 11, isoform 12 and isoform
FT                                13). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_012483.
FT   VAR_SEQ     453    481       Missing (in isoform 1, isoform 2, isoform
FT                                4 and isoform 5).
FT                                {ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|PubMed:2831431,
FT                                ECO:0000303|PubMed:3171221}.
FT                                /FTId=VSP_012484.
FT   VAR_SEQ     500    500       F -> FALLNLA (in isoform 1, isoform 9 and
FT                                isoform 10).
FT                                {ECO:0000303|PubMed:3171221}.
FT                                /FTId=VSP_012485.
FT   VAR_SEQ     555    570       AAAKSAAKVAAKAQLR -> G (in isoform 8).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012486.
FT   VAR_SEQ     612    644       Missing (in isoform 1, isoform 2, isoform
FT                                5, isoform 6, isoform 7, isoform 8,
FT                                isoform 10, isoform 11, isoform 12 and
FT                                isoform 13).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|PubMed:2831431,
FT                                ECO:0000303|PubMed:3171221,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_012487.
FT   VAR_SEQ     740    757       Missing (in isoform 5, isoform 6, isoform
FT                                7, isoform 8, isoform 11 and isoform 12).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_012488.
FT   VARIANT     211    211       P -> S (found as homozygous mutation in a
FT                                patient with autosomal recessive cutis
FT                                laxa also carrying a mutation in FBLN5;
FT                                unknown pathological significance;
FT                                dbSNP:rs1064793880).
FT                                {ECO:0000269|PubMed:19194475}.
FT                                /FTId=VAR_072395.
FT   VARIANT     422    422       G -> S (in dbSNP:rs2071307).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2831431,
FT                                ECO:0000269|PubMed:3039501,
FT                                ECO:0000269|PubMed:3171221,
FT                                ECO:0000269|PubMed:8689688,
FT                                ECO:0000269|PubMed:9215670}.
FT                                /FTId=VAR_020882.
FT   VARIANT     610    610       G -> R (in dbSNP:rs17855988).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9215670}.
FT                                /FTId=VAR_056869.
FT   CONFLICT    317    317       G -> E (in Ref. 4; CAD97910).
FT                                {ECO:0000305}.
FT   CONFLICT    553    553       V -> I (in Ref. 3; BAC85506).
FT                                {ECO:0000305}.
FT   CONFLICT    691    691       A -> T (in Ref. 4; CAD98065).
FT                                {ECO:0000305}.
FT   CONFLICT    773    773       G -> D (in Ref. 4; CAD97910).
FT                                {ECO:0000305}.
SQ   SEQUENCE   786 AA;  68398 MW;  4A128EC9EA2CC29F CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPGAGLGA LGGGALGPGG
     KPLKPVPGGL AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG
     LGVSAGAVVP QPGAGVKPGK VPGVGLPGVY PGGVLPGARF PGVGVLPGVP TGAGVKPKAP
     GVGGAFAGIP GVGPFGGPQP GVPLGYPIKA PKLPGGYGLP YTTGKLPYGY GPGGVAGAAG
     KAGYPTGTGV GPQAAAAAAA KAAAKFGAGA AGVLPGVGGA GVPGVPGAIP GIGGIAGVGT
     PAAAAAAAAA AKAAKYGAAA GLVPGGPGFG PGVVGVPGAG VPGVGVPGAG IPVVPGAGIP
     GAAVPGVVSP EAAAKAAAKA AKYGARPGVG VGGIPTYGVG AGGFPGFGVG VGGIPGVAGV
     PGVGGVPGVG GVPGVGISPE AQAAAAAKAA KYGAAGAGVL GGLVPGAPGA VPGVPGTGGV
     PGVGTPAAAA AKAAAKAAQF GLVPGVGVAP GVGVAPGVGV APGVGLAPGV GVAPGVGVAP
     GVGVAPGIGP GGVAAAAKSA AKVAAKAQLR AAAGLGAGIP GLGVGVGVPG LGVGAGVPGL
     GVGAGVPGFG AGADEGVRRS LSPELREGDP SSSQHLPSTP SSPRVPGALA AAKAAKYGAA
     VPGVLGGLGA LGGVGIPGGV VGAGPAAAAA AAKAAAKAAQ FGLVGAAGLG GLGVGGLGVP
     GVGGLGGIPP AAAAKAAKYG AAGLGGVLGG AGQFPLGGVA ARPGFGLSPI FPGGACLGKA
     CGRKRK
//
ID   Q59H17_HUMAN            Unreviewed;       106 AA.
AC   Q59H17;
DT   26-APR-2005, integrated into UniProtKB/TrEMBL.
DT   26-APR-2005, sequence version 1.
DT   07-JUN-2017, entry version 27.
DE   SubName: Full=Elastin variant {ECO:0000313|EMBL:BAD92179.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD92179.1};
RN   [1] {ECO:0000313|EMBL:BAD92179.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAD92179.1};
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AB208942; BAD92179.1; -; mRNA.
DR   RefSeq; NP_001265846.1; NM_001278917.1.
DR   UniGene; Hs.647061; -.
DR   GeneID; 2006; -.
DR   CTD; 2006; -.
DR   GenomeRNAi; 2006; -.
PE   2: Evidence at transcript level;
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAD92179.1}.
SQ   SEQUENCE   106 AA;  11629 MW;  228761EADB87A94A CRC64;
     RRRPRGPESS CSCCPSSTPL GLEGSLGPFL VEFLEESFIQ RWGLEANLLS QFPEGLRVLA
     LGQGSAPSPQ LPFRGLWCLV EWLTLLQPIK LLRLALGLVV SQELVA
//
ID   Q6ZUN2_HUMAN            Unreviewed;       559 AA.
AC   Q6ZUN2;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   10-OCT-2018, entry version 54.
DE   SubName: Full=cDNA FLJ43523 fis, clone PLACE5000282, weakly similar to Homo sapiens elastin (supravalvular aortic stenosis, Williams-Beuren syndrome) (ELN) {ECO:0000313|EMBL:BAC86188.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAC86188.1};
RN   [1] {ECO:0000313|EMBL:BAC86188.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAC86188.1};
RA   Oshima A., Takahashi-Fujii A., Tanase T., Imose N., Takeuchi K.,
RA   Arita M., Musashino K., Yuuki H., Hara H., Sugiyama T., Irie R.,
RA   Otsuki T., Sato H., Wakamatsu A., Ishii S., Yamamoto J., Isono Y.,
RA   Kawai-Hio Y., Saito K., Nishikawa T., Kimura K., Yamashita H.,
RA   Matsuo K., Nakamura Y., Sekine M., Kikuchi H., Kanda K., Wagatsuma M.,
RA   Murakawa K., Kanehori K., Sugiyama A., Kawakami B., Suzuki Y.,
RA   Sugano S., Nagahari K., Masuho Y., Nagai K., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK125511; BAC86188.1; -; mRNA.
DR   RefSeq; NP_001265843.1; NM_001278914.1.
DR   UniGene; Hs.647061; -.
DR   ProteinModelPortal; Q6ZUN2; -.
DR   SMR; Q6ZUN2; -.
DR   PeptideAtlas; Q6ZUN2; -.
DR   PRIDE; Q6ZUN2; -.
DR   GeneID; 2006; -.
DR   CTD; 2006; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   GenomeRNAi; 2006; -.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 1.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     26       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        27    559       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004283926.
SQ   SEQUENCE   559 AA;  53787 MW;  20938FFEC5492A01 CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPALGPGG KPLKPVPGGL
     AGAGLGAGLG AFPAVTFPGA LVPGGVADAA AAYKAAKAGA GLGGVPGVGG LGVSAAPSVP
     GAVVPQPGAG VKPGKVPGVG LPGVYPGGVL PGARFPGVGV LPGVPTGAGV KPKAPGVGGA
     FAGIPGVGPF GGPQPGVPLG YPIKAPKLPG GYGLPYTTGK LPYGYGPGGV AGAAGKAGYP
     TGTGVGPQAA AAAAAKAAAK FGAGAAGVLP GVGGAGVPGV PGAIPGIGGI AGVGTPAAAA
     AAAAAAKAAK YGAAAGLVPG GPGFGPGVVG VPGAGVPGVG VPGAGIPVVP GAGIPGAAVP
     GVVSPEAAAK AAAKAAKYGA RPGVGVGGIP TYGVGAGGFP GFGVGVGGIP GVAGVPGVGG
     SRSRRCPGSW HFPRSSGSSC RQGCQVRVSS WCRRGSWSWR GSWCRCGSWS WLGSWSWRGS
     WSWCGSWRWR GSRHWPWWSC SCSKIRCQGG CQSPAPSCSW AWCWHPWTWS WCRRPWTWSW
     CWCSWTWSWC WCSWLRGST
//
ID   Q8NBI4_HUMAN            Unreviewed;       643 AA.
AC   Q8NBI4;
DT   01-OCT-2002, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2002, sequence version 1.
DT   18-JUL-2018, entry version 69.
DE   SubName: Full=cDNA PSEC0254 fis, clone NT2RP3003474, moderately similar to ELASTIN {ECO:0000313|EMBL:BAC11696.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAC11696.1};
RN   [1] {ECO:0000313|EMBL:BAC11696.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK075554; BAC11696.1; -; mRNA.
DR   RefSeq; NP_001265842.1; NM_001278913.1.
DR   UniGene; Hs.647061; -.
DR   PeptideAtlas; Q8NBI4; -.
DR   PRIDE; Q8NBI4; -.
DR   GeneID; 2006; -.
DR   CTD; 2006; -.
DR   eggNOG; ENOG410IZT8; Eukaryota.
DR   eggNOG; ENOG4111817; LUCA.
DR   GenomeRNAi; 2006; -.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 3.
DR   PRINTS; PR01500; TROPOELASTIN.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     26       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        27    643       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004312895.
SQ   SEQUENCE   643 AA;  55629 MW;  FDFC042617E72A69 CRC64;
     MAGLTAAAPR PGVLLLLLSI LHPSRPGGVP GAIPGGVPGG VFYPGAGLGA LGGGALGPGG
     KPLKPGLGAF PAVTFPGALV PGGVADAAAA YKAAKAGAGL GGVPGVGGLG VSAGAVVPQP
     GAGVKPGKVP GVGLPGVYPG GVLPGARFPG VGVLPGVPTG AGVKPKAPGV GPFGGPQPGV
     PLGYPIKAPK LPGYGPGGVA GAAGKAGYPT GTGVGPQAAA AAAAKAAAKF GAGAAGVLPG
     VGGAGVPGVP GAIPGIGGIA GVGTPAAAAA AAAAAKAAKY GAAAGLVPGG PGFGPGVVGV
     PGAGVPGVGV PGAGIPVVPG AGIPGAAVPG VVSPEAAAKA AAKAAKYGAR PGVGVGGIPT
     YGVGAGGFPG FGVGVGAEAQ AAAAAKAAKY GLVPGVGVAP GVGVAPGVGV APGVGLAPGV
     GVAPGVGVAP GVGVAPGIGP GGVAAAAKSA AKVAAKAQLR AAAGLGAGIP GLGVGVGVPG
     LGVGAGVPGL GVGAGVPGFG AVPGALAAAK AANYGAAVPG VLGGLGALGG VGIPGGVVGA
     GPAAAAAAAK AAAKAAQFGL VGAAGLGGLG VGGLGVPGVG GLGGIPPAAA AKAAKYGAAG
     LGGVLGGAGQ FPLGGVAARP GFGLSPIFPG GACLGKACGR KRK
//
ID   D3DXE4_HUMAN            Unreviewed;       300 AA.
AC   D3DXE4;
DT   23-MAR-2010, integrated into UniProtKB/TrEMBL.
DT   23-MAR-2010, sequence version 1.
DT   16-JAN-2019, entry version 51.
DE   SubName: Full=KIAA0773 gene product, isoform CRA_b {ECO:0000313|EMBL:EAW51856.1};
GN   Name=KIAA0773 {ECO:0000313|EMBL:EAW51856.1};
GN   ORFNames=hCG_1736562 {ECO:0000313|EMBL:EAW51856.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW51856.1};
RN   [1] {ECO:0000313|EMBL:EAW51856.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW51856.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471198; EAW51855.1; -; Genomic_DNA.
DR   EMBL; CH471198; EAW51856.1; -; Genomic_DNA.
DR   EMBL; CH471198; EAW51857.1; -; Genomic_DNA.
DR   RefSeq; XP_006716249.1; XM_006716186.2.
DR   UniGene; Hs.648908; -.
DR   PRIDE; D3DXE4; -.
DR   GeneID; 9715; -.
DR   CTD; 9715; -.
DR   eggNOG; ENOG410IECV; Eukaryota.
DR   eggNOG; ENOG4111H79; LUCA.
DR   OrthoDB; 864510at2759; -.
DR   GenomeRNAi; 9715; -.
DR   InterPro; IPR026782; FAM131.
DR   PANTHER; PTHR15736; PTHR15736; 1.
DR   Pfam; PF15010; FAM131; 1.
PE   4: Predicted;
SQ   SEQUENCE   300 AA;  32236 MW;  0062FE69E407E645 CRC64;
     MEDTTSILPK LKRNSNAYGI GALAKSSFSG ISRSMKDHVT KPTAMGQGRV AHMIEWQGWG
     KTPAVQPQHS HESVRRDTDA YSDLSDGEKE ARFLAGVMEQ FAISEATLMA WSSMDGEDMS
     VNSTQEPLGC NYSDNYQELM DSQDALAQAP MDGWPHSYVS QGMYCLGSSD AWEASDQSLI
     ASPATGSYLG PAFDDSQPSL HEMGPSQPAS GYSALEPPPL LGGDTDWAPG VGAVDLARGP
     AEEEKRPLAP EEEEDAGCRD LESLSPREDP EMSTALSRKV SDVTSSGVQS FDEEEGEANN
//
ID   O94871_HUMAN            Unreviewed;       336 AA.
AC   O94871;
DT   01-MAY-1999, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 2.
DT   16-JAN-2019, entry version 77.
DE   SubName: Full=KIAA0773 protein {ECO:0000313|EMBL:BAA34493.2};
DE   Flags: Fragment;
GN   Name=KIAA0773 {ECO:0000313|EMBL:BAA34493.2};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAA34493.2};
RN   [1] {ECO:0000313|EMBL:BAA34493.2}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAA34493.2};
RX   PubMed=9872452; DOI=10.1093/dnares/5.5.277;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XI.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:277-286(1998).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AB018316; BAA34493.2; -; mRNA.
DR   RefSeq; NP_001265226.1; NM_001278297.1.
DR   UniGene; Hs.648908; -.
DR   ProteinModelPortal; O94871; -.
DR   MaxQB; O94871; -.
DR   PeptideAtlas; O94871; -.
DR   PRIDE; O94871; -.
DR   GeneID; 9715; -.
DR   CTD; 9715; -.
DR   eggNOG; ENOG410IECV; Eukaryota.
DR   eggNOG; ENOG4111H79; LUCA.
DR   HOGENOM; HOG000013105; -.
DR   HOVERGEN; HBG081012; -.
DR   OrthoDB; 864510at2759; -.
DR   GenomeRNAi; 9715; -.
DR   InterPro; IPR026782; FAM131.
DR   PANTHER; PTHR15736; PTHR15736; 1.
DR   Pfam; PF15010; FAM131; 1.
PE   2: Evidence at transcript level;
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAA34493.2}.
SQ   SEQUENCE   336 AA;  36496 MW;  189A7E6BD2774DE6 CRC64;
     FLLGRHQRTV STHVLNLCPS FPEHWGYIPP WDSWLSMEDT TSILPKLKRN SNAYGIGALA
     KSSFSGISRS MKDHVTKPTA MGQGRVAHMI EWQGWGKTPA VQPQHSHESV RRDTDAYSDL
     SDGEKEARFL AGVMEQFAIS EATLMAWSSM DGEDMSVNST QEPLGCNYSD NYQELMDSQD
     ALAQAPMDGW PHSYVSQGMY CLGSSDAWEA SDQSLIASPA TGSYLGPAFD DSQPSLHEMG
     PSQPASGYSA LEPPPLLGGD TDWAPGVGAV DLARGPAEEE KRPLAPEEEE DAGCRDLESL
     SPREDPEMST ALSRKVSDVT SSGVQSFDEE EGEANN
//
ID   F131B_HUMAN             Reviewed;         332 AA.
AC   Q86XD5; A4D2H6; A6NDW3; A8K605; B8ZZN2; D3DXE3; J3KQX2; Q7L0D6;
AC   Q86T97;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   13-FEB-2019, entry version 112.
DE   RecName: Full=Protein FAM131B;
GN   Name=FAM131B; Synonyms=KIAA0773;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Spinal cord;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   THR-307.
RC   TISSUE=Brain, and Hypothalamus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   MYRISTOYLATION AT GLY-2 (ISOFORM 2).
RX   PubMed=20213681; DOI=10.1002/pmic.200900783;
RA   Suzuki T., Moriya K., Nagatoshi K., Ota Y., Ezure T., Ando E.,
RA   Tsunasawa S., Utsumi T.;
RT   "Strategy for comprehensive identification of human N-myristoylated
RT   proteins using an insect cell-free protein synthesis system.";
RL   Proteomics 10:1780-1793(2010).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-117, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
CC   -!- INTERACTION:
CC       Q9BSI4:TINF2; NbExp=2; IntAct=EBI-11308812, EBI-717399;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q86XD5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86XD5-2; Sequence=VSP_041633;
CC         Note=Initiator Met-1 is removed. Contains a N-myristoyl glycine
CC         at position 2.;
CC       Name=3;
CC         IsoId=Q86XD5-3; Sequence=VSP_046798;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the FAM131 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAS07501.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK291470; BAF84159.1; -; mRNA.
DR   EMBL; AL832579; CAD89938.1; -; mRNA.
DR   EMBL; AC093673; AAS07501.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH236959; EAL23787.1; -; Genomic_DNA.
DR   EMBL; CH471198; EAW51853.1; -; Genomic_DNA.
DR   EMBL; CH471198; EAW51854.1; -; Genomic_DNA.
DR   EMBL; BC045611; AAH45611.2; -; mRNA.
DR   EMBL; BC050543; AAH50543.2; -; mRNA.
DR   CCDS; CCDS47734.1; -. [Q86XD5-3]
DR   CCDS; CCDS5882.1; -. [Q86XD5-1]
DR   RefSeq; NP_001026860.2; NM_001031690.2. [Q86XD5-3]
DR   RefSeq; NP_001265226.1; NM_001278297.1.
DR   RefSeq; NP_055505.3; NM_014690.4. [Q86XD5-1]
DR   RefSeq; XP_005250130.1; XM_005250073.3. [Q86XD5-1]
DR   RefSeq; XP_006716249.1; XM_006716186.2.
DR   UniGene; Hs.648908; -.
DR   ProteinModelPortal; Q86XD5; -.
DR   BioGrid; 115064; 34.
DR   IntAct; Q86XD5; 3.
DR   STRING; 9606.ENSP00000410603; -.
DR   iPTMnet; Q86XD5; -.
DR   PhosphoSitePlus; Q86XD5; -.
DR   SwissPalm; Q86XD5; -.
DR   BioMuta; FAM131B; -.
DR   EPD; Q86XD5; -.
DR   jPOST; Q86XD5; -.
DR   MaxQB; Q86XD5; -.
DR   PaxDb; Q86XD5; -.
DR   PeptideAtlas; Q86XD5; -.
DR   PRIDE; Q86XD5; -.
DR   ProteomicsDB; 70264; -.
DR   ProteomicsDB; 70265; -. [Q86XD5-2]
DR   DNASU; 9715; -.
DR   Ensembl; ENST00000409222; ENSP00000387147; ENSG00000159784. [Q86XD5-1]
DR   Ensembl; ENST00000409346; ENSP00000386984; ENSG00000159784. [Q86XD5-1]
DR   Ensembl; ENST00000409408; ENSP00000387017; ENSG00000159784. [Q86XD5-1]
DR   Ensembl; ENST00000409578; ENSP00000386568; ENSG00000159784. [Q86XD5-2]
DR   Ensembl; ENST00000443739; ENSP00000410603; ENSG00000159784. [Q86XD5-3]
DR   GeneID; 9715; -.
DR   KEGG; hsa:9715; -.
DR   UCSC; uc003wct.4; human. [Q86XD5-1]
DR   CTD; 9715; -.
DR   DisGeNET; 9715; -.
DR   EuPathDB; HostDB:ENSG00000159784.17; -.
DR   GeneCards; FAM131B; -.
DR   H-InvDB; HIX0007170; -.
DR   HGNC; HGNC:22202; FAM131B.
DR   HPA; HPA021371; -.
DR   HPA; HPA029992; -.
DR   neXtProt; NX_Q86XD5; -.
DR   OpenTargets; ENSG00000159784; -.
DR   PharmGKB; PA162386065; -.
DR   eggNOG; ENOG410IECV; Eukaryota.
DR   eggNOG; ENOG4111H79; LUCA.
DR   GeneTree; ENSGT00390000015421; -.
DR   HOVERGEN; HBG081012; -.
DR   InParanoid; Q86XD5; -.
DR   OMA; DSWPHSY; -.
DR   OrthoDB; 864510at2759; -.
DR   PhylomeDB; Q86XD5; -.
DR   TreeFam; TF331537; -.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   ChiTaRS; FAM131B; human.
DR   GenomeRNAi; 9715; -.
DR   PRO; PR:Q86XD5; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000159784; Expressed in 136 organ(s), highest expression level in C1 segment of cervical spinal cord.
DR   ExpressionAtlas; Q86XD5; baseline and differential.
DR   Genevisible; Q86XD5; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   InterPro; IPR026782; FAM131.
DR   PANTHER; PTHR15736; PTHR15736; 1.
DR   Pfam; PF15010; FAM131; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Lipoprotein; Myristate;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    332       Protein FAM131B.
FT                                /FTId=PRO_0000253032.
FT   COMPBIAS    283    286       Poly-Glu.
FT   MOD_RES      47     47       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3TY60}.
FT   MOD_RES     114    114       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3TY60}.
FT   MOD_RES     117    117       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     295    295       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3TY60}.
FT   MOD_RES     297    297       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3TY60}.
FT   MOD_RES     313    313       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3TY60}.
FT   MOD_RES     316    316       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q3TY60}.
FT   MOD_RES     317    317       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3TY60}.
FT   MOD_RES     318    318       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3TY60}.
FT   MOD_RES     322    322       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3TY60}.
FT   VAR_SEQ       1     30       MDSTSSLHGSSLHRPSTEQTRTDFSWDGIN -> MGCIGSR
FT                                TVGNEVIAVDWKGLKDVDQINMDSTSSLHGSSLHRPSTE
FT                                (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_041633.
FT   VAR_SEQ       1      1       M -> MGCIGSRTVGNEVIAVDWKGLKDVDQINM (in
FT                                isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_046798.
FT   VARIANT     307    307       A -> T (in dbSNP:rs17854363).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_053920.
FT   CONFLICT     47     47       S -> F (in Ref. 2; CAD89938).
FT                                {ECO:0000305}.
FT   CONFLICT    141    141       M -> T (in Ref. 2; CAD89938).
FT                                {ECO:0000305}.
FT   CONFLICT    285    285       E -> G (in Ref. 6; AAH45611).
FT                                {ECO:0000305}.
FT   CONFLICT    291    291       R -> Q (in Ref. 6; AAH45611).
FT                                {ECO:0000305}.
SQ   SEQUENCE   332 AA;  35769 MW;  35FE42189855034F CRC64;
     MDSTSSLHGS SLHRPSTEQT RTDFSWDGIN LSMEDTTSIL PKLKRNSNAY GIGALAKSSF
     SGISRSMKDH VTKPTAMGQG RVAHMIEWQG WGKTPAVQPQ HSHESVRRDT DAYSDLSDGE
     KEARFLAGVM EQFAISEATL MAWSSMDGED MSVNSTQEPL GCNYSDNYQE LMDSQDALAQ
     APMDGWPHSY VSQGMYCLGS SDAWEASDQS LIASPATGSY LGPAFDDSQP SLHEMGPSQP
     ASGYSALEPP PLLGGDTDWA PGVGAVDLAR GPAEEEKRPL APEEEEDAGC RDLESLSPRE
     DPEMSTALSR KVSDVTSSGV QSFDEEEGEA NN
//
ID   B7ZL13_HUMAN            Unreviewed;       607 AA.
AC   B7ZL13;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   16-JAN-2019, entry version 64.
DE   SubName: Full=FNBP1 protein {ECO:0000313|EMBL:AAI43515.1};
GN   Name=FNBP1 {ECO:0000313|EMBL:AAI43515.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI43515.1};
RN   [1] {ECO:0000313|EMBL:AAI43515.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver {ECO:0000313|EMBL:AAI43515.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; BC143514; AAI43515.1; -; mRNA.
DR   RefSeq; XP_005251883.1; XM_005251826.2.
DR   UniGene; Hs.189409; -.
DR   ProteinModelPortal; B7ZL13; -.
DR   PeptideAtlas; B7ZL13; -.
DR   PRIDE; B7ZL13; -.
DR   GeneID; 23048; -.
DR   CTD; 23048; -.
DR   eggNOG; ENOG410INNY; Eukaryota.
DR   eggNOG; ENOG410ZU0I; LUCA.
DR   HOGENOM; HOG000231767; -.
DR   HOVERGEN; HBG002489; -.
DR   OrthoDB; 348563at2759; -.
DR   ChiTaRS; FNBP1; human.
DR   GenomeRNAi; 23048; -.
DR   GO; GO:0006897; P:endocytosis; IEA:InterPro.
DR   CDD; cd07676; F-BAR_FBP17; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR028532; FNBP1/FBP17.
DR   InterPro; IPR037449; FNBP1_F-BAR.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR43990:SF5; PTHR43990:SF5; 1.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|PROSITE-ProRule:PRU01077,
KW   ECO:0000256|SAAS:SAAS00803874, ECO:0000256|SAM:Coils};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192,
KW   ECO:0000256|SAAS:SAAS00989295}.
FT   DOMAIN        1    264       F-BAR. {ECO:0000259|PROSITE:PS51741}.
FT   DOMAIN      540    601       SH3. {ECO:0000259|PROSITE:PS50002}.
FT   COILED      155    175       {ECO:0000256|SAM:Coils}.
FT   COILED      401    428       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   607 AA;  70198 MW;  17B8BD7F171A49B8 CRC64;
     MSWGTELWDQ FDNLEKHTQW GIDILEKYIK FVKERTEIEL SYAKQLRNLS KKYQPKKNSK
     EEEEYKYTSC KAFISNLNEM NDYAGQHEVI SENMASQIIV DLARYVQELK QERKSNFHDG
     RKAQQHIETC WKQLESSKRR FERDCKEADR AQQYFEKMDA DINVTKADVE KARQQAQIRH
     QMAEDSKADY SSILQKFNHE QHEYYHTHIP NIFQKIQEME ERRIVRMGES MKTYAEVDRQ
     VIPIIGKCLD GIVKAAESID QKNDSQLVIE AYKSGFEPPG DIEFEDYTQP MKRTVSDNSL
     SNSRGEGKPD LKFGGKSKGK LWPFIKKNKP PPPPPASASP SAVPNGPQSP KQQKEPLSHR
     FNEFMTSKPK IHCFRSLKRG LSLKLGATPE DFSNLPPEQR RKKLQQKVDE LNKEIQKEMD
     QRDAITKMKD VYLKNPQMGD PASLDHKLAE VSQNIEKLRV ETQKFEAWLA EVEGRLPARS
     EQARRQSGLY DSQNPPTVNN CAQDRESPDG SYTEEQSQES EMKVLATDFD DEFDDEEPLP
     AIGTCKALYT FEGQNEGTIS VVEGETLYVI EEDKGDGWTR IRRNEDEEGY VPTSYVEVCL
     DKNAKDS
//
ID   B7ZL14_HUMAN            Unreviewed;       551 AA.
AC   B7ZL14; E7EPB7;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   13-FEB-2019, entry version 82.
DE   SubName: Full=FNBP1 protein {ECO:0000313|EMBL:AAI43516.1};
DE   SubName: Full=Formin-binding protein 1 {ECO:0000313|Ensembl:ENSP00000389117};
GN   Name=FNBP1 {ECO:0000313|EMBL:AAI43516.1,
GN   ECO:0000313|Ensembl:ENSP00000389117};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI43516.1};
RN   [1] {ECO:0000213|PubMed:15144186}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [2] {ECO:0000313|EMBL:AAI43516.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver {ECO:0000313|EMBL:AAI43516.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000313|Ensembl:ENSP00000389117, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4] {ECO:0000213|PubMed:16964243}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [5] {ECO:0000213|PubMed:19367720}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [6] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [9] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [11] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [13] {ECO:0000313|Ensembl:ENSP00000389117}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [14] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AL136141; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL158207; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC143515; AAI43516.1; -; mRNA.
DR   RefSeq; XP_005251891.1; XM_005251834.2.
DR   UniGene; Hs.189409; -.
DR   Ensembl; ENST00000443566; ENSP00000389117; ENSG00000187239.
DR   GeneID; 23048; -.
DR   UCSC; uc004bza.2; human.
DR   CTD; 23048; -.
DR   EuPathDB; HostDB:ENSG00000187239.16; -.
DR   HGNC; HGNC:17069; FNBP1.
DR   OpenTargets; ENSG00000187239; -.
DR   GeneTree; ENSGT00510000046403; -.
DR   HOGENOM; HOG000231767; -.
DR   HOVERGEN; HBG002489; -.
DR   OrthoDB; 348563at2759; -.
DR   ChiTaRS; FNBP1; human.
DR   GenomeRNAi; 23048; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000187239; Expressed in 239 organ(s), highest expression level in corpus callosum.
DR   GO; GO:0006897; P:endocytosis; IEA:InterPro.
DR   CDD; cd07676; F-BAR_FBP17; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR028532; FNBP1/FBP17.
DR   InterPro; IPR037449; FNBP1_F-BAR.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR43990:SF5; PTHR43990:SF5; 2.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|PROSITE-ProRule:PRU01077,
KW   ECO:0000256|SAAS:SAAS00803874, ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:B7ZL14,
KW   ECO:0000213|MaxQB:B7ZL14, ECO:0000213|PeptideAtlas:B7ZL14};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192,
KW   ECO:0000256|SAAS:SAAS00989295}.
FT   DOMAIN        1    264       F-BAR. {ECO:0000259|PROSITE:PS51741}.
FT   DOMAIN      484    545       SH3. {ECO:0000259|PROSITE:PS50002}.
FT   COILED      155    175       {ECO:0000256|SAM:Coils}.
FT   COILED      345    372       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   551 AA;  64071 MW;  CCA04989BE12E604 CRC64;
     MSWGTELWDQ FDNLEKHTQW GIDILEKYIK FVKERTEIEL SYAKQLRNLS KKYQPKKNSK
     EEEEYKYTSC KAFISNLNEM NDYAGQHEVI SENMASQIIV DLARYVQELK QERKSNFHDG
     RKAQQHIETC WKQLESSKRR FERDCKEADR AQQYFEKMDA DINVTKADVE KARQQAQIRH
     QMAEDSKADY SSILQKFNHE QHEYYHTHIP NIFQKIQEME ERRIVRMGES MKTYAEVDRQ
     VIPIIGKCLD GIVKAAESID QKNDSQLVIE AYKSGFEPPG DIEFEDYTQP MKRTVSDNSL
     SNSRGEGKPD LKFGGKSKGK LWPFIKKNKG ATPEDFSNLP PEQRRKKLQQ KVDELNKEIQ
     KEMDQRDAIT KMKDVYLKNP QMGDPASLDH KLAEVSQNIE KLRVETQKFE AWLAEVEGRL
     PARSEQARRQ SGLYDSQNPP TVNNCAQDRE SPDGSYTEEQ SQESEMKVLA TDFDDEFDDE
     EPLPAIGTCK ALYTFEGQNE GTISVVEGET LYVIEEDKGD GWTRIRRNED EEGYVPTSYV
     EVCLDKNAKD S
//
ID   FNBP1_HUMAN             Reviewed;         617 AA.
AC   Q96RU3; B7ZL12; E9PGQ4; O60301; Q3MIN8; Q5TC87; Q5TC88; Q6P658;
AC   Q7LGG2; Q9H8H8; Q9NWD1;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 2.
DT   13-FEB-2019, entry version 150.
DE   RecName: Full=Formin-binding protein 1;
DE   AltName: Full=Formin-binding protein 17;
DE            Short=hFBP17;
GN   Name=FNBP1; Synonyms=FBP17, KIAA0554;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH SNX2,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND CHROMOSOMAL
RP   TRANSLOCATION WITH KMT2A/MLL1.
RX   PubMed=11438682; DOI=10.1073/pnas.121433898;
RA   Fuchs U., Rehkamp G.F., Haas O.A., Slany R., Koenig M., Bojesen S.,
RA   Bohle R.M., Damm-Welk C., Ludwig W.-D., Harbott J., Borkhardt A.;
RT   "The human formin-binding protein 17 (FBP17) interacts with sorting
RT   nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous
RT   leukemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8756-8761(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 36-617 (ISOFORM 2), AND VARIANT
RP   ASN-490.
RC   TISSUE=Embryo, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 5), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-409 (ISOFORM 4).
RC   TISSUE=Liver, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH ARHGAP17.
RX   PubMed=11431473; DOI=10.1074/jbc.M103540200;
RA   Richnau N., Aspenstroem P.;
RT   "Rich, a rho GTPase-activating protein domain-containing protein
RT   involved in signaling by Cdc42 and Rac1.";
RL   J. Biol. Chem. 276:35060-35070(2001).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH FASLG.
RX   PubMed=12023017; DOI=10.1016/S0014-5793(02)02709-6;
RA   Ghadimi M.P., Sanzenbacher R., Thiede B., Wenzel J., Jing Q.,
RA   Plomann M., Borkhardt A., Kabelitz D., Janssen O.;
RT   "Identification of interaction partners of the cytosolic polyproline
RT   region of CD95 ligand (CD178).";
RL   FEBS Lett. 519:50-58(2002).
RN   [8]
RP   INTERACTION WITH SNX2 AND TNKS, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF ARG-515; ASP-519 AND 515-ARG--GLY-520.
RX   PubMed=14596906; DOI=10.1016/S0014-5793(03)01063-9;
RA   Fuchs U., Rehkamp G.F., Slany R., Follo M., Borkhardt A.;
RT   "The formin-binding protein 17, FBP17, binds via a TNKS binding motif
RT   to tankyrase, a protein involved in telomere maintenance.";
RL   FEBS Lett. 554:10-16(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [10]
RP   FUNCTION, SELF-ASSOCIATION, INTERACTION WITH DNM1; DNM2 AND DNM3,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF PRO-602.
RX   PubMed=15252009; DOI=10.1074/jbc.M404899200;
RA   Kamioka Y., Fukuhara S., Sawa H., Nagashima K., Masuda M., Matsuda M.,
RA   Mochizuki N.;
RT   "A novel dynamin-associating molecule, formin-binding protein 17,
RT   induces tubular membrane invaginations and participates in
RT   endocytosis.";
RL   J. Biol. Chem. 279:40091-40099(2004).
RN   [11]
RP   INTERACTION WITH AKAP9, AND SUBCELLULAR LOCATION.
RX   PubMed=15047863; DOI=10.1091/mbc.E03-10-0757;
RA   Larocca M.C., Shanks R.A., Tian L., Nelson D.L., Stewart D.M.,
RA   Goldenring J.R.;
RT   "AKAP350 interaction with cdc42 interacting protein 4 at the Golgi
RT   apparatus.";
RL   Mol. Biol. Cell 15:2771-2781(2004).
RN   [12]
RP   FUNCTION, SELF-ASSOCIATION, INTERACTION WITH DNM1 AND WASL,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LEU-7.
RX   PubMed=16326391; DOI=10.1016/j.devcel.2005.11.005;
RA   Itoh T., Erdmann K.S., Roux A., Habermann B., Werner H.,
RA   De Camilli P.;
RT   "Dynamin and the actin cytoskeleton cooperatively regulate plasma
RT   membrane invagination by BAR and F-BAR proteins.";
RL   Dev. Cell 9:791-804(2005).
RN   [13]
RP   FUNCTION, INTERACTION WITH FASLG, AND SUBCELLULAR LOCATION.
RX   PubMed=16318909; DOI=10.1016/j.cellsig.2005.10.015;
RA   Qian J., Chen W., Lettau M., Podda G., Zoernig M., Kabelitz D.,
RA   Janssen O.;
RT   "Regulation of FasL expression: a SH3 domain containing protein family
RT   involved in the lysosomal association of FasL.";
RL   Cell. Signal. 18:1327-1337(2006).
RN   [14]
RP   INTERACTION WITH DAAM1; DIAPH1 AND DIAPH2.
RX   PubMed=16630611; DOI=10.1016/j.yexcr.2006.03.013;
RA   Aspenstroem P., Richnau N., Johansson A.-S.;
RT   "The diaphanous-related formin DAAM1 collaborates with the Rho GTPases
RT   RhoA and Cdc42, CIP4 and Src in regulating cell morphogenesis and
RT   actin dynamics.";
RL   Exp. Cell Res. 312:2180-2194(2006).
RN   [15]
RP   FUNCTION, INTERACTION WITH DNM2 AND WASL, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF LYS-33; ARG-35; 51-LYS-LYS-52 AND 113-ARG-LYS-114.
RX   PubMed=16418535; DOI=10.1083/jcb.200508091;
RA   Tsujita K., Suetsugu S., Sasaki N., Furutani M., Oikawa T.,
RA   Takenawa T.;
RT   "Coordination between the actin cytoskeleton and membrane deformation
RT   by a novel membrane tubulation domain of PCH proteins is involved in
RT   endocytosis.";
RL   J. Cell Biol. 172:269-279(2006).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296; SER-299; SER-349
RP   AND SER-359, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-359, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-66 AND LYS-110, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296 AND SER-359, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296 AND SER-299, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296 AND SER-359, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.61 ANGSTROMS) OF 1-300, FUNCTION, SUBUNIT,
RP   SUBCELLULAR LOCATION, DOMAIN F-BAR, COILED-COIL DOMAIN, AND
RP   MUTAGENESIS OF LYS-33; THR-165; LYS-166; ASP-168 AND PRO-210.
RX   PubMed=17512409; DOI=10.1016/j.cell.2007.03.040;
RA   Shimada A., Niwa H., Tsujita K., Suetsugu S., Nitta K.,
RA   Hanawa-Suetsugu K., Akasaka R., Nishino Y., Toyama M., Chen L.,
RA   Liu Z.-J., Wang B.C., Yamamoto M., Terada T., Miyazawa A., Tanaka A.,
RA   Sugano S., Shirouzu M., Nagayama K., Takenawa T., Yokoyama S.;
RT   "Curved EFC/F-BAR-domain dimers are joined end to end into a filament
RT   for membrane invagination in endocytosis.";
RL   Cell 129:761-772(2007).
CC   -!- FUNCTION: May act as a link between RND2 signaling and regulation
CC       of the actin cytoskeleton (By similarity). Required to coordinate
CC       membrane tubulation with reorganization of the actin cytoskeleton
CC       during the late stage of clathrin-mediated endocytosis. Binds to
CC       lipids such as phosphatidylinositol 4,5-bisphosphate and
CC       phosphatidylserine and promotes membrane invagination and the
CC       formation of tubules. Also enhances actin polymerization via the
CC       recruitment of WASL/N-WASP, which in turn activates the Arp2/3
CC       complex. Actin polymerization may promote the fission of membrane
CC       tubules to form endocytic vesicles. May be required for the
CC       lysosomal retention of FASLG/FASL. {ECO:0000250,
CC       ECO:0000269|PubMed:15252009, ECO:0000269|PubMed:16318909,
CC       ECO:0000269|PubMed:16326391, ECO:0000269|PubMed:16418535,
CC       ECO:0000269|PubMed:17512409}.
CC   -!- SUBUNIT: Interacts specifically with GTP-bound RND2 and CDC42.
CC       Interacts with PDE6G and microtubules (By similarity).
CC       Homodimerizes, the dimers can polymerize end-to-end to form
CC       filamentous structures. Interacts with AKAP9, ARHGAP17, DAAM1,
CC       DIAPH1, DIAPH2, DNM1, DNM2, DNM3, FASLG/FASL, SNX2 and WASL/N-
CC       WASP. May interact with TNKS. {ECO:0000250,
CC       ECO:0000269|PubMed:11431473, ECO:0000269|PubMed:11438682,
CC       ECO:0000269|PubMed:12023017, ECO:0000269|PubMed:14596906,
CC       ECO:0000269|PubMed:15047863, ECO:0000269|PubMed:15252009,
CC       ECO:0000269|PubMed:16318909, ECO:0000269|PubMed:16326391,
CC       ECO:0000269|PubMed:16418535, ECO:0000269|PubMed:16630611,
CC       ECO:0000269|PubMed:17512409}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-1111248, EBI-1111248;
CC       Q05193:DNM1; NbExp=5; IntAct=EBI-1111248, EBI-713135;
CC       P48023:FASLG; NbExp=4; IntAct=EBI-1111248, EBI-495538;
CC       O95166:GABARAP; NbExp=2; IntAct=EBI-1111248, EBI-712001;
CC       P97573:Inpp5d (xeno); NbExp=2; IntAct=EBI-1111248, EBI-8008869;
CC       O60749:SNX2; NbExp=4; IntAct=EBI-1111248, EBI-1046690;
CC       O95271:TNKS; NbExp=4; IntAct=EBI-1111248, EBI-1105254;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton.
CC       Cytoplasm, cell cortex. Lysosome. Cytoplasmic vesicle. Cell
CC       membrane; Peripheral membrane protein; Cytoplasmic side. Membrane,
CC       clathrin-coated pit. Note=Enriched in cortical regions coincident
CC       with F-actin. Also localizes to endocytic vesicles and lysosomes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q96RU3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96RU3-2; Sequence=VSP_021695, VSP_021696;
CC       Name=3;
CC         IsoId=Q96RU3-3; Sequence=VSP_021694, VSP_021696;
CC       Name=4;
CC         IsoId=Q96RU3-4; Sequence=VSP_021693;
CC       Name=5;
CC         IsoId=Q96RU3-5; Sequence=VSP_021695;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Very highly expressed in the epithelial cells
CC       of the gastrointestinal tract, respiratory, reproductive and
CC       urinary systems. Also highly expressed in brown adipose tissue,
CC       cardiomyocytes, enteric ganglia and glucagon producing cells of
CC       the pancreas. Expressed in germ cells of the testis and all
CC       regions of the brain. {ECO:0000269|PubMed:11438682,
CC       ECO:0000269|PubMed:15252009}.
CC   -!- DOMAIN: The F-BAR domain binds the phospholipid membrane with its
CC       concave surface. The end-to-end polymerization of dimers of these
CC       domains provides a curved surface that fits best membranes with
CC       around 600 A diameter, and may drive tubulation.
CC       {ECO:0000269|PubMed:17512409}.
CC   -!- DISEASE: Note=A chromosomal aberration involving FNBP1 is found in
CC       acute leukemias. Translocation t(9;11)(q34;q23) with KMT2A/MLL1.
CC       The relatively low incidence of the KMT2A/MLL1-FNBP1 fusion
CC       protein in acute leukemia may reflect the marginal capacity of
CC       this fusion protein to induce cellular transformation.
CC   -!- SIMILARITY: Belongs to the FNBP1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH62463.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAK49824.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA25480.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA91451.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FBP17ID353.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF265550; AAK49824.1; ALT_INIT; mRNA.
DR   EMBL; AB011126; BAA25480.1; ALT_INIT; mRNA.
DR   EMBL; AK000975; BAA91451.1; ALT_INIT; mRNA.
DR   EMBL; AK023681; BAB14638.1; -; mRNA.
DR   EMBL; AL136141; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL158207; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC062463; AAH62463.1; ALT_SEQ; mRNA.
DR   EMBL; BC101755; AAI01756.1; -; mRNA.
DR   EMBL; BC143513; AAI43514.1; -; mRNA.
DR   CCDS; CCDS48040.1; -. [Q96RU3-1]
DR   CCDS; CCDS87699.1; -. [Q96RU3-3]
DR   RefSeq; NP_055848.1; NM_015033.2. [Q96RU3-1]
DR   RefSeq; XP_005251880.1; XM_005251823.2. [Q96RU3-2]
DR   RefSeq; XP_005251881.1; XM_005251824.2. [Q96RU3-5]
DR   RefSeq; XP_005251886.1; XM_005251829.2.
DR   UniGene; Hs.189409; -.
DR   PDB; 2EFL; X-ray; 2.61 A; A=1-300.
DR   PDBsum; 2EFL; -.
DR   ProteinModelPortal; Q96RU3; -.
DR   SMR; Q96RU3; -.
DR   BioGrid; 116686; 28.
DR   DIP; DIP-35355N; -.
DR   ELM; Q96RU3; -.
DR   IntAct; Q96RU3; 27.
DR   MINT; Q96RU3; -.
DR   STRING; 9606.ENSP00000413625; -.
DR   iPTMnet; Q96RU3; -.
DR   PhosphoSitePlus; Q96RU3; -.
DR   BioMuta; FNBP1; -.
DR   DMDM; 118572321; -.
DR   EPD; Q96RU3; -.
DR   jPOST; Q96RU3; -.
DR   MaxQB; Q96RU3; -.
DR   PaxDb; Q96RU3; -.
DR   PeptideAtlas; Q96RU3; -.
DR   PRIDE; Q96RU3; -.
DR   ProteomicsDB; 78035; -.
DR   ProteomicsDB; 78036; -. [Q96RU3-2]
DR   ProteomicsDB; 78037; -. [Q96RU3-3]
DR   ProteomicsDB; 78038; -. [Q96RU3-4]
DR   Ensembl; ENST00000355681; ENSP00000347907; ENSG00000187239. [Q96RU3-3]
DR   Ensembl; ENST00000420781; ENSP00000407548; ENSG00000187239. [Q96RU3-5]
DR   Ensembl; ENST00000446176; ENSP00000413625; ENSG00000187239. [Q96RU3-1]
DR   GeneID; 23048; -.
DR   KEGG; hsa:23048; -.
DR   UCSC; uc004byw.2; human. [Q96RU3-1]
DR   CTD; 23048; -.
DR   DisGeNET; 23048; -.
DR   EuPathDB; HostDB:ENSG00000187239.16; -.
DR   GeneCards; FNBP1; -.
DR   HGNC; HGNC:17069; FNBP1.
DR   HPA; HPA019691; -.
DR   HPA; HPA022119; -.
DR   MIM; 606191; gene.
DR   neXtProt; NX_Q96RU3; -.
DR   OpenTargets; ENSG00000187239; -.
DR   PharmGKB; PA128394597; -.
DR   eggNOG; ENOG410INNY; Eukaryota.
DR   eggNOG; ENOG410ZU0I; LUCA.
DR   GeneTree; ENSGT00510000046403; -.
DR   HOGENOM; HOG000231767; -.
DR   HOVERGEN; HBG002489; -.
DR   InParanoid; Q96RU3; -.
DR   KO; K20121; -.
DR   OMA; SYIECTL; -.
DR   OrthoDB; 348563at2759; -.
DR   PhylomeDB; Q96RU3; -.
DR   TreeFam; TF351162; -.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   ChiTaRS; FNBP1; human.
DR   EvolutionaryTrace; Q96RU3; -.
DR   GeneWiki; FNBP1; -.
DR   GenomeRNAi; 23048; -.
DR   PMAP-CutDB; Q96RU3; -.
DR   PRO; PR:Q96RU3; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000187239; Expressed in 239 organ(s), highest expression level in corpus callosum.
DR   ExpressionAtlas; Q96RU3; baseline and differential.
DR   Genevisible; Q96RU3; HS.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0005905; C:clathrin-coated pit; IEA:UniProtKB-SubCell.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   CDD; cd07676; F-BAR_FBP17; 1.
DR   CDD; cd12071; SH3_FBP17; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR028532; FNBP1/FBP17.
DR   InterPro; IPR037449; FNBP1_F-BAR.
DR   InterPro; IPR035492; FNBP1_SH3.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR43990:SF5; PTHR43990:SF5; 1.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS51860; REM_1; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell membrane;
KW   Chromosomal rearrangement; Coated pit; Coiled coil; Complete proteome;
KW   Cytoplasm; Cytoplasmic vesicle; Cytoskeleton; Endocytosis;
KW   Lipid-binding; Lysosome; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; SH3 domain.
FT   CHAIN         1    617       Formin-binding protein 1.
FT                                /FTId=PRO_0000261430.
FT   DOMAIN        1    264       F-BAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01077}.
FT   DOMAIN      404    481       REM-1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01207}.
FT   DOMAIN      550    611       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   REGION        1    335       Interaction with microtubules.
FT                                {ECO:0000250}.
FT   REGION        1     79       Required for self-association and
FT                                induction of membrane tubulation.
FT   REGION      251    617       Required for self-association and
FT                                induction of membrane tubulation.
FT   REGION      400    552       Interaction with RND2. {ECO:0000250}.
FT   REGION      495    617       Interaction with PDE6G. {ECO:0000250}.
FT   REGION      514    617       Required for interaction with TNKS.
FT                                {ECO:0000269|PubMed:14596906}.
FT   REGION      535    617       Interaction with DNM1 and DNM3.
FT                                {ECO:0000269|PubMed:15252009}.
FT   REGION      550    617       Interaction with ARHGAP17, DAAM1, DIAPH1
FT                                and DIAPH2. {ECO:0000269|PubMed:11431473,
FT                                ECO:0000269|PubMed:16630611}.
FT   REGION      553    610       Interaction with FASLG.
FT   REGION      553    609       Interaction with DNM2 and WASL.
FT   COILED       67    259       {ECO:0000269|PubMed:17512409}.
FT   COILED      398    490       {ECO:0000250}.
FT   COMPBIAS    340    345       Poly-Pro.
FT   SITE        166    166       Mediates end-to-end attachment of dimers.
FT   MOD_RES      66     66       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     110    110       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     296    296       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     299    299       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     359    359       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     497    497       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q80TY0}.
FT   MOD_RES     500    500       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q80TY0}.
FT   MOD_RES     521    521       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8R511}.
FT   VAR_SEQ     329    394       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_021693.
FT   VAR_SEQ     330    358       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_021694.
FT   VAR_SEQ     391    395       Missing (in isoform 2 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_021695.
FT   VAR_SEQ     616    617       DS -> GAKTYI (in isoform 2 and isoform
FT                                3). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_021696.
FT   VARIANT     490    490       S -> N (in dbSNP:rs1023000).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_029388.
FT   MUTAGEN       7      7       L->E: Impairs membrane tubulation but
FT                                does not affect lipid-binding.
FT                                {ECO:0000269|PubMed:16326391}.
FT   MUTAGEN      33     33       K->E: Abolishes membrane invagination.
FT                                {ECO:0000269|PubMed:16418535,
FT                                ECO:0000269|PubMed:17512409}.
FT   MUTAGEN      33     33       K->Q: Impairs lipid-binding and induction
FT                                of membrane tubulation; when associated
FT                                with Q-35. {ECO:0000269|PubMed:16418535,
FT                                ECO:0000269|PubMed:17512409}.
FT   MUTAGEN      35     35       R->Q: Impairs lipid-binding and induction
FT                                of membrane tubulation; when associated
FT                                with Q-33. {ECO:0000269|PubMed:16418535}.
FT   MUTAGEN      51     52       KK->QQ: Impairs lipid-binding and
FT                                induction of membrane tubulation.
FT                                {ECO:0000269|PubMed:16418535}.
FT   MUTAGEN     113    114       RK->QQ: Impairs lipid-binding and
FT                                induction of membrane tubulation.
FT                                {ECO:0000269|PubMed:16418535}.
FT   MUTAGEN     165    165       T->A: Abolishes membrane invagination.
FT                                {ECO:0000269|PubMed:17512409}.
FT   MUTAGEN     166    166       K->A: Abolishes membrane invagination.
FT                                {ECO:0000269|PubMed:17512409}.
FT   MUTAGEN     168    168       D->A,N,R: No significant effect.
FT                                {ECO:0000269|PubMed:17512409}.
FT   MUTAGEN     210    210       P->A: Disrupts helix kink and moderately
FT                                increases diameter of the induced tubular
FT                                membrane. {ECO:0000269|PubMed:17512409}.
FT   MUTAGEN     515    520       Missing: Abrogates interaction with TNKS.
FT                                {ECO:0000269|PubMed:14596906}.
FT   MUTAGEN     515    515       R->A: Impairs interaction with TNKS.
FT                                {ECO:0000269|PubMed:14596906}.
FT   MUTAGEN     519    519       D->A: Impairs interaction with TNKS; when
FT                                associated with A-515.
FT                                {ECO:0000269|PubMed:14596906}.
FT   MUTAGEN     602    602       P->L: Abrogates interaction with DNM1,
FT                                DNM2 and DNM3.
FT                                {ECO:0000269|PubMed:15252009}.
FT   CONFLICT    388    388       K -> E (in Ref. 3; BAA91451).
FT                                {ECO:0000305}.
FT   HELIX         3      6       {ECO:0000244|PDB:2EFL}.
FT   TURN          7      9       {ECO:0000244|PDB:2EFL}.
FT   HELIX        11     52       {ECO:0000244|PDB:2EFL}.
FT   HELIX        68    160       {ECO:0000244|PDB:2EFL}.
FT   HELIX       166    206       {ECO:0000244|PDB:2EFL}.
FT   HELIX       208    238       {ECO:0000244|PDB:2EFL}.
FT   HELIX       241    257       {ECO:0000244|PDB:2EFL}.
FT   HELIX       261    272       {ECO:0000244|PDB:2EFL}.
SQ   SEQUENCE   617 AA;  71307 MW;  F06E847C6E631EC3 CRC64;
     MSWGTELWDQ FDNLEKHTQW GIDILEKYIK FVKERTEIEL SYAKQLRNLS KKYQPKKNSK
     EEEEYKYTSC KAFISNLNEM NDYAGQHEVI SENMASQIIV DLARYVQELK QERKSNFHDG
     RKAQQHIETC WKQLESSKRR FERDCKEADR AQQYFEKMDA DINVTKADVE KARQQAQIRH
     QMAEDSKADY SSILQKFNHE QHEYYHTHIP NIFQKIQEME ERRIVRMGES MKTYAEVDRQ
     VIPIIGKCLD GIVKAAESID QKNDSQLVIE AYKSGFEPPG DIEFEDYTQP MKRTVSDNSL
     SNSRGEGKPD LKFGGKSKGK LWPFIKKNKL MSLLTSPHQP PPPPPASASP SAVPNGPQSP
     KQQKEPLSHR FNEFMTSKPK IHCFRSLKRG LSLKLGATPE DFSNLPPEQR RKKLQQKVDE
     LNKEIQKEMD QRDAITKMKD VYLKNPQMGD PASLDHKLAE VSQNIEKLRV ETQKFEAWLA
     EVEGRLPARS EQARRQSGLY DSQNPPTVNN CAQDRESPDG SYTEEQSQES EMKVLATDFD
     DEFDDEEPLP AIGTCKALYT FEGQNEGTIS VVEGETLYVI EEDKGDGWTR IRRNEDEEGY
     VPTSYVEVCL DKNAKDS
//
ID   A0A140VJK6_HUMAN        Unreviewed;       693 AA.
AC   A0A140VJK6;
DT   08-JUN-2016, integrated into UniProtKB/TrEMBL.
DT   08-JUN-2016, sequence version 1.
DT   16-JAN-2019, entry version 16.
DE   SubName: Full=Testicular tissue protein Li 82 {ECO:0000313|EMBL:AEE60993.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEE60993.1};
RN   [1] {ECO:0000313|EMBL:AEE60993.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; HM005395; AEE60993.1; -; mRNA.
DR   RefSeq; NP_003866.1; NM_003875.2.
DR   UniGene; Hs.591314; -.
DR   ProteinModelPortal; A0A140VJK6; -.
DR   SMR; A0A140VJK6; -.
DR   PRIDE; A0A140VJK6; -.
DR   GeneID; 8833; -.
DR   KEGG; hsa:8833; -.
DR   CTD; 8833; -.
DR   KO; K01951; -.
DR   OMA; KRKIIGH; -.
DR   OrthoDB; 392369at2759; -.
DR   PhylomeDB; A0A140VJK6; -.
DR   GenomeRNAi; 8833; -.
DR   ExpressionAtlas; A0A140VJK6; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003922; F:GMP synthase (glutamine-hydrolyzing) activity; IEA:InterPro.
DR   GO; GO:0016462; F:pyrophosphatase activity; IEA:InterPro.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0006177; P:GMP biosynthetic process; IEA:UniProtKB-UniRule.
DR   CDD; cd01742; GATase1_GMP_Synthase; 1.
DR   CDD; cd01997; GMP_synthase_C; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   Gene3D; 3.40.50.880; -; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR017926; GATASE.
DR   InterPro; IPR001674; GMP_synth_C.
DR   InterPro; IPR004739; GMP_synth_GATase.
DR   InterPro; IPR025777; GMPS_ATP_PPase_dom.
DR   InterPro; IPR022310; NAD/GMP_synthase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00117; GATase; 1.
DR   Pfam; PF00958; GMP_synt_C; 1.
DR   Pfam; PF02540; NAD_synthase; 1.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   TIGRFAMs; TIGR00888; guaA_Nterm; 1.
DR   PROSITE; PS51273; GATASE_TYPE_1; 1.
DR   PROSITE; PS51553; GMPS_ATP_PPASE; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|PROSITE-ProRule:PRU00886};
KW   Glutamine amidotransferase {ECO:0000256|PROSITE-ProRule:PRU00605};
KW   GMP biosynthesis {ECO:0000256|PROSITE-ProRule:PRU00886};
KW   Nucleotide-binding {ECO:0000256|PROSITE-ProRule:PRU00886};
KW   Purine biosynthesis {ECO:0000256|PROSITE-ProRule:PRU00886}.
FT   DOMAIN       27    216       Glutamine amidotransferase type-1.
FT                                {ECO:0000259|PROSITE:PS51273}.
FT   DOMAIN      217    435       GMPS ATP-PPase.
FT                                {ECO:0000259|PROSITE:PS51553}.
FT   NP_BIND     244    250       ATP. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00886}.
FT   ACT_SITE    104    104       Nucleophile. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00605}.
FT   ACT_SITE    190    190       {ECO:0000256|PROSITE-ProRule:PRU00605}.
FT   ACT_SITE    192    192       {ECO:0000256|PROSITE-ProRule:PRU00605}.
SQ   SEQUENCE   693 AA;  76715 MW;  1CDA0DD3B244728D CRC64;
     MALCNGDSKL ENAGGDLKDG HHHYEGAVVI LDAGAQYGKV IDRRVRELFV QSEIFPLETP
     AFAIKEQGFR AIIISGGPNS VYAEDAPWFD PAIFTIGKPV LGICYGMQMM NKVFGGTVHK
     KSVREDGVFN ISVDNTCSLF RGLQKEEVVL LTHGDSVDKV ADGFKVVARS GNIVAGIANE
     SKKLYGAQFH PEVGLTENGK VILKNFLYDI AGCSGTFTVQ NRELECIREI KERVGTSKVL
     VLLSGGVDST VCTALLNRAL NQEQVIAVHI DNGFMRKRES QSVEEALKKL GIQVKVINAA
     HSFYNGTTTL PISDEDRTPR KRISKTLNMT TSPEEKRKII GDTFVKIANE VIGEMNLKPE
     EVFLAQGTLR PDLIESASLV ASGKAELIKT HHNDTELIRK LREEGKVIEP LKDFHKDEVR
     ILGRELGLPE ELVSRHPFPG PGLAIRVICA EEPYICKDFP ETNNILKIVA DFSASVKKPH
     TLLQRVKACT TEEDQEKLMQ ITSLHSLNAF LLPIKTVGVQ GDCRSYSYVC GISSKDEPDW
     ESLIFLARLI PRMCHNVNRV VYIFGPPVKE PPTDVTPTFL TTGVLSTLRQ ADFEAHNILR
     ESGYAGKISQ MPVILTPLHF DRDPLQKQPS CQRSVVIRTF ITSDFMTGIP ATPGNEIPVE
     VVLKMVTEIK KIPGISRIMY DLTSKPPGTT EWE
//
ID   GUAA_HUMAN              Reviewed;         693 AA.
AC   P49915; A8K639; B4DXV7; F8W720;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   13-FEB-2019, entry version 192.
DE   RecName: Full=GMP synthase [glutamine-hydrolyzing];
DE            EC=6.3.5.2;
DE   AltName: Full=GMP synthetase;
DE   AltName: Full=Glutamine amidotransferase;
GN   Name=GMPS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=8089153;
RA   Hirst M., Haliday E., Nakamura J., Lou L.;
RT   "Human GMP synthetase. Protein purification, cloning, and functional
RT   expression of cDNA.";
RL   J. Biol. Chem. 269:23830-23837(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CHROMOSOMAL TRANSLOCATION WITH KMT2A/MLL1.
RX   PubMed=11110714;
RA   Pegram L.D., Megonigal M.D., Lange B.J., Nowell P.C., Rowley J.D.,
RA   Rappaport E.F., Felix C.A.;
RT   "t(3;11) translocation in treatment-related acute myeloid leukemia
RT   fuses MLL with the GMPS (guanosine 5-prime monophosphate synthetase)
RT   gene.";
RL   Blood 96:4360-4362(2000).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-9, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-318 AND SER-332, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8 AND SER-332, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 20-693, SUBSTRATE-BINDING
RP   SITES, ACTIVE SITE, AND SUBUNIT.
RX   PubMed=23816837; DOI=10.1016/j.jmb.2013.06.032;
RA   Welin M., Lehtio L., Johansson A., Flodin S., Nyman T., Tresaugues L.,
RA   Hammarstrom M., Graslund S., Nordlund P.;
RT   "Substrate specificity and oligomerization of human GMP synthetase.";
RL   J. Mol. Biol. 425:4323-4333(2013).
CC   -!- FUNCTION: Involved in the de novo synthesis of guanine nucleotides
CC       which are not only essential for DNA and RNA synthesis, but also
CC       provide GTP, which is involved in a number of cellular processes
CC       important for cell division.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + L-glutamine + XMP = AMP + diphosphate + GMP +
CC         2 H(+) + L-glutamate; Xref=Rhea:RHEA:11680, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29985, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57464, ChEBI:CHEBI:58115,
CC         ChEBI:CHEBI:58359, ChEBI:CHEBI:456215; EC=6.3.5.2;
CC   -!- PATHWAY: Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln
CC       route): step 1/1.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:23816837}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P49915-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49915-2; Sequence=VSP_053933;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Note=A chromosomal aberration involving GMPS is found in
CC       acute myeloid leukemias. Translocation t(3,11)(q25,q23) with
CC       KMT2A/MLL1.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GMPSID229.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U10860; AAA60331.1; -; mRNA.
DR   EMBL; AK291504; BAF84193.1; -; mRNA.
DR   EMBL; AK302148; BAG63519.1; -; mRNA.
DR   EMBL; AK315832; BAF98723.1; -; mRNA.
DR   EMBL; AC067721; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104472; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC140753; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78741.1; -; Genomic_DNA.
DR   EMBL; BC012178; AAH12178.1; -; mRNA.
DR   CCDS; CCDS46941.1; -. [P49915-1]
DR   PIR; A54847; A54847.
DR   RefSeq; NP_003866.1; NM_003875.2. [P49915-1]
DR   UniGene; Hs.591314; -.
DR   PDB; 2VPI; X-ray; 2.40 A; A/B=25-219.
DR   PDB; 2VXO; X-ray; 2.50 A; A/B=20-693.
DR   PDBsum; 2VPI; -.
DR   PDBsum; 2VXO; -.
DR   ProteinModelPortal; P49915; -.
DR   SMR; P49915; -.
DR   BioGrid; 114360; 63.
DR   IntAct; P49915; 25.
DR   MINT; P49915; -.
DR   STRING; 9606.ENSP00000419851; -.
DR   ChEMBL; CHEMBL5721; -.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB00130; L-Glutamine.
DR   MEROPS; C26.950; -.
DR   iPTMnet; P49915; -.
DR   PhosphoSitePlus; P49915; -.
DR   SwissPalm; P49915; -.
DR   BioMuta; GMPS; -.
DR   DMDM; 1708072; -.
DR   REPRODUCTION-2DPAGE; IPI00029079; -.
DR   EPD; P49915; -.
DR   jPOST; P49915; -.
DR   MaxQB; P49915; -.
DR   PaxDb; P49915; -.
DR   PeptideAtlas; P49915; -.
DR   PRIDE; P49915; -.
DR   ProteomicsDB; 56180; -.
DR   DNASU; 8833; -.
DR   Ensembl; ENST00000295920; ENSP00000295920; ENSG00000163655. [P49915-2]
DR   Ensembl; ENST00000496455; ENSP00000419851; ENSG00000163655. [P49915-1]
DR   GeneID; 8833; -.
DR   KEGG; hsa:8833; -.
DR   UCSC; uc003faq.4; human. [P49915-1]
DR   CTD; 8833; -.
DR   DisGeNET; 8833; -.
DR   EuPathDB; HostDB:ENSG00000163655.15; -.
DR   GeneCards; GMPS; -.
DR   HGNC; HGNC:4378; GMPS.
DR   HPA; HPA046630; -.
DR   MIM; 600358; gene.
DR   neXtProt; NX_P49915; -.
DR   OpenTargets; ENSG00000163655; -.
DR   PharmGKB; PA28763; -.
DR   eggNOG; KOG1622; Eukaryota.
DR   eggNOG; COG0518; LUCA.
DR   eggNOG; COG0519; LUCA.
DR   GeneTree; ENSGT00390000006591; -.
DR   HOGENOM; HOG000223965; -.
DR   HOVERGEN; HBG005929; -.
DR   InParanoid; P49915; -.
DR   KO; K01951; -.
DR   OMA; KRKIIGH; -.
DR   OrthoDB; 392369at2759; -.
DR   PhylomeDB; P49915; -.
DR   TreeFam; TF106132; -.
DR   BRENDA; 6.3.5.2; 2681.
DR   Reactome; R-HSA-73817; Purine ribonucleoside monophosphate biosynthesis.
DR   SIGNOR; P49915; -.
DR   UniPathway; UPA00189; UER00296.
DR   ChiTaRS; GMPS; human.
DR   EvolutionaryTrace; P49915; -.
DR   GeneWiki; GMP_synthase; -.
DR   GenomeRNAi; 8833; -.
DR   PRO; PR:P49915; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000163655; Expressed in 184 organ(s), highest expression level in testis.
DR   ExpressionAtlas; P49915; baseline and differential.
DR   Genevisible; P49915; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003922; F:GMP synthase (glutamine-hydrolyzing) activity; IBA:GO_Central.
DR   GO; GO:0003921; F:GMP synthase activity; EXP:Reactome.
DR   GO; GO:0016462; F:pyrophosphatase activity; IEA:InterPro.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006177; P:GMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0009113; P:purine nucleobase biosynthetic process; TAS:ProtInc.
DR   GO; GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome.
DR   CDD; cd01742; GATase1_GMP_Synthase; 1.
DR   CDD; cd01997; GMP_synthase_C; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   Gene3D; 3.40.50.880; -; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR017926; GATASE.
DR   InterPro; IPR001674; GMP_synth_C.
DR   InterPro; IPR004739; GMP_synth_GATase.
DR   InterPro; IPR025777; GMPS_ATP_PPase_dom.
DR   InterPro; IPR022310; NAD/GMP_synthase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   Pfam; PF00117; GATase; 1.
DR   Pfam; PF00958; GMP_synt_C; 1.
DR   Pfam; PF02540; NAD_synthase; 1.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   TIGRFAMs; TIGR00888; guaA_Nterm; 1.
DR   PROSITE; PS51273; GATASE_TYPE_1; 1.
DR   PROSITE; PS51553; GMPS_ATP_PPASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Chromosomal rearrangement; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Glutamine amidotransferase;
KW   GMP biosynthesis; Ligase; Nucleotide-binding; Phosphoprotein;
KW   Proto-oncogene; Purine biosynthesis; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    693       GMP synthase [glutamine-hydrolyzing].
FT                                /FTId=PRO_0000140257.
FT   DOMAIN       27    216       Glutamine amidotransferase type-1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00605}.
FT   DOMAIN      217    435       GMPS ATP-PPase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00886}.
FT   NP_BIND     244    250       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00886}.
FT   ACT_SITE    104    104       For GATase activity.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00605,
FT                                ECO:0000269|PubMed:23816837}.
FT   ACT_SITE    190    190       For GATase activity.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00605,
FT                                ECO:0000269|PubMed:23816837}.
FT   ACT_SITE    192    192       For GATase activity.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00605,
FT                                ECO:0000269|PubMed:23816837}.
FT   BINDING     337    337       Substrate.
FT   BINDING     522    522       Substrate.
FT   BINDING     610    610       Substrate.
FT   BINDING     685    685       Substrate.
FT   BINDING     691    691       Substrate.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES       8      8       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES       9      9       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     318    318       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     332    332       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      10    108       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053933.
FT   CONFLICT    261    261       N -> D (in Ref. 2; BAG63519).
FT                                {ECO:0000305}.
FT   CONFLICT    415    415       H -> I (in Ref. 1; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       28     32       {ECO:0000244|PDB:2VPI}.
FT   TURN         35     38       {ECO:0000244|PDB:2VPI}.
FT   HELIX        39     47       {ECO:0000244|PDB:2VPI}.
FT   STRAND       52     54       {ECO:0000244|PDB:2VPI}.
FT   HELIX        61     67       {ECO:0000244|PDB:2VPI}.
FT   STRAND       70     76       {ECO:0000244|PDB:2VPI}.
FT   HELIX        91     94       {ECO:0000244|PDB:2VPI}.
FT   STRAND      100    104       {ECO:0000244|PDB:2VPI}.
FT   HELIX       105    113       {ECO:0000244|PDB:2VPI}.
FT   STRAND      118    123       {ECO:0000244|PDB:2VPI}.
FT   STRAND      127    133       {ECO:0000244|PDB:2VPI}.
FT   HELIX       138    140       {ECO:0000244|PDB:2VPI}.
FT   STRAND      145    151       {ECO:0000244|PDB:2VPI}.
FT   STRAND      153    159       {ECO:0000244|PDB:2VPI}.
FT   STRAND      165    170       {ECO:0000244|PDB:2VPI}.
FT   STRAND      173    179       {ECO:0000244|PDB:2VPI}.
FT   TURN        180    183       {ECO:0000244|PDB:2VPI}.
FT   STRAND      184    189       {ECO:0000244|PDB:2VPI}.
FT   STRAND      193    196       {ECO:0000244|PDB:2VXO}.
FT   HELIX       199    207       {ECO:0000244|PDB:2VPI}.
FT   TURN        208    211       {ECO:0000244|PDB:2VPI}.
FT   HELIX       219    234       {ECO:0000244|PDB:2VXO}.
FT   STRAND      238    242       {ECO:0000244|PDB:2VXO}.
FT   HELIX       247    259       {ECO:0000244|PDB:2VXO}.
FT   HELIX       262    264       {ECO:0000244|PDB:2VXO}.
FT   STRAND      265    271       {ECO:0000244|PDB:2VXO}.
FT   HELIX       281    289       {ECO:0000244|PDB:2VXO}.
FT   STRAND      294    298       {ECO:0000244|PDB:2VXO}.
FT   HELIX       300    304       {ECO:0000244|PDB:2VXO}.
FT   HELIX       327    329       {ECO:0000244|PDB:2VXO}.
FT   HELIX       333    354       {ECO:0000244|PDB:2VXO}.
FT   STRAND      361    365       {ECO:0000244|PDB:2VXO}.
FT   HELIX       377    382       {ECO:0000244|PDB:2VXO}.
FT   HELIX       387    389       {ECO:0000244|PDB:2VXO}.
FT   HELIX       396    403       {ECO:0000244|PDB:2VXO}.
FT   HELIX       410    413       {ECO:0000244|PDB:2VXO}.
FT   HELIX       416    425       {ECO:0000244|PDB:2VXO}.
FT   HELIX       430    433       {ECO:0000244|PDB:2VXO}.
FT   HELIX       442    446       {ECO:0000244|PDB:2VXO}.
FT   STRAND      450    452       {ECO:0000244|PDB:2VXO}.
FT   HELIX       459    470       {ECO:0000244|PDB:2VXO}.
FT   HELIX       472    475       {ECO:0000244|PDB:2VXO}.
FT   HELIX       481    489       {ECO:0000244|PDB:2VXO}.
FT   HELIX       492    504       {ECO:0000244|PDB:2VXO}.
FT   STRAND      507    520       {ECO:0000244|PDB:2VXO}.
FT   STRAND      523    536       {ECO:0000244|PDB:2VXO}.
FT   HELIX       540    553       {ECO:0000244|PDB:2VXO}.
FT   STRAND      557    563       {ECO:0000244|PDB:2VXO}.
FT   HELIX       582    601       {ECO:0000244|PDB:2VXO}.
FT   HELIX       605    607       {ECO:0000244|PDB:2VXO}.
FT   STRAND      613    617       {ECO:0000244|PDB:2VXO}.
FT   HELIX       624    626       {ECO:0000244|PDB:2VXO}.
FT   STRAND      633    637       {ECO:0000244|PDB:2VXO}.
FT   STRAND      643    649       {ECO:0000244|PDB:2VXO}.
FT   TURN        654    656       {ECO:0000244|PDB:2VXO}.
FT   HELIX       659    671       {ECO:0000244|PDB:2VXO}.
FT   STRAND      675    681       {ECO:0000244|PDB:2VXO}.
SQ   SEQUENCE   693 AA;  76715 MW;  1CDA0DD3B244728D CRC64;
     MALCNGDSKL ENAGGDLKDG HHHYEGAVVI LDAGAQYGKV IDRRVRELFV QSEIFPLETP
     AFAIKEQGFR AIIISGGPNS VYAEDAPWFD PAIFTIGKPV LGICYGMQMM NKVFGGTVHK
     KSVREDGVFN ISVDNTCSLF RGLQKEEVVL LTHGDSVDKV ADGFKVVARS GNIVAGIANE
     SKKLYGAQFH PEVGLTENGK VILKNFLYDI AGCSGTFTVQ NRELECIREI KERVGTSKVL
     VLLSGGVDST VCTALLNRAL NQEQVIAVHI DNGFMRKRES QSVEEALKKL GIQVKVINAA
     HSFYNGTTTL PISDEDRTPR KRISKTLNMT TSPEEKRKII GDTFVKIANE VIGEMNLKPE
     EVFLAQGTLR PDLIESASLV ASGKAELIKT HHNDTELIRK LREEGKVIEP LKDFHKDEVR
     ILGRELGLPE ELVSRHPFPG PGLAIRVICA EEPYICKDFP ETNNILKIVA DFSASVKKPH
     TLLQRVKACT TEEDQEKLMQ ITSLHSLNAF LLPIKTVGVQ GDCRSYSYVC GISSKDEPDW
     ESLIFLARLI PRMCHNVNRV VYIFGPPVKE PPTDVTPTFL TTGVLSTLRQ ADFEAHNILR
     ESGYAGKISQ MPVILTPLHF DRDPLQKQPS CQRSVVIRTF ITSDFMTGIP ATPGNEIPVE
     VVLKMVTEIK KIPGISRIMY DLTSKPPGTT EWE
//
ID   JAZF1_HUMAN             Reviewed;         243 AA.
AC   Q86VZ6; A4D195; Q8N3L7;
DT   11-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2003, sequence version 2.
DT   13-FEB-2019, entry version 145.
DE   RecName: Full=Juxtaposed with another zinc finger protein 1;
DE   AltName: Full=TAK1-interacting protein 27;
DE   AltName: Full=Zinc finger protein 802;
GN   Name=JAZF1; Synonyms=TIP27, ZNF802;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH
RP   NR2C2, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   LYS-47; TYR-60; ALA-69 AND LEU-76.
RX   PubMed=15302918; DOI=10.1093/nar/gkh741;
RA   Nakajima T., Fujino S., Nakanishi G., Kim Y.S., Jetten A.M.;
RT   "TIP27: a novel repressor of the nuclear orphan receptor TAK1/TR4.";
RL   Nucleic Acids Res. 32:4194-4204(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PARTIAL NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH SUZ12.
RX   PubMed=11371647; DOI=10.1073/pnas.101132598;
RA   Koontz J.I., Soreng A.L., Nucci M., Kuo F.C., Pauwels P.,
RA   van Den Berghe H., Cin P.D., Fletcher J.A., Sklar J.;
RT   "Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal
RT   tumors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:6348-6353(2001).
RN   [7]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH PHF1.
RX   PubMed=16397222; DOI=10.1158/0008-5472.CAN-05-2485;
RA   Micci F., Panagopoulos I., Bjerkehagen B., Heim S.;
RT   "Consistent rearrangement of chromosomal band 6p21 with generation of
RT   fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal
RT   sarcoma.";
RL   Cancer Res. 66:107-112(2006).
RN   [8]
RP   TRANS-SPLICING.
RX   PubMed=18772439; DOI=10.1126/science.1156725;
RA   Li H., Wang J., Mor G., Sklar J.;
RT   "A neoplastic gene fusion mimics trans-splicing of RNAs in normal
RT   human cells.";
RL   Science 321:1357-1361(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-113, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Acts as a transcriptional corepressor of orphan nuclear
CC       receptor NR2C2 (PubMed:15302918). Inhibits expression of the
CC       gluconeogenesis enzyme PCK2 through inhibition of NR2C2 activity
CC       (By similarity). Also involved in transcriptional activation of
CC       NAMPT by promoting expression of PPARA and PPARD (By similarity).
CC       Plays a role in lipid metabolism by suppressing lipogenesis,
CC       increasing lipolysis and decreasing lipid accumulation in adipose
CC       tissue (By similarity). Plays a role in glucose homeostasis by
CC       improving glucose metabolism and insulin sensitivity (By
CC       similarity). {ECO:0000250|UniProtKB:Q80ZQ5,
CC       ECO:0000269|PubMed:15302918}.
CC   -!- SUBUNIT: Interacts with NR2C2 (via ligand-binding region).
CC       {ECO:0000269|PubMed:15302918}.
CC   -!- INTERACTION:
CC       P49116:NR2C2; NbExp=6; IntAct=EBI-11023753, EBI-2652582;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15302918}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q86VZ6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86VZ6-2; Sequence=VSP_007755;
CC         Note=Incomplete sequence. No experimental confirmation
CC         available.;
CC   -!- TISSUE SPECIFICITY: Highest expression in testis with moderate
CC       levels in colon, placenta, prostate and ovary and low levels in
CC       brain, spleen, liver and small intestine.
CC       {ECO:0000269|PubMed:15302918}.
CC   -!- DISEASE: Note=A chromosomal aberration involving JAZF1 may be a
CC       cause of endometrial stromal tumors. Translocation
CC       t(7;17)(p15;q21) with SUZ12. The translocation generates the
CC       JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1
CC       and the C-terminus part of SUZ12. It is frequently found in all
CC       cases of endometrial stromal tumors, except in endometrial stromal
CC       sarcomas, where it is rarer. Translocation t(6;7)(p21;p22) with
CC       PHF1. {ECO:0000269|PubMed:11371647, ECO:0000269|PubMed:16397222}.
CC   -!- MISCELLANEOUS: Under hypoxic conditions, the precursor SUZ12 RNA
CC       undergoes regulated trans-splicing with the JAZF1 RNA, resulting
CC       in a chimeric isoform which may be protective against apoptosis.
CC       The chimeric transcript is characterized by JAZF1 exons 1-3 joined
CC       to SUZ12 exon 2-16. The chimeric transcript is expressed primarily
CC       in the endometrium from late secretory and early proliferative
CC       phases of the menstrual cycle, but not in normal myometrium at any
CC       phase of the cycle. Its expression is slightly induced by low
CC       levels of progesterone, but suppressed by both estrogen and high
CC       levels of progesterone (PubMed:18772439).
CC       {ECO:0000305|PubMed:18772439}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/JAZF1ID41036ch7p15.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AY372319; AAQ74874.1; -; mRNA.
DR   EMBL; AK091311; BAG52333.1; -; mRNA.
DR   EMBL; CH236948; EAL24212.1; -; Genomic_DNA.
DR   EMBL; BC042441; AAH42441.1; -; mRNA.
DR   EMBL; AL834234; CAD38912.1; -; mRNA.
DR   CCDS; CCDS5416.1; -. [Q86VZ6-1]
DR   RefSeq; NP_778231.2; NM_175061.3. [Q86VZ6-1]
DR   UniGene; Hs.368944; -.
DR   ProteinModelPortal; Q86VZ6; -.
DR   BioGrid; 128764; 13.
DR   IntAct; Q86VZ6; 4.
DR   STRING; 9606.ENSP00000283928; -.
DR   iPTMnet; Q86VZ6; -.
DR   PhosphoSitePlus; Q86VZ6; -.
DR   BioMuta; JAZF1; -.
DR   DMDM; 32699538; -.
DR   EPD; Q86VZ6; -.
DR   jPOST; Q86VZ6; -.
DR   MaxQB; Q86VZ6; -.
DR   PaxDb; Q86VZ6; -.
DR   PeptideAtlas; Q86VZ6; -.
DR   PRIDE; Q86VZ6; -.
DR   ProteomicsDB; 70098; -.
DR   ProteomicsDB; 70099; -. [Q86VZ6-2]
DR   DNASU; 221895; -.
DR   Ensembl; ENST00000283928; ENSP00000283928; ENSG00000153814. [Q86VZ6-1]
DR   GeneID; 221895; -.
DR   KEGG; hsa:221895; -.
DR   UCSC; uc003szn.4; human. [Q86VZ6-1]
DR   CTD; 221895; -.
DR   DisGeNET; 221895; -.
DR   EuPathDB; HostDB:ENSG00000153814.11; -.
DR   GeneCards; JAZF1; -.
DR   HGNC; HGNC:28917; JAZF1.
DR   HPA; CAB019271; -.
DR   HPA; HPA066967; -.
DR   MalaCards; JAZF1; -.
DR   MIM; 606246; gene.
DR   neXtProt; NX_Q86VZ6; -.
DR   OpenTargets; ENSG00000153814; -.
DR   Orphanet; 213711; Endometrial stromal sarcoma.
DR   Orphanet; 536; Systemic lupus erythematosus.
DR   PharmGKB; PA162392484; -.
DR   eggNOG; KOG4124; Eukaryota.
DR   eggNOG; COG5189; LUCA.
DR   GeneTree; ENSGT00390000003635; -.
DR   HOGENOM; HOG000252946; -.
DR   HOVERGEN; HBG052161; -.
DR   InParanoid; Q86VZ6; -.
DR   KO; K19495; -.
DR   OMA; QHIEDNH; -.
DR   OrthoDB; 1617085at2759; -.
DR   PhylomeDB; Q86VZ6; -.
DR   TreeFam; TF324161; -.
DR   SIGNOR; Q86VZ6; -.
DR   ChiTaRS; JAZF1; human.
DR   GeneWiki; JAZF1; -.
DR   GenomeRNAi; 221895; -.
DR   PRO; PR:Q86VZ6; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000153814; Expressed in 197 organ(s), highest expression level in trabecular bone tissue.
DR   ExpressionAtlas; Q86VZ6; baseline and differential.
DR   Genevisible; Q86VZ6; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0017053; C:transcriptional repressor complex; IDA:MGI.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; NAS:NTNU_SB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:MGI.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:MGI.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   SMART; SM00355; ZnF_C2H2; 3.
DR   SUPFAM; SSF57667; SSF57667; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Complete proteome;
KW   Lipid metabolism; Metal-binding; Nucleus; Phosphoprotein;
KW   Proto-oncogene; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN         1    243       Juxtaposed with another zinc finger
FT                                protein 1.
FT                                /FTId=PRO_0000046985.
FT   ZN_FING      12     37       C2H2-type 1.
FT   ZN_FING     173    198       C2H2-type 2.
FT   ZN_FING     208    230       C2H2-type 3; degenerate.
FT   REGION       39     79       Required for interaction with NR2C2.
FT                                {ECO:0000269|PubMed:15302918}.
FT   SITE        129    130       Breakpoint for translocation to form
FT                                JAZF1-SUZ12 oncogene.
FT   MOD_RES     109    109       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q80ZQ5}.
FT   MOD_RES     113    113       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     38       MTGIAAASFFSNTCRFGGCGLHFPTLADLIEHIEDNHI ->
FT                                YFVLGSLIYSDAKSKKNRNCVFIT (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_007755.
FT   MUTAGEN      47     47       K->P: Little effect on interaction with
FT                                NR2C2. {ECO:0000269|PubMed:15302918}.
FT   MUTAGEN      60     60       Y->D: Abolishes interaction with NR2C2.
FT                                {ECO:0000269|PubMed:15302918}.
FT   MUTAGEN      69     69       A->P: Little effect on interaction with
FT                                NR2C2. {ECO:0000269|PubMed:15302918}.
FT   MUTAGEN      76     76       L->P: Reduces interaction with NR2C2.
FT                                {ECO:0000269|PubMed:15302918}.
FT   CONFLICT    133    133       D -> G (in Ref. 4; AAH42441).
FT                                {ECO:0000305}.
SQ   SEQUENCE   243 AA;  27079 MW;  878A6EE3D82C0588 CRC64;
     MTGIAAASFF SNTCRFGGCG LHFPTLADLI EHIEDNHIDT DPRVLEKQEL QQPTYVALSY
     INRFMTDAAR REQESLKKKI QPKLSLTLSS SVSRGNVSTP PRHSSGSLTP PVTPPITPSS
     SFRSSTPTGS EYDEEEVDYE ESDSDESWTT ESAISSEAIL SSMCMNGGEE KPFACPVPGC
     KKRYKNVNGI KYHAKNGHRT QIRVRKPFKC RCGKSYKTAQ GLRHHTINFH PPVSAEIIRK
     MQQ
//
ID   K1549_HUMAN             Reviewed;        1950 AA.
AC   Q9HCM3; B6HY55; B6HY56; B6HY58; B6HY60; B6HY61; B6HY62; B6HY63;
AC   B6HY64; B6HY65; B6HY66; Q5BJD6; Q8IY15; Q9H0M3;
DT   01-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 4.
DT   13-FEB-2019, entry version 115.
DE   RecName: Full=UPF0606 protein KIAA1549;
GN   Name=KIAA1549;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2; 3 AND 4),
RP   DISEASE, AND CHROMOSOMAL REARRANGEMENT.
RC   TISSUE=Brain;
RX   PubMed=18974108; DOI=10.1158/0008-5472.CAN-08-2097;
RA   Jones D.T.W., Kocialkowski S., Liu L., Pearson D.M., Backlund L.M.,
RA   Ichimura K., Collins V.P.;
RT   "Tandem duplication producing a novel oncogenic BRAF fusion gene
RT   defines the majority of pilocytic astrocytomas.";
RL   Cancer Res. 68:8673-8677(2008).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 70-1950 (ISOFORM 2), AND
RP   VARIANT LEU-652.
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1128-1950 (ISOFORM 1).
RC   TISSUE=Brain, and Duodenum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1811-1950 (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1395, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   GLYCOSYLATION.
RX   PubMed=28512129; DOI=10.1074/jbc.M117.794487;
RA   Larsen I.S.B., Narimatsu Y., Joshi H.J., Yang Z., Harrison O.J.,
RA   Brasch J., Shapiro L., Honig B., Vakhrushev S.Y., Clausen H.,
RA   Halim A.;
RT   "Mammalian O-mannosylation of cadherins and plexins is independent of
RT   protein O-mannosyltransferases 1 and 2.";
RL   J. Biol. Chem. 292:11586-11598(2017).
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=v2 long-form;
CC         IsoId=Q9HCM3-1; Sequence=Displayed;
CC       Name=2; Synonyms=v1 long-form;
CC         IsoId=Q9HCM3-2; Sequence=VSP_034448;
CC       Name=3; Synonyms=v1 short-form;
CC         IsoId=Q9HCM3-3; Sequence=VSP_040885, VSP_040886, VSP_034448;
CC         Note=Produced by alternative promoter usage.;
CC       Name=4; Synonyms=v2 short-form;
CC         IsoId=Q9HCM3-4; Sequence=VSP_040885, VSP_040886;
CC         Note=Produced by alternative promoter usage.;
CC   -!- PTM: O-glycosylated. O-mannosylated by POMT1 and POMT2 and
CC       elongated by POMGNT1. {ECO:0000269|PubMed:28512129}.
CC   -!- DISEASE: Note=A chromosomal aberration involving KIAA1549 is found
CC       in pilocytic astrocytoma. A tandem duplication of 2 Mb at 7q34
CC       leads to the expression of a KIAA1549-BRAF fusion protein with a
CC       constitutive kinase activity and inducing cell transformation.
CC       {ECO:0000269|PubMed:18974108}.
CC   -!- SIMILARITY: Belongs to the UPF0606 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH38232.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AM989467; CAQ43105.1; -; Genomic_DNA.
DR   EMBL; AM989467; CAQ43106.1; -; Genomic_DNA.
DR   EMBL; AM989468; CAQ43107.1; -; mRNA.
DR   EMBL; AM989469; CAQ43108.1; -; mRNA.
DR   EMBL; AM989470; CAQ43109.1; -; mRNA.
DR   EMBL; AM989471; CAQ43110.1; -; mRNA.
DR   EMBL; AM989472; CAQ43111.1; ALT_TERM; mRNA.
DR   EMBL; AM989473; CAQ43112.1; ALT_TERM; mRNA.
DR   EMBL; AM989474; CAQ43113.1; ALT_TERM; mRNA.
DR   EMBL; AM989475; CAQ43114.1; ALT_TERM; mRNA.
DR   EMBL; AM989476; CAQ43115.1; ALT_TERM; mRNA.
DR   EMBL; AM989477; CAQ43116.1; ALT_TERM; mRNA.
DR   EMBL; AC018663; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC083868; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093144; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB046769; BAB13375.2; -; mRNA.
DR   EMBL; BC038232; AAH38232.1; ALT_INIT; mRNA.
DR   EMBL; BC091523; AAH91523.1; -; mRNA.
DR   EMBL; AL136736; CAB66670.2; -; mRNA.
DR   CCDS; CCDS47723.2; -. [Q9HCM3-2]
DR   CCDS; CCDS56513.1; -. [Q9HCM3-1]
DR   RefSeq; NP_001158137.1; NM_001164665.1. [Q9HCM3-1]
DR   RefSeq; NP_065961.2; NM_020910.2. [Q9HCM3-2]
DR   UniGene; Hs.605380; -.
DR   ProteinModelPortal; Q9HCM3; -.
DR   BioGrid; 121702; 26.
DR   IntAct; Q9HCM3; 14.
DR   MINT; Q9HCM3; -.
DR   STRING; 9606.ENSP00000416040; -.
DR   iPTMnet; Q9HCM3; -.
DR   PhosphoSitePlus; Q9HCM3; -.
DR   BioMuta; KIAA1549; -.
DR   DMDM; 327478603; -.
DR   EPD; Q9HCM3; -.
DR   jPOST; Q9HCM3; -.
DR   MaxQB; Q9HCM3; -.
DR   PaxDb; Q9HCM3; -.
DR   PeptideAtlas; Q9HCM3; -.
DR   PRIDE; Q9HCM3; -.
DR   ProteomicsDB; 81759; -.
DR   ProteomicsDB; 81760; -. [Q9HCM3-2]
DR   ProteomicsDB; 81761; -. [Q9HCM3-3]
DR   ProteomicsDB; 81762; -. [Q9HCM3-4]
DR   Ensembl; ENST00000422774; ENSP00000416040; ENSG00000122778. [Q9HCM3-1]
DR   Ensembl; ENST00000440172; ENSP00000406661; ENSG00000122778. [Q9HCM3-2]
DR   GeneID; 57670; -.
DR   KEGG; hsa:57670; -.
DR   UCSC; uc011kqj.3; human. [Q9HCM3-1]
DR   CTD; 57670; -.
DR   DisGeNET; 57670; -.
DR   EuPathDB; HostDB:ENSG00000122778.9; -.
DR   GeneCards; KIAA1549; -.
DR   HGNC; HGNC:22219; KIAA1549.
DR   HPA; HPA019560; -.
DR   MalaCards; KIAA1549; -.
DR   MIM; 613344; gene.
DR   neXtProt; NX_Q9HCM3; -.
DR   OpenTargets; ENSG00000122778; -.
DR   Orphanet; 251615; Pilomyxoid astrocytoma.
DR   PharmGKB; PA162393138; -.
DR   eggNOG; ENOG410IFU4; Eukaryota.
DR   eggNOG; ENOG410XX42; LUCA.
DR   GeneTree; ENSGT00530000063472; -.
DR   HOVERGEN; HBG108038; -.
DR   InParanoid; Q9HCM3; -.
DR   OMA; LFADFTF; -.
DR   OrthoDB; 33154at2759; -.
DR   PhylomeDB; Q9HCM3; -.
DR   TreeFam; TF332690; -.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   ChiTaRS; KIAA1549; human.
DR   GenomeRNAi; 57670; -.
DR   PRO; PR:Q9HCM3; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000122778; Expressed in 160 organ(s), highest expression level in neocortex.
DR   Genevisible; Q9HCM3; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISM:NTNU_SB.
DR   InterPro; IPR024606; DUF3827.
DR   PANTHER; PTHR21590; PTHR21590; 1.
DR   Pfam; PF12877; DUF3827; 1.
PE   1: Evidence at protein level;
KW   Alternative promoter usage; Alternative splicing;
KW   Chromosomal rearrangement; Complete proteome; Membrane;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1   1950       UPF0606 protein KIAA1549.
FT                                /FTId=PRO_0000342405.
FT   TRANSMEM    998   1018       Helical. {ECO:0000255}.
FT   TRANSMEM   1299   1319       Helical. {ECO:0000255}.
FT   COMPBIAS    494    764       Ser-rich.
FT   SITE       1643   1644       Breakpoint for translocation to form
FT                                KIAA1549-BRAF fusion protein.
FT   SITE       1749   1750       Breakpoint for translocation to form
FT                                KIAA1549-BRAF fusion protein.
FT   MOD_RES    1388   1388       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q68FD9}.
FT   MOD_RES    1395   1395       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983}.
FT   MOD_RES    1554   1554       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q68FD9}.
FT   MOD_RES    1555   1555       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q68FD9}.
FT   MOD_RES    1622   1622       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q68FD9}.
FT   MOD_RES    1624   1624       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q68FD9}.
FT   VAR_SEQ       1   1216       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:18974108}.
FT                                /FTId=VSP_040885.
FT   VAR_SEQ    1217   1222       AGNSVV -> MVSAIF (in isoform 3 and
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:18974108}.
FT                                /FTId=VSP_040886.
FT   VAR_SEQ    1867   1882       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:10997877,
FT                                ECO:0000303|PubMed:11230166,
FT                                ECO:0000303|PubMed:18974108}.
FT                                /FTId=VSP_034448.
FT   VARIANT     448    448       A -> P (in dbSNP:rs2718131).
FT                                /FTId=VAR_044187.
FT   VARIANT     652    652       P -> L (in dbSNP:rs2774960).
FT                                {ECO:0000269|PubMed:10997877}.
FT                                /FTId=VAR_057812.
FT   VARIANT     851    851       V -> G (in dbSNP:rs2354336).
FT                                /FTId=VAR_044188.
FT   CONFLICT    486    486       P -> A (in Ref. 3; BAB13375).
FT                                {ECO:0000305}.
FT   CONFLICT    617    617       R -> G (in Ref. 3; BAB13375).
FT                                {ECO:0000305}.
FT   CONFLICT    849    849       S -> L (in Ref. 3; BAB13375).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1950 AA;  210755 MW;  3F7FD3A94CE4EE93 CRC64;
     MPGARRRRRG AAMEGKPRAG VALAPGPSGR RPSARCARRR RPGLLLPGLW LLLLARPASC
     APDELSPEQH NLSLYSMELV LKKSTGHSAA QVALTETAPG SQHSSPLHVT APPSATTFDT
     AFFNQGKQTK STADPSIFVA TYVSVTSKEV AVNDDEMDNF LPDTHWTTPR MVSPIQYITV
     SPPGLPREAL EPMLTPSLPM VSLQDEEVTS GWQNTTRQPA AYAESASHFH TFRSAFRTSE
     GIVPTPGRNL VLYPTDAYSH LSSRTLPEIV ASLTEGVETT LFLSSRSLMP QPLGDGITIP
     LPSLGEVSQP PEEVWATSAD RYTDVTTVLS QSLEETISPR TYPTVTASHA ALAFSRTHSP
     LLSTPLAFAS SASPTDVSSN PFLPSDSSKT SELHSNSALP GPVDNTHILS PVSSFRPYTW
     CAACTVPSPQ QVLATSLMEK DVGSGDGAET LCMTVLEESS ISLMSSVVAD FSEFEEDPQV
     FNTLFPSRPI VPLSSRSMEI SETSVGISAE VDMSSVTTTQ VPPAHGRLSV PASLDPTAGS
     LSVAETQVTP SSVTTAFFSV ITSILLDSSF SVIANKNTPS LAVRDPSVFT PYSLVPSVES
     SLFSDQERSS FSEHKPRGAL DFASSFFSTP PLELSGSISS PSEAPASLSL MPSDLSPFTS
     QSFSPLVETF TLFDSSDLQS SQLSLPSSTN LEFSQLQPSS ELPLNTIMLL PSRSEVSPWS
     SFPSDSLEFV EASTVSLTDS EAHFTSAFIE TTSYLESSLI SHESAVTALV PPGSESFDIL
     TAGIQATSPL TTVHTTPILT ESSLFSTLTP PDDQISALDG HVSVLASFSK AIPTGTVLIT
     DAYLPSGSSF VSEATPFPLP TELTVVGPSL TPTEVPLNTS TEVSTTSTGA ATGGPLDSTL
     MGDAASQSPP ESSAAPPLPS LRPVTAFTLE ATVDTPTLAT AKPPYVCDIT VPDAYLITTV
     LARRAVQEYI ITAIKEVLRI HFNRAVELKV YELFTDFTFL VTSGPFVYTA ISVINVLINS
     KLVRDQTPLI LSVKPSFLVP ESRFQVQTVL QFVPPSVDTG FCNFTQRIEK GLMTALFEVR
     KHHQGTYNLT VQILNITISS SRVTPRRGPV NIIFAVKSTQ GFLNGSEVSE LLRNLSVVEF
     SFYLGYPVLQ IAEPFQYPQL NLSQLLKSSW VRTVLLGVME KQLQNEVFQA EMERKLAQLL
     SEVSTRRRMW RRATVAAGNS VVQVVNVSRL EGDDNPVQLI YFVEDQDGER LSAVKSSDLI
     NKMDLQRAAI ILGYRIQGVI AQPVDRVKRP SPESQSNNLW VIVGVVIPVL VVMVIVVILY
     WKLCRTDKLD FQPDTVANIQ QRQKLQIPSV KGFDFAKQHL GQHNKDDILI IHEPAPLPGP
     LKDHTTPSEN GDVPSPKSKI PSKNVRHRGR VSPSDADSTV SEESSERDAG DKTPGAVNDG
     RSHRAPQSGP PLPSSGNEQH SSASIFEHVD RISRPPEASR RVPSKIQLIA MQPIPAPPVQ
     RPSPADRVAE SNKINKEIQT ALRHKSEIEH HRNKIRLRAK RRGHYEFPVV DDLSSGDTKE
     RHRVYRRAQM QIDKILDPTA SVPSVFIEPR KSSRIKRSPK PRRKHQVNGC PADAEKDRLI
     TTDSDGTYRR PPGVHNSAYI GCPSDPDLPA DVQTPSSVEL GRYPALPFPA SQYIPPQPSI
     EEARQTMHSL LDDAFALVAP SSQPASTAGV GPGVPPGLPA NSTPSQEERR ATQWGSFYSP
     AQTANNPCSR YEDYGMTPPT GPLPRPGFGP GLLQSTELVP PDPQQPQASA EAPFAARGIY
     SEEMPSVARP RPVGGTTGSQ IQHLTQVGIA SRIGAQPVEI PPSRGSQYGG PGWPSYGEDE
     AGRREATHML GHQEYSSSPL FQVPRTSGRE PSAPSGNLPH RGLQGPGLGY PTSSTEDLQP
     GHSSASLIKA IREELLRLSQ KQSTVQNFHS
//
ID   SHOT1_HUMAN             Reviewed;         631 AA.
AC   A0MZ66; A8MYU7; B3KRD3; B3KRH2; B3KTE0; B3KTJ7; B3KTJ8; B4E3U1;
AC   B7Z7Z9; Q68DG1; Q6PIM5; Q9HCH4; Q9NUV0;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 4.
DT   13-FEB-2019, entry version 111.
DE   RecName: Full=Shootin-1 {ECO:0000312|HGNC:HGNC:29319};
DE   AltName: Full=Shootin1 {ECO:0000250|UniProtKB:A0MZ67};
GN   Name=SHTN1 {ECO:0000312|HGNC:HGNC:29319}; Synonyms=KIAA1598;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=17030985; DOI=10.1083/jcb.200604160;
RA   Toriyama M., Shimada T., Kim K.B., Mitsuba M., Nomura E., Katsuta K.,
RA   Sakumura Y., Roepstorff P., Inagaki N.;
RT   "Shootin1: a protein involved in the organization of an asymmetric
RT   signal for neuronal polarization.";
RL   J. Cell Biol. 175:147-157(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 5; 6; 7 AND 8),
RP   AND NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 349-631 (ISOFORM 1).
RC   TISSUE=Brain, Placenta, Testis, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 388-631 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 11-631 (ISOFORM 2).
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes.
RT   XVIII. The complete sequences of 100 new cDNA clones from brain which
RT   code for large proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [8]
RP   PROTEIN SEQUENCE OF 9-17; 160-169; 187-197 AND 467-479, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-506; SER-515; SER-532
RP   AND THR-537, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-506, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249; THR-496; SER-506;
RP   SER-532 AND THR-537, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-506, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-249; SER-375;
RP   SER-473; THR-487; SER-494; SER-506; SER-532; SER-534 AND THR-537, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375; SER-494 AND
RP   SER-506, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Involved in the generation of internal asymmetric
CC       signals required for neuronal polarization and neurite outgrowth.
CC       Mediates netrin-1-induced F-actin-substrate coupling or 'clutch
CC       engagement' within the axon growth cone through activation of
CC       CDC42, RAC1 and PAK1-dependent signaling pathway, thereby
CC       converting the F-actin retrograde flow into traction forces,
CC       concomitantly with filopodium extension and axon outgrowth. Plays
CC       a role in cytoskeletal organization by regulating the subcellular
CC       localization of phosphoinositide 3-kinase (PI3K) activity at the
CC       axonal growth cone. Plays also a role in regenerative neurite
CC       outgrowth. In the developing cortex, cooperates with KIF20B to
CC       promote both the transition from the multipolar to the bipolar
CC       stage and the radial migration of cortical neurons from the
CC       ventricular zone toward the superficial layer of the neocortex.
CC       Involved in the accumulation of phosphatidylinositol 3,4,5-
CC       trisphosphate (PIP3) in the growth cone of primary hippocampal
CC       neurons. {ECO:0000250|UniProtKB:A0MZ67,
CC       ECO:0000250|UniProtKB:Q8K2Q9}.
CC   -!- SUBUNIT: Interacts with L1CAM; this interaction occurs in axonal
CC       growth cones. Interacts with actin filament retrograde flow; this
CC       interaction is enhanced in a netrin-1- and PAK1-dependent manner
CC       and promotes F-actin-substrate coupling and concomitant formation
CC       of traction forces at axonal growth cones. Interacts with RUFY3.
CC       Interacts with PFN2. Interacts (via N-terminus) with KIF20B; this
CC       interaction is direct and promotes the association of SHTN1 to
CC       microtubules in primary neurons. Associates with microtubule.
CC       {ECO:0000250|UniProtKB:A0MZ67, ECO:0000250|UniProtKB:Q8K2Q9}.
CC   -!- INTERACTION:
CC       O75936:BBOX1; NbExp=3; IntAct=EBI-10171490, EBI-715662;
CC       P62508:ESRRG; NbExp=3; IntAct=EBI-308778, EBI-2834260;
CC       P05413:FABP3; NbExp=3; IntAct=EBI-308778, EBI-704216;
CC       Q6PJR7:IGL@; NbExp=3; IntAct=EBI-308778, EBI-10254102;
CC       Q9Y5B8:NME7; NbExp=3; IntAct=EBI-308778, EBI-744782;
CC       Q12800:TFCP2; NbExp=3; IntAct=EBI-10171490, EBI-717422;
CC   -!- SUBCELLULAR LOCATION: Perikaryon {ECO:0000250|UniProtKB:Q8K2Q9}.
CC       Cell projection, axon {ECO:0000250|UniProtKB:Q8K2Q9}. Cell
CC       projection, growth cone {ECO:0000250|UniProtKB:Q8K2Q9}. Cytoplasm,
CC       cytoskeleton {ECO:0000250|UniProtKB:Q8K2Q9}. Cell projection,
CC       filopodium {ECO:0000250|UniProtKB:A0MZ67}. Cell projection,
CC       lamellipodium {ECO:0000250|UniProtKB:A0MZ67}. Note=Localizes in
CC       multiple growth cones at neurite tips before the neuronal
CC       symmetry-breaking step. Accumulates in growth cones of a single
CC       nascent axon in a neurite length-dependent manner during the
CC       neuronal symmetry-breaking step; when absent from the nascent
CC       axon's siblings, probably due to competitive transport, prevents
CC       the formation of surplus axons. Transported anterogradely from the
CC       soma to the axon growth cone in an actin and myosin-dependent
CC       manner and passively diffuses back to the cell bodies. Colocalized
CC       with L1CAM in close apposition with actin filaments in filopodia
CC       and lamellipodia of axonal growth cones in hippocampal neurons.
CC       Exhibits retrograde movements in filopodia and lamellopodia of
CC       axonal growth cones. Colocalized with KIF20B along microtubules to
CC       the tip of the growing cone in primary hippocampal neurons.
CC       Recruted to the growth cone of developing axon in a KIF20B- and
CC       microtubule-dependent manner. {ECO:0000250|UniProtKB:A0MZ67,
CC       ECO:0000250|UniProtKB:Q8K2Q9}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=1;
CC         IsoId=A0MZ66-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A0MZ66-2; Sequence=VSP_027050, VSP_027051;
CC       Name=3;
CC         IsoId=A0MZ66-3; Sequence=VSP_027053;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=A0MZ66-4; Sequence=VSP_027052;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=A0MZ66-5; Sequence=VSP_036498;
CC       Name=6;
CC         IsoId=A0MZ66-6; Sequence=VSP_036499;
CC       Name=7;
CC         IsoId=A0MZ66-7; Sequence=VSP_036497;
CC       Name=8;
CC         IsoId=A0MZ66-8; Sequence=VSP_036498, VSP_027052;
CC   -!- DOMAIN: The N-terminus region is necessary for interaction with
CC       actin retrograde filament flow and accumulation in neuronal growth
CC       cones. {ECO:0000250|UniProtKB:A0MZ67}.
CC   -!- PTM: Phosphorylated on Ser-101 and Ser-249 by PAK1 through a
CC       CDC42- and RAC1-dependent signaling pathway, which enhances its
CC       association with F-actin retrograde flow in filopodia and
CC       lamellipodia of axonal growth cones. Phosphorylation on Ser-101
CC       and Ser-249 is increased by netrin-1.
CC       {ECO:0000250|UniProtKB:A0MZ67}.
CC   -!- SIMILARITY: Belongs to the shootin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH22348.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA92019.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAG53052.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAG53110.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; EF055487; ABK56022.1; -; mRNA.
DR   EMBL; AK001984; BAA92019.1; ALT_INIT; mRNA.
DR   EMBL; AK091381; BAG52345.1; -; mRNA.
DR   EMBL; AK091578; BAG52384.1; -; mRNA.
DR   EMBL; AK095419; BAG53052.1; ALT_INIT; mRNA.
DR   EMBL; AK095703; BAG53109.1; -; mRNA.
DR   EMBL; AK095709; BAG53110.1; ALT_INIT; mRNA.
DR   EMBL; AK302705; BAH13785.1; -; mRNA.
DR   EMBL; AK304865; BAG65603.1; -; mRNA.
DR   EMBL; CR749417; CAH18259.1; -; mRNA.
DR   EMBL; AC012308; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023283; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL731557; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49434.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49438.1; -; Genomic_DNA.
DR   EMBL; BC022348; AAH22348.1; ALT_INIT; mRNA.
DR   EMBL; BC032303; AAH32303.1; -; mRNA.
DR   EMBL; AB046818; BAB13424.1; -; mRNA.
DR   CCDS; CCDS31293.1; -. [A0MZ66-2]
DR   CCDS; CCDS44482.1; -. [A0MZ66-1]
DR   CCDS; CCDS58097.1; -. [A0MZ66-8]
DR   CCDS; CCDS73207.1; -. [A0MZ66-5]
DR   CCDS; CCDS73208.1; -. [A0MZ66-4]
DR   RefSeq; NP_001120683.1; NM_001127211.2. [A0MZ66-1]
DR   RefSeq; NP_001245227.1; NM_001258298.1. [A0MZ66-5]
DR   RefSeq; NP_001245228.1; NM_001258299.1. [A0MZ66-4]
DR   RefSeq; NP_001245229.1; NM_001258300.1. [A0MZ66-8]
DR   RefSeq; NP_060800.2; NM_018330.6. [A0MZ66-2]
DR   RefSeq; XP_016871951.1; XM_017016462.1.
DR   UniGene; Hs.501140; -.
DR   ProteinModelPortal; A0MZ66; -.
DR   SMR; A0MZ66; -.
DR   BioGrid; 121723; 43.
DR   IntAct; A0MZ66; 17.
DR   MINT; A0MZ66; -.
DR   STRING; 9606.ENSP00000347532; -.
DR   iPTMnet; A0MZ66; -.
DR   PhosphoSitePlus; A0MZ66; -.
DR   BioMuta; SHTN1; -.
DR   EPD; A0MZ66; -.
DR   jPOST; A0MZ66; -.
DR   MaxQB; A0MZ66; -.
DR   PaxDb; A0MZ66; -.
DR   PRIDE; A0MZ66; -.
DR   ProteomicsDB; 45; -.
DR   ProteomicsDB; 46; -. [A0MZ66-2]
DR   ProteomicsDB; 47; -. [A0MZ66-3]
DR   ProteomicsDB; 48; -. [A0MZ66-4]
DR   ProteomicsDB; 49; -. [A0MZ66-5]
DR   ProteomicsDB; 50; -. [A0MZ66-6]
DR   ProteomicsDB; 51; -. [A0MZ66-7]
DR   Ensembl; ENST00000260777; ENSP00000260777; ENSG00000187164. [A0MZ66-5]
DR   Ensembl; ENST00000355371; ENSP00000347532; ENSG00000187164. [A0MZ66-1]
DR   Ensembl; ENST00000392901; ENSP00000376635; ENSG00000187164. [A0MZ66-8]
DR   Ensembl; ENST00000392903; ENSP00000376636; ENSG00000187164. [A0MZ66-4]
DR   Ensembl; ENST00000615301; ENSP00000480109; ENSG00000187164. [A0MZ66-2]
DR   GeneID; 57698; -.
DR   KEGG; hsa:57698; -.
DR   UCSC; uc001lcz.6; human. [A0MZ66-1]
DR   CTD; 57698; -.
DR   DisGeNET; 57698; -.
DR   EuPathDB; HostDB:ENSG00000187164.17; -.
DR   GeneCards; SHTN1; -.
DR   H-InvDB; HIX0009241; -.
DR   H-InvDB; HIX0170297; -.
DR   H-InvDB; HIX0170438; -.
DR   HGNC; HGNC:29319; SHTN1.
DR   HPA; HPA037942; -.
DR   HPA; HPA037943; -.
DR   MIM; 611171; gene.
DR   neXtProt; NX_A0MZ66; -.
DR   OpenTargets; ENSG00000187164; -.
DR   PharmGKB; PA134973737; -.
DR   eggNOG; ENOG410IFIH; Eukaryota.
DR   eggNOG; ENOG4111HDU; LUCA.
DR   GeneTree; ENSGT00510000048167; -.
DR   HOGENOM; HOG000154318; -.
DR   HOVERGEN; HBG108488; -.
DR   InParanoid; A0MZ66; -.
DR   OMA; KCNRVSV; -.
DR   OrthoDB; 744654at2759; -.
DR   PhylomeDB; A0MZ66; -.
DR   TreeFam; TF326250; -.
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   ChiTaRS; SHTN1; human.
DR   GenomeRNAi; 57698; -.
DR   PRO; PR:A0MZ66; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000187164; Expressed in 218 organ(s), highest expression level in substantia nigra.
DR   Genevisible; A0MZ66; HS.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0044295; C:axonal growth cone; ISS:UniProtKB.
DR   GO; GO:0031252; C:cell leading edge; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0030175; C:filopodium; ISS:UniProtKB.
DR   GO; GO:0030426; C:growth cone; ISS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IEA:Ensembl.
DR   GO; GO:0005875; C:microtubule associated complex; ISS:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; ISS:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0019894; F:kinesin binding; IEA:Ensembl.
DR   GO; GO:0061573; P:actin filament bundle retrograde transport; ISS:UniProtKB.
DR   GO; GO:0007409; P:axonogenesis; ISS:UniProtKB.
DR   GO; GO:0032488; P:Cdc42 protein signal transduction; ISS:UniProtKB.
DR   GO; GO:0060327; P:cytoplasmic actin-based contraction involved in cell motility; ISS:UniProtKB.
DR   GO; GO:0061163; P:endoplasmic reticulum polarization; ISS:UniProtKB.
DR   GO; GO:0038007; P:netrin-activated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB.
DR   GO; GO:0045773; P:positive regulation of axon extension; ISS:UniProtKB.
DR   GO; GO:2001224; P:positive regulation of neuron migration; IDA:UniProtKB.
DR   GO; GO:0007265; P:Ras protein signal transduction; ISS:UniProtKB.
DR   GO; GO:2000114; P:regulation of establishment of cell polarity; ISS:UniProtKB.
DR   GO; GO:0006930; P:substrate-dependent cell migration, cell extension; ISS:UniProtKB.
DR   InterPro; IPR024849; Shootin-1.
DR   PANTHER; PTHR23213:SF29; PTHR23213:SF29; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell projection; Coiled coil;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Developmental protein;
KW   Direct protein sequencing; Phosphoprotein; Reference proteome.
FT   CHAIN         1    631       Shootin-1.
FT                                /FTId=PRO_0000295740.
FT   COILED        7    353       {ECO:0000255}.
FT   COMPBIAS    353    369       Pro-rich.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000250|UniProtKB:Q8K2Q9}.
FT   MOD_RES       3      3       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8K2Q9}.
FT   MOD_RES       4      4       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     101    101       Phosphoserine; by PAK1.
FT                                {ECO:0000250|UniProtKB:A0MZ67}.
FT   MOD_RES     249    249       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     375    375       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     473    473       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     487    487       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     494    494       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     496    496       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     506    506       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     515    515       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     532    532       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     534    534       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     537    537       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    412       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036497.
FT   VAR_SEQ       1     60       Missing (in isoform 5 and isoform 8).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036498.
FT   VAR_SEQ       1     37       MNSSDEEKQLQLITSLKEQAIGEYEDLRAENQKTKEK ->
FT                                MPRILKQ (in isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036499.
FT   VAR_SEQ     454    456       GTL -> ASQ (in isoform 2).
FT                                {ECO:0000303|PubMed:10997877,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:17030985}.
FT                                /FTId=VSP_027050.
FT   VAR_SEQ     457    631       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10997877,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:17030985}.
FT                                /FTId=VSP_027051.
FT   VAR_SEQ     559    631       Missing (in isoform 4 and isoform 8).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_027052.
FT   VAR_SEQ     623    631       VRETDSSNC -> FFPFHFGFEGVLPLAGVTLSTKARDPK
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_027053.
FT   CONFLICT    399    399       T -> A (in Ref. 4; AC023283).
FT                                {ECO:0000305}.
FT   CONFLICT    417    417       I -> V (in Ref. 2; BAG52345).
FT                                {ECO:0000305}.
SQ   SEQUENCE   631 AA;  71640 MW;  826B88F18151228D CRC64;
     MNSSDEEKQL QLITSLKEQA IGEYEDLRAE NQKTKEKCDK IRQERDEAVK KLEEFQKISH
     MVIEEVNFMQ NHLEIEKTCR ESAEALATKL NKENKTLKRI SMLYMAKLGP DVITEEINID
     DEDSTTDTDG AAETCVSVQC QKQIKELRDQ IVSVQEEKKI LAIELENLKS KLVEVIEEVN
     KVKQEKTVLN SEVLEQRKVL EKCNRVSMLA VEEYEEMQVN LELEKDLRKK AESFAQEMFI
     EQNKLKRQSH LLLQSSIPDQ QLLKALDENA KLTQQLEEER IQHQQKVKEL EEQLENETLH
     KEIHNLKQQL ELLEEDKKEL ELKYQNSEEK ARNLKHSVDE LQKRVNQSEN SVPPPPPPPP
     PLPPPPPNPI RSLMSMIRKR SHPSGSGAKK EKATQPETTE EVTDLKRQAV EEMMDRIKKG
     VHLRPVNQTA RPKTKPESSK GCESAVDELK GILGTLNKST SSRSLKSLDP ENSETELERI
     LRRRKVTAEA DSSSPTGILA TSESKSMPVL GSVSSVTKTA LNKKTLEAEF NSPSPPTPEP
     GEGPRKLEGC TSSKVTFQPP SSIGCRKKYI DGEKQAEPVV VLDPVSTHEP QTKDQVAEKD
     PTQHKEDEGE IQPENKEDSI ENVRETDSSN C
//
ID   A0A024RDT4_HUMAN        Unreviewed;       627 AA.
AC   A0A024RDT4;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   16-JAN-2019, entry version 37.
DE   SubName: Full=Lymphocyte cytosolic protein 1 (L-plastin), isoform CRA_a {ECO:0000313|EMBL:EAX08758.1};
GN   Name=LCP1 {ECO:0000313|EMBL:EAX08758.1};
GN   ORFNames=hCG_2020552 {ECO:0000313|EMBL:EAX08758.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX08758.1};
RN   [1] {ECO:0000313|EMBL:EAX08758.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX08758.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471075; EAX08758.1; -; Genomic_DNA.
DR   RefSeq; NP_002289.2; NM_002298.4.
DR   RefSeq; XP_005266431.1; XM_005266374.1.
DR   UniGene; Hs.381099; -.
DR   UniGene; Hs.658408; -.
DR   ProteinModelPortal; A0A024RDT4; -.
DR   SMR; A0A024RDT4; -.
DR   PRIDE; A0A024RDT4; -.
DR   GeneID; 3936; -.
DR   KEGG; hsa:3936; -.
DR   CTD; 3936; -.
DR   EuPathDB; HostDB:ENSG00000136167.13; -.
DR   eggNOG; KOG0046; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   KO; K17276; -.
DR   OMA; NAFQMTE; -.
DR   OrthoDB; 312506at2759; -.
DR   PhylomeDB; A0A024RDT4; -.
DR   ChiTaRS; LCP1; human.
DR   GenomeRNAi; 3936; -.
DR   Bgee; ENSG00000136167; Expressed in 176 organ(s), highest expression level in blood.
DR   ExpressionAtlas; A0A024RDT4; baseline and differential.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005884; C:actin filament; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0001891; C:phagocytic cup; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0001726; C:ruffle; IEA:Ensembl.
DR   GO; GO:0051015; F:actin filament binding; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0051017; P:actin filament bundle assembly; IEA:Ensembl.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   CDD; cd00014; CH; 2.
DR   CDD; cd00051; EFh; 1.
DR   Gene3D; 1.10.418.10; -; 4.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR039959; Fimbrin/Plastin.
DR   InterPro; IPR039953; LCP-1.
DR   PANTHER; PTHR19961; PTHR19961; 1.
DR   PANTHER; PTHR19961:SF35; PTHR19961:SF35; 1.
DR   Pfam; PF00307; CH; 4.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SMART; SM00033; CH; 4.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS00019; ACTININ_1; 1.
DR   PROSITE; PS00020; ACTININ_2; 2.
DR   PROSITE; PS50021; CH; 4.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   4: Predicted;
KW   Actin-binding {ECO:0000256|SAAS:SAAS00782879};
KW   Calcium {ECO:0000256|PROSITE-ProRule:PRU00448};
KW   Repeat {ECO:0000256|SAAS:SAAS00782917}.
FT   DOMAIN        9     44       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN       49     84       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      120    236       Calponin-homology (CH).
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   DOMAIN      264    375       Calponin-homology (CH).
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   DOMAIN      394    503       Calponin-homology (CH).
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   DOMAIN      515    624       Calponin-homology (CH).
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   CA_BIND      22     33       {ECO:0000256|PROSITE-ProRule:PRU00448}.
FT   CA_BIND      62     73       {ECO:0000256|PROSITE-ProRule:PRU00448}.
SQ   SEQUENCE   627 AA;  70288 MW;  668E4AA6A3FC7B58 CRC64;
     MARGSVSDEE MMELREAFAK VDTDGNGYIS FNELNDLFKA ACLPLPGYRV REITENLMAT
     GDLDQDGRIS FDEFIKIFHG LKSTDVAKTF RKAINKKEGI CAIGGTSEQS SVGTQHSYSE
     EEKYAFVNWI NKALENDPDC RHVIPMNPNT NDLFNAVGDG IVLCKMINLS VPDTIDERTI
     NKKKLTPFTI QENLNLALNS ASAIGCHVVN IGAEDLKEGK PYLVLGLLWQ VIKIGLFADI
     ELSRNEALIA LLREGESLED LMKLSPEELL LRWANYHLEN AGCNKIGNFS TDIKDSKAYY
     HLLEQVAPKG DEEGVPAVVI DMSGLREKDD IQRAECMLQQ AERLGCRQFV TATDVVRGNP
     KLNLAFIANL FNRYPALHKP ENQDIDWGAL EGETREERTF RNWMNSLGVN PRVNHLYSDL
     SDALVIFQLY EKIKVPVDWN RVNKPPYPKL GGNMKKLENC NYAVELGKNQ AKFSLVGIGG
     QDLNEGNRTL TLALIWQLMR RYTLNILEEI GGGQKVNDDI IVNWVNETLR EAKKSSSISS
     FKDPKISTSL PVLDLIDAIQ PGSINYDLLK TENLNDDEKL NNAKYAISMA RKIGARVYAL
     PEDLVEVNPK MVMTVFACLM GKGMKRV
//
ID   PLSL_HUMAN              Reviewed;         627 AA.
AC   P13796; B2R613; B4DUA0; Q5TBN4;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 6.
DT   13-FEB-2019, entry version 216.
DE   RecName: Full=Plastin-2;
DE   AltName: Full=L-plastin;
DE   AltName: Full=LC64P;
DE   AltName: Full=Lymphocyte cytosolic protein 1;
DE            Short=LCP-1;
GN   Name=LCP1; Synonyms=PLS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLU-533.
RX   PubMed=2252891; DOI=10.1021/bi00488a017;
RA   Zu Y., Shigesada K., Nishida E., Kubota I., Kohno M., Hanaoka M.,
RA   Namba Y.;
RT   "65-kilodalton protein phosphorylated by interleukin 2 stimulation
RT   bears two putative actin-binding sites and two calcium-binding
RT   sites.";
RL   Biochemistry 29:8319-8324(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   GLU-533.
RC   TISSUE=Amygdala, and Prostate;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLU-533.
RC   TISSUE=Lymph, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 58-627 (ISOFORM 1), PARTIAL PROTEIN
RP   SEQUENCE, AND VARIANT GLU-533.
RX   PubMed=3211125; DOI=10.1128/MCB.8.11.4659;
RA   Lin C.-S., Aebersold R.H., Kent S.B., Varma M., Leavitt J.;
RT   "Molecular cloning and characterization of plastin, a human leukocyte
RT   protein expressed in transformed human fibroblasts.";
RL   Mol. Cell. Biol. 8:4659-4668(1988).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-140 (ISOFORM 1), AND SEQUENCE
RP   REVISION.
RX   PubMed=2378651; DOI=10.1128/MCB.10.4.1818;
RA   Lin C.-S., Aebersold R.H., Leavitt J.;
RT   "Correction of the N-terminal sequences of the human plastin isoforms
RT   by using anchored polymerase chain reaction: identification of a
RT   potential calcium-binding domain.";
RL   Mol. Cell. Biol. 10:1818-1821(1990).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-14; 20-31; 184-192 AND 534-541, CLEAVAGE OF
RP   INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=T-cell;
RA   Bienvenut W.V., Kanor S., Tissot J.-D., Quadroni M.;
RL   Submitted (MAY-2006) to UniProtKB.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 585-627.
RX   PubMed=8428952;
RA   Lin C.-S., Park T., Chen Z.P., Leavitt J.;
RT   "Human plastin genes. Comparative gene structure, chromosome location,
RT   and differential expression in normal and neoplastic cells.";
RL   J. Biol. Chem. 268:2781-2792(1993).
RN   [10]
RP   PROTEIN SEQUENCE OF 264-283; 517-533 AND 593-609, AND VARIANT GLU-533.
RX   PubMed=2111166; DOI=10.1021/bi00456a030;
RA   Zu Y., Kohno M., Kubota I., Nishida E., Hanaoka M., Namba Y.;
RT   "Characterization of interleukin 2 stimulated 65-kilodalton
RT   phosphoprotein in human T cells.";
RL   Biochemistry 29:1055-1062(1990).
RN   [11]
RP   PROTEIN SEQUENCE OF 590-611, AND TISSUE SPECIFICITY.
RX   PubMed=3261603; DOI=10.1021/bi00410a037;
RA   Matsushima K., Shiroo M., Kung H.F., Copeland T.D.;
RT   "Purification and characterization of a cytosolic 65-kilodalton
RT   phosphoprotein in human leukocytes whose phosphorylation is augmented
RT   by stimulation with interleukin 1.";
RL   Biochemistry 27:3765-3770(1988).
RN   [12]
RP   INVOLVEMENT IN B-CELL NON-HODGKIN LYMPHOMA, AND CHROMOSOMAL
RP   TRANSLOCATION WITH BCL6.
RX   PubMed=10469447;
RX   DOI=10.1002/(SICI)1098-2264(199910)26:2<97::AID-GCC1>3.3.CO;2-0;
RA   Galiegue-Zouitina S., Quief S., Hildebrand M.P., Denis C.,
RA   Detourmignies L., Lai J.L., Kerckaert J.P.;
RT   "Nonrandom fusion of L-plastin(LCP1) and LAZ3(BCL6) genes by
RT   t(3;13)(q27;q14) chromosome translocation in two cases of B-cell non-
RT   Hodgkin lymphoma.";
RL   Genes Chromosomes Cancer 26:97-105(1999).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A.,
RA   Mann M.;
RT   "Proteomic characterization of the human centrosome by protein
RT   correlation profiling.";
RL   Nature 426:570-574(2003).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-124, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [15]
RP   FUNCTION, ACTIN-BINDING, INTERACTION WITH ACTIN FIBERS, SUBCELLULAR
RP   LOCATION, MUTAGENESIS OF SER-5, AND PHOSPHORYLATION AT SER-5.
RX   PubMed=16636079; DOI=10.1242/jcs.02874;
RA   Janji B., Giganti A., De Corte V., Catillon M., Bruyneel E., Lentz D.,
RA   Plastino J., Gettemans J., Friederich E.;
RT   "Phosphorylation on Ser5 increases the F-actin-binding activity of L-
RT   plastin and promotes its targeting to sites of actin assembly in
RT   cells.";
RL   J. Cell Sci. 119:1947-1960(2006).
RN   [16]
RP   SUBCELLULAR LOCATION, FUNCTION, MUTAGENESIS OF SER-5, PHOSPHORYLATION
RP   AT SER-5, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17294403; DOI=10.1002/eji.200636320;
RA   Wabnitz G.H., Koecher T., Lohneis P., Stober C., Konstandin M.H.,
RA   Funk B., Sester U., Wilm M., Klemke M., Samstag Y.;
RT   "Costimulation induced phosphorylation of L-plastin facilitates
RT   surface transport of the T cell activation molecules CD69 and CD25.";
RL   Eur. J. Immunol. 37:649-662(2007).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; TYR-28; SER-30;
RP   SER-257 AND SER-323, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-76; LYS-88; LYS-294;
RP   LYS-297; LYS-361; LYS-472; LYS-542 AND LYS-579, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5; SER-257; SER-290;
RP   THR-291; THR-353; SER-406 AND SER-474, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-406, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [25]
RP   STRUCTURE BY NMR OF 513-627.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the fourth CH domain from human L-plastin.";
RL   Submitted (JUN-2006) to the PDB data bank.
RN   [26]
RP   VARIANT SER-608, CHARACTERIZATION OF VARIANT SER-608, FUNCTION, AND
RP   INTERACTION WITH ACTIN.
RX   PubMed=28493397; DOI=10.1002/humu.23246;
RG   UK10K;
RA   Rainger J., Williamson K.A., Soares D.C., Truch J., Kurian D.,
RA   Gillessen-Kaesbach G., Seawright A., Prendergast J., Halachev M.,
RA   Wheeler A., McTeir L., Gill A.C., van Heyningen V., Davey M.G.,
RA   FitzPatrick D.R.;
RT   "A recurrent de novo mutation in ACTG1 causes isolated ocular
RT   coloboma.";
RL   Hum. Mutat. 38:942-946(2017).
CC   -!- FUNCTION: Actin-binding protein (PubMed:16636079, PubMed:17294403,
CC       PubMed:28493397). Plays a role in the activation of T-cells in
CC       response to costimulation through TCR/CD3 and CD2 or CD28
CC       (PubMed:17294403). Modulates the cell surface expression of
CC       IL2RA/CD25 and CD69 (PubMed:17294403).
CC       {ECO:0000269|PubMed:16636079, ECO:0000269|PubMed:17294403,
CC       ECO:0000269|PubMed:28493397}.
CC   -!- SUBUNIT: Monomer. Interacts with AIF1 (By similarity). Interacts
CC       with actin (PubMed:28493397). {ECO:0000250|UniProtKB:Q61233,
CC       ECO:0000269|PubMed:16636079, ECO:0000269|PubMed:28493397}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:16636079}. Cell junction
CC       {ECO:0000269|PubMed:17294403}. Cell projection
CC       {ECO:0000269|PubMed:16636079}. Cell projection, ruffle membrane
CC       {ECO:0000250|UniProtKB:Q61233, ECO:0000269|PubMed:16636079};
CC       Peripheral membrane protein {ECO:0000250|UniProtKB:Q61233};
CC       Cytoplasmic side {ECO:0000250|UniProtKB:Q61233}. Note=Relocalizes
CC       to the immunological synapse between peripheral blood T-
CC       lymphocytes and antibody-presenting cells in response to
CC       costimulation through TCR/CD3 and CD2 or CD28 (PubMed:17294403).
CC       Associated with the actin cytoskeleton at membrane ruffles.
CC       Relocalizes to actin-rich cell projections upon serine
CC       phosphorylation (PubMed:16636079). {ECO:0000250|UniProtKB:Q61233,
CC       ECO:0000269|PubMed:16636079, ECO:0000269|PubMed:17294403}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P13796-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P13796-2; Sequence=VSP_056450, VSP_056451;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in intestinal microvilli, hair cell
CC       stereocilia, and fibroblast filopodia, in spleen and other lymph
CC       node-containing organs. Expressed in peripheral blood T-
CC       lymphocytes, neutrophils, monocytes, B-lymphocytes, and myeloid
CC       cells. {ECO:0000269|PubMed:3261603}.
CC   -!- PTM: Phosphorylated on a serine residue in response to
CC       costimulation through TCR/CD3 and CD2 or CD28. Serine
CC       phosphorylation promotes association with the actin cytoskeleton
CC       and targeting to peripheral cell projections.
CC       {ECO:0000269|PubMed:16636079, ECO:0000269|PubMed:17294403}.
CC   -!- DISEASE: Note=Chromosomal aberrations involving LCP1 is a cause of
CC       B-cell non-Hodgkin lymphomas (B-cell NHL). Translocation
CC       t(3;13)(q27;q14), with BCL6. {ECO:0000269|PubMed:10469447}.
CC   -!- DISEASE: Note=Defects in LCP1 has been found in a patient with
CC       isolated coloboma, a defect of the eye characterized by the
CC       absence of ocular structures due to abnormal morphogenesis of the
CC       optic cup and stalk, and the fusion of the fetal fissure (optic
CC       fissure). Isolated colobomas may be associated with an abnormally
CC       small eye (microphthalmia) or small cornea.
CC       {ECO:0000269|PubMed:28493397}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/LCP1ID95.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; J02923; AAA63236.1; -; mRNA.
DR   EMBL; AK300556; BAG62262.1; -; mRNA.
DR   EMBL; AK312393; BAG35310.1; -; mRNA.
DR   EMBL; AL137141; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471075; EAX08757.1; -; Genomic_DNA.
DR   EMBL; BC007673; AAH07673.1; -; mRNA.
DR   EMBL; BC010271; AAH10271.1; -; mRNA.
DR   EMBL; M22300; AAB02845.1; -; mRNA.
DR   EMBL; AH002870; AAA59529.1; -; Genomic_DNA.
DR   EMBL; M34426; AAA36184.1; -; mRNA.
DR   CCDS; CCDS9403.1; -. [P13796-1]
DR   PIR; A35836; A35836.
DR   RefSeq; NP_002289.2; NM_002298.4. [P13796-1]
DR   RefSeq; XP_005266431.1; XM_005266374.1. [P13796-1]
DR   UniGene; Hs.381099; -.
DR   UniGene; Hs.658408; -.
DR   PDB; 2D85; NMR; -; A=517-627.
DR   PDB; 5JOJ; NMR; -; A=1-97.
DR   PDB; 5JOL; NMR; -; A=1-82.
DR   PDBsum; 2D85; -.
DR   PDBsum; 5JOJ; -.
DR   PDBsum; 5JOL; -.
DR   ProteinModelPortal; P13796; -.
DR   SMR; P13796; -.
DR   BioGrid; 110128; 23.
DR   DIP; DIP-34767N; -.
DR   ELM; P13796; -.
DR   IntAct; P13796; 10.
DR   MINT; P13796; -.
DR   STRING; 9606.ENSP00000315757; -.
DR   iPTMnet; P13796; -.
DR   PhosphoSitePlus; P13796; -.
DR   SwissPalm; P13796; -.
DR   BioMuta; LCP1; -.
DR   DMDM; 308153685; -.
DR   EPD; P13796; -.
DR   jPOST; P13796; -.
DR   MaxQB; P13796; -.
DR   PaxDb; P13796; -.
DR   PeptideAtlas; P13796; -.
DR   PRIDE; P13796; -.
DR   ProteomicsDB; 52986; -.
DR   DNASU; 3936; -.
DR   Ensembl; ENST00000323076; ENSP00000315757; ENSG00000136167. [P13796-1]
DR   Ensembl; ENST00000398576; ENSP00000381581; ENSG00000136167. [P13796-1]
DR   GeneID; 3936; -.
DR   KEGG; hsa:3936; -.
DR   UCSC; uc001vba.5; human. [P13796-1]
DR   CTD; 3936; -.
DR   DisGeNET; 3936; -.
DR   EuPathDB; HostDB:ENSG00000136167.13; -.
DR   GeneCards; LCP1; -.
DR   H-InvDB; HIX0130592; -.
DR   HGNC; HGNC:6528; LCP1.
DR   HPA; CAB020673; -.
DR   HPA; HPA019493; -.
DR   MIM; 153430; gene.
DR   neXtProt; NX_P13796; -.
DR   OpenTargets; ENSG00000136167; -.
DR   PharmGKB; PA30312; -.
DR   eggNOG; KOG0046; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   GeneTree; ENSGT00940000153719; -.
DR   HOGENOM; HOG000213447; -.
DR   HOVERGEN; HBG003082; -.
DR   InParanoid; P13796; -.
DR   KO; K17276; -.
DR   OMA; NAFQMTE; -.
DR   OrthoDB; 312506at2759; -.
DR   PhylomeDB; P13796; -.
DR   TreeFam; TF300680; -.
DR   Reactome; R-HSA-8950505; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation.
DR   SIGNOR; P13796; -.
DR   ChiTaRS; LCP1; human.
DR   EvolutionaryTrace; P13796; -.
DR   GeneWiki; LCP1; -.
DR   GenomeRNAi; 3936; -.
DR   PRO; PR:P13796; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000136167; Expressed in 176 organ(s), highest expression level in blood.
DR   ExpressionAtlas; P13796; baseline and differential.
DR   Genevisible; P13796; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005884; C:actin filament; IMP:UniProtKB.
DR   GO; GO:0032432; C:actin filament bundle; IMP:UniProtKB.
DR   GO; GO:0030054; C:cell junction; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0030175; C:filopodium; IMP:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IMP:UniProtKB.
DR   GO; GO:0001891; C:phagocytic cup; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0002102; C:podosome; IDA:UniProtKB.
DR   GO; GO:0001726; C:ruffle; IMP:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003779; F:actin binding; NAS:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IMP:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; NAS:UniProtKB.
DR   GO; GO:0051020; F:GTPase binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0005178; F:integrin binding; IPI:ARUK-UCL.
DR   GO; GO:0051017; P:actin filament bundle assembly; IMP:UniProtKB.
DR   GO; GO:0051639; P:actin filament network formation; IBA:GO_Central.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0016477; P:cell migration; IMP:UniProtKB.
DR   GO; GO:0022617; P:extracellular matrix disassembly; IMP:UniProtKB.
DR   GO; GO:0035722; P:interleukin-12-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0071803; P:positive regulation of podosome assembly; IMP:UniProtKB.
DR   GO; GO:0010737; P:protein kinase A signaling; IMP:UniProtKB.
DR   GO; GO:0033157; P:regulation of intracellular protein transport; IDA:UniProtKB.
DR   GO; GO:0002286; P:T cell activation involved in immune response; IDA:UniProtKB.
DR   CDD; cd00014; CH; 2.
DR   CDD; cd00051; EFh; 1.
DR   Gene3D; 1.10.418.10; -; 4.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR039959; Fimbrin/Plastin.
DR   InterPro; IPR039953; LCP-1.
DR   PANTHER; PTHR19961; PTHR19961; 1.
DR   PANTHER; PTHR19961:SF35; PTHR19961:SF35; 1.
DR   Pfam; PF00307; CH; 4.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SMART; SM00033; CH; 4.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS00019; ACTININ_1; 2.
DR   PROSITE; PS00020; ACTININ_2; 2.
DR   PROSITE; PS50021; CH; 4.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing;
KW   Calcium; Cell junction; Cell membrane; Cell projection;
KW   Chromosomal rearrangement; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Disease mutation; Membrane; Metal-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat.
FT   INIT_MET      1      1       Removed. {ECO:0000269|Ref.8}.
FT   CHAIN         2    627       Plastin-2.
FT                                /FTId=PRO_0000073743.
FT   DOMAIN        9     44       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN       49     84       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      120    236       Calponin-homology (CH) 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00044}.
FT   DOMAIN      264    375       Calponin-homology (CH) 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00044}.
FT   DOMAIN      394    503       Calponin-homology (CH) 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00044}.
FT   DOMAIN      515    624       Calponin-homology (CH) 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00044}.
FT   CA_BIND      22     33       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND      62     73       2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   REGION      106    379       Actin-binding 1.
FT   REGION      380    624       Actin-binding 2.
FT   MOD_RES       2      2       N-acetylalanine. {ECO:0000269|Ref.8}.
FT   MOD_RES       5      5       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:16636079,
FT                                ECO:0000269|PubMed:17294403}.
FT   MOD_RES       7      7       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES      28     28       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES      30     30       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES      76     76       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      88     88       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     124    124       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455}.
FT   MOD_RES     257    257       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     290    290       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     291    291       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     294    294       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     297    297       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     323    323       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     353    353       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     361    361       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     406    406       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     472    472       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     474    474       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     542    542       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     579    579       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1     25       MARGSVSDEEMMELREAFAKVDTDG -> MCAEDGDSKFSM
FT                                SISMNSPFLEILH (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056450.
FT   VAR_SEQ      26    456       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056451.
FT   VARIANT      24     24       D -> E.
FT                                /FTId=VAR_001371.
FT   VARIANT     533    533       K -> E (in dbSNP:rs4941543).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2111166,
FT                                ECO:0000269|PubMed:2252891,
FT                                ECO:0000269|PubMed:3211125}.
FT                                /FTId=VAR_024398.
FT   VARIANT     544    544       P -> A (in dbSNP:rs17067725).
FT                                /FTId=VAR_030826.
FT   VARIANT     608    608       N -> S (found in a patient with isolated
FT                                coloboma; increases interaction with
FT                                actin). {ECO:0000269|PubMed:28493397}.
FT                                /FTId=VAR_079850.
FT   MUTAGEN       5      5       S->A: Abolishes phosphorylation and
FT                                reduces the cell surface expression of
FT                                CD69 and IL2RA. Reduces association with
FT                                the actin cytoskeleton.
FT                                {ECO:0000269|PubMed:16636079,
FT                                ECO:0000269|PubMed:17294403}.
FT   MUTAGEN       5      5       S->E: Promotes association with the actin
FT                                cytoskeleton.
FT                                {ECO:0000269|PubMed:16636079,
FT                                ECO:0000269|PubMed:17294403}.
FT   CONFLICT    611    611       M -> T (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX         8     21       {ECO:0000244|PDB:5JOJ}.
FT   STRAND       27     29       {ECO:0000244|PDB:5JOJ}.
FT   HELIX        31     40       {ECO:0000244|PDB:5JOJ}.
FT   HELIX        47     59       {ECO:0000244|PDB:5JOJ}.
FT   STRAND       61     63       {ECO:0000244|PDB:5JOL}.
FT   TURN         64     66       {ECO:0000244|PDB:5JOL}.
FT   HELIX        71     80       {ECO:0000244|PDB:5JOJ}.
FT   HELIX        85     94       {ECO:0000244|PDB:5JOJ}.
FT   HELIX       520    532       {ECO:0000244|PDB:2D85}.
FT   HELIX       545    548       {ECO:0000244|PDB:2D85}.
FT   HELIX       550    559       {ECO:0000244|PDB:2D85}.
FT   TURN        566    568       {ECO:0000244|PDB:2D85}.
FT   HELIX       576    593       {ECO:0000244|PDB:2D85}.
FT   HELIX       601    604       {ECO:0000244|PDB:2D85}.
FT   TURN        605    607       {ECO:0000244|PDB:2D85}.
FT   HELIX       609    612       {ECO:0000244|PDB:2D85}.
FT   HELIX       615    620       {ECO:0000244|PDB:2D85}.
FT   TURN        621    623       {ECO:0000244|PDB:2D85}.
SQ   SEQUENCE   627 AA;  70288 MW;  668E4AA6A3FC7B58 CRC64;
     MARGSVSDEE MMELREAFAK VDTDGNGYIS FNELNDLFKA ACLPLPGYRV REITENLMAT
     GDLDQDGRIS FDEFIKIFHG LKSTDVAKTF RKAINKKEGI CAIGGTSEQS SVGTQHSYSE
     EEKYAFVNWI NKALENDPDC RHVIPMNPNT NDLFNAVGDG IVLCKMINLS VPDTIDERTI
     NKKKLTPFTI QENLNLALNS ASAIGCHVVN IGAEDLKEGK PYLVLGLLWQ VIKIGLFADI
     ELSRNEALIA LLREGESLED LMKLSPEELL LRWANYHLEN AGCNKIGNFS TDIKDSKAYY
     HLLEQVAPKG DEEGVPAVVI DMSGLREKDD IQRAECMLQQ AERLGCRQFV TATDVVRGNP
     KLNLAFIANL FNRYPALHKP ENQDIDWGAL EGETREERTF RNWMNSLGVN PRVNHLYSDL
     SDALVIFQLY EKIKVPVDWN RVNKPPYPKL GGNMKKLENC NYAVELGKNQ AKFSLVGIGG
     QDLNEGNRTL TLALIWQLMR RYTLNILEEI GGGQKVNDDI IVNWVNETLR EAKKSSSISS
     FKDPKISTSL PVLDLIDAIQ PGSINYDLLK TENLNDDEKL NNAKYAISMA RKIGARVYAL
     PEDLVEVNPK MVMTVFACLM GKGMKRV
//
ID   A0A024RDR1_HUMAN        Unreviewed;       200 AA.
AC   A0A024RDR1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   16-JAN-2019, entry version 27.
DE   SubName: Full=Lipoma HMGIC fusion partner, isoform CRA_a {ECO:0000313|EMBL:EAX08617.1};
GN   Name=LHFP {ECO:0000313|EMBL:EAX08617.1};
GN   ORFNames=hCG_32195 {ECO:0000313|EMBL:EAX08617.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX08617.1};
RN   [1] {ECO:0000313|EMBL:EAX08617.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX08617.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471075; EAX08617.1; -; Genomic_DNA.
DR   RefSeq; NP_005771.1; NM_005780.2.
DR   RefSeq; XP_011533163.1; XM_011534861.1.
DR   UniGene; Hs.507798; -.
DR   ProteinModelPortal; A0A024RDR1; -.
DR   PRIDE; A0A024RDR1; -.
DR   GeneID; 10186; -.
DR   KEGG; hsa:10186; -.
DR   CTD; 10186; -.
DR   EuPathDB; HostDB:ENSG00000183722.7; -.
DR   eggNOG; KOG4026; Eukaryota.
DR   eggNOG; ENOG410XSUB; LUCA.
DR   OMA; STEWRIC; -.
DR   OrthoDB; 1383327at2759; -.
DR   PhylomeDB; A0A024RDR1; -.
DR   ChiTaRS; LHFP; human.
DR   GenomeRNAi; 10186; -.
DR   Bgee; ENSG00000183722; Expressed in 231 organ(s), highest expression level in female reproductive system.
DR   ExpressionAtlas; A0A024RDR1; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR019372; LHFPL.
DR   PANTHER; PTHR12489; PTHR12489; 1.
DR   Pfam; PF10242; L_HMGIC_fpl; 1.
PE   4: Predicted;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     21       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        22    200       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001536767.
FT   TRANSMEM     87    108       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    120    141       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    168    190       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   200 AA;  21598 MW;  49D1161602966423 CRC64;
     MASSLTCTGV IWALLSFLCA ATSCVGFFMP YWLWGSQLGK PVSFGTFRRC SYPVHDESRQ
     MMVMVEECGR YASFQGIPSA EWRICTIVTG LGCGLLLLVA LTALMGCCVS DLISRTVGRV
     AGGIQFLGGL LIGAGCALYP LGWDSEEVRQ TCGYTSGQFD LGKCEIGWAY YCTGAGATAA
     MLLCTWLACF SGKKQKHYPY
//
ID   LHPL6_HUMAN             Reviewed;         200 AA.
AC   Q9Y693; B2R7M2; Q53FC0; Q96SH5;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   13-FEB-2019, entry version 126.
DE   RecName: Full=LHFPL tetraspan subfamily member 6 protein {ECO:0000312|HGNC:HGNC:6586};
DE   AltName: Full=Lipoma HMGIC fusion partner {ECO:0000312|HGNC:HGNC:6586};
DE   Flags: Precursor;
GN   Name=LHFPL6 {ECO:0000312|HGNC:HGNC:6586};
GN   Synonyms=LHFP {ECO:0000312|HGNC:HGNC:6586};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DISEASE.
RX   PubMed=10329012; DOI=10.1006/geno.1999.5778;
RA   Petit M.M.R., Schoenmakers E.F.P.M., Huysmans C., Geurts J.M.W.,
RA   Mandahl N., Van de Ven W.J.M.;
RT   "LHFP, a novel translocation partner gene of HMGIC in a lipoma, is a
RT   member of a new family of LHFP-like genes.";
RL   Genomics 57:438-441(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 141-200.
RC   TISSUE=Dermoid cancer;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Pancreas, kidney, skeletal muscle, liver, lung
CC       brain, heart, colon, small intestine, uterus, testis, prostate,
CC       thymus, spleen and placenta. {ECO:0000269|PubMed:10329012}.
CC   -!- DISEASE: Note=A chromosomal aberration involving LHFP is
CC       associated with a subclass of benign mesenchymal tumors known as
CC       lipomas. Translocation t(12;13)(q13-q15;q12) with HMGA2 is shown
CC       in lipomas. {ECO:0000269|PubMed:10329012}.
CC   -!- SIMILARITY: Belongs to the LHFP family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/LHFPID248ch13q12.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF098807; AAD31386.1; -; mRNA.
DR   EMBL; AL138685; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136358; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL158194; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471075; EAX08616.1; -; Genomic_DNA.
DR   EMBL; BC017824; AAH17824.1; -; mRNA.
DR   EMBL; AK223369; BAD97089.1; -; mRNA.
DR   EMBL; AK313036; BAG35869.1; -; mRNA.
DR   CCDS; CCDS9369.1; -.
DR   RefSeq; NP_005771.1; NM_005780.2.
DR   RefSeq; XP_011533163.1; XM_011534861.1.
DR   UniGene; Hs.507798; -.
DR   ProteinModelPortal; Q9Y693; -.
DR   STRING; 9606.ENSP00000368908; -.
DR   TCDB; 1.A.82.1.6; the lhfpl tetraspan protein (ltsp) family.
DR   iPTMnet; Q9Y693; -.
DR   PhosphoSitePlus; Q9Y693; -.
DR   SwissPalm; Q9Y693; -.
DR   BioMuta; LHFPL6; -.
DR   DMDM; 74753519; -.
DR   jPOST; Q9Y693; -.
DR   MaxQB; Q9Y693; -.
DR   PaxDb; Q9Y693; -.
DR   PeptideAtlas; Q9Y693; -.
DR   PRIDE; Q9Y693; -.
DR   ProteomicsDB; 86627; -.
DR   DNASU; 10186; -.
DR   Ensembl; ENST00000379589; ENSP00000368908; ENSG00000183722.
DR   Ensembl; ENST00000648377; ENSP00000496801; ENSG00000183722.
DR   GeneID; 10186; -.
DR   KEGG; hsa:10186; -.
DR   UCSC; uc001uxf.4; human.
DR   CTD; 10186; -.
DR   DisGeNET; 10186; -.
DR   EuPathDB; HostDB:ENSG00000183722.7; -.
DR   GeneCards; LHFPL6; -.
DR   HGNC; HGNC:6586; LHFPL6.
DR   HPA; HPA058975; -.
DR   MIM; 606710; gene.
DR   neXtProt; NX_Q9Y693; -.
DR   OpenTargets; ENSG00000183722; -.
DR   PharmGKB; PA30358; -.
DR   eggNOG; KOG4026; Eukaryota.
DR   eggNOG; ENOG410XSUB; LUCA.
DR   GeneTree; ENSGT00940000154316; -.
DR   HOGENOM; HOG000007007; -.
DR   HOVERGEN; HBG080585; -.
DR   InParanoid; Q9Y693; -.
DR   OMA; STEWRIC; -.
DR   OrthoDB; 1383327at2759; -.
DR   PhylomeDB; Q9Y693; -.
DR   TreeFam; TF321143; -.
DR   ChiTaRS; LHFP; human.
DR   GeneWiki; LHFP; -.
DR   GenomeRNAi; 10186; -.
DR   PRO; PR:Q9Y693; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000183722; Expressed in 231 organ(s), highest expression level in female reproductive system.
DR   ExpressionAtlas; Q9Y693; baseline and differential.
DR   Genevisible; Q9Y693; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR019372; LHFPL.
DR   PANTHER; PTHR12489; PTHR12489; 1.
DR   Pfam; PF10242; L_HMGIC_fpl; 1.
PE   2: Evidence at transcript level;
KW   Chromosomal rearrangement; Complete proteome; Membrane;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    200       LHFPL tetraspan subfamily member 6
FT                                protein.
FT                                /FTId=PRO_0000244756.
FT   TRANSMEM     84    104       Helical. {ECO:0000255}.
FT   TRANSMEM    123    143       Helical. {ECO:0000255}.
FT   TRANSMEM    166    186       Helical. {ECO:0000255}.
SQ   SEQUENCE   200 AA;  21598 MW;  49D1161602966423 CRC64;
     MASSLTCTGV IWALLSFLCA ATSCVGFFMP YWLWGSQLGK PVSFGTFRRC SYPVHDESRQ
     MMVMVEECGR YASFQGIPSA EWRICTIVTG LGCGLLLLVA LTALMGCCVS DLISRTVGRV
     AGGIQFLGGL LIGAGCALYP LGWDSEEVRQ TCGYTSGQFD LGKCEIGWAY YCTGAGATAA
     MLLCTWLACF SGKKQKHYPY
//
ID   LS14A_HUMAN             Reviewed;         463 AA.
AC   Q8ND56; B4DTG6; Q76LX7; Q96AR3; Q96K73; Q96SN5; Q9UFR3;
DT   02-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   02-AUG-2005, sequence version 3.
DT   13-FEB-2019, entry version 146.
DE   RecName: Full=Protein LSM14 homolog A;
DE   AltName: Full=Protein FAM61A;
DE   AltName: Full=Protein SCD6 homolog;
DE   AltName: Full=Putative alpha-synuclein-binding protein;
DE            Short=AlphaSNBP;
DE   AltName: Full=RNA-associated protein 55A;
DE            Short=hRAP55;
DE            Short=hRAP55A;
GN   Name=LSM14A; Synonyms=C19orf13, FAM61A, RAP55, RAP55A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RA   Takeda K., Araki W., Tabira T.;
RT   "Possible alpha synuclein binding protein.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   GLN-238.
RC   TISSUE=Mammary gland, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLN-238.
RC   TISSUE=Brain, and Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17074753; DOI=10.1074/jbc.M609059200;
RA   Tanaka K.J., Ogawa K., Takagi M., Imamoto N., Matsumoto K.,
RA   Tsujimoto M.;
RT   "RAP55, a cytoplasmic mRNP component, represses translation in Xenopus
RT   oocytes.";
RL   J. Biol. Chem. 281:40096-40106(2006).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DOMAIN.
RX   PubMed=16484376; DOI=10.1261/rna.2302706;
RA   Yang W.H., Yu J.H., Gulick T., Bloch K.D., Bloch D.B.;
RT   "RNA-associated protein 55 (RAP55) localizes to mRNA processing bodies
RT   and stress granules.";
RL   RNA 12:547-554(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-182; SER-183; SER-192;
RP   THR-194 AND SER-216, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   REVIEW.
RX   PubMed=18723115; DOI=10.1016/j.biocel.2008.06.015;
RA   Marnef A., Sommerville J., Ladomery M.R.;
RT   "RAP55: insights into an evolutionarily conserved protein family.";
RL   Int. J. Biochem. Cell Biol. 41:977-981(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183; SER-192 AND
RP   SER-216, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-192 AND SER-216, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-178; SER-183; SER-192;
RP   SER-216 AND SER-227, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Essential for formation of P-bodies, cytoplasmic
CC       structures that provide storage sites for non-translating mRNAs.
CC       {ECO:0000269|PubMed:16484376, ECO:0000269|PubMed:17074753}.
CC   -!- SUBUNIT: Component of a ribonucleoprotein (RNP) complex.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, P-body
CC       {ECO:0000269|PubMed:16484376, ECO:0000269|PubMed:17074753}.
CC       Cytoplasm, Stress granule {ECO:0000269|PubMed:16484376}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=AlphaSNBP(A);
CC         IsoId=Q8ND56-1; Sequence=Displayed;
CC       Name=2; Synonyms=AlphaSNBP(B);
CC         IsoId=Q8ND56-2; Sequence=VSP_014650;
CC       Name=3;
CC         IsoId=Q8ND56-3; Sequence=VSP_057232;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The LSM14 domain and the RGG repeats are required for
CC       accumulation in P-bodies, and the region containing the FDF motif
CC       is responsible for cytoplasmic retention.
CC       {ECO:0000269|PubMed:16484376}.
CC   -!- SIMILARITY: Belongs to the LSM14 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB55066.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AB069974; BAC99045.1; -; mRNA.
DR   EMBL; AB069975; BAC99046.1; -; mRNA.
DR   EMBL; AK027369; BAB55066.1; ALT_INIT; mRNA.
DR   EMBL; AK027643; BAB55259.1; -; mRNA.
DR   EMBL; AK300208; BAG61978.1; -; mRNA.
DR   EMBL; AL834398; CAD39060.2; -; mRNA.
DR   EMBL; AL117499; CAB55964.1; -; mRNA.
DR   EMBL; AC010614; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC016842; AAH16842.1; -; mRNA.
DR   CCDS; CCDS12435.1; -. [Q8ND56-2]
DR   CCDS; CCDS46040.1; -. [Q8ND56-1]
DR   PIR; T17274; T17274.
DR   RefSeq; NP_001107565.1; NM_001114093.1. [Q8ND56-1]
DR   RefSeq; NP_056393.2; NM_015578.2. [Q8ND56-2]
DR   UniGene; Hs.744009; -.
DR   PDB; 6F9W; X-ray; 2.62 A; A=1-84.
DR   PDBsum; 6F9W; -.
DR   ProteinModelPortal; Q8ND56; -.
DR   SMR; Q8ND56; -.
DR   BioGrid; 117527; 24.
DR   IntAct; Q8ND56; 9.
DR   MINT; Q8ND56; -.
DR   STRING; 9606.ENSP00000413964; -.
DR   iPTMnet; Q8ND56; -.
DR   PhosphoSitePlus; Q8ND56; -.
DR   BioMuta; LSM14A; -.
DR   EPD; Q8ND56; -.
DR   jPOST; Q8ND56; -.
DR   MaxQB; Q8ND56; -.
DR   PaxDb; Q8ND56; -.
DR   PeptideAtlas; Q8ND56; -.
DR   PRIDE; Q8ND56; -.
DR   ProteomicsDB; 72979; -.
DR   ProteomicsDB; 72980; -. [Q8ND56-2]
DR   Ensembl; ENST00000433627; ENSP00000413964; ENSG00000257103. [Q8ND56-1]
DR   Ensembl; ENST00000540746; ENSP00000446451; ENSG00000257103. [Q8ND56-3]
DR   Ensembl; ENST00000544216; ENSP00000446271; ENSG00000257103. [Q8ND56-2]
DR   Ensembl; ENST00000570462; ENSP00000459843; ENSG00000262860. [Q8ND56-1]
DR   Ensembl; ENST00000575811; ENSP00000461225; ENSG00000262860. [Q8ND56-2]
DR   GeneID; 26065; -.
DR   KEGG; hsa:26065; -.
DR   UCSC; uc002nva.5; human. [Q8ND56-1]
DR   CTD; 26065; -.
DR   DisGeNET; 26065; -.
DR   EuPathDB; HostDB:ENSG00000257103.8; -.
DR   GeneCards; LSM14A; -.
DR   HGNC; HGNC:24489; LSM14A.
DR   HPA; HPA017961; -.
DR   MIM; 610677; gene.
DR   neXtProt; NX_Q8ND56; -.
DR   OpenTargets; ENSG00000257103; -.
DR   PharmGKB; PA134989467; -.
DR   eggNOG; KOG1073; Eukaryota.
DR   eggNOG; ENOG41122RA; LUCA.
DR   GeneTree; ENSGT00940000154415; -.
DR   HOGENOM; HOG000231251; -.
DR   HOVERGEN; HBG054326; -.
DR   InParanoid; Q8ND56; -.
DR   KO; K18749; -.
DR   OMA; VYSMGTE; -.
DR   OrthoDB; 1569369at2759; -.
DR   PhylomeDB; Q8ND56; -.
DR   TreeFam; TF313514; -.
DR   ChiTaRS; LSM14A; human.
DR   GenomeRNAi; 26065; -.
DR   PRO; PR:Q8ND56; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000257103; Expressed in 236 organ(s), highest expression level in female gonad.
DR   ExpressionAtlas; Q8ND56; baseline and differential.
DR   Genevisible; Q8ND56; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:HPA.
DR   GO; GO:0010494; C:cytoplasmic stress granule; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000932; C:P-body; IDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IEA:Ensembl.
DR   GO; GO:0003725; F:double-stranded RNA binding; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:Ensembl.
DR   GO; GO:0033962; P:cytoplasmic mRNA processing body assembly; IDA:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0006417; P:regulation of translation; IEA:UniProtKB-KW.
DR   GO; GO:0039529; P:RIG-I signaling pathway; IEA:Ensembl.
DR   CDD; cd01736; LSm14_N; 1.
DR   InterPro; IPR025762; DFDF.
DR   InterPro; IPR019050; FDF_dom.
DR   InterPro; IPR025761; FFD_box.
DR   InterPro; IPR025609; Lsm14-like_N.
DR   InterPro; IPR010920; LSM_dom_sf.
DR   InterPro; IPR025768; TFG_box.
DR   Pfam; PF09532; FDF; 1.
DR   Pfam; PF12701; LSM14; 1.
DR   SMART; SM01199; FDF; 1.
DR   SMART; SM01271; LSM14; 1.
DR   SUPFAM; SSF50182; SSF50182; 1.
DR   PROSITE; PS51512; DFDF; 1.
DR   PROSITE; PS51513; FFD; 1.
DR   PROSITE; PS51536; TFG; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Developmental protein; Methylation; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repressor; Ribonucleoprotein;
KW   Translation regulation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895}.
FT   CHAIN         2    463       Protein LSM14 homolog A.
FT                                /FTId=PRO_0000187090.
FT   DOMAIN      284    320       DFDF. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00845}.
FT   MOTIF       361    377       FFD box.
FT   MOTIF       380    400       TFG box.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895}.
FT   MOD_RES     178    178       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     182    182       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     183    183       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     192    192       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     194    194       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     216    216       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19367720,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     227    227       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     401    401       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:Q8K2F8}.
FT   VAR_SEQ     139    179       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057232.
FT   VAR_SEQ     458    463       TTAFGP -> DNKVAA (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_014650.
FT   VARIANT     238    238       R -> Q (in dbSNP:rs36006556).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_057532.
FT   VARIANT     448    448       R -> Q (in dbSNP:rs2274896).
FT                                /FTId=VAR_022884.
FT   CONFLICT     17     17       K -> Q (in Ref. 3; CAD39060).
FT                                {ECO:0000305}.
FT   STRAND       11     16       {ECO:0000244|PDB:6F9W}.
FT   STRAND       21     30       {ECO:0000244|PDB:6F9W}.
FT   TURN         31     34       {ECO:0000244|PDB:6F9W}.
FT   STRAND       35     46       {ECO:0000244|PDB:6F9W}.
FT   STRAND       61     68       {ECO:0000244|PDB:6F9W}.
FT   HELIX        69     71       {ECO:0000244|PDB:6F9W}.
FT   STRAND       72     77       {ECO:0000244|PDB:6F9W}.
SQ   SEQUENCE   463 AA;  50530 MW;  703BE8E8C54799DF CRC64;
     MSGGTPYIGS KISLISKAEI RYEGILYTID TENSTVALAK VRSFGTEDRP TDRPIPPRDE
     VFEYIIFRGS DIKDLTVCEP PKPQCSLPQD PAIVQSSLGS STSSFQSMGS YGPFGRMPTY
     SQFSPSSLVG QQFGAVGVAG SSLTSFGTET SNSGTLPQSS AVGSAFTQDT RSLKTQLSQG
     RSSPQLDPLR KSPTMEQAVQ TASAHLPAPA AVGRRSPVST RPLPSASQKA GENQEHRRAE
     VHKVSRPENE QLRNDNKRQV APGAPSAPRR GRGGHRGGRG RFGIRRDGPM KFEKDFDFES
     ANAQFNKEEI DREFHNKLKL KEDKLEKQEK PVNGEDKGDS GVDTQNSEGN ADEEDPLGPN
     CYYDKTKSFF DNISCDDNRE RRPTWAEERR LNAETFGIPL RPNRGRGGYR GRGGLGFRGG
     RGRGGGRGGT FTAPRGFRGG FRGGRGGREF ADFEYRKTTA FGP
//
ID   A0A024RAF8_HUMAN        Unreviewed;       140 AA.
AC   A0A024RAF8;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   16-JAN-2019, entry version 25.
DE   SubName: Full=HCG2036965, isoform CRA_a {ECO:0000313|EMBL:EAW95064.1};
GN   ORFNames=hCG_2036965 {ECO:0000313|EMBL:EAW95064.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW95064.1};
RN   [1] {ECO:0000313|EMBL:EAW95064.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW95064.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471134; EAW95063.1; -; Genomic_DNA.
DR   EMBL; CH471134; EAW95064.1; -; Genomic_DNA.
DR   RefSeq; NP_001335004.1; NM_001348075.1.
DR   UniGene; Hs.523369; -.
DR   GeneID; 259283; -.
DR   KEGG; hsa:259283; -.
DR   CTD; 259283; -.
DR   EuPathDB; HostDB:ENSG00000197880.8; -.
DR   eggNOG; ENOG410KF2D; Eukaryota.
DR   eggNOG; ENOG4110NT4; LUCA.
DR   OMA; FPPCEDP; -.
DR   OrthoDB; 1377081at2759; -.
DR   Bgee; ENSG00000197880; Expressed in 74 organ(s), highest expression level in blood.
PE   4: Predicted;
SQ   SEQUENCE   140 AA;  15384 MW;  839BC22233659334 CRC64;
     MLQAADFIER TETAGELSRG LIGVLSSQIS WCLLNVNLSK LPTRLQRLSC SVLNSSPAMR
     GGARGRPQLT LERPLRPGCR LHSCSEAEKG GFVRRKEIIL FPPCEDPARG WLSANPGREP
     SPGICWHLNL GLPSLHNCEE
//
ID   MDS2_HUMAN              Reviewed;         140 AA.
AC   Q8NDY4;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   13-FEB-2019, entry version 86.
DE   RecName: Full=Myelodysplastic syndrome 2 translocation-associated protein;
GN   Name=MDS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND CHROMOSOMAL
RP   TRANSLOCATION WITH ETV6.
RX   PubMed=12203785; DOI=10.1002/gcc.10090;
RA   Odero M.D., Vizmanos J.L., Roman J.P., Lahortiga I., Panizo C.,
RA   Calasanz M.J., Zeleznik-Le N.J., Rowley J.D., Novo F.J.;
RT   "A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a
RT   patient with myelodysplastic syndrome.";
RL   Genes Chromosomes Cancer 35:11-19(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
CC   -!- TISSUE SPECIFICITY: Highly expressed in peripheral blood
CC       leukocytes, spleen, thymus, kidney, pancreas and lung.
CC       {ECO:0000269|PubMed:12203785}.
CC   -!- DISEASE: Note=A chromosomal aberration involving MDS2 is a cause
CC       of myelodysplastic syndrome (MDS). Translocation
CC       t(1;12)(p36.1;p13) with ETV6. {ECO:0000269|PubMed:12203785}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MDS2ID476.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ310434; CAD27416.1; -; mRNA.
DR   EMBL; AL451000; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001335004.1; NM_001348075.1.
DR   UniGene; Hs.523369; -.
DR   ProteinModelPortal; Q8NDY4; -.
DR   STRING; 9606.ENSP00000363683; -.
DR   BioMuta; MDS2; -.
DR   DMDM; 74751237; -.
DR   PaxDb; Q8NDY4; -.
DR   PeptideAtlas; Q8NDY4; -.
DR   PRIDE; Q8NDY4; -.
DR   ProteomicsDB; 73091; -.
DR   GeneID; 259283; -.
DR   KEGG; hsa:259283; -.
DR   UCSC; uc057dgf.1; human.
DR   CTD; 259283; -.
DR   DisGeNET; 259283; -.
DR   EuPathDB; HostDB:ENSG00000197880.8; -.
DR   GeneCards; MDS2; -.
DR   H-InvDB; HIX0028629; -.
DR   HGNC; HGNC:29633; MDS2.
DR   HPA; HPA052999; -.
DR   MIM; 607305; gene.
DR   neXtProt; NX_Q8NDY4; -.
DR   eggNOG; ENOG410KF2D; Eukaryota.
DR   eggNOG; ENOG4110NT4; LUCA.
DR   HOGENOM; HOG000113512; -.
DR   InParanoid; Q8NDY4; -.
DR   OMA; FPPCEDP; -.
DR   OrthoDB; 1377081at2759; -.
DR   PhylomeDB; Q8NDY4; -.
DR   ChiTaRS; MDS2; human.
DR   PRO; PR:Q8NDY4; -.
DR   Proteomes; UP000005640; Unplaced.
DR   Bgee; ENSG00000197880; Expressed in 74 organ(s), highest expression level in blood.
DR   Genevisible; Q8NDY4; HS.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
PE   2: Evidence at transcript level;
KW   Chromosomal rearrangement; Complete proteome; Proto-oncogene;
KW   Reference proteome.
FT   CHAIN         1    140       Myelodysplastic syndrome 2 translocation-
FT                                associated protein.
FT                                /FTId=PRO_0000252477.
SQ   SEQUENCE   140 AA;  15384 MW;  839BC22233659334 CRC64;
     MLQAADFIER TETAGELSRG LIGVLSSQIS WCLLNVNLSK LPTRLQRLSC SVLNSSPAMR
     GGARGRPQLT LERPLRPGCR LHSCSEAEKG GFVRRKEIIL FPPCEDPARG WLSANPGREP
     SPGICWHLNL GLPSLHNCEE
//
ID   MNX1_HUMAN              Reviewed;         401 AA.
AC   P50219; F5H401; Q9Y648;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 3.
DT   13-FEB-2019, entry version 161.
DE   RecName: Full=Motor neuron and pancreas homeobox protein 1;
DE   AltName: Full=Homeobox protein HB9;
GN   Name=MNX1; Synonyms=HLXB9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=7914194;
RA   Harrison K.A., Druey K.M., Deguchi Y., Tuscano J.M., Kehrl J.H.;
RT   "A novel human homeobox gene distantly related to proboscipedia is
RT   expressed in lymphoid and pancreatic tissues.";
RL   J. Biol. Chem. 269:19968-19975(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-353 (ISOFORM 1).
RX   PubMed=10329000; DOI=10.1006/geno.1999.5796;
RA   Heus H.C., Hing A., van Baren M.J., Joosse M., Breedveld G.J.,
RA   Wang J.C., Burgess A., Donnis-Keller H., Berglund C., Zguricas J.,
RA   Scherer S.W., Rommens J.M., Oostra B.A., Heutink P.;
RT   "A physical and transcriptional map of the preaxial polydactyly locus
RT   on chromosome 7q36.";
RL   Genomics 57:342-351(1999).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77 AND SER-79, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   VARIANTS CURRAS SER-246 AND TRP-293.
RX   PubMed=10631160; DOI=10.1086/302723;
RA   Belloni E., Martucciello G., Verderio D., Ponti E., Seri M.,
RA   Jasonni V., Torre M., Ferrari M., Tsui L.-C., Scherer S.W.;
RT   "Involvement of the HLXB9 homeobox gene in Currarino syndrome.";
RL   Am. J. Hum. Genet. 66:312-319(2000).
RN   [8]
RP   VARIANTS CURRAS HIS-245; GLY-245; GLY-288; LEU-288; PRO-290; TRP-292
RP   AND GLN-293.
RX   PubMed=10749657; DOI=10.1086/302899;
RA   Hagan D.M., Ross A.J., Strachan T., Lynch S.A., Ruiz-Perez V.,
RA   Wang Y.M., Scambler P., Custard E., Reardon W., Hassan S., Nixon P.,
RA   Papapetrou C., Winter R.M., Edwards Y., Morrison K., Barrow M.,
RA   Cordier-Alex M.P., Correia P., Galvin-Parton P.A., Gaskill S.,
RA   Gaskin K.J., Garcia-Minaur S., Gereige R., Hayward R., Homfray T.,
RA   McKeown C., Murday V., Plauchu H., Shannon N., Spitz L., Lindsay S.;
RT   "Mutation analysis and embryonic expression of the HLXB9 Currarino
RT   syndrome gene.";
RL   Am. J. Hum. Genet. 66:1504-1515(2000).
RN   [9]
RP   ERRATUM.
RA   Hagan D.M., Ross A.J., Strachan T., Lynch S.A., Ruiz-Perez V.,
RA   Wang Y.M., Scambler P., Custard E., Reardon W., Hassan S., Nixon P.,
RA   Papapetrou C., Winter R.M., Edwards Y., Morrison K., Barrow M.,
RA   Cordier-Alex M.P., Correia P., Galvin-Parton P.A., Gaskill S.,
RA   Gaskin K.J., Garcia-Minaur S., Gereige R., Hayward R., Homfray T.,
RA   McKeown C., Murday V., Plauchu H., Shannon N., Spitz L., Lindsay S.;
RL   Am. J. Hum. Genet. 67:769-769(2000).
RN   [10]
RP   VARIANTS CURRAS TRP-243 AND GLY-288.
RX   PubMed=19853743; DOI=10.1016/j.jpedsurg.2009.03.039;
RA   Garcia-Barcelo M.M., Lui V.C., So M.T., Miao X., Leon T.Y., Yuan Z.W.,
RA   Ngan E.S., Ehsan T., Chung P.H., Khong P.L., Wong K.K., Tam P.K.;
RT   "MNX1 (HLXB9) mutations in Currarino patients.";
RL   J. Pediatr. Surg. 44:1892-1898(2009).
RN   [11]
RP   VARIANT CURRAS SER-289.
RX   PubMed=22820079; DOI=10.1016/j.gene.2012.06.096;
RA   Markljung E., Adamovic T., Cao J., Naji H., Kaiser S., Wester T.,
RA   Nordenskjold A.;
RT   "Novel mutations in the MNX1 gene in two families with Currarino
RT   syndrome and variable phenotype.";
RL   Gene 507:50-53(2012).
CC   -!- FUNCTION: Putative transcription factor involved in pancreas
CC       development and function.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P50219-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P50219-2; Sequence=VSP_046773, VSP_046774;
CC         Note=Gene prediction based on EST data.;
CC   -!- TISSUE SPECIFICITY: Expressed in lymphoid and pancreatic tissues.
CC   -!- DISEASE: Currarino syndrome (CURRAS) [MIM:176450]: The triad of a
CC       presacral tumor, sacral agenesis and anorectal malformation
CC       constitutes the Currarino syndrome which is caused by dorsal-
CC       ventral patterning defects during embryonic development. The
CC       syndrome occurs in the majority of patients as an autosomal
CC       dominant trait. {ECO:0000269|PubMed:10631160,
CC       ECO:0000269|PubMed:10749657, ECO:0000269|PubMed:19853743,
CC       ECO:0000269|PubMed:22820079}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/HLXB9ID393.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U07664; AAB60647.1; -; Genomic_DNA.
DR   EMBL; U07663; AAB60647.1; JOINED; Genomic_DNA.
DR   EMBL; AC006357; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AH007909; AAD41467.1; -; Genomic_DNA.
DR   CCDS; CCDS34788.1; -. [P50219-1]
DR   CCDS; CCDS55187.1; -. [P50219-2]
DR   RefSeq; NP_001158727.1; NM_001165255.1. [P50219-2]
DR   RefSeq; NP_005506.3; NM_005515.3. [P50219-1]
DR   UniGene; Hs.37035; -.
DR   ProteinModelPortal; P50219; -.
DR   SMR; P50219; -.
DR   BioGrid; 109355; 3.
DR   IntAct; P50219; 2.
DR   STRING; 9606.ENSP00000252971; -.
DR   iPTMnet; P50219; -.
DR   PhosphoSitePlus; P50219; -.
DR   BioMuta; MNX1; -.
DR   DMDM; 259016336; -.
DR   EPD; P50219; -.
DR   jPOST; P50219; -.
DR   MaxQB; P50219; -.
DR   PaxDb; P50219; -.
DR   PeptideAtlas; P50219; -.
DR   PRIDE; P50219; -.
DR   ProteomicsDB; 56203; -.
DR   DNASU; 3110; -.
DR   Ensembl; ENST00000252971; ENSP00000252971; ENSG00000130675. [P50219-1]
DR   Ensembl; ENST00000543409; ENSP00000438552; ENSG00000130675. [P50219-2]
DR   GeneID; 3110; -.
DR   KEGG; hsa:3110; -.
DR   UCSC; uc003wnc.1; human. [P50219-1]
DR   CTD; 3110; -.
DR   DisGeNET; 3110; -.
DR   EuPathDB; HostDB:ENSG00000130675.14; -.
DR   GeneCards; MNX1; -.
DR   H-InvDB; HIX0033536; -.
DR   HGNC; HGNC:4979; MNX1.
DR   HPA; HPA071717; -.
DR   MalaCards; MNX1; -.
DR   MIM; 142994; gene.
DR   MIM; 176450; phenotype.
DR   neXtProt; NX_P50219; -.
DR   OpenTargets; ENSG00000130675; -.
DR   Orphanet; 1552; Currarino syndrome.
DR   PharmGKB; PA162396041; -.
DR   eggNOG; KOG0489; Eukaryota.
DR   eggNOG; ENOG410ZTBY; LUCA.
DR   GeneTree; ENSGT00940000160059; -.
DR   HOGENOM; HOG000234345; -.
DR   HOVERGEN; HBG051910; -.
DR   InParanoid; P50219; -.
DR   KO; K08025; -.
DR   OrthoDB; 1327265at2759; -.
DR   PhylomeDB; P50219; -.
DR   TreeFam; TF351530; -.
DR   SIGNOR; P50219; -.
DR   GeneWiki; MNX1; -.
DR   GenomeRNAi; 3110; -.
DR   PRO; PR:P50219; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000130675; Expressed in 84 organ(s), highest expression level in body of pancreas.
DR   ExpressionAtlas; P50219; baseline and differential.
DR   Genevisible; P50219; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0031018; P:endocrine pancreas development; IBA:GO_Central.
DR   GO; GO:0006959; P:humoral immune response; TAS:ProtInc.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:ProtInc.
DR   GO; GO:0021520; P:spinal cord motor neuron cell fate specification; IBA:GO_Central.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   Pfam; PF00046; Homeodomain; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; DNA-binding; Homeobox; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN         1    401       Motor neuron and pancreas homeobox
FT                                protein 1.
FT                                /FTId=PRO_0000048905.
FT   DNA_BIND    241    300       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   COMPBIAS     35     38       Poly-Ala.
FT   COMPBIAS     40     49       Poly-Gly.
FT   COMPBIAS     98    112       Poly-Gly.
FT   COMPBIAS    121    134       Poly-Ala.
FT   COMPBIAS    168    176       Poly-Ala.
FT   COMPBIAS    315    324       Poly-Gly.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES      77     77       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      79     79       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    212       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_046773.
FT   VAR_SEQ     213    231       WLRASTAGMILPKMPDFNS -> MGGLSTVGACPGILGAQQ
FT                                A (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_046774.
FT   VARIANT     243    243       R -> W (in CURRAS).
FT                                {ECO:0000269|PubMed:19853743}.
FT                                /FTId=VAR_068473.
FT   VARIANT     245    245       R -> G (in CURRAS).
FT                                {ECO:0000269|PubMed:10749657}.
FT                                /FTId=VAR_017874.
FT   VARIANT     245    245       R -> H (in CURRAS).
FT                                {ECO:0000269|PubMed:10749657}.
FT                                /FTId=VAR_017875.
FT   VARIANT     246    246       T -> S (in CURRAS; dbSNP:rs121912548).
FT                                {ECO:0000269|PubMed:10631160}.
FT                                /FTId=VAR_017876.
FT   VARIANT     288    288       W -> G (in CURRAS).
FT                                {ECO:0000269|PubMed:10749657,
FT                                ECO:0000269|PubMed:19853743}.
FT                                /FTId=VAR_017877.
FT   VARIANT     288    288       W -> L (in CURRAS).
FT                                {ECO:0000269|PubMed:10749657}.
FT                                /FTId=VAR_017878.
FT   VARIANT     289    289       F -> S (in CURRAS).
FT                                {ECO:0000269|PubMed:22820079}.
FT                                /FTId=VAR_068474.
FT   VARIANT     290    290       Q -> P (in CURRAS).
FT                                {ECO:0000269|PubMed:10749657}.
FT                                /FTId=VAR_017879.
FT   VARIANT     292    292       R -> W (in CURRAS).
FT                                {ECO:0000269|PubMed:10749657}.
FT                                /FTId=VAR_017880.
FT   VARIANT     293    293       R -> Q (in CURRAS).
FT                                {ECO:0000269|PubMed:10749657}.
FT                                /FTId=VAR_017881.
FT   VARIANT     293    293       R -> W (in CURRAS).
FT                                {ECO:0000269|PubMed:10631160}.
FT                                /FTId=VAR_017882.
FT   CONFLICT     10     37       DALLAVDPPRAASAQSAPLALVTSLAAA -> EPCWRWTPH
FT                                EPPLAERALAKVTSPPVP (in Ref. 1; AAB60647).
FT                                {ECO:0000305}.
FT   CONFLICT    121    121       A -> AAA (in Ref. 1; AAB60647).
FT                                {ECO:0000305}.
FT   CONFLICT    121    121       A -> ARA (in Ref. 3; AAD41467).
FT                                {ECO:0000305}.
FT   CONFLICT    262    262       L -> F (in Ref. 1; AAB60647).
FT                                {ECO:0000305}.
FT   CONFLICT    340    340       G -> R (in Ref. 1; AAB60647).
FT                                {ECO:0000305}.
FT   CONFLICT    346    349       RRLR -> PPA (in Ref. 1; AAB60647).
FT                                {ECO:0000305}.
SQ   SEQUENCE   401 AA;  40569 MW;  67527C8F789DFFDB CRC64;
     MEKSKNFRID ALLAVDPPRA ASAQSAPLAL VTSLAAAASG TGGGGGGGGA SGGTSGSCSP
     ASSEPPAAPA DRLRAESPSP PRLLAAHCAL LPKPGFLGAG GGGGGTGGGH GGPHHHAHPG
     AAAAAAAAAA AAAAGGLALG LHPGGAQGGA GLPAQAALYG HPVYGYSAAA AAAALAGQHP
     ALSYSYPQVQ GAHPAHPADP IKLGAGTFQL DQWLRASTAG MILPKMPDFN SQAQSNLLGK
     CRRPRTAFTS QQLLELEHQF KLNKYLSRPK RFEVATSLML TETQVKIWFQ NRRMKWKRSK
     KAKEQAAQEA EKQKGGGGGA GKGGAEEPGA EELLGPPAPG DKGSGRRLRD LRDSDPEEDE
     DEDDEDHFPY SNGASVHAAS SDCSSEDDSP PPRPSHQPAP Q
//
ID   A0A024RB41_HUMAN        Unreviewed;       215 AA.
AC   A0A024RB41;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   16-JAN-2019, entry version 30.
DE   SubName: Full=HCG2016482, isoform CRA_b {ECO:0000313|EMBL:EAW96961.1};
GN   ORFNames=hCG_2016482 {ECO:0000313|EMBL:EAW96961.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW96961.1};
RN   [1] {ECO:0000313|EMBL:EAW96961.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW96961.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471054; EAW96961.1; -; Genomic_DNA.
DR   RefSeq; NP_001106672.1; NM_001113201.2.
DR   RefSeq; NP_001106673.1; NM_001113202.1.
DR   RefSeq; NP_001307122.1; NM_001320193.1.
DR   RefSeq; NP_005585.1; NM_005594.5.
DR   UniGene; Hs.505735; -.
DR   ProteinModelPortal; A0A024RB41; -.
DR   SMR; A0A024RB41; -.
DR   PRIDE; A0A024RB41; -.
DR   GeneID; 4666; -.
DR   KEGG; hsa:4666; -.
DR   CTD; 4666; -.
DR   EuPathDB; HostDB:ENSG00000196531.10; -.
DR   eggNOG; KOG2239; Eukaryota.
DR   eggNOG; COG1308; LUCA.
DR   KO; K03626; -.
DR   OrthoDB; 1331328at2759; -.
DR   PhylomeDB; A0A024RB41; -.
DR   GenomeRNAi; 4666; -.
DR   Bgee; ENSG00000196531; Expressed in 241 organ(s), highest expression level in testis.
DR   ExpressionAtlas; A0A024RB41; baseline and differential.
DR   GO; GO:0005854; C:nascent polypeptide-associated complex; IEA:InterPro.
DR   Gene3D; 2.20.70.30; -; 1.
DR   InterPro; IPR016641; EGD2/NACA.
DR   InterPro; IPR038187; NAC_A/B_dom_sf.
DR   InterPro; IPR002715; Nas_poly-pep-assoc_cplx_dom.
DR   PANTHER; PTHR21713; PTHR21713; 1.
DR   Pfam; PF01849; NAC; 1.
DR   PIRSF; PIRSF015901; NAC_alpha; 1.
DR   SMART; SM01407; NAC; 1.
DR   PROSITE; PS51151; NAC_AB; 1.
PE   4: Predicted;
FT   DOMAIN       70    135       NAC-A/B. {ECO:0000259|PROSITE:PS51151}.
SQ   SEQUENCE   215 AA;  23384 MW;  05DC563A8BEF307C CRC64;
     MPGEATETVP ATEQELPQPQ AETGSGTESD SDESVPELEE QDSTQATTQQ AQLAAAAEID
     EEPVSKAKQS RSEKKARKAM SKLGLRQVTG VTRVTIRKSK NILFVITKPD VYKSPASDTY
     IVFGEAKIED LSQQAQLAAA EKFKVQGEAV SNIQENTQTP TVQEESEEEE VDETGVEVKD
     IELVMSQANV SRAKAVRALK NNSNDIVNAI MELTM
//
ID   NACAM_HUMAN             Reviewed;        2078 AA.
AC   E9PAV3;
DT   19-FEB-2014, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 1.
DT   13-FEB-2019, entry version 67.
DE   RecName: Full=Nascent polypeptide-associated complex subunit alpha, muscle-specific form;
DE   AltName: Full=Alpha-NAC, muscle-specific form;
DE            Short=skNAC;
GN   Name=NACA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SKNAC-2), AND VARIANTS
RP   GLU-336; SER-405; SER-519; THR-1795 AND PRO-1841.
RC   TISSUE=Pericardium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   IDENTIFICATION, REPEATS, AND ALTERNATIVE SPLICING.
RX   PubMed=19211926; DOI=10.1096/fj.08-125542;
RA   Li H., Randall W.R., Du S.J.;
RT   "skNAC (skeletal Naca), a muscle-specific isoform of Naca (nascent
RT   polypeptide-associated complex alpha), is required for myofibril
RT   organization.";
RL   FASEB J. 23:1988-2000(2009).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2049, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2029, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-2024; SER-2029 AND
RP   SER-2054, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2029, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-2005, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2049; SER-2054 AND
RP   SER-2066, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2029, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1995, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-2005, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Cardiac- and muscle-specific transcription factor. May
CC       act to regulate the expression of genes involved in the
CC       development of myotubes. Plays a critical role in ventricular
CC       cardiomyocyte expansion and regulates postnatal skeletal muscle
CC       growth and regeneration. Involved in the organized assembly of
CC       thick and thin filaments of myofibril sarcomeres (By similarity).
CC       {ECO:0000250|UniProtKB:P70670}.
CC   -!- SUBUNIT: Interacts (via PXLXP motif) with the muscle-restricted
CC       histone methyltransferase SMYD1 (via MYND-type zinc finger).
CC       {ECO:0000250|UniProtKB:P70670}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P70670}.
CC       Nucleus {ECO:0000250|UniProtKB:P70670}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=skNAC;
CC         IsoId=E9PAV3-1; Sequence=Displayed;
CC         Note=No experimental confirmation available. {ECO:0000305};
CC       Name=1;
CC         IsoId=Q13765-1; Sequence=External;
CC       Name=skNAC-2; Synonyms=2;
CC         IsoId=E9PAV3-2; Sequence=VSP_053722, VSP_053723;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The proline-rich muscle-specific exon 3 contains eighteen
CC       approximate 23-AA repeats. {ECO:0000269|PubMed:19211926}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK096699; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC117378; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS44925.2; -. [E9PAV3-2]
DR   RefSeq; XP_011536691.1; XM_011538389.1. [E9PAV3-1]
DR   UniGene; Hs.505735; -.
DR   ProteinModelPortal; E9PAV3; -.
DR   SMR; E9PAV3; -.
DR   BioGrid; 110748; 63.
DR   IntAct; E9PAV3; 5.
DR   STRING; 9606.ENSP00000448035; -.
DR   iPTMnet; E9PAV3; -.
DR   PhosphoSitePlus; E9PAV3; -.
DR   BioMuta; NACA; -.
DR   EPD; E9PAV3; -.
DR   jPOST; E9PAV3; -.
DR   PaxDb; E9PAV3; -.
DR   PRIDE; E9PAV3; -.
DR   ProteomicsDB; 19086; -.
DR   Ensembl; ENST00000454682; ENSP00000403817; ENSG00000196531. [E9PAV3-1]
DR   Ensembl; ENST00000550952; ENSP00000448035; ENSG00000196531. [E9PAV3-2]
DR   GeneID; 4666; -.
DR   UCSC; uc001sma.3; human. [E9PAV3-1]
DR   CTD; 4666; -.
DR   DisGeNET; 4666; -.
DR   EuPathDB; HostDB:ENSG00000196531.10; -.
DR   GeneCards; NACA; -.
DR   HGNC; HGNC:7629; NACA.
DR   HPA; HPA073152; -.
DR   HPA; HPA073648; -.
DR   neXtProt; NX_E9PAV3; -.
DR   OpenTargets; ENSG00000196531; -.
DR   eggNOG; KOG2239; Eukaryota.
DR   eggNOG; COG1308; LUCA.
DR   GeneTree; ENSGT00440000033468; -.
DR   OMA; KESQATP; -.
DR   OrthoDB; 1331328at2759; -.
DR   PhylomeDB; E9PAV3; -.
DR   SIGNOR; E9PAV3; -.
DR   ChiTaRS; NACA; human.
DR   GenomeRNAi; 4666; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000196531; Expressed in 241 organ(s), highest expression level in testis.
DR   ExpressionAtlas; E9PAV3; baseline and differential.
DR   Genevisible; E9PAV3; HS.
DR   GO; GO:0005854; C:nascent polypeptide-associated complex; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   Gene3D; 2.20.70.30; -; 1.
DR   InterPro; IPR016641; EGD2/NACA.
DR   InterPro; IPR038187; NAC_A/B_dom_sf.
DR   InterPro; IPR002715; Nas_poly-pep-assoc_cplx_dom.
DR   PANTHER; PTHR21713; PTHR21713; 1.
DR   Pfam; PF01849; NAC; 1.
DR   SMART; SM01407; NAC; 1.
DR   PROSITE; PS51151; NAC_AB; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Alternative splicing; Complete proteome;
KW   Cytoplasm; DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN         1   2078       Nascent polypeptide-associated complex
FT                                subunit alpha, muscle-specific form.
FT                                /FTId=PRO_0000425571.
FT   DOMAIN     1933   1998       NAC-A/B. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00507}.
FT   DOMAIN     2039   2078       UBA.
FT   REGION     1932   1943       Required for DNA-binding.
FT                                {ECO:0000250|UniProtKB:P70670}.
FT   MOTIF      1841   1845       PXLXP. {ECO:0000250|UniProtKB:P70670}.
FT   COMPBIAS     41   1880       Pro-rich.
FT   MOD_RES     917    917       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70670}.
FT   MOD_RES    1181   1181       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70670}.
FT   MOD_RES    1397   1397       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70670}.
FT   MOD_RES    1474   1474       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70670}.
FT   MOD_RES    1906   1906       Phosphoserine; by ILK1.
FT                                {ECO:0000250|UniProtKB:P70670}.
FT   MOD_RES    1995   1995       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2005   2005       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    2022   2022       Phosphothreonine; by GSK3-beta.
FT                                {ECO:0000250|UniProtKB:P70670}.
FT   MOD_RES    2024   2024       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    2029   2029       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES    2049   2049       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES    2054   2054       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES    2066   2066       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   CROSSLNK   2005   2005       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     602    644       Missing (in isoform skNAC-2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053722.
FT   VAR_SEQ     665   1774       Missing (in isoform skNAC-2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053723.
FT   VARIANT     336    336       V -> E (in dbSNP:rs2958127).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_070547.
FT   VARIANT     405    405       F -> S (in dbSNP:rs2926743).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_070548.
FT   VARIANT     519    519       P -> S (in dbSNP:rs185561121).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_070549.
FT   VARIANT    1795   1795       S -> T (in dbSNP:rs2926747).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_070550.
FT   VARIANT    1841   1841       L -> P (in dbSNP:rs2958149).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_070551.
FT   CONFLICT    417    417       S -> N (in Ref. 1; AK096699).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2078 AA;  205422 MW;  9A07C05D3F24C34B CRC64;
     MPGEATETVP ATEQELPQPQ AETAVLPMSS ALSVTAALGQ PGPTLPPPCS PAPQQCPLSA
     ANQASPFPSP STIASTPLEV PFPQSSSGTA LPLGTAPEAP TFLPNLIGPP ISPAALALAS
     PMIAPTLKGT PSSSAPLALV ALAPHSVQKS SAFPPNLLTS PPSVAVAESG SVITLSAPIA
     PSEPKTNLNK VPSEVVPNPK GTPSPPCIVS TVPYHCVTPM ASIQSGVASL PQTTPTTTLA
     IASPQVKDTT ISSVLISPQN PGSLSLKGPV SPPAALSLST QSLPVVTSSQ KTAGPNTPPD
     FPISLGSHLA PLHQSSFGSV QLLGQTGPSA LSDPTVKTIS VDHSSTGASY PSQRSVIPPL
     PSRNEVVPAT VAAFPVVAPS VDKGPSTISS ITCSPSGSLN VATSFSLSPT TSLILKSSPN
     ATYHYPLVAQ MPVSSVGTTP LVVTNPCTIA AAPTTTFEVA TCVSPPMSSG PISNIEPTSP
     AALVMAPVAP KEPSTQVATT LRIPVSPPLP DPEDLKNLPS SVLVKFPTQK DLQTVPASLE
     GAPFSPAQAG LTTKKDPTVL PLVQAAPKNS PSFQSTSSSP EIPLSPEATL AKKSLGEPLP
     IGKPASSMTS PLGVNSSASV IKTDSYAGPD SAGPLLKSSL ITPTVAAFPL ESADPAGVAP
     TTAKGTSTYT TTASPFLEGT VSLAPKNHPV KEGTLTTLPL VPTASENCPV APSPQNTCAP
     LATLVLAPEI PKSVPSPSLP PAGTPPGTKK VDGISHTSAL APVASSPKEC PTEDSGASAT
     ASSKGTLTYL ADSPSPLGVS VSPQTKRPPT KKGSAGPDTP IGNLSSPVSP VEASFLPENS
     LSFQGSKDSP ATTHSPTPPS PKGAPTPSAV TPLSPKGVTL PPKETPTPSV VNLPFPKEGP
     ATPAPKQAPA LSMTSSSPKK ARATPAPKGI PASPSPKGAP TPPAATPPSP KGGPATPSPK
     WAPTPPAATP PSPKGGPATP SPKGAPTPPA ATPPSPKGGP ATPSPKGAPT PPAVTPPSPK
     GSPAATPFPK GASTPPAATP PSPKGSPAAT PLPKGAPTTP AATLPSPKGG PATPSLKGAP
     TPPAATPPSP KGGPATPSPK GAPMPPAATP PSPKGGLATP PHKGAPTTPA ATPPSPKGGL
     ATPPPKGAPT TPAATPPSPK GGLATPPPKG APTTPAATPP SPKGGLATPS PKGAPTTPAA
     TPPSPKGGLA TPSPKGAPTT PAATPPSPKG GLATPSPKGA PTTPAATPPS PKGGPATPPP
     KGAPTPPAAT PPSLKGGLAT PPHKGAPNPA VVTPPSPKGG PATSPPKGAP TPPAATPPSP
     KGSPGTPPPK GAPTPPAVTP PSPKGTPTLP ATTPSSKGGP TTPSSKEGPT PPAATPSHKG
     GPAMTPPSPK RGPAIPSPKG DPTSPAVIPL SPKKAPATPV TREGAATPSK GDLTPPAVTP
     VSLKKAPATS APKGGPATPS SKGDPTLPAV TPPSPKEPPA PKQVATSSSP KKAPATPAPM
     GAPTLPAVIP SSPKEVPATP SSRRDPIAPT ATLLSKKTPA TLAPKEALIP PAMTVPSPKK
     TPAIPTPKEA PATPSSKEAS SPPAVTPSTY KGAPSPKELL IPPAVTSPSP KEAPTPPAVT
     PPSPEKGPAT PAPKGTPTSP PVTPSSLKDS PTSPASVTCK MGATVPQASK GLPAKKGPTA
     LKEVLVAPAP ESTPIITAPT RKGPQTKKSS ATSPPICPDP SAKNGSKGPL STVAPAPLLP
     VQKDSSKTAK GKDASHSPKG PLAPPESKAS TPLTAAAFEK VLPKPESASV SAAPSPPVSL
     PLAPSPVPTL PPKQQFLPSS PGLVLESPSK PLAPADEDEL LPLIPPEPIS GGVPFQSVLV
     NMPTPKSAGI PVPTPSAKQP VTKNNKGSGT ESDSDESVPE LEEQDSTQAT TQQAQLAAAA
     EIDEEPVSKA KQSRSEKKAR KAMSKLGLRQ VTGVTRVTIR KSKNILFVIT KPDVYKSPAS
     DTYIVFGEAK IEDLSQQAQL AAAEKFKVQG EAVSNIQENT QTPTVQEESE EEEVDETGVE
     VKDIELVMSQ ANVSRAKAVR ALKNNSNDIV NAIMELTM
//
ID   NACA_HUMAN              Reviewed;         215 AA.
AC   Q13765; A8MTN7; B2R4P8; F8VU71; Q3KQV4; Q53A18; Q53G46;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   13-FEB-2019, entry version 170.
DE   RecName: Full=Nascent polypeptide-associated complex subunit alpha;
DE            Short=NAC-alpha;
DE   AltName: Full=Alpha-NAC;
DE   AltName: Allergen=Hom s 2;
GN   Name=NACA; ORFNames=HSD48;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Neuroblastoma;
RX   PubMed=12209604; DOI=10.1002/ijc.10550;
RA   Behrends U., Jandl T., Golbeck A., Lechner B., Mueller-Weihrich S.,
RA   Schmid I., Till H., Berthold F., Voltz R., Mautner J.M.;
RT   "Novel products of the HuD, HuC, NNP-1 and alpha-internexin genes
RT   identified by autologous antibody screening of a pediatric
RT   neuroblastoma library.";
RL   Int. J. Cancer 100:669-677(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=15196207; DOI=10.1111/j.1365-2567.2004.01893.x;
RA   Al-Shanti N., Steward C.G., Garland R.J., Rowbottom A.W.;
RT   "Investigation of alpha nascent polypeptide-associated complex
RT   functions in a human CD8(+) T cell ex vivo expansion model using
RT   antisense oligonucleotides.";
RL   Immunology 112:397-403(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Sakai H., Chew C., Wang S., Wiedmann B., Geromanos S., Tempst P.,
RA   Wiedmann M.;
RT   "Nascent polypeptide-associate complex (NAC): a novel type of
RT   polypeptide binding protein.";
RL   Submitted (AUG-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-173 (ISOFORM 1).
RC   TISSUE=Testis;
RA   Yuan L.G., Tian Y.Q., Qiao Y., Miao S.Y., Wang L.F.;
RT   "A new spermatogenesis-related gene.";
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   PROTEIN SEQUENCE OF 101-142 AND 180-192, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [13]
RP   PROTEIN SEQUENCE OF 101-142; 145-192 AND 201-215, PHOSPHORYLATION AT
RP   SER-166, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [14]
RP   ALLERGEN.
RX   PubMed=9806765;
RA   Natter S., Seiberler S., Hufnagl P., Binder B.R., Hirschl A.M.,
RA   Ring J., Abeck D., Schmidt T., Valent P., Valenta R.;
RT   "Isolation of cDNA clones coding for IgE autoantigens with serum IgE
RT   from atopic dermatitis patients.";
RL   FASEB J. 12:1559-1569(1998).
RN   [15]
RP   FUNCTION.
RX   PubMed=9877153; DOI=10.1016/S0014-5793(98)01440-9;
RA   Moeller I., Beatrix B., Kreibich G., Sakai H., Lauring B.,
RA   Wiedmann M.;
RT   "Unregulated exposure of the ribosomal M-site caused by NAC depletion
RT   results in delivery of non-secretory polypeptides to the Sec61
RT   complex.";
RL   FEBS Lett. 441:1-5(1998).
RN   [16]
RP   FUNCTION, INTERACTION WITH BTF3, ASSOCIATION WITH RIBOSOMES, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=10982809; DOI=10.1074/jbc.M006368200;
RA   Beatrix B., Sakai H., Wiedmann M.;
RT   "The alpha and beta subunit of the nascent polypeptide-associated
RT   complex have distinct functions.";
RL   J. Biol. Chem. 275:37838-37845(2000).
RN   [17]
RP   INTERACTION WITH FADD.
RX   PubMed=12684039; DOI=10.1016/S0006-291X(03)00487-X;
RA   Stilo R., Liguoro D., di Jeso B., Leonardi A., Vito P.;
RT   "The alpha-chain of the nascent polypeptide-associated complex binds
RT   to and regulates FADD function.";
RL   Biochem. Biophys. Res. Commun. 303:1034-1041(2003).
RN   [18]
RP   SUBCELLULAR LOCATION, AND POSSIBLE INVOLVEMENT IN OSTEOSARCOMA.
RX   PubMed=12689679; DOI=10.1016/S8756-3282(03)00026-7;
RA   Papachristou D.J., Batistatou A., Sykiotis G.P., Varakis I.,
RA   Papavassiliou A.G.;
RT   "Activation of the JNK-AP-1 signal transduction pathway is associated
RT   with pathogenesis and progression of human osteosarcomas.";
RL   Bone 32:364-371(2003).
RN   [19]
RP   PHOSPHORYLATION AT SER-43, AND SUBCELLULAR LOCATION.
RX   PubMed=15299025; DOI=10.1074/jbc.M406310200;
RA   Quelo I., Gauthier C., Hannigan G.E., Dedhar S., St-Arnaud R.;
RT   "Integrin-linked kinase regulates the nuclear entry of the c-Jun
RT   coactivator alpha-NAC and its coactivation potency.";
RL   J. Biol. Chem. 279:43893-43899(2004).
RN   [20]
RP   FUNCTION.
RX   PubMed=15784678; DOI=10.1242/jcs.02295;
RA   Lopez S., Stuhl L., Fichelson S., Dubart-Kupperschmitt A.,
RA   St Arnaud R., Galindo J.-R., Murati A., Berda N., Dubreuil P.,
RA   Gomez S.;
RT   "NACA is a positive regulator of human erythroid-cell
RT   differentiation.";
RL   J. Cell Sci. 118:1595-1605(2005).
RN   [21]
RP   TISSUE SPECIFICITY.
RX   PubMed=16201836; DOI=10.1371/journal.pbio.0030357;
RA   Marques A.C., Dupanloup I., Vinckenbosch N., Reymond A., Kaessmann H.;
RT   "Emergence of young human genes after a burst of retroposition in
RT   primates.";
RL   PLoS Biol. 3:E357-E357(2005).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-161; SER-166 AND
RP   SER-191, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-142, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186; SER-191 AND
RP   SER-203, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [33]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [35]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-142, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 84-136, SUBUNIT,
RP   DNA/RNA-BINDING REGION, AND SUBCELLULAR LOCATION.
RX   PubMed=20214399; DOI=10.1021/bi902050p;
RA   Liu Y., Hu Y., Li X., Niu L., Teng M.;
RT   "The crystal structure of the human nascent polypeptide-associated
RT   complex domain reveals a nucleic acid-binding region on the NACA
RT   subunit.";
RL   Biochemistry 49:2890-2896(2010).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 79-132, AND SUBUNIT.
RX   PubMed=21203952; DOI=10.1007/s13238-010-0049-3;
RA   Wang L., Zhang W., Wang L., Zhang X.C., Li X., Rao Z.;
RT   "Crystal structures of NAC domains of human nascent polypeptide-
RT   associated complex (NAC) and its alphaNAC subunit.";
RL   Protein Cell 1:406-416(2010).
CC   -!- FUNCTION: Prevents inappropriate targeting of non-secretory
CC       polypeptides to the endoplasmic reticulum (ER). Binds to nascent
CC       polypeptide chains as they emerge from the ribosome and blocks
CC       their interaction with the signal recognition particle (SRP),
CC       which normally targets nascent secretory peptides to the ER. Also
CC       reduces the inherent affinity of ribosomes for protein
CC       translocation sites in the ER membrane (M sites). May act as a
CC       specific coactivator for JUN, binding to DNA and stabilizing the
CC       interaction of JUN homodimers with target gene promoters.
CC       {ECO:0000269|PubMed:10982809, ECO:0000269|PubMed:15784678,
CC       ECO:0000269|PubMed:9877153}.
CC   -!- SUBUNIT: Interacts with TBP and JUN (By similarity). Part of the
CC       nascent polypeptide-associated complex (NAC), which is a
CC       heterodimer of NACA and BTF3 (via NAC-A/B domains). NAC associates
CC       with ribosomes through the BTF3/NACB subunit and contacts the
CC       ribosomal protein L23, which is positioned near the exiting site.
CC       Both subunits can contact nascent polypeptide chains. NACA may
CC       also form homodimers, and only this form binds DNA. {ECO:0000250,
CC       ECO:0000269|PubMed:10982809, ECO:0000269|PubMed:12684039,
CC       ECO:0000269|PubMed:20214399, ECO:0000269|PubMed:21203952}.
CC   -!- INTERACTION:
CC       P40222:TXLNA; NbExp=2; IntAct=EBI-712216, EBI-359793;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=The heterodimer is
CC       located mainly in the cytosol, and the homodimer in the nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q13765-1; Sequence=Displayed;
CC       Name=skNAC-2; Synonyms=2;
CC         IsoId=E9PAV3-2; Sequence=External;
CC         Note=No experimental confirmation available.;
CC       Name=skNAC;
CC         IsoId=E9PAV3-1; Sequence=External;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:16201836}.
CC   -!- DOMAIN: The positively charged inner surface of the NAC-A/B domain
CC       is crucial for NACA localization in the nucleus and DNA-binding.
CC       This region is blocked from binding nucleic acids in the
CC       heterodimeric complex by a helix region in the beta-subunit, it
CC       also displays much higher affinity for RNA than DNA.
CC   -!- PTM: Phosphorylation of Thr-159 by GSK3B may promote proteasome
CC       mediated degradation (By similarity). Phosphorylation of Ser-43 by
CC       ILK during cell adhesion may promote nuclear localization.
CC       {ECO:0000250, ECO:0000269|PubMed:15299025, ECO:0000269|Ref.13}.
CC   -!- ALLERGEN: Causes an allergic reaction in human. Binds to IgE from
CC       atopic dermatitis (AD) patients. Identified as an IgE autoantigen
CC       in atopic dermatitis (AD) patients with severe skin
CC       manifestations. {ECO:0000269|PubMed:9806765}.
CC   -!- SIMILARITY: Belongs to the NAC-alpha family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAV83778.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AY034001; AAK57544.1; -; mRNA.
DR   EMBL; AY911673; AAX14393.1; -; mRNA.
DR   EMBL; X80909; CAA56869.1; -; mRNA.
DR   EMBL; AF054187; AAC99403.1; -; mRNA.
DR   EMBL; AK090650; BAG52208.1; -; mRNA.
DR   EMBL; AK311904; BAG34845.1; -; mRNA.
DR   EMBL; CR450295; CAG29291.1; -; mRNA.
DR   EMBL; AK223085; BAD96805.1; -; mRNA.
DR   EMBL; AC117378; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW96960.1; -; Genomic_DNA.
DR   EMBL; BC105120; AAI05121.1; -; mRNA.
DR   EMBL; BC105122; AAI05123.1; -; mRNA.
DR   EMBL; BC106041; AAI06042.1; -; mRNA.
DR   EMBL; AY605660; AAV83778.1; ALT_INIT; mRNA.
DR   CCDS; CCDS31837.1; -. [Q13765-1]
DR   PIR; S49326; S49326.
DR   RefSeq; NP_001106672.1; NM_001113201.2. [Q13765-1]
DR   RefSeq; NP_001106673.1; NM_001113202.1. [Q13765-1]
DR   RefSeq; NP_001106674.2; NM_001113203.2.
DR   RefSeq; NP_001307122.1; NM_001320193.1. [Q13765-1]
DR   RefSeq; NP_001307123.1; NM_001320194.1.
DR   RefSeq; NP_005585.1; NM_005594.5. [Q13765-1]
DR   UniGene; Hs.505735; -.
DR   PDB; 3LKX; X-ray; 2.50 A; B=84-136.
DR   PDB; 3MCB; X-ray; 1.90 A; A=79-132.
DR   PDB; 3MCE; X-ray; 2.40 A; A/B/C/D=81-133.
DR   PDBsum; 3LKX; -.
DR   PDBsum; 3MCB; -.
DR   PDBsum; 3MCE; -.
DR   ProteinModelPortal; Q13765; -.
DR   SMR; Q13765; -.
DR   BioGrid; 110748; 63.
DR   DIP; DIP-43878N; -.
DR   IntAct; Q13765; 32.
DR   MINT; Q13765; -.
DR   Allergome; 3323; Hom s 2.0101.
DR   Allergome; 412; Hom s 2.
DR   iPTMnet; Q13765; -.
DR   SwissPalm; Q13765; -.
DR   BioMuta; NACA; -.
DR   DMDM; 71151996; -.
DR   EPD; Q13765; -.
DR   jPOST; Q13765; -.
DR   MaxQB; Q13765; -.
DR   PeptideAtlas; Q13765; -.
DR   PRIDE; Q13765; -.
DR   ProteomicsDB; 59679; -.
DR   TopDownProteomics; Q13765-1; -. [Q13765-1]
DR   Ensembl; ENST00000356769; ENSP00000349212; ENSG00000196531. [Q13765-1]
DR   Ensembl; ENST00000393891; ENSP00000377469; ENSG00000196531. [Q13765-1]
DR   Ensembl; ENST00000546392; ENSP00000446801; ENSG00000196531. [Q13765-1]
DR   Ensembl; ENST00000552540; ENSP00000447821; ENSG00000196531. [Q13765-1]
DR   GeneID; 4666; -.
DR   KEGG; hsa:4666; -.
DR   UCSC; uc001sly.3; human. [Q13765-1]
DR   CTD; 4666; -.
DR   DisGeNET; 4666; -.
DR   EuPathDB; HostDB:ENSG00000196531.10; -.
DR   GeneCards; NACA; -.
DR   H-InvDB; HIX0034277; -.
DR   HGNC; HGNC:7629; NACA.
DR   HPA; HPA073152; -.
DR   HPA; HPA073648; -.
DR   MIM; 601234; gene.
DR   neXtProt; NX_Q13765; -.
DR   OpenTargets; ENSG00000196531; -.
DR   PharmGKB; PA31433; -.
DR   eggNOG; KOG2239; Eukaryota.
DR   eggNOG; COG1308; LUCA.
DR   GeneTree; ENSGT00440000033468; -.
DR   HOVERGEN; HBG082004; -.
DR   InParanoid; Q13765; -.
DR   KO; K03626; -.
DR   OrthoDB; 1331328at2759; -.
DR   PhylomeDB; Q13765; -.
DR   TreeFam; TF313348; -.
DR   SIGNOR; Q13765; -.
DR   ChiTaRS; NACA; human.
DR   EvolutionaryTrace; Q13765; -.
DR   GeneWiki; NACA_(gene); -.
DR   GenomeRNAi; 4666; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000196531; Expressed in 241 organ(s), highest expression level in testis.
DR   ExpressionAtlas; Q13765; baseline and differential.
DR   Genevisible; Q13765; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005854; C:nascent polypeptide-associated complex; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; NAS:BHF-UCL.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003713; F:transcription coactivator activity; NAS:BHF-UCL.
DR   GO; GO:0003231; P:cardiac ventricle development; ISS:BHF-UCL.
DR   GO; GO:0061384; P:heart trabecula morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0010664; P:negative regulation of striated muscle cell apoptotic process; ISS:BHF-UCL.
DR   GO; GO:1901227; P:negative regulation of transcription from RNA polymerase II promoter involved in heart development; ISS:BHF-UCL.
DR   GO; GO:2000138; P:positive regulation of cell proliferation involved in heart morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0048633; P:positive regulation of skeletal muscle tissue growth; ISS:BHF-UCL.
DR   GO; GO:1901228; P:positive regulation of transcription from RNA polymerase II promoter involved in heart development; ISS:BHF-UCL.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0048742; P:regulation of skeletal muscle fiber development; ISS:BHF-UCL.
DR   GO; GO:0043403; P:skeletal muscle tissue regeneration; ISS:BHF-UCL.
DR   GO; GO:0006412; P:translation; TAS:ProtInc.
DR   Gene3D; 2.20.70.30; -; 1.
DR   InterPro; IPR016641; EGD2/NACA.
DR   InterPro; IPR038187; NAC_A/B_dom_sf.
DR   InterPro; IPR002715; Nas_poly-pep-assoc_cplx_dom.
DR   PANTHER; PTHR21713; PTHR21713; 1.
DR   Pfam; PF01849; NAC; 1.
DR   PIRSF; PIRSF015901; NAC_alpha; 1.
DR   SMART; SM01407; NAC; 1.
DR   PROSITE; PS51151; NAC_AB; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allergen; Alternative splicing; Chaperone;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; DNA-binding;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Protein transport;
KW   Reference proteome; Transcription; Transport; Ubl conjugation.
FT   CHAIN         1    215       Nascent polypeptide-associated complex
FT                                subunit alpha.
FT                                /FTId=PRO_0000135576.
FT   DOMAIN       70    135       NAC-A/B. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00507}.
FT   DOMAIN      176    213       UBA.
FT   REGION       69     80       Required for DNA-binding. {ECO:0000250}.
FT   REGION       93    108       RNA/DNA-binding.
FT   MOD_RES      43     43       Phosphoserine; by ILK1.
FT                                {ECO:0000269|PubMed:15299025}.
FT   MOD_RES     132    132       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     142    142       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     159    159       Phosphothreonine; by GSK3-beta.
FT                                {ECO:0000250|UniProtKB:Q60817}.
FT   MOD_RES     161    161       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     166    166       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|Ref.13}.
FT   MOD_RES     186    186       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     191    191       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     203    203       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   CROSSLNK    142    142       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CONFLICT    213    213       L -> S (in Ref. 7; BAD96805).
FT                                {ECO:0000305}.
FT   HELIX        80     83       {ECO:0000244|PDB:3MCB}.
FT   STRAND       86     88       {ECO:0000244|PDB:3LKX}.
FT   STRAND       91    108       {ECO:0000244|PDB:3MCB}.
FT   STRAND      110    113       {ECO:0000244|PDB:3MCB}.
FT   STRAND      117    124       {ECO:0000244|PDB:3MCB}.
FT   STRAND      126    130       {ECO:0000244|PDB:3MCB}.
SQ   SEQUENCE   215 AA;  23384 MW;  05DC563A8BEF307C CRC64;
     MPGEATETVP ATEQELPQPQ AETGSGTESD SDESVPELEE QDSTQATTQQ AQLAAAAEID
     EEPVSKAKQS RSEKKARKAM SKLGLRQVTG VTRVTIRKSK NILFVITKPD VYKSPASDTY
     IVFGEAKIED LSQQAQLAAA EKFKVQGEAV SNIQENTQTP TVQEESEEEE VDETGVEVKD
     IELVMSQANV SRAKAVRALK NNSNDIVNAI MELTM
//
ID   SPN90_HUMAN             Reviewed;         722 AA.
AC   Q9NZQ3; B4DFL5; Q6GU34; Q6SPF3; Q8TC10; Q9UGM8;
DT   05-DEC-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   13-FEB-2019, entry version 169.
DE   RecName: Full=NCK-interacting protein with SH3 domain;
DE   AltName: Full=54 kDa VacA-interacting protein;
DE   AltName: Full=54 kDa vimentin-interacting protein;
DE            Short=VIP54;
DE   AltName: Full=90 kDa SH3 protein interacting with Nck;
DE   AltName: Full=AF3p21;
DE   AltName: Full=Dia-interacting protein 1;
DE            Short=DIP-1;
DE   AltName: Full=Diaphanous protein-interacting protein;
DE   AltName: Full=SH3 adapter protein SPIN90;
DE   AltName: Full=WASP-interacting SH3-domain protein;
DE            Short=WISH;
DE   AltName: Full=Wiskott-Aldrich syndrome protein-interacting protein;
GN   Name=NCKIPSD; Synonyms=AF3P21, SPIN90;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION
RP   WITH KMT2A/MLL1.
RC   TISSUE=Leukemia;
RX   PubMed=10648423;
RA   Sano K., Hayakawa A., Piao J.-H., Kosaka Y., Nakamura H.;
RT   "Novel SH3 protein encoded by the AF3p21 gene is fused to the mixed
RT   lineage leukemia protein in a therapy-related leukemia with
RT   t(3;11)(p21;q23).";
RL   Blood 95:1066-1068(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), INTERACTION WITH VACA, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10619843; DOI=10.1093/emboj/19.1.48;
RA   de Bernard M., Moschioni M., Napolitani G., Rappuoli R.,
RA   Montecucco C.;
RT   "The VacA toxin of Helicobacter pylori identifies a new intermediate
RT   filament-interacting protein.";
RL   EMBO J. 19:48-56(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Cervix carcinoma;
RX   PubMed=11241789; DOI=10.1002/gcc.1102;
RA   Hayakawa A., Matsuda Y., Daibata M., Nakamura H., Sano K.;
RT   "Genomic organization, tissue expression and cellular localization of
RT   AF3p21, a fusion partner of MLL in therapy-related leukemia.";
RL   Genes Chromosomes Cancer 30:364-374(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=11278500; DOI=10.1074/jbc.M009411200;
RA   Lim C.S., Park E.S., Kim D.J., Song Y.H., Eom S.H., Chun J.-S.,
RA   Kim J.H., Kim J.-K., Park D., Song W.K.;
RT   "SPIN90 (SH3 protein interacting with Nck, 90 kDa), an adapter protein
RT   that is developmentally regulated during cardiac myocyte
RT   differentiation.";
RL   J. Biol. Chem. 276:12871-12878(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORMS
RP   1 AND 2).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=11509578; DOI=10.1074/jbc.M107026200;
RA   Satoh S., Tominaga T.;
RT   "mDia-interacting protein acts downstream of rho-mDia and modifies src
RT   activation and stress fiber formation.";
RL   J. Biol. Chem. 276:39290-39294(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND INTERACTION WITH FHOD1.
RC   TISSUE=Bone marrow;
RX   PubMed=15095401; DOI=10.1002/jcb.20031;
RA   Westendorf J.J., Koka S.;
RT   "Identification of FHOD1-binding proteins and mechanisms of FHOD1-
RT   regulated actin dynamics.";
RL   J. Cell. Biochem. 92:29-41(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   SER-660.
RC   TISSUE=Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 448-722 (ISOFORM 5).
RC   TISSUE=Brain cortex;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [11]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL
RT   (CD178) by phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   FUNCTION IN ANGIOGENESIS, AND INTERACTION WITH TMIGD2.
RX   PubMed=22419821; DOI=10.1091/mbc.E11-11-0934;
RA   Rahimi N., Rezazadeh K., Mahoney J.E., Hartsough E., Meyer R.D.;
RT   "Identification of IGPR-1 as a novel adhesion molecule involved in
RT   angiogenesis.";
RL   Mol. Biol. Cell 23:1646-1656(2012).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-181, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Has an important role in stress fiber formation induced
CC       by active diaphanous protein homolog 1 (DRF1). Induces microspike
CC       formation, in vivo (By similarity). In vitro, stimulates N-WASP-
CC       induced ARP2/3 complex activation in the absence of CDC42 (By
CC       similarity). May play an important role in the maintenance of
CC       sarcomeres and/or in the assembly of myofibrils into sarcomeres.
CC       Implicated in regulation of actin polymerization and cell
CC       adhesion. Plays a role in angiogenesis. {ECO:0000250,
CC       ECO:0000269|PubMed:22419821}.
CC   -!- SUBUNIT: Associates with the intermediate filaments, vimentin and
CC       desmin. Binds the first and third SH3 domains of NCK. Binds the
CC       proline-rich domains of N-WASP through its SH3 domain (By
CC       similarity). Similarly, binds diaphanous protein homolog 1 (DRF1).
CC       Binds the SH3 domains of GRB2 through its proline-rich domains.
CC       Interacts with Helicobacter pylori toxin vacA. Isoform 4 interacts
CC       with FHOD1. Interacts with FASLG. Interacts with TMIGD2.
CC       {ECO:0000250, ECO:0000269|PubMed:10619843,
CC       ECO:0000269|PubMed:15095401, ECO:0000269|PubMed:19807924,
CC       ECO:0000269|PubMed:22419821}.
CC   -!- INTERACTION:
CC       Q60437:BAIAP2 (xeno); NbExp=3; IntAct=EBI-745080, EBI-7010040;
CC       Q9UQB8:BAIAP2; NbExp=2; IntAct=EBI-745080, EBI-525456;
CC       P06241:FYN; NbExp=2; IntAct=EBI-745080, EBI-515315;
CC       Q9Z0W5:Pacsin1 (xeno); NbExp=6; IntAct=EBI-745080, EBI-1550185;
CC       Q9QY17:Pacsin2 (xeno); NbExp=2; IntAct=EBI-745080, EBI-491201;
CC       O00233:PSMD9; NbExp=3; IntAct=EBI-745080, EBI-750973;
CC       O60504:SORBS3; NbExp=3; IntAct=EBI-745080, EBI-741237;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Note=Colocalizes with DRF1 at
CC       membrane ruffles, and with Nck at Z-disks in mature cardiac
CC       myocytes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q9NZQ3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NZQ3-2; Sequence=VSP_003971;
CC       Name=3;
CC         IsoId=Q9NZQ3-3; Sequence=VSP_039422;
CC         Note=No experimental confirmation available.;
CC       Name=4; Synonyms=WISH-B;
CC         IsoId=Q9NZQ3-4; Sequence=VSP_039422, VSP_039425, VSP_039426;
CC       Name=5;
CC         IsoId=Q9NZQ3-5; Sequence=VSP_039423, VSP_039424;
CC         Note=Found in a brain affected by Alzheimer disease. May be due
CC         to intron retention. No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highest expression in heart, brain, skeletal
CC       muscle, kidney and liver. Lower levels in placenta, lung, small
CC       intestine and leukocytes. Weak expression in colon, thymus and
CC       spleen. {ECO:0000269|PubMed:10619843}.
CC   -!- DISEASE: Note=A chromosomal aberration involving NCKIPSD/AF3p21 is
CC       found in therapy-related leukemia. Translocation t(3;11)(p21;q23)
CC       with KMT2A/MLL1. {ECO:0000269|PubMed:10648423}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAG57476.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AF3p21ID228.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF178432; AAF35985.1; -; mRNA.
DR   EMBL; AJ242655; CAB65089.2; -; mRNA.
DR   EMBL; AF303581; AAK09094.1; -; mRNA.
DR   EMBL; AB069981; BAB63204.1; -; Genomic_DNA.
DR   EMBL; AB069982; BAB63205.1; -; Genomic_DNA.
DR   EMBL; AY453794; AAR83735.1; -; mRNA.
DR   EMBL; AC141002; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC016052; AAH16052.1; -; mRNA.
DR   EMBL; BC026280; AAH26280.1; -; mRNA.
DR   EMBL; AK294151; BAG57476.1; ALT_INIT; mRNA.
DR   CCDS; CCDS2776.1; -. [Q9NZQ3-1]
DR   CCDS; CCDS46827.1; -. [Q9NZQ3-3]
DR   RefSeq; NP_057537.1; NM_016453.3. [Q9NZQ3-1]
DR   RefSeq; NP_909119.1; NM_184231.2. [Q9NZQ3-3]
DR   UniGene; Hs.655006; -.
DR   PDB; 6DEC; X-ray; 4.60 A; M/P=269-722.
DR   PDB; 6DED; X-ray; 2.20 A; A/B=350-722.
DR   PDB; 6DEE; X-ray; 3.04 A; A=306-722.
DR   PDBsum; 6DEC; -.
DR   PDBsum; 6DED; -.
DR   PDBsum; 6DEE; -.
DR   ProteinModelPortal; Q9NZQ3; -.
DR   SMR; Q9NZQ3; -.
DR   BioGrid; 119583; 54.
DR   IntAct; Q9NZQ3; 55.
DR   MINT; Q9NZQ3; -.
DR   STRING; 9606.ENSP00000294129; -.
DR   iPTMnet; Q9NZQ3; -.
DR   PhosphoSitePlus; Q9NZQ3; -.
DR   BioMuta; NCKIPSD; -.
DR   DMDM; 17433253; -.
DR   EPD; Q9NZQ3; -.
DR   jPOST; Q9NZQ3; -.
DR   MaxQB; Q9NZQ3; -.
DR   PaxDb; Q9NZQ3; -.
DR   PeptideAtlas; Q9NZQ3; -.
DR   PRIDE; Q9NZQ3; -.
DR   ProteomicsDB; 83478; -.
DR   ProteomicsDB; 83479; -. [Q9NZQ3-2]
DR   ProteomicsDB; 83480; -. [Q9NZQ3-3]
DR   ProteomicsDB; 83481; -. [Q9NZQ3-4]
DR   ProteomicsDB; 83482; -. [Q9NZQ3-5]
DR   DNASU; 51517; -.
DR   Ensembl; ENST00000294129; ENSP00000294129; ENSG00000213672. [Q9NZQ3-1]
DR   Ensembl; ENST00000416649; ENSP00000389059; ENSG00000213672. [Q9NZQ3-3]
DR   GeneID; 51517; -.
DR   KEGG; hsa:51517; -.
DR   UCSC; uc003cum.5; human. [Q9NZQ3-1]
DR   CTD; 51517; -.
DR   DisGeNET; 51517; -.
DR   EuPathDB; HostDB:ENSG00000213672.7; -.
DR   GeneCards; NCKIPSD; -.
DR   HGNC; HGNC:15486; NCKIPSD.
DR   HPA; CAB019267; -.
DR   HPA; HPA050005; -.
DR   MIM; 606671; gene.
DR   neXtProt; NX_Q9NZQ3; -.
DR   OpenTargets; ENSG00000213672; -.
DR   PharmGKB; PA134872724; -.
DR   eggNOG; KOG4035; Eukaryota.
DR   eggNOG; ENOG410Y8WT; LUCA.
DR   GeneTree; ENSGT00390000015725; -.
DR   HOGENOM; HOG000008184; -.
DR   HOVERGEN; HBG061630; -.
DR   InParanoid; Q9NZQ3; -.
DR   OMA; METRWSI; -.
DR   OrthoDB; 649314at2759; -.
DR   PhylomeDB; Q9NZQ3; -.
DR   TreeFam; TF324522; -.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-5663213; RHO GTPases Activate WASPs and WAVEs.
DR   SignaLink; Q9NZQ3; -.
DR   SIGNOR; Q9NZQ3; -.
DR   ChiTaRS; NCKIPSD; human.
DR   GeneWiki; NCKIPSD; -.
DR   GenomeRNAi; 51517; -.
DR   PRO; PR:Q9NZQ3; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000213672; Expressed in 212 organ(s), highest expression level in anterior cingulate cortex.
DR   ExpressionAtlas; Q9NZQ3; baseline and differential.
DR   Genevisible; Q9NZQ3; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005882; C:intermediate filament; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0008092; F:cytoskeletal protein binding; NAS:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0007010; P:cytoskeleton organization; NAS:UniProtKB.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   CDD; cd11849; SH3_SPIN90; 1.
DR   InterPro; IPR018556; DUF2013.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR035514; SPIN90_SH3.
DR   Pfam; PF09431; DUF2013; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosomal rearrangement;
KW   Complete proteome; Nucleus; Phosphoprotein; Polymorphism;
KW   Proto-oncogene; Reference proteome; SH3 domain; SH3-binding.
FT   CHAIN         1    722       NCK-interacting protein with SH3 domain.
FT                                /FTId=PRO_0000072130.
FT   DOMAIN        1     58       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   MOTIF       175    192       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS    171    275       Pro-rich.
FT   COMPBIAS    197    240       Ser/Thr-rich.
FT   COMPBIAS    442    487       Leu-rich.
FT   COMPBIAS    534    601       Leu-rich.
FT   SITE         57     58       Breakpoint for translocation to form
FT                                KMT2A/MLL1-AF3P21 oncogene.
FT   MOD_RES     120    120       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ESJ4}.
FT   MOD_RES     181    181       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     294    294       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ESJ4}.
FT   VAR_SEQ     165    171       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:15095401,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039422.
FT   VAR_SEQ     567    596       AADQNVIMAALSKHANVKIFSEKLLLLLNR -> GGVGPGW
FT                                AVAEHMVALRLSTLSIPMSFLSC (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_039423.
FT   VAR_SEQ     597    722       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_039424.
FT   VAR_SEQ     656    722       LRMEYLSLMHAIVRTTPYLQHRHRLPDLQAILRRILNEEET
FT                                SPQCQMDRMIVREMCKEFLVLGEAPS -> GPFGAGQRPWP
FT                                GVPRLLEPGSTPSREPHPVERSGVPALTSSWASGCPRPLHP
FT                                ALQLVIDSAFGGRSV (in isoform 2).
FT                                {ECO:0000303|PubMed:10619843}.
FT                                /FTId=VSP_003971.
FT   VAR_SEQ     656    658       LRM -> GVH (in isoform 4).
FT                                {ECO:0000303|PubMed:15095401}.
FT                                /FTId=VSP_039425.
FT   VAR_SEQ     659    722       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15095401}.
FT                                /FTId=VSP_039426.
FT   VARIANT     324    324       T -> S (in dbSNP:rs6785620).
FT                                /FTId=VAR_051378.
FT   VARIANT     660    660       Y -> S (in dbSNP:rs17855516).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_063400.
FT   HELIX       312    324       {ECO:0000244|PDB:6DEE}.
FT   HELIX       328    345       {ECO:0000244|PDB:6DEE}.
FT   HELIX       350    359       {ECO:0000244|PDB:6DEE}.
FT   HELIX       377    390       {ECO:0000244|PDB:6DED}.
FT   HELIX       401    404       {ECO:0000244|PDB:6DED}.
FT   HELIX       407    423       {ECO:0000244|PDB:6DED}.
FT   HELIX       426    450       {ECO:0000244|PDB:6DED}.
FT   HELIX       454    470       {ECO:0000244|PDB:6DED}.
FT   HELIX       472    480       {ECO:0000244|PDB:6DED}.
FT   HELIX       483    493       {ECO:0000244|PDB:6DED}.
FT   HELIX       498    511       {ECO:0000244|PDB:6DED}.
FT   TURN        512    514       {ECO:0000244|PDB:6DED}.
FT   HELIX       520    524       {ECO:0000244|PDB:6DED}.
FT   HELIX       528    539       {ECO:0000244|PDB:6DED}.
FT   HELIX       550    562       {ECO:0000244|PDB:6DED}.
FT   STRAND      568    570       {ECO:0000244|PDB:6DED}.
FT   HELIX       572    578       {ECO:0000244|PDB:6DED}.
FT   HELIX       584    596       {ECO:0000244|PDB:6DED}.
FT   HELIX       613    621       {ECO:0000244|PDB:6DED}.
FT   HELIX       625    628       {ECO:0000244|PDB:6DED}.
FT   HELIX       633    649       {ECO:0000244|PDB:6DED}.
FT   HELIX       657    670       {ECO:0000244|PDB:6DED}.
FT   HELIX       673    676       {ECO:0000244|PDB:6DED}.
FT   HELIX       680    691       {ECO:0000244|PDB:6DED}.
FT   HELIX       698    713       {ECO:0000244|PDB:6DED}.
FT   HELIX       715    717       {ECO:0000244|PDB:6DED}.
SQ   SEQUENCE   722 AA;  78960 MW;  7683046B94647332 CRC64;
     MYRALYAFRS AEPNALAFAA GETFLVLERS SAHWWLAARA RSGETGYVPP AYLRRLQGLE
     QDVLQAIDRA IEAVHNTAMR DGGKYSLEQR GVLQKLIHHR KETLSRRGPS ASSVAVMTSS
     TSDHHLDAAA ARQPNGVCRA GFERQHSLPS SEHLGADGGL YQIPLPSSQI PPQPRRAAPT
     TPPPPVKRRD REALMASGSG GHNTMPSGGN SVSSGSSVSS TSLDTLYTSS SPSEPGSSCS
     PTPPPVPRRG THTTVSQVQP PPSKASAPEP PAEEEVATGT TSASDDLEAL GTLSLGTTEE
     KAAAEAAVPR TIGAELMELV RRNTGLSHEL CRVAIGIIVG HIQASVPASS PVMEQVLLSL
     VEGKDLSMAL PSGQVCHDQQ RLEVIFADLA RRKDDAQQRS WALYEDEGVI RCYLEELLHI
     LTDADPEVCK KMCKRNEFES VLALVAYYQM EHRASLRLLL LKCFGAMCSL DAAIISTLVS
     SVLPVELARD MQTDTQDHQK LCYSALILAM VFSMGEAVPY AHYEHLGTPF AQFLLNIVED
     GLPLDTTEQL PDLCVNLLLA LNLHLPAADQ NVIMAALSKH ANVKIFSEKL LLLLNRGDDP
     VRIFKHEPQP PHSVLKFLQD VFGSPATAAI FYHTDMMALI DITVRHIADL SPGDKLRMEY
     LSLMHAIVRT TPYLQHRHRL PDLQAILRRI LNEEETSPQC QMDRMIVREM CKEFLVLGEA
     PS
//
ID   OMD_HUMAN               Reviewed;         421 AA.
AC   Q99983; Q5TBF4;
DT   11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   13-FEB-2019, entry version 165.
DE   RecName: Full=Osteomodulin;
DE   AltName: Full=Keratan sulfate proteoglycan osteomodulin;
DE            Short=KSPG osteomodulin;
DE   AltName: Full=Osteoadherin;
DE            Short=OSAD;
DE   Flags: Precursor;
GN   Name=OMD; Synonyms=SLRR2C; ORFNames=UNQ190/PRO216;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Osteoblast;
RA   Ohno I., Hashimoto J., Takaoka K., Ochi T., Okubo K., Matsubara K.;
RT   "The cloning of a cDNA for novel genes expressed in human
RT   osteoblast.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Ohno I., Matsubara K., Okubo K.;
RT   "Human osteomodulin gene: intron-exon junctions and chromosomal
RT   localization.";
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   SULFATION AT TYR-22; TYR-25; TYR-31; TYR-39; TYR-51; TYR-58; TYR-77;
RP   TYR-416 AND TYR-417, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=14551184; DOI=10.1074/jbc.M308689200;
RA   Onnerfjord P., Heathfield T.F., Heinegaard D.;
RT   "Identification of tyrosine sulfation in extracellular leucine-rich
RT   repeat proteins using mass spectrometry.";
RL   J. Biol. Chem. 279:26-33(2004).
CC   -!- FUNCTION: May be implicated in biomineralization processes. Has a
CC       function in binding of osteoblasts via the alpha(V)beta(3)-
CC       integrin (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Binds the alpha(V)beta(3)-integrin. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Bone specific.
CC   -!- PTM: Binds keratan sulfate chains. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the small leucine-rich proteoglycan (SLRP)
CC       family. SLRP class II subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AB000114; BAA19055.1; -; mRNA.
DR   EMBL; AB009589; BAA23982.1; -; Genomic_DNA.
DR   EMBL; AY358872; AAQ89231.1; -; mRNA.
DR   EMBL; AL137848; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471089; EAW62821.1; -; Genomic_DNA.
DR   EMBL; BC046356; AAH46356.1; -; mRNA.
DR   CCDS; CCDS6696.1; -.
DR   RefSeq; NP_005005.1; NM_005014.2.
DR   UniGene; Hs.94070; -.
DR   PDB; 5YQ5; X-ray; 2.17 A; A/B/C/D=21-421.
DR   PDBsum; 5YQ5; -.
DR   ProteinModelPortal; Q99983; -.
DR   SMR; Q99983; -.
DR   BioGrid; 111011; 4.
DR   IntAct; Q99983; 1.
DR   STRING; 9606.ENSP00000364700; -.
DR   GlyConnect; 1588; -.
DR   iPTMnet; Q99983; -.
DR   PhosphoSitePlus; Q99983; -.
DR   BioMuta; OMD; -.
DR   DMDM; 20138850; -.
DR   jPOST; Q99983; -.
DR   PaxDb; Q99983; -.
DR   PeptideAtlas; Q99983; -.
DR   PRIDE; Q99983; -.
DR   ProteomicsDB; 78561; -.
DR   Ensembl; ENST00000375550; ENSP00000364700; ENSG00000127083.
DR   GeneID; 4958; -.
DR   KEGG; hsa:4958; -.
DR   UCSC; uc004asd.5; human.
DR   CTD; 4958; -.
DR   DisGeNET; 4958; -.
DR   EuPathDB; HostDB:ENSG00000127083.7; -.
DR   GeneCards; OMD; -.
DR   HGNC; HGNC:8134; OMD.
DR   HPA; HPA005731; -.
DR   HPA; HPA069948; -.
DR   neXtProt; NX_Q99983; -.
DR   OpenTargets; ENSG00000127083; -.
DR   PharmGKB; PA31921; -.
DR   eggNOG; KOG0619; Eukaryota.
DR   eggNOG; COG4886; LUCA.
DR   GeneTree; ENSGT00940000160986; -.
DR   HOGENOM; HOG000234447; -.
DR   HOVERGEN; HBG108061; -.
DR   InParanoid; Q99983; -.
DR   KO; K08124; -.
DR   OMA; AFYIPRN; -.
DR   OrthoDB; 826997at2759; -.
DR   PhylomeDB; Q99983; -.
DR   TreeFam; TF334562; -.
DR   Reactome; R-HSA-2022854; Keratan sulfate biosynthesis.
DR   Reactome; R-HSA-2022857; Keratan sulfate degradation.
DR   Reactome; R-HSA-3656225; Defective CHST6 causes MCDC1.
DR   Reactome; R-HSA-3656243; Defective ST3GAL3 causes MCT12 and EIEE15.
DR   Reactome; R-HSA-3656244; Defective B4GALT1 causes B4GALT1-CDG (CDG-2d).
DR   SIGNOR; Q99983; -.
DR   GeneWiki; OMD_(gene); -.
DR   GenomeRNAi; 4958; -.
DR   PRO; PR:Q99983; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000127083; Expressed in 161 organ(s), highest expression level in periodontal ligament.
DR   Genevisible; Q99983; HS.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IEA:InterPro.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0018146; P:keratan sulfate biosynthetic process; TAS:Reactome.
DR   GO; GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome.
DR   GO; GO:0030500; P:regulation of bone mineralization; IEA:InterPro.
DR   Gene3D; 3.80.10.10; -; 2.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR000372; LRRNT.
DR   InterPro; IPR030705; Osteomodulin.
DR   PANTHER; PTHR24373:SF155; PTHR24373:SF155; 1.
DR   Pfam; PF13855; LRR_8; 3.
DR   SMART; SM00369; LRR_TYP; 7.
DR   SMART; SM00013; LRRNT; 1.
DR   PROSITE; PS51450; LRR; 8.
PE   1: Evidence at protein level;
KW   3D-structure; Cell adhesion; Complete proteome; Disulfide bond;
KW   Extracellular matrix; Glycoprotein; Leucine-rich repeat; Polymorphism;
KW   Proteoglycan; Reference proteome; Repeat; Secreted; Signal; Sulfation.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    421       Osteomodulin.
FT                                /FTId=PRO_0000032754.
FT   DOMAIN       53     91       LRRNT.
FT   REPEAT       92    113       LRR 1.
FT   REPEAT      116    129       LRR 2.
FT   REPEAT      142    164       LRR 3.
FT   REPEAT      165    184       LRR 4.
FT   REPEAT      187    210       LRR 5.
FT   REPEAT      213    233       LRR 6.
FT   REPEAT      234    255       LRR 7.
FT   REPEAT      258    280       LRR 8.
FT   REPEAT      281    294       LRR 9.
FT   REPEAT      301    321       LRR 10.
FT   REPEAT      331    353       LRR 11.
FT   COMPBIAS     62     78       Cys-rich.
FT   COMPBIAS    385    409       Asp/Glu-rich (acidic).
FT   MOD_RES      22     22       Sulfotyrosine.
FT                                {ECO:0000305|PubMed:14551184}.
FT   MOD_RES      25     25       Sulfotyrosine.
FT                                {ECO:0000305|PubMed:14551184}.
FT   MOD_RES      31     31       Sulfotyrosine.
FT                                {ECO:0000305|PubMed:14551184}.
FT   MOD_RES      39     39       Sulfotyrosine.
FT                                {ECO:0000269|PubMed:14551184}.
FT   MOD_RES      51     51       Sulfotyrosine.
FT                                {ECO:0000305|PubMed:14551184}.
FT   MOD_RES      58     58       Sulfotyrosine.
FT                                {ECO:0000305|PubMed:14551184}.
FT   MOD_RES      77     77       Sulfotyrosine.
FT                                {ECO:0000305|PubMed:14551184}.
FT   MOD_RES     416    416       Sulfotyrosine.
FT                                {ECO:0000269|PubMed:14551184}.
FT   MOD_RES     417    417       Sulfotyrosine.
FT                                {ECO:0000269|PubMed:14551184}.
FT   CARBOHYD    113    113       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    121    121       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    187    187       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    242    242       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    316    316       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    321    353       {ECO:0000250}.
FT   VARIANT     200    200       D -> G (in dbSNP:rs34069871).
FT                                /FTId=VAR_052014.
FT   VARIANT     212    212       E -> G (in dbSNP:rs34413259).
FT                                /FTId=VAR_052015.
FT   VARIANT     221    221       S -> N (in dbSNP:rs34860658).
FT                                /FTId=VAR_052016.
FT   VARIANT     282    282       I -> T (in dbSNP:rs35779901).
FT                                /FTId=VAR_052017.
FT   VARIANT     353    353       C -> W (in dbSNP:rs34059114).
FT                                /FTId=VAR_052018.
FT   STRAND       75     77       {ECO:0000244|PDB:5YQ5}.
FT   STRAND       95     97       {ECO:0000244|PDB:5YQ5}.
FT   HELIX       108    111       {ECO:0000244|PDB:5YQ5}.
FT   STRAND      119    121       {ECO:0000244|PDB:5YQ5}.
FT   HELIX       129    131       {ECO:0000244|PDB:5YQ5}.
FT   TURN        134    139       {ECO:0000244|PDB:5YQ5}.
FT   STRAND      145    147       {ECO:0000244|PDB:5YQ5}.
FT   STRAND      166    168       {ECO:0000244|PDB:5YQ5}.
FT   TURN        179    184       {ECO:0000244|PDB:5YQ5}.
FT   STRAND      190    192       {ECO:0000244|PDB:5YQ5}.
FT   HELIX       200    203       {ECO:0000244|PDB:5YQ5}.
FT   TURN        204    210       {ECO:0000244|PDB:5YQ5}.
FT   STRAND      216    218       {ECO:0000244|PDB:5YQ5}.
FT   STRAND      237    239       {ECO:0000244|PDB:5YQ5}.
FT   HELIX       252    255       {ECO:0000244|PDB:5YQ5}.
FT   STRAND      261    263       {ECO:0000244|PDB:5YQ5}.
FT   TURN        274    277       {ECO:0000244|PDB:5YQ5}.
FT   STRAND      284    286       {ECO:0000244|PDB:5YQ5}.
FT   STRAND      304    306       {ECO:0000244|PDB:5YQ5}.
FT   HELIX       317    320       {ECO:0000244|PDB:5YQ5}.
FT   STRAND      334    336       {ECO:0000244|PDB:5YQ5}.
FT   HELIX       350    353       {ECO:0000244|PDB:5YQ5}.
FT   STRAND      359    361       {ECO:0000244|PDB:5YQ5}.
SQ   SEQUENCE   421 AA;  49492 MW;  CED47B2BC33BB872 CRC64;
     MGFLSPIYVI FFFFGVKVHC QYETYQWDED YDQEPDDDYQ TGFPFRQNVD YGVPFHQYTL
     GCVSECFCPT NFPSSMYCDN RKLKTIPNIP MHIQQLYLQF NEIEAVTANS FINATHLKEI
     NLSHNKIKSQ KIDYGVFAKL PNLLQLHLEH NNLEEFPFPL PKSLERLLLG YNEISKLQTN
     AMDGLVNLTM LDLCYNYLHD SLLKDKIFAK MEKLMQLNLC SNRLESMPPG LPSSLMYLSL
     ENNSISSIPE KYFDKLPKLH TLRMSHNKLQ DIPYNIFNLP NIVELSVGHN KLKQAFYIPR
     NLEHLYLQNN EIEKMNLTVM CPSIDPLHYH HLTYIRVDQN KLKEPISSYI FFCFPHIHTI
     YYGEQRSTNG QTIQLKTQVF RRFPDDDDES EDHDDPDNAH ESPEQEGAEG HFDLHYYENQ
     E
//
ID   PWP2A_HUMAN             Reviewed;         755 AA.
AC   Q96N64; G5EA07; Q2HJJ2; Q8IYR3; Q96PV3;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 2.
DT   13-FEB-2019, entry version 119.
DE   RecName: Full=PWWP domain-containing protein 2A;
GN   Name=PWWP2A; Synonyms=KIAA1935, MST101;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-435.
RC   TISSUE=Brain;
RX   PubMed=11572484; DOI=10.1093/dnares/8.4.179;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XXI.
RT   The complete sequences of 60 new cDNA clones from brain which code for
RT   large proteins.";
RL   DNA Res. 8:179-187(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 241-755.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116 AND SER-119, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81; SER-116 AND SER-119,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102 AND SER-119, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-208, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [14]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH H2AFZ,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=28645917; DOI=10.15252/embj.201695757;
RA   Puenzeler S., Link S., Wagner G., Keilhauer E.C., Kronbeck N.,
RA   Spitzer R.M., Leidescher S., Markaki Y., Mentele E., Regnard C.,
RA   Schneider K., Takahashi D., Kusakabe M., Vardabasso C., Zink L.M.,
RA   Straub T., Bernstein E., Harata M., Leonhardt H., Mann M., Rupp R.A.,
RA   Hake S.B.;
RT   "Multivalent binding of PWWP2A to H2A.Z regulates mitosis and neural
RT   crest differentiation.";
RL   EMBO J. 36:2263-2279(2017).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-208, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: H2A.Z-specific chromatin binding protein which may play
CC       an important role in the neural crest stem cell migration and
CC       differentiation during early development. Also required for proper
CC       mitosis progression. {ECO:0000269|PubMed:28645917}.
CC   -!- SUBUNIT: Interacts with H2A.Z/H2AFZ.
CC       {ECO:0000269|PubMed:28645917}.
CC   -!- INTERACTION:
CC       Q13547:HDAC1; NbExp=5; IntAct=EBI-6597774, EBI-301834;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:28645917}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q96N64-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96N64-2; Sequence=VSP_029547, VSP_029548;
CC       Name=3;
CC         IsoId=Q96N64-3; Sequence=VSP_054064, VSP_054065;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH35076.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB67828.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAB71045.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AB067522; BAB67828.1; ALT_INIT; mRNA.
DR   EMBL; AK055921; BAB71045.1; ALT_INIT; mRNA.
DR   EMBL; AC008706; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61567.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61568.1; -; Genomic_DNA.
DR   EMBL; BC035076; AAH35076.2; ALT_INIT; mRNA.
DR   EMBL; BC105110; AAI05111.1; -; mRNA.
DR   CCDS; CCDS47331.1; -. [Q96N64-2]
DR   CCDS; CCDS47332.1; -. [Q96N64-1]
DR   CCDS; CCDS58990.1; -. [Q96N64-3]
DR   RefSeq; NP_001124336.1; NM_001130864.1. [Q96N64-1]
DR   RefSeq; NP_001253964.1; NM_001267035.1. [Q96N64-3]
DR   RefSeq; NP_443159.1; NM_052927.2. [Q96N64-2]
DR   UniGene; Hs.744960; -.
DR   ProteinModelPortal; Q96N64; -.
DR   SMR; Q96N64; -.
DR   BioGrid; 125375; 10.
DR   IntAct; Q96N64; 13.
DR   STRING; 9606.ENSP00000305151; -.
DR   iPTMnet; Q96N64; -.
DR   PhosphoSitePlus; Q96N64; -.
DR   BioMuta; PWWP2A; -.
DR   DMDM; 160419226; -.
DR   EPD; Q96N64; -.
DR   jPOST; Q96N64; -.
DR   MaxQB; Q96N64; -.
DR   PaxDb; Q96N64; -.
DR   PeptideAtlas; Q96N64; -.
DR   PRIDE; Q96N64; -.
DR   ProteomicsDB; 77468; -.
DR   ProteomicsDB; 77469; -. [Q96N64-2]
DR   Ensembl; ENST00000307063; ENSP00000305151; ENSG00000170234. [Q96N64-1]
DR   Ensembl; ENST00000456329; ENSP00000390462; ENSG00000170234. [Q96N64-2]
DR   Ensembl; ENST00000523662; ENSP00000428143; ENSG00000170234. [Q96N64-3]
DR   GeneID; 114825; -.
DR   KEGG; hsa:114825; -.
DR   UCSC; uc003lxv.5; human. [Q96N64-1]
DR   CTD; 114825; -.
DR   EuPathDB; HostDB:ENSG00000170234.12; -.
DR   GeneCards; PWWP2A; -.
DR   H-InvDB; HIX0005372; -.
DR   HGNC; HGNC:29406; PWWP2A.
DR   HPA; HPA046733; -.
DR   HPA; HPA058233; -.
DR   MIM; 617823; gene.
DR   neXtProt; NX_Q96N64; -.
DR   OpenTargets; ENSG00000170234; -.
DR   PharmGKB; PA162400500; -.
DR   eggNOG; ENOG410IXQI; Eukaryota.
DR   eggNOG; ENOG4111IWH; LUCA.
DR   GeneTree; ENSGT00940000157692; -.
DR   HOGENOM; HOG000060329; -.
DR   HOVERGEN; HBG108311; -.
DR   InParanoid; Q96N64; -.
DR   OMA; ARVSWFG; -.
DR   OrthoDB; 326248at2759; -.
DR   PhylomeDB; Q96N64; -.
DR   TreeFam; TF331271; -.
DR   ChiTaRS; PWWP2A; human.
DR   GenomeRNAi; 114825; -.
DR   PRO; PR:Q96N64; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000170234; Expressed in 199 organ(s), highest expression level in corpus callosum.
DR   ExpressionAtlas; Q96N64; baseline and differential.
DR   Genevisible; Q96N64; HS.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0042393; F:histone binding; IPI:UniProtKB.
DR   InterPro; IPR000313; PWWP_dom.
DR   Pfam; PF00855; PWWP; 1.
DR   SMART; SM00293; PWWP; 1.
DR   PROSITE; PS50812; PWWP; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN         1    755       PWWP domain-containing protein 2A.
FT                                /FTId=PRO_0000311363.
FT   DOMAIN      655    715       PWWP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00162}.
FT   REGION      423    574       Interaction with the H2A.Z/H2AFZ.
FT                                {ECO:0000269|PubMed:28645917}.
FT   COMPBIAS     61    146       Pro-rich.
FT   COMPBIAS    240    291       Pro-rich.
FT   COMPBIAS    575    632       Ser-rich.
FT   MOD_RES      81     81       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     102    102       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     116    116       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     119    119       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   CROSSLNK    208    208       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ     517    520       GEAP -> AQRH (in isoform 3).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_054064.
FT   VAR_SEQ     518    560       EAPSENQSPSKGPEEASSEVQDTNEVHVPGDQDEPQTLGKK
FT                                GS -> LNKWQLLHQTVTSPAAPLQCLTDHCGFRLGALKLT
FT                                VKRAAQRH (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029547.
FT   VAR_SEQ     521    755       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_054065.
FT   VAR_SEQ     561    755       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_029548.
FT   CONFLICT    154    154       S -> L (in Ref. 5; AAH35076).
FT                                {ECO:0000305}.
SQ   SEQUENCE   755 AA;  81960 MW;  6BF89E9C8D68EAA0 CRC64;
     MAAVAAEAAA TAASPGEGGA GEAEPEMEPI PGSEAGTDPL PVTATEASVP DGETDGQQSA
     PQADEPPLPP PPPPPGELAR SPEAVGPELE AEEKLSVRVA ESAAAAPQGG PELPPSPASP
     PEQPPAPEER EEPPLPQPVA PALVPPAGGD STVSQLIPGS EVRVTLDHII EDALVVSFRF
     GEKLFSGVLM DLSKRFGPHG IPVTVFPKRE YKDKPEAMPL QSNTFQEGTE VKCEANGAVP
     DDPSPVPHPE LSLAESLWTS KPPPLFHEGA PYPPPLFIRD TYNQSIPQPP PRKIKRPKRK
     MYREEPTSIM NAIKLRPRQV LCDKCKNSVV AEKKEIRKGS SATDSSKYED KKRRNESVTT
     VNKKLKTDHK VDGKNQNESQ KRNAVVKVSN IAHSRGRVVK VSAQANTSKA QLSTKKVLQS
     KNMDHAKARE VLKIAKEKAQ KKQNETSTSK NAHSKVHFTR RYQNPSSGSL PPRVRLKPQR
     YRNEENDSSL KTGLEKMRSG KMAPKPQSRC TSTRSAGEAP SENQSPSKGP EEASSEVQDT
     NEVHVPGDQD EPQTLGKKGS KNNISVYMTL NQKKSDSSSA SVCSIDSTDD LKSSNSECSS
     SESFDFPPGS MHAPSTSSTS SSSKEEKKLS NSLKMKVFSK NVSKCVTPDG RTICVGDIVW
     AKIYGFPWWP ARILTITVSR KDNGLLVRQE ARISWFGSPT TSFLALSQLS PFLENFQSRF
     NKKRKGLYRK AITEAAKAAK QLTPEVRALL TQFET
//
ID   GNDS_HUMAN              Reviewed;         914 AA.
AC   Q12967; B7Z753; E7ER93; E7ERZ0; Q5T7V4; Q6KH11; Q6PCE1; Q6ZSD5;
AC   Q9HAX7; Q9HAY1; Q9HCT1; Q9P2N8;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   20-JUN-2001, sequence version 2.
DT   13-FEB-2019, entry version 180.
DE   RecName: Full=Ral guanine nucleotide dissociation stimulator;
DE            Short=RalGDS;
DE   AltName: Full=Ral guanine nucleotide exchange factor;
DE            Short=RalGEF;
GN   Name=RALGDS; Synonyms=KIAA1308, RGF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9365783; DOI=10.1017/S0003480097006246;
RA   Humphrey D., Kwiatkowska J., Henske E.P., Haines J.L., Halley D.,
RA   van Slegtenhorst M., Kwiatkowski D.J.;
RT   "Cloning and evaluation of RALGDS as a candidate for the tuberous
RT   sclerosis gene TSC1.";
RL   Ann. Hum. Genet. 61:299-305(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Yu L., Zhao S.Y.;
RL   Submitted (SEP-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 205-912 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 587-914 (ISOFORM 1).
RX   PubMed=7972015; DOI=10.1073/pnas.91.23.11089;
RA   Hofer F., Fields S., Schneider C., Martin G.S.;
RT   "Activated Ras interacts with the Ral guanine nucleotide dissociation
RT   stimulator.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:11089-11093(1994).
RN   [9]
RP   STRUCTURE BY NMR OF 788-884.
RX   PubMed=9302994; DOI=10.1038/nsb0997-694;
RA   Geyer M., Herrmann C., Wohlgemuth S., Wittinghofer A., Kalbitzer H.R.;
RT   "Structure of the Ras-binding domain of RalGEF and implications for
RT   Ras binding and signalling.";
RL   Nat. Struct. Biol. 4:694-699(1997).
RN   [10]
RP   STRUCTURE BY NMR OF 771-886.
RA   Mueller T.D., Handel L., Schmieder P., Oschkinat H.;
RT   "High-resolution structure of the RA-domain of human RalGDS and a
RT   dynamics study of its binding loop to Ras.";
RL   Submitted (MAR-1999) to the PDB data bank.
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-496.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Stimulates the dissociation of GDP from the Ras-related
CC       RalA and RalB GTPases which allows GTP binding and activation of
CC       the GTPases. Interacts and acts as an effector molecule for R-Ras,
CC       H-Ras, K-Ras, and Rap.
CC   -!- SUBUNIT: Interacts with RIT1 and RIT2. {ECO:0000250}.
CC   -!- INTERACTION:
CC       P01112:HRAS; NbExp=3; IntAct=EBI-365861, EBI-350145;
CC       P61224:RAP1B; NbExp=2; IntAct=EBI-365861, EBI-358143;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q03385}.
CC       Nucleus {ECO:0000250|UniProtKB:Q03385}. Note=Localizes mainly in
CC       the peripheral region of the cytoplasmic membrane in oocytes and
CC       in preimplantation embryos until the 8-cell stage. Between the
CC       late 1-cell and the early 2-cell stages, nuclear localization
CC       becomes stronger. After the 4-cell stage, not detected in the
CC       nucleus. {ECO:0000250|UniProtKB:Q03385}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q12967-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q12967-2; Sequence=VSP_035301;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q12967-3; Sequence=VSP_043659;
CC       Name=4;
CC         IsoId=Q12967-4; Sequence=VSP_055215, VSP_055217;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q12967-5; Sequence=VSP_055216;
CC         Note=No experimental confirmation available. Ref.3 (BAC87018)
CC         sequence is in conflict in position: 3:R->W. {ECO:0000305};
CC       Name=6;
CC         IsoId=Q12967-6; Sequence=VSP_055217;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The Ras-associating domain interacts with Ras.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF295773; AAG02122.1; -; mRNA.
DR   EMBL; AK127524; BAC87018.1; -; mRNA.
DR   EMBL; AK301470; BAH13489.1; -; mRNA.
DR   EMBL; AF295775; AAG10221.1; -; Genomic_DNA.
DR   EMBL; AF295778; AAG10221.1; JOINED; Genomic_DNA.
DR   EMBL; AF295780; AAG10225.1; -; Genomic_DNA.
DR   EMBL; AF027169; AAQ13414.1; -; mRNA.
DR   EMBL; AL162417; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471090; EAW88040.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW88042.1; -; Genomic_DNA.
DR   EMBL; BC059362; AAH59362.1; -; mRNA.
DR   EMBL; AB037729; BAA92546.1; -; mRNA.
DR   EMBL; U14417; AAA52360.1; -; mRNA.
DR   CCDS; CCDS43897.1; -. [Q12967-3]
DR   CCDS; CCDS65172.1; -. [Q12967-6]
DR   CCDS; CCDS65173.1; -. [Q12967-5]
DR   CCDS; CCDS65174.1; -. [Q12967-4]
DR   CCDS; CCDS6959.1; -. [Q12967-1]
DR   PIR; I38853; I38853.
DR   RefSeq; NP_001035827.1; NM_001042368.2. [Q12967-3]
DR   RefSeq; NP_001258703.1; NM_001271774.1. [Q12967-4]
DR   RefSeq; NP_001258704.1; NM_001271775.1. [Q12967-5]
DR   RefSeq; NP_001258705.1; NM_001271776.1. [Q12967-6]
DR   RefSeq; NP_006257.1; NM_006266.3. [Q12967-1]
DR   UniGene; Hs.106185; -.
DR   PDB; 1RAX; NMR; -; A=775-886.
DR   PDB; 2B3A; NMR; -; A=798-884.
DR   PDB; 2RGF; NMR; -; A=788-884.
DR   PDB; 3KH0; X-ray; 2.10 A; A/B=793-914.
DR   PDBsum; 1RAX; -.
DR   PDBsum; 2B3A; -.
DR   PDBsum; 2RGF; -.
DR   PDBsum; 3KH0; -.
DR   ProteinModelPortal; Q12967; -.
DR   SMR; Q12967; -.
DR   BioGrid; 111836; 24.
DR   DIP; DIP-31375N; -.
DR   IntAct; Q12967; 21.
DR   MINT; Q12967; -.
DR   STRING; 9606.ENSP00000361120; -.
DR   iPTMnet; Q12967; -.
DR   PhosphoSitePlus; Q12967; -.
DR   BioMuta; RALGDS; -.
DR   DMDM; 14549162; -.
DR   jPOST; Q12967; -.
DR   MaxQB; Q12967; -.
DR   PaxDb; Q12967; -.
DR   PeptideAtlas; Q12967; -.
DR   PRIDE; Q12967; -.
DR   ProteomicsDB; 59058; -.
DR   ProteomicsDB; 59059; -. [Q12967-2]
DR   ProteomicsDB; 59060; -. [Q12967-3]
DR   DNASU; 5900; -.
DR   Ensembl; ENST00000372047; ENSP00000361117; ENSG00000160271. [Q12967-6]
DR   Ensembl; ENST00000372050; ENSP00000361120; ENSG00000160271. [Q12967-1]
DR   Ensembl; ENST00000372062; ENSP00000361132; ENSG00000160271. [Q12967-4]
DR   Ensembl; ENST00000393157; ENSP00000376864; ENSG00000160271. [Q12967-5]
DR   Ensembl; ENST00000393160; ENSP00000376867; ENSG00000160271. [Q12967-3]
DR   GeneID; 5900; -.
DR   KEGG; hsa:5900; -.
DR   UCSC; uc004cco.5; human. [Q12967-1]
DR   CTD; 5900; -.
DR   DisGeNET; 5900; -.
DR   EuPathDB; HostDB:ENSG00000160271.14; -.
DR   GeneCards; RALGDS; -.
DR   H-InvDB; HIX0008210; -.
DR   HGNC; HGNC:9842; RALGDS.
DR   HPA; CAB032582; -.
DR   HPA; HPA025961; -.
DR   MIM; 601619; gene.
DR   neXtProt; NX_Q12967; -.
DR   OpenTargets; ENSG00000160271; -.
DR   PharmGKB; PA34200; -.
DR   eggNOG; KOG3629; Eukaryota.
DR   eggNOG; ENOG410ZUT5; LUCA.
DR   GeneTree; ENSGT00940000153181; -.
DR   HOGENOM; HOG000231592; -.
DR   HOVERGEN; HBG005864; -.
DR   InParanoid; Q12967; -.
DR   KO; K08732; -.
DR   OMA; NDSTYVT; -.
DR   OrthoDB; 940219at2759; -.
DR   PhylomeDB; Q12967; -.
DR   TreeFam; TF315204; -.
DR   Reactome; R-HSA-171007; p38MAPK events.
DR   SIGNOR; Q12967; -.
DR   ChiTaRS; RALGDS; human.
DR   EvolutionaryTrace; Q12967; -.
DR   GeneWiki; RALGDS; -.
DR   GenomeRNAi; 5900; -.
DR   PRO; PR:Q12967; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000160271; Expressed in 231 organ(s), highest expression level in adenohypophysis.
DR   ExpressionAtlas; Q12967; baseline and differential.
DR   Genevisible; Q12967; HS.
DR   GO; GO:0005903; C:brush border; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0030695; F:GTPase regulator activity; IDA:UniProtKB.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0007265; P:Ras protein signal transduction; TAS:Reactome.
DR   CDD; cd00155; RasGEF; 1.
DR   CDD; cd06224; REM; 1.
DR   Gene3D; 1.10.840.10; -; 1.
DR   InterPro; IPR000159; RA_dom.
DR   InterPro; IPR015758; RalGDS.
DR   InterPro; IPR008937; Ras-like_GEF.
DR   InterPro; IPR000651; Ras-like_Gua-exchang_fac_N.
DR   InterPro; IPR019804; Ras_G-nucl-exch_fac_CS.
DR   InterPro; IPR023578; Ras_GEF_dom_sf.
DR   InterPro; IPR001895; RASGEF_cat_dom.
DR   InterPro; IPR036964; RASGEF_cat_dom_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR23113; PTHR23113; 1.
DR   PANTHER; PTHR23113:SF35; PTHR23113:SF35; 1.
DR   Pfam; PF00788; RA; 1.
DR   Pfam; PF00617; RasGEF; 1.
DR   Pfam; PF00618; RasGEF_N; 1.
DR   SMART; SM00314; RA; 1.
DR   SMART; SM00147; RasGEF; 1.
DR   SMART; SM00229; RasGEFN; 1.
DR   SUPFAM; SSF48366; SSF48366; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50200; RA; 1.
DR   PROSITE; PS00720; RASGEF; 1.
DR   PROSITE; PS50009; RASGEF_CAT; 1.
DR   PROSITE; PS50212; RASGEF_NTER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Guanine-nucleotide releasing factor; Nucleus; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    914       Ral guanine nucleotide dissociation
FT                                stimulator.
FT                                /FTId=PRO_0000068877.
FT   DOMAIN      112    249       N-terminal Ras-GEF. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00135}.
FT   DOMAIN      386    648       Ras-GEF. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00168}.
FT   DOMAIN      798    885       Ras-associating. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00166}.
FT   COMPBIAS    714    717       Poly-Ser.
FT   COMPBIAS    753    765       Poly-Ser.
FT   COMPBIAS    839    844       Poly-Glu.
FT   VAR_SEQ       1     61       MVQRMWAEAAGPAGGAEPLFPGSRRSRSVWDAVRLEVGVPD
FT                                SCPVVLHSFTQLDPDLPRPE -> MMVDCQ (in
FT                                isoform 3). {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_043659.
FT   VAR_SEQ       1     61       MVQRMWAEAAGPAGGAEPLFPGSRRSRSVWDAVRLEVGVPD
FT                                SCPVVLHSFTQLDPDLPRPE -> MCLWGHSTAPAHTLSSP
FT                                PLLFCSLPCALHLQPGTGHPPGQVPRK (in isoform
FT                                4). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055215.
FT   VAR_SEQ       1     60       MVQRMWAEAAGPAGGAEPLFPGSRRSRSVWDAVRLEVGVPD
FT                                SCPVVLHSFTQLDPDLPRP -> MAREAGQVCARPAVPRGR
FT                                KGSVFFACVSVVTARRRAVARRAALQSPTPWLAPLPAPATT
FT                                (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055216.
FT   VAR_SEQ     163    174       Missing (in isoform 4 and isoform 6).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055217.
FT   VAR_SEQ     738    912       FWESASQSSPETSGISSASSSTSSSSASTTPVAATRTHKRS
FT                                VSGLCNSSSALPLYNQQVGDCCIIRVSLDVDNGNMYKSILV
FT                                TSQDKAPAVIRKAMDKHNLEEEEPEDYELLQILSDDRKLKI
FT                                PENANVFYAMNSTANYDFVLKKRTFTKGVKVKHGASSTLPR
FT                                MKQKGLKIAKG -> VTACPSPQYPFPSPHSKSMHGARKPW
FT                                ILNTASRRFPIWQLAWGAPTGQWDLLILPSPSVLGISLTVI
FT                                PGDLRHQLSLQQHLVLLSLHHARGCHTHPQALCLRALQLQL
FT                                RAAALQPAGGRLLYHPRQPGRGQWQHVQEHPGKPAGVAWVP
FT                                PSTGGKCTLNTVHHPCPPGVYLVVGGEGQMSARYRNEEGSD
FT                                QGQGWPEGRGGGKEQPCKAPRS (in isoform 2).
FT                                {ECO:0000303|PubMed:10718198}.
FT                                /FTId=VSP_035301.
FT   VARIANT     496    496       R -> L (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035822.
FT   CONFLICT     97     97       L -> F (in Ref. 3; BAC87018).
FT                                {ECO:0000305}.
FT   CONFLICT    869    869       A -> T (in Ref. 3; BAH13489).
FT                                {ECO:0000305}.
FT   STRAND      791    793       {ECO:0000244|PDB:2RGF}.
FT   STRAND      795    797       {ECO:0000244|PDB:3KH0}.
FT   STRAND      799    807       {ECO:0000244|PDB:3KH0}.
FT   STRAND      809    820       {ECO:0000244|PDB:3KH0}.
FT   HELIX       825    835       {ECO:0000244|PDB:3KH0}.
FT   TURN        836    839       {ECO:0000244|PDB:2RGF}.
FT   HELIX       843    845       {ECO:0000244|PDB:3KH0}.
FT   STRAND      846    853       {ECO:0000244|PDB:3KH0}.
FT   STRAND      856    859       {ECO:0000244|PDB:3KH0}.
FT   STRAND      862    864       {ECO:0000244|PDB:2B3A}.
FT   HELIX       866    869       {ECO:0000244|PDB:3KH0}.
FT   STRAND      877    882       {ECO:0000244|PDB:3KH0}.
SQ   SEQUENCE   914 AA;  100607 MW;  EA5A5CF25AF3D523 CRC64;
     MVQRMWAEAA GPAGGAEPLF PGSRRSRSVW DAVRLEVGVP DSCPVVLHSF TQLDPDLPRP
     ESSTQEIGEE LINGVIYSIS LRKVQLHHGG NKGQRWLGYE NESALNLYET CKVRTVKAGT
     LEKLVEHLVP AFQGSDLSYV TIFLCTYRAF TTTQQVLDLL FKRYGRCDAL TASSRYGCIL
     PYSDEDGGPQ DQLKNAISSI LGTWLDQYSE DFCQPPDFPC LKQLVAYVQL NMPGSDLERR
     AHLLLAQLEH SEPIEAEPEA LSPVPALKPT PELELALTPA RAPSPVPAPA PEPEPAPTPA
     PGSELEVAPA PAPELQQAPE PAVGLESAPA PALELEPAPE QDPAPSQTLE LEPAPAPVPS
     LQPSWPSPVV AENGLSEEKP HLLVFPPDLV AEQFTLMDAE LFKKVVPYHC LGSIWSQRDK
     KGKEHLAPTI RATVTQFNSV ANCVITTCLG NRSTKAPDRA RVVEHWIEVA RECRILKNFS
     SLYAILSALQ SNSIHRLKKT WEDVSRDSFR IFQKLSEIFS DENNYSLSRE LLIKEGTSKF
     ATLEMNPKRA QKRPKETGII QGTVPYLGTF LTDLVMLDTA MKDYLYGRLI NFEKRRKEFE
     VIAQIKLLQS ACNNYSIAPD EQFGAWFRAV ERLSETESYN LSCELEPPSE SASNTLRTKK
     NTAIVKRWSD RQAPSTELST SGSSHSKSCD QLRCGPYLSS GDIADALSVH SAGSSSSDVE
     EINISFVPES PDGQEKKFWE SASQSSPETS GISSASSSTS SSSASTTPVA ATRTHKRSVS
     GLCNSSSALP LYNQQVGDCC IIRVSLDVDN GNMYKSILVT SQDKAPAVIR KAMDKHNLEE
     EEPEDYELLQ ILSDDRKLKI PENANVFYAM NSTANYDFVL KKRTFTKGVK VKHGASSTLP
     RMKQKGLKIA KGIF
//
ID   Q8N4Y1_HUMAN            Unreviewed;       411 AA.
AC   Q8N4Y1;
DT   01-OCT-2002, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2002, sequence version 1.
DT   16-JAN-2019, entry version 107.
DE   SubName: Full=Uncharacterized protein {ECO:0000313|EMBL:AAH33198.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH33198.1};
RN   [1] {ECO:0000313|EMBL:AAH33198.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Primary B-Cells {ECO:0000313|EMBL:AAH33198.1};
RA   Strausberg R.;
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; BC033198; AAH33198.1; -; mRNA.
DR   RefSeq; NP_001035827.1; NM_001042368.2.
DR   RefSeq; NP_001258703.1; NM_001271774.1.
DR   RefSeq; NP_001258704.1; NM_001271775.1.
DR   RefSeq; NP_001258705.1; NM_001271776.1.
DR   RefSeq; NP_006257.1; NM_006266.3.
DR   UniGene; Hs.106185; -.
DR   ProteinModelPortal; Q8N4Y1; -.
DR   PeptideAtlas; Q8N4Y1; -.
DR   PRIDE; Q8N4Y1; -.
DR   DNASU; 5900; -.
DR   GeneID; 5900; -.
DR   KEGG; hsa:5900; -.
DR   CTD; 5900; -.
DR   PharmGKB; PA34200; -.
DR   eggNOG; KOG3629; Eukaryota.
DR   eggNOG; ENOG410ZUT5; LUCA.
DR   HOVERGEN; HBG005864; -.
DR   KO; K08732; -.
DR   OrthoDB; 940219at2759; -.
DR   GenomeRNAi; 5900; -.
DR   Genevisible; Q8N4Y1; HS.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   Gene3D; 1.10.840.10; -; 1.
DR   InterPro; IPR000159; RA_dom.
DR   InterPro; IPR015758; RalGDS.
DR   InterPro; IPR008937; Ras-like_GEF.
DR   InterPro; IPR019804; Ras_G-nucl-exch_fac_CS.
DR   InterPro; IPR023578; Ras_GEF_dom_sf.
DR   InterPro; IPR001895; RASGEF_cat_dom.
DR   InterPro; IPR036964; RASGEF_cat_dom_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR23113; PTHR23113; 1.
DR   PANTHER; PTHR23113:SF35; PTHR23113:SF35; 1.
DR   Pfam; PF00788; RA; 1.
DR   Pfam; PF00617; RasGEF; 1.
DR   SMART; SM00314; RA; 1.
DR   SMART; SM00147; RasGEF; 1.
DR   SUPFAM; SSF48366; SSF48366; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50200; RA; 1.
DR   PROSITE; PS00720; RASGEF; 1.
DR   PROSITE; PS50009; RASGEF_CAT; 1.
PE   2: Evidence at transcript level;
KW   Guanine-nucleotide releasing factor {ECO:0000256|PROSITE-
KW   ProRule:PRU00168, ECO:0000256|SAAS:SAAS01081641}.
FT   DOMAIN        1    145       Ras-GEF. {ECO:0000259|PROSITE:PS50009}.
FT   DOMAIN      295    382       Ras-associating.
FT                                {ECO:0000259|PROSITE:PS50200}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAH33198.1}.
SQ   SEQUENCE   411 AA;  45526 MW;  114CF1F26F923B79 CRC64;
     VSRDSFRIFQ KLSEIFSDEN NYSLSRELLI KEGTSKFATL EMNPKRAQKR PKETGIIQGT
     VPYLGTFLTD LVMLDTAMKD YLYGRLINFE KRRKEFEVIA QIKLLQSACN NYSIAPDEQF
     GAWFRAVERL SETESYNLSC ELEPPSESAS NTLRTKKNTA IVKRWSDRQA PSTELSTSGS
     SHSKSCDQLR CGPYLSSGDI ADALSVHSAG SSSSDVEEIN ISFVPESPDG QEKKFWESAS
     QSSPETSGIS SASSSTSSSS ASTTPVAATR THKRSVSGLC NSSSALPLYN QQVGDCCIIR
     VSLDVDNGNM YKSILVTSQD KAPAVIRKAM DKHNLEEEEP EDYELLQILS DDRKLKIPEN
     ANVFYAMNST ANYDFVLKKR TFTKGVKVKH GASSTLPRMK QKGLKIAKGI F
//
ID   SNX29_HUMAN             Reviewed;         813 AA.
AC   Q8TEQ0; B5MDW2; Q8N2X2; Q9HA26;
DT   21-AUG-2007, integrated into UniProtKB/Swiss-Prot.
DT   19-OCT-2011, sequence version 3.
DT   13-FEB-2019, entry version 115.
DE   RecName: Full=Sorting nexin-29;
DE   AltName: Full=RUN domain-containing protein 2A;
GN   Name=SNX29; Synonyms=RUNDC2A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-375 (ISOFORM 1).
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 441-813 (ISOFORM 1).
RC   TISSUE=Spleen;
RX   PubMed=12693554; DOI=10.1093/dnares/10.1.49;
RA   Jikuya H., Takano J., Kikuno R., Hirosawa M., Nagase T., Nomura N.,
RA   Ohara O.;
RT   "Characterization of long cDNA clones from human adult spleen. II. The
RT   complete sequences of 81 cDNA clones.";
RL   DNA Res. 10:49-57(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 512-813 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268 AND SER-330, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TEQ0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TEQ0-2; Sequence=VSP_027281;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the sorting nexin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14033.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AC007216; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC007598; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC007601; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010333; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092365; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131391; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK022425; BAB14033.1; ALT_SEQ; mRNA.
DR   EMBL; AK074072; BAB84898.1; -; mRNA.
DR   EMBL; BC029857; AAH29857.1; -; mRNA.
DR   CCDS; CCDS10553.2; -. [Q8TEQ0-1]
DR   RefSeq; NP_115543.3; NM_032167.4. [Q8TEQ0-1]
DR   UniGene; Hs.458401; -.
DR   ProteinModelPortal; Q8TEQ0; -.
DR   SMR; Q8TEQ0; -.
DR   BioGrid; 124903; 10.
DR   IntAct; Q8TEQ0; 8.
DR   iPTMnet; Q8TEQ0; -.
DR   PhosphoSitePlus; Q8TEQ0; -.
DR   BioMuta; SNX29; -.
DR   DMDM; 353526314; -.
DR   EPD; Q8TEQ0; -.
DR   jPOST; Q8TEQ0; -.
DR   MaxQB; Q8TEQ0; -.
DR   PaxDb; Q8TEQ0; -.
DR   PeptideAtlas; Q8TEQ0; -.
DR   PRIDE; Q8TEQ0; -.
DR   ProteomicsDB; 74476; -.
DR   ProteomicsDB; 74477; -. [Q8TEQ0-2]
DR   DNASU; 92017; -.
DR   Ensembl; ENST00000566228; ENSP00000456480; ENSG00000048471. [Q8TEQ0-1]
DR   GeneID; 92017; -.
DR   KEGG; hsa:92017; -.
DR   UCSC; uc002dby.6; human. [Q8TEQ0-1]
DR   CTD; 92017; -.
DR   EuPathDB; HostDB:ENSG00000048471.13; -.
DR   GeneCards; SNX29; -.
DR   H-InvDB; HIX0012826; -.
DR   HGNC; HGNC:30542; SNX29.
DR   HPA; HPA008889; -.
DR   neXtProt; NX_Q8TEQ0; -.
DR   OpenTargets; ENSG00000048471; -.
DR   PharmGKB; PA142670962; -.
DR   PharmGKB; PA162404312; -.
DR   eggNOG; KOG4381; Eukaryota.
DR   eggNOG; ENOG410XRAX; LUCA.
DR   GeneTree; ENSGT00730000110975; -.
DR   HOGENOM; HOG000154364; -.
DR   HOVERGEN; HBG108498; -.
DR   InParanoid; Q8TEQ0; -.
DR   KO; K17935; -.
DR   OMA; HEQERFS; -.
DR   OrthoDB; 543799at2759; -.
DR   ChiTaRS; SNX29; human.
DR   GenomeRNAi; 92017; -.
DR   PRO; PR:Q8TEQ0; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000048471; Expressed in 193 organ(s), highest expression level in metanephros.
DR   ExpressionAtlas; Q8TEQ0; baseline and differential.
DR   Genevisible; Q8TEQ0; HS.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IEA:InterPro.
DR   CDD; cd07277; PX_RUN; 1.
DR   Gene3D; 3.30.1520.10; -; 1.
DR   InterPro; IPR001683; Phox.
DR   InterPro; IPR036871; PX_dom_sf.
DR   InterPro; IPR004012; Run_dom.
DR   InterPro; IPR037213; Run_dom_sf.
DR   InterPro; IPR037916; SNX29_PX.
DR   Pfam; PF00787; PX; 1.
DR   Pfam; PF02759; RUN; 1.
DR   SMART; SM00312; PX; 1.
DR   SMART; SM00593; RUN; 1.
DR   SUPFAM; SSF140741; SSF140741; 1.
DR   SUPFAM; SSF64268; SSF64268; 1.
DR   PROSITE; PS50195; PX; 1.
DR   PROSITE; PS50826; RUN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN         1    813       Sorting nexin-29.
FT                                /FTId=PRO_0000297565.
FT   DOMAIN       36    180       RUN. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00178}.
FT   DOMAIN      656    779       PX. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00147}.
FT   COILED      466    545       {ECO:0000255}.
FT   MOD_RES     268    268       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     291    291       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D3S3}.
FT   MOD_RES     292    292       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D3S3}.
FT   MOD_RES     330    330       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     344    344       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D3S3}.
FT   MOD_RES     445    445       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D3S3}.
FT   MOD_RES     450    450       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D3S3}.
FT   MOD_RES     639    639       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D3S3}.
FT   MOD_RES     641    641       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9D3S3}.
FT   MOD_RES     642    642       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D3S3}.
FT   MOD_RES     646    646       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D3S3}.
FT   VAR_SEQ     775    813       ITPPGEPVNSRPKAASRFPKLSRGQPRETRNVEPQSGDL
FT                                -> WISLFGNGRDSSREEFSSS (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_027281.
FT   CONFLICT    183    183       N -> D (in Ref. 2; BAB14033).
FT                                {ECO:0000305}.
FT   CONFLICT    344    344       S -> G (in Ref. 2; BAB14033).
FT                                {ECO:0000305}.
SQ   SEQUENCE   813 AA;  91254 MW;  A1868A682CCFBE0C CRC64;
     MSGSQNNDKR QFLLERLLDA VKQCQIRFGG RKEIASDSDS RVTCLCAQFE AVLQHGLKRS
     RGLALTAAAI KQAAGFASKT ETEPVFWYYV KEVLNKHELQ RFYSLRHIAS DVGRGRAWLR
     CALNEHSLER YLHMLLADRC RLSTFYEDWS FVMDEERSSM LPTMAAGLNS ILFAINIDNK
     DLNGQSKFAP TVSDLLKEST QNVTSLLKES TQGVSSLFRE ITASSAVSIL IKPEQETDPL
     PVVSRNVSAD AKCKKERKKK KKVTNIISFD DEEDEQNSGD VFKKTPGAGE SSEDNSDRSS
     VNIMSAFESP FGPNSNGSQS SNSWKIDSLS LNGEFGYQKL DVKSIDDEDV DENEDDVYGN
     SSGRKHRGHS ESPEKPLEGN TCLSQMHSWA PLKVLHNDSD ILFPVSGVGS YSPADAPLGS
     LENGTGPEDH VLPDPGLRYS VEASSPGHGS PLSSLLPSAS VPESMTISEL RQATVAMMNR
     KDELEEENRS LRNLLDGEME HSAALRQEVD TLKRKVAEQE ERQGMKVQAL ARENEVLKVQ
     LKKYVGAVQM LKREGQTAEV PNLWSVDGEV TVAEQKPGEI AEELASSYER KLIEVAEMHG
     ELIEFNERLH RALVAKEALV SQMRQELIDL RGPVPGDLSQ TSEDQSLSDF EISNRALINV
     WIPSVFLRGK AANAFHVYQV YIRIKDDEWN IYRRYTEFRS LHHKLQNKYP QVRAYNFPPK
     KAIGNKDAKF VEERRKQLQN YLRSVMNKVI QMVPEFAASP KKETLIQLMP FFVDITPPGE
     PVNSRPKAAS RFPKLSRGQP RETRNVEPQS GDL
//
ID   S10A7_HUMAN             Reviewed;         101 AA.
AC   P31151; Q5SY67; Q6FGE3; Q9H1E2;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   26-FEB-2008, sequence version 4.
DT   13-FEB-2019, entry version 188.
DE   RecName: Full=Protein S100-A7;
DE   AltName: Full=Psoriasin;
DE   AltName: Full=S100 calcium-binding protein A7;
GN   Name=S100A7; Synonyms=PSOR1, S100A7C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASP-28.
RC   TISSUE=Keratinocyte;
RX   PubMed=1940442; DOI=10.1111/1523-1747.ep12484041;
RA   Madsen P., Rasmussen H.H., Leffers H., Honore B., Dejgaard K.,
RA   Olsen E., Kiil J., Walbum E., Andersen A.H., Basse B., Lauridsen J.B.,
RA   Ratz G.P., Celis A., Vandekerckhove J., Celis J.E.;
RT   "Molecular cloning, occurrence, and expression of a novel partially
RT   secreted protein 'psoriasin' that is highly up-regulated in psoriatic
RT   skin.";
RL   J. Invest. Dermatol. 97:701-712(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASP-28.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ASP-28.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-89, AND VARIANT ASP-28.
RA   Glaeser R., Harder J., Christophers E., Schroeder J.M.;
RT   "Genomic organization of human psoriasin (S100A7) gene.";
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PROTEIN SEQUENCE OF 2-101, MASS SPECTROMETRY, AND ACETYLATION AT
RP   SER-2.
RC   TISSUE=Psoriatic skin;
RX   PubMed=8526920; DOI=10.1006/bbrc.1995.2772;
RA   Burgisser D.M., Siegenthaler G., Kuster T., Hellman U., Hunziker P.,
RA   Birchler N., Heizmann C.W.;
RT   "Amino acid sequence analysis of human S100A7 (psoriasin) by tandem
RT   mass spectrometry.";
RL   Biochem. Biophys. Res. Commun. 217:257-263(1995).
RN   [7]
RP   PROTEIN SEQUENCE OF 9-19; 38-48; 50-61; 69-87 AND 89-101.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [8]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=8618345; DOI=10.1016/S0022-5347(01)66118-4;
RA   Celis J.E., Rasmussen H.H., Vorum H., Madsen P., Honore B., Wolf H.,
RA   Orntoft T.F.;
RT   "Bladder squamous cell carcinomas express psoriasin and externalize it
RT   to the urine.";
RL   J. Urol. 155:2105-2112(1996).
RN   [9]
RP   INTERACTION WITH RANBP9.
RX   PubMed=12421467; DOI=10.1186/1471-2407-2-28;
RA   Emberley E.D., Gietz R.D., Campbell J.D., Hayglass K.T., Murphy L.C.,
RA   Watson P.H.;
RT   "RanBPM interacts with psoriasin in vitro and their expression
RT   correlates with specific clinical features in vivo in breast cancer.";
RL   BMC Cancer 2:28-28(2002).
RN   [10]
RP   GENOMIC ORGANIZATION.
RX   PubMed=12664160; DOI=10.1007/s00239-002-2410-5;
RA   Kulski J.K., Lim C.P., Dunn D.S., Bellgard M.;
RT   "Genomic and phylogenetic analysis of the S100A7 (psoriasin) gene
RT   duplications within the region of the S100 gene cluster on human
RT   chromosome 1q21.";
RL   J. Mol. Evol. 56:397-406(2003).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.05 ANGSTROMS).
RX   PubMed=9562557; DOI=10.1016/S0969-2126(98)00049-5;
RA   Brodersen D.E., Etzerodt M., Madsen P., Celis J.E., Thoegersen H.C.,
RA   Nyborg J., Kjeldgaard M.;
RT   "EF-hands at atomic resolution: the structure of human psoriasin
RT   (S100A7) solved by MAD phasing.";
RL   Structure 6:477-489(1998).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS).
RX   PubMed=10026247; DOI=10.1021/bi982483d;
RA   Brodersen D.E., Nyborg J., Kjeldgaard M.;
RT   "Zinc-binding site of an S100 protein revealed. Two crystal structures
RT   of Ca2+-bound human psoriasin (S100A7) in the Zn2+-loaded and Zn2+-
RT   free states.";
RL   Biochemistry 38:1695-1704(1999).
CC   -!- SUBUNIT: Interacts with RANBP9. {ECO:0000269|PubMed:12421467}.
CC   -!- INTERACTION:
CC       Q96S59:RANBP9; NbExp=3; IntAct=EBI-357520, EBI-636085;
CC       Q5SY68:S100A7L2; NbExp=4; IntAct=EBI-357520, EBI-12006206;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:8618345}.
CC       Secreted {ECO:0000269|PubMed:8618345}. Note=Secreted by a non-
CC       classical secretory pathway.
CC   -!- TISSUE SPECIFICITY: Fetal ear, skin, and tongue and human cell
CC       lines. Highly up-regulated in psoriatic epidermis. Also highly
CC       expressed in the urine of bladder squamous cell carcinoma (SCC)
CC       bearing patients. {ECO:0000269|PubMed:8618345}.
CC   -!- MASS SPECTROMETRY: Mass=11365; Mass_error=0.7;
CC       Method=Electrospray; Range=2-101;
CC       Evidence={ECO:0000269|PubMed:8526920};
CC   -!- SIMILARITY: Belongs to the S-100 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/S100A7ID42194ch1q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; M86757; AAA60210.1; -; mRNA.
DR   EMBL; CR542164; CAG46961.1; -; mRNA.
DR   EMBL; AL591704; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC034687; AAH34687.1; -; mRNA.
DR   EMBL; AJ012825; CAC20409.1; -; Genomic_DNA.
DR   EMBL; BR000043; FAA00017.1; -; Genomic_DNA.
DR   CCDS; CCDS1039.1; -.
DR   PIR; A54327; A54327.
DR   RefSeq; NP_002954.2; NM_002963.3.
DR   UniGene; Hs.112408; -.
DR   PDB; 1PSR; X-ray; 1.05 A; A/B=2-101.
DR   PDB; 2PSR; X-ray; 2.05 A; A=2-101.
DR   PDB; 2WND; X-ray; 1.60 A; A=2-97.
DR   PDB; 2WOR; X-ray; 1.70 A; A=2-101.
DR   PDB; 2WOS; X-ray; 1.70 A; A=2-101.
DR   PDB; 3PSR; X-ray; 2.50 A; A/B=2-101.
DR   PDB; 4AQJ; X-ray; 1.60 A; A=1-101.
DR   PDBsum; 1PSR; -.
DR   PDBsum; 2PSR; -.
DR   PDBsum; 2WND; -.
DR   PDBsum; 2WOR; -.
DR   PDBsum; 2WOS; -.
DR   PDBsum; 3PSR; -.
DR   PDBsum; 4AQJ; -.
DR   ProteinModelPortal; P31151; -.
DR   SMR; P31151; -.
DR   BioGrid; 112186; 60.
DR   IntAct; P31151; 23.
DR   STRING; 9606.ENSP00000357711; -.
DR   DrugBank; DB04474; 1-Anilino-8-Naphthalene Sulfonate.
DR   iPTMnet; P31151; -.
DR   PhosphoSitePlus; P31151; -.
DR   BioMuta; S100A7; -.
DR   DMDM; 172046820; -.
DR   UCD-2DPAGE; P31151; -.
DR   EPD; P31151; -.
DR   jPOST; P31151; -.
DR   MaxQB; P31151; -.
DR   PaxDb; P31151; -.
DR   PeptideAtlas; P31151; -.
DR   PRIDE; P31151; -.
DR   ProteomicsDB; 54761; -.
DR   TopDownProteomics; P31151; -.
DR   DNASU; 6278; -.
DR   Ensembl; ENST00000368722; ENSP00000357711; ENSG00000143556.
DR   Ensembl; ENST00000368723; ENSP00000357712; ENSG00000143556.
DR   GeneID; 6278; -.
DR   KEGG; hsa:6278; -.
DR   UCSC; uc001fbv.2; human.
DR   CTD; 6278; -.
DR   DisGeNET; 6278; -.
DR   EuPathDB; HostDB:ENSG00000143556.8; -.
DR   GeneCards; S100A7; -.
DR   H-InvDB; HIX0200006; -.
DR   HGNC; HGNC:10497; S100A7.
DR   HPA; CAB001453; -.
DR   HPA; CAB033766; -.
DR   HPA; HPA006997; -.
DR   MIM; 600353; gene.
DR   neXtProt; NX_P31151; -.
DR   OpenTargets; ENSG00000143556; -.
DR   PharmGKB; PA34909; -.
DR   eggNOG; ENOG410JEQ8; Eukaryota.
DR   eggNOG; ENOG41114XT; LUCA.
DR   GeneTree; ENSGT00940000163488; -.
DR   HOGENOM; HOG000154231; -.
DR   HOVERGEN; HBG095357; -.
DR   InParanoid; P31151; -.
DR   KO; K21126; -.
DR   OMA; SHGAPAC; -.
DR   OrthoDB; 1486203at2759; -.
DR   PhylomeDB; P31151; -.
DR   TreeFam; TF341148; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-6799990; Metal sequestration by antimicrobial proteins.
DR   EvolutionaryTrace; P31151; -.
DR   GeneWiki; S100A7; -.
DR   GenomeRNAi; 6278; -.
DR   PRO; PR:P31151; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143556; Expressed in 76 organ(s), highest expression level in ectocervix.
DR   Genevisible; P31151; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0050786; F:RAGE receptor binding; IPI:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; NAS:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; NAS:UniProtKB.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IMP:UniProtKB.
DR   GO; GO:0019730; P:antimicrobial humoral response; TAS:Reactome.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; IMP:UniProtKB.
DR   GO; GO:0008544; P:epidermis development; TAS:ProtInc.
DR   GO; GO:0045087; P:innate immune response; NAS:UniProtKB.
DR   GO; GO:0030216; P:keratinocyte differentiation; NAS:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:UniProtKB.
DR   GO; GO:0071624; P:positive regulation of granulocyte chemotaxis; IDA:UniProtKB.
DR   GO; GO:0090026; P:positive regulation of monocyte chemotaxis; IDA:UniProtKB.
DR   GO; GO:0010820; P:positive regulation of T cell chemotaxis; IDA:UniProtKB.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:UniProtKB.
DR   GO; GO:0000302; P:response to reactive oxygen species; IDA:UniProtKB.
DR   GO; GO:0051238; P:sequestering of metal ion; IDA:UniProtKB.
DR   CDD; cd00213; S-100; 1.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR034325; S-100_dom.
DR   InterPro; IPR001751; S100/CaBP-9k_CS.
DR   InterPro; IPR013787; S100_Ca-bd_sub.
DR   InterPro; IPR028477; S100A7.
DR   PANTHER; PTHR11639:SF64; PTHR11639:SF64; 1.
DR   Pfam; PF01023; S_100; 1.
DR   SMART; SM01394; S_100; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
DR   PROSITE; PS00303; S100_CABP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Calcium; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disulfide bond; Metal-binding;
KW   Polymorphism; Reference proteome; Repeat; Secreted; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:8526920}.
FT   CHAIN         2    101       Protein S100-A7.
FT                                /FTId=PRO_0000143990.
FT   DOMAIN       13     48       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN       50     85       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND      63     74       2; high affinity.
FT   METAL        18     18       Zinc.
FT   METAL        25     25       Zinc.
FT   METAL        87     87       Zinc.
FT   METAL        91     91       Zinc.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000269|PubMed:8526920}.
FT   DISULFID     47     96
FT   VARIANT      28     28       E -> D (in dbSNP:rs3014837).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:1940442,
FT                                ECO:0000269|Ref.2, ECO:0000269|Ref.5}.
FT                                /FTId=VAR_039118.
FT   HELIX         5     19       {ECO:0000244|PDB:1PSR}.
FT   HELIX        29     39       {ECO:0000244|PDB:1PSR}.
FT   HELIX        41     49       {ECO:0000244|PDB:1PSR}.
FT   HELIX        54     56       {ECO:0000244|PDB:1PSR}.
FT   HELIX        58     62       {ECO:0000244|PDB:1PSR}.
FT   STRAND       67     70       {ECO:0000244|PDB:2WND}.
FT   HELIX        72     89       {ECO:0000244|PDB:1PSR}.
FT   TURN         90     92       {ECO:0000244|PDB:1PSR}.
SQ   SEQUENCE   101 AA;  11471 MW;  02C4CE39BF140971 CRC64;
     MSNTQAERSI IGMIDMFHKY TRRDDKIEKP SLLTMMKENF PNFLSACDKK GTNYLADVFE
     KKDKNEDKKI DFSEFLSLLG DIATDYHKQS HGAAPCSGGS Q
//
ID   SEPT5_HUMAN             Reviewed;         369 AA.
AC   Q99719; O15251; Q96MY5;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   13-FEB-2019, entry version 171.
DE   RecName: Full=Septin-5;
DE   AltName: Full=Cell division control-related protein 1;
DE            Short=CDCrel-1;
DE   AltName: Full=Peanut-like protein 1;
GN   Name=SEPT5; Synonyms=PNUTL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9022087; DOI=10.1172/JCI119188;
RA   Zieger B., Hashimoto Y., Ware J.;
RT   "Alternative expression of platelet glycoprotein Ib(beta) mRNA from an
RT   adjacent 5' gene with an imperfect polyadenylation signal sequence.";
RL   J. Clin. Invest. 99:520-525(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=9385360; DOI=10.1007/s004390050576;
RA   McKie J., Sutherland H., Harvey E., Kim U.J., Scambler P.J.;
RT   "A human gene similar to Drosophila melanogaster peanut maps to the
RT   DiGeorge syndrome region of 22q11.";
RL   Hum. Genet. 101:6-12(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=9611266; DOI=10.1016/S0378-1119(98)00146-2;
RA   Yagi M., Zieger B., Roth G.J., Ware J.;
RT   "Structure and expression of the human septin gene HCDCREL-1.";
RL   Gene 212:229-236(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 23-36; 42-71; 82-90; 182-190; 297-308 AND 325-343,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   INTERACTION WITH SEPT8, AND TISSUE SPECIFICITY.
RX   PubMed=12023038; DOI=10.1016/S0014-5793(02)02749-7;
RA   Blaeser S., Jersch K., Hainmann I., Wunderle D., Zgaga-Griesz A.,
RA   Busse A., Zieger B.;
RT   "Human septin-septin interaction: CDCrel-1 partners with KIAA0202.";
RL   FEBS Lett. 519:169-172(2002).
RN   [11]
RP   IDENTIFICATION IN A COMPLEX WITH STX4, AND PHOSPHORYLATION.
RX   PubMed=11880646; DOI=10.1073/pnas.052715199;
RA   Dent J., Kato K., Peng X.-R., Martinez C., Cattaneo M., Poujol C.,
RA   Nurden P., Nurden A., Trimble W.S., Ware J.;
RT   "A prototypic platelet septin and its participation in secretion.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:3064-3069(2002).
RN   [12]
RP   POSSIBLE INVOLVEMENT IN PRKN.
RX   PubMed=14530399; DOI=10.1073/pnas.2132992100;
RA   Dong Z., Ferger B., Paterna J.-C., Vogel D., Furler S., Osinde M.,
RA   Feldon J., Bueeler H.;
RT   "Dopamine-dependent neurodegeneration in rats induced by viral vector-
RT   mediated overexpression of the parkin target protein, CDCrel-1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:12438-12443(2003).
RN   [13]
RP   TISSUE SPECIFICITY.
RX   PubMed=15915442; DOI=10.1002/path.1789;
RA   Hall P.A., Jung K., Hillan K.J., Russell S.E.H.;
RT   "Expression profiling the human septin gene family.";
RL   J. Pathol. 206:269-278(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225 AND SER-327, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225 AND SER-327, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Filament-forming cytoskeletal GTPase (By similarity).
CC       May play a role in cytokinesis (Potential). May play a role in
CC       platelet secretion (By similarity). {ECO:0000250, ECO:0000305}.
CC   -!- SUBUNIT: Septins polymerize into heterooligomeric protein
CC       complexes that form filaments, and can associate with cellular
CC       membranes, actin filaments and microtubules. GTPase activity is
CC       required for filament formation (By similarity). Interacts with
CC       SEPT2 and SEPT5. In platelets, associated with a complex
CC       containing STX4. Interacts with PRKN. This interaction leads to
CC       SEPT5 ubiquitination and degradation (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q8WYJ6:SEPT1; NbExp=9; IntAct=EBI-373345, EBI-693002;
CC       B5ME97:SEPT10; NbExp=3; IntAct=EBI-373345, EBI-10176098;
CC       Q9P0V9:SEPT10; NbExp=3; IntAct=EBI-373345, EBI-3943788;
CC       Q9NVA2:SEPT11; NbExp=9; IntAct=EBI-373345, EBI-957999;
CC       Q15019:SEPT2; NbExp=4; IntAct=EBI-373345, EBI-741220;
CC       Q14141:SEPT6; NbExp=5; IntAct=EBI-373345, EBI-745901;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cytoplasm,
CC       cytoskeleton {ECO:0000250}. Note=In platelets, found in areas
CC       surrounding alpha-granules.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q99719-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99719-2; Sequence=VSP_042689, VSP_042690;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in the CNS, as well
CC       as in heart and platelets (at protein level).
CC       {ECO:0000269|PubMed:12023038, ECO:0000269|PubMed:15915442}.
CC   -!- PTM: In platelets, phosphorylated in response to thrombin,
CC       phorbol-12-myristate-13-acetate and collagen.
CC       {ECO:0000269|PubMed:11880646}.
CC   -!- MISCELLANEOUS: In a heterologous system, SEPT5 overexpression has
CC       been shown to exert dopamine-dependent neurotoxicity. As wild-type
CC       PRKN, but not familial-linked PRKN mutants, ubiquitinates mouse
CC       SEPT5 and promotes its degradation, it has been suggested that a
CC       deficiency in SEPT5 degradation may contribute to the development
CC       of early onset Parkinson disease 2 (PARK2).
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-
CC       like GTPase superfamily. Septin GTPase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01056}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/hCDCRel-1ID220.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U74628; AAB93438.1; -; mRNA.
DR   EMBL; Y11593; CAA72332.1; -; mRNA.
DR   EMBL; AF006988; AAC39779.1; -; Genomic_DNA.
DR   EMBL; CR456545; CAG30431.1; -; mRNA.
DR   EMBL; AK056273; BAB71133.1; -; mRNA.
DR   EMBL; AC000093; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471176; EAX03032.1; -; Genomic_DNA.
DR   EMBL; BC025261; AAH25261.1; -; mRNA.
DR   CCDS; CCDS13764.1; -. [Q99719-1]
DR   CCDS; CCDS56224.1; -. [Q99719-2]
DR   RefSeq; NP_001009939.1; NM_001009939.2. [Q99719-2]
DR   RefSeq; NP_002679.2; NM_002688.5. [Q99719-1]
DR   UniGene; Hs.728762; -.
DR   ProteinModelPortal; Q99719; -.
DR   SMR; Q99719; -.
DR   BioGrid; 111414; 26.
DR   DIP; DIP-31201N; -.
DR   IntAct; Q99719; 19.
DR   MINT; Q99719; -.
DR   STRING; 9606.ENSP00000391311; -.
DR   iPTMnet; Q99719; -.
DR   PhosphoSitePlus; Q99719; -.
DR   SwissPalm; Q99719; -.
DR   BioMuta; SEPT5; -.
DR   DMDM; 6685760; -.
DR   UCD-2DPAGE; Q99719; -.
DR   EPD; Q99719; -.
DR   jPOST; Q99719; -.
DR   PaxDb; Q99719; -.
DR   PeptideAtlas; Q99719; -.
DR   PRIDE; Q99719; -.
DR   ProteomicsDB; 78433; -.
DR   ProteomicsDB; 78434; -. [Q99719-2]
DR   DNASU; 5413; -.
DR   Ensembl; ENST00000438754; ENSP00000394541; ENSG00000184702. [Q99719-2]
DR   Ensembl; ENST00000455784; ENSP00000391311; ENSG00000184702. [Q99719-1]
DR   GeneID; 5413; -.
DR   KEGG; hsa:5413; -.
DR   UCSC; uc002zpw.2; human. [Q99719-1]
DR   CTD; 5413; -.
DR   DisGeNET; 5413; -.
DR   EuPathDB; HostDB:ENSG00000184702.17; -.
DR   GeneCards; SEPT5; -.
DR   H-InvDB; HIX0016241; -.
DR   HGNC; HGNC:9164; SEPT5.
DR   HPA; CAB016120; -.
DR   HPA; HPA029095; -.
DR   HPA; HPA063885; -.
DR   MIM; 602724; gene.
DR   neXtProt; NX_Q99719; -.
DR   OpenTargets; ENSG00000184702; -.
DR   PharmGKB; PA33486; -.
DR   eggNOG; KOG2655; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   GeneTree; ENSGT00940000159913; -.
DR   HOGENOM; HOG000233586; -.
DR   HOVERGEN; HBG065093; -.
DR   InParanoid; Q99719; -.
DR   KO; K04557; -.
DR   OrthoDB; 845354at2759; -.
DR   PhylomeDB; Q99719; -.
DR   TreeFam; TF101079; -.
DR   ChiTaRS; SEPT5; human.
DR   GeneWiki; SEPT5; -.
DR   GenomeRNAi; 5413; -.
DR   PRO; PR:Q99719; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000184702; Expressed in 182 organ(s), highest expression level in right frontal lobe.
DR   ExpressionAtlas; Q99719; baseline and differential.
DR   Genevisible; Q99719; HS.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031105; C:septin complex; ISS:UniProtKB.
DR   GO; GO:0005940; C:septin ring; IBA:GO_Central.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0032947; F:protein-containing complex scaffold activity; IBA:GO_Central.
DR   GO; GO:0005198; F:structural molecule activity; TAS:ProtInc.
DR   GO; GO:0030534; P:adult behavior; ISS:UniProtKB.
DR   GO; GO:0061640; P:cytoskeleton-dependent cytokinesis; IBA:GO_Central.
DR   GO; GO:0017157; P:regulation of exocytosis; IMP:UniProtKB.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0035176; P:social behavior; ISS:UniProtKB.
DR   GO; GO:0016080; P:synaptic vesicle targeting; TAS:UniProtKB.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030647; SEPT5.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF68; PTHR18884:SF68; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Cell division; Coiled coil;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   GTP-binding; Methylation; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN         1    369       Septin-5.
FT                                /FTId=PRO_0000173521.
FT   DOMAIN       41    314       Septin-type G. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   NP_BIND      51     58       GTP. {ECO:0000250}.
FT   NP_BIND     190    198       GTP. {ECO:0000250}.
FT   REGION       51     58       G1 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   REGION      108    111       G3 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   REGION      189    192       G4 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   COILED      338    369       {ECO:0000255}.
FT   BINDING      85     85       GTP. {ECO:0000250}.
FT   BINDING     111    111       GTP; via amide nitrogen. {ECO:0000250}.
FT   BINDING     248    248       GTP; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000250}.
FT   BINDING     263    263       GTP. {ECO:0000250}.
FT   MOD_RES      13     13       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9Z2Q6}.
FT   MOD_RES     168    168       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q9Z2Q6}.
FT   MOD_RES     225    225       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     327    327       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     336    336       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9Z2Q6}.
FT   VAR_SEQ       1     18       MSTGLRYKSKLATPEDKQ -> MDSLAAPQDRLVEQLLSPR
FT                                TQAQRRLK (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042689.
FT   VAR_SEQ     272    369       VENQAHCDFVKLRNMLIRTHMHDLKDVTCDVHYENYRAHCI
FT                                QQMTSKLTQDSRMESPIPILPLPTPDAETEKLIRMKDEELR
FT                                RMQEMLQRMKQQMQDQ -> GALRLREAAQHAHPHAYARPQ
FT                                GRDVRRALRELPRALHPADDQQTDPGQPHGEPHPDPAAAHP
FT                                GRRD (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042690.
FT   CONFLICT    224    224       D -> N (in Ref. 2; CAA72332).
FT                                {ECO:0000305}.
SQ   SEQUENCE   369 AA;  42777 MW;  47054765DEA10D33 CRC64;
     MSTGLRYKSK LATPEDKQDI DKQYVGFATL PNQVHRKSVK KGFDFTLMVA GESGLGKSTL
     VHSLFLTDLY KDRKLLSAEE RISQTVEILK HTVDIEEKGV KLKLTIVDTP GFGDAVNNTE
     CWKPITDYVD QQFEQYFRDE SGLNRKNIQD NRVHCCLYFI SPFGHGLRPV DVGFMKALHE
     KVNIVPLIAK ADCLVPSEIR KLKERIREEI DKFGIHVYQF PECDSDEDED FKQQDRELKE
     SAPFAVIGSN TVVEAKGQRV RGRLYPWGIV EVENQAHCDF VKLRNMLIRT HMHDLKDVTC
     DVHYENYRAH CIQQMTSKLT QDSRMESPIP ILPLPTPDAE TEKLIRMKDE ELRRMQEMLQ
     RMKQQMQDQ
//
ID   X5DNA9_HUMAN            Unreviewed;       369 AA.
AC   X5DNA9;
DT   11-JUN-2014, integrated into UniProtKB/TrEMBL.
DT   11-JUN-2014, sequence version 1.
DT   13-FEB-2019, entry version 47.
DE   SubName: Full=HCG2002594, isoform CRA_d {ECO:0000313|EMBL:EAX03030.1};
DE   SubName: Full=Septin 5 isoform A {ECO:0000313|EMBL:AHW56396.1};
DE   Flags: Fragment;
GN   Name=SEPT5 {ECO:0000313|EMBL:AHW56396.1};
GN   ORFNames=hCG_2002594 {ECO:0000313|EMBL:EAX03030.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AHW56396.1};
RN   [1] {ECO:0000313|EMBL:EAX03030.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX03030.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AHW56396.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Adult whole brain {ECO:0000313|EMBL:AHW56396.1};
RX   PubMed=24722188;
RA   Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L.,
RA   Broly M., Rodriguez M., Tam S., Wanamaker S.A., Fan C., Yi S.,
RA   Tasan M., Lemmens I., Kuang X., Zhao N., Malhotra D., Michaelson J.J.,
RA   Vacic V., Calderwood M.A., Roth F.P., Tavernier J., Horvath S.,
RA   Salehi-Ashtiani K., Korkin D., Sebat J., Hill D.E., Hao T., Vidal M.,
RA   Iakoucheva L.M.;
RT   "Protein interaction network of alternatively spliced isoforms from
RT   brain links genetic risk factors for autism.";
RL   Nat. Commun. 5:3650-3650(2014).
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-
CC       like GTPase superfamily. Septin GTPase family.
CC       {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00534725}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; KJ534756; AHW56396.1; -; mRNA.
DR   EMBL; CH471176; EAX03030.1; -; Genomic_DNA.
DR   RefSeq; NP_002679.2; NM_002688.5.
DR   UniGene; Hs.728762; -.
DR   GeneID; 5413; -.
DR   KEGG; hsa:5413; -.
DR   UCSC; uc002zpv.3; human.
DR   CTD; 5413; -.
DR   EuPathDB; HostDB:ENSG00000184702.17; -.
DR   eggNOG; KOG2655; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   KO; K04557; -.
DR   OrthoDB; 845354at2759; -.
DR   ChiTaRS; SEPT5; human.
DR   GenomeRNAi; 5413; -.
DR   Bgee; ENSG00000184702; Expressed in 182 organ(s), highest expression level in right frontal lobe.
DR   GO; GO:0008021; C:synaptic vesicle; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0017157; P:regulation of exocytosis; IEA:InterPro.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030647; SEPT5.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF68; PTHR18884:SF68; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   GTP-binding {ECO:0000256|PIRSR:PIRSR006698-2,
KW   ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00494966};
KW   Nucleotide-binding {ECO:0000256|PIRSR:PIRSR006698-2,
KW   ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00494966}.
FT   DOMAIN       41    314       Septin-type G.
FT                                {ECO:0000259|PROSITE:PS51719}.
FT   COILED      345    368       {ECO:0000256|SAM:Coils}.
FT   SITE        163    163       Important for dimerization.
FT                                {ECO:0000256|PIRSR:PIRSR006698-2}.
FT   NON_TER     369    369       {ECO:0000313|EMBL:AHW56396.1}.
SQ   SEQUENCE   369 AA;  42777 MW;  47054765DEA10D33 CRC64;
     MSTGLRYKSK LATPEDKQDI DKQYVGFATL PNQVHRKSVK KGFDFTLMVA GESGLGKSTL
     VHSLFLTDLY KDRKLLSAEE RISQTVEILK HTVDIEEKGV KLKLTIVDTP GFGDAVNNTE
     CWKPITDYVD QQFEQYFRDE SGLNRKNIQD NRVHCCLYFI SPFGHGLRPV DVGFMKALHE
     KVNIVPLIAK ADCLVPSEIR KLKERIREEI DKFGIHVYQF PECDSDEDED FKQQDRELKE
     SAPFAVIGSN TVVEAKGQRV RGRLYPWGIV EVENQAHCDF VKLRNMLIRT HMHDLKDVTC
     DVHYENYRAH CIQQMTSKLT QDSRMESPIP ILPLPTPDAE TEKLIRMKDE ELRRMQEMLQ
     RMKQQMQDQ
//
ID   B1AMS2_HUMAN            Unreviewed;       431 AA.
AC   B1AMS2;
DT   08-APR-2008, integrated into UniProtKB/TrEMBL.
DT   08-APR-2008, sequence version 1.
DT   16-JAN-2019, entry version 101.
DE   SubName: Full=Septin 6, isoform CRA_b {ECO:0000313|EMBL:EAW89852.1};
DE   SubName: Full=Septin-6 {ECO:0000313|Ensembl:ENSP00000346397};
GN   Name=SEPT6 {ECO:0000313|EMBL:EAW89852.1,
GN   ECO:0000313|Ensembl:ENSP00000346397};
GN   ORFNames=hCG_23191 {ECO:0000313|EMBL:EAW89852.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000346397, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW89852.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000346397, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3] {ECO:0000313|EMBL:EAW89852.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000213|PubMed:17525332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y.,
RA   Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [5] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [7] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8] {ECO:0000313|Ensembl:ENSP00000346397}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [9] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-
CC       like GTPase superfamily. Septin GTPase family.
CC       {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00534725}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AC004913; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005052; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355348; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471161; EAW89852.1; -; Genomic_DNA.
DR   RefSeq; XP_006724811.1; XM_006724748.2.
DR   UniGene; Hs.496666; -.
DR   EPD; B1AMS2; -.
DR   jPOST; B1AMS2; -.
DR   MaxQB; B1AMS2; -.
DR   PRIDE; B1AMS2; -.
DR   Ensembl; ENST00000354416; ENSP00000346397; ENSG00000125354.
DR   GeneID; 23157; -.
DR   UCSC; uc065awu.1; human.
DR   CTD; 23157; -.
DR   EuPathDB; HostDB:ENSG00000125354.22; -.
DR   HGNC; HGNC:15848; SEPT6.
DR   OpenTargets; ENSG00000125354; -.
DR   eggNOG; KOG2655; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   GeneTree; ENSGT00940000158026; -.
DR   HOVERGEN; HBG065093; -.
DR   OrthoDB; 845354at2759; -.
DR   ChiTaRS; SEPT6; human.
DR   GenomeRNAi; 23157; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000125354; Expressed in 227 organ(s), highest expression level in lower esophagus.
DR   ExpressionAtlas; B1AMS2; baseline and differential.
DR   GO; GO:0031105; C:septin complex; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030644; SEPT6.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF55; PTHR18884:SF55; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   GTP-binding {ECO:0000256|RuleBase:RU004560,
KW   ECO:0000256|SAAS:SAAS00494966};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU004560,
KW   ECO:0000256|SAAS:SAAS00494966};
KW   Proteomics identification {ECO:0000213|EPD:B1AMS2,
KW   ECO:0000213|MaxQB:B1AMS2, ECO:0000213|PeptideAtlas:B1AMS2};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       39    305       Septin-type G.
FT                                {ECO:0000259|PROSITE:PS51719}.
FT   COILED      321    341       {ECO:0000256|SAM:Coils}.
FT   COILED      343    399       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   431 AA;  49303 MW;  6A891C3002EB88E3 CRC64;
     MAATDIARQV GEGCRTVPLA GHVGFDSLPD QLVNKSVSQG FCFNILCVGE TGLGKSTLMD
     TLFNTKFEGE PATHTQPGVQ LQSNTYDLQE SNVRLKLTIV STVGFGDQIN KEDSYKPIVE
     FIDAQFEAYL QEELKIRRVL HTYHDSRIHV CLYFIAPTGH SLKSLDLVTM KKLDSKVNII
     PIIAKADAIS KSELTKFKIK ITSELVSNGV QIYQFPTDDE SVAEINGTMN AHLPFAVIGS
     TEELKIGNKM MRARQYPWGT VQVENEAHCD FVKLREMLIR VNMEDLREQT HTRHYELYRR
     CKLEEMGFKD TDPDSKPFSL QETYEAKRNE FLGELQKKEE EMRQMFVQRV KEKEAELKEA
     EKELHEKFDR LKKLHQDEKK KLEDKKKSLD DEVNAFKQRK TAAELLQSQG SQAGGSQTLK
     RDKEKKNLGF L
//
ID   SEPT6_HUMAN             Reviewed;         434 AA.
AC   Q14141; Q5JTK0; Q969W5; Q96A13; Q96GR1; Q96P86; Q96P87;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   13-FEB-2019, entry version 175.
DE   RecName: Full=Septin-6;
GN   Name=SEPT6; Synonyms=KIAA0128, SEP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS I; II; IV AND V).
RX   PubMed=11809673;
RA   Ono R., Taki T., Taketani T., Kawaguchi H., Taniwaki M., Okamura T.,
RA   Kawa K., Hanada R., Kobayashi M., Hayashi Y.;
RT   "SEPTIN6, a human homologue to mouse Septin6, is fused to MLL in
RT   infant acute myeloid leukemia with complex chromosomal abnormalities
RT   involving 11q23 and Xq24.";
RL   Cancer Res. 62:333-337(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS II AND V).
RC   TISSUE=Muscle, Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-8, AND ACETYLATION AT ALA-2.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-427 (ISOFORM I).
RC   TISSUE=Bone marrow;
RX   PubMed=8590280; DOI=10.1093/dnares/2.4.167;
RA   Nagase T., Seki N., Tanaka A., Ishikawa K., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. IV.
RT   The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 2:167-174(1995).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=15915442; DOI=10.1002/path.1789;
RA   Hall P.A., Jung K., Hillan K.J., Russell S.E.H.;
RT   "Expression profiling the human septin gene family.";
RL   J. Pathol. 206:269-278(2005).
RN   [7]
RP   COORDINATED EXPRESSION WITH SEPT2 AND SEPT7.
RX   PubMed=16093351; DOI=10.1091/mbc.E05-03-0267;
RA   Kremer B.E., Haystead T., Macara I.G.;
RT   "Mammalian septins regulate microtubule stability through interaction
RT   with the microtubule-binding protein MAP4.";
RL   Mol. Biol. Cell 16:4648-4659(2005).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15774761; DOI=10.1126/science.1106823;
RA   Spiliotis E.T., Kinoshita M., Nelson W.J.;
RT   "A mitotic septin scaffold required for mammalian chromosome
RT   congression and segregation.";
RL   Science 307:1781-1785(2005).
RN   [9]
RP   INTERACTION WITH SEPT2 AND SEPT7.
RX   PubMed=16914550; DOI=10.1074/jbc.M605179200;
RA   Low C., Macara I.G.;
RT   "Structural analysis of septin 2, 6, and 7 complexes.";
RL   J. Biol. Chem. 281:30697-30706(2006).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH SOCS7.
RX   PubMed=17803907; DOI=10.1016/j.cell.2007.06.053;
RA   Kremer B.E., Adang L.A., Macara I.G.;
RT   "Septins regulate actin organization and cell-cycle arrest through
RT   nuclear accumulation of NCK mediated by SOCS7.";
RL   Cell 130:837-850(2007).
RN   [11]
RP   INTERACTION WITH SEPT12.
RX   PubMed=18047794; DOI=10.5483/BMBRep.2007.40.6.973;
RA   Ding X., Yu W., Liu M., Shen S., Chen F., Wan B., Yu L.;
RT   "SEPT12 interacts with SEPT6 and this interaction alters the filament
RT   structure of SEPT6 in Hela cells.";
RL   J. Biochem. Mol. Biol. 40:973-978(2007).
RN   [12]
RP   INTERACTION WITH HNRNPA1 AND HCV NS5B (MICROBIAL INFECTION), AND
RP   FUNCTION.
RX   PubMed=17229681; DOI=10.1128/JVI.01311-06;
RA   Kim C.S., Seol S.K., Song O.-K., Park J.H., Jang S.K.;
RT   "An RNA-binding protein, hnRNP A1, and a scaffold protein, septin 6,
RT   facilitate hepatitis C virus replication.";
RL   J. Virol. 81:3852-3865(2007).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   INTERACTION WITH SEPT9.
RX   PubMed=19145258; DOI=10.1371/journal.pone.0004196;
RA   Mostowy S., Nam Tham T., Danckaert A., Guadagnini S.,
RA   Boisson-Dupuis S., Pizarro-Cerda J., Cossart P.;
RT   "Septins regulate bacterial entry into host cells.";
RL   PLoS ONE 4:E4196-E4196(2009).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-367, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-416 AND THR-418,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=25588830; DOI=10.1242/jcs.158998;
RA   Kuo Y.C., Shen Y.R., Chen H.I., Lin Y.H., Wang Y.Y., Chen Y.R.,
RA   Wang C.Y., Kuo P.L.;
RT   "SEPT12 orchestrates the formation of mammalian sperm annulus by
RT   organizing core octomeric complexes with other SEPT proteins.";
RL   J. Cell Sci. 128:923-934(2015).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (4.0 ANGSTROMS) OF 1-427 IN COMPLEX WITH GTP,
RP   ELECTRON MICROSCOPY OF SEPTIN COMPLEX, AND SUBUNIT.
RX   PubMed=17637674; DOI=10.1038/nature06052;
RA   Sirajuddin M., Farkasovsky M., Hauer F., Kuehlmann D., Macara I.G.,
RA   Weyand M., Stark H., Wittinghofer A.;
RT   "Structural insight into filament formation by mammalian septins.";
RL   Nature 449:311-315(2007).
CC   -!- FUNCTION: Filament-forming cytoskeletal GTPase. Required for
CC       normal organization of the actin cytoskeleton. Involved in
CC       cytokinesis. May play a role in HCV RNA replication. Forms a
CC       filamentous structure with SEPT12, SEPT6, SEPT2 and probably SEPT4
CC       at the sperm annulus which is required for the structural
CC       integrity and motility of the sperm tail during postmeiotic
CC       differentiation (PubMed:25588830). {ECO:0000269|PubMed:17229681,
CC       ECO:0000269|PubMed:17803907, ECO:0000305|PubMed:25588830}.
CC   -!- SUBUNIT: Septins polymerize into heterooligomeric protein
CC       complexes that form filaments, and associate with cellular
CC       membranes, actin filaments and microtubules. GTPase activity is
CC       required for filament formation. Filaments are assembled from
CC       asymmetrical heterotrimers, composed of SEPT2, SEPT6 and SEPT7
CC       that associate head-to-head to form a hexameric unit. Within the
CC       trimer, directly interacts with SEPT2 and SEPT7. Also interacts
CC       with SEPT9 and SEPT12. Interaction with SEPT12 alters filament
CC       structure. Component of a septin core octomeric complex consisting
CC       of SEPT12, SEPT7, SEPT6 and SEPT2 or SEPT4 in the order 12-7-6-2-
CC       2-6-7-12 or 12-7-6-4-4-6-7-12 and located in the sperm annulus.
CC       Interacts with SOCS7. Interacts with HNRNPA1.
CC       {ECO:0000269|PubMed:16914550, ECO:0000269|PubMed:17229681,
CC       ECO:0000269|PubMed:17637674, ECO:0000269|PubMed:17803907,
CC       ECO:0000269|PubMed:18047794, ECO:0000269|PubMed:19145258,
CC       ECO:0000269|PubMed:25588830}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HCV NS5B.
CC       {ECO:0000269|PubMed:17229681}.
CC   -!- INTERACTION:
CC       P27958:- (xeno); NbExp=4; IntAct=EBI-745901, EBI-6904388;
CC       P09651:HNRNPA1; NbExp=3; IntAct=EBI-745901, EBI-352662;
CC       Q8NDC4:MORN4; NbExp=5; IntAct=EBI-745901, EBI-10269566;
CC       Q9H8W4:PLEKHF2; NbExp=3; IntAct=EBI-745901, EBI-742388;
CC       Q8WYJ6:SEPT1; NbExp=6; IntAct=EBI-745901, EBI-693002;
CC       Q8IYM1:SEPT12; NbExp=14; IntAct=EBI-745901, EBI-2585067;
CC       Q15019:SEPT2; NbExp=10; IntAct=EBI-745901, EBI-741220;
CC       Q9UH03:SEPT3; NbExp=3; IntAct=EBI-745901, EBI-727037;
CC       Q99719:SEPT5; NbExp=5; IntAct=EBI-745901, EBI-373345;
CC       Q16181:SEPT7; NbExp=3; IntAct=EBI-745901, EBI-2009373;
CC       A0A0S2Z5W9:SEPT9; NbExp=3; IntAct=EBI-745901, EBI-16437910;
CC       Q9UHD8:SEPT9; NbExp=3; IntAct=EBI-745901, EBI-851542;
CC       O14512-1:SOCS7; NbExp=2; IntAct=EBI-745901, EBI-1539617;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15774761}.
CC       Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:15774761}.
CC       Chromosome, centromere, kinetochore {ECO:0000269|PubMed:15774761}.
CC       Cleavage furrow {ECO:0000269|PubMed:15774761}. Midbody
CC       {ECO:0000269|PubMed:15774761}. Cell projection, cilium, flagellum
CC       {ECO:0000269|PubMed:25588830}. Note=In metaphase cells, localized
CC       within the microtubule spindle. At the metaphase plate, in close
CC       apposition to the kinetochores of the congressed chromosomes. In
CC       cells undergoing cytokinesis, localized to the midbody, the
CC       ingressing cleavage furrow, and the central spindle. Found in the
CC       sperm annulus (PubMed:25588830). {ECO:0000269|PubMed:25588830}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=II;
CC         IsoId=Q14141-1; Sequence=Displayed;
CC       Name=I; Synonyms=III;
CC         IsoId=Q14141-2; Sequence=VSP_006053;
CC       Name=IV;
CC         IsoId=Q14141-3; Sequence=VSP_006051, VSP_006052;
CC       Name=V;
CC         IsoId=Q14141-4; Sequence=VSP_006054;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:15915442}.
CC   -!- MISCELLANEOUS: Coordinated expression with SEPT2 and SEPT7.
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-
CC       like GTPase superfamily. Septin GTPase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01056}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SEPTIN6ID376.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF403058; AAK98547.1; -; mRNA.
DR   EMBL; AF403059; AAK98548.1; -; mRNA.
DR   EMBL; AF403060; AAK98549.1; -; mRNA.
DR   EMBL; AF403061; AAK98550.1; -; mRNA.
DR   EMBL; AF403062; AAK98551.1; -; mRNA.
DR   EMBL; AC004913; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005052; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355348; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009291; AAH09291.1; -; mRNA.
DR   EMBL; BC011922; AAH11922.3; -; mRNA.
DR   EMBL; BC036240; AAH36240.1; -; mRNA.
DR   EMBL; D50918; BAA09477.1; -; mRNA.
DR   CCDS; CCDS14583.1; -. [Q14141-4]
DR   CCDS; CCDS14584.1; -. [Q14141-1]
DR   CCDS; CCDS14585.1; -. [Q14141-2]
DR   RefSeq; NP_055944.2; NM_015129.5. [Q14141-1]
DR   RefSeq; NP_665798.1; NM_145799.3. [Q14141-2]
DR   RefSeq; NP_665799.1; NM_145800.3. [Q14141-2]
DR   RefSeq; NP_665801.1; NM_145802.3. [Q14141-4]
DR   RefSeq; XP_006724813.1; XM_006724750.2. [Q14141-2]
DR   UniGene; Hs.496666; -.
DR   PDB; 2QAG; X-ray; 4.00 A; B=1-427.
DR   PDBsum; 2QAG; -.
DR   ProteinModelPortal; Q14141; -.
DR   SMR; Q14141; -.
DR   BioGrid; 116770; 44.
DR   DIP; DIP-38218N; -.
DR   IntAct; Q14141; 27.
DR   MINT; Q14141; -.
DR   STRING; 9606.ENSP00000341524; -.
DR   iPTMnet; Q14141; -.
DR   PhosphoSitePlus; Q14141; -.
DR   BioMuta; SEPT6; -.
DR   DMDM; 20178343; -.
DR   OGP; Q14141; -.
DR   EPD; Q14141; -.
DR   jPOST; Q14141; -.
DR   MaxQB; Q14141; -.
DR   PaxDb; Q14141; -.
DR   PeptideAtlas; Q14141; -.
DR   PRIDE; Q14141; -.
DR   ProteomicsDB; 59843; -.
DR   ProteomicsDB; 59844; -. [Q14141-2]
DR   ProteomicsDB; 59845; -. [Q14141-3]
DR   ProteomicsDB; 59846; -. [Q14141-4]
DR   DNASU; 23157; -.
DR   Ensembl; ENST00000343984; ENSP00000341524; ENSG00000125354. [Q14141-1]
DR   Ensembl; ENST00000354228; ENSP00000346169; ENSG00000125354. [Q14141-4]
DR   Ensembl; ENST00000360156; ENSP00000353278; ENSG00000125354. [Q14141-2]
DR   Ensembl; ENST00000394610; ENSP00000378108; ENSG00000125354. [Q14141-2]
DR   Ensembl; ENST00000460411; ENSP00000435818; ENSG00000125354. [Q14141-3]
DR   Ensembl; ENST00000489216; ENSP00000418715; ENSG00000125354. [Q14141-2]
DR   GeneID; 23157; -.
DR   KEGG; hsa:23157; -.
DR   UCSC; uc004erv.4; human. [Q14141-1]
DR   CTD; 23157; -.
DR   DisGeNET; 23157; -.
DR   EuPathDB; HostDB:ENSG00000125354.22; -.
DR   GeneCards; SEPT6; -.
DR   HGNC; HGNC:15848; SEPT6.
DR   HPA; HPA003459; -.
DR   HPA; HPA005665; -.
DR   MIM; 300683; gene.
DR   neXtProt; NX_Q14141; -.
DR   OpenTargets; ENSG00000125354; -.
DR   PharmGKB; PA134941944; -.
DR   eggNOG; KOG2655; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   GeneTree; ENSGT00940000158026; -.
DR   HOVERGEN; HBG065093; -.
DR   InParanoid; Q14141; -.
DR   KO; K16939; -.
DR   OMA; QQTCEAK; -.
DR   OrthoDB; 845354at2759; -.
DR   PhylomeDB; Q14141; -.
DR   TreeFam; TF101080; -.
DR   SIGNOR; Q14141; -.
DR   ChiTaRS; SEPT6; human.
DR   EvolutionaryTrace; Q14141; -.
DR   GeneWiki; SEPT6; -.
DR   GenomeRNAi; 23157; -.
DR   PRO; PR:Q14141; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000125354; Expressed in 227 organ(s), highest expression level in lower esophagus.
DR   ExpressionAtlas; Q14141; baseline and differential.
DR   Genevisible; Q14141; HS.
DR   GO; GO:0043679; C:axon terminus; IEA:Ensembl.
DR   GO; GO:0032154; C:cleavage furrow; IEA:UniProtKB-SubCell.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IBA:GO_Central.
DR   GO; GO:0030496; C:midbody; IEA:UniProtKB-SubCell.
DR   GO; GO:0032173; C:septin collar; IEA:Ensembl.
DR   GO; GO:0031105; C:septin complex; IDA:UniProtKB.
DR   GO; GO:0005940; C:septin ring; IBA:GO_Central.
DR   GO; GO:0097227; C:sperm annulus; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; IEA:UniProtKB-SubCell.
DR   GO; GO:0008021; C:synaptic vesicle; IEA:Ensembl.
DR   GO; GO:0005525; F:GTP binding; TAS:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0032947; F:protein-containing complex scaffold activity; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0060271; P:cilium assembly; IBA:GO_Central.
DR   GO; GO:0061640; P:cytoskeleton-dependent cytokinesis; IBA:GO_Central.
DR   GO; GO:0000281; P:mitotic cytokinesis; TAS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030644; SEPT6.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF55; PTHR18884:SF55; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell cycle;
KW   Cell division; Cell projection; Centromere; Chromosome; Cilium;
KW   Coiled coil; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Differentiation; Direct protein sequencing; Flagellum; GTP-binding;
KW   Host-virus interaction; Kinetochore; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Spermatogenesis.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|PubMed:12665801}.
FT   CHAIN         2    434       Septin-6.
FT                                /FTId=PRO_0000173525.
FT   DOMAIN       39    305       Septin-type G. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   NP_BIND      49     56       GTP. {ECO:0000269|PubMed:17637674}.
FT   NP_BIND     185    193       GTP. {ECO:0000269|PubMed:17637674}.
FT   REGION       49     56       G1 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   REGION      101    104       G3 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   REGION      184    187       G4 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   COILED      321    409       {ECO:0000255}.
FT   BINDING     104    104       GTP; via amide nitrogen. {ECO:0000250}.
FT   BINDING     239    239       GTP; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000250}.
FT   BINDING     254    254       GTP. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|PubMed:12665801}.
FT   MOD_RES      27     27       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     367    367       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     416    416       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     418    418       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     263    267       VENEA -> AAREV (in isoform IV).
FT                                {ECO:0000303|PubMed:11809673}.
FT                                /FTId=VSP_006051.
FT   VAR_SEQ     268    434       Missing (in isoform IV).
FT                                {ECO:0000303|PubMed:11809673}.
FT                                /FTId=VSP_006052.
FT   VAR_SEQ     428    434       Missing (in isoform I).
FT                                {ECO:0000303|PubMed:11809673,
FT                                ECO:0000303|PubMed:8590280}.
FT                                /FTId=VSP_006053.
FT   VAR_SEQ     428    434       NPWLCTE -> FF (in isoform V).
FT                                {ECO:0000303|PubMed:11809673,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_006054.
FT   CONFLICT    406    406       L -> P (in Ref. 3; AAH09291).
FT                                {ECO:0000305}.
SQ   SEQUENCE   434 AA;  49717 MW;  E684AE6A93B32362 CRC64;
     MAATDIARQV GEGCRTVPLA GHVGFDSLPD QLVNKSVSQG FCFNILCVGE TGLGKSTLMD
     TLFNTKFEGE PATHTQPGVQ LQSNTYDLQE SNVRLKLTIV STVGFGDQIN KEDSYKPIVE
     FIDAQFEAYL QEELKIRRVL HTYHDSRIHV CLYFIAPTGH SLKSLDLVTM KKLDSKVNII
     PIIAKADAIS KSELTKFKIK ITSELVSNGV QIYQFPTDDE SVAEINGTMN AHLPFAVIGS
     TEELKIGNKM MRARQYPWGT VQVENEAHCD FVKLREMLIR VNMEDLREQT HTRHYELYRR
     CKLEEMGFKD TDPDSKPFSL QETYEAKRNE FLGELQKKEE EMRQMFVQRV KEKEAELKEA
     EKELHEKFDR LKKLHQDEKK KLEDKKKSLD DEVNAFKQRK TAAELLQSQG SQAGGSQTLK
     RDKEKKNNPW LCTE
//
ID   Q541S4_HUMAN            Unreviewed;       427 AA.
AC   Q541S4;
DT   05-FEB-2008, integrated into UniProtKB/TrEMBL.
DT   05-FEB-2008, sequence version 1.
DT   13-FEB-2019, entry version 109.
DE   SubName: Full=Septin 6 {ECO:0000313|EMBL:AAK61492.1};
DE   SubName: Full=Septin 6, isoform CRA_d {ECO:0000313|EMBL:EAW89854.1};
DE   SubName: Full=cDNA FLJ58747, highly similar to Septin-6 {ECO:0000313|EMBL:BAG61293.1};
GN   Name=SEPT6 {ECO:0000313|EMBL:EAW89854.1};
GN   ORFNames=hCG_23191 {ECO:0000313|EMBL:EAW89854.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAK61492.1};
RN   [1] {ECO:0000313|EMBL:AAF97496.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Yu L.;
RL   Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:EAW89854.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [3] {ECO:0000313|EMBL:AAK61492.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Peng J., Yu L.;
RT   "Molecular cloning and characterization of human septins which are
RT   expressed in liver.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:EAW89854.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:BAG61293.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-
CC       like GTPase superfamily. Septin GTPase family.
CC       {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00534725}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AY005981; AAF97496.1; -; mRNA.
DR   EMBL; AY034177; AAK61492.1; -; mRNA.
DR   EMBL; AK299273; BAG61293.1; -; mRNA.
DR   EMBL; CH471161; EAW89854.1; -; Genomic_DNA.
DR   EMBL; CH471161; EAW89856.1; -; Genomic_DNA.
DR   RefSeq; NP_665798.1; NM_145799.3.
DR   RefSeq; NP_665799.1; NM_145800.3.
DR   RefSeq; XP_006724813.1; XM_006724750.2.
DR   UniGene; Hs.496666; -.
DR   DNASU; 23157; -.
DR   GeneID; 23157; -.
DR   UCSC; uc004ers.4; human.
DR   CTD; 23157; -.
DR   EuPathDB; HostDB:ENSG00000125354.22; -.
DR   PharmGKB; PA134941944; -.
DR   eggNOG; KOG2655; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   HOVERGEN; HBG065093; -.
DR   OrthoDB; 845354at2759; -.
DR   ChiTaRS; SEPT6; human.
DR   GenomeRNAi; 23157; -.
DR   Bgee; ENSG00000125354; Expressed in 227 organ(s), highest expression level in lower esophagus.
DR   GO; GO:0031105; C:septin complex; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030644; SEPT6.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF55; PTHR18884:SF55; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   GTP-binding {ECO:0000256|RuleBase:RU004560,
KW   ECO:0000256|SAAS:SAAS00494966};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU004560,
KW   ECO:0000256|SAAS:SAAS00494966}.
FT   DOMAIN       39    305       Septin-type G.
FT                                {ECO:0000259|PROSITE:PS51719}.
FT   COILED      321    341       {ECO:0000256|SAM:Coils}.
FT   COILED      343    399       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   427 AA;  48873 MW;  62EB88E308386ADE CRC64;
     MAATDIARQV GEGCRTVPLA GHVGFDSLPD QLVNKSVSQG FCFNILCVGE TGLGKSTLMD
     TLFNTKFEGE PATHTQPGVQ LQSNTYDLQE SNVRLKLTIV STVGFGDQIN KEDSYKPIVE
     FIDAQFEAYL QEELKIRRVL HTYHDSRIHV CLYFIAPTGH SLKSLDLVTM KKLDSKVNII
     PIIAKADAIS KSELTKFKIK ITSELVSNGV QIYQFPTDDE SVAEINGTMN AHLPFAVIGS
     TEELKIGNKM MRARQYPWGT VQVENEAHCD FVKLREMLIR VNMEDLREQT HTRHYELYRR
     CKLEEMGFKD TDPDSKPFSL QETYEAKRNE FLGELQKKEE EMRQMFVQRV KEKEAELKEA
     EKELHEKFDR LKKLHQDEKK KLEDKKKSLD DEVNAFKQRK TAAELLQSQG SQAGGSQTLK
     RDKEKKN
//
ID   Q548C9_HUMAN            Unreviewed;       429 AA.
AC   Q548C9;
DT   05-FEB-2008, integrated into UniProtKB/TrEMBL.
DT   05-FEB-2008, sequence version 1.
DT   13-FEB-2019, entry version 101.
DE   SubName: Full=Septin 6 {ECO:0000313|EMBL:AAN76547.1};
DE   SubName: Full=Septin 6, isoform CRA_e {ECO:0000313|EMBL:EAW89855.1};
DE   SubName: Full=cDNA FLJ77872, highly similar to Homo sapiens SEPTIN6 type V (SEPTIN6) mRNA {ECO:0000313|EMBL:BAF83666.1};
GN   Name=SEPT6 {ECO:0000313|EMBL:EAW89855.1};
GN   ORFNames=hCG_23191 {ECO:0000313|EMBL:EAW89855.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAN76547.1};
RN   [1] {ECO:0000313|EMBL:EAW89855.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAN76547.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mao Y., Xie Y., Wu Q.;
RT   "Cloning and characterization of a novel human septin 6.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:EAW89855.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAF83666.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-
CC       like GTPase superfamily. Septin GTPase family.
CC       {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00534725}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF397023; AAN76547.1; -; mRNA.
DR   EMBL; AK290977; BAF83666.1; -; mRNA.
DR   EMBL; CH471161; EAW89855.1; -; Genomic_DNA.
DR   RefSeq; NP_665801.1; NM_145802.3.
DR   UniGene; Hs.496666; -.
DR   DNASU; 23157; -.
DR   GeneID; 23157; -.
DR   UCSC; uc004ert.4; human.
DR   CTD; 23157; -.
DR   EuPathDB; HostDB:ENSG00000125354.22; -.
DR   PharmGKB; PA134941944; -.
DR   eggNOG; KOG2655; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   HOVERGEN; HBG065093; -.
DR   OrthoDB; 845354at2759; -.
DR   ChiTaRS; SEPT6; human.
DR   GenomeRNAi; 23157; -.
DR   Bgee; ENSG00000125354; Expressed in 227 organ(s), highest expression level in lower esophagus.
DR   GO; GO:0031105; C:septin complex; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030644; SEPT6.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF55; PTHR18884:SF55; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   GTP-binding {ECO:0000256|RuleBase:RU004560,
KW   ECO:0000256|SAAS:SAAS00494966};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU004560,
KW   ECO:0000256|SAAS:SAAS00494966}.
FT   DOMAIN       39    305       Septin-type G.
FT                                {ECO:0000259|PROSITE:PS51719}.
FT   COILED      321    341       {ECO:0000256|SAM:Coils}.
FT   COILED      343    399       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   429 AA;  49167 MW;  3D8EE2EB88E30838 CRC64;
     MAATDIARQV GEGCRTVPLA GHVGFDSLPD QLVNKSVSQG FCFNILCVGE TGLGKSTLMD
     TLFNTKFEGE PATHTQPGVQ LQSNTYDLQE SNVRLKLTIV STVGFGDQIN KEDSYKPIVE
     FIDAQFEAYL QEELKIRRVL HTYHDSRIHV CLYFIAPTGH SLKSLDLVTM KKLDSKVNII
     PIIAKADAIS KSELTKFKIK ITSELVSNGV QIYQFPTDDE SVAEINGTMN AHLPFAVIGS
     TEELKIGNKM MRARQYPWGT VQVENEAHCD FVKLREMLIR VNMEDLREQT HTRHYELYRR
     CKLEEMGFKD TDPDSKPFSL QETYEAKRNE FLGELQKKEE EMRQMFVQRV KEKEAELKEA
     EKELHEKFDR LKKLHQDEKK KLEDKKKSLD DEVNAFKQRK TAAELLQSQG SQAGGSQTLK
     RDKEKKNFF
//
ID   A0A0S2Z5A5_HUMAN        Unreviewed;       568 AA.
AC   A0A0S2Z5A5;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   16-JAN-2019, entry version 19.
DE   SubName: Full=Septin 9 isoform 1 {ECO:0000313|EMBL:ALQ33997.1};
DE   Flags: Fragment;
GN   Name=SEPT9 {ECO:0000313|EMBL:ALQ33997.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33997.1};
RN   [1] {ECO:0000313|EMBL:ALQ33997.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-
CC       like GTPase superfamily. Septin GTPase family.
CC       {ECO:0000256|RuleBase:RU004560, ECO:0000256|SAAS:SAAS00534725}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178539; ALQ33997.1; -; mRNA.
DR   RefSeq; NP_006631.2; NM_006640.4.
DR   UniGene; Hs.440932; -.
DR   SMR; A0A0S2Z5A5; -.
DR   PRIDE; A0A0S2Z5A5; -.
DR   GeneID; 10801; -.
DR   CTD; 10801; -.
DR   OrthoDB; 845354at2759; -.
DR   ChiTaRS; SEPT9; human.
DR   GenomeRNAi; 10801; -.
DR   ExpressionAtlas; A0A0S2Z5A5; baseline and differential.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030645; SEPT9.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF47; PTHR18884:SF47; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   2: Evidence at transcript level;
KW   GTP-binding {ECO:0000256|RuleBase:RU004560,
KW   ECO:0000256|SAAS:SAAS00494966};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU004560,
KW   ECO:0000256|SAAS:SAAS00494966}.
FT   DOMAIN      277    549       Septin-type G.
FT                                {ECO:0000259|PROSITE:PS51719}.
FT   NON_TER     568    568       {ECO:0000313|EMBL:ALQ33997.1}.
SQ   SEQUENCE   568 AA;  63666 MW;  47A03DD79B5D6147 CRC64;
     MERDRISALK RSFEVEEVET PNSTPPRRVQ TPLLRATVAS STQKFQDLGV KNSEPSARHV
     DSLSQRSPKA SLRRVELSGP KAAEPVSRRT ELSIDISSKQ VENAGAIGPS RFGLKRAEVL
     GHKTPEPAPR RTEITIVKPQ ESAHRRMEPP ASKVPEVPTA PATDAAPKRV EIQMPKPAEA
     PTAPSPAQTL ENSEPAPVSQ LQSRLEPKPQ PPVAEATPRS QEATEAAPSC VGDMADTPRD
     AGLKQAPASR NEKAPVDFGY VGIDSILEQM RRKAMKQGFE FNIMVVGQSG LGKSTLINTL
     FKSKISRKSV QPTSEERIPK TIEIKSITHD IEEKGVRMKL TVIDTPGFGD HINNENCWQP
     IMKFINDQYE KYLQEEVNIN RKKRIPDTRV HCCLYFIPAT GHSLRPLDIE FMKRLSKVVN
     IVPVIAKADT LTLEERVHFK QRITADLLSN GIDVYPQKEF DEDSEDRLVN EKFREMIPFA
     VVGSDHEYQV NGKRILGRKT KWGTIEVENT THCEFAYLRD LLIRTHMQNI KDITSSIHFE
     AYRVKRLNEG SSAMANGMEE KEPEAPEM
//
ID   SEPT9_HUMAN             Reviewed;         586 AA.
AC   Q9UHD8; A8K2V3; B3KPM0; B4DTL9; B4E0N2; B4E274; B7Z654; Q96QF3;
AC   Q96QF4; Q96QF5; Q9HA04; Q9UG40; Q9Y5W4;
DT   21-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2006, sequence version 2.
DT   13-FEB-2019, entry version 178.
DE   RecName: Full=Septin-9;
DE   AltName: Full=MLL septin-like fusion protein MSF-A;
DE            Short=MLL septin-like fusion protein;
DE   AltName: Full=Ovarian/Breast septin;
DE            Short=Ov/Br septin;
DE   AltName: Full=Septin D1;
GN   Name=SEPT9; Synonyms=KIAA0991, MSF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), VARIANT VAL-576, TISSUE
RP   SPECIFICITY, DISEASE, AND CHROMOSOMAL TRANSLOCATION.
RX   PubMed=10339604; DOI=10.1073/pnas.96.11.6428;
RA   Osaka M., Rowley J.D., Zeleznik-Le N.J.;
RT   "MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a
RT   therapy-related acute myeloid leukemia with a t(11;17)(q23;q25).";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:6428-6433(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4 AND 5), AND VARIANTS
RP   CYS-76; LEU-145 AND VAL-576.
RX   PubMed=10987277;
RA   Russell S.E.H., McIlhatton M.A., Burrows J.F., Donaghy P.G.,
RA   Chanduloy S., Petty E.M., Kalikin L.M., Church S.W., McIlroy S.,
RA   Harkin D.P., Keilty G.W., Cranston A.N., Weissenbach J., Hickey I.,
RA   Johnston P.G.;
RT   "Isolation and mapping of a human septin gene to a region on
RT   chromosome 17q, commonly deleted in sporadic epithelial ovarian
RT   tumors.";
RL   Cancer Res. 60:4729-4734(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), VARIANT VAL-576, TISSUE
RP   SPECIFICITY, AND ALTERNATIVE SPLICING.
RX   PubMed=10673329; DOI=10.1006/geno.1999.6077;
RA   Kalikin L.M., Sims H.L., Petty E.M.;
RT   "Genomic and expression analyses of alternatively spliced transcripts
RT   of the MLL septin-like fusion gene (MSF) that map to a 17q25 region of
RT   loss in breast and ovarian tumors.";
RL   Genomics 63:165-172(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT VAL-576.
RA   Zhang W., He L., Wan T., Yuan Z., Zhu X., Cao X.;
RT   "Novel human cell division control protein septin D1.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3; 4; 5; 7; 8 AND 9),
RP   AND VARIANTS LEU-145 AND VAL-576.
RC   TISSUE=Fetal brain, Mammary gland, Placenta, Teratocarcinoma, Thymus,
RC   Tongue, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   VAL-576.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-576.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   VAL-576.
RC   TISSUE=Eye, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 26-586, AND VARIANT VAL-576.
RC   TISSUE=Brain;
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 353-586, AND VARIANT
RP   VAL-576.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [11]
RP   TISSUE SPECIFICITY, AND ALTERNATIVE SPLICING.
RX   PubMed=11593400; DOI=10.1038/sj.onc.1204752;
RA   McIlhatton M.A., Burrows J.F., Donaghy P.G., Chanduloy S.,
RA   Johnston P.G., Russell S.E.;
RT   "Genomic organization, complex splicing pattern and expression of a
RT   human septin gene on chromosome 17q25.3.";
RL   Oncogene 20:5930-5939(2001).
RN   [12]
RP   INTERACTION WITH SEPT7 AND SEPT11.
RX   PubMed=15485874; DOI=10.1074/jbc.M406153200;
RA   Nagata K., Asano T., Nozawa Y., Inagaki M.;
RT   "Biochemical and cell biological analyses of a mammalian septin
RT   complex, Sept7/9b/11.";
RL   J. Biol. Chem. 279:55895-55904(2004).
RN   [13]
RP   TISSUE SPECIFICITY.
RX   PubMed=15915442; DOI=10.1002/path.1789;
RA   Hall P.A., Jung K., Hillan K.J., Russell S.E.H.;
RT   "Expression profiling the human septin gene family.";
RL   J. Pathol. 206:269-278(2005).
RN   [14]
RP   INTERACTION WITH ARHGEF18.
RX   PubMed=15558029; DOI=10.1038/sj.onc.1208101;
RA   Nagata K., Inagaki M.;
RT   "Cytoskeletal modification of Rho guanine nucleotide exchange factor
RT   activity: identification of a Rho guanine nucleotide exchange factor
RT   as a binding partner for Sept9b, a mammalian septin.";
RL   Oncogene 24:65-76(2005).
RN   [15]
RP   INTERACTION WITH RTKN.
RX   PubMed=16007136; DOI=10.1038/sj.onc.1208862;
RA   Ito H., Iwamoto I., Morishita R., Nozawa Y., Narumiya S., Asano T.,
RA   Nagata K.;
RT   "Possible role of Rho/Rhotekin signaling in mammalian septin
RT   organization.";
RL   Oncogene 24:7064-7072(2005).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30 AND THR-42, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [18]
RP   SUBCELLULAR LOCATION, INTERACTION WITH SEPT4, AND VARIANTS HNA TRP-106
RP   AND PHE-111.
RX   PubMed=17546647; DOI=10.1002/humu.20554;
RA   Sudo K., Ito H., Iwamoto I., Morishita R., Asano T., Nagata K.;
RT   "SEPT9 sequence alternations causing hereditary neuralgic amyotrophy
RT   are associated with altered interactions with SEPT4/SEPT11 and
RT   resistance to Rho/Rhotekin-signaling.";
RL   Hum. Mutat. 28:1005-1013(2007).
RN   [19]
RP   INTERACTION WITH SEPT14, AND SUBCELLULAR LOCATION.
RX   PubMed=17922164; DOI=10.1007/s00335-007-9065-x;
RA   Peterson E.A., Kalikin L.M., Steels J.D., Estey M.P., Trimble W.S.,
RA   Petty E.M.;
RT   "Characterization of a SEPT9 interacting protein, SEPT14, a novel
RT   testis-specific septin.";
RL   Mamm. Genome 18:796-807(2007).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30; THR-38 AND THR-42,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [23]
RP   INTERACTION WITH SEPT2; SEPT6; SEPT7 AND SEPT11, AND ASSOCIATION WITH
RP   ACTIN FILAMENTS AND MICROTUBULES.
RX   PubMed=19145258; DOI=10.1371/journal.pone.0004196;
RA   Mostowy S., Nam Tham T., Danckaert A., Guadagnini S.,
RA   Boisson-Dupuis S., Pizarro-Cerda J., Cossart P.;
RT   "Septins regulate bacterial entry into host cells.";
RL   PLoS ONE 4:E4196-E4196(2009).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30 AND TYR-278, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30; SER-82; SER-85;
RP   SER-96 AND THR-142, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30; SER-85 AND SER-327,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, ACETYLATION [LARGE SCALE
RP   ANALYSIS] AT MET-1 (ISOFORM 3), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22; SER-30; THR-42;
RP   THR-49; SER-85; SER-89; THR-142 AND SER-332, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [32]
RP   VARIANTS HNA TRP-106 AND PHE-111.
RX   PubMed=16186812; DOI=10.1038/ng1649;
RA   Kuhlenbaeumer G., Hannibal M.C., Nelis E., Schirmacher A.,
RA   Verpoorten N., Meuleman J., Watts G.D.J., De Vriendt E., Young P.,
RA   Stoegbauer F., Halfter H., Irobi J., Goossens D., Del-Favero J.,
RA   Betz B.G., Hor H., Kurlemann G., Bird T.D., Airaksinen E., Mononen T.,
RA   Serradell A.P., Prats J.M., Van Broeckhoven C., De Jonghe P.,
RA   Timmerman V., Ringelstein E.B., Chance P.F.;
RT   "Mutations in SEPT9 cause hereditary neuralgic amyotrophy.";
RL   Nat. Genet. 37:1044-1046(2005).
RN   [33]
RP   VARIANT HNA TRP-106.
RX   PubMed=18492087; DOI=10.1111/j.1399-0004.2008.01022.x;
RA   Laccone F., Hannibal M.C., Neesen J., Grisold W., Chance P.F.,
RA   Rehder H.;
RT   "Dysmorphic syndrome of hereditary neuralgic amyotrophy associated
RT   with a SEPT9 gene mutation -- a family study.";
RL   Clin. Genet. 74:279-283(2008).
RN   [34]
RP   VARIANTS HNA TRP-106 AND PHE-111, AND VARIANT LEU-145.
RX   PubMed=19451530; DOI=10.1212/WNL.0b013e3181a609e3;
RA   Hannibal M.C., Ruzzo E.K., Miller L.R., Betz B., Buchan J.G.,
RA   Knutzen D.M., Barnett K., Landsverk M.L., Brice A., LeGuern E.,
RA   Bedford H.M., Worrall B.B., Lovitt S., Appel S.H., Andermann E.,
RA   Bird T.D., Chance P.F.;
RT   "SEPT9 gene sequencing analysis reveals recurrent mutations in
RT   hereditary neuralgic amyotrophy.";
RL   Neurology 72:1755-1759(2009).
CC   -!- FUNCTION: Filament-forming cytoskeletal GTPase (By similarity).
CC       May play a role in cytokinesis (Potential). May play a role in the
CC       internalization of 2 intracellular microbial pathogens, Listeria
CC       monocytogenes and Shigella flexneri. {ECO:0000250, ECO:0000305}.
CC   -!- SUBUNIT: Septins polymerize into heterooligomeric protein
CC       complexes that form filaments, and associate with cellular
CC       membranes, actin filaments, and microtubules. GTPase activity is
CC       required for filament formation. Interacts with SEPT2, SEPT6,
CC       SEPT7, SEPT11 and SEPT14. Interacts with RTKN and ARHGEF18. In a
CC       mesenchymal cell line, Rho/RTKN signals cause disruption of wild-
CC       type septin filaments, but not of those containing isoform 2
CC       variants HNA Trp-106 and Phe-111. In a mesenchymal cell line,
CC       isoform 2 variants HNA Trp-106 and Phe-111, but not wild type,
CC       form filaments with SEPT4. {ECO:0000269|PubMed:15485874,
CC       ECO:0000269|PubMed:15558029, ECO:0000269|PubMed:16007136,
CC       ECO:0000269|PubMed:17546647, ECO:0000269|PubMed:17922164,
CC       ECO:0000269|PubMed:19145258}.
CC   -!- INTERACTION:
CC       Q16665:HIF1A; NbExp=4; IntAct=EBI-851558, EBI-447269;
CC       Q6ZU15:SEPT14; NbExp=3; IntAct=EBI-851558, EBI-2009297;
CC       Q14141:SEPT6; NbExp=3; IntAct=EBI-851542, EBI-745901;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:17546647, ECO:0000269|PubMed:17922164}.
CC       Note=In an epithelial cell line, concentrates at cell-cell contact
CC       areas. After TGF-beta1 treatment and induction of epithelial to
CC       mesenchymal transition, colocalizes partly with actin stress
CC       fibers. During bacterial infection, displays a collar shape
CC       structure next to actin at the pole of invading bacteria.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=There are potentially 18 isoforms.;
CC       Name=1; Synonyms=Epsilon, MSF-A;
CC         IsoId=Q9UHD8-1; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha;
CC         IsoId=Q9UHD8-2; Sequence=VSP_012337;
CC       Name=3; Synonyms=Beta, MSF-B;
CC         IsoId=Q9UHD8-3; Sequence=VSP_012336;
CC         Note=Contains a N-acetylmethionine at position 1.
CC         {ECO:0000244|PubMed:22814378};
CC       Name=4; Synonyms=Delta;
CC         IsoId=Q9UHD8-4; Sequence=VSP_012335;
CC       Name=5; Synonyms=Gamma;
CC         IsoId=Q9UHD8-5; Sequence=VSP_012338;
CC       Name=7;
CC         IsoId=Q9UHD8-7; Sequence=VSP_038317;
CC         Note=No experimental confirmation available.;
CC       Name=8;
CC         IsoId=Q9UHD8-8; Sequence=VSP_038316, VSP_038318;
CC         Note=No experimental confirmation available.;
CC       Name=9;
CC         IsoId=Q9UHD8-9; Sequence=VSP_038315, VSP_038319;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Isoforms are differentially
CC       expressed in testes, kidney, liver heart, spleen, brain,
CC       peripheral blood leukocytes, skeletal muscle and kidney. Specific
CC       isoforms appear to demonstrate tissue specificity. Isoform 5 is
CC       the most highly expressed in fetal tissue. Isoform 1 is detected
CC       in all tissues except the brain and thymus, while isoform 2,
CC       isoform 3, and isoform 4 are detected at low levels in
CC       approximately half of the fetal tissues.
CC       {ECO:0000269|PubMed:10339604, ECO:0000269|PubMed:10673329,
CC       ECO:0000269|PubMed:11593400, ECO:0000269|PubMed:15915442}.
CC   -!- DISEASE: Note=A chromosomal aberration involving SEPT9/MSF is
CC       found in therapy-related acute myeloid leukemia (t-AML).
CC       Translocation t(11;17)(q23;q25) with KMT2A/MLL1.
CC       {ECO:0000269|PubMed:10339604}.
CC   -!- DISEASE: Hereditary neuralgic amyotrophy (HNA) [MIM:162100]:
CC       Autosomal dominant form of recurrent focal neuropathy
CC       characterized clinically by acute, recurrent episodes of brachial
CC       plexus neuropathy with muscle weakness and atrophy preceded by
CC       severe pain in the affected arm. HNA is triggered by environmental
CC       factors such as infection or parturition.
CC       {ECO:0000269|PubMed:16186812, ECO:0000269|PubMed:17546647,
CC       ECO:0000269|PubMed:18492087, ECO:0000269|PubMed:19451530}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-
CC       like GTPase superfamily. Septin GTPase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01056}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14057.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MSFID208.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF123052; AAD39749.1; -; mRNA.
DR   EMBL; AJ312319; CAC42221.1; -; mRNA.
DR   EMBL; AJ312320; CAC42222.1; -; mRNA.
DR   EMBL; AJ312321; CAC42223.1; -; mRNA.
DR   EMBL; AJ312322; CAC42224.1; -; mRNA.
DR   EMBL; AF189712; AAF23373.1; -; mRNA.
DR   EMBL; AF189713; AAF23374.1; -; mRNA.
DR   EMBL; AF142408; AAG27919.1; -; mRNA.
DR   EMBL; AK022493; BAB14057.1; ALT_SEQ; mRNA.
DR   EMBL; AK290368; BAF83057.1; -; mRNA.
DR   EMBL; AK056495; BAG51732.1; -; mRNA.
DR   EMBL; AK300270; BAG62031.1; -; mRNA.
DR   EMBL; AK303449; BAG64494.1; -; mRNA.
DR   EMBL; AK304143; BAG65036.1; -; mRNA.
DR   EMBL; AK299828; BAH13140.1; -; mRNA.
DR   EMBL; AK316473; BAH14844.1; -; mRNA.
DR   EMBL; BT007215; AAP35879.1; -; mRNA.
DR   EMBL; CH471099; EAW89462.1; -; Genomic_DNA.
DR   EMBL; CH471099; EAW89463.1; -; Genomic_DNA.
DR   EMBL; CH471099; EAW89468.1; -; Genomic_DNA.
DR   EMBL; BC021192; AAH21192.1; -; mRNA.
DR   EMBL; BC054004; AAH54004.1; -; mRNA.
DR   EMBL; AB023208; BAA76835.2; -; mRNA.
DR   EMBL; AL080131; CAB45728.1; -; mRNA.
DR   CCDS; CCDS45790.1; -. [Q9UHD8-1]
DR   CCDS; CCDS45791.1; -. [Q9UHD8-2]
DR   CCDS; CCDS45792.1; -. [Q9UHD8-5]
DR   CCDS; CCDS45793.1; -. [Q9UHD8-3]
DR   CCDS; CCDS45794.1; -. [Q9UHD8-8]
DR   CCDS; CCDS45795.1; -. [Q9UHD8-4]
DR   CCDS; CCDS74166.1; -. [Q9UHD8-9]
DR   CCDS; CCDS77122.1; -. [Q9UHD8-7]
DR   PIR; T12519; T12519.
DR   RefSeq; NP_001106963.1; NM_001113491.1. [Q9UHD8-1]
DR   RefSeq; NP_001106964.1; NM_001113492.1. [Q9UHD8-3]
DR   RefSeq; NP_001106965.1; NM_001113493.1. [Q9UHD8-5]
DR   RefSeq; NP_001106966.1; NM_001113494.1. [Q9UHD8-3]
DR   RefSeq; NP_001106967.1; NM_001113495.1. [Q9UHD8-8]
DR   RefSeq; NP_001106968.1; NM_001113496.1. [Q9UHD8-4]
DR   RefSeq; NP_001280624.1; NM_001293695.1. [Q9UHD8-7]
DR   RefSeq; NP_001280625.1; NM_001293696.1. [Q9UHD8-9]
DR   RefSeq; NP_001280626.1; NM_001293697.1. [Q9UHD8-4]
DR   RefSeq; NP_001280627.1; NM_001293698.1. [Q9UHD8-4]
DR   RefSeq; NP_006631.2; NM_006640.4. [Q9UHD8-2]
DR   RefSeq; XP_005257019.1; XM_005256962.1.
DR   RefSeq; XP_006721706.1; XM_006721643.2.
DR   RefSeq; XP_006721707.1; XM_006721644.1.
DR   RefSeq; XP_011522509.1; XM_011524207.1.
DR   RefSeq; XP_011522510.1; XM_011524208.2.
DR   RefSeq; XP_016879520.1; XM_017024031.1.
DR   RefSeq; XP_016879521.1; XM_017024032.1.
DR   UniGene; Hs.440932; -.
DR   PDB; 4YQF; X-ray; 2.73 A; A/B=296-565.
DR   PDB; 5CYO; X-ray; 2.04 A; A/B=295-568.
DR   PDB; 5CYP; X-ray; 2.89 A; A/B/C/D=293-566.
DR   PDBsum; 4YQF; -.
DR   PDBsum; 5CYO; -.
DR   PDBsum; 5CYP; -.
DR   ProteinModelPortal; Q9UHD8; -.
DR   SMR; Q9UHD8; -.
DR   BioGrid; 116015; 73.
DR   CORUM; Q9UHD8; -.
DR   DIP; DIP-36697N; -.
DR   IntAct; Q9UHD8; 35.
DR   MINT; Q9UHD8; -.
DR   STRING; 9606.ENSP00000391249; -.
DR   CarbonylDB; Q9UHD8; -.
DR   iPTMnet; Q9UHD8; -.
DR   PhosphoSitePlus; Q9UHD8; -.
DR   SwissPalm; Q9UHD8; -.
DR   BioMuta; SEPT9; -.
DR   DMDM; 93141311; -.
DR   EPD; Q9UHD8; -.
DR   jPOST; Q9UHD8; -.
DR   PaxDb; Q9UHD8; -.
DR   PeptideAtlas; Q9UHD8; -.
DR   PRIDE; Q9UHD8; -.
DR   ProteomicsDB; 84325; -.
DR   ProteomicsDB; 84326; -. [Q9UHD8-2]
DR   ProteomicsDB; 84327; -. [Q9UHD8-3]
DR   ProteomicsDB; 84328; -. [Q9UHD8-4]
DR   ProteomicsDB; 84329; -. [Q9UHD8-5]
DR   ProteomicsDB; 84330; -. [Q9UHD8-7]
DR   ProteomicsDB; 84331; -. [Q9UHD8-8]
DR   ProteomicsDB; 84332; -. [Q9UHD8-9]
DR   DNASU; 10801; -.
DR   Ensembl; ENST00000329047; ENSP00000329161; ENSG00000184640. [Q9UHD8-2]
DR   Ensembl; ENST00000423034; ENSP00000405877; ENSG00000184640. [Q9UHD8-5]
DR   Ensembl; ENST00000427177; ENSP00000391249; ENSG00000184640. [Q9UHD8-1]
DR   Ensembl; ENST00000427180; ENSP00000415624; ENSG00000184640. [Q9UHD8-8]
DR   Ensembl; ENST00000427674; ENSP00000403194; ENSG00000184640. [Q9UHD8-3]
DR   Ensembl; ENST00000431235; ENSP00000406987; ENSG00000184640. [Q9UHD8-3]
DR   Ensembl; ENST00000449803; ENSP00000400181; ENSG00000184640. [Q9UHD8-3]
DR   Ensembl; ENST00000541152; ENSP00000438089; ENSG00000184640. [Q9UHD8-4]
DR   Ensembl; ENST00000585930; ENSP00000468120; ENSG00000184640. [Q9UHD8-9]
DR   Ensembl; ENST00000588690; ENSP00000468668; ENSG00000184640. [Q9UHD8-3]
DR   Ensembl; ENST00000590294; ENSP00000465464; ENSG00000184640. [Q9UHD8-2]
DR   Ensembl; ENST00000591088; ENSP00000466247; ENSG00000184640. [Q9UHD8-4]
DR   Ensembl; ENST00000591198; ENSP00000468406; ENSG00000184640. [Q9UHD8-7]
DR   Ensembl; ENST00000592951; ENSP00000466648; ENSG00000184640. [Q9UHD8-4]
DR   GeneID; 10801; -.
DR   KEGG; hsa:10801; -.
DR   UCSC; uc002jts.5; human. [Q9UHD8-1]
DR   CTD; 10801; -.
DR   DisGeNET; 10801; -.
DR   EuPathDB; HostDB:ENSG00000184640.17; -.
DR   GeneCards; SEPT9; -.
DR   GeneReviews; SEPT9; -.
DR   HGNC; HGNC:7323; SEPT9.
DR   HPA; HPA042564; -.
DR   HPA; HPA050627; -.
DR   MalaCards; SEPT9; -.
DR   MIM; 162100; phenotype.
DR   MIM; 604061; gene.
DR   neXtProt; NX_Q9UHD8; -.
DR   OpenTargets; ENSG00000184640; -.
DR   Orphanet; 2901; Neuralgic amyotrophy.
DR   PharmGKB; PA31132; -.
DR   eggNOG; KOG1547; Eukaryota.
DR   eggNOG; COG5019; LUCA.
DR   GeneTree; ENSGT00940000157195; -.
DR   HOVERGEN; HBG098529; -.
DR   InParanoid; Q9UHD8; -.
DR   KO; K16938; -.
DR   OMA; GECHRLP; -.
DR   OrthoDB; 188544at2759; -.
DR   PhylomeDB; Q9UHD8; -.
DR   TreeFam; TF101078; -.
DR   SIGNOR; Q9UHD8; -.
DR   ChiTaRS; SEPT9; human.
DR   GeneWiki; SEPT9; -.
DR   GenomeRNAi; 10801; -.
DR   PRO; PR:Q9UHD8; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000184640; Expressed in 231 organ(s), highest expression level in parotid gland.
DR   ExpressionAtlas; Q9UHD8; baseline and differential.
DR   Genevisible; Q9UHD8; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005930; C:axoneme; IDA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IBA:GO_Central.
DR   GO; GO:0097730; C:non-motile cilium; IDA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031105; C:septin complex; IDA:GO_Central.
DR   GO; GO:0005940; C:septin ring; IBA:GO_Central.
DR   GO; GO:0001725; C:stress fiber; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0032947; F:protein-containing complex scaffold activity; IBA:GO_Central.
DR   GO; GO:0061640; P:cytoskeleton-dependent cytokinesis; IBA:GO_Central.
DR   GO; GO:1902857; P:positive regulation of non-motile cilium assembly; IMP:GO_Central.
DR   GO; GO:0051291; P:protein heterooligomerization; IDA:UniProtKB.
DR   CDD; cd01850; CDC_Septin; 1.
DR   InterPro; IPR030379; G_SEPTIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR030645; SEPT9.
DR   InterPro; IPR016491; Septin.
DR   PANTHER; PTHR18884:SF47; PTHR18884:SF47; 1.
DR   Pfam; PF00735; Septin; 1.
DR   PIRSF; PIRSF006698; Septin; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51719; G_SEPTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell cycle;
KW   Cell division; Chromosomal rearrangement; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Disease mutation; GTP-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    586       Septin-9.
FT                                /FTId=PRO_0000173535.
FT   DOMAIN      295    567       Septin-type G. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   NP_BIND     305    312       GTP. {ECO:0000250}.
FT   NP_BIND     445    453       GTP. {ECO:0000250}.
FT   REGION      305    312       G1 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   REGION      362    365       G3 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   REGION      444    447       G4 motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01056}.
FT   BINDING     339    339       GTP. {ECO:0000250}.
FT   BINDING     365    365       GTP; via amide nitrogen. {ECO:0000250}.
FT   BINDING     501    501       GTP; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000250}.
FT   BINDING     516    516       GTP. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES      22     22       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      30     30       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      38     38       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      42     42       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      49     49       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      62     62       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q80UG5}.
FT   MOD_RES      82     82       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES      85     85       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      89     89       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      96     96       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     142    142       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     278    278       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     327    327       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     332    332       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    251       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:10987277,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_012335.
FT   VAR_SEQ       1    224       Missing (in isoform 9).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038315.
FT   VAR_SEQ       1    164       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10673329,
FT                                ECO:0000303|PubMed:10987277,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012336.
FT   VAR_SEQ       1    112       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038316.
FT   VAR_SEQ       1     25       MKKSYSGGTRTSSGRLRRLGDSSGP -> MERDRIS (in
FT                                isoform 2). {ECO:0000303|PubMed:10339604,
FT                                ECO:0000303|PubMed:10987277,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.4, ECO:0000303|Ref.6}.
FT                                /FTId=VSP_012337.
FT   VAR_SEQ       1     25       MKKSYSGGTRTSSGRLRRLGDSSGP -> MSDPAVNAQLDG
FT                                IISDFE (in isoform 5).
FT                                {ECO:0000303|PubMed:10987277,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_012338.
FT   VAR_SEQ       7     25       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038317.
FT   VAR_SEQ     113    240       DISSKQVENAGAIGPSRFGLKRAEVLGHKTPEPAPRRTEIT
FT                                IVKPQESAHRRMEPPASKVPEVPTAPATDAAPKRVEIQMPK
FT                                PAEAPTAPSPAQTLENSEPAPVSQLQSRLEPKPQPPVAEAT
FT                                PRSQE -> MGSSFWEGLQVAVGLPQGCWPQGLDSGEPAEG
FT                                GQLEAAPVCIVTRQSKETAGPTLGRGGWRQGSLRRGKGTSC
FT                                RCRQLSPGHGPGRLTGCGECHRLPCRGLVSGFTGLRGQEED
FT                                DLAFCLATIGSDRQ (in isoform 8).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038318.
FT   VAR_SEQ     225    240       PKPQPPVAEATPRSQE -> MAGAGCTGTWSWLWGT (in
FT                                isoform 9).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038319.
FT   VARIANT      76     76       R -> C (in dbSNP:rs202079794).
FT                                {ECO:0000269|PubMed:10987277}.
FT                                /FTId=VAR_020667.
FT   VARIANT     106    106       R -> W (in HNA; dbSNP:rs80338761).
FT                                {ECO:0000269|PubMed:16186812,
FT                                ECO:0000269|PubMed:17546647,
FT                                ECO:0000269|PubMed:18492087,
FT                                ECO:0000269|PubMed:19451530}.
FT                                /FTId=VAR_033101.
FT   VARIANT     111    111       S -> F (in HNA; dbSNP:rs80338762).
FT                                {ECO:0000269|PubMed:16186812,
FT                                ECO:0000269|PubMed:17546647,
FT                                ECO:0000269|PubMed:19451530}.
FT                                /FTId=VAR_033102.
FT   VARIANT     145    145       P -> L (in dbSNP:rs34587622).
FT                                {ECO:0000269|PubMed:10987277,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:19451530}.
FT                                /FTId=VAR_020668.
FT   VARIANT     576    576       M -> V (in dbSNP:rs2627223).
FT                                {ECO:0000269|PubMed:10231032,
FT                                ECO:0000269|PubMed:10339604,
FT                                ECO:0000269|PubMed:10673329,
FT                                ECO:0000269|PubMed:10987277,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|Ref.4, ECO:0000269|Ref.6,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_020669.
FT   CONFLICT    251    251       D -> G (in Ref. 5; BAG64494).
FT                                {ECO:0000305}.
FT   CONFLICT    487    487       V -> E (in Ref. 5; BAB14057).
FT                                {ECO:0000305}.
FT   STRAND      297    305       {ECO:0000244|PDB:5CYO}.
FT   HELIX       311    322       {ECO:0000244|PDB:5CYO}.
FT   STRAND      343    351       {ECO:0000244|PDB:5CYO}.
FT   STRAND      354    362       {ECO:0000244|PDB:5CYO}.
FT   STRAND      369    371       {ECO:0000244|PDB:5CYO}.
FT   TURN        373    376       {ECO:0000244|PDB:5CYO}.
FT   HELIX       377    395       {ECO:0000244|PDB:5CYO}.
FT   STRAND      410    415       {ECO:0000244|PDB:5CYO}.
FT   STRAND      419    421       {ECO:0000244|PDB:5CYP}.
FT   HELIX       424    434       {ECO:0000244|PDB:5CYO}.
FT   STRAND      437    443       {ECO:0000244|PDB:5CYO}.
FT   HELIX       446    448       {ECO:0000244|PDB:5CYO}.
FT   HELIX       451    467       {ECO:0000244|PDB:5CYO}.
FT   STRAND      472    474       {ECO:0000244|PDB:4YQF}.
FT   HELIX       476    478       {ECO:0000244|PDB:5CYO}.
FT   HELIX       482    494       {ECO:0000244|PDB:5CYO}.
FT   STRAND      496    498       {ECO:0000244|PDB:5CYO}.
FT   STRAND      503    508       {ECO:0000244|PDB:5CYO}.
FT   STRAND      511    517       {ECO:0000244|PDB:5CYO}.
FT   STRAND      522    524       {ECO:0000244|PDB:5CYO}.
FT   TURN        528    530       {ECO:0000244|PDB:5CYO}.
FT   HELIX       533    539       {ECO:0000244|PDB:5CYO}.
FT   HELIX       542    554       {ECO:0000244|PDB:5CYO}.
FT   HELIX       556    567       {ECO:0000244|PDB:5CYO}.
SQ   SEQUENCE   586 AA;  65401 MW;  D4404578328CFCFE CRC64;
     MKKSYSGGTR TSSGRLRRLG DSSGPALKRS FEVEEVETPN STPPRRVQTP LLRATVASST
     QKFQDLGVKN SEPSARHVDS LSQRSPKASL RRVELSGPKA AEPVSRRTEL SIDISSKQVE
     NAGAIGPSRF GLKRAEVLGH KTPEPAPRRT EITIVKPQES AHRRMEPPAS KVPEVPTAPA
     TDAAPKRVEI QMPKPAEAPT APSPAQTLEN SEPAPVSQLQ SRLEPKPQPP VAEATPRSQE
     ATEAAPSCVG DMADTPRDAG LKQAPASRNE KAPVDFGYVG IDSILEQMRR KAMKQGFEFN
     IMVVGQSGLG KSTLINTLFK SKISRKSVQP TSEERIPKTI EIKSITHDIE EKGVRMKLTV
     IDTPGFGDHI NNENCWQPIM KFINDQYEKY LQEEVNINRK KRIPDTRVHC CLYFIPATGH
     SLRPLDIEFM KRLSKVVNIV PVIAKADTLT LEERVHFKQR ITADLLSNGI DVYPQKEFDE
     DSEDRLVNEK FREMIPFAVV GSDHEYQVNG KRILGRKTKW GTIEVENTTH CEFAYLRDLL
     IRTHMQNIKD ITSSIHFEAY RVKRLNEGSS AMANGMEEKE PEAPEM
//
ID   A0A024QYY9_HUMAN        Unreviewed;      1068 AA.
AC   A0A024QYY9;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   13-FEB-2019, entry version 40.
DE   SubName: Full=Spectrin domain with coiled-coils 1, isoform CRA_a {ECO:0000313|EMBL:EAW50917.1};
GN   Name=SPECC1 {ECO:0000313|EMBL:EAW50917.1};
GN   ORFNames=hCG_28279 {ECO:0000313|EMBL:EAW50917.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW50917.1};
RN   [1] {ECO:0000313|EMBL:EAW50917.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW50917.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471212; EAW50914.1; -; Genomic_DNA.
DR   EMBL; CH471212; EAW50917.1; -; Genomic_DNA.
DR   RefSeq; NP_001028725.1; NM_001033553.2.
DR   RefSeq; NP_001230368.1; NM_001243439.1.
DR   UniGene; Hs.431045; -.
DR   GeneID; 92521; -.
DR   KEGG; hsa:92521; -.
DR   CTD; 92521; -.
DR   EuPathDB; HostDB:ENSG00000128487.16; -.
DR   eggNOG; KOG4678; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   KO; K23028; -.
DR   OMA; IYLEHSP; -.
DR   ChiTaRS; SPECC1; human.
DR   GenomeRNAi; 92521; -.
DR   Bgee; ENSG00000128487; Expressed in 153 organ(s), highest expression level in corpus callosum.
DR   CDD; cd00014; CH; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR040166; CYTSA/B.
DR   PANTHER; PTHR23167; PTHR23167; 1.
DR   Pfam; PF00307; CH; 1.
DR   SMART; SM00033; CH; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS50021; CH; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN      962   1067       Calponin-homology (CH).
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   COILED      163    197       {ECO:0000256|SAM:Coils}.
FT   COILED      226    260       {ECO:0000256|SAM:Coils}.
FT   COILED      363    453       {ECO:0000256|SAM:Coils}.
FT   COILED      481    529       {ECO:0000256|SAM:Coils}.
FT   COILED      584    611       {ECO:0000256|SAM:Coils}.
FT   COILED      651    678       {ECO:0000256|SAM:Coils}.
FT   COILED      686    727       {ECO:0000256|SAM:Coils}.
FT   COILED      746    773       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1068 AA;  118585 MW;  E6FB6987C835A1CA CRC64;
     MRSAAKPWNP AIRAGGHGPD RVRPLPAASS GMKSSKSSTS LAFESRLSRL KRASSEDTLN
     KPGSTAASGV VRLKKTATAG AISELTESRL RSGTGAFTTT KRTGIPAPRE FSVTVSRERS
     VPRGPSNPRK SVSSPTSSNT PTPTKHLRTP STKPKQENEG GEKAALESQV RELLAEAKAK
     DSEINRLRSE LKKYKEKRTL NAEGTDALGP NVDGTSVSPG DTEPMIRALE EKNKNFQKEL
     SDLEEENRVL KEKLIYLEHS PNSEGAASHT GDSSCPTSIT QESSFGSPTG NQMSSDIDEY
     KKNIHGNALR TSGSSSSDVT KASLSPDASD FEHITAETPS RPLSSTSNPF KSSKCSTAGS
     SPNSVSELSL ASLTEKIQKM EENHHSTAEE LQATLQELSD QQQMVQELTA ENEKLVDEKT
     ILETSFHQHR ERAEQLSQEN EKLMNLLQER VKNEEPTTQE GKIIELEQKC TGILEQGRFE
     REKLLNIQQQ LTCSLRKVEE ENQGALEMIK RLKEENEKLN EFLELERHNN NMMAKTLEEC
     RVTLEGLKME NGSLKSHLQG EKQKATEASA VEQTAESCEV QEMLKVARAE KDLLELSCNE
     LRQELLKANG EIKHVSSLLA KVEKDYSYLK EICDHQAEQL SRTSLKLQEK ASESDAEIKD
     MKETIFELED QVEQHRAVKL HNNQLISELE SSVIKLEEQK SDLERQLKTL TKQMKEETEE
     WRRFQADLQT AVVVANDIKC EAQQELRTVK RKLLEEEEKN ARLQKELGDV QGHGRVVTSR
     AAPPPVDEEP ESSEVDAAGR WPGVCVSRTS PTPPESATTV KSLIKSFDLG RPGGAGQNIS
     VHKTPRSPLS GIPVRTAPAA AVSPMQRHST YSSVRPASRG VTQRLDLPDL PLSDILKGRT
     ETLKPDPHLR KSPSLESLSR PPSLGFGDTR LLSASTRAWK PQSKLSVERK DPLAALAREY
     GGSKRNALLK WCQKKTQGYA NIDITNFSSS WSDGLAFCAL LHTYLPAHIP YQELNSQEKK
     RNLLLAFEAA ESVGIKPSLE LSEMLYTDRP DWQSVMQYVA QIYKYFET
//
ID   B4DW07_HUMAN            Unreviewed;       408 AA.
AC   B4DW07;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   13-FEB-2019, entry version 47.
DE   SubName: Full=cDNA FLJ50032, highly similar to Homo sapiens spectrin domain with coiled-coils 1 (SPECC1), transcript variant, mRNA {ECO:0000313|EMBL:BAG62869.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG62869.1};
RN   [1] {ECO:0000313|EMBL:BAG62869.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Stomach {ECO:0000313|EMBL:BAG62869.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK301318; BAG62869.1; -; mRNA.
DR   RefSeq; NP_001028725.1; NM_001033553.2.
DR   RefSeq; NP_001028727.1; NM_001033555.2.
DR   RefSeq; NP_001230368.1; NM_001243439.1.
DR   UniGene; Hs.431045; -.
DR   ProteinModelPortal; B4DW07; -.
DR   PeptideAtlas; B4DW07; -.
DR   PRIDE; B4DW07; -.
DR   GeneID; 92521; -.
DR   KEGG; hsa:92521; -.
DR   CTD; 92521; -.
DR   eggNOG; KOG4678; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   HOVERGEN; HBG056096; -.
DR   KO; K23028; -.
DR   GenomeRNAi; 92521; -.
DR   Genevisible; B4DW07; HS.
DR   CDD; cd00014; CH; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR040166; CYTSA/B.
DR   PANTHER; PTHR23167; PTHR23167; 1.
DR   Pfam; PF00307; CH; 1.
DR   SMART; SM00033; CH; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS50021; CH; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN      302    407       Calponin-homology (CH).
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   COILED       26     67       {ECO:0000256|SAM:Coils}.
FT   COILED       86    113       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   408 AA;  45731 MW;  47B8B76A19A7329F CRC64;
     MKETIFELED QVEQHRAVKL HNNQLISELE SSVIKLEEQK SDLERQLKTL TKQMKEETEE
     WRRFQADLQT AVVVANDIKC EAQQELRTVK RKLLEEEEKN ARLQKELGDV QGHGRVVTSR
     AAPPPVDEEP ESSEVDAAGR WPGVCVSRTS PTPPESATTV KSLIKSFDLG RPGGAGQNIS
     VHKTPRSPLS GIPVRTAPAA AVSPMQRHST YSSVRPASRG VTQRLDLPDL PLSDILKGRT
     ETLKPDPHLR KSPSLESLSR PPSLGFGDTR LLSASTRAWK PQNKLSVERK DPLAALAREY
     GGSKRNALLK WCQKKTQGYA NIDITNFSSS WSDGLAFCAL LHTYLPAHIP YQELNSQEKK
     RNLLLAFEAA ESVGIKPSLE LSEMLYTDRP DWQSVMQYVA QIYKYFET
//
ID   B4E2A4_HUMAN            Unreviewed;       987 AA.
AC   B4E2A4;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   13-FEB-2019, entry version 47.
DE   SubName: Full=cDNA FLJ53275, highly similar to Homo sapiens spectrin domain with coiled-coils 1 (SPECC1), transcript variant, mRNA {ECO:0000313|EMBL:BAG65066.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG65066.1};
RN   [1] {ECO:0000313|EMBL:BAG65066.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG65066.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK304186; BAG65066.1; -; mRNA.
DR   RefSeq; NP_001028725.1; NM_001033553.2.
DR   RefSeq; NP_001028726.1; NM_001033554.2.
DR   RefSeq; NP_001028727.1; NM_001033555.2.
DR   RefSeq; NP_001230367.1; NM_001243438.1.
DR   RefSeq; NP_001230368.1; NM_001243439.1.
DR   RefSeq; NP_690868.3; NM_152904.4.
DR   UniGene; Hs.431045; -.
DR   ProteinModelPortal; B4E2A4; -.
DR   PeptideAtlas; B4E2A4; -.
DR   PRIDE; B4E2A4; -.
DR   GeneID; 92521; -.
DR   KEGG; hsa:92521; -.
DR   CTD; 92521; -.
DR   eggNOG; KOG4678; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   HOVERGEN; HBG056096; -.
DR   KO; K23028; -.
DR   GenomeRNAi; 92521; -.
DR   Genevisible; B4E2A4; HS.
DR   CDD; cd00014; CH; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR040166; CYTSA/B.
DR   PANTHER; PTHR23167; PTHR23167; 1.
DR   Pfam; PF00307; CH; 1.
DR   SMART; SM00033; CH; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS50021; CH; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN      881    986       Calponin-homology (CH).
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   COILED       82    116       {ECO:0000256|SAM:Coils}.
FT   COILED      145    179       {ECO:0000256|SAM:Coils}.
FT   COILED      282    372       {ECO:0000256|SAM:Coils}.
FT   COILED      400    448       {ECO:0000256|SAM:Coils}.
FT   COILED      503    530       {ECO:0000256|SAM:Coils}.
FT   COILED      570    597       {ECO:0000256|SAM:Coils}.
FT   COILED      605    646       {ECO:0000256|SAM:Coils}.
FT   COILED      665    692       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   987 AA;  110293 MW;  9039F4C840B6B338 CRC64;
     MGNHSGRPED PEPGAFTTTK RTGIPAPREF SVTVSRERSV PRGPSNPRKS VSSPTSSNTP
     TPTKHLRTPS TKPKQENEGG EKAALESQVR ELLAEAKAKD SEINRLRSEL KKYKEKRTLN
     AEGTDALGPN VDGTSVSPGD TEPMIRALEE KNKNFQKELS DLEEENRVLK EKLIYLEHSP
     NSEGAASHTG DSRCPTSITQ ESSFGSPTGN QLSSDIDEYK KNIHGNALRT SGSSSSDVTK
     ASLSPDASDF EHITAETPSR PLSSTSNPFK SSKCSTAGSS PNSVSELSLA SLTEKIQKME
     ENHHSTAEEL QATLQELSDQ QQMVQELTAE NEKLVDEKTI LETSFHQHRE RAEQLSQENE
     KLMNLLQERV KNEEPTTQEG KIIELEQKCT GILEQGRFER EKLLNIQQQL TCSLRKVEEE
     NQGALEMIKR LKEENEKLNE FLELERHNNN MMAKTLEECR VTLEGLKMEN GSLKSHLQGE
     KQKATEASAV EQTAESCEVQ EMLKVARAEK DLLELSCNEL RQELLKANGE IKHVSSLLAK
     VEKDYSYLKE ICDHQAEQLS RTSLKLQEKA SESDAEIKDM KETIFELEDQ VEQHRAVKLH
     NNQLISELES SVIKLEEQKS DLERQLKTLT KQMKEETEEW RRFQADLQTA VVVANDIKCE
     AQQELRTVKR KLLEEEEKNA RLQKELGDVQ GHGRVVTSRA APPPVDEEPE SSEVDAAGRW
     PGVCVSRTSP TPPESATTVK SLIKSFDLGR PGGAGQNISV HKTPRSPLSG IPVRTAPAAA
     VSPMQRHSTY SSVRPASRGV TQRLDLPDLP LSDILKGRTE TLKPDPHLRK SPSLESLSRP
     PSLGFGDTRL LSASTRAWKP QSKLSVERKD PLAALAREYG GSKRNALLKW CQKKTQGYAN
     IDITNFSSSW SDGLAFCALL HTYLPAHIPY QELNSQEKKR NLLLAFEAAE SVGIKPSLEL
     SEMLYTDRPD WQSVMQYVAQ IYKYFET
//
ID   CYTSB_HUMAN             Reviewed;        1068 AA.
AC   Q5M775; B4DHH0; B7WNS8; Q5IBP1; Q5IBP2; Q5IBP3; Q5IBP4; Q5M772;
AC   Q5M773; Q5M774; Q86XT8; Q8N4U4; Q8WU84; Q9HCQ3;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 1.
DT   13-FEB-2019, entry version 122.
DE   RecName: Full=Cytospin-B;
DE   AltName: Full=Nuclear structure protein 5;
DE            Short=NSP5;
DE   AltName: Full=Sperm antigen HCMOGT-1;
DE   AltName: Full=Sperm antigen with calponin homology and coiled-coil domains 1;
GN   Name=SPECC1; Synonyms=CYTSB, NSP5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANTS ARG-274 AND
RP   LEU-293.
RC   TISSUE=Testis;
RA   Komori S.;
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), VARIANT LEU-293,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=15602574; DOI=10.1038/sj.onc.1207988;
RA   Sang N., Fath D.M., Giordano A.;
RT   "A gene highly expressed in tumor cells encodes novel structure
RT   proteins.";
RL   Oncogene 23:9438-9446(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   LEU-293.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 313-1068 (ISOFORMS 2/3), AND VARIANT
RP   LEU-293.
RC   TISSUE=Brain, Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CHROMOSOMAL TRANSLOCATION WITH PDGFRB.
RX   PubMed=15087372; DOI=10.1158/0008-5472.CAN-03-4026;
RA   Morerio C., Acquila M., Rosanda C., Rapella A., Dufour C.,
RA   Locatelli F., Maserati E., Pasquali F., Panarello C.;
RT   "HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile
RT   myelomonocytic leukemia with t(5;17)(q33;p11.2).";
RL   Cancer Res. 64:2649-2651(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-134; SER-138;
RP   THR-142; SER-218; SER-847; SER-863 AND SER-912, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-218; SER-241; SER-425;
RP   SER-847 AND SER-912, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-55; THR-78; SER-112;
RP   SER-131; SER-134; SER-218; SER-241; SER-425; SER-847; SER-863 AND
RP   SER-914, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   MYRISTOYLATION AT GLY-2 (ISOFORMS 3; 4 AND 5), CLEAVAGE OF INITIATOR
RP   METHIONINE (ISOFORMS 3; 4 AND 5), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=25807930; DOI=10.1002/anie.201500342;
RA   Broncel M., Serwa R.A., Ciepla P., Krause E., Dallman M.J.,
RA   Magee A.I., Tate E.W.;
RT   "Multifunctional reagents for quantitative proteome-wide analysis of
RT   protein modification in human cells and dynamic profiling of protein
RT   lipidation during vertebrate development.";
RL   Angew. Chem. Int. Ed. 54:5948-5951(2015).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15602574}.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Membrane {ECO:0000305}; Lipid-
CC       anchor {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Membrane {ECO:0000305}; Lipid-
CC       anchor {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 5: Membrane {ECO:0000305}; Lipid-
CC       anchor {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=NSP5beta3beta;
CC         IsoId=Q5M775-1; Sequence=Displayed;
CC       Name=2; Synonyms=NSP5beta3alpha;
CC         IsoId=Q5M775-2; Sequence=VSP_021164, VSP_021165;
CC       Name=3; Synonyms=NSP5alpha3alpha;
CC         IsoId=Q5M775-3; Sequence=VSP_021162, VSP_021164, VSP_021165;
CC         Note=Initiator Met-1 is removed. Contains a N-myristoyl glycine
CC         at position 2. {ECO:0000269|PubMed:25807930};
CC       Name=4; Synonyms=NSP5alpha3beta;
CC         IsoId=Q5M775-4; Sequence=VSP_021162;
CC         Note=Initiator Met-1 is removed. Contains a N-myristoyl glycine
CC         at position 2. {ECO:0000269|PubMed:25807930};
CC       Name=5;
CC         IsoId=Q5M775-5; Sequence=VSP_021162, VSP_021163;
CC         Note=Initiator Met-1 is removed. Contains a N-myristoyl glycine
CC         at position 2. {ECO:0000269|PubMed:25807930};
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis. Barely detectable
CC       in other tissues. Also highly expressed in some cancer cell lines.
CC       {ECO:0000269|PubMed:15602574}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CYTSB may be a
CC       cause of juvenile myelomonocytic leukemia. Translocation
CC       t(5;17)(q33;p11.2) with PDGFRB. {ECO:0000269|PubMed:15087372}.
CC   -!- SIMILARITY: Belongs to the cytospin-A family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH33618.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAB16440.1; Type=Frameshift; Positions=8; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/HCMOGT1ID174.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AB041533; BAB16440.1; ALT_FRAME; mRNA.
DR   EMBL; AY816326; AAW29999.1; -; mRNA.
DR   EMBL; AY816327; AAW30000.1; -; mRNA.
DR   EMBL; AY816328; AAW30001.1; -; mRNA.
DR   EMBL; AY816329; AAW30002.1; -; mRNA.
DR   EMBL; BK005598; DAA05629.1; -; Genomic_DNA.
DR   EMBL; BK005598; DAA05630.1; -; Genomic_DNA.
DR   EMBL; BK005598; DAA05631.1; -; Genomic_DNA.
DR   EMBL; BK005598; DAA05632.1; -; Genomic_DNA.
DR   EMBL; AK295093; BAG58132.1; -; mRNA.
DR   EMBL; AC005730; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC021123; AAH21123.2; -; mRNA.
DR   EMBL; BC033618; AAH33618.1; ALT_INIT; mRNA.
DR   EMBL; BC050058; AAH50058.1; -; mRNA.
DR   CCDS; CCDS32590.1; -. [Q5M775-1]
DR   CCDS; CCDS42280.1; -. [Q5M775-2]
DR   CCDS; CCDS42281.1; -. [Q5M775-4]
DR   CCDS; CCDS45628.1; -. [Q5M775-3]
DR   CCDS; CCDS58531.1; -. [Q5M775-5]
DR   RefSeq; NP_001028725.1; NM_001033553.2. [Q5M775-1]
DR   RefSeq; NP_001028726.1; NM_001033554.2. [Q5M775-3]
DR   RefSeq; NP_001028727.1; NM_001033555.2. [Q5M775-4]
DR   RefSeq; NP_001230367.1; NM_001243438.1. [Q5M775-5]
DR   RefSeq; NP_001230368.1; NM_001243439.1. [Q5M775-1]
DR   RefSeq; NP_690868.3; NM_152904.4. [Q5M775-2]
DR   RefSeq; XP_016880814.1; XM_017025325.1. [Q5M775-2]
DR   UniGene; Hs.431045; -.
DR   ProteinModelPortal; Q5M775; -.
DR   SMR; Q5M775; -.
DR   BioGrid; 124953; 64.
DR   IntAct; Q5M775; 49.
DR   STRING; 9606.ENSP00000261503; -.
DR   iPTMnet; Q5M775; -.
DR   PhosphoSitePlus; Q5M775; -.
DR   BioMuta; SPECC1; -.
DR   DMDM; 74722683; -.
DR   EPD; Q5M775; -.
DR   jPOST; Q5M775; -.
DR   MaxQB; Q5M775; -.
DR   PaxDb; Q5M775; -.
DR   PeptideAtlas; Q5M775; -.
DR   PRIDE; Q5M775; -.
DR   ProteomicsDB; 63559; -.
DR   ProteomicsDB; 63560; -. [Q5M775-2]
DR   ProteomicsDB; 63561; -. [Q5M775-3]
DR   ProteomicsDB; 63562; -. [Q5M775-4]
DR   ProteomicsDB; 63563; -. [Q5M775-5]
DR   Ensembl; ENST00000261503; ENSP00000261503; ENSG00000128487. [Q5M775-1]
DR   Ensembl; ENST00000395522; ENSP00000378893; ENSG00000128487. [Q5M775-5]
DR   Ensembl; ENST00000395525; ENSP00000378896; ENSG00000128487. [Q5M775-3]
DR   Ensembl; ENST00000395527; ENSP00000378898; ENSG00000128487. [Q5M775-1]
DR   Ensembl; ENST00000395529; ENSP00000378900; ENSG00000128487. [Q5M775-2]
DR   Ensembl; ENST00000395530; ENSP00000378901; ENSG00000128487. [Q5M775-4]
DR   GeneID; 92521; -.
DR   KEGG; hsa:92521; -.
DR   UCSC; uc002gwq.4; human. [Q5M775-1]
DR   CTD; 92521; -.
DR   DisGeNET; 92521; -.
DR   EuPathDB; HostDB:ENSG00000128487.16; -.
DR   GeneCards; SPECC1; -.
DR   H-InvDB; HIX0027112; -.
DR   HGNC; HGNC:30615; SPECC1.
DR   HPA; HPA021421; -.
DR   HPA; HPA021430; -.
DR   MIM; 608793; gene.
DR   neXtProt; NX_Q5M775; -.
DR   OpenTargets; ENSG00000128487; -.
DR   PharmGKB; PA164718712; -.
DR   eggNOG; KOG4678; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   GeneTree; ENSGT00940000153592; -.
DR   InParanoid; Q5M775; -.
DR   KO; K23028; -.
DR   OMA; IYLEHSP; -.
DR   PhylomeDB; Q5M775; -.
DR   TreeFam; TF316716; -.
DR   ChiTaRS; SPECC1; human.
DR   GeneWiki; SPECC1; -.
DR   GenomeRNAi; 92521; -.
DR   PRO; PR:Q5M775; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000128487; Expressed in 153 organ(s), highest expression level in corpus callosum.
DR   ExpressionAtlas; Q5M775; baseline and differential.
DR   Genevisible; Q5M775; HS.
DR   GO; GO:0031941; C:filamentous actin; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005815; C:microtubule organizing center; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   CDD; cd00014; CH; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR040166; CYTSA/B.
DR   PANTHER; PTHR23167; PTHR23167; 1.
DR   Pfam; PF00307; CH; 1.
DR   SMART; SM00033; CH; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS50021; CH; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Coiled coil;
KW   Complete proteome; Lipoprotein; Membrane; Myristate; Nucleus;
KW   Phosphoprotein; Polymorphism; Proto-oncogene; Reference proteome.
FT   CHAIN         1   1068       Cytospin-B.
FT                                /FTId=PRO_0000254033.
FT   DOMAIN      962   1067       Calponin-homology (CH).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00044}.
FT   COILED      579    773       {ECO:0000255}.
FT   COMPBIAS    260    372       Ser-rich.
FT   MOD_RES      38     38       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5SXY1}.
FT   MOD_RES      55     55       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      78     78       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     112    112       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     131    131       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     134    134       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     137    137       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5SXY1}.
FT   MOD_RES     138    138       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     142    142       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     218    218       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     241    241       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     361    361       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5SXY1}.
FT   MOD_RES     366    366       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5SXY1}.
FT   MOD_RES     369    369       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q5SXY1}.
FT   MOD_RES     425    425       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     847    847       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     863    863       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     912    912       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     914    914       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     94       MRSAAKPWNPAIRAGGHGPDRVRPLPAASSGMKSSKSSTSL
FT                                AFESRLSRLKRASSEDTLNKPGSTAASGVVRLKKTATAGAI
FT                                SELTESRLRSGT -> MGNHSGRPEDPEP (in isoform
FT                                3, isoform 4 and isoform 5).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:15602574}.
FT                                /FTId=VSP_021162.
FT   VAR_SEQ     785   1068       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_021163.
FT   VAR_SEQ     785    790       PVDEEP -> SLGSVS (in isoform 2 and
FT                                isoform 3). {ECO:0000303|PubMed:15602574,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_021164.
FT   VAR_SEQ     791   1068       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:15602574,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_021165.
FT   VARIANT     274    274       S -> R (in dbSNP:rs9908032).
FT                                {ECO:0000269|Ref.1}.
FT                                /FTId=VAR_053055.
FT   VARIANT     293    293       M -> L (in dbSNP:rs2703806).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:15602574,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_028800.
FT   VARIANT     769    769       D -> N (in dbSNP:rs35835131).
FT                                /FTId=VAR_053056.
FT   CONFLICT    164    170       AALESQV -> VRLSPKF (in Ref. 1; BAB16440).
FT                                {ECO:0000305}.
FT   CONFLICT    179    179       A -> S (in Ref. 1; BAB16440 and 2;
FT                                AAW30001). {ECO:0000305}.
FT   CONFLICT    330    330       D -> N (in Ref. 5; AAH50058).
FT                                {ECO:0000305}.
FT   CONFLICT    359    359       G -> R (in Ref. 5; AAH50058).
FT                                {ECO:0000305}.
FT   CONFLICT    364    364       S -> I (in Ref. 5; AAH33618).
FT                                {ECO:0000305}.
FT   CONFLICT    382    382       E -> G (in Ref. 2; AAW29999/AAW30000/
FT                                AAW30002). {ECO:0000305}.
FT   CONFLICT    434    435       EQ -> DE (in Ref. 5; AAH50058).
FT                                {ECO:0000305}.
FT   CONFLICT    831    831       R -> G (in Ref. 2; AAW30000/AAW30002).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1068 AA;  118585 MW;  E6FB6987C835A1CA CRC64;
     MRSAAKPWNP AIRAGGHGPD RVRPLPAASS GMKSSKSSTS LAFESRLSRL KRASSEDTLN
     KPGSTAASGV VRLKKTATAG AISELTESRL RSGTGAFTTT KRTGIPAPRE FSVTVSRERS
     VPRGPSNPRK SVSSPTSSNT PTPTKHLRTP STKPKQENEG GEKAALESQV RELLAEAKAK
     DSEINRLRSE LKKYKEKRTL NAEGTDALGP NVDGTSVSPG DTEPMIRALE EKNKNFQKEL
     SDLEEENRVL KEKLIYLEHS PNSEGAASHT GDSSCPTSIT QESSFGSPTG NQMSSDIDEY
     KKNIHGNALR TSGSSSSDVT KASLSPDASD FEHITAETPS RPLSSTSNPF KSSKCSTAGS
     SPNSVSELSL ASLTEKIQKM EENHHSTAEE LQATLQELSD QQQMVQELTA ENEKLVDEKT
     ILETSFHQHR ERAEQLSQEN EKLMNLLQER VKNEEPTTQE GKIIELEQKC TGILEQGRFE
     REKLLNIQQQ LTCSLRKVEE ENQGALEMIK RLKEENEKLN EFLELERHNN NMMAKTLEEC
     RVTLEGLKME NGSLKSHLQG EKQKATEASA VEQTAESCEV QEMLKVARAE KDLLELSCNE
     LRQELLKANG EIKHVSSLLA KVEKDYSYLK EICDHQAEQL SRTSLKLQEK ASESDAEIKD
     MKETIFELED QVEQHRAVKL HNNQLISELE SSVIKLEEQK SDLERQLKTL TKQMKEETEE
     WRRFQADLQT AVVVANDIKC EAQQELRTVK RKLLEEEEKN ARLQKELGDV QGHGRVVTSR
     AAPPPVDEEP ESSEVDAAGR WPGVCVSRTS PTPPESATTV KSLIKSFDLG RPGGAGQNIS
     VHKTPRSPLS GIPVRTAPAA AVSPMQRHST YSSVRPASRG VTQRLDLPDL PLSDILKGRT
     ETLKPDPHLR KSPSLESLSR PPSLGFGDTR LLSASTRAWK PQSKLSVERK DPLAALAREY
     GGSKRNALLK WCQKKTQGYA NIDITNFSSS WSDGLAFCAL LHTYLPAHIP YQELNSQEKK
     RNLLLAFEAA ESVGIKPSLE LSEMLYTDRP DWQSVMQYVA QIYKYFET
//
ID   SRGP3_HUMAN             Reviewed;        1099 AA.
AC   O43295; Q8IX13; Q8IZV8;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2004, sequence version 3.
DT   13-FEB-2019, entry version 172.
DE   RecName: Full=SLIT-ROBO Rho GTPase-activating protein 3;
DE            Short=srGAP3;
DE   AltName: Full=Mental disorder-associated GAP;
DE   AltName: Full=Rho GTPase-activating protein 14;
DE   AltName: Full=WAVE-associated Rac GTPase-activating protein;
DE            Short=WRP;
GN   Name=SRGAP3; Synonyms=ARHGAP14, KIAA0411, KIAA1156, MEGAP, SRGAP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TISSUE SPECIFICITY,
RP   AND INTERACTION WITH WASF1.
RX   PubMed=12447388; DOI=10.1038/ncb886;
RA   Soderling S.H., Binns K.L., Wayman G.A., Davee S.M., Ong S.H.,
RA   Pawson T., Scott J.D.;
RT   "The WRP component of the WAVE-1 complex attenuates Rac-mediated
RT   signalling.";
RL   Nat. Cell Biol. 4:970-975(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING (ISOFORMS
RP   2 AND 3), FUNCTION, TISSUE SPECIFICITY, AND CHROMOSOMAL TRANSLOCATION.
RX   PubMed=12195014; DOI=10.1073/pnas.162241099;
RA   Endris V., Wogatzky B., Leimer U., Bartsch D., Zatyka M., Latif F.,
RA   Maher E.R., Tariverdian G., Kirsch S., Karch D., Rappold G.A.;
RT   "The novel Rho-GTPase activating gene MEGAP/ srGAP3 has a putative
RT   role in severe mental retardation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:11754-11759(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 15-1099 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=9455477; DOI=10.1093/dnares/4.5.307;
RA   Ishikawa K., Nagase T., Nakajima D., Seki N., Ohira M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VIII.
RT   78 new cDNA clones from brain which code for large proteins in
RT   vitro.";
RL   DNA Res. 4:307-313(1997).
RN   [4]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [5]
RP   INTERACTION WITH ROBO1.
RX   PubMed=11672528; DOI=10.1016/S0092-8674(01)00530-X;
RA   Wong K., Ren X.R., Huang Y.Z., Xie Y., Liu G., Saito H., Tang H.,
RA   Wen L., Brady-Kalnay S.M., Mei L., Wu J.Y., Xiong W.C., Rao Y.;
RT   "Signal transduction in neuronal migration: roles of GTPase activating
RT   proteins and the small GTPase Cdc42 in the Slit-Robo pathway.";
RL   Cell 107:209-221(2001).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-837, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL
RT   (CD178) by phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [9]
RP   VARIANT [LARGE SCALE ANALYSIS] ILE-623.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: GTPase-activating protein for RAC1 and perhaps Cdc42,
CC       but not for RhoA small GTPase. May attenuate RAC1 signaling in
CC       neurons. {ECO:0000269|PubMed:12195014,
CC       ECO:0000269|PubMed:12447388}.
CC   -!- SUBUNIT: Homodimer (Probable). Forms a heterooligomer with SRGAP1
CC       and SRGAP2 through its F-BAR domain. Interacts with WASF1.
CC       Probably interacts with ROBO1. Interacts with FASLG.
CC       {ECO:0000269|PubMed:11672528, ECO:0000269|PubMed:12447388,
CC       ECO:0000269|PubMed:19807924, ECO:0000305}.
CC   -!- INTERACTION:
CC       O08838:Amph (xeno); NbExp=3; IntAct=EBI-368166, EBI-80080;
CC       P62993:GRB2; NbExp=2; IntAct=EBI-368166, EBI-401755;
CC       P42858:HTT; NbExp=4; IntAct=EBI-368166, EBI-466029;
CC       O35964:Sh3gl1 (xeno); NbExp=3; IntAct=EBI-368166, EBI-1149235;
CC       O35179:Sh3gl2 (xeno); NbExp=3; IntAct=EBI-368166, EBI-1149197;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=MEGAPa, srGAP3a;
CC         IsoId=O43295-1; Sequence=Displayed;
CC       Name=2; Synonyms=MEGAPb, srGAP3b;
CC         IsoId=O43295-2; Sequence=VSP_010581;
CC       Name=3; Synonyms=MEGAPc, srGAP3c;
CC         IsoId=O43295-3; Sequence=VSP_010582, VSP_010583;
CC   -!- TISSUE SPECIFICITY: Highly expressed in adult and fetal brain.
CC       Expressed at low levels in kidney. Isoform 3 is expressed in the
CC       kidney but is absent in the brain. {ECO:0000269|PubMed:12195014,
CC       ECO:0000269|PubMed:12447388}.
CC   -!- DOMAIN: The F-BAR domain mediates oligomerization, binds
CC       membranes, and induces plasma membrane protrusions.
CC   -!- DISEASE: Note=A chromosomal aberration involving SRGAP3 is found
CC       in a patient with severe idiopathic mental retardation
CC       (PubMed:12195014). Translocation t(X;3)(p11.2;p25)
CC       (PubMed:12195014). {ECO:0000269|PubMed:12195014}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF464189; AAN57784.1; -; mRNA.
DR   EMBL; AF427144; AAN07095.1; -; mRNA.
DR   EMBL; AB007871; BAA24841.2; -; mRNA.
DR   CCDS; CCDS2572.1; -. [O43295-1]
DR   CCDS; CCDS33689.1; -. [O43295-2]
DR   RefSeq; NP_001028289.1; NM_001033117.2. [O43295-2]
DR   RefSeq; NP_055665.1; NM_014850.3. [O43295-1]
DR   UniGene; Hs.654743; -.
DR   ProteinModelPortal; O43295; -.
DR   SMR; O43295; -.
DR   BioGrid; 115230; 21.
DR   IntAct; O43295; 22.
DR   MINT; O43295; -.
DR   STRING; 9606.ENSP00000373347; -.
DR   iPTMnet; O43295; -.
DR   PhosphoSitePlus; O43295; -.
DR   BioMuta; SRGAP3; -.
DR   EPD; O43295; -.
DR   jPOST; O43295; -.
DR   MaxQB; O43295; -.
DR   PaxDb; O43295; -.
DR   PeptideAtlas; O43295; -.
DR   PRIDE; O43295; -.
DR   ProteomicsDB; 48867; -.
DR   ProteomicsDB; 48868; -. [O43295-2]
DR   ProteomicsDB; 48869; -. [O43295-3]
DR   DNASU; 9901; -.
DR   Ensembl; ENST00000360413; ENSP00000353587; ENSG00000196220. [O43295-2]
DR   Ensembl; ENST00000383836; ENSP00000373347; ENSG00000196220. [O43295-1]
DR   GeneID; 9901; -.
DR   KEGG; hsa:9901; -.
DR   UCSC; uc003brf.4; human. [O43295-1]
DR   CTD; 9901; -.
DR   DisGeNET; 9901; -.
DR   EuPathDB; HostDB:ENSG00000196220.15; -.
DR   GeneCards; SRGAP3; -.
DR   HGNC; HGNC:19744; SRGAP3.
DR   HPA; HPA036959; -.
DR   HPA; HPA044074; -.
DR   MalaCards; SRGAP3; -.
DR   MIM; 606525; gene.
DR   neXtProt; NX_O43295; -.
DR   OpenTargets; ENSG00000196220; -.
DR   Orphanet; 251615; Pilomyxoid astrocytoma.
DR   PharmGKB; PA134935463; -.
DR   eggNOG; KOG3565; Eukaryota.
DR   eggNOG; ENOG410XS44; LUCA.
DR   GeneTree; ENSGT00940000153545; -.
DR   HOGENOM; HOG000039980; -.
DR   HOVERGEN; HBG051637; -.
DR   InParanoid; O43295; -.
DR   KO; K07526; -.
DR   OMA; LFNGCME; -.
DR   OrthoDB; 1245523at2759; -.
DR   PhylomeDB; O43295; -.
DR   TreeFam; TF315892; -.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   Reactome; R-HSA-428543; Inactivation of CDC42 and RAC1.
DR   SIGNOR; O43295; -.
DR   ChiTaRS; SRGAP3; human.
DR   GeneWiki; SRGAP3; -.
DR   GenomeRNAi; 9901; -.
DR   PRO; PR:O43295; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000196220; Expressed in 171 organ(s), highest expression level in middle temporal gyrus.
DR   ExpressionAtlas; O43295; baseline and differential.
DR   Genevisible; O43295; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005096; F:GTPase activator activity; TAS:Reactome.
DR   GO; GO:0048365; F:Rac GTPase binding; IBA:GO_Central.
DR   GO; GO:0030336; P:negative regulation of cell migration; IBA:GO_Central.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd11955; SH3_srGAP1-3; 1.
DR   Gene3D; 1.10.555.10; -; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR035648; srGAP1/2/3_SH3.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Coiled coil;
KW   Complete proteome; GTPase activation; Phosphoprotein; Polymorphism;
KW   Reference proteome; SH3 domain.
FT   CHAIN         1   1099       SLIT-ROBO Rho GTPase-activating protein
FT                                3.
FT                                /FTId=PRO_0000056769.
FT   DOMAIN       19    314       F-BAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01077}.
FT   DOMAIN      482    670       Rho-GAP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00172}.
FT   DOMAIN      744    803       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   COILED      352    392       {ECO:0000255}.
FT   COILED      952    987       {ECO:0000255}.
FT   MOD_RES     817    817       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q812A2}.
FT   MOD_RES     820    820       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q812A2}.
FT   MOD_RES     821    821       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q812A2}.
FT   MOD_RES     837    837       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     858    858       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q812A2}.
FT   MOD_RES     954    954       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q812A2}.
FT   VAR_SEQ     480    513       PPCLPPKPQKMRRPRPLSVYSHKLFNGSMEAFIK -> GRR
FT                                NARTRNQ (in isoform 2).
FT                                {ECO:0000303|PubMed:12447388,
FT                                ECO:0000303|PubMed:9455477}.
FT                                /FTId=VSP_010581.
FT   VAR_SEQ     480    489       PPCLPPKPQK -> IQDKLYRL (in isoform 3).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_010582.
FT   VAR_SEQ     490   1099       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_010583.
FT   VARIANT     623    623       L -> I (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035550.
FT   VARIANT     628    628       I -> V (in dbSNP:rs2271207).
FT                                /FTId=VAR_049159.
SQ   SEQUENCE   1099 AA;  124504 MW;  2D1BA2D338E1BF13 CRC64;
     MSSQTKFKKD KEIIAEYEAQ IKEIRTQLVE QFKCLEQQSE SRLQLLQDLQ EFFRRKAEIE
     LEYSRSLEKL AERFSSKIRS SREHQFKKDQ YLLSPVNCWY LVLHQTRRES RDHATLNDIF
     MNNVIVRLSQ ISEDVIRLFK KSKEIGLQMH EELLKVTNEL YTVMKTYHMY HAESISAESK
     LKEAEKQEEK QFNKSGDLSM NLLRHEDRPQ RRSSVKKIEK MKEKRQAKYS ENKLKCTKAR
     NDYLLNLAAT NAAISKYYIH DVSDLIDCCD LGFHASLART FRTYLSAEYN LETSRHEGLD
     VIENAVDNLD SRSDKHTVMD MCNQVFCPPL KFEFQPHMGD EVCQVSAQQP VQTELLMRYH
     QLQSRLATLK IENEEVRKTL DATMQTLQDM LTVEDFDVSD AFQHSRSTES VKSAASETYM
     SKINIAKRRA NQQETEMFYF TKFKEYVNGS NLITKLQAKH DLLKQTLGEG ERAECGTTRP
     PCLPPKPQKM RRPRPLSVYS HKLFNGSMEA FIKDSGQAIP LVVESCIRYI NLYGLQQQGI
     FRVPGSQVEV NDIKNSFERG EDPLVDDQNE RDINSVAGVL KLYFRGLENP LFPKERFQDL
     ISTIKLENPA ERVHQIQQIL VTLPRVVIVV MRYLFAFLNH LSQYSDENMM DPYNLAICFG
     PTLMHIPDGQ DPVSCQAHIN EVIKTIIIHH EAIFPSPREL EGPVYEKCMA GGEEYCDSPH
     SEPGAIDEVD HDNGTEPHTS DEEVEQIEAI AKFDYMGRSP RELSFKKGAS LLLYHRASED
     WWEGRHNGVD GLIPHQYIVV QDMDDAFSDS LSQKADSEAS SGPLLDDKAS SKNDLQSPTE
     HISDYGFGGV MGRVRLRSDG AAIPRRRSGG DTHSPPRGLG PSIDTPPRAA ACPSSPHKIP
     LTRGRIESPE KRRMATFGSA GSINYPDKKA LSEGHSMRST CGSTRHSSLG DHKSLEAEAL
     AEDIEKTMST ALHELRELER QNTVKQAPDV VLDTLEPLKN PPGPVSSEPA SPLHTIVIRD
     PDAAMRRSSS SSTEMMTTFK PALSARLAGA QLRPPPMRPV RPVVQHRSSS SSSSGVGSPA
     VTPTEKMFPN SSADKSGTM
//
ID   A0A024R4Q5_HUMAN        Unreviewed;       253 AA.
AC   A0A024R4Q5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   13-FEB-2019, entry version 44.
DE   SubName: Full=TCF3 (E2A) fusion partner (In childhood Leukemia), isoform CRA_c {ECO:0000313|EMBL:EAW72188.1};
GN   Name=TFPT {ECO:0000313|EMBL:EAW72188.1};
GN   ORFNames=hCG_20946 {ECO:0000313|EMBL:EAW72188.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW72188.1};
RN   [1] {ECO:0000313|EMBL:EAW72188.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW72188.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [4] {ECO:0000213|PubMed:18220336}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.D., Yates J.R.;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [8] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [9] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- INTERACTION:
CC       O95273:CCNDBP1; NbExp=3; IntAct=EBI-11527449, EBI-748961;
CC       P51911:CNN1; NbExp=4; IntAct=EBI-11527449, EBI-2873130;
CC       Q96D03:DDIT4L; NbExp=4; IntAct=EBI-11527449, EBI-742054;
CC       Q9UBB9:TFIP11; NbExp=4; IntAct=EBI-11527449, EBI-1105213;
CC       P06753:TPM3; NbExp=6; IntAct=EBI-11527449, EBI-355607;
CC       Q13077:TRAF1; NbExp=4; IntAct=EBI-11527449, EBI-359224;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471135; EAW72187.1; -; Genomic_DNA.
DR   EMBL; CH471135; EAW72188.1; -; Genomic_DNA.
DR   RefSeq; NP_037474.1; NM_013342.3.
DR   UniGene; Hs.590939; -.
DR   UniGene; Hs.745267; -.
DR   IntAct; A0A024R4Q5; 6.
DR   GeneID; 29844; -.
DR   KEGG; hsa:29844; -.
DR   CTD; 29844; -.
DR   eggNOG; ENOG410IY8E; Eukaryota.
DR   eggNOG; ENOG4111UBX; LUCA.
DR   KO; K11670; -.
DR   OMA; FTIMLED; -.
DR   OrthoDB; 1308382at2759; -.
DR   ChiTaRS; TFPT; human.
DR   GenomeRNAi; 29844; -.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0006915; P:apoptotic process; IEA:InterPro.
DR   InterPro; IPR033555; TFPT.
DR   PANTHER; PTHR35084; PTHR35084; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   COILED       96    116       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   253 AA;  28278 MW;  C57CC8436F963F36 CRC64;
     MELEQREGTM AAVGFEEFSA PPGSELALPP LFGGHILESE LETEVEFVSG GLGGSGLRER
     DEEEEAARGR RRRQRELNRR KYQALGRRCR EIEQVNERVL NRLHQVQRIT RRLQQERRFL
     MRVLDSYGDD YRASQFTIVL EDEGSQGTDA PTPGNAENEP PEKETLSPPR RTPAPPEPGS
     PAPGEGPSGR KRRRVPRDGR RAGNALTPEL APVQIKVEED FGFEADEALD SSWVSRGPDK
     LLPYPTLASP ASD
//
ID   TFPT_HUMAN              Reviewed;         253 AA.
AC   P0C1Z6; G5E9B5;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   31-OCT-2006, sequence version 1.
DT   13-FEB-2019, entry version 116.
DE   RecName: Full=TCF3 fusion partner;
DE   AltName: Full=INO80 complex subunit F;
DE   AltName: Full=Protein FB1;
GN   Name=TFPT; Synonyms=INO80F;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION
RP   WITH TCF3.
RC   TISSUE=Leukemia;
RX   PubMed=10086727; DOI=10.1038/sj/leu/2401338;
RA   Brambillasca F., Mosna G., Colombo M., Rivolta A., Caslini C.,
RA   Minuzzo M., Giudici G., Mizzi L., Biondi A., Privitera E.;
RT   "Identification of a novel molecular partner of the E2A gene in
RT   childhood leukemia.";
RL   Leukemia 13:369-375(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Retinoblastoma, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION IN INO80 COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16230350; DOI=10.1074/jbc.M509128200;
RA   Jin J., Cai Y., Yao T., Gottschalk A.J., Florens L., Swanson S.K.,
RA   Gutierrez J.L., Coleman M.K., Workman J.L., Mushegian A.,
RA   Washburn M.P., Conaway R.C., Conaway J.W.;
RT   "A mammalian chromatin remodeling complex with similarities to the
RT   yeast INO80 complex.";
RL   J. Biol. Chem. 280:41207-41212(2005).
RN   [6]
RP   POSSIBLE FUNCTION IN APOPTOSIS.
RX   PubMed=17041757; DOI=10.1007/s10495-006-0195-5;
RA   Franchini C., Fontana F., Minuzzo M., Babbio F., Privitera E.;
RT   "Apoptosis promoted by up-regulation of TFPT (TCF3 fusion partner)
RT   appears p53 independent, cell type restricted and cell density
RT   influenced.";
RL   Apoptosis 11:2217-2224(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-180; SER-249 AND
RP   SER-252, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-180, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [9]
RP   IDENTIFICATION IN THE INO80 COMPLEX, SUBCELLULAR LOCATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=18922472; DOI=10.1016/j.molcel.2008.08.027;
RA   Yao T., Song L., Jin J., Cai Y., Takahashi H., Swanson S.K.,
RA   Washburn M.P., Florens L., Conaway R.C., Cohen R.E., Conaway J.W.;
RT   "Distinct modes of regulation of the Uch37 deubiquitinating enzyme in
RT   the proteasome and in the Ino80 chromatin-remodeling complex.";
RL   Mol. Cell 31:909-917(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-180; SER-188; SER-249
RP   AND SER-252, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-180; THR-207; SER-249
RP   AND SER-252, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION IN THE INO80 COMPLEX.
RX   PubMed=21303910; DOI=10.1074/jbc.M111.222505;
RA   Chen L., Cai Y., Jin J., Florens L., Swanson S.K., Washburn M.P.,
RA   Conaway J.W., Conaway R.C.;
RT   "Subunit organization of the human INO80 chromatin remodeling complex:
RT   An evolutionarily conserved core complex catalyzes ATP-dependent
RT   nucleosome remodeling.";
RL   J. Biol. Chem. 286:11283-11289(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249 AND SER-252, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-167; SER-180; THR-207;
RP   SER-249 AND SER-252, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-172; SER-180 AND
RP   SER-252, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-216, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Appears to promote apoptosis in a p53/TP53-independent
CC       manner.
CC   -!- FUNCTION: Putative regulatory component of the chromatin
CC       remodeling INO80 complex which is involved in transcriptional
CC       regulation, DNA replication and probably DNA repair.
CC   -!- SUBUNIT: Interacts with NOL3; translocates NOL3 into the nucleus
CC       and negatively regulated TFPT-induced cell death (By similarity).
CC       Component of the chromatin remodeling INO80 complex; specifically
CC       part of a complex module associated with the N-terminus of INO80.
CC       {ECO:0000250, ECO:0000250|UniProtKB:Q9JMG6,
CC       ECO:0000269|PubMed:16230350, ECO:0000269|PubMed:18922472,
CC       ECO:0000269|PubMed:21303910}.
CC   -!- INTERACTION:
CC       Q504U0:C4orf46; NbExp=3; IntAct=EBI-10178002, EBI-6657981;
CC       Q96GN5:CDCA7L; NbExp=3; IntAct=EBI-10178002, EBI-5278764;
CC       Q05D60:DEUP1; NbExp=3; IntAct=EBI-10178002, EBI-748597;
CC       Q8WWB3:DYDC1; NbExp=3; IntAct=EBI-10178002, EBI-740680;
CC       Q96CJ1:EAF2; NbExp=4; IntAct=EBI-1245626, EBI-1245604;
CC       Q96C92-2:ENTR1; NbExp=3; IntAct=EBI-10178002, EBI-10178036;
CC       Q96CS2:HAUS1; NbExp=3; IntAct=EBI-10178002, EBI-2514791;
CC       P08727:KRT19; NbExp=3; IntAct=EBI-10178002, EBI-742756;
CC       P25791:LMO2; NbExp=3; IntAct=EBI-10178002, EBI-739696;
CC       P11309:PIM1; NbExp=3; IntAct=EBI-10178002, EBI-696621;
CC       Q15311:RALBP1; NbExp=5; IntAct=EBI-10178002, EBI-749285;
CC       Q96KN7:RPGRIP1; NbExp=3; IntAct=EBI-10178002, EBI-1050213;
CC       Q59EK9:RUNDC3A; NbExp=3; IntAct=EBI-10178002, EBI-747225;
CC       Q13188:STK3; NbExp=3; IntAct=EBI-10178002, EBI-992580;
CC       Q9UBB9:TFIP11; NbExp=3; IntAct=EBI-10178002, EBI-1105213;
CC       P09493-10:TPM1; NbExp=3; IntAct=EBI-1245626, EBI-12123928;
CC       P09493-5:TPM1; NbExp=3; IntAct=EBI-10178002, EBI-10196387;
CC       P06753:TPM3; NbExp=6; IntAct=EBI-1245626, EBI-355607;
CC       Q5VU62:TPM3; NbExp=3; IntAct=EBI-10178002, EBI-10184033;
CC       Q9Y5K5:UCHL5; NbExp=3; IntAct=EBI-1245626, EBI-1051183;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18922472}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P0C1Z6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P0C1Z6-2; Sequence=VSP_058937;
CC   -!- DISEASE: Note=A chromosomal aberration involving TFPT is a cause
CC       of pre-B-cell acute lymphoblastic leukemia (B-ALL). Inversion
CC       inv(19)(p13;q13) with TCF3. {ECO:0000269|PubMed:10086727}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TFPTID495ch19q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF052052; AAD45182.1; -; mRNA.
DR   EMBL; AC012314; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC245052; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471135; EAW72186.1; -; Genomic_DNA.
DR   EMBL; BC001728; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC004281; AAH04281.1; -; mRNA.
DR   EMBL; BC007776; AAH07776.1; -; mRNA.
DR   CCDS; CCDS12878.1; -. [P0C1Z6-1]
DR   CCDS; CCDS82396.1; -. [P0C1Z6-2]
DR   RefSeq; NP_001308721.1; NM_001321792.1. [P0C1Z6-2]
DR   RefSeq; NP_037474.1; NM_013342.3. [P0C1Z6-1]
DR   UniGene; Hs.590939; -.
DR   UniGene; Hs.745267; -.
DR   ProteinModelPortal; P0C1Z6; -.
DR   BioGrid; 118931; 82.
DR   ComplexPortal; CPX-846; INO80 chromatin remodeling complex.
DR   IntAct; P0C1Z6; 38.
DR   STRING; 9606.ENSP00000375639; -.
DR   iPTMnet; P0C1Z6; -.
DR   PhosphoSitePlus; P0C1Z6; -.
DR   BioMuta; TFPT; -.
DR   DMDM; 126352246; -.
DR   EPD; P0C1Z6; -.
DR   jPOST; P0C1Z6; -.
DR   MaxQB; P0C1Z6; -.
DR   PaxDb; P0C1Z6; -.
DR   PeptideAtlas; P0C1Z6; -.
DR   PRIDE; P0C1Z6; -.
DR   ProteomicsDB; 52299; -.
DR   DNASU; 29844; -.
DR   Ensembl; ENST00000391758; ENSP00000375638; ENSG00000105619. [P0C1Z6-2]
DR   Ensembl; ENST00000391759; ENSP00000375639; ENSG00000105619. [P0C1Z6-1]
DR   Ensembl; ENST00000611344; ENSP00000484338; ENSG00000276504. [P0C1Z6-2]
DR   Ensembl; ENST00000616798; ENSP00000480169; ENSG00000276504. [P0C1Z6-1]
DR   GeneID; 29844; -.
DR   KEGG; hsa:29844; -.
DR   UCSC; uc010yej.1; human. [P0C1Z6-1]
DR   UCSC; uc061cmq.1; human.
DR   CTD; 29844; -.
DR   DisGeNET; 29844; -.
DR   EuPathDB; HostDB:ENSG00000105619.13; -.
DR   GeneCards; TFPT; -.
DR   HGNC; HGNC:13630; TFPT.
DR   HPA; HPA034958; -.
DR   HPA; HPA058534; -.
DR   MIM; 609519; gene.
DR   neXtProt; NX_P0C1Z6; -.
DR   OpenTargets; ENSG00000105619; -.
DR   PharmGKB; PA37802; -.
DR   eggNOG; ENOG410IY8E; Eukaryota.
DR   eggNOG; ENOG4111UBX; LUCA.
DR   GeneTree; ENSGT00390000016605; -.
DR   HOGENOM; HOG000139148; -.
DR   HOVERGEN; HBG056588; -.
DR   InParanoid; P0C1Z6; -.
DR   KO; K11670; -.
DR   OMA; FTIMLED; -.
DR   OrthoDB; 1308382at2759; -.
DR   PhylomeDB; P0C1Z6; -.
DR   TreeFam; TF338152; -.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5696394; DNA Damage Recognition in GG-NER.
DR   ChiTaRS; TFPT; human.
DR   GeneWiki; TFPT; -.
DR   GenomeRNAi; 29844; -.
DR   PRO; PR:P0C1Z6; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105619; Expressed in 194 organ(s), highest expression level in amygdala.
DR   ExpressionAtlas; P0C1Z6; baseline and differential.
DR   Genevisible; P0C1Z6; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0031011; C:Ino80 complex; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IBA:GO_Central.
DR   GO; GO:0097190; P:apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006310; P:DNA recombination; IEA:UniProtKB-KW.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   InterPro; IPR033555; TFPT.
DR   PANTHER; PTHR35084; PTHR35084; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Chromosomal rearrangement;
KW   Complete proteome; DNA damage; DNA recombination; DNA repair;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Proto-oncogene;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN         1    253       TCF3 fusion partner.
FT                                /FTId=PRO_0000254581.
FT   MOD_RES     167    167       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     172    172       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     180    180       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     188    188       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     207    207       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     249    249       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     252    252       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   CROSSLNK    216    216       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1      9       Missing (in isoform 2).
FT                                /FTId=VSP_058937.
SQ   SEQUENCE   253 AA;  28278 MW;  C57CC8436F963F36 CRC64;
     MELEQREGTM AAVGFEEFSA PPGSELALPP LFGGHILESE LETEVEFVSG GLGGSGLRER
     DEEEEAARGR RRRQRELNRR KYQALGRRCR EIEQVNERVL NRLHQVQRIT RRLQQERRFL
     MRVLDSYGDD YRASQFTIVL EDEGSQGTDA PTPGNAENEP PEKETLSPPR RTPAPPEPGS
     PAPGEGPSGR KRRRVPRDGR RAGNALTPEL APVQIKVEED FGFEADEALD SSWVSRGPDK
     LLPYPTLASP ASD
//
ID   A8K6Q8_HUMAN            Unreviewed;       760 AA.
AC   A8K6Q8;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   16-JAN-2019, entry version 65.
DE   SubName: Full=cDNA FLJ75881, highly similar to Homo sapiens transferrin receptor (p90, CD71) (TFRC), mRNA {ECO:0000313|EMBL:BAF84412.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF84412.1};
RN   [1] {ECO:0000313|EMBL:BAF84412.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAF84412.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK291723; BAF84412.1; -; mRNA.
DR   RefSeq; NP_003225.2; NM_003234.3.
DR   UniGene; Hs.529618; -.
DR   PeptideAtlas; A8K6Q8; -.
DR   PRIDE; A8K6Q8; -.
DR   DNASU; 7037; -.
DR   GeneID; 7037; -.
DR   CTD; 7037; -.
DR   PharmGKB; PA36478; -.
DR   eggNOG; KOG2195; Eukaryota.
DR   eggNOG; COG2234; LUCA.
DR   HOVERGEN; HBG023177; -.
DR   OrthoDB; 804230at2759; -.
DR   GenomeRNAi; 7037; -.
DR   Genevisible; A8K6Q8; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:InterPro.
DR   GO; GO:0004998; F:transferrin receptor activity; IEA:InterPro.
DR   GO; GO:0033570; F:transferrin transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IEA:InterPro.
DR   CDD; cd02128; PA_TfR; 1.
DR   Gene3D; 1.20.930.40; -; 1.
DR   InterPro; IPR003137; PA_domain.
DR   InterPro; IPR007484; Peptidase_M28.
DR   InterPro; IPR039373; Peptidase_M28B.
DR   InterPro; IPR029513; TfR.
DR   InterPro; IPR007365; TFR-like_dimer_dom.
DR   InterPro; IPR036757; TFR-like_dimer_dom_sf.
DR   InterPro; IPR037324; TfR1/2_PA.
DR   PANTHER; PTHR10404; PTHR10404; 1.
DR   PANTHER; PTHR10404:SF26; PTHR10404:SF26; 1.
DR   Pfam; PF02225; PA; 1.
DR   Pfam; PF04389; Peptidase_M28; 1.
DR   Pfam; PF04253; TFR_dimer; 1.
DR   SUPFAM; SSF47672; SSF47672; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000313|EMBL:BAF84412.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     66     88       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      228    345       PA. {ECO:0000259|Pfam:PF02225}.
FT   DOMAIN      388    576       Peptidase_M28.
FT                                {ECO:0000259|Pfam:PF04389}.
FT   DOMAIN      637    749       TFR_dimer. {ECO:0000259|Pfam:PF04253}.
SQ   SEQUENCE   760 AA;  84873 MW;  3DAEE97671E394D4 CRC64;
     MMDQARSAFS NLFGGEPLSY TRFSLARQVD GDNSHVEMKL AVDEEENADN NTKANVTKPK
     RCSGSICYGT IAVIVFFLIG FMIGYLGYCK GVEPKTECER LAGTESPVRE EPGEDFPAAR
     RLYWDDLKRK LSEKLDSTDF TSTIKLLNEN SYVPREAGSQ KDENLALYVE NQFREFKLSK
     VWRDQHFVKI QVKDSAQNSV IIVDKNGRLV YLVENPGGYV AYSKAATATG KLVHANFGTK
     KDFEDLYTPV NGSIVIVRAG KITFAEKVAN AESLNAIGVL IYMDQTKFPI VNAELSFFGH
     AHLGTGDPYT PGFPSFNHTQ FPPSRSSGLP NIPVQTISRA AAEKLFGNME GDCPSDWKTD
     STCRMVTSES KNVKLTVSNV LKEIKILNIF GVIKGFVEPD HYVVVGAQRD AWGPGAAKSG
     VGTALLLKLA QMFSDMVLKD GFQPSRSIIF ASWSAGDFGS VGATEWLEGY LSSLHLKAFT
     YINLDKAVLG TSNFKVSASP LLYTLIEKTM QNVKHPVTGQ FLYQDSNWAS KVEKLTLDNA
     AFPFLAYSGI PAVSFCFCED TDYPYLGTTM DTYKELIERI PELNKVARAA AEVAGQFVIK
     LTHDVELNLD YERYNSQLLS FVRDLNQYRA DIKEMGLSLQ WLYSARGDFF RATSRLTTDF
     GNAEKTDRFV MKKLNDRVMR VEYHFLSPYV SPKESPFRHV FWGSGSHTLP ALLENLKLRK
     QNNGAFNETL FRNQLALATW TIQGAANALS GDVWDIDNEF
//
ID   B7Z2I6_HUMAN            Unreviewed;       478 AA.
AC   B7Z2I6;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   16-JAN-2019, entry version 45.
DE   SubName: Full=cDNA FLJ57106, highly similar to Transferrin receptor protein 1 {ECO:0000313|EMBL:BAH11872.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH11872.1};
RN   [1] {ECO:0000313|EMBL:BAH11872.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAH11872.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK294758; BAH11872.1; -; mRNA.
DR   RefSeq; NP_001300895.1; NM_001313966.1.
DR   UniGene; Hs.529618; -.
DR   SMR; B7Z2I6; -.
DR   PeptideAtlas; B7Z2I6; -.
DR   GeneID; 7037; -.
DR   CTD; 7037; -.
DR   eggNOG; KOG2195; Eukaryota.
DR   eggNOG; COG2234; LUCA.
DR   HOGENOM; HOG000124067; -.
DR   HOVERGEN; HBG023177; -.
DR   OrthoDB; 804230at2759; -.
DR   GenomeRNAi; 7037; -.
DR   GO; GO:0005886; C:plasma membrane; IEA:InterPro.
DR   GO; GO:0004998; F:transferrin receptor activity; IEA:InterPro.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IEA:InterPro.
DR   GO; GO:0033572; P:transferrin transport; IEA:InterPro.
DR   Gene3D; 1.20.930.40; -; 1.
DR   InterPro; IPR007484; Peptidase_M28.
DR   InterPro; IPR039373; Peptidase_M28B.
DR   InterPro; IPR029513; TfR.
DR   InterPro; IPR007365; TFR-like_dimer_dom.
DR   InterPro; IPR036757; TFR-like_dimer_dom_sf.
DR   PANTHER; PTHR10404; PTHR10404; 1.
DR   PANTHER; PTHR10404:SF26; PTHR10404:SF26; 1.
DR   Pfam; PF04389; Peptidase_M28; 1.
DR   Pfam; PF04253; TFR_dimer; 1.
DR   SUPFAM; SSF47672; SSF47672; 1.
PE   2: Evidence at transcript level;
KW   Receptor {ECO:0000313|EMBL:BAH11872.1}.
FT   DOMAIN      106    294       Peptidase_M28.
FT                                {ECO:0000259|Pfam:PF04389}.
FT   DOMAIN      355    467       TFR_dimer. {ECO:0000259|Pfam:PF04253}.
SQ   SEQUENCE   478 AA;  53484 MW;  D23C6217E3CC79EB CRC64;
     MDQTKFPIVN AELSFFGHAH LGTGDPYTPG FPSFNHTQFP PSRSSGLPNI PVQTISRAAA
     EKLFGNMEGD CPSDWKTDST CRMVTSESKN VKLTVSNVLK EIKILNIFGV IKGFVEPDHY
     VVVGAQRDAW GPGAAKSGVG TALLLKLAQM FSDMVLKDGF QPSRSIIFAS WSAGDFGSVG
     ATEWLEGYLS SLHLKAFTYI NLDKAVLGTS NFKVSASPLL YTLIEKTMQN VKHPFTGQFL
     YQDSNWASKV EKLTLDNAAF PFLAYSGIPA VSFCFCEDTD YPYLGTTMDT YKELIERIPE
     LNKVARAAAE VAGQFVIKLT HDVELNLDYE RYNSQLLSFV RDLNQYRADI KEMGLSLQWL
     YSARGDFFRA TSRLTTDFGN AEKTDRFVMK KLNDRVMRVE YHFLSPYVSP KESPFRHVFW
     GSGSHTLPAL LENLKLRKQN NGAFNETLFR NQLALATWTI QGAANALSGD VWDIDNEF
//
ID   G3V0E5_HUMAN            Unreviewed;       679 AA.
AC   G3V0E5;
DT   16-NOV-2011, integrated into UniProtKB/TrEMBL.
DT   16-NOV-2011, sequence version 1.
DT   13-FEB-2019, entry version 78.
DE   SubName: Full=Transferrin receptor (P90, CD71), isoform CRA_c {ECO:0000313|EMBL:EAW53672.1};
DE   SubName: Full=Transferrin receptor protein 1 {ECO:0000313|Ensembl:ENSP00000390133};
GN   Name=TFRC {ECO:0000313|EMBL:EAW53672.1,
GN   ECO:0000313|Ensembl:ENSP00000390133};
GN   ORFNames=hCG_22086 {ECO:0000313|EMBL:EAW53672.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000390133, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW53672.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW53672.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000390133, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000390133}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2011) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AC024937; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471191; EAW53672.1; -; Genomic_DNA.
DR   RefSeq; NP_001300894.1; NM_001313965.1.
DR   UniGene; Hs.529618; -.
DR   SwissPalm; G3V0E5; -.
DR   EPD; G3V0E5; -.
DR   jPOST; G3V0E5; -.
DR   MaxQB; G3V0E5; -.
DR   Ensembl; ENST00000420415; ENSP00000390133; ENSG00000072274.
DR   GeneID; 7037; -.
DR   UCSC; uc010hzy.4; human.
DR   CTD; 7037; -.
DR   EuPathDB; HostDB:ENSG00000072274.12; -.
DR   HGNC; HGNC:11763; TFRC.
DR   OpenTargets; ENSG00000072274; -.
DR   eggNOG; KOG2195; Eukaryota.
DR   eggNOG; COG2234; LUCA.
DR   GeneTree; ENSGT00940000153978; -.
DR   OrthoDB; 804230at2759; -.
DR   ChiTaRS; TFRC; human.
DR   GenomeRNAi; 7037; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000072274; Expressed in 243 organ(s), highest expression level in liver.
DR   ExpressionAtlas; G3V0E5; baseline and differential.
DR   GO; GO:0005886; C:plasma membrane; IEA:InterPro.
DR   GO; GO:0004998; F:transferrin receptor activity; IEA:InterPro.
DR   GO; GO:0033570; F:transferrin transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IEA:InterPro.
DR   CDD; cd02128; PA_TfR; 1.
DR   Gene3D; 1.20.930.40; -; 1.
DR   InterPro; IPR003137; PA_domain.
DR   InterPro; IPR007484; Peptidase_M28.
DR   InterPro; IPR039373; Peptidase_M28B.
DR   InterPro; IPR029513; TfR.
DR   InterPro; IPR007365; TFR-like_dimer_dom.
DR   InterPro; IPR036757; TFR-like_dimer_dom_sf.
DR   InterPro; IPR037324; TfR1/2_PA.
DR   PANTHER; PTHR10404; PTHR10404; 1.
DR   PANTHER; PTHR10404:SF26; PTHR10404:SF26; 1.
DR   Pfam; PF02225; PA; 1.
DR   Pfam; PF04389; Peptidase_M28; 1.
DR   Pfam; PF04253; TFR_dimer; 1.
DR   SUPFAM; SSF47672; SSF47672; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:G3V0E5,
KW   ECO:0000213|MaxQB:G3V0E5, ECO:0000213|PeptideAtlas:G3V0E5};
KW   Receptor {ECO:0000313|EMBL:EAW53672.1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      147    264       PA. {ECO:0000259|Pfam:PF02225}.
FT   DOMAIN      307    495       Peptidase_M28.
FT                                {ECO:0000259|Pfam:PF04389}.
FT   DOMAIN      556    668       TFR_dimer. {ECO:0000259|Pfam:PF04253}.
SQ   SEQUENCE   679 AA;  75964 MW;  00830FDA9668C11B CRC64;
     MIGYLGYCKG VEPKTECERL AGTESPVREE PGEDFPAARR LYWDDLKRKL SEKLDSTDFT
     GTIKLLNENS YVPREAGSQK DENLALYVEN QFREFKLSKV WRDQHFVKIQ VKDSAQNSVI
     IVDKNGRLVY LVENPGGYVA YSKAATVTGK LVHANFGTKK DFEDLYTPVN GSIVIVRAGK
     ITFAEKVANA ESLNAIGVLI YMDQTKFPIV NAELSFFGHA HLGTGDPYTP GFPSFNHTQF
     PPSRSSGLPN IPVQTISRAA AEKLFGNMEG DCPSDWKTDS TCRMVTSESK NVKLTVSNVL
     KEIKILNIFG VIKGFVEPDH YVVVGAQRDA WGPGAAKSGV GTALLLKLAQ MFSDMVLKDG
     FQPSRSIIFA SWSAGDFGSV GATEWLEGYL SSLHLKAFTY INLDKAVLGT SNFKVSASPL
     LYTLIEKTMQ NVKHPVTGQF LYQDSNWASK VEKLTLDNAA FPFLAYSGIP AVSFCFCEDT
     DYPYLGTTMD TYKELIERIP ELNKVARAAA EVAGQFVIKL THDVELNLDY ERYNSQLLSF
     VRDLNQYRAD IKEMGLSLQW LYSARGDFFR ATSRLTTDFG NAEKTDRFVM KKLNDRVMRV
     EYHFLSPYVS PKESPFRHVF WGSGSHTLPA LLENLKLRKQ NNGAFNETLF RNQLALATWT
     IQGAANALSG DVWDIDNEF
//
ID   TFR1_HUMAN              Reviewed;         760 AA.
AC   P02786; D3DXB0; Q1HE24; Q59G55; Q9UCN0; Q9UCU5; Q9UDF9; Q9UK21;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2006, sequence version 2.
DT   13-FEB-2019, entry version 231.
DE   RecName: Full=Transferrin receptor protein 1;
DE            Short=TR;
DE            Short=TfR;
DE            Short=TfR1;
DE            Short=Trfr;
DE   AltName: Full=T9;
DE   AltName: Full=p90;
DE   AltName: CD_antigen=CD71;
DE   Contains:
DE     RecName: Full=Transferrin receptor protein 1, serum form;
DE              Short=sTfR;
GN   Name=TFRC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-142.
RX   PubMed=6090955; DOI=10.1038/311675b0;
RA   Schneider C., Owen M.J., Banville D., Williams J.G.;
RT   "Primary structure of human transferrin receptor deduced from the mRNA
RT   sequence.";
RL   Nature 311:675-678(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-142.
RX   PubMed=6094009; DOI=10.1016/0092-8674(84)90004-7;
RA   McClelland A., Kuhn L.C., Ruddle F.H.;
RT   "The human transferrin receptor gene: genomic organization, and the
RT   complete primary structure of the receptor deduced from a cDNA
RT   sequence.";
RL   Cell 39:267-274(1984).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=9358047; DOI=10.1016/S0378-1119(97)00356-9;
RA   Evans P., Kemp J.;
RT   "Exon/intron structure of the human transferrin receptor gene.";
RL   Gene 199:123-131(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RA   Wheeler D.L.;
RT   "Molecular and evolutionary studies of the transferrin receptor.";
RL   Thesis (1999), University of Iowa, United States.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 101-119 (STFR).
RX   PubMed=2229063;
RA   Shih Y.J., Baynes R.D., Hudson B.G., Flowers C.H., Skikne B.S.,
RA   Cook J.D.;
RT   "Serum transferrin receptor is a truncated form of tissue receptor.";
RL   J. Biol. Chem. 265:19077-19081(1990).
RN   [10]
RP   PROTEIN SEQUENCE OF 101-123 (STFR), AND CHARACTERIZATION.
RC   TISSUE=Erythroleukemia;
RX   PubMed=1871153; DOI=10.3181/00379727-197-43276;
RA   Baynes R.D., Shih Y.J., Hudson B.G., Cook J.D.;
RT   "Characterization of transferrin receptor released by K562
RT   erythroleukemia cells.";
RL   Proc. Soc. Exp. Biol. Med. 197:416-423(1991).
RN   [11]
RP   PROTEIN SEQUENCE OF 288-302; 694-708 AND 721-730.
RC   TISSUE=Prostatic carcinoma;
RX   PubMed=7864799; DOI=10.1042/bj3060129;
RA   Coppolino M., Migliorini M., Argraves W.S., Dedhar S.;
RT   "Identification of a novel form of the alpha 3 integrin subunit:
RT   covalent association with transferrin receptor.";
RL   Biochem. J. 306:129-134(1995).
RN   [12]
RP   PROTEIN SEQUENCE OF 680-696.
RX   PubMed=1380674; DOI=10.1038/358764a0;
RA   Chicz R.M., Urban R.G., Lane W.S., Gorga J.C., Stern L.J.,
RA   Vignali D.A.A., Strominger J.L.;
RT   "Predominant naturally processed peptides bound to HLA-DR1 are derived
RT   from MHC-related molecules and are heterogeneous in size.";
RL   Nature 358:764-768(1992).
RN   [13]
RP   FUNCTION.
RX   PubMed=3568132; DOI=10.1016/0092-8674(87)90295-9;
RA   Rothenberger S., Iacopetta B.J., Kuhn L.C.;
RT   "Endocytosis of the transferrin receptor requires the cytoplasmic
RT   domain but not its phosphorylation site.";
RL   Cell 49:423-431(1987).
RN   [14]
RP   PALMITOYLATION AT CYS-62 AND CYS-67.
RX   PubMed=3582362;
RA   Jing S., Trowbridge I.S.;
RT   "Identification of the intermolecular disulfide bonds of the human
RT   transferrin receptor and its lipid-attachment site.";
RL   EMBO J. 6:327-331(1987).
RN   [15]
RP   MUTAGENESIS OF CYSTEINE RESIDUES INVOLVED IN INTERMOLECULAR BONDS.
RX   PubMed=2507316;
RA   Alvarez E., Girones N., Davis R.J.;
RT   "Intermolecular disulfide bonds are not required for the expression of
RT   the dimeric state and functional activity of the transferrin
RT   receptor.";
RL   EMBO J. 8:2231-2240(1989).
RN   [16]
RP   MUTAGENESIS OF TYR-20.
RX   PubMed=2327986; DOI=10.1042/bj2670031;
RA   Alvarez E., Girones N., Davis R.J.;
RT   "A point mutation in the cytoplasmic domain of the transferrin
RT   receptor inhibits endocytosis.";
RL   Biochem. J. 267:31-35(1990).
RN   [17]
RP   INTERNALIZATION SEQUENCE, AND MUTAGENESIS OF TYR-20.
RX   PubMed=2298808; DOI=10.1083/jcb.110.2.283;
RA   Jing S., Spencer T., Miller K., Hopkins C., Trowbridge I.S.;
RT   "Role of the human transferrin receptor cytoplasmic domain in
RT   endocytosis: localization of a specific signal sequence for
RT   internalization.";
RL   J. Cell Biol. 110:283-294(1990).
RN   [18]
RP   GLYCOSYLATION AT THR-104.
RX   PubMed=1421756; DOI=10.1093/glycob/2.4.345;
RA   Do S.-I., Cummings R.D.;
RT   "Presence of O-linked oligosaccharide on a threonine residue in the
RT   human transferrin receptor.";
RL   Glycobiology 2:345-353(1992).
RN   [19]
RP   GLYCOSYLATION AT THR-104.
RX   PubMed=1421757; DOI=10.1093/glycob/2.4.355;
RA   Hayes G.R., Enns C.A., Lucas J.J.;
RT   "Identification of the O-linked glycosylation site of the human
RT   transferrin receptor.";
RL   Glycobiology 2:355-359(1992).
RN   [20]
RP   MUTAGENESIS OF 20-TYR--PHE-23; TYR-20; THR-21 AND PHE-23.
RX   PubMed=8408022;
RA   Collawn J.F., Lai A., Domingo D.L., Fitch M., Hatton S.,
RA   Trowbridge I.S.;
RT   "YTRF is the conserved internalization signal of the transferrin
RT   receptor, and a second YTRF signal at position 31-34 enhances
RT   endocytosis.";
RL   J. Biol. Chem. 268:21686-21692(1993).
RN   [21]
RP   GLYCOSYLATION AT ASN-727, AND STRUCTURE OF CARBOHYDRATES ON ASN-727.
RX   PubMed=7780197; DOI=10.1093/glycob/5.2.227;
RA   Hayes G.R., Williams A., Costello C.E., Enns C.A., Lucas J.J.;
RT   "The critical glycosylation site of human transferrin receptor
RT   contains a high-mannose oligosaccharide.";
RL   Glycobiology 5:227-232(1995).
RN   [22]
RP   IDENTIFICATION OF LIGAND-BINDING DOMAIN.
RX   PubMed=8631371; DOI=10.1111/j.1432-1033.1996.0009u.x;
RA   Buchegger F., Trowbridge I.S., Liu L.F., White S., Collawn J.F.;
RT   "Functional analysis of human/chicken transferrin receptor chimeras
RT   indicates that the carboxy-terminal region is important for ligand
RT   binding.";
RL   Eur. J. Biochem. 235:9-17(1996).
RN   [23]
RP   MUTAGENESIS OF ARG-646; GLY-647 AND ASP-648.
RX   PubMed=10377239; DOI=10.1042/bj3410011;
RA   Dubljevic V., Sali A., Goding J.W.;
RT   "A conserved RGD (Arg-Gly-Asp) motif in the transferrin receptor is
RT   required for binding to transferrin.";
RL   Biochem. J. 341:11-14(1999).
RN   [24]
RP   MUTAGENESIS.
RX   PubMed=11800564; DOI=10.1006/jmbi.2001.5048;
RA   West A.P. Jr., Giannetti A.M., Herr A.B., Bennett M.J., Nangiana J.S.,
RA   Pierce J.R., Weiner L.P., Snow P.M., Bjorkman P.J.;
RT   "Mutational analysis of the transferrin receptor reveals overlapping
RT   HFE and transferrin binding sites.";
RL   J. Mol. Biol. 313:385-397(2001).
RN   [25]
RP   INTERACTION WITH SH3BP4.
RX   PubMed=16325581; DOI=10.1016/j.cell.2005.10.021;
RA   Tosoni D., Puri C., Confalonieri S., Salcini A.E., De Camilli P.,
RA   Tacchetti C., Di Fiore P.P.;
RT   "TTP specifically regulates the internalization of the transferrin
RT   receptor.";
RL   Cell 123:875-888(2005).
RN   [26]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [28]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [29]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH MACHUPO VIRUS
RP   PROTEIN GLYCOPROTEIN COMPLEX.
RX   PubMed=17287727; DOI=10.1038/nature05539;
RA   Radoshitzky S.R., Abraham J., Spiropoulou C.F., Kuhn J.H., Nguyen D.,
RA   Li W., Nagel J., Schmidt P.J., Nunberg J.H., Andrews N.C., Farzan M.,
RA   Choe H.;
RT   "Transferrin receptor 1 is a cellular receptor for New World
RT   haemorrhagic fever arenaviruses.";
RL   Nature 446:92-96(2007).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-21, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [31]
RP   FUNCTION (MICROBIAL INFECTION), INTERACTION WITH GUANARITO VIRUS
RP   GLYCOPROTEIN COMPLEX, INTERACTION WITH JUNIN VIRUS GLYCOPROTEIN
RP   COMPLEX, AND INTERACTION WITH MACHUPO VIRUS GLYCOPROTEIN COMPLEX.
RX   PubMed=18268337; DOI=10.1073/pnas.0709254105;
RA   Radoshitzky S.R., Kuhn J.H., Spiropoulou C.F., Albarino C.G.,
RA   Nguyen D.P., Salazar-Bravo J., Dorfman T., Lee A.S., Wang E.,
RA   Ross S.R., Choe H., Farzan M.;
RT   "Receptor determinants of zoonotic transmission of New World
RT   hemorrhagic fever arenaviruses.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:2664-2669(2008).
RN   [32]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251 AND ASN-727.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [33]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [36]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [38]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [40]
RP   ELECTRON MICROSCOPY, AND PHOSPHORYLATION AT SER-24.
RX   PubMed=9782058; DOI=10.1016/S0969-2126(98)00124-5;
RA   Fuchs H., Luecken W., Tauber R., Engel A.;
RT   "Structural model of phospholipid-reconstituted human transferrin
RT   receptor derived by electron microscopy.";
RL   Structure 6:1235-1243(1998).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 121-760, AND GLYCOSYLATION AT
RP   ASN-251; ASN-317 AND ASN-727.
RX   PubMed=10531064; DOI=10.1126/science.286.5440.779;
RA   Lawrence C.M., Ray S., Babyonyshev M., Galluser R., Borhani D.W.,
RA   Harrison S.C.;
RT   "Crystal structure of the ectodomain of human transferrin receptor.";
RL   Science 286:779-782(1999).
RN   [42]
RP   VARIANT SER-142.
RX   PubMed=11702220; DOI=10.1007/s004390100599;
RA   Douabin-Gicquel V., Soriano N., Ferran H., Wojcik F., Palierne E.,
RA   Tamim S., Jovelin T., McKie A.T., Le Gall J.-Y., David V., Mosser J.;
RT   "Identification of 96 single nucleotide polymorphisms in eight genes
RT   involved in iron metabolism: efficiency of bioinformatic extraction
RT   compared with a systematic sequencing approach.";
RL   Hum. Genet. 109:393-401(2001).
RN   [43]
RP   INVOLVEMENT IN IMD46, VARIANT IMD46 HIS-20, CHARACTERIZATION OF
RP   VARIANT IMD46 HIS-20, FUNCTION, AND INTERACTION WITH STEAP3.
RX   PubMed=26642240; DOI=10.1038/ng.3465;
RA   Jabara H.H., Boyden S.E., Chou J., Ramesh N., Massaad M.J., Benson H.,
RA   Bainter W., Fraulino D., Rahimov F., Sieff C., Liu Z.J.,
RA   Alshemmari S.H., Al-Ramadi B.K., Al-Dhekri H., Arnaout R.,
RA   Abu-Shukair M., Vatsayan A., Silver E., Ahuja S., Davies E.G.,
RA   Sola-Visner M., Ohsumi T.K., Andrews N.C., Notarangelo L.D.,
RA   Fleming M.D., Al-Herz W., Kunkel L.M., Geha R.S.;
RT   "A missense mutation in TFRC, encoding transferrin receptor 1, causes
RT   combined immunodeficiency.";
RL   Nat. Genet. 48:74-78(2016).
CC   -!- FUNCTION: Cellular uptake of iron occurs via receptor-mediated
CC       endocytosis of ligand-occupied transferrin receptor into
CC       specialized endosomes. Endosomal acidification leads to iron
CC       release. The apotransferrin-receptor complex is then recycled to
CC       the cell surface with a return to neutral pH and the concomitant
CC       loss of affinity of apotransferrin for its receptor. Transferrin
CC       receptor is necessary for development of erythrocytes and the
CC       nervous system (By similarity). A second ligand, the heditary
CC       hemochromatosis protein HFE, competes for binding with transferrin
CC       for an overlapping C-terminal binding site. Positively regulates T
CC       and B cell proliferation through iron uptake (PubMed:26642240).
CC       {ECO:0000250, ECO:0000269|PubMed:26642240,
CC       ECO:0000269|PubMed:3568132}.
CC   -!- FUNCTION: (Microbial infection) Acts as a receptor for new-world
CC       arenaviruses: Guanarito, Junin and Machupo virus.
CC       {ECO:0000269|PubMed:17287727, ECO:0000269|PubMed:18268337}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Binds one transferrin or HFE
CC       molecule per subunit. Binds the HLA class II histocompatibility
CC       antigen, DR1. Interacts with SH3BP3. Interacts with STEAP3;
CC       facilitates TFRC endocytosis in erythroid precursor cells
CC       (PubMed:26642240). {ECO:0000269|PubMed:16325581,
CC       ECO:0000269|PubMed:26642240}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Guanarito, Junin and
CC       Machupo arenavirus glycoprotein complex (PubMed:17287727,
CC       PubMed:18268337). {ECO:0000269|PubMed:17287727,
CC       ECO:0000269|PubMed:18268337}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-355727, EBI-355727;
CC       P02768:ALB; NbExp=2; IntAct=EBI-355727, EBI-714423;
CC       P02794:FTH1; NbExp=2; IntAct=EBI-355727, EBI-713259;
CC       Q30201:HFE; NbExp=3; IntAct=EBI-355727, EBI-1028850;
CC       Q30201-1:HFE; NbExp=3; IntAct=EBI-355727, EBI-15489346;
CC       A5K736:PVX_094255 (xeno); NbExp=7; IntAct=EBI-355727, EBI-20622076;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-355727, EBI-347996;
CC       Q9P0V3:SH3BP4; NbExp=6; IntAct=EBI-355727, EBI-1049513;
CC       P02787:TF; NbExp=11; IntAct=EBI-355727, EBI-714319;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17081065};
CC       Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:17081065}. Melanosome
CC       {ECO:0000269|PubMed:17081065}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC       {ECO:0000269|PubMed:17081065}.
CC   -!- SUBCELLULAR LOCATION: Transferrin receptor protein 1, serum form:
CC       Secreted {ECO:0000269|PubMed:17081065}.
CC   -!- INDUCTION: Regulated by cellular iron levels through binding of
CC       the iron regulatory proteins, IRP1 and IRP2, to iron-responsive
CC       elements in the 3'-UTR. Up-regulated upon mitogenic stimulation.
CC   -!- PTM: N- and O-glycosylated, phosphorylated and palmitoylated. The
CC       serum form is only glycosylated. {ECO:0000269|PubMed:1421756,
CC       ECO:0000269|PubMed:1421757, ECO:0000269|PubMed:16335952,
CC       ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19349973,
CC       ECO:0000269|PubMed:3582362}.
CC   -!- PTM: Proteolytically cleaved on Arg-100 to produce the soluble
CC       serum form (sTfR).
CC   -!- PTM: Palmitoylated on both Cys-62 and Cys-67. Cys-62 seems to be
CC       the major site of palmitoylation. {ECO:0000269|PubMed:3582362}.
CC   -!- DISEASE: Immunodeficiency 46 (IMD46) [MIM:616740]: An autosomal
CC       recessive primary immunodeficiency disorder characterized by
CC       early-onset chronic diarrhea, recurrent infections, hypo- or
CC       agammaglobulinemia, normal lymphocyte counts, intermittent
CC       neutropenia, and intermittent thrombocytopenia.
CC       {ECO:0000269|PubMed:26642240}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Serum transferrin receptor (sTfR) is used as a
CC       means of detecting erythropoietin (EPO) misuse by athletes and as
CC       a diagnostic test for anemia resulting from a number of conditions
CC       including rheumatoid arthritis, pregnancy, irritable bowel
CC       syndrome and in HIV patients.
CC   -!- MISCELLANEOUS: Canine and feline parvoviruses bind human and
CC       feline transferrin receptors and use these receptors to enter and
CC       infect cells.
CC   -!- SIMILARITY: Belongs to the peptidase M28 family. M28B subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92491.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TFRCID259ch3q29.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; X01060; CAA25527.1; -; mRNA.
DR   EMBL; M11507; AAA61153.1; -; mRNA.
DR   EMBL; AF187320; AAF04564.1; -; Genomic_DNA.
DR   EMBL; AB209254; BAD92491.1; ALT_INIT; mRNA.
DR   EMBL; DQ496099; ABF47088.1; -; Genomic_DNA.
DR   EMBL; CH471191; EAW53670.1; -; Genomic_DNA.
DR   EMBL; CH471191; EAW53673.1; -; Genomic_DNA.
DR   EMBL; BC001188; AAH01188.1; -; mRNA.
DR   CCDS; CCDS3312.1; -.
DR   PIR; A93343; JXHU.
DR   RefSeq; NP_001121620.1; NM_001128148.2.
DR   RefSeq; NP_001300894.1; NM_001313965.1.
DR   RefSeq; NP_001300895.1; NM_001313966.1.
DR   RefSeq; NP_003225.2; NM_003234.3.
DR   UniGene; Hs.529618; -.
DR   PDB; 1CX8; X-ray; 3.20 A; A/B/C/D/E/F/G/H=122-760.
DR   PDB; 1DE4; X-ray; 2.80 A; C/F/I=121-760.
DR   PDB; 1SUV; EM; 7.50 A; A/B=122-760.
DR   PDB; 2NSU; EM; 27.00 A; A/B=122-760.
DR   PDB; 3KAS; X-ray; 2.40 A; A=121-760.
DR   PDB; 3S9L; X-ray; 3.22 A; A/B=120-760.
DR   PDB; 3S9M; X-ray; 3.32 A; A/B=120-760.
DR   PDB; 3S9N; X-ray; 3.25 A; A/B=120-760.
DR   PDB; 6D03; EM; 3.68 A; A/B=121-760.
DR   PDB; 6D04; EM; 3.74 A; A/B=121-760.
DR   PDB; 6D05; EM; 3.80 A; A/B=121-760.
DR   PDBsum; 1CX8; -.
DR   PDBsum; 1DE4; -.
DR   PDBsum; 1SUV; -.
DR   PDBsum; 2NSU; -.
DR   PDBsum; 3KAS; -.
DR   PDBsum; 3S9L; -.
DR   PDBsum; 3S9M; -.
DR   PDBsum; 3S9N; -.
DR   PDBsum; 6D03; -.
DR   PDBsum; 6D04; -.
DR   PDBsum; 6D05; -.
DR   ProteinModelPortal; P02786; -.
DR   SMR; P02786; -.
DR   BioGrid; 112895; 98.
DR   CORUM; P02786; -.
DR   DIP; DIP-2736N; -.
DR   ELM; P02786; -.
DR   IntAct; P02786; 101.
DR   MINT; P02786; -.
DR   STRING; 9606.ENSP00000353224; -.
DR   ChEMBL; CHEMBL3712860; -.
DR   DrugBank; DB09412; Gallium citrate Ga-67.
DR   DrugBank; DB05260; Gallium nitrate.
DR   MEROPS; M28.972; -.
DR   TCDB; 9.B.229.1.1; the transferrin receptor, cd71, (tfr) family.
DR   GlyConnect; 607; -.
DR   iPTMnet; P02786; -.
DR   PhosphoSitePlus; P02786; -.
DR   SwissPalm; P02786; -.
DR   UniCarbKB; P02786; -.
DR   BioMuta; TFRC; -.
DR   DMDM; 108935939; -.
DR   EPD; P02786; -.
DR   jPOST; P02786; -.
DR   MaxQB; P02786; -.
DR   PaxDb; P02786; -.
DR   PeptideAtlas; P02786; -.
DR   PRIDE; P02786; -.
DR   ProteomicsDB; 51595; -.
DR   DNASU; 7037; -.
DR   Ensembl; ENST00000360110; ENSP00000353224; ENSG00000072274.
DR   Ensembl; ENST00000392396; ENSP00000376197; ENSG00000072274.
DR   GeneID; 7037; -.
DR   KEGG; hsa:7037; -.
DR   UCSC; uc003fvz.5; human.
DR   CTD; 7037; -.
DR   DisGeNET; 7037; -.
DR   EuPathDB; HostDB:ENSG00000072274.12; -.
DR   GeneCards; TFRC; -.
DR   HGNC; HGNC:11763; TFRC.
DR   HPA; CAB000153; -.
DR   HPA; HPA028598; -.
DR   MalaCards; TFRC; -.
DR   MIM; 190010; gene.
DR   MIM; 616740; phenotype.
DR   neXtProt; NX_P02786; -.
DR   OpenTargets; ENSG00000072274; -.
DR   Orphanet; 476113; Combined immunodeficiency due to TFRC deficiency.
DR   PharmGKB; PA36478; -.
DR   eggNOG; KOG2195; Eukaryota.
DR   eggNOG; COG2234; LUCA.
DR   GeneTree; ENSGT00940000153978; -.
DR   HOVERGEN; HBG023177; -.
DR   InParanoid; P02786; -.
DR   KO; K06503; -.
DR   OMA; IMKVEYH; -.
DR   OrthoDB; 156519at2759; -.
DR   PhylomeDB; P02786; -.
DR   TreeFam; TF312981; -.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-917977; Transferrin endocytosis and recycling.
DR   SIGNOR; P02786; -.
DR   ChiTaRS; TFRC; human.
DR   EvolutionaryTrace; P02786; -.
DR   GeneWiki; TFRC; -.
DR   GenomeRNAi; 7037; -.
DR   PRO; PR:P02786; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000072274; Expressed in 243 organ(s), highest expression level in liver.
DR   ExpressionAtlas; P02786; baseline and differential.
DR   Genevisible; P02786; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005905; C:clathrin-coated pit; IDA:UniProtKB.
DR   GO; GO:0030665; C:clathrin-coated vesicle membrane; TAS:Reactome.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:MGI.
DR   GO; GO:0005769; C:early endosome; IEA:Ensembl.
DR   GO; GO:0005768; C:endosome; IDA:MGI.
DR   GO; GO:0010008; C:endosome membrane; IDA:CAFA.
DR   GO; GO:0009897; C:external side of plasma membrane; IGI:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:1903561; C:extracellular vesicle; HDA:UniProtKB.
DR   GO; GO:1990712; C:HFE-transferrin receptor complex; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; IGI:BHF-UCL.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:CAFA.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0055037; C:recycling endosome; IDA:UniProtKB.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0004998; F:transferrin receptor activity; IDA:UniProtKB.
DR   GO; GO:0033570; F:transferrin transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; TAS:ProtInc.
DR   GO; GO:0035690; P:cellular response to drug; IDA:MGI.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0006826; P:iron ion transport; IDA:UniProtKB.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0030316; P:osteoclast differentiation; IEA:Ensembl.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; IDA:UniProtKB.
DR   GO; GO:0045780; P:positive regulation of bone resorption; IEA:Ensembl.
DR   GO; GO:0045830; P:positive regulation of isotype switching; IDA:UniProtKB.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IDA:UniProtKB.
DR   GO; GO:0031623; P:receptor internalization; IDA:UniProtKB.
DR   GO; GO:0033572; P:transferrin transport; IDA:UniProtKB.
DR   CDD; cd02128; PA_TfR; 1.
DR   Gene3D; 1.20.930.40; -; 1.
DR   InterPro; IPR003137; PA_domain.
DR   InterPro; IPR007484; Peptidase_M28.
DR   InterPro; IPR039373; Peptidase_M28B.
DR   InterPro; IPR029513; TfR.
DR   InterPro; IPR007365; TFR-like_dimer_dom.
DR   InterPro; IPR036757; TFR-like_dimer_dom_sf.
DR   InterPro; IPR037324; TfR1/2_PA.
DR   PANTHER; PTHR10404; PTHR10404; 1.
DR   PANTHER; PTHR10404:SF26; PTHR10404:SF26; 1.
DR   Pfam; PF02225; PA; 1.
DR   Pfam; PF04389; Peptidase_M28; 1.
DR   Pfam; PF04253; TFR_dimer; 1.
DR   SUPFAM; SSF47672; SSF47672; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Endocytosis; Glycoprotein; Host cell receptor for virus entry;
KW   Host-virus interaction; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome; Secreted;
KW   Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN         1    760       Transferrin receptor protein 1.
FT                                /FTId=PRO_0000174132.
FT   CHAIN       101    760       Transferrin receptor protein 1, serum
FT                                form.
FT                                /FTId=PRO_0000292265.
FT   TOPO_DOM      1     67       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     68     88       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     89    760       Extracellular. {ECO:0000255}.
FT   DOMAIN      223    313       PA.
FT   REGION        1     67       Mediates interaction with SH3BP4.
FT                                {ECO:0000269|PubMed:16325581}.
FT   REGION      569    760       Ligand-binding.
FT   MOTIF        20     23       Endocytosis signal.
FT   MOTIF        58     61       Stop-transfer sequence.
FT   MOTIF       646    648       Cell attachment site; required for
FT                                binding to transferrin.
FT   SITE        100    101       Cleavage; by trypsin; to produce soluble
FT                                form.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      19     19       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62351}.
FT   MOD_RES      20     20       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES      21     21       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      24     24       Phosphoserine.
FT                                {ECO:0000269|PubMed:9782058}.
FT   LIPID        62     62       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:3582362}.
FT   LIPID        67     67       S-palmitoyl cysteine.
FT                                {ECO:0000305|PubMed:3582362}.
FT   CARBOHYD    104    104       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:1421756,
FT                                ECO:0000269|PubMed:1421757}.
FT                                /FTId=CAR_000072.
FT   CARBOHYD    251    251       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:1CX8,
FT                                ECO:0000269|PubMed:10531064,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    317    317       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:1CX8,
FT                                ECO:0000269|PubMed:10531064}.
FT   CARBOHYD    727    727       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:1CX8,
FT                                ECO:0000269|PubMed:10531064,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:7780197}.
FT                                /FTId=CAR_000173.
FT   DISULFID     89     89       Interchain.
FT   DISULFID     98     98       Interchain.
FT   VARIANT      20     20       Y -> H (in IMD46; increases protein
FT                                expression; increases cell surface
FT                                expression on T and B cells; increases
FT                                soluble form level; impairs receptor
FT                                internalization; impairs transferrin
FT                                transport; impairs T and B cell
FT                                proliferation as well as B cell class-
FT                                switching; interacts with STEAP3; doesn't
FT                                affect receptor internalization in
FT                                erythroid precursor cells;
FT                                dbSNP:rs863225436).
FT                                {ECO:0000269|PubMed:26642240}.
FT                                /FTId=VAR_076365.
FT   VARIANT     142    142       G -> S (rare polymorphism;
FT                                dbSNP:rs3817672).
FT                                {ECO:0000269|PubMed:11702220,
FT                                ECO:0000269|PubMed:6090955,
FT                                ECO:0000269|PubMed:6094009}.
FT                                /FTId=VAR_012737.
FT   VARIANT     212    212       L -> V (in dbSNP:rs41301381).
FT                                /FTId=VAR_051806.
FT   VARIANT     420    420       G -> S (in dbSNP:rs41295879).
FT                                /FTId=VAR_051807.
FT   VARIANT     677    677       R -> H (in dbSNP:rs41298067).
FT                                /FTId=VAR_051808.
FT   MUTAGEN       9     12       FSNL->YTRF: Only 80% as active as wild-
FT                                type receptor.
FT   MUTAGEN      20     34       YTRFSLARQVDGDNS->PPGYSLARQVDYTRF: No
FT                                influence on endocytic uptake of the
FT                                receptor.
FT   MUTAGEN      20     23       YTRF->PPGY: Only 16% as active as wild-
FT                                type receptor.
FT                                {ECO:0000269|PubMed:8408022}.
FT   MUTAGEN      20     20       Y->C: Only 35% as active as wild-type
FT                                receptor. {ECO:0000269|PubMed:2298808,
FT                                ECO:0000269|PubMed:2327986,
FT                                ECO:0000269|PubMed:8408022}.
FT   MUTAGEN      20     20       Y->G: Only 20% as active as wild-type
FT                                receptor. {ECO:0000269|PubMed:2298808,
FT                                ECO:0000269|PubMed:2327986,
FT                                ECO:0000269|PubMed:8408022}.
FT   MUTAGEN      21     21       T->F: Only 88% as active as wild-type
FT                                receptor. {ECO:0000269|PubMed:8408022}.
FT   MUTAGEN      21     21       T->TA: Only 14% as active as wild-type
FT                                receptor. {ECO:0000269|PubMed:8408022}.
FT   MUTAGEN      21     21       T->TAA: Only 19% as active as wild-type
FT                                receptor. {ECO:0000269|PubMed:8408022}.
FT   MUTAGEN      23     23       F->Y: Only 48% as active as wild-type
FT                                receptor. {ECO:0000269|PubMed:8408022}.
FT   MUTAGEN      31     34       GDNS->YTRF: 2-fold increase of the
FT                                endocytic uptake of the receptor.
FT   MUTAGEN      47     50       NADN->YTRF: 1.27-fold increase of the
FT                                endocytic uptake of the receptor.
FT   MUTAGEN     619    619       L->A: 20-fold reduced affinity for
FT                                transferrin receptor. No binding to HFE.
FT   MUTAGEN     622    622       V->A: No significant effect on binding to
FT                                transferrin nor HFE.
FT   MUTAGEN     623    623       R->A: No significant effect on binding to
FT                                transferrin nor HFE.
FT   MUTAGEN     629    629       R->A: >5-fold reduced affinity for
FT                                transferrin. >10-fold reduced affinity
FT                                for HFE.
FT   MUTAGEN     640    640       Q->A: No effect on binding to
FT                                transferrin. >10-fold reduced affinity
FT                                for HFE.
FT   MUTAGEN     641    641       W->A: No significant effect on binding to
FT                                transferrin nor HFE.
FT   MUTAGEN     643    643       Y->A: 20-fold reduced affinity for
FT                                transferrin. No binding to HFE.
FT   MUTAGEN     644    644       S->A: No significant effect on binding to
FT                                transferrin nor HFE.
FT   MUTAGEN     646    646       R->A,H: No binding to transferrin.
FT                                {ECO:0000269|PubMed:10377239}.
FT   MUTAGEN     646    646       R->K: 5% binding to transferrin.
FT                                {ECO:0000269|PubMed:10377239}.
FT   MUTAGEN     647    647       G->A: Large effect on affinity for
FT                                transferrin. 4-fold reduced affinity for
FT                                HFE. {ECO:0000269|PubMed:10377239}.
FT   MUTAGEN     648    648       D->A: 16% binding to transferrin.
FT                                {ECO:0000269|PubMed:10377239}.
FT   MUTAGEN     648    648       D->E: 57% binding to transferrin.
FT                                {ECO:0000269|PubMed:10377239}.
FT   MUTAGEN     650    650       F->Q: >5-fold reduced affinity for
FT                                transferrin. >10-fold reduced affinity
FT                                for HFE.
FT   CONFLICT    104    104       T -> K (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    109    109       R -> V (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    123    123       Y -> T (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX       124    136       {ECO:0000244|PDB:3KAS}.
FT   HELIX       140    146       {ECO:0000244|PDB:3KAS}.
FT   TURN        150    152       {ECO:0000244|PDB:3KAS}.
FT   HELIX       160    176       {ECO:0000244|PDB:3KAS}.
FT   STRAND      179    192       {ECO:0000244|PDB:3KAS}.
FT   STRAND      199    204       {ECO:0000244|PDB:3KAS}.
FT   TURN        205    208       {ECO:0000244|PDB:3KAS}.
FT   STRAND      209    214       {ECO:0000244|PDB:3KAS}.
FT   STRAND      220    222       {ECO:0000244|PDB:3S9L}.
FT   STRAND      226    230       {ECO:0000244|PDB:3KAS}.
FT   STRAND      232    234       {ECO:0000244|PDB:3KAS}.
FT   TURN        236    238       {ECO:0000244|PDB:1CX8}.
FT   HELIX       240    244       {ECO:0000244|PDB:3KAS}.
FT   STRAND      245    248       {ECO:0000244|PDB:1CX8}.
FT   STRAND      253    259       {ECO:0000244|PDB:3KAS}.
FT   HELIX       264    272       {ECO:0000244|PDB:3KAS}.
FT   TURN        273    275       {ECO:0000244|PDB:3KAS}.
FT   STRAND      277    282       {ECO:0000244|PDB:3KAS}.
FT   TURN        285    287       {ECO:0000244|PDB:3KAS}.
FT   STRAND      303    306       {ECO:0000244|PDB:3KAS}.
FT   STRAND      308    310       {ECO:0000244|PDB:3S9L}.
FT   STRAND      311    313       {ECO:0000244|PDB:1CX8}.
FT   HELIX       317    319       {ECO:0000244|PDB:1DE4}.
FT   STRAND      334    336       {ECO:0000244|PDB:3KAS}.
FT   HELIX       339    346       {ECO:0000244|PDB:3KAS}.
FT   STRAND      349    352       {ECO:0000244|PDB:3KAS}.
FT   HELIX       355    357       {ECO:0000244|PDB:3KAS}.
FT   STRAND      364    367       {ECO:0000244|PDB:3KAS}.
FT   STRAND      371    377       {ECO:0000244|PDB:3KAS}.
FT   STRAND      380    393       {ECO:0000244|PDB:3KAS}.
FT   STRAND      396    408       {ECO:0000244|PDB:3KAS}.
FT   STRAND      411    413       {ECO:0000244|PDB:3S9N}.
FT   TURN        416    419       {ECO:0000244|PDB:3KAS}.
FT   HELIX       420    438       {ECO:0000244|PDB:3KAS}.
FT   STRAND      445    455       {ECO:0000244|PDB:3KAS}.
FT   HELIX       456    458       {ECO:0000244|PDB:3KAS}.
FT   HELIX       461    469       {ECO:0000244|PDB:3KAS}.
FT   TURN        470    473       {ECO:0000244|PDB:3KAS}.
FT   HELIX       474    476       {ECO:0000244|PDB:3KAS}.
FT   STRAND      478    483       {ECO:0000244|PDB:3KAS}.
FT   STRAND      491    498       {ECO:0000244|PDB:3KAS}.
FT   HELIX       500    502       {ECO:0000244|PDB:3KAS}.
FT   HELIX       503    510       {ECO:0000244|PDB:3KAS}.
FT   TURN        516    518       {ECO:0000244|PDB:3KAS}.
FT   STRAND      520    522       {ECO:0000244|PDB:3KAS}.
FT   HELIX       528    531       {ECO:0000244|PDB:3KAS}.
FT   HELIX       541    546       {ECO:0000244|PDB:3KAS}.
FT   STRAND      552    558       {ECO:0000244|PDB:3KAS}.
FT   TURN        564    567       {ECO:0000244|PDB:3KAS}.
FT   HELIX       573    579       {ECO:0000244|PDB:3KAS}.
FT   HELIX       583    603       {ECO:0000244|PDB:3KAS}.
FT   STRAND      604    606       {ECO:0000244|PDB:3KAS}.
FT   HELIX       613    625       {ECO:0000244|PDB:3KAS}.
FT   HELIX       626    628       {ECO:0000244|PDB:3KAS}.
FT   TURN        629    636       {ECO:0000244|PDB:3KAS}.
FT   HELIX       640    662       {ECO:0000244|PDB:3KAS}.
FT   HELIX       668    680       {ECO:0000244|PDB:3KAS}.
FT   HELIX       682    685       {ECO:0000244|PDB:3KAS}.
FT   STRAND      688    690       {ECO:0000244|PDB:3S9L}.
FT   TURN        692    694       {ECO:0000244|PDB:3KAS}.
FT   TURN        700    702       {ECO:0000244|PDB:3KAS}.
FT   STRAND      705    708       {ECO:0000244|PDB:3S9M}.
FT   HELIX       709    717       {ECO:0000244|PDB:3KAS}.
FT   TURN        718    722       {ECO:0000244|PDB:3S9L}.
FT   HELIX       728    749       {ECO:0000244|PDB:3KAS}.
FT   HELIX       753    755       {ECO:0000244|PDB:1DE4}.
SQ   SEQUENCE   760 AA;  84871 MW;  C886F14000D90154 CRC64;
     MMDQARSAFS NLFGGEPLSY TRFSLARQVD GDNSHVEMKL AVDEEENADN NTKANVTKPK
     RCSGSICYGT IAVIVFFLIG FMIGYLGYCK GVEPKTECER LAGTESPVRE EPGEDFPAAR
     RLYWDDLKRK LSEKLDSTDF TGTIKLLNEN SYVPREAGSQ KDENLALYVE NQFREFKLSK
     VWRDQHFVKI QVKDSAQNSV IIVDKNGRLV YLVENPGGYV AYSKAATVTG KLVHANFGTK
     KDFEDLYTPV NGSIVIVRAG KITFAEKVAN AESLNAIGVL IYMDQTKFPI VNAELSFFGH
     AHLGTGDPYT PGFPSFNHTQ FPPSRSSGLP NIPVQTISRA AAEKLFGNME GDCPSDWKTD
     STCRMVTSES KNVKLTVSNV LKEIKILNIF GVIKGFVEPD HYVVVGAQRD AWGPGAAKSG
     VGTALLLKLA QMFSDMVLKD GFQPSRSIIF ASWSAGDFGS VGATEWLEGY LSSLHLKAFT
     YINLDKAVLG TSNFKVSASP LLYTLIEKTM QNVKHPVTGQ FLYQDSNWAS KVEKLTLDNA
     AFPFLAYSGI PAVSFCFCED TDYPYLGTTM DTYKELIERI PELNKVARAA AEVAGQFVIK
     LTHDVELNLD YERYNSQLLS FVRDLNQYRA DIKEMGLSLQ WLYSARGDFF RATSRLTTDF
     GNAEKTDRFV MKKLNDRVMR VEYHFLSPYV SPKESPFRHV FWGSGSHTLP ALLENLKLRK
     QNNGAFNETL FRNQLALATW TIQGAANALS GDVWDIDNEF
//
ID   Q7Z3E0_HUMAN            Unreviewed;        13 AA.
AC   Q7Z3E0;
DT   01-OCT-2003, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2003, sequence version 1.
DT   16-JAN-2019, entry version 42.
DE   SubName: Full=Uncharacterized protein DKFZp686O0451 {ECO:0000313|EMBL:CAD97930.1};
GN   Name=DKFZp686O0451 {ECO:0000313|EMBL:CAD97930.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAD97930.1};
RN   [1] {ECO:0000313|EMBL:CAD97930.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Human endometrium carcinoma cell line
RC   {ECO:0000313|EMBL:CAD97930.1};
RA   Poustka A., Albert R., Moosmayer P., Schupp I., Wellenreuther R.,
RA   Mewes H.W., Weil B., Amid C., Osanger A., Fobo G., Han M., Wiemann S.;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; BX537966; CAD97930.1; -; mRNA.
DR   RefSeq; NP_001121620.1; NM_001128148.2.
DR   RefSeq; NP_001300894.1; NM_001313965.1.
DR   RefSeq; NP_003225.2; NM_003234.3.
DR   UniGene; Hs.529618; -.
DR   GeneID; 7037; -.
DR   KEGG; hsa:7037; -.
DR   CTD; 7037; -.
DR   KO; K06503; -.
DR   OrthoDB; 804230at2759; -.
DR   GenomeRNAi; 7037; -.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   13 AA;  1468 MW;  8FE0E6255E80CDC5 CRC64;
     MDQARSAFSN LDL
//
ID   TR150_HUMAN             Reviewed;         955 AA.
AC   Q9Y2W1; D3DPS5; Q5VTK6;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 2.
DT   13-FEB-2019, entry version 181.
DE   RecName: Full=Thyroid hormone receptor-associated protein 3;
DE   AltName: Full=BCLAF1 and THRAP3 family member 2 {ECO:0000312|HGNC:HGNC:22964};
DE   AltName: Full=Thyroid hormone receptor-associated protein complex 150 kDa component;
DE            Short=Trap150;
GN   Name=THRAP3 {ECO:0000312|HGNC:HGNC:22964};
GN   Synonyms=BCLAF2 {ECO:0000312|HGNC:HGNC:22964}, TRAP150;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 490-500, TISSUE
RP   SPECIFICITY, IDENTIFICATION IN TRAP COMPLEX, AND VARIANT VAL-201.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10198638; DOI=10.1016/S1097-2765(00)80463-3;
RA   Ito M., Yuan C.-X., Malik S., Gu W., Fondell J.D., Yamamura S.,
RA   Fu Z.-Y., Zhang X., Qin J., Roeder R.G.;
RT   "Identity between TRAP and SMCC complexes indicates novel pathways for
RT   the function of nuclear receptors and diverse mammalian activators.";
RL   Mol. Cell 3:361-370(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-201.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-201.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 186-202; 216-245; 253-261; 314-333; 376-387;
RP   443-451; 468-481; 486-498; 573-591; 609-653; 678-687; 710-718;
RP   792-802; 864-876; 879-893 AND 927-944, METHYLATION AT ARG-17,
RP   PHOSPHORYLATION AT SER-243; SER-320 AND SER-682, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma, and Ovarian carcinoma;
RA   Bienvenut W.V., Heiserich L., Boulahbel H., Gottlieb E., Lilla S.,
RA   von Kriegsheim A., Lempens A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A.,
RA   Mann M.;
RT   "Proteomic characterization of the human centrosome by protein
RT   correlation profiling.";
RL   Nature 426:570-574(2003).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240; SER-243; SER-248;
RP   SER-253; SER-315; SER-320; SER-575; SER-672 AND SER-928, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [11]
RP   SUBUNIT.
RX   PubMed=17095540; DOI=10.1261/rna.336807;
RA   Merz C., Urlaub H., Will C.L., Luhrmann R.;
RT   "Protein composition of human mRNPs spliced in vitro and differential
RT   requirements for mRNP protein recruitment.";
RL   RNA 13:116-128(2007).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [13]
RP   IDENTIFICATION IN THE SNARP COMPLEX.
RX   PubMed=18794151; DOI=10.1158/0008-5472.CAN-08-1217;
RA   Bracken C.P., Wall S.J., Barre B., Panov K.I., Ajuh P.M.,
RA   Perkins N.D.;
RT   "Regulation of cyclin D1 RNA stability by SNIP1.";
RL   Cancer Res. 68:7621-7628(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-248 AND
RP   SER-253, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232; SER-237; SER-240;
RP   SER-243; SER-248; SER-253; SER-379; SER-406; SER-408; SER-575;
RP   SER-682; THR-874; SER-928 AND SER-939, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-928, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-874; SER-928 AND
RP   SER-939, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-221; LYS-455; LYS-519 AND
RP   LYS-811, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH SFPQ.
RX   PubMed=20932480; DOI=10.1016/j.molcel.2010.09.013;
RA   Heyd F., Lynch K.W.;
RT   "Phosphorylation-dependent regulation of PSF by GSK3 controls CD45
RT   alternative splicing.";
RL   Mol. Cell 40:126-137(2010).
RN   [23]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH NXF1.
RX   PubMed=20123736; DOI=10.1093/nar/gkq017;
RA   Lee K.M., Hsu I.W., Tarn W.Y.;
RT   "TRAP150 activates pre-mRNA splicing and promotes nuclear mRNA
RT   degradation.";
RL   Nucleic Acids Res. 38:3340-3350(2010).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232; SER-243; SER-248;
RP   SER-253; SER-257; SER-315; SER-320; SER-379; SER-408; SER-575;
RP   SER-622; SER-682; SER-698; SER-928 AND SER-939, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-253; SER-315;
RP   SER-320; SER-339; SER-379; SER-406; SER-408; SER-535; SER-575;
RP   SER-622; SER-682; SER-698; SER-928 AND SER-939, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [27]
RP   FUNCTION, PHOSPHORYLATION, AND MUTAGENESIS OF SER-406 AND SER-408.
RX   PubMed=22424773; DOI=10.1016/j.molcel.2012.01.026;
RA   Beli P., Lukashchuk N., Wagner S.A., Weinert B.T., Olsen J.V.,
RA   Baskcomb L., Mann M., Jackson S.P., Choudhary C.;
RT   "Proteomic investigations reveal a role for RNA processing factor
RT   THRAP3 in the DNA damage response.";
RL   Mol. Cell 46:212-225(2012).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [29]
RP   IDENTIFICATION IN A MACOM-LIKE COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=24100041; DOI=10.1074/jbc.M113.500397;
RA   Horiuchi K., Kawamura T., Iwanari H., Ohashi R., Naito M., Kodama T.,
RA   Hamakubo T.;
RT   "Identification of Wilms' tumor 1-associating protein complex and its
RT   role in alternative splicing and the cell cycle.";
RL   J. Biol. Chem. 288:33292-33302(2013).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-220; SER-232; SER-237;
RP   SER-240; SER-243; SER-248; SER-253; SER-257; SER-315; SER-320;
RP   SER-323; SER-326; SER-377; SER-379; THR-397; SER-406; SER-408;
RP   SER-444; SER-468; SER-560; SER-562; SER-575; SER-619; SER-682;
RP   SER-698; THR-874; SER-928 AND SER-939, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [31]
RP   ADP-RIBOSYLATION.
RX   PubMed=24055347; DOI=10.1016/j.molcel.2013.08.026;
RA   Jungmichel S., Rosenthal F., Altmeyer M., Lukas J., Hottiger M.O.,
RA   Nielsen M.L.;
RT   "Proteome-wide identification of poly(ADP-Ribosyl)ation targets in
RT   different genotoxic stress responses.";
RL   Mol. Cell 52:272-285(2013).
RN   [32]
RP   FUNCTION, INTERACTION WITH HELZ2 AND PPARG, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=23525231; DOI=10.1210/me.2012-1332;
RA   Katano-Toki A., Satoh T., Tomaru T., Yoshino S., Ishizuka T.,
RA   Ishii S., Ozawa A., Shibusawa N., Tsuchiya T., Saito T., Shimizu H.,
RA   Hashimoto K., Okada S., Yamada M., Mori M.;
RT   "THRAP3 interacts with HELZ2 and plays a novel role in adipocyte
RT   differentiation.";
RL   Mol. Endocrinol. 27:769-780(2013).
RN   [33]
RP   FUNCTION.
RX   PubMed=24043798; DOI=10.1073/pnas.1305980110;
RA   Lande-Diner L., Boyault C., Kim J.Y., Weitz C.J.;
RT   "A positive feedback loop links circadian clock factor CLOCK-BMAL1 to
RT   the basic transcriptional machinery.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:16021-16026(2013).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-248; SER-253; SER-257;
RP   SER-320; SER-377; SER-560; SER-575; SER-682 AND SER-684, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [35]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-66; ARG-101; ARG-108 AND
RP   LYS-252, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [36]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-451; LYS-467; LYS-470;
RP   LYS-486; LYS-705; LYS-711; LYS-756 AND LYS-759, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [37]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-202; LYS-387 AND LYS-451,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [38]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-486, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [39]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-396; LYS-427; LYS-451;
RP   LYS-470; LYS-486; LYS-527; LYS-697; LYS-705 AND LYS-711, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [40]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-202; LYS-215; LYS-221;
RP   LYS-252; LYS-333; LYS-346; LYS-353; LYS-375; LYS-387; LYS-389;
RP   LYS-396; LYS-401; LYS-421; LYS-427; LYS-451; LYS-455; LYS-461;
RP   LYS-467; LYS-470; LYS-481; LYS-486; LYS-527; LYS-551; LYS-558;
RP   LYS-602; LYS-697; LYS-705; LYS-709; LYS-711; LYS-876 AND LYS-879, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Involved in pre-mRNA splicing. Remains associated with
CC       spliced mRNA after splicing which probably involves interactions
CC       with the exon junction complex (EJC). Can trigger mRNA decay which
CC       seems to be independent of nonsense-mediated decay involving
CC       premature stop codons (PTC) recognition. May be involved in
CC       nuclear mRNA decay. Involved in regulation of signal-induced
CC       alternative splicing. During splicing of PTPRC/CD45 is proposed to
CC       sequester phosphorylated SFPQ from PTPRC/CD45 pre-mRNA in resting
CC       T-cells. Involved in cyclin-D1/CCND1 mRNA stability probably by
CC       acting as component of the SNARP complex which associates with
CC       both the 3'end of the CCND1 gene and its mRNA. Involved in
CC       response to DNA damage. Is excluced from DNA damage sites in a
CC       manner that parallels transcription inhibition; the function may
CC       involve the SNARP complex. Initially thought to play a role in
CC       transcriptional coactivation through its association with the TRAP
CC       complex; however, it is not regarded as a stable Mediator complex
CC       subunit. Cooperatively with HELZ2, enhances the transcriptional
CC       activation mediated by PPARG, maybe through the stabilization of
CC       the PPARG binding to DNA in presence of ligand. May play a role in
CC       the terminal stage of adipocyte differentiation. Plays a role in
CC       the positive regulation of the circadian clock. Acts as a
CC       coactivator of the CLOCK-ARNTL/BMAL1 heterodimer and promotes its
CC       transcriptional activator activity and binding to circadian target
CC       genes (PubMed:24043798). {ECO:0000269|PubMed:20123736,
CC       ECO:0000269|PubMed:20932480, ECO:0000269|PubMed:22424773,
CC       ECO:0000269|PubMed:23525231, ECO:0000269|PubMed:24043798}.
CC   -!- SUBUNIT: Associated with the large multiprotein complex TRAP
CC       (Mediator complex-like). Interacts with SFPQ; the interaction is
CC       dependent on SFPQ phosphorylation at 'Thr-687' and inhibits
CC       binding of SFPQ to an ESS1 exonic splicing silencer element-
CC       containing RNA. Interacts with NXF1. Component of the SNARP
CC       complex which consists at least of SNIP1, SNW1, THRAP3, BCLAF1 and
CC       PNN. Associated with spliced mRNP complexes. Interacts with HELZ2
CC       and PPARG. Interacts with CLOCK and ARNTL/BMAL1 (By similarity).
CC       Component of a MACOM-like complex, named WTAP complex, composed of
CC       WTAP, ZC3H13, CBLL1, KIAA1429, RBM15, BCLAF1 and THRAP3.
CC       {ECO:0000250|UniProtKB:Q569Z6, ECO:0000269|PubMed:10198638,
CC       ECO:0000269|PubMed:17095540, ECO:0000269|PubMed:18794151,
CC       ECO:0000269|PubMed:20123736, ECO:0000269|PubMed:20932480,
CC       ECO:0000269|PubMed:23525231, ECO:0000269|PubMed:24100041}.
CC   -!- INTERACTION:
CC       P38919:EIF4A3; NbExp=2; IntAct=EBI-352039, EBI-299104;
CC       Q9UBU9:NXF1; NbExp=4; IntAct=EBI-352039, EBI-398874;
CC       P23246:SFPQ; NbExp=6; IntAct=EBI-352039, EBI-355453;
CC       Q13573:SNW1; NbExp=4; IntAct=EBI-352039, EBI-632715;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20123736,
CC       ECO:0000269|PubMed:23525231}. Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:24100041}. Nucleus speckle
CC       {ECO:0000269|PubMed:24100041}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10198638}.
CC   -!- PTM: ADP-ribosylation during genotoxic stress promotes
CC       accumulation in nuclear speckles.
CC   -!- SIMILARITY: Belongs to the BCLAF1/THRAP3 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH37554.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/THRAP3ID42960ch1p34.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF117756; AAD22034.1; -; mRNA.
DR   EMBL; AL591845; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07379.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07380.1; -; Genomic_DNA.
DR   EMBL; BC037554; AAH37554.1; ALT_SEQ; mRNA.
DR   EMBL; BC112330; AAI12331.1; -; mRNA.
DR   EMBL; BC112350; AAI12351.1; -; mRNA.
DR   CCDS; CCDS405.1; -.
DR   RefSeq; NP_001308400.1; NM_001321471.1.
DR   RefSeq; NP_001308402.1; NM_001321473.1.
DR   RefSeq; NP_005110.2; NM_005119.3.
DR   UniGene; Hs.744057; -.
DR   ProteinModelPortal; Q9Y2W1; -.
DR   BioGrid; 115292; 185.
DR   CORUM; Q9Y2W1; -.
DR   IntAct; Q9Y2W1; 71.
DR   MINT; Q9Y2W1; -.
DR   STRING; 9606.ENSP00000346634; -.
DR   iPTMnet; Q9Y2W1; -.
DR   PhosphoSitePlus; Q9Y2W1; -.
DR   SwissPalm; Q9Y2W1; -.
DR   BioMuta; THRAP3; -.
DR   DMDM; 97537467; -.
DR   EPD; Q9Y2W1; -.
DR   jPOST; Q9Y2W1; -.
DR   MaxQB; Q9Y2W1; -.
DR   PaxDb; Q9Y2W1; -.
DR   PeptideAtlas; Q9Y2W1; -.
DR   PRIDE; Q9Y2W1; -.
DR   ProteomicsDB; 85914; -.
DR   TopDownProteomics; Q9Y2W1; -.
DR   DNASU; 9967; -.
DR   Ensembl; ENST00000354618; ENSP00000346634; ENSG00000054118.
DR   Ensembl; ENST00000469141; ENSP00000433825; ENSG00000054118.
DR   GeneID; 9967; -.
DR   KEGG; hsa:9967; -.
DR   UCSC; uc001cae.5; human.
DR   CTD; 9967; -.
DR   DisGeNET; 9967; -.
DR   EuPathDB; HostDB:ENSG00000054118.13; -.
DR   GeneCards; THRAP3; -.
DR   HGNC; HGNC:22964; THRAP3.
DR   HPA; CAB017472; -.
DR   HPA; HPA012041; -.
DR   HPA; HPA063765; -.
DR   MIM; 603809; gene.
DR   neXtProt; NX_Q9Y2W1; -.
DR   OpenTargets; ENSG00000054118; -.
DR   PharmGKB; PA134893249; -.
DR   eggNOG; ENOG410IE11; Eukaryota.
DR   eggNOG; ENOG410ZR5P; LUCA.
DR   GeneTree; ENSGT00940000154789; -.
DR   HOGENOM; HOG000231570; -.
DR   HOVERGEN; HBG054554; -.
DR   InParanoid; Q9Y2W1; -.
DR   KO; K13112; -.
DR   OMA; EKWVSRG; -.
DR   OrthoDB; 380969at2759; -.
DR   PhylomeDB; Q9Y2W1; -.
DR   TreeFam; TF335939; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   SignaLink; Q9Y2W1; -.
DR   SIGNOR; Q9Y2W1; -.
DR   ChiTaRS; THRAP3; human.
DR   GeneWiki; THRAP3; -.
DR   GenomeRNAi; 9967; -.
DR   PRO; PR:Q9Y2W1; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000054118; Expressed in 205 organ(s), highest expression level in lung.
DR   Genevisible; Q9Y2W1; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016592; C:mediator complex; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030374; F:nuclear receptor transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0051219; F:phosphoprotein binding; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000980; F:RNA polymerase II distal enhancer sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0046966; F:thyroid hormone receptor binding; IDA:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:MGI.
DR   GO; GO:0003712; F:transcription coregulator activity; IDA:UniProtKB.
DR   GO; GO:0042809; F:vitamin D receptor binding; NAS:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0048255; P:mRNA stabilization; IMP:UniProtKB.
DR   GO; GO:0000956; P:nuclear-transcribed mRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0042753; P:positive regulation of circadian rhythm; IMP:UniProtKB.
DR   GO; GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IMP:UniProtKB.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; IDA:UniProtKB.
DR   InterPro; IPR026667; THRAP3.
DR   InterPro; IPR029199; THRAP3_BCLAF1.
DR   PANTHER; PTHR15268; PTHR15268; 1.
DR   PANTHER; PTHR15268:SF16; PTHR15268:SF16; 1.
DR   Pfam; PF15440; THRAP3_BCLAF1; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; ADP-ribosylation; ATP-binding;
KW   Biological rhythms; Complete proteome; Direct protein sequencing;
KW   Isopeptide bond; Methylation; mRNA processing; mRNA splicing;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism; Receptor;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    955       Thyroid hormone receptor-associated
FT                                protein 3.
FT                                /FTId=PRO_0000065583.
FT   NP_BIND     552    559       ATP. {ECO:0000255}.
FT   REGION        2    190       Required for mRNA splicing activation.
FT   REGION      359    955       Required for mRNA decay activity.
FT   COMPBIAS      7    339       Ser-rich.
FT   COMPBIAS     12    161       Arg-rich.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES      17     17       Dimethylated arginine.
FT                                {ECO:0000269|Ref.5}.
FT   MOD_RES      66     66       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     101    101       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     108    108       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     220    220       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     221    221       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     232    232       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     237    237       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     240    240       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     243    243       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19367720,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|Ref.5}.
FT   MOD_RES     248    248       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     252    252       N6-methyllysine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     253    253       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     257    257       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     315    315       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     320    320       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|Ref.5}.
FT   MOD_RES     323    323       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     324    324       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q569Z6}.
FT   MOD_RES     326    326       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     328    328       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q569Z6}.
FT   MOD_RES     339    339       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     346    346       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q569Z6}.
FT   MOD_RES     377    377       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     379    379       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     397    397       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     406    406       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     408    408       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     444    444       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     455    455       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     468    468       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     470    470       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q569Z6}.
FT   MOD_RES     481    481       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q569Z6}.
FT   MOD_RES     519    519       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     527    527       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q569Z6}.
FT   MOD_RES     535    535       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     558    558       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q569Z6}.
FT   MOD_RES     560    560       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     562    562       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     575    575       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     619    619       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     622    622       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     672    672       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983}.
FT   MOD_RES     682    682       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|Ref.5}.
FT   MOD_RES     684    684       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     698    698       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     811    811       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     845    845       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:Q569Z6}.
FT   MOD_RES     874    874       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     928    928       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     939    939       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    202    202       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    202    202       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    215    215       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    221    221       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    252    252       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    333    333       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    346    346       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    353    353       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    375    375       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    387    387       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    387    387       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    389    389       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    396    396       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    401    401       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    421    421       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    427    427       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    451    451       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    451    451       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    455    455       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    461    461       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    467    467       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    470    470       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    481    481       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    486    486       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    527    527       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    551    551       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    558    558       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    602    602       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    697    697       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    705    705       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    709    709       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    711    711       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    756    756       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   CROSSLNK    759    759       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   CROSSLNK    876    876       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    879    879       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VARIANT     201    201       A -> V (in dbSNP:rs6425977).
FT                                {ECO:0000269|PubMed:10198638,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_024552.
FT   MUTAGEN     406    406       S->A: Reduces phosphorylation upon DNA
FT                                damage; when associated with A-408.
FT                                {ECO:0000269|PubMed:22424773}.
FT   MUTAGEN     408    408       S->A: Reduces phosphorylation upon DNA
FT                                damage; when associated with A-406.
FT                                {ECO:0000269|PubMed:22424773}.
SQ   SEQUENCE   955 AA;  108666 MW;  01131D2479B8C0F4 CRC64;
     MSKTNKSKSG SRSSRSRSAS RSRSRSFSKS RSRSRSLSRS RKRRLSSRSR SRSYSPAHNR
     ERNHPRVYQN RDFRGHNRGY RRPYYFRGRN RGFYPWGQYN RGGYGNYRSN WQNYRQAYSP
     RRGRSRSRSP KRRSPSPRSR SHSRNSDKSS SDRSRRSSSS RSSSNHSRVE SSKRKSAKEK
     KSSSKDSRPS QAAGDNQGDE AKEQTFSGGT SQDTKASESS KPWPDATYGT GSASRASAVS
     ELSPRERSPA LKSPLQSVVV RRRSPRPSPV PKPSPPLSST SQMGSTLPSG AGYQSGTHQG
     QFDHGSGSLS PSKKSPVGKS PPSTGSTYGS SQKEESAASG GAAYTKRYLE EQKTENGKDK
     EQKQTNTDKE KIKEKGSFSD TGLGDGKMKS DSFAPKTDSE KPFRGSQSPK RYKLRDDFEK
     KMADFHKEEM DDQDKDKAKG RKESEFDDEP KFMSKVIGAN KNQEEEKSGK WEGLVYAPPG
     KEKQRKTEEL EEESFPERSK KEDRGKRSEG GHRGFVPEKN FRVTAYKAVQ EKSSSPPPRK
     TSESRDKLGA KGDFPTGKSS FSITREAQVN VRMDSFDEDL ARPSGLLAQE RKLCRDLVHS
     NKKEQEFRSI FQHIQSAQSQ RSPSELFAQH IVTIVHHVKE HHFGSSGMTL HERFTKYLKR
     GTEQEAAKNK KSPEIHRRID ISPSTFRKHG LAHDEMKSPR EPGYKAEGKY KDDPVDLRLD
     IERRKKHKER DLKRGKSRES VDSRDSSHSR ERSAEKTEKT HKGSKKQKKH RRARDRSRSS
     SSSSQSSHSY KAEEYTEETE EREESTTGFD KSRLGTKDFV GPSERGGGRA RGTFQFRARG
     RGWGRGNYSG NNNNNSNNDF QKRNREEEWD PEYTPKSKKY YLHDDREGEG SDKWVSRGRG
     RGAFPRGRGR FMFRKSSTSP KWAHDKFSGE EGEIEDDESG TENREEKDNI QPTTE
//
ID   A0A0A0MR07_HUMAN        Unreviewed;       823 AA.
AC   A0A0A0MR07;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   16-JAN-2019, entry version 40.
DE   SubName: Full=Proto-oncogene vav {ECO:0000313|Ensembl:ENSP00000302269};
GN   Name=VAV1 {ECO:0000313|Ensembl:ENSP00000302269};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000302269, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000302269, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000213|PubMed:15592455}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|Ensembl:ENSP00000302269}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AC010647; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020895; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020954; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022156; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001245135.1; NM_001258206.1.
DR   UniGene; Hs.116237; -.
DR   ProteinModelPortal; A0A0A0MR07; -.
DR   jPOST; A0A0A0MR07; -.
DR   PeptideAtlas; A0A0A0MR07; -.
DR   PRIDE; A0A0A0MR07; -.
DR   Ensembl; ENST00000304076; ENSP00000302269; ENSG00000141968.
DR   GeneID; 7409; -.
DR   UCSC; uc010dva.3; human.
DR   CTD; 7409; -.
DR   EuPathDB; HostDB:ENSG00000141968.7; -.
DR   HGNC; HGNC:12657; VAV1.
DR   OpenTargets; ENSG00000141968; -.
DR   eggNOG; KOG2996; Eukaryota.
DR   eggNOG; ENOG410XPH6; LUCA.
DR   GeneTree; ENSGT00940000159125; -.
DR   OrthoDB; 710582at2759; -.
DR   ChiTaRS; VAV1; human.
DR   GenomeRNAi; 7409; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000141968; Expressed in 124 organ(s), highest expression level in blood.
DR   ExpressionAtlas; A0A0A0MR07; baseline and differential.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   CDD; cd00029; C1; 1.
DR   CDD; cd01223; PH_Vav; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   CDD; cd10405; SH2_Vav1; 1.
DR   CDD; cd11976; SH3_VAV1_2; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR022613; CAMSAP_CH.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR037832; PH_Vav.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR003096; SM22_calponin.
DR   InterPro; IPR028530; Vav1.
DR   InterPro; IPR035879; VAV1_SH2.
DR   InterPro; IPR035729; VAV1_SH3_2.
DR   PANTHER; PTHR22826:SF112; PTHR22826:SF112; 2.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF11971; CAMSAP_CH; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00888; SM22CALPONIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00033; CH; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   PROSITE; PS50021; CH; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Guanine-nucleotide releasing factor {ECO:0000256|SAAS:SAAS01126870};
KW   Metal-binding {ECO:0000256|SAAS:SAAS00515414};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MR07,
KW   ECO:0000213|MaxQB:A0A0A0MR07, ECO:0000213|PeptideAtlas:A0A0A0MR07};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   SH2 domain {ECO:0000256|PROSITE-ProRule:PRU00191};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192,
KW   ECO:0000256|SAAS:SAAS01042643}; Zinc {ECO:0000256|SAAS:SAAS00515409}.
FT   DOMAIN        1    119       Calponin-homology (CH).
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   DOMAIN      194    373       DH. {ECO:0000259|PROSITE:PS50010}.
FT   DOMAIN      402    504       PH. {ECO:0000259|PROSITE:PS50003}.
FT   DOMAIN      515    564       Phorbol-ester/DAG-type.
FT                                {ECO:0000259|PROSITE:PS50081}.
FT   DOMAIN      649    743       SH2. {ECO:0000259|PROSITE:PS50001}.
FT   DOMAIN      760    820       SH3. {ECO:0000259|PROSITE:PS50002}.
SQ   SEQUENCE   823 AA;  95756 MW;  16D1B7D394372FFE CRC64;
     MELWRQCTHW LIQCRVLPPS HRVTWDGAQV CELAQALRDG VLLCQLLNNL LPHAINLREV
     NLRPQMSQFL CLKNIRTFLS TCCEKFGLKR SELFEAFDLF DVQDFGKVIY TLSALSWTPI
     AQNRGIMPFP TEEESVGDED IYSGLSDQID DTVEEDEDLY DCVENEEAEG DEIYEDLMRS
     EPVSMPPKMT EYDKRCCCLR EIQQTEEKYT DTLGSIQQHF LKPLQRFLKP QDIEIIFINI
     EDLLRVHTHF LKEMKEALGT PGAANLYQVF IKYKERFLVY GRYCSQVESA SKHLDRVAAA
     REDVQMKLEE CSQRANNGRF TLRDLLMVPM QRVLKYHLLL QELVKHTQEA MEKENLRLAL
     DAMRDLAQCV NEVKRDNETL RQITNFQLSI ENLDQSLAHY GRPKIDGELK ITSVERRSKM
     DRYAFLLDKA LLICKRRGDS YDLKDFVNLH SFQVRDDSSG DRDNKKWSHM FLLIEDQGAQ
     GYELFFKTRE LKKKWMEQFE MAISNIYPEN ATANGHDFQM FSFEETTSCK ACQMLLRGTF
     YQGYRCHRCR ASAHKECLGR VPPCGRHGQD FPGTMKKDKL HRRAQDKKRN ELGLPKMEVF
     QEYYGLPPPP GAIGPFLRLN PGDIVELTKA EAEQNWWEGP PQDLSVHLWY AGPMERAGAE
     SILANRSDGT FLVRQRVKDA AEFAISIKYN VEVKHIKIMT AEGLYRITEK KAFRGLTELV
     EFYQQNSLKD CFKSLDTTLQ FPFKEPEKRT ISRPAVGSTK YFGTAKARYD FCARDRSELS
     LKEGDIIKIL NKKGQQGWWR GEIYGRVGWF PANYVEEDYS EYC
//
ID   B2R8B5_HUMAN            Unreviewed;       845 AA.
AC   B2R8B5;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   16-JAN-2019, entry version 80.
DE   SubName: Full=cDNA, FLJ93820, highly similar to Homo sapiens vav 1 oncogene (VAV1), mRNA {ECO:0000313|EMBL:BAG36112.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG36112.1};
RN   [1] {ECO:0000313|EMBL:BAG36112.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Spleen {ECO:0000313|EMBL:BAG36112.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK313307; BAG36112.1; -; mRNA.
DR   RefSeq; NP_005419.2; NM_005428.3.
DR   UniGene; Hs.116237; -.
DR   ProteinModelPortal; B2R8B5; -.
DR   PeptideAtlas; B2R8B5; -.
DR   PRIDE; B2R8B5; -.
DR   GeneID; 7409; -.
DR   KEGG; hsa:7409; -.
DR   CTD; 7409; -.
DR   eggNOG; KOG2996; Eukaryota.
DR   eggNOG; ENOG410XPH6; LUCA.
DR   HOVERGEN; HBG018066; -.
DR   KO; K05730; -.
DR   OrthoDB; 710582at2759; -.
DR   SignaLink; B2R8B5; -.
DR   GenomeRNAi; 7409; -.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   CDD; cd00029; C1; 1.
DR   CDD; cd01223; PH_Vav; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   CDD; cd10405; SH2_Vav1; 1.
DR   CDD; cd11979; SH3_VAV1_1; 1.
DR   CDD; cd11976; SH3_VAV1_2; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR037832; PH_Vav.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR003096; SM22_calponin.
DR   InterPro; IPR028530; Vav1.
DR   InterPro; IPR035879; VAV1_SH2.
DR   InterPro; IPR035730; VAV1_SH3_1.
DR   InterPro; IPR035729; VAV1_SH3_2.
DR   PANTHER; PTHR22826:SF112; PTHR22826:SF112; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00307; CH; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 2.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00888; SM22CALPONIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00033; CH; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 2.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   PROSITE; PS50021; CH; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 2.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   2: Evidence at transcript level;
KW   Guanine-nucleotide releasing factor {ECO:0000256|SAAS:SAAS01126870};
KW   Metal-binding {ECO:0000256|SAAS:SAAS00515414};
KW   SH2 domain {ECO:0000256|PROSITE-ProRule:PRU00191};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192,
KW   ECO:0000256|SAAS:SAAS01042643}; Zinc {ECO:0000256|SAAS:SAAS00515409}.
FT   DOMAIN        1    119       Calponin-homology (CH).
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   DOMAIN      194    373       DH. {ECO:0000259|PROSITE:PS50010}.
FT   DOMAIN      402    504       PH. {ECO:0000259|PROSITE:PS50003}.
FT   DOMAIN      515    564       Phorbol-ester/DAG-type.
FT                                {ECO:0000259|PROSITE:PS50081}.
FT   DOMAIN      592    660       SH3. {ECO:0000259|PROSITE:PS50002}.
FT   DOMAIN      671    765       SH2. {ECO:0000259|PROSITE:PS50001}.
FT   DOMAIN      782    842       SH3. {ECO:0000259|PROSITE:PS50002}.
SQ   SEQUENCE   845 AA;  98193 MW;  13CC0DA535C844B2 CRC64;
     MELWRQCTHW LIQCRVLPPS HRVTWDGAQA CELAQALRDG VLLCQLLNNL LPHAINLREV
     NLRPQMSQFL CLKNIRTFLS TCCEKFGLKR SELFEAFDLF DVQDFGKVIY TLSALSWTPI
     AQNRGIMPFP TEEESVGDED IYSGLSDQID DTVEEDEDLY DCVENEEAEG DEIYEDLMRS
     EPVSMPPKMT EYDKRCCCLR EIQQTEEKYT DTLGSIQQHF LKPLQRFLKP QDIEIIFINI
     EDLLRVHTHF LKEMKEALGT PGAANLYQVF IKYKERFLVY GRYCSQVESA SKHLDRVAAA
     REDVQMKLEE CSQRANNGRL TLRDLLMVPM QRVLKYHLLL QELVKHTQEA MEKENLRLAL
     DAMRDLAQCV NEVKRDDETL RQITNSQLSI ENLDQSLAHY GRPKIDGELK ITSVERRSKM
     DRYAFLLDKA LLICKRRGDS YDLKDFVNLH SFQVRDDSSG DRDNKKWSHM FLLIEDQGAQ
     GYELFFKTRE LKKKWMEQFE MAISNIYPEN ATANGHDFQM FSFEETTSCK ACQMLLRGTF
     YQGYRCHRCR ASAHKECLGR VPPCGRHGQD FPGTMKKDKL HRRAQDKKRN ELGLPKMEVF
     QEYYGLPPPP GAIGPFLRLN PGDIVELTKA EAEQNWWEGR NTSTNEIGWF PCNRVKPYVH
     GPPQDLSVHL WYAGPMERAG AESILANRSD GTFLVRQRVK DAAEFAISIK YNVEVKHIKI
     MTAEGLYRIT EKKAFRGLTE LVEFYQQNSL KDCFKSLDTT LQFPFKEPEK RTISRPAVGS
     TKYFGTAKAR YDFCARDRSE LSLKEGDIIK ILNKKGQQGW WRGEIYGRVG WFPANYVEED
     YSEYC
//
ID   VAV_HUMAN               Reviewed;         845 AA.
AC   P15498; B4DVK9; M0QXX6; Q15860;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2001, sequence version 4.
DT   13-FEB-2019, entry version 221.
DE   RecName: Full=Proto-oncogene vav;
GN   Name=VAV1; Synonyms=VAV;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND MUTAGENESIS OF CYS-529.
RX   PubMed=2069873;
RA   Coppola J., Bryant S., Koda T., Conway D., Barbacid M.;
RT   "Mechanism of activation of the vav protooncogene.";
RL   Cell Growth Differ. 2:95-105(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10760587; DOI=10.1016/S0167-4781(00)00008-7;
RA   Denkinger D.J., Borges C.R., Butler C.L., Cushman A.M., Kawahara R.S.;
RT   "Genomic organization and regulation of the vav proto-oncogene.";
RL   Biochim. Biophys. Acta 1491:253-262(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-61.
RX   PubMed=2005887; DOI=10.1128/MCB.11.4.1912;
RA   Katzav S., Cleveland J.L., Heslop H.E., Pulido D.;
RT   "Loss of the amino-terminal helix-loop-helix domain of the vav proto-
RT   oncogene activates its transforming potential.";
RL   Mol. Cell. Biol. 11:1912-1920(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 51-813 (ISOFORM 2).
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 68-845 (ISOFORM 1).
RX   PubMed=2477241;
RA   Katzav S., Martin-Zanca D., Barbacid M.;
RT   "vav, a novel human oncogene derived from a locus ubiquitously
RT   expressed in hematopoietic cells.";
RL   EMBO J. 8:2283-2290(1989).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 299-837 (ISOFORM 1).
RA   Romero F.;
RL   Submitted (JAN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 299-334 (ISOFORM 1).
RX   PubMed=7478592;
RA   Ramos-Morales F., Romero F., Schweighoffer F., Bismuth G., Camonis J.,
RA   Tortolero M., Fischer S.;
RT   "The proline-rich region of Vav binds to Grb2 and Grb3-3.";
RL   Oncogene 11:1665-1669(1995).
RN   [9]
RP   SIMILARITY TO CDC24 FAMILY.
RX   PubMed=1565462;
RA   Adams J.M., Houston H., Allen J., Lints T., Harvey R.;
RT   "The hematopoietically expressed vav proto-oncogene shares homology
RT   with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene
RT   (CDC24) involved in cytoskeletal organization.";
RL   Oncogene 7:611-618(1992).
RN   [10]
RP   INTERACTION WITH SYK, AND MUTAGENESIS OF ARG-696.
RX   PubMed=8986718; DOI=10.1016/S1074-7613(00)80273-3;
RA   Deckert M., Tartare-Deckert S., Couture C., Mustelin T., Altman A.;
RT   "Functional and physical interactions of Syk family kinases with the
RT   Vav proto-oncogene product.";
RL   Immunity 5:591-604(1996).
RN   [11]
RP   INTERACTION WITH CBLB.
RX   PubMed=9399639; DOI=10.1038/sj.onc.1201430;
RA   Bustelo X.R., Crespo P., Lopez-Barahona M., Gutkind J.S., Barbacid M.;
RT   "Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-
RT   mediated c-Jun N-terminal kinase activation.";
RL   Oncogene 15:2511-2520(1997).
RN   [12]
RP   INTERACTION WITH BLNK; PLCG1; GRB2 AND NCK1.
RX   PubMed=9697839; DOI=10.1016/S1074-7613(00)80591-9;
RA   Fu C., Turck C.W., Kurosaki T., Chan A.C.;
RT   "BLNK: a central linker protein in B cell activation.";
RL   Immunity 9:93-103(1998).
RN   [13]
RP   INTERACTION WITH SIAH2.
RX   PubMed=10207103; DOI=10.1128/MCB.19.5.3798;
RA   Germani A., Romero F., Houlard M., Camonis J., Gisselbrecht S.,
RA   Fischer S., Varin-Blank N.;
RT   "hSiah2 is a new Vav binding protein which inhibits Vav-mediated
RT   signaling pathways.";
RL   Mol. Cell. Biol. 19:3798-3807(1999).
RN   [14]
RP   PHOSPHORYLATION BY FYN.
RX   PubMed=11005864; DOI=10.1073/pnas.97.20.10923;
RA   Huang J., Tilly D., Altman A., Sugie K., Grey H.M.;
RT   "T-cell receptor antagonists induce Vav phosphorylation by selective
RT   activation of Fyn kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:10923-10929(2000).
RN   [15]
RP   INTERACTION WITH DOCK2.
RX   PubMed=12393632; DOI=10.1182/blood-2001-11-0032;
RA   Nishihara H., Maeda M., Oda A., Tsuda M., Sawa H., Nagashima K.,
RA   Tanaka S.;
RT   "DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell
RT   lines.";
RL   Blood 100:3968-3974(2002).
RN   [16]
RP   INTERACTION WITH SHB.
RX   PubMed=12084069; DOI=10.1046/j.1432-1033.2002.03008.x;
RA   Lindholm C.K., Henriksson M.L., Hallberg B., Welsh M.;
RT   "Shb links SLP-76 and Vav with the CD3 complex in Jurkat T cells.";
RL   Eur. J. Biochem. 269:3279-3288(2002).
RN   [17]
RP   INTERACTION WITH APS.
RX   PubMed=12400014; DOI=10.1038/sj.onc.1205927;
RA   Yabana N., Shibuya M.;
RT   "Adaptor protein APS binds the NH2-terminal autoinhibitory domain of
RT   guanine nucleotide exchange factor Vav3 and augments its activity.";
RL   Oncogene 21:7720-7729(2002).
RN   [18]
RP   INTERACTION WITH ITK.
RX   PubMed=15661896; DOI=10.4049/jimmunol.174.3.1385;
RA   Dombroski D., Houghtling R.A., Labno C.M., Precht P., Takesono A.,
RA   Caplen N.J., Billadeau D.D., Wange R.L., Burkhardt J.K.,
RA   Schwartzberg P.L.;
RT   "Kinase-independent functions for Itk in TCR-induced regulation of Vav
RT   and the actin cytoskeleton.";
RL   J. Immunol. 174:1385-1392(2005).
RN   [19]
RP   INTERACTION WITH NEK3.
RX   PubMed=15618286; DOI=10.1210/me.2004-0443;
RA   Miller S.L., DeMaria J.E., Freier D.O., Riegel A.M., Clevenger C.V.;
RT   "Novel association of Vav2 and Nek3 modulates signaling through the
RT   human prolactin receptor.";
RL   Mol. Endocrinol. 19:939-949(2005).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-826, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [21]
RP   INTERACTION WITH ZNF655/VIK.
RX   PubMed=15558030; DOI=10.1038/sj.onc.1208043;
RA   Houlard M., Romero-Portillo F., Germani A., Depaux A.,
RA   Regnier-Ricard F., Gisselbrecht S., Varin-Blank N.;
RT   "Characterization of VIK-1: a new Vav-interacting Kruppel-like
RT   protein.";
RL   Oncogene 24:28-38(2005).
RN   [22]
RP   INTERACTION WITH PTK2B/PYK2.
RX   PubMed=19207108; DOI=10.1042/BJ20090037;
RA   Gao C., Blystone S.D.;
RT   "A Pyk2-Vav1 complex is recruited to beta3-adhesion sites to initiate
RT   Rho activation.";
RL   Biochem. J. 420:49-56(2009).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   STRUCTURE BY NMR OF 661-775.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the SH2 domain of human proto-oncogene protein
RT   VAV1.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: Couples tyrosine kinase signals with the activation of
CC       the Rho/Rac GTPases, thus leading to cell differentiation and/or
CC       proliferation.
CC   -!- SUBUNIT: Interacts with SHB (PubMed:12084069). Interacts with APS,
CC       GRB2, GRB3, DOCK2, SLA, TEC and ZNF655/VIK (PubMed:12393632,
CC       PubMed:12400014, PubMed:15558030). Interacts with SIAH2; without
CC       leading to its degradation (PubMed:10207103). Associates with
CC       BLNK, PLCG1, GRB2 and NCK1 in a B-cell antigen receptor-dependent
CC       fashion (PubMed:9697839). Interacts with CBLB; which inhibits
CC       tyrosine phosphorylation and down-regulates activity
CC       (PubMed:9399639). May interact with CCPG1. Interacts with CLNK.
CC       Interacts with THEMIS2 (By similarity). Interacts with NEK3 and
CC       this interaction is prolactin-dependent (PubMed:15618286).
CC       Interacts with ITK (PubMed:15661896). Interacts with PTK2B/PYK2
CC       (By similarity). Interacts with HCK. Interacts with PTK2B/PYK2
CC       (PubMed:19207108). Interacts (via SH2 domain) with SYK
CC       (PubMed:8986718). Interacts with ANKRD54. Interacts with CD6 (By
CC       similarity). {ECO:0000250|UniProtKB:P27870,
CC       ECO:0000269|PubMed:10207103, ECO:0000269|PubMed:12084069,
CC       ECO:0000269|PubMed:12393632, ECO:0000269|PubMed:12400014,
CC       ECO:0000269|PubMed:15558030, ECO:0000269|PubMed:15618286,
CC       ECO:0000269|PubMed:15661896, ECO:0000269|PubMed:19207108,
CC       ECO:0000269|PubMed:8986718, ECO:0000269|PubMed:9399639,
CC       ECO:0000269|PubMed:9697839}.
CC   -!- INTERACTION:
CC       Q8IZP0:ABI1; NbExp=2; IntAct=EBI-625518, EBI-375446;
CC       P00519:ABL1; NbExp=5; IntAct=EBI-625518, EBI-375543;
CC       Q13480:GAB1; NbExp=2; IntAct=EBI-625518, EBI-517684;
CC       P62993:GRB2; NbExp=3; IntAct=EBI-625518, EBI-401755;
CC       Q07666:KHDRBS1; NbExp=3; IntAct=EBI-625518, EBI-1364;
CC       Q13094:LCP2; NbExp=9; IntAct=EBI-625518, EBI-346946;
CC       P08487:PLCG1 (xeno); NbExp=4; IntAct=EBI-625518, EBI-8013886;
CC       P63000:RAC1; NbExp=2; IntAct=EBI-625518, EBI-413628;
CC       P78314:SH3BP2; NbExp=8; IntAct=EBI-625518, EBI-727062;
CC       Q8N720:ZNF655; NbExp=5; IntAct=EBI-625518, EBI-625509;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P15498-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P15498-2; Sequence=VSP_047563;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed in hematopoietic cells but
CC       not in other cell types.
CC   -!- DOMAIN: The DH domain is involved in interaction with CCPG1.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated on tyrosine residues by HCK in response to
CC       IFNG and bacterial lipopolysaccharide (LPS) (By similarity).
CC       Phosphorylated by FYN. {ECO:0000250, ECO:0000269|PubMed:11005864}.
CC   -!- MISCELLANEOUS: 'Vav' stands for the sixth letter of the Hebrew
CC       alphabet.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAG62721.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAA34383.1; Type=Frameshift; Positions=322, 355; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/VAV1ID195ch19p13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AF030227; AAC25011.1; -; Genomic_DNA.
DR   EMBL; AF030201; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030202; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030203; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030204; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030205; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030206; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030207; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030208; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030209; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030210; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030211; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030212; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030213; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030214; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030215; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030216; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030217; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030218; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030219; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030220; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030221; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030222; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030223; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030224; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030225; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AF030226; AAC25011.1; JOINED; Genomic_DNA.
DR   EMBL; AC010647; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020895; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020954; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022156; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M59834; AAA63267.1; -; Genomic_DNA.
DR   EMBL; AK301128; BAG62721.1; ALT_INIT; mRNA.
DR   EMBL; X16316; CAA34383.1; ALT_FRAME; mRNA.
DR   EMBL; X83931; CAA58783.1; -; mRNA.
DR   CCDS; CCDS12174.1; -. [P15498-1]
DR   CCDS; CCDS59342.1; -. [P15498-2]
DR   PIR; B39576; TVHUVV.
DR   RefSeq; NP_001245136.1; NM_001258207.1. [P15498-2]
DR   RefSeq; NP_005419.2; NM_005428.3. [P15498-1]
DR   UniGene; Hs.116237; -.
DR   PDB; 2CRH; NMR; -; A=629-775.
DR   PDB; 2LCT; NMR; -; A=664-767.
DR   PDB; 2MC1; NMR; -; A=664-767.
DR   PDB; 2ROR; NMR; -; A=629-775.
DR   PDB; 3BJI; X-ray; 2.60 A; A/B=189-565.
DR   PDB; 3KY9; X-ray; 2.73 A; A/B=2-584.
DR   PDBsum; 2CRH; -.
DR   PDBsum; 2LCT; -.
DR   PDBsum; 2MC1; -.
DR   PDBsum; 2ROR; -.
DR   PDBsum; 3BJI; -.
DR   PDBsum; 3KY9; -.
DR   ProteinModelPortal; P15498; -.
DR   SMR; P15498; -.
DR   BioGrid; 113252; 88.
DR   CORUM; P15498; -.
DR   DIP; DIP-1061N; -.
DR   IntAct; P15498; 30.
DR   MINT; P15498; -.
DR   STRING; 9606.ENSP00000472929; -.
DR   BindingDB; P15498; -.
DR   ChEMBL; CHEMBL3259472; -.
DR   iPTMnet; P15498; -.
DR   PhosphoSitePlus; P15498; -.
DR   BioMuta; VAV1; -.
DR   DMDM; 13124807; -.
DR   EPD; P15498; -.
DR   jPOST; P15498; -.
DR   MaxQB; P15498; -.
DR   PaxDb; P15498; -.
DR   PeptideAtlas; P15498; -.
DR   PRIDE; P15498; -.
DR   ProteomicsDB; 53143; -.
DR   DNASU; 7409; -.
DR   Ensembl; ENST00000596764; ENSP00000469450; ENSG00000141968. [P15498-2]
DR   Ensembl; ENST00000602142; ENSP00000472929; ENSG00000141968. [P15498-1]
DR   GeneID; 7409; -.
DR   KEGG; hsa:7409; -.
DR   UCSC; uc002mfu.3; human. [P15498-1]
DR   CTD; 7409; -.
DR   DisGeNET; 7409; -.
DR   EuPathDB; HostDB:ENSG00000141968.7; -.
DR   GeneCards; VAV1; -.
DR   H-InvDB; HIX0202828; -.
DR   HGNC; HGNC:12657; VAV1.
DR   HPA; HPA001864; -.
DR   MIM; 164875; gene.
DR   neXtProt; NX_P15498; -.
DR   OpenTargets; ENSG00000141968; -.
DR   PharmGKB; PA37280; -.
DR   eggNOG; KOG2996; Eukaryota.
DR   eggNOG; ENOG410XPH6; LUCA.
DR   GeneTree; ENSGT00940000159125; -.
DR   HOGENOM; HOG000234364; -.
DR   HOVERGEN; HBG018066; -.
DR   InParanoid; P15498; -.
DR   KO; K05730; -.
DR   OMA; DKRECCL; -.
DR   OrthoDB; 710582at2759; -.
DR   PhylomeDB; P15498; -.
DR   TreeFam; TF316171; -.
DR   Reactome; R-HSA-114604; GPVI-mediated activation cascade.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-1433557; Signaling by SCF-KIT.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer.
DR   Reactome; R-HSA-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-HSA-389359; CD28 dependent Vav1 pathway.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-512988; Interleukin-3, Interleukin-5 and GM-CSF signaling.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-HSA-9027284; Erythropoietin activates RAS.
DR   Reactome; R-HSA-912631; Regulation of signaling by CBL.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SignaLink; P15498; -.
DR   SIGNOR; P15498; -.
DR   ChiTaRS; VAV1; human.
DR   EvolutionaryTrace; P15498; -.
DR   GenomeRNAi; 7409; -.
DR   PMAP-CutDB; P15498; -.
DR   PRO; PR:P15498; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000141968; Expressed in 124 organ(s), highest expression level in blood.
DR   ExpressionAtlas; P15498; baseline and differential.
DR   Genevisible; P15498; HS.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; EXP:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046934; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; TAS:Reactome.
DR   GO; GO:0001784; F:phosphotyrosine residue binding; IPI:CAFA.
DR   GO; GO:0030676; F:Rac guanyl-nucleotide exchange factor activity; IEA:Ensembl.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IEA:Ensembl.
DR   GO; GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; TAS:Reactome.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; TAS:Reactome.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; IEA:Ensembl.
DR   GO; GO:0008361; P:regulation of cell size; IGI:UniProtKB.
DR   GO; GO:0043087; P:regulation of GTPase activity; IGI:UniProtKB.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0030217; P:T cell differentiation; IEA:Ensembl.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome.
DR   CDD; cd00029; C1; 1.
DR   CDD; cd01223; PH_Vav; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   CDD; cd10405; SH2_Vav1; 1.
DR   CDD; cd11979; SH3_VAV1_1; 1.
DR   CDD; cd11976; SH3_VAV1_2; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR022613; CAMSAP_CH.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR037832; PH_Vav.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR003096; SM22_calponin.
DR   InterPro; IPR028530; Vav1.
DR   InterPro; IPR035879; VAV1_SH2.
DR   InterPro; IPR035730; VAV1_SH3_1.
DR   InterPro; IPR035729; VAV1_SH3_2.
DR   PANTHER; PTHR22826:SF112; PTHR22826:SF112; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF11971; CAMSAP_CH; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 2.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00888; SM22CALPONIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00033; CH; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 2.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   PROSITE; PS50021; CH; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 2.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Guanine-nucleotide releasing factor; Metal-binding; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Reference proteome; Repeat; SH2 domain;
KW   SH3 domain; Zinc; Zinc-finger.
FT   CHAIN         1    845       Proto-oncogene vav.
FT                                /FTId=PRO_0000080980.
FT   DOMAIN        1    119       Calponin-homology (CH).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00044}.
FT   DOMAIN      194    373       DH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00062}.
FT   DOMAIN      402    504       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN      592    660       SH3 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN      671    765       SH2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   DOMAIN      782    842       SH3 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   ZN_FING     515    564       Phorbol-ester/DAG-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   COMPBIAS     33     99       Leu-rich.
FT   MOD_RES     826    826       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455}.
FT   MOD_RES     844    844       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P27870}.
FT   VAR_SEQ     187    218       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047563.
FT   VARIANT     739    739       T -> M (in dbSNP:rs36097961).
FT                                /FTId=VAR_051997.
FT   MUTAGEN     529    529       C->R: Abolishes transforming activity.
FT                                {ECO:0000269|PubMed:2069873}.
FT   MUTAGEN     696    696       R->L: Loss of interaction with SYK.
FT                                {ECO:0000269|PubMed:8986718}.
FT   CONFLICT    264    264       A -> P (in Ref. 6; CAA34383).
FT                                {ECO:0000305}.
FT   CONFLICT    368    368       Q -> R (in Ref. 5; BAG62721).
FT                                {ECO:0000305}.
FT   CONFLICT    718    718       I -> TV (in Ref. 6). {ECO:0000305}.
FT   HELIX         3     13       {ECO:0000244|PDB:3KY9}.
FT   TURN         22     24       {ECO:0000244|PDB:3KY9}.
FT   HELIX        30     37       {ECO:0000244|PDB:3KY9}.
FT   HELIX        41     50       {ECO:0000244|PDB:3KY9}.
FT   HELIX        57     59       {ECO:0000244|PDB:3KY9}.
FT   HELIX        68     84       {ECO:0000244|PDB:3KY9}.
FT   HELIX        96    100       {ECO:0000244|PDB:3KY9}.
FT   HELIX       105    117       {ECO:0000244|PDB:3KY9}.
FT   TURN        119    121       {ECO:0000244|PDB:3KY9}.
FT   HELIX       122    124       {ECO:0000244|PDB:3KY9}.
FT   HELIX       145    149       {ECO:0000244|PDB:3KY9}.
FT   HELIX       159    162       {ECO:0000244|PDB:3KY9}.
FT   HELIX       168    178       {ECO:0000244|PDB:3KY9}.
FT   HELIX       191    218       {ECO:0000244|PDB:3BJI}.
FT   HELIX       221    224       {ECO:0000244|PDB:3BJI}.
FT   TURN        225    227       {ECO:0000244|PDB:3BJI}.
FT   HELIX       230    237       {ECO:0000244|PDB:3BJI}.
FT   HELIX       240    259       {ECO:0000244|PDB:3BJI}.
FT   TURN        260    262       {ECO:0000244|PDB:3BJI}.
FT   HELIX       267    273       {ECO:0000244|PDB:3BJI}.
FT   HELIX       276    278       {ECO:0000244|PDB:3BJI}.
FT   HELIX       279    300       {ECO:0000244|PDB:3BJI}.
FT   HELIX       302    316       {ECO:0000244|PDB:3BJI}.
FT   STRAND      317    319       {ECO:0000244|PDB:3KY9}.
FT   HELIX       322    326       {ECO:0000244|PDB:3BJI}.
FT   HELIX       328    333       {ECO:0000244|PDB:3BJI}.
FT   HELIX       336    344       {ECO:0000244|PDB:3BJI}.
FT   HELIX       351    388       {ECO:0000244|PDB:3BJI}.
FT   HELIX       397    400       {ECO:0000244|PDB:3BJI}.
FT   STRAND      403    412       {ECO:0000244|PDB:3BJI}.
FT   STRAND      420    435       {ECO:0000244|PDB:3BJI}.
FT   STRAND      442    448       {ECO:0000244|PDB:3BJI}.
FT   HELIX       449    451       {ECO:0000244|PDB:3BJI}.
FT   STRAND      452    456       {ECO:0000244|PDB:3BJI}.
FT   STRAND      469    479       {ECO:0000244|PDB:3BJI}.
FT   STRAND      481    488       {ECO:0000244|PDB:3BJI}.
FT   HELIX       489    506       {ECO:0000244|PDB:3BJI}.
FT   TURN        509    512       {ECO:0000244|PDB:3BJI}.
FT   HELIX       513    515       {ECO:0000244|PDB:3BJI}.
FT   STRAND      518    521       {ECO:0000244|PDB:3BJI}.
FT   TURN        530    532       {ECO:0000244|PDB:3BJI}.
FT   STRAND      538    540       {ECO:0000244|PDB:3BJI}.
FT   STRAND      543    546       {ECO:0000244|PDB:3BJI}.
FT   TURN        547    549       {ECO:0000244|PDB:3BJI}.
FT   HELIX       555    560       {ECO:0000244|PDB:3BJI}.
FT   HELIX       666    668       {ECO:0000244|PDB:2CRH}.
FT   STRAND      669    672       {ECO:0000244|PDB:2CRH}.
FT   HELIX       678    684       {ECO:0000244|PDB:2CRH}.
FT   TURN        685    687       {ECO:0000244|PDB:2CRH}.
FT   STRAND      692    696       {ECO:0000244|PDB:2CRH}.
FT   STRAND      700    702       {ECO:0000244|PDB:2LCT}.
FT   STRAND      706    711       {ECO:0000244|PDB:2CRH}.
FT   STRAND      714    719       {ECO:0000244|PDB:2CRH}.
FT   STRAND      721    723       {ECO:0000244|PDB:2CRH}.
FT   STRAND      726    730       {ECO:0000244|PDB:2CRH}.
FT   STRAND      735    737       {ECO:0000244|PDB:2CRH}.
FT   HELIX       738    745       {ECO:0000244|PDB:2CRH}.
FT   HELIX       750    752       {ECO:0000244|PDB:2CRH}.
FT   STRAND      754    756       {ECO:0000244|PDB:2LCT}.
FT   STRAND      763    766       {ECO:0000244|PDB:2CRH}.
SQ   SEQUENCE   845 AA;  98314 MW;  AC3BC9736FD2F138 CRC64;
     MELWRQCTHW LIQCRVLPPS HRVTWDGAQV CELAQALRDG VLLCQLLNNL LPHAINLREV
     NLRPQMSQFL CLKNIRTFLS TCCEKFGLKR SELFEAFDLF DVQDFGKVIY TLSALSWTPI
     AQNRGIMPFP TEEESVGDED IYSGLSDQID DTVEEDEDLY DCVENEEAEG DEIYEDLMRS
     EPVSMPPKMT EYDKRCCCLR EIQQTEEKYT DTLGSIQQHF LKPLQRFLKP QDIEIIFINI
     EDLLRVHTHF LKEMKEALGT PGAANLYQVF IKYKERFLVY GRYCSQVESA SKHLDRVAAA
     REDVQMKLEE CSQRANNGRF TLRDLLMVPM QRVLKYHLLL QELVKHTQEA MEKENLRLAL
     DAMRDLAQCV NEVKRDNETL RQITNFQLSI ENLDQSLAHY GRPKIDGELK ITSVERRSKM
     DRYAFLLDKA LLICKRRGDS YDLKDFVNLH SFQVRDDSSG DRDNKKWSHM FLLIEDQGAQ
     GYELFFKTRE LKKKWMEQFE MAISNIYPEN ATANGHDFQM FSFEETTSCK ACQMLLRGTF
     YQGYRCHRCR ASAHKECLGR VPPCGRHGQD FPGTMKKDKL HRRAQDKKRN ELGLPKMEVF
     QEYYGLPPPP GAIGPFLRLN PGDIVELTKA EAEQNWWEGR NTSTNEIGWF PCNRVKPYVH
     GPPQDLSVHL WYAGPMERAG AESILANRSD GTFLVRQRVK DAAEFAISIK YNVEVKHIKI
     MTAEGLYRIT EKKAFRGLTE LVEFYQQNSL KDCFKSLDTT LQFPFKEPEK RTISRPAVGS
     TKYFGTAKAR YDFCARDRSE LSLKEGDIIK ILNKKGQQGW WRGEIYGRVG WFPANYVEED
     YSEYC
//
ID   Q96D37_HUMAN            Unreviewed;       790 AA.
AC   Q96D37;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-MAR-2004, sequence version 2.
DT   13-FEB-2019, entry version 148.
DE   SubName: Full=Proto-oncogene vav {ECO:0000313|Ensembl:ENSP00000472803};
DE   SubName: Full=VAV1 protein {ECO:0000313|EMBL:AAH13361.2};
GN   Name=VAV1 {ECO:0000313|EMBL:AAH13361.2,
GN   ECO:0000313|Ensembl:ENSP00000472803};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH13361.2};
RN   [1] {ECO:0000313|EMBL:AAH13361.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta {ECO:0000313|EMBL:AAH13361.2};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000472803, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3] {ECO:0000213|PubMed:15592455}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000472803}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2013) to UniProtKB.
CC   -!- INTERACTION:
CC       P04626:ERBB2; NbExp=2; IntAct=EBI-7875353, EBI-641062;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AC010647; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020895; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020954; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022156; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC013361; AAH13361.2; -; mRNA.
DR   RefSeq; NP_001245135.1; NM_001258206.1.
DR   RefSeq; NP_001245136.1; NM_001258207.1.
DR   RefSeq; NP_005419.2; NM_005428.3.
DR   UniGene; Hs.116237; -.
DR   IntAct; Q96D37; 3.
DR   Ensembl; ENST00000599806; ENSP00000472803; ENSG00000141968.
DR   GeneID; 7409; -.
DR   KEGG; hsa:7409; -.
DR   UCSC; uc002mfv.2; human.
DR   CTD; 7409; -.
DR   EuPathDB; HostDB:ENSG00000141968.7; -.
DR   HGNC; HGNC:12657; VAV1.
DR   OpenTargets; ENSG00000141968; -.
DR   eggNOG; KOG2996; Eukaryota.
DR   eggNOG; ENOG410XPH6; LUCA.
DR   GeneTree; ENSGT00940000159125; -.
DR   HOVERGEN; HBG018066; -.
DR   KO; K05730; -.
DR   OrthoDB; 710582at2759; -.
DR   ChiTaRS; VAV1; human.
DR   GenomeRNAi; 7409; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000141968; Expressed in 124 organ(s), highest expression level in blood.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   CDD; cd00029; C1; 1.
DR   CDD; cd01223; PH_Vav; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   CDD; cd10405; SH2_Vav1; 1.
DR   CDD; cd11979; SH3_VAV1_1; 1.
DR   CDD; cd11976; SH3_VAV1_2; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR037832; PH_Vav.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR028530; Vav1.
DR   InterPro; IPR035879; VAV1_SH2.
DR   InterPro; IPR035730; VAV1_SH3_1.
DR   InterPro; IPR035729; VAV1_SH3_2.
DR   PANTHER; PTHR22826:SF112; PTHR22826:SF112; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00307; CH; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 2.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 2.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   PROSITE; PS50021; CH; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 2.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Guanine-nucleotide releasing factor {ECO:0000256|SAAS:SAAS01126870};
KW   Metal-binding {ECO:0000256|SAAS:SAAS00515414};
KW   Proteomics identification {ECO:0000213|EPD:Q96D37,
KW   ECO:0000213|MaxQB:Q96D37, ECO:0000213|PeptideAtlas:Q96D37};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   SH2 domain {ECO:0000256|PROSITE-ProRule:PRU00191};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192,
KW   ECO:0000256|SAAS:SAAS01042643}; Zinc {ECO:0000256|SAAS:SAAS00515409}.
FT   DOMAIN        1     64       Calponin-homology (CH).
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   DOMAIN      139    318       DH. {ECO:0000259|PROSITE:PS50010}.
FT   DOMAIN      347    449       PH. {ECO:0000259|PROSITE:PS50003}.
FT   DOMAIN      460    509       Phorbol-ester/DAG-type.
FT                                {ECO:0000259|PROSITE:PS50081}.
FT   DOMAIN      537    605       SH3. {ECO:0000259|PROSITE:PS50002}.
FT   DOMAIN      616    710       SH2. {ECO:0000259|PROSITE:PS50001}.
FT   DOMAIN      727    787       SH3. {ECO:0000259|PROSITE:PS50002}.
SQ   SEQUENCE   790 AA;  91991 MW;  4A92899AAA3FDCF5 CRC64;
     MIVLPLYSRL DKRFLCLKNI RTFLSTCCEK FGLKRSELFE AFDLFDVQDF GKVIYTLSAL
     SWTPIAQNRG IMPFPTEEES VGDEDIYSGL SDQIDDTVEE DEDLYDCVEN EEAEGDEIYE
     DLMRSEPVSM PPKMTEYDKR CCCLREIQQT EEKYTDTLGS IQQHFLKPLQ RFLKPQDIEI
     IFINIEDLLR VHTHFLKEMK EALGTPGAAN LYQVFIKYKE RFLVYGRYCS QVESASKHLD
     RVAAAREDVQ MKLEECSQRA NNGRFTLRDL LMVPMQRVLK YHLLLQELVK HTQEAMEKEN
     LRLALDAMRD LAQCVNEVKR DNETLRQITN FQLSIENLDQ SLAHYGRPKI DGELKITSVE
     RRSKMDRYAF LLDKALLICK RRGDSYDLKD FVNLHSFQVR DDSSGDRDNK KWSHMFLLIE
     DQGAQGYELF FKTRELKKKW MEQFEMAISN IYPENATANG HDFQMFSFEE TTSCKACQML
     LRGTFYQGYR CHRCRASAHK ECLGRVPPCG RHGQDFPGTM KKDKLHRRAQ DKKRNELGLP
     KMEVFQEYYG LPPPPGAIGP FLRLNPGDIV ELTKAEAEQN WWEGRNTSTN EIGWFPCNRV
     KPYVHGPPQD LSVHLWYAGP MERAGAESIL ANRSDGTFLV RQRVKDAAEF AISIKYNVEV
     KHIKIMTAEG LYRITEKKAF RGLTELVEFY QQNSLKDCFK SLDTTLQFPF KEPEKRTISR
     PAVGSTKYFG TAKARYDFCA RDRSELSLKE GDIIKILNKK GQQGWWRGEI YGRVGWFPAN
     YVEEDYSEYC
//
ID   VTI1A_HUMAN             Reviewed;         217 AA.
AC   Q96AJ9; A2A307; B4E137; Q5W0D7;
DT   25-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   25-JAN-2012, sequence version 2.
DT   13-FEB-2019, entry version 141.
DE   RecName: Full=Vesicle transport through interaction with t-SNAREs homolog 1A;
DE   AltName: Full=Vesicle transport v-SNARE protein Vti1-like 2;
DE   AltName: Full=Vti1-rp2;
GN   Name=VTI1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAH17052.1};
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3] {ECO:0000312|EMBL:AAH17052.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=18195106; DOI=10.1083/jcb.200707136;
RA   Ganley I.G., Espinosa E., Pfeffer S.R.;
RT   "A syntaxin 10-SNARE complex distinguishes two distinct transport
RT   routes from endosomes to the trans-Golgi in human cells.";
RL   J. Cell Biol. 180:159-172(2008).
RN   [6]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19138172; DOI=10.1042/BJ20081736;
RA   Flowerdew S.E., Burgoyne R.D.;
RT   "A VAMP7/Vti1a SNARE complex distinguishes a non-conventional traffic
RT   route to the cell surface used by KChIP1 and Kv4 potassium channels.";
RL   Biochem. J. 418:529-540(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: V-SNARE that mediates vesicle transport pathways through
CC       interactions with t-SNAREs on the target membrane. These
CC       interactions are proposed to mediate aspects of the specificity of
CC       vesicle trafficking and to promote fusion of the lipid bilayers.
CC       Involved in vesicular transport from the late endosomes to the
CC       trans-Golgi network. Along with VAMP7, involved in an non-
CC       conventional RAB1-dependent traffic route to the cell surface used
CC       by KCNIP1 and KCND2. May be involved in increased cytokine
CC       secretion associated with cellular senescence.
CC       {ECO:0000269|PubMed:18195106, ECO:0000269|PubMed:19138172}.
CC   -!- SUBUNIT: Interacts with distinct SNARE complexes that contain
CC       either STX5 or STX6. Interacts with NAPA and, to a lesser extent,
CC       with NAPG. Identified in a complex containing STX6, STX12, VAMP4
CC       and VTI1A. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle
CC       {ECO:0000269|PubMed:19138172}. Golgi apparatus membrane
CC       {ECO:0000250}; Single-pass type IV membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=2;
CC         IsoId=Q96AJ9-2; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q96AJ9-1; Sequence=VSP_039848;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the VTI1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK303646; BAG64649.1; -; mRNA.
DR   EMBL; AC022018; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL139120; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL158212; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49524.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49525.1; -; Genomic_DNA.
DR   EMBL; BC017052; AAH17052.1; -; mRNA.
DR   CCDS; CCDS7575.2; -. [Q96AJ9-2]
DR   RefSeq; NP_001305132.1; NM_001318203.1.
DR   RefSeq; NP_001305134.1; NM_001318205.1.
DR   RefSeq; NP_660207.2; NM_145206.3. [Q96AJ9-2]
DR   RefSeq; XP_005269601.1; XM_005269544.4. [Q96AJ9-1]
DR   UniGene; Hs.194554; -.
DR   UniGene; Hs.287723; -.
DR   UniGene; Hs.742069; -.
DR   ProteinModelPortal; Q96AJ9; -.
DR   SMR; Q96AJ9; -.
DR   BioGrid; 126789; 16.
DR   CORUM; Q96AJ9; -.
DR   DIP; DIP-44223N; -.
DR   IntAct; Q96AJ9; 7.
DR   MINT; Q96AJ9; -.
DR   STRING; 9606.ENSP00000376792; -.
DR   iPTMnet; Q96AJ9; -.
DR   PhosphoSitePlus; Q96AJ9; -.
DR   BioMuta; VTI1A; -.
DR   DMDM; 374095459; -.
DR   EPD; Q96AJ9; -.
DR   jPOST; Q96AJ9; -.
DR   PaxDb; Q96AJ9; -.
DR   PeptideAtlas; Q96AJ9; -.
DR   PRIDE; Q96AJ9; -.
DR   ProteomicsDB; 75969; -.
DR   ProteomicsDB; 75970; -. [Q96AJ9-1]
DR   DNASU; 143187; -.
DR   Ensembl; ENST00000393077; ENSP00000376792; ENSG00000151532. [Q96AJ9-2]
DR   Ensembl; ENST00000432306; ENSP00000395017; ENSG00000151532. [Q96AJ9-1]
DR   GeneID; 143187; -.
DR   KEGG; hsa:143187; -.
DR   UCSC; uc001kzz.5; human. [Q96AJ9-2]
DR   CTD; 143187; -.
DR   DisGeNET; 143187; -.
DR   EuPathDB; HostDB:ENSG00000151532.13; -.
DR   GeneCards; VTI1A; -.
DR   H-InvDB; HIX0023094; -.
DR   HGNC; HGNC:17792; VTI1A.
DR   HPA; HPA054108; -.
DR   MIM; 614316; gene.
DR   neXtProt; NX_Q96AJ9; -.
DR   OpenTargets; ENSG00000151532; -.
DR   PharmGKB; PA134928049; -.
DR   eggNOG; KOG1666; Eukaryota.
DR   eggNOG; ENOG4111J90; LUCA.
DR   GeneTree; ENSGT00940000154084; -.
DR   HOGENOM; HOG000116573; -.
DR   HOVERGEN; HBG104027; -.
DR   InParanoid; Q96AJ9; -.
DR   KO; K08493; -.
DR   OMA; VESHRAE; -.
DR   OrthoDB; 831280at2759; -.
DR   PhylomeDB; Q96AJ9; -.
DR   TreeFam; TF312874; -.
DR   Reactome; R-HSA-6811438; Intra-Golgi traffic.
DR   Reactome; R-HSA-6811440; Retrograde transport at the Trans-Golgi-Network.
DR   SIGNOR; Q96AJ9; -.
DR   ChiTaRS; VTI1A; human.
DR   GeneWiki; VTI1A; -.
DR   GenomeRNAi; 143187; -.
DR   PRO; PR:Q96AJ9; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000151532; Expressed in 191 organ(s), highest expression level in corpus callosum.
DR   Genevisible; Q96AJ9; HS.
DR   GO; GO:0005776; C:autophagosome; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0030136; C:clathrin-coated vesicle; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; IEA:GOC.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0005768; C:endosome; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; IBA:GO_Central.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0031902; C:late endosome membrane; IBA:GO_Central.
DR   GO; GO:0044306; C:neuron projection terminus; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0043025; C:neuronal cell body; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0031201; C:SNARE complex; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0008021; C:synaptic vesicle; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0032588; C:trans-Golgi network membrane; TAS:Reactome.
DR   GO; GO:0005484; F:SNAP receptor activity; IDA:HGNC.
DR   GO; GO:0000149; F:SNARE binding; IBA:GO_Central.
DR   GO; GO:0006914; P:autophagy; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006888; P:endoplasmic reticulum to Golgi vesicle-mediated transport; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0090161; P:Golgi ribbon formation; IMP:UniProtKB.
DR   GO; GO:0006896; P:Golgi to vacuole transport; IBA:GO_Central.
DR   GO; GO:0006891; P:intra-Golgi vesicle-mediated transport; IBA:GO_Central.
DR   GO; GO:0006623; P:protein targeting to vacuole; IBA:GO_Central.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IDA:UniProtKB.
DR   GO; GO:0048280; P:vesicle fusion with Golgi apparatus; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0050882; P:voluntary musculoskeletal movement; IMP:UniProtKB.
DR   Gene3D; 1.20.58.400; -; 1.
DR   InterPro; IPR027027; GOSR2/Membrin/Bos1.
DR   InterPro; IPR010989; SNARE.
DR   InterPro; IPR000727; T_SNARE_dom.
DR   InterPro; IPR038407; v-SNARE_N_sf.
DR   InterPro; IPR007705; Vesicle_trsprt_v-SNARE_N.
DR   Pfam; PF05008; V-SNARE; 1.
DR   PIRSF; PIRSF028865; Membrin-2; 1.
DR   SMART; SM00397; t_SNARE; 1.
DR   SUPFAM; SSF47661; SSF47661; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome;
KW   Cytoplasmic vesicle; Golgi apparatus; Membrane; Protein transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    217       Vesicle transport through interaction
FT                                with t-SNAREs homolog 1A.
FT                                /FTId=PRO_0000218225.
FT   TOPO_DOM      1    192       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    193    213       Helical. {ECO:0000255}.
FT   TOPO_DOM    214    217       Extracellular. {ECO:0000255}.
FT   COILED       31     92       {ECO:0000255}.
FT   COILED      112    178       {ECO:0000255}.
FT   VAR_SEQ     188    217       IIQNRILLVILGIIVVITILMAITFSVRRH -> GCSVKKQ
FT                                CNLSLAPKA (in isoform 1).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039848.
FT   CONFLICT     83     83       K -> E (in Ref. 1; BAG64649).
FT                                {ECO:0000305}.
SQ   SEQUENCE   217 AA;  25218 MW;  3FE5FE787B5958F0 CRC64;
     MSSDFEGYEQ DFAVLTAEIT SKIARVPRLP PDEKKQMVAN VEKQLEEAKE LLEQMDLEVR
     EIPPQSRGMY SNRMRSYKQE MGKLETDFKR SRIAYSDEVR NELLGDDGNS SENQRAHLLD
     NTERLERSSR RLEAGYQIAV ETEQIGQEML ENLSHDREKI QRARERLRET DANLGKSSRI
     LTGMLRRIIQ NRILLVILGI IVVITILMAI TFSVRRH
//
ID   ZCHC8_HUMAN             Reviewed;         707 AA.
AC   Q6NZY4; Q7L2P6; Q8N2K5; Q96SK7; Q9NSS2; Q9NSS3;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2005, sequence version 2.
DT   13-FEB-2019, entry version 150.
DE   RecName: Full=Zinc finger CCHC domain-containing protein 8;
DE   AltName: Full=TRAMP-like complex RNA-binding factor ZCCHC8;
GN   Name=ZCCHC8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Duodenum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE
RP   SPLICEOSOMAL C COMPLEX.
RX   PubMed=11991638; DOI=10.1017/S1355838202021088;
RA   Jurica M.S., Licklider L.J., Gygi S.P., Grigorieff N., Moore M.J.;
RT   "Purification and characterization of native spliceosomes suitable for
RT   three-dimensional structural analysis.";
RL   RNA 8:426-439(2002).
RN   [5]
RP   FUNCTION, PHOSPHORYLATION AT THR-492, MUTAGENESIS OF THR-492, PTM,
RP   INTERACTION WITH MTREX AND RBM7, SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=16263084; DOI=10.1016/j.bbrc.2005.10.090;
RA   Gustafson M.P., Welcker M., Hwang H.C., Clurman B.E.;
RT   "Zcchc8 is a glycogen synthase kinase-3 substrate that interacts with
RT   RNA-binding proteins.";
RL   Biochem. Biophys. Res. Commun. 338:1359-1367(2005).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-598 AND SER-658, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-658, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-479; THR-485 AND
RP   SER-658, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION IN A TRAMP-LIKE COMPLEX, SUBUNIT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=21855801; DOI=10.1016/j.molcel.2011.06.028;
RA   Lubas M., Christensen M.S., Kristiansen M.S., Domanski M.,
RA   Falkenby L.G., Lykke-Andersen S., Andersen J.S., Dziembowski A.,
RA   Jensen T.H.;
RT   "Interaction profiling identifies the human nuclear exosome targeting
RT   complex.";
RL   Mol. Cell 43:624-637(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   REVIEW ON RNA EXOSOMES.
RX   PubMed=22817747; DOI=10.1042/BST20120061;
RA   Sloan K.E., Schneider C., Watkins N.J.;
RT   "Comparison of the yeast and human nuclear exosome complexes.";
RL   Biochem. Soc. Trans. 40:850-855(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-342; THR-479; THR-485;
RP   THR-492; THR-577; SER-598; THR-648; SER-649; SER-658 AND SER-695, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-472; THR-479; THR-492
RP   AND SER-658, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   FUNCTION, SUBUNIT, AND INTERACTION WITH RBM7 AND MTREX.
RX   PubMed=27871484; DOI=10.1016/j.molcel.2016.09.025;
RA   Meola N., Domanski M., Karadoulama E., Chen Y., Gentil C., Pultz D.,
RA   Vitting-Seerup K., Lykke-Andersen S., Andersen J.S., Sandelin A.,
RA   Jensen T.H.;
RT   "Identification of a nuclear exosome decay pathway for processed
RT   transcripts.";
RL   Mol. Cell 64:520-533(2016).
RN   [18]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-413, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 285-324 IN COMPLEX WITH RBM7
RP   AND MTREX, SUBUNIT, INTERACTION WITH RBM7 AND MTREX, AND MUTAGENESIS
RP   OF LEU-295; LEU-299; PHE-309 AND MET-313.
RX   PubMed=27905398; DOI=10.1038/ncomms13573;
RA   Falk S., Finogenova K., Melko M., Benda C., Lykke-Andersen S.,
RA   Jensen T.H., Conti E.;
RT   "Structure of the RBM7-ZCCHC8 core of the NEXT complex reveals
RT   connections to splicing factors.";
RL   Nat. Commun. 7:13573-13573(2016).
CC   -!- FUNCTION: Scaffolding subunit of the trimeric nuclear exosome
CC       targeting (NEXT) complex, a complex that directs a subset of non-
CC       coding short-lived RNAs for exosomal degradation. The RNA exosome
CC       is fundamental for the degradation of RNA in eukaryotic nuclei.
CC       Substrate targeting is facilitated by its cofactor MTREX, which
CC       links to RNA-binding protein adapters (PubMed:27871484). May be
CC       involved in pre-mRNA splicing (Probable).
CC       {ECO:0000269|PubMed:27871484, ECO:0000305|PubMed:16263084}.
CC   -!- SUBUNIT: Component of a nuclear TRAMP-like complex, an ATP-
CC       dependent exosome regulatory complex consisting of a helicase
CC       (MTREX), an oligadenylate polymerase (TENT4B or TENT4A), and a
CC       substrate specific RNA-binding factor (ZCCHC7 or ZCCHC8). Several
CC       TRAMP-like complexes exist with specific compositions and are
CC       associated with nuclear, or nucleolar RNA exosomes. Identified in
CC       the spliceosome C complex. Component of the nuclear exosome
CC       targeting (NEXT) complex composed of MTREX, ZCCHC8, and RBM7 that
CC       directs a subset of non-coding short-lived RNAs for exosomal
CC       degradation (PubMed:27905398, PubMed:27871484). Interacts with
CC       proteins involved in RNA processing and degradation such as MTREX
CC       and RBM7 (PubMed:16263084, PubMed:27905398, PubMed:27871484).
CC       {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:16263084,
CC       ECO:0000269|PubMed:21855801, ECO:0000269|PubMed:27871484,
CC       ECO:0000269|PubMed:27905398}.
CC   -!- INTERACTION:
CC       P38398:BRCA1; NbExp=2; IntAct=EBI-1263058, EBI-349905;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:16263084, ECO:0000269|PubMed:21855801}.
CC       Nucleus {ECO:0000255|PROSITE-ProRule:PRU00768}. Note=Excluded from
CC       nucleolus. {ECO:0000269|PubMed:21855801}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6NZY4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6NZY4-2; Sequence=VSP_013717;
CC         Note=No experimental confirmation available.;
CC   -!- INDUCTION: Slight accumulation in cells entering S phase of the
CC       cell cycle. {ECO:0000269|PubMed:16263084}.
CC   -!- PTM: Phosphorylation at Thr-492 by GSK3 is triggered in cells
CC       entering mitosis; this phosphorylation is greatly enhanced by
CC       nocodazole treatment, but reduced by lithium.
CC       {ECO:0000269|PubMed:16263084}.
CC   -!- SIMILARITY: Belongs to the ZCCHC8 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK027702; BAB55308.1; -; mRNA.
DR   EMBL; AK074638; BAC11105.1; -; mRNA.
DR   EMBL; AL157433; CAB75657.1; -; mRNA.
DR   EMBL; AL157434; CAB75658.1; -; mRNA.
DR   EMBL; BC017704; AAH17704.2; -; mRNA.
DR   EMBL; BC065918; AAH65918.1; -; mRNA.
DR   CCDS; CCDS86340.1; -. [Q6NZY4-2]
DR   PIR; T46929; T46929.
DR   PIR; T46930; T46930.
DR   RefSeq; NP_060082.2; NM_017612.4. [Q6NZY4-1]
DR   UniGene; Hs.37706; -.
DR   PDB; 5LXR; X-ray; 2.00 A; B=285-324.
DR   PDB; 5LXY; X-ray; 2.85 A; C/D/F/H/J/L/N=285-324.
DR   PDB; 6C90; X-ray; 2.20 A; B=659-707.
DR   PDBsum; 5LXR; -.
DR   PDBsum; 5LXY; -.
DR   PDBsum; 6C90; -.
DR   ProteinModelPortal; Q6NZY4; -.
DR   SMR; Q6NZY4; -.
DR   BioGrid; 120739; 63.
DR   CORUM; Q6NZY4; -.
DR   IntAct; Q6NZY4; 28.
DR   MINT; Q6NZY4; -.
DR   STRING; 9606.ENSP00000337313; -.
DR   iPTMnet; Q6NZY4; -.
DR   PhosphoSitePlus; Q6NZY4; -.
DR   BioMuta; ZCCHC8; -.
DR   DMDM; 66774213; -.
DR   EPD; Q6NZY4; -.
DR   jPOST; Q6NZY4; -.
DR   MaxQB; Q6NZY4; -.
DR   PaxDb; Q6NZY4; -.
DR   PeptideAtlas; Q6NZY4; -.
DR   PRIDE; Q6NZY4; -.
DR   Ensembl; ENST00000536306; ENSP00000441423; ENSG00000033030. [Q6NZY4-2]
DR   Ensembl; ENST00000543897; ENSP00000438993; ENSG00000033030. [Q6NZY4-2]
DR   Ensembl; ENST00000633063; ENSP00000488055; ENSG00000033030. [Q6NZY4-1]
DR   GeneID; 55596; -.
DR   KEGG; hsa:55596; -.
DR   UCSC; uc009zxp.4; human. [Q6NZY4-1]
DR   CTD; 55596; -.
DR   DisGeNET; 55596; -.
DR   EuPathDB; HostDB:ENSG00000033030.13; -.
DR   GeneCards; ZCCHC8; -.
DR   H-InvDB; HIX0011095; -.
DR   HGNC; HGNC:25265; ZCCHC8.
DR   HPA; HPA037483; -.
DR   HPA; HPA037484; -.
DR   MIM; 616381; gene.
DR   neXtProt; NX_Q6NZY4; -.
DR   OpenTargets; ENSG00000033030; -.
DR   PharmGKB; PA134889410; -.
DR   eggNOG; KOG2673; Eukaryota.
DR   eggNOG; ENOG410XPDY; LUCA.
DR   GeneTree; ENSGT00390000011475; -.
DR   HOGENOM; HOG000155769; -.
DR   HOVERGEN; HBG079371; -.
DR   InParanoid; Q6NZY4; -.
DR   KO; K13128; -.
DR   OMA; WLKEAEM; -.
DR   OrthoDB; 338817at2759; -.
DR   PhylomeDB; Q6NZY4; -.
DR   TreeFam; TF321837; -.
DR   ChiTaRS; ZCCHC8; human.
DR   GeneWiki; ZCCHC8; -.
DR   GenomeRNAi; 55596; -.
DR   PMAP-CutDB; Q6NZY4; -.
DR   PRO; PR:Q6NZY4; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000033030; Expressed in 219 organ(s), highest expression level in cervix squamous epithelium.
DR   ExpressionAtlas; Q6NZY4; baseline and differential.
DR   Genevisible; Q6NZY4; HS.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; IDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031499; C:TRAMP complex; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB.
DR   InterPro; IPR006568; PSP_pro-rich.
DR   InterPro; IPR001878; Znf_CCHC.
DR   Pfam; PF04046; PSP; 1.
DR   Pfam; PF00098; zf-CCHC; 1.
DR   SMART; SM00581; PSP; 1.
DR   SMART; SM00343; ZnF_C2HC; 1.
DR   PROSITE; PS50158; ZF_CCHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Coiled coil;
KW   Complete proteome; Isopeptide bond; Metal-binding; mRNA processing;
KW   mRNA splicing; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Spliceosome; Ubl conjugation; Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    707       Zinc finger CCHC domain-containing
FT                                protein 8.
FT                                /FTId=PRO_0000150960.
FT   ZN_FING     227    244       CCHC-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00047}.
FT   REGION      286    299       RBM7 binding. {ECO:0000244|PDB:5LXR,
FT                                ECO:0000244|PDB:5LXY,
FT                                ECO:0000269|PubMed:27905398}.
FT   REGION      309    324       RBM7 binding. {ECO:0000244|PDB:5LXR,
FT                                ECO:0000244|PDB:5LXY,
FT                                ECO:0000269|PubMed:27905398}.
FT   COILED       45     80       {ECO:0000255}.
FT   COILED      516    539       {ECO:0000255}.
FT   COMPBIAS    466    501       Pro-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00015}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     342    342       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     472    472       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     479    479       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     485    485       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     492    492       Phosphothreonine; by GSK3.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:16263084}.
FT   MOD_RES     577    577       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     598    598       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     648    648       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     649    649       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     658    658       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     695    695       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    413    413       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1    238       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_013717.
FT   VARIANT     672    672       P -> A (in dbSNP:rs1063155).
FT                                /FTId=VAR_034585.
FT   MUTAGEN     295    295       L->E: Impaired interaction with ZCCHC8;
FT                                when associated with E-299.
FT                                {ECO:0000269|PubMed:27905398}.
FT   MUTAGEN     299    299       L->E: Impaired interaction with ZCCHC8;
FT                                when associated with E-295.
FT                                {ECO:0000269|PubMed:27905398}.
FT   MUTAGEN     309    309       F->A: Reduced interaction with ZCCHC8;
FT                                when associated with E-313.
FT                                {ECO:0000269|PubMed:27905398}.
FT   MUTAGEN     313    313       M->E: Reduced interaction with ZCCHC8;
FT                                when associated with A-309.
FT                                {ECO:0000269|PubMed:27905398}.
FT   MUTAGEN     492    492       T->A: Impaired phosphorylation by GSK3.
FT                                {ECO:0000269|PubMed:16263084}.
FT   CONFLICT     20     20       E -> G (in Ref. 1; BAB55308).
FT                                {ECO:0000305}.
FT   CONFLICT    216    219       QEIQ -> DAWV (in Ref. 3; AAH17704).
FT                                {ECO:0000305}.
FT   CONFLICT    326    326       A -> V (in Ref. 3; AAH65918).
FT                                {ECO:0000305}.
FT   CONFLICT    461    461       S -> G (in Ref. 1; BAB55308).
FT                                {ECO:0000305}.
FT   CONFLICT    582    582       E -> G (in Ref. 1; BAC11105).
FT                                {ECO:0000305}.
FT   CONFLICT    663    663       M -> V (in Ref. 2; CAB75658).
FT                                {ECO:0000305}.
FT   HELIX       293    299       {ECO:0000244|PDB:5LXR}.
FT   HELIX       308    316       {ECO:0000244|PDB:5LXR}.
FT   HELIX       320    322       {ECO:0000244|PDB:5LXR}.
FT   HELIX       663    667       {ECO:0000244|PDB:6C90}.
FT   HELIX       684    690       {ECO:0000244|PDB:6C90}.
FT   HELIX       696    699       {ECO:0000244|PDB:6C90}.
SQ   SEQUENCE   707 AA;  78577 MW;  7BE6E30F919A4771 CRC64;
     MAAEVYFGDL ELFEPFDHPE ESIPKPVHTR FKDDDGDEED ENGVGDAELR ERLRQCEETI
     EQLRAENQEL KRKLNILTRP SGILVNDTKL DGPILQILFM NNAISKQYHQ EIEEFVSNLV
     KRFEEQQKND VEKTSFNLLP QPSSIVLEED HKVEESCAIK NNKEAFSVVG SVLYFTNFCL
     DKLGQPLLNE NPQLSEGWEI PKYHQVFSHI VSLEGQEIQV KAKRPKPHCF NCGSEEHQMK
     DCPMPRNAAR ISEKRKEYMD ACGEANNQNF QQRYHAEEVE ERFGRFKPGV ISEELQDALG
     VTDKSLPPFI YRMRQLGYPP GWLKEAELEN SGLALYDGKD GTDGETEVGE IQQNKSVTYD
     LSKLVNYPGF NISTPRGIPD EWRIFGSIPM QACQQKDVFA NYLTSNFQAP GVKSGNKRSS
     SHSSPGSPKK QKNESNSAGS PADMELDSDM EVPHGSQSSE SFQFQPPLPP DTPPLPRGTP
     PPVFTPPLPK GTPPLTPSDS PQTRTASGAV DEDALTLEEL EEQQRRIWAA LEQAESVNSD
     SDVPVDTPLT GNSVASSPCP NELDLPVPEG KTSEKQTLDE PEVPEIFTKK SEAGHASSPD
     SEVTSLCQKE KAELAPVNTE GALLDNGSVV PNCDISNGGS QKLFPADTSP STATKIHSPI
     PDMSKFATGI TPFEFENMAE STGMYLRIRS LLKNSPRNQQ KNKKASE
//
